<SEC-DOCUMENT>0001495231-25-000102.txt : 20250513
<SEC-HEADER>0001495231-25-000102.hdr.sgml : 20250513
<ACCEPTANCE-DATETIME>20250513160319
ACCESSION NUMBER:		0001495231-25-000102
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20250331
FILED AS OF DATE:		20250513
DATE AS OF CHANGE:		20250513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IZEA Worldwide, Inc.
		CENTRAL INDEX KEY:			0001495231
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-ADVERTISING [7310]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				371530765
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37703
		FILM NUMBER:		25939873

	BUSINESS ADDRESS:	
		STREET 1:		1317 EDGEWATER DR #1880
		CITY:			ORLANDO
		STATE:			FL
		ZIP:			32804
		BUSINESS PHONE:		407-674-6911

	MAIL ADDRESS:	
		STREET 1:		1317 EDGEWATER DR #1880
		CITY:			ORLANDO
		STATE:			FL
		ZIP:			32804

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IZEA, Inc.
		DATE OF NAME CHANGE:	20120522

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	IZEA Holdings, Inc.
		DATE OF NAME CHANGE:	20110519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Rapid Holdings Inc.
		DATE OF NAME CHANGE:	20100624
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>izea-20250331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:bad81cd4-934d-4330-9ea3-36401c97abe6,g:5878b1fc-f8cc-483b-8e63-779470b36094,d:9682eec2a1c34cccbfbd9132fedc17cf-->
<html xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:izea="http://www.izea.com/20250331" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>izea-20250331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-27">0001495231</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-28">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" id="f-29">Non-accelerated Filer</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-30">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-31">Q1</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-32">false</ix:nonNumeric><ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-33">16,926,102</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-100">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-101">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="4" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-102">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-103">10,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-104">10,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-105">10,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-106">no</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-107">no</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-108">no</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-109">no</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-110">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-111">&#8212;</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-112">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-113">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-114">0.0001</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-115">0.0001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-116">50,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-117">50,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-118">50,000,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-119">17,661,220</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-120">17,518,018</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-121">16,893,885</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-122">16,931,169</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-123">767,335</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-124">586,849</ix:nonFraction><ix:nonNumeric contextRef="c-1" name="izea:HoldingPeriodOfMarketableSecurities" id="f-398">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="izea-20250331.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="director"><xbrli:measure>izea:director</xbrli:measure></xbrli:unit><xbrli:unit id="h"><xbrli:measure>utr:H</xbrli:measure></xbrli:unit><xbrli:unit id="reportable_operating_segment"><xbrli:measure>izea:Reportable_Operating_Segment</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-05-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">izea:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">izea:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">izea:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">izea:HoozuHoldingPTYLtd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-12-01</xbrli:startDate><xbrli:endDate>2023-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">izea:HoozuHoldingPTYLtd.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">izea:DepreciationandAmortizationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">izea:DepreciationandAmortizationExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">izea:DigitalAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">izea:DigitalAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ActiveRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ActiveRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ExpiredAndActiveRepurchaseProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ExpiredAndActiveRepurchaseProgramsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-12-12</xbrli:startDate><xbrli:endDate>2024-12-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TheAmendedandRestatedMay2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:IndependentDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:NonExecutiveEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:NonExecutiveEmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:EmployeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="izea:StockOwnershipPlanAxis">izea:IndividualStockOwnershipInExcessOf10PercentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="izea:VestingFrequencyAxis">izea:TotalvestingperiodMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="izea:VestingFrequencyAxis">izea:TwelveMonthsAfterGrantDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="izea:VestingFrequencyAxis">izea:MonthlyInEqualInstallmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">izea:HoozuHoldingsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:A2014EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:A2014EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:A2014EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-28</xbrli:startDate><xbrli:endDate>2024-05-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:CurrencyTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:CurrencyTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ManagedServicesRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ManagedServicesRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SaaSServicesSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SaaSServicesSegmentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SponsoredSocialRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SponsoredSocialRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ContentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ContentRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:MarketplaceSpendFeesnetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:MarketplaceSpendFeesnetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:OtherFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:OtherFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">izea:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001495231</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">izea:OtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-367 f-373 f-379 f-385 f-391 f-397" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-1" order="1"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-352 f-353 f-354 f-355 f-356 f-357 f-358 f-359 f-360 f-361 f-362 f-363 f-364 f-365 f-366 f-367 f-368 f-369 f-370 f-371 f-372 f-373" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-2" order="2"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-374 f-375 f-376 f-377 f-378 f-379 f-380 f-381 f-382 f-383 f-384 f-385 f-386 f-387 f-388 f-389 f-390 f-391" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-3" order="3"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-669 f-670 f-671" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-4" order="4"/><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="f-700 f-701" linkRole="http://www.xbrl.org/2003/role/link" toRefs="fn-5" order="5"/></ix:resources></ix:header></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_16">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington D.C. 20549</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:3.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">March 31, 2025</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:3.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.648%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________________ to _________________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File No.: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-37703</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="izea-20250331_g1.jpg" alt="Logotype_Purple-LARGE.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:86px" id="i-1"/></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">IZEA WORLDWIDE, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Nevada</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">37-1530765</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State&#160;or&#160;other&#160;jurisdiction&#160;of<br/>incorporation&#160;or&#160;organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S.&#160;Employer<br/>Identification&#160;No.)</span></td></tr></table></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"/><td style="width:243.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:19.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:243.25pt"/><td style="width:1.0pt"/></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">1317 Edgewater Dr.</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10"># 1880</ix:nonNumeric>, </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Orlando</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">FL</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">32804</ix:nonNumeric></span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">(407)</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">674-6911</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:513.00pt"><tr><td style="width:1.0pt"/><td style="width:220.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:55.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:220.75pt"/><td style="width:1.0pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol (s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">IZEA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Series A Junior Participating Preferred Stock Purchase Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">-</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-20">Yes</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;No&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-21">Yes</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_16">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.883%"><tr><td style="width:1.0%"/><td style="width:19.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.062%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-22">Non-Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-23">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-24">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160; Yes&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:115%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:115%"> &#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-25">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:115%">x</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;As of May&#160;8, 2025, there were <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-26">16,926,102</ix:nonFraction> shares of our common stock&#160;outstanding.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_16">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Form 10-Q </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended March&#160;31, 2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:91.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Table of Contents</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_91">Item 1.     Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_91">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:60pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_100">Unaudited Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_100">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:60pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_106">Unaudited Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_106">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:60pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_109">Unaudited Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_109">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:60pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_115">Unaudited Consolidated Statements of Stockholders&#8217; Equity for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_115">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:60pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_118">Unaudited Consolidated Statement of Cash Flows for the Three Months Ended March 31, 2025 and 2024</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_118">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:60pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_121">Notes to the Unaudited Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_124">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_178">Item 2.     Management's Discussion and Analysis of Financial Condition and Results of Operation</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_178">28</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_211">Item 3.     Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_211">38</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_214">Item 4.     Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_214">39</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_232">Item1.     Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_232">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_235">Item 1A.  Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_235">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_238">Item 2.     Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_238">41</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_241">Item 3.     Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_241">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_244">Item 4.     Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_244">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_247">Item 5.     Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_247">42</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_250">Item 6.     Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_250">43</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_280">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_283">46</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i9682eec2a1c34cccbfbd9132fedc17cf_16">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_91"></div><div style="margin-bottom:6pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1.  &#8212;  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_100"></div><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Consolidated Balance Sheets</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:68.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.562%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.564%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-34">50,612,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-35">44,644,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="1" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-36">4,269,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="0" id="f-37">7,781,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="0" id="f-38">697,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="0" id="f-39">1,079,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="0" id="f-40">1,572,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="0" id="f-41">6,427,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-42">10,511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-43">97,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-44">57,161,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="0" id="f-45">60,030,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-46">80,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-47">103,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs, net of accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="0" id="f-48">2,098,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="0" id="f-49">2,086,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="0" id="f-50">59,341,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="0" id="f-51">62,220,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AccountsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-52">892,636</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccountsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-53">1,511,747</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-54">3,081,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-55">3,734,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-56">7,095,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="0" id="f-57">8,188,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-58">11,069,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-59">13,434,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance obligation, less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="0" id="f-60">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-61">4,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="0" id="f-62">11,069,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="0" id="f-63">13,438,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and Contingencies (Note 9)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-64"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-65"></ix:nonFraction></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-66"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-67">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-68"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-69">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-70"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-71"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-72"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-73">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="f-74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="0" id="f-75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-76"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-77">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-78"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-79">50,000,000</ix:nonFraction></ix:nonFraction> shares authorized; shares issued: <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-80">17,661,220</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-81">17,518,018</ix:nonFraction>, respectively, shares outstanding: <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-82">16,893,885</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-83">16,931,169</ix:nonFraction>, respectively.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="0" id="f-84">1,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="0" id="f-85">1,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock at cost: <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-86">767,335</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-87">586,849</ix:nonFraction> shares at March&#160;31, 2025 and December&#160;31, 2024, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="0" id="f-88">2,065,873</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="0" id="f-89">1,622,065</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="0" id="f-90">154,793,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="0" id="f-91">154,593,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="0" id="f-92">104,439,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="0" id="f-93">104,297,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-94">18,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-95">105,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-96">48,271,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-97">48,781,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-98">59,341,031</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-99">62,220,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Consolidated Statements of Operations</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.374%"><tr><td style="width:1.0%"/><td style="width:63.380%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.440%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.020%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.020%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-125">7,968,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-126">6,952,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-127">4,401,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="0" id="f-128">3,967,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="0" id="f-129">1,121,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="0" id="f-130">3,056,291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-131">2,940,507</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="0" id="f-132">3,783,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-133"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-134">160,352</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-135"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-136">204,186</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="0" id="f-137">8,624,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="0" id="f-138">11,011,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-139">655,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-140">4,058,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of digital assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="izea:ChangeInTheFairValueOfDigitalAssets" format="ixt:fixed-zero" scale="0" id="f-141">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="izea:ChangeInTheFairValueOfDigitalAssets" format="ixt:num-dot-decimal" scale="0" id="f-142">106,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="0" id="f-143">1,654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="0" id="f-144">2,001</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-145">514,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-146">669,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-147">513,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="0" id="f-148">774,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="f-149">142,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncomeLossAttributableToParent" format="ixt:num-dot-decimal" scale="0" id="f-150">3,284,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-152">18,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-153">142,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-154">3,265,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic and diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-155"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-156">16,927,166</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-157"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-158">16,333,415</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted loss per common share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-159"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-160">0.01</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-161"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-162">0.20</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the consolidated financial statements.</span></div><div style="height:51.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_109"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:62.736%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.428%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-163">142,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-164">3,265,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on securities held</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-165">13,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-166">58,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on currency translation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax" format="ixt:num-dot-decimal" scale="0" id="f-167">109,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax" format="ixt:num-dot-decimal" scale="0" id="f-168">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-169">123,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-170">62,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive income (loss)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-171">266,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-172">3,203,503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the consolidated financial statements.</span></div><div style="height:47.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_115"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Consolidated Statements of Stockholders&#8217; Equity</span></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Three Months Ended March 31, 2025 and 2024</span></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:22.179%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.880%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.466%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-173">16,602,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-174">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-175">152,027,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-176">1,019,997</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-177">85,444,794</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-178">250,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-179">65,313,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock issued for payment of services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-180">32,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" id="f-181">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-182">75,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-183">75,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-184">50,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="f-185">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-186">354,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-187">354,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares withheld to cover statutory taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-188">18,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="0" id="f-189">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-190">37,232</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-191">37,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="0" id="f-192">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="0" id="f-193">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized gain on securities held</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-194">58,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-195">58,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-196">3,265,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-197">3,265,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-198">16,666,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-199">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-200">152,419,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-201">1,019,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-202">88,710,644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-203">188,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-204">62,501,847</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"/><td style="width:117.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:51.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:37.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:54.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:49.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:54.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:57.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:52.00pt"/><td style="width:1.0pt"/></tr><tr style="height:29pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, December 31, 2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-24" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-205">17,518,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-206">1,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-207">154,593,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-208">1,622,065</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-209">104,297,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-210">105,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-211">48,781,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock issued for payment of services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-212">42,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="0" id="f-213">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-214">89,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-215">90,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-216">156,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="0" id="f-217">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-218">285,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-219">285,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares withheld to cover statutory taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-220">56,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="0" id="f-221">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-222">174,990</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-223">174,996</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="0" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="0" id="f-224">443,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="0" id="f-225">443,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:21pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="0" id="f-226">109,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="0" id="f-227">109,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized (loss) on securities held</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-228">13,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="0" id="f-229">13,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-230">142,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-231">142,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance, March 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-232">17,661,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-233">1,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-234">154,793,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-235">2,065,873</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-236">104,439,855</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-237">18,075</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-238">48,271,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the consolidated financial statements.</span></div><div style="height:47.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.128%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.422%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-239">142,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-240">3,265,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used for operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustment to fair market value of digital assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="izea:AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" format="ixt:fixed-zero" scale="0" id="f-241">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="izea:AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="0" id="f-242">106,159</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="f-243">22,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="f-244">26,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="0" id="f-245">137,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AdjustmentForAmortization" format="ixt:num-dot-decimal" scale="0" id="f-246">177,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax benefit, divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" format="ixt:fixed-zero" scale="0" id="f-247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" format="ixt:num-dot-decimal" scale="0" id="f-248">18,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-249">285,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-250"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-251">354,189</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Value of stock issued or to be issued for payment of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="0" id="f-252">90,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="0" id="f-253">75,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-254">3,512,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-255">213,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="0" id="f-256">468,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="0" id="f-257">243,987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="0" id="f-258">619,111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="0" id="f-259">347,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-260">652,859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" format="ixt:num-dot-decimal" scale="0" id="f-261">148,183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-262">1,093,406</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-263">58,121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="f-264">2,008,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="0" id="f-265">3,341,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from investment maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="0" id="f-266">4,869,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="0" id="f-267">5,059,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-268">4,034</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-269">14,846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalization of software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="0" id="f-270">149,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="0" id="f-271">73,678</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="0" id="f-272">4,715,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="0" id="f-273">4,971,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:PaymentsForRepurchaseOfEquity" format="ixt:num-dot-decimal" scale="0" id="f-274">443,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PaymentsForRepurchaseOfEquity" format="ixt:fixed-zero" scale="0" id="f-275">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on shares withheld for statutory taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-276">174,996</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-277">37,233</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="0" id="f-278">618,804</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="0" id="f-279">37,233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-280">137,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-281">3,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="0" id="f-282">5,967,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="0" id="f-283">1,592,018</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-284">44,644,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-285">37,446,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-286">50,612,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="0" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="0" id="f-287">39,035,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="0" id="f-288">1,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="0" id="f-289">2,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline">Supplemental non-cash activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair Value of common stock issued for services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="0" id="f-290">90,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:StockIssued1" format="ixt:num-dot-decimal" scale="0" id="f-291">75,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to the consolidated financial statements.</span></div><div style="height:51.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_124"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-292" continuedAt="f-292-1" escape="true">COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-292-1" continuedAt="f-292-2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate Information and <ix:nonNumeric contextRef="c-1" name="izea:NatureOfBusinessPolicyTextBlock" id="f-293" continuedAt="f-293-1" escape="true">Nature of Business</ix:nonNumeric></span></div><ix:continuation id="f-293-1"><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IZEA Worldwide, Inc. (together with its wholly-owned subsidiaries, &#8220;IZEA&#8221; or the &#8220;Company&#8221;) is a Nevada corporation founded in February 2006 under the name PayPerPost, Inc. and became a public company in May 2011. In March 2016, the Company formed IZEA Canada, Inc., a wholly-owned subsidiary incorporated in Ontario, Canada. In December 2023, IZEA purchased all of Hoozu Holdings' outstanding shares of capital stock, which it subsequently divested in December 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company helps power the creator economy by enabling individuals to monetize their content, creativity, and influence through global brands and marketers. IZEA compensates these creators for producing unique content, such as long and short-form text, videos, photos, status updates, and illustrations for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#8220;Managed Services&#8221;). While the majority of the marketers engage the Company to perform the Managed Services on their behalf, marketers may also access IZEA&#8217;s marketplaces to engage creators for influencer marketing campaigns or to produce custom content on a self-service basis by licensing the Company&#8217;s technology.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated balance sheet as of March&#160;31, 2025, the consolidated statements of operations for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of comprehensive loss for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of stockholders' equity for the three months ended March&#160;31, 2025 and 2024, and the consolidated statements of cash flows for the three months ended March&#160;31, 2025 and 2024 are unaudited but include all adjustments that are, in the opinion of management, necessary for a fair presentation of its financial position at such dates and its results of operations and cash flows for the periods then ended in conformity with generally accepted accounting principles in the United States ("GAAP"). The consolidated balance sheet as of December&#160;31, 2024 has been derived from the audited consolidated financial statements at that date but, in accordance with the rules and regulations of the SEC, does not include all of the information and notes required by GAAP for complete financial statements. Operating results for the three months ended March&#160;31, 2025 are not necessarily indicative of results that may be expected for the entire fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December&#160;31, 2024, included in the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2025.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-294" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Principles of Consolidation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of IZEA Worldwide, Inc. and its wholly-owned subsidiaries subsequent to the subsidiaries&#8217; acquisition, merger, or formation dates, as applicable. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-295" continuedAt="f-295-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-295-1">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-296" continuedAt="f-296-1" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-296-1">The Company considers all highly liquid investments purchased with an original maturity of three months or less from the date of purchase to be cash equivalents. Deposits made to Company bank accounts are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to a maximum amount of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CashFDICInsuredAmount" format="ixt:num-dot-decimal" scale="0" id="f-297">250,000</ix:nonFraction>. The Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) insures deposits made to the Company&#8217;s bank accounts in Canada up to CAD <ix:nonFraction unitRef="cad" contextRef="c-3" decimals="0" name="izea:CashCDICInsuredAmount" format="ixt:num-dot-decimal" scale="0" id="f-298">100,000</ix:nonFraction>. Deposit balances exceeding the various limits were approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashUninsuredAmount" scale="6" id="f-299">50.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:CashUninsuredAmount" scale="6" id="f-300">44.2</ix:nonFraction> million as of March&#160;31, 2025 and December&#160;31, 2024, respectively.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-301" continuedAt="f-301-1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Accounts Receivable and Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable balance consists of trade receivables, contract assets, and a reserve for doubtful accounts. Trade receivables are customer obligations due under normal trade terms. Contract assets represent amounts owed for work performed but not yet billed. The Company had net trade receivables of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" scale="6" id="f-302">4.3</ix:nonFraction> million, including $4.2 million of accounts </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-292-2" continuedAt="f-292-3"><ix:continuation id="f-301-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivable and contract assets of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ContractWithCustomerAssetReclassifiedToReceivable" format="ixt:num-dot-decimal" scale="0" id="f-303">61,480</ix:nonFraction> on March&#160;31, 2025. The Company had net trade receivables of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-304">7.8</ix:nonFraction> million, including $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="izea:AccountsReceivableExcludingContractAsset" scale="6" id="f-305">7.6</ix:nonFraction> million of accounts receivable and contract assets of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:UnbilledReceivablesCurrent" scale="6" id="f-306">0.2</ix:nonFraction> million on December&#160;31, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer&#8217;s financial condition, credit history, and current economic conditions. We will continue to monitor these factors and adjust our credit and collection policies as necessary to address evolving market conditions and potential risks to financial performance. An account is deemed delinquent when the customer has not paid an amount due by its associated due date. If a portion of the account balance is deemed uncollectible, the Company will either write off the amount owed or provide a reserve based on its best estimate of the uncollectible portion of the account. We assess collectability risk both generally and by specific aged invoices. Our loss history informs a general reserve percentage, which we apply to all invoices less than 90 days from the invoice due date, currently <ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:FinancingReceivablePercentPastDue1" scale="-2" id="f-307">1</ix:nonFraction>% of the outstanding balance. The general reserve, which we update periodically, recognizes that some invoices will likely become a collection risk. When an invoice ages <ix:nonNumeric contextRef="c-3" name="us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue" format="ixt-sec:durday" id="f-308">90</ix:nonNumeric> past its due date, we consider each invoice to determine a reserve for collectability based on our prior history and recent communications with the customer, to determine a reserve amount. Generally, our reserve for such aged invoices will approach 100% of the invoice amount. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had a reserve for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-309">0.2</ix:nonFraction> million as of March&#160;31, 2025, and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-310">0.2</ix:nonFraction> million as of December&#160;31, 2024. Management believes this estimate is reasonable, but there can be no assurance that the estimate will not change due to economic or business conditions within the industry, the individual customers, or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. The Company did <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="0" id="f-311"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" format="ixt:fixed-zero" scale="0" id="f-312">not</ix:nonFraction></ix:nonFraction> recognize any bad debt expense in the three months ended March&#160;31, 2025 and March&#160;31, 2024.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-313" escape="true">Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company&#8217;s customer base, thus spreading the trade credit risk. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. The Company had three customers that each accounted for more than <ix:nonFraction unitRef="number" contextRef="c-39" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-314">10</ix:nonFraction>% of total accounts receivable on March&#160;31, 2025 and two customers that accounted for more than <ix:nonFraction unitRef="number" contextRef="c-39" decimals="1" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-315">10</ix:nonFraction>% of total accounts receivable on December&#160;31, 2024. The Company had three customers that each accounted for more than <ix:nonFraction unitRef="number" contextRef="c-40" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-316">10</ix:nonFraction>% of its revenue during the three months ended March&#160;31, 2025, and one customer that accounted for more than <ix:nonFraction unitRef="number" contextRef="c-41" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-317">10</ix:nonFraction>% of its revenue during the three months ended March&#160;31, 2024.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-318" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Property and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost, or if acquired in a business combination, at the acquisition date fair value. <ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-319" continuedAt="f-319-1" escape="true">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</ix:nonNumeric></span></div><ix:continuation id="f-319-1" continuedAt="f-319-2"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-42" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-320">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-43" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-321">3</ix:nonNumeric> - <ix:nonNumeric contextRef="c-44" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-322">10</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and Fixtures</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-45" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-323">5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-46" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-324">10</ix:nonNumeric> years</span></div></td></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the year of disposal, with resulting gains or losses included in general and administrative expense in the consolidated statements of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsFiniteLivedPolicy" id="f-325" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-08, Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60), which requires certain crypto assets to be measured at fair value each reporting period, with changes recognized in net income. It also introduces new disclosure requirements, including asset name, fair value, units held, cost basis, and annual reconciliations. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance early and sold all digital assets in September 2024. As of March 31, 2025, no digital assets were held, and no impairments were recognized for the three months ended March 31, 2025 or 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets, including capitalized software and intangible assets, for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable. Impairments are recognized when the asset&#8217;s fair value is less than its carrying amount. In connection with the Company&#8217;s 2024 reorganization and divestitures, all acquired intangible assets were written off. See &#8220;Note 5 &#8211; Intangible Assets&#8221; for additional details.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="f-326" continuedAt="f-326-1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Software Development Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 350-40,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Use Software,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i)&#160;the research and planning </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-292-3" continuedAt="f-292-4"><ix:continuation id="f-326-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stage, (ii)&#160;the application and development stage, and (iii)&#160;the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. The Company also capitalizes costs related to cloud computing arrangements (&#8220;CCAs&#8221;). These software developments and CCA costs are amortized on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="c-1" name="izea:AmortizationPeriodOfSoftwareDevelopmentCosts" format="ixt-sec:durwordsen" id="f-327">five years</ix:nonNumeric> upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess carrying value over the fair value in its consolidated statements of operations. In December 2024, the Company reviewed its software assets, wrote off fully amortized balances no longer active, and accelerated the amortization of certain software assets no longer in use, with further details provided in "Note 6 - Software Development Costs.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-328" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, established a right-of-use model that requires a lessee to record a right-of-use asset and a right-of-use liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company does not record leases on the balance sheet with a lease term of 12 months or less at the commencement date.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="f-329" continuedAt="f-329-1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue primarily from Managed Services when a marketer (typically a brand, agency, or partner) pays us to provide custom content, influencer marketing, amplification, or other campaign management services (&#8220;Managed Services&#8221;); additionally, we generate revenue from subscription fees charged to access our software platforms, license and transaction fees from self-service customers, and fees from such as inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#8220;SaaS Services Revenue&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 606&#8221;). Under ASC 606, revenue is recognized based on a five-step model as follows: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) performance obligations are satisfied. The core principle of ASC 606 is that revenue is recognized when the transfer of promised goods or services to customers is made in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are distinct performance obligations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also determines whether it acts as an agent or a principal for each identified performance obligation. The determination of whether the Company acts as principal or agent is highly subjective and requires the Company to evaluate a number of indicators individually and as a whole in order to make its determination. For transactions in which the Company acts as a principal, revenue is reported on a gross basis as the amount paid by the marketer for the purchase of content or sponsorship, promotion, and other related services, and the Company records the amounts it pays to third-party creators as cost of revenue. For transactions in which the Company acts as an agent, revenue is reported on a net basis as the amount the Company charged to the self-service marketer using the Company&#8217;s platforms, less the amounts paid to the third-party creators providing the service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains separate arrangements with each marketer and content creator either in the form of a master agreement or terms of service, which specify the terms of the relationship and access to its platforms, or by a statement of work, which specifies the price and the services to be performed, along with other terms. The transaction price is determined based on the fixed fee stated in the statement of work and does not contain variable consideration. Marketers who contract with the Company to manage their advertising campaigns or custom content requests may prepay for services or request credit terms. Payment terms are typically <ix:nonNumeric contextRef="c-1" name="izea:InvoicePaymentTerms" format="ixt-sec:durday" id="f-330">30</ix:nonNumeric> days from the invoice date. The agreement typically provides for either a non-refundable deposit or a cancellation fee if the agreement is canceled by the customer prior to the completion of services. Billings in advance of completed services are recorded as a contract liability until earned. The Company assesses collectability based on several factors, including the creditworthiness of the customer and payment and transaction history.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-292-4" continuedAt="f-292-5"><ix:continuation id="f-329-1"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not typically engage in contracts that are longer than <ix:nonNumeric contextRef="c-1" name="izea:ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" format="ixt-sec:durwordsen" id="f-331">one year</ix:nonNumeric>. Therefore, the Company does not capitalize costs to obtain its customer contracts as these amounts generally would be recognized over a period of less than one year and are not material. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Services Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Managed Services Revenue, the Company enters into an agreement to provide services that may include multiple distinct performance obligations in the form of (i) an integrated marketing campaign to provide influencer marketing services, which may include the provision of blogs, tweets, photos, or videos shared through social network offerings and content promotion, such as click-through advertisements appearing in websites and social media channels, and (ii) custom content items, such as a research or news articles, informational material or videos. Marketers typically purchase influencer marketing services to provide public awareness or advertising buzz regarding the marketer&#8217;s brand and purchase custom content for internal and external use.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company views its obligation to deliver influencer marketing services, including management services, as a single performance obligation that is satisfied over time as the customer receives the benefits from the services. The majority of revenue is recognized using an input method of costs incurred compared to total expected costs to measure the progress toward satisfying the overall performance obligation of the marketing campaign. The Company&#8217;s performance obligation in certain contracts with customers may be a stand-ready promise to provide influencer marketing services for an unknown or unspecified quantity of deliverables for a specified term. Under a stand-ready obligation, the Company&#8217;s performance obligation is satisfied over time throughout the contract term, and therefore, revenue is recognized straight-line over the life of the contract. The Company may provide one type or a combination of all types of these influencer marketing services on a statement of work for a lump sum fee. When multiple performance obligations exist in a contract, the Company allocates revenue to each distinct performance obligation at contract inception based on its relative standalone selling price. These performance obligations are to be provided over a period that generally ranges from one day to one year. The delivery of custom content represents a distinct performance obligation that is satisfied at a point in time when each piece of content is delivered to the customer. Based on the Company&#8217;s evaluations, revenue from Managed Services is reported on a gross basis because the Company has the primary obligation to fulfill the performance obligations, and it creates, reviews, and controls the services. The Company takes on the risk of payment to any third-party creators and establishes the contract price directly with its customers based on the services requested in the statement of work.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SaaS Services Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SaaS services revenue includes subscription fees charged to access our software platforms, license and transaction fees from self-service customers, inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#8220;SaaS Services Revenue&#8221;). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscription and license revenue is generated by granting customers limited, non-exclusive, non-transferable access to the Company&#8217;s technology platforms for an agreed-upon subscription period. Customers access the platforms to manage their influencer marketing campaigns. Fees for subscription or licensing services are recognized straight-line over the term of the service. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-service customers instruct creators found through the Company&#8217;s platforms to provide and/or distribute custom content for an agreed-upon transaction price. The Company&#8217;s platforms control the contracting, description of services, acceptance of, and payment for the requested content. This service is used primarily by news agencies or marketers to control the outsourcing of their content and advertising needs. The Company charges the self-service customer the transaction price plus a fee based on the contract (&#8220;Marketplace Spend Fees&#8221;). Revenue is recognized when the transaction is completed by the creator and accepted by the marketer or verified as posted by the system. Based on the Company&#8217;s evaluations, this revenue is reported on a net basis since the Company is acting as an agent through its platform for the third-party creator to provide the services or content directly to the self-service customer or to post approved content through one or more social media platforms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Fees Revenue is generated when fees are charged to the Company&#8217;s platform users primarily related to monthly plan fees, which are recognized within the month they relate to.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-332" continuedAt="f-332-1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advertising Costs</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-332-1">Advertising costs are charged to expense as they are incurred, including payments to content creators to promote the Company. Advertising costs charged to operations for the three months ended March&#160;31, 2025, and 2024 were approximately $<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:AdvertisingExpense" scale="3" id="f-333">5</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-2" name="us-gaap:AdvertisingExpense" scale="3" id="f-334">617.5</ix:nonFraction> thousand, respectively. Advertising costs are included in sales and marketing expenses in the accompanying consolidated statements of operations.</ix:continuation> </span></div></ix:continuation><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-292-5" continuedAt="f-292-6"><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-335" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes are accounted for using the balance sheet approach, which requires recognizing deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the assets and liabilities tax basis. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized. The Company incurs state franchise tax in ten states, which is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits, and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company&#8217;s tax years subject to examination based on the statute of limitations by the IRS is generally three years; however, the IRS may examine records and other evidence from the year the net operating loss was generated when the Company utilizes net operating loss carryforwards in future periods. The Company&#8217;s tax years subject to examination by the Canadian Revenue Agency is generally four years.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-336" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on quoted market prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on quoted market prices for similar assets and liabilities in active markets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management&#8217;s best estimate of what market participants would use as fair value.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. As of March&#160;31, 2025, the Company holds Level 1 and Level 2 financial assets; this is discussed further in Note 3 - Financial Instruments of Notes to the Consolidated Financial Statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-337" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation for options granted under the 2011 Equity Incentive Plan and the 2023 Inducement Plan is measured at grant-date fair value and expensed on a straight-line basis over the requisite service period. Fair value is estimated using the Black-Scholes model. The Company applies the simplified method to estimate the expected term, assuming even exercise between vesting and expiration, and uses the grant-date closing stock price as the fair value of common stock. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates forfeitures when recognizing compensation expense, and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and a revised amount of unamortized compensation expense to be recognized in future periods.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may issue restricted stock or restricted stock units (&#8220;RSUs&#8221;) that vest over time, including up to <ix:nonFraction unitRef="shares" contextRef="c-49" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-338">1,800,000</ix:nonFraction> performance- or time-based RSUs granted under the IZEA Inducement Plan adopted on November 30, 2023. The plan was established to provide equity awards to new employees hired through acquisitions transactions. These awards are recorded at fair value on the grant date and expensed on a straight-line basis over the vesting period. See &#8220;Note 10 Stockholder&#8217;s Equity&#8221; for more details.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationsPolicy" id="f-339" continuedAt="f-339-1" escape="true"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Business Combinations and Asset Acquisitions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations in accordance with Accounting Standards Codification (ASC) Topic 805, &#8220;Business Combinations.&#8221; The acquisition method of accounting is applied to all business combinations, whereby the identifiable assets acquired, liabilities assumed, and any non-controlling interests in the acquiree are recognized and measured at their fair values as of the acquisition date. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets acquired and liabilities assumed in a business combination. Goodwill is allocated to reporting units, </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-292-6"><ix:continuation id="f-339-1"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which are expected to benefit from the synergies of the combination and is subject to annual impairment testing. Acquisition-related costs, including advisory, legal, and due diligence fees, are expensed as incurred and are included in general and administrative expenses in the period in which the acquisition occurs. The financial statements include the results of operations and the financial position of businesses acquired from their respective acquisition dates. Any adjustments to the preliminary fair values of assets acquired and liabilities assumed, known as measurement period adjustments, are recorded during the period of the adjustment.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-340" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Segment Reporting: Improvements to Reportable Segment Disclosures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improving Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This update is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The ASU also requires all annual disclosures currently required by Topic 280 to be included in the interim periods. The update is effective for fiscal years beginning after December 15, 2023, and interim periods within the fiscal years beginning after December 15, 2024, with early adoption permitted and requiring retrospective application to all prior periods presented in the financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes: Improvements to Income Tax Disclosures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company adopted this ASU for the annual period beginning on January 1, 2025 and does not expect a material impact on the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Disaggregation of Income Expenses:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2024, the FASB issued ASU No. 2024-03 (Subtopic 220-40) Disaggregation of Income Expenses, which requires entities to provide enhanced disclosures related to certain disclosures related to certain expense categories included in the income statement. The update is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company is currently assessing the timing and impact of adopting the updated provisions.</span></div></ix:nonNumeric></ix:continuation><div id="i9682eec2a1c34cccbfbd9132fedc17cf_130"></div><div style="margin-top:6pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-341" continuedAt="f-341-1" escape="true">BUSINESS ACQUISITIONS AND DIVESTITURES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-341-1" continuedAt="f-341-2"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Hoozu Holdings PTY Ltd.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 18, 2024, the Company completed the divestiture of Hoozu Holdings PTY Ltd. (&#8220;Hoozu&#8221;) through its sale to a private Australian company, as part of a strategy to optimize its market focus and enhance the profitability of its North American operations. The acquisition of Hoozu was completed on December 1, 2023, for $<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="0" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-342">2.5</ix:nonFraction>&#160;million in cash, common stock, and contingent consideration.</span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-341-2">The sale of Hoozu resulted in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="0" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="0" id="f-343">73,529</ix:nonFraction>, net of approximately $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="0" name="us-gaap:CashDivestedFromDeconsolidation" format="ixt:num-dot-decimal" scale="0" id="f-344">28,000</ix:nonFraction> in transaction costs, and resulted in a net loss of $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="0" sign="-" name="izea:LossOfDivesitureOfBusinessNetOfTransactionCosts" scale="6" id="f-345">1.9</ix:nonFraction> million, net of a $<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="6" id="f-346">0.3</ix:nonFraction>&#160;million deferred tax benefit, which, together with the year-to-date results of operations through the sale date, is reflected in the Company&#8217;s financial statements for the period ended December&#160;31, 2024.</ix:continuation> </span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_133"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FinancialInstrumentsDisclosureTextBlock" id="f-347" continuedAt="f-347-1" escape="true">FINANCIAL INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="f-347-1" continuedAt="f-347-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Marketable Securities (Available for Sale)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has appointed a leading national bank for custody services with respect to investment securities. Investments comply with the Company&#8217;s revised investment strategy policy, designed to preserve capital, minimize investment risks, and maximize returns.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesTextBlock" id="f-348" continuedAt="f-348-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s cash, cash equivalents, and marketable securities by significant investment category as of March&#160;31, 2025:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IZEA Worldwide, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-347-2"><ix:continuation id="f-348-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"/><td style="width:31.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.767%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Marketable Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="0" id="f-349">6,623,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="0" id="f-350">6,623,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-351">6,623,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-53" xsi:nil="true" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" id="f-352"></ix:nonFraction></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="0" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="0" id="f-355">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="0" id="f-357">43,989,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-358">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="0" id="f-359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="0" id="f-360">43,989,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-361">43,989,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="0" id="f-362">1,010,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-363">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-364">1,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="0" id="f-365">1,008,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-367">1,008,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="0" id="f-368">44,999,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-369">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-370">1,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="0" id="f-371">44,997,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-372">43,989,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-373">1,008,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset back securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="0" id="f-374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="0" id="f-376">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="0" id="f-377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:fixed-zero" scale="0" id="f-379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="0" id="f-380">563,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="0" id="f-382">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="0" id="f-383">563,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-385">563,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="0" id="f-386">563,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="0" id="f-388">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="0" id="f-389">563,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="0" id="f-390">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-391">563,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="0" id="f-392">52,186,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="0" id="f-393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-394">1,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="0" id="f-395">52,184,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="0" id="f-396">50,612,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-397">1,572,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:footnote id="fn-1" footnoteRole="http://www.xbrl.org/2003/role/footnote">Current Marketable Securities have a holding period under <span style="-sec-ix-hidden:f-398">one</span> year</ix:footnote>.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">      (2)     </span><ix:footnote id="fn-2" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 1 fair value estimates are based on quoted prices in active markets for identical assets and liabilities.</span></ix:footnote></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><ix:footnote id="fn-3" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;padding-left:7.44pt;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.</span></ix:footnote></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the fair value of cash equivalents and marketable securities on the balance sheet. The adjusted cost, which includes unrealized gains and losses, reflects settlement amounts if all investments are held to maturity. The Company recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:GainOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="0" id="f-399">23,799</ix:nonFraction> for the three months ended March&#160;31, 2025, and recognized a gain of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:GainOnSaleOfInvestments" scale="0" id="f-400">810</ix:nonFraction> for the three months ended March&#160;31, 2024, respectively. Realized gains and losses are a component of other income (expense), net. Unrealized gains and losses are a component of other comprehensive income (loss) (&#8220;OCI&#8221;).</span></div><ix:nonNumeric contextRef="c-1" name="izea:FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" id="f-401" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of investments in marketable debt securities by stated contractual maturity dates:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March&#160;31, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31, 2024</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-402">1,572,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-403">6,427,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="0" id="f-404">1,572,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="0" id="f-405">6,427,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="f-406" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents fair values and net unrealized gains (losses) recorded to OCI, aggregated by investment category:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:32.429%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.520%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-407">50,612,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:fixed-zero" scale="0" id="f-408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-409">44,644,468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:fixed-zero" scale="0" id="f-410">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-411">1,008,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="0" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-412">1,685</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-413">998,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="0" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-414">5,103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-415">563,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="0" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" scale="0" id="f-416">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-417">4,430,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="0" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-418">5,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="f-419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:fixed-zero" scale="0" id="f-420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-421">998,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-422">22,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-423">52,184,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-424">1,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="izea:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="0" id="f-425">51,071,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" format="ixt:num-dot-decimal" scale="0" id="f-426">12,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025, the Company did not recognize any credit losses and had no ending allowance balance for credit losses.</span></div></ix:continuation><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-427" continuedAt="f-427-1" escape="true">PROPERTY AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="f-427-1"><ix:continuation id="f-319-2"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following: </span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-428">29,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-429">29,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-430">8,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-431">8,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-432">277,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-433">277,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-434">316,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="0" id="f-435">316,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-436">235,653</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="0" id="f-437">212,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-438">80,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="0" id="f-439">103,574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense on property and equipment recorded in depreciation and amortization expense in the consolidated statements of operations and comprehensive loss was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="f-440">22,955</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="0" id="f-441">26,557</ix:nonFraction> for the three months ended March&#160;31, 2025 and 2024, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_139"></div><div style="margin-bottom:9pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-442" continuedAt="f-442-1" escape="true">INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="f-442-1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no definite-lived intangible assets on its balance sheet as of December 31, 2024.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense recorded in depreciation and amortization in the accompanying consolidated statements of operations and comprehensive loss was $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="0" name="us-gaap:AmortizationOfIntangibleAssets" scale="0" id="f-443">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="0" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="0" id="f-444">49,287</ix:nonFraction> for the three months ended March&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of its digital assets on a recurring basis in accordance with ASU 2023-8, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for and Disclosure of Crypto Assets</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, based on quoted prices on the active exchange(s) that have been determined to be the principal market for such assets (Level 1 inputs). The Company performs an analysis monthly to identify whether the fair market value of the digital assets has changed. If the then-current carrying value of a digital asset is different from the fair value so determined, an adjustment in the amount equal to the difference between their carrying value and the price determined is recognized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses on digital assets are recognized within other income in the consolidated statements of operations and comprehensive loss in the period in which the change to fair market value is identified. In determining the gain to be recognized upon sale, the Company calculates the difference between the sales price and the carrying value of the digital assets sold immediately prior to the sale.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had <ix:nonFraction unitRef="usd" contextRef="c-74" decimals="0" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="0" id="f-445">no</ix:nonFraction> digital assets on its balance sheet as of December 31, 2024. the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="0" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-446">0.1</ix:nonFraction>&#160;million for the three months ended March 31, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no goodwill balance as of March&#160;31, 2025 and December&#160;31, 2024.</span></div></ix:continuation><div id="i9682eec2a1c34cccbfbd9132fedc17cf_142"></div><div style="margin-bottom:9pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="f-447" continuedAt="f-447-1" escape="true">SOFTWARE DEVELOPMENT COSTS</ix:nonNumeric></span></div><ix:continuation id="f-447-1" continuedAt="f-447-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-448" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs consist of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="0" id="f-449">3,045,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="0" id="f-450">2,896,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="0" id="f-451">946,835</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization" format="ixt:num-dot-decimal" scale="0" id="f-452">809,439</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="0" id="f-453">2,098,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="0" id="f-454">2,086,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:1pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized software development costs of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CapitalizedComputerSoftwareAdditions" scale="6" id="f-455">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CapitalizedComputerSoftwareAdditions" scale="6" id="f-456">0.1</ix:nonFraction> million during the three months ended March&#160;31, 2025 and 2024, respectively. As of March&#160;31, 2025, the Company has capitalized $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareGross" scale="6" id="f-457">3.0</ix:nonFraction> million in direct materials, consulting, payroll, and benefit costs to its internal-use software development costs in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company amortizes its software development costs, commencing upon the initial release of the software or additional features, on a straight-line basis over the estimated useful life of <ix:nonNumeric contextRef="c-76" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-458">five years</ix:nonNumeric>, which is consistent with the amount of </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-447-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time its legacy platforms were in service or its actual useful life, if shorter. The Company recorded amortization expenses associated with its capitalized software development cost of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="f-459">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="6" id="f-460">0.1</ix:nonFraction> million during the three months ended March&#160;31, 2025 and 2024, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-461" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, future estimated amortization expense related to software development costs is set forth in the following schedule:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Software Development Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="0" id="f-462">374,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:CapitalizedComputerSoftwareExpectedAmortizationYearOne" format="ixt:num-dot-decimal" scale="0" id="f-463">598,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:CapitalizedComputerSoftwareExpectedAmortizationYearTwo" format="ixt:num-dot-decimal" scale="0" id="f-464">567,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:CapitalizedComputerSoftwareExpectedAmortizationYearThree" format="ixt:num-dot-decimal" scale="0" id="f-465">301,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:CapitalizedComputerSoftwareExpectedAmortizationYearFour" format="ixt:num-dot-decimal" scale="0" id="f-466">157,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:CapitalizedComputerSoftwareExpectedAmortizationYearFive" format="ixt:num-dot-decimal" scale="0" id="f-467">99,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:CapitalizedComputerSoftwareNet" format="ixt:num-dot-decimal" scale="0" id="f-468">2,098,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_145"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 7. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-469" continuedAt="f-469-1" escape="true">ACCRUED EXPENSES</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-470" escape="true"><ix:continuation id="f-469-1"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AccruedSalariesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-471">2,338,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccruedSalariesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-472">2,189,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AccruedIncomeTaxes" format="ixt:num-dot-decimal" scale="0" id="f-473">11,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccruedIncomeTaxes" format="ixt:num-dot-decimal" scale="0" id="f-474">47,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="izea:CurrentPortionOfFinanceObligation" format="ixt:num-dot-decimal" scale="0" id="f-475">48,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="izea:CurrentPortionOfFinanceObligation" format="ixt:num-dot-decimal" scale="0" id="f-476">59,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-477">683,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="0" id="f-478">1,438,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-479">3,081,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="0" id="f-480">3,734,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">During the quarter ended September 30, 2024, the Company announced the departure of two executives. In accordance with their Separation Agreements and the payments they are entitled to receive, a severance amount of $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="0" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="f-481">0.9</ix:nonFraction>&#160;million was accrued and will be paid over a twelve-month period. In December 2024, in conjunction with a targeted workforce reduction, the Company accrued $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits" format="ixt:num-dot-decimal" scale="6" id="f-482">0.3</ix:nonFraction>&#160;million in severance costs to be paid in January 2025. As of March 31, 2025, the remaining balance for severance accrued is $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits" format="ixt:num-dot-decimal" scale="6" id="f-483">0.4</ix:nonFraction>&#160;million.</span></div></ix:continuation></ix:nonNumeric><div id="i9682eec2a1c34cccbfbd9132fedc17cf_148"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-484" continuedAt="f-484-1" escape="true">NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="f-484-1"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Obligation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays for its laptop computer equipment through long-term payment plans, using an imputed interest rate of <ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-485">12.9</ix:nonFraction>%, based on its incremental borrowing rate, to determine the present value of its financial obligation and to record interest expense over the term of the plan. The Company refreshed a portion of its computer inventory during the fourth quarter of 2022, entering a new <ix:nonNumeric contextRef="c-3" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="f-486">three-year</ix:nonNumeric> payment plan with the same vendor. The total balance owed was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-487">48,573</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-488">63,420</ix:nonFraction> as of March&#160;31, 2025 and December&#160;31, 2024, respectively, with the short-term portion of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="0" id="f-489">48,573</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="0" id="f-490">59,386</ix:nonFraction> recorded under accrued expenses in the consolidated balance sheets as of March&#160;31, 2025, and December 31, 2024, respectively. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on financing arrangements recorded in the Company&#8217;s consolidated statements of operations was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="0" id="f-491">1,654</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="0" id="f-492">2,001</ix:nonFraction> during the three months ended March&#160;31, 2025 and 2024, respectively. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-493" continuedAt="f-493-1" escape="true">As of March&#160;31, 2025, the future contractual maturities of the Company&#8217;s long-term payment obligations by year are set forth in the following schedule:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="f-493-1"><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="0" id="f-494">41,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="0" id="f-495">6,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="0" id="f-496">48,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-497" continuedAt="f-497-1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="f-497-1" continuedAt="f-497-2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Commitments </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any operating or finance leases greater than 12 months in duration as of March&#160;31, 2025.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plans</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a 401(k) plan to its eligible employees. The Company matches participant contributions in an amount equal to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-498"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-499">50</ix:nonFraction></ix:nonFraction>% of each participant&#8217;s contribution up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-500">8</ix:nonFraction>% of the participant&#8217;s salary. The participants become vested in <ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" scale="-2" id="f-501">20</ix:nonFraction>% annual increments after <ix:nonNumeric contextRef="c-1" name="izea:DefinedContributionPlanEmployersMatchingContributionYearsOfService" format="ixt-sec:durwordsen" id="f-502"><ix:nonNumeric contextRef="c-1" name="izea:DefinedContributionPlanEmployersMatchingContributionYearsOfService" format="ixt-sec:durwordsen" id="f-503">two years</ix:nonNumeric></ix:nonNumeric> of service or fully vest upon the age of 60. <ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedContributionPlanDisclosuresTableTextBlock" id="f-504" continuedAt="f-504-1" escape="true">Total expense for employer matching contributions during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#8217;s consolidated statements of operations as follows: </ix:nonNumeric></span></div><ix:continuation id="f-504-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-505">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-506">22,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-507">16,524</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-508">43,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-509">16,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-510">44,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-511">19,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="0" id="f-512">110,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Negative expense in Sales and Marketing due to our targeted workforce reduction that was announced in December, 2024 and executed in January 2025.</span></div></ix:continuation><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div></ix:continuation><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-497-2">From time to time, the Company may become involved in lawsuits and various other legal proceedings that arise in the ordinary course of its business. Litigation is, however, subject to inherent uncertainties and an adverse result in any such litigation that may arise from time to time that may harm the Company&#8217;s business. The Company is currently not party to any legal proceedings or claims that it believes would or could have, individually or in the aggregate, a material adverse effect on the Company.</ix:continuation> </span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_154"></div><div style="margin-top:6pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="f-513" continuedAt="f-513-1" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="f-513-1" continuedAt="f-513-2"><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-514">50,000,000</ix:nonFraction> authorized shares of common stock and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-515">10,000,000</ix:nonFraction> authorized shares of preferred stock, each with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-516">0.0001</ix:nonFraction> per share. <ix:nonFraction unitRef="shares" contextRef="c-82" decimals="0" name="us-gaap:PreferredStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-517">500,000</ix:nonFraction> shares of preferred stock are designated as Series A Junior Participating Preferred Stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2024, the Company announced that its Board of Directors had authorized a $<ix:nonFraction unitRef="shares" contextRef="c-83" decimals="0" name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="f-518">5.0</ix:nonFraction>&#160;million share repurchase program of the Company&#8217;s common stock. In conjunction with the Cooperation Agreement signed on September 6, 2024, the repurchase maximum was raised to $<ix:nonFraction unitRef="shares" contextRef="c-84" decimals="0" name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" id="f-519"><ix:nonFraction unitRef="shares" contextRef="c-84" decimals="0" name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" id="f-520">10.0</ix:nonFraction></ix:nonFraction> million. On September 30, 2024, the Company entered into an agreement adopted under the safe harbor provided by Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The agreement assists the Company in implementing its stock repurchase programs, providing for the purchase of up to $<ix:nonFraction unitRef="shares" contextRef="c-85" decimals="0" name="us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="f-521">9.0</ix:nonFraction>&#160;million, the remaining amount under its $<ix:nonFraction unitRef="shares" contextRef="c-85" decimals="0" name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" id="f-522">10.0</ix:nonFraction> million share repurchase program. Purchases under the Rule 10b5-1 plan commenced on November 1, 2024, and terminate on the earliest of May 15, 2025, until the aggregate number of shares are repurchased or upon certain other events. Purchases will be made from time to time, depending on market conditions, in open market or privately negotiated transactions, at prices deemed appropriate by management. As of March&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-86" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-523">401,480</ix:nonFraction> shares had been repurchased under the active program with an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-86" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-524">2.61</ix:nonFraction>, for a total of $<ix:nonFraction unitRef="shares" contextRef="c-87" decimals="0" name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" scale="6" id="f-525">1.0</ix:nonFraction> million. <ix:nonFraction unitRef="shares" contextRef="c-88" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="f-526">767,335</ix:nonFraction> shares have been purchased under expired and active programs with an average price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-88" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="f-527">2.65</ix:nonFraction>, for a total of $<ix:nonFraction unitRef="shares" contextRef="c-89" decimals="0" name="srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" format="ixt:num-dot-decimal" scale="6" id="f-528">2.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders approved an amendment and restatement of the 2011 Equity Incentive Plan at the Company&#8217;s 2024 Annual Meeting of Stockholders held on December 12, 2024, to increase the number of plan shares by <ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="izea:CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-529">700,000</ix:nonFraction> shares, from <ix:nonFraction unitRef="shares" contextRef="c-91" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-530">3,675,000</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="c-92" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-531">4,375,000</ix:nonFraction> shares. As of March&#160;31, 2025, the Company had <ix:nonFraction unitRef="shares" contextRef="c-93" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-532">1,269,384</ix:nonFraction> remaining shares of common stock available for issuance pursuant to future grants under the 2011 Equity Incentive Plan. </span></div></ix:continuation><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-513-2" continuedAt="f-513-3"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2011 Equity Incentive Plan, the Board determines the terms and conditions of each restricted stock issuance, including any future vesting restrictions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, the Company issued a total of <ix:nonFraction unitRef="shares" contextRef="c-94" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-533">125,863</ix:nonFraction> shares of restricted common stock with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="6" id="f-534">0.3</ix:nonFraction> million for their annual service as independent directors of the Company. The stock was granted in installments on the last day of each quarter and vested immediately.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March&#160;31, 2025, the Company issued its <ix:nonFraction unitRef="director" contextRef="c-1" decimals="INF" name="izea:Numberofindependentdirectors" format="ixt-sec:numwordsen" scale="0" id="f-535">six</ix:nonFraction> independent directors a total of <ix:nonFraction unitRef="shares" contextRef="c-95" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-536">42,858</ix:nonFraction> shares of restricted common stock, respectively, with an aggregate grant date valuation of $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-537">90,002</ix:nonFraction> for their service as directors of the Company.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-538" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about restricted stock issued during the years ended December&#160;31, 2024 and March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:50.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.175%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="f-539">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-96" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-540">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-97" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-541">125,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-97" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-542">2.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-97" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-543">125,863</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-97" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-544">2.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-98" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="f-545">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-98" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-546">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-99" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-547">42,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-99" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-548">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-99" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-549">42,858</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-99" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-550">2.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-100" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="0" id="f-551">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-100" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although restricted stock is issued upon the grant of an award, the Company excludes restricted stock from the computations within the financial statements of total shares outstanding and basic earnings per share until such time as the restricted stock vests. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses recognized on restricted stock issued to independent directors for services were $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="0" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="0" id="f-553">90,002</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="0" name="us-gaap:RestrictedStockExpense" format="ixt:num-dot-decimal" scale="0" id="f-554">75,006</ix:nonFraction> during the three months ended March&#160;31, 2025 and 2024, respectively. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;31, 2025, the fair value of the Company&#8217;s common stock was approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="c-100" decimals="2" name="izea:CommonStockFairValue" scale="0" id="f-555">2.10</ix:nonFraction> per share, and the intrinsic value of the non-vested restricted stock was $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="0" id="f-556">0</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board determines the terms and conditions of each restricted stock unit award issued under the 2011 Equity Incentive Plan. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024, the Company issued a total of <ix:nonFraction unitRef="shares" contextRef="c-102" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-557">474,195</ix:nonFraction> time-based restricted stock units, initially valued at $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-558">980,632</ix:nonFraction>, as additional compensation: <ix:nonFraction unitRef="shares" contextRef="c-103" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-559">346,918</ix:nonFraction> restricted stock units initially valued at $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="6" id="f-560">0.7</ix:nonFraction> million to non-executive employees and <ix:nonFraction unitRef="shares" contextRef="c-104" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-561">127,277</ix:nonFraction> restricted stock units initially valued at $<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="6" id="f-562">0.3</ix:nonFraction> million to executives. These restricted stock units have vesting periods ranging from <ix:nonNumeric contextRef="c-105" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="f-563">36</ix:nonNumeric> to <ix:nonNumeric contextRef="c-106" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="f-564">48</ix:nonNumeric> months from issuance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025, the Company issued a total of <ix:nonFraction unitRef="shares" contextRef="c-107" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-565">47,280</ix:nonFraction> time-based and performance-based restricted stock units, initially valued at $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="6" id="f-566">0.1</ix:nonFraction> million, as additional compensation: <ix:nonFraction unitRef="shares" contextRef="c-108" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-567">23,600</ix:nonFraction> time-based restricted stock units, initially valued at $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-568">59,000</ix:nonFraction>, to non-executive employees and <ix:nonFraction unitRef="shares" contextRef="c-109" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-569">23,680</ix:nonFraction> time-based restricted stock units, initially valued at $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="0" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" format="ixt:num-dot-decimal" scale="0" id="f-570">59,200</ix:nonFraction>, to executives. These time-based restricted stock units have vesting periods ranging from <ix:nonNumeric contextRef="c-110" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="f-571">36</ix:nonNumeric> to <ix:nonNumeric contextRef="c-111" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durmonth" id="f-572">48</ix:nonNumeric> months from issuance. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance based restricted stock units include a market condition tied to the Company&#8217;s stock performance. These awards vest only if certain stock price targets are achieved over a specified performance period. Because the vesting is based on market conditions rather than service or financial performance metrics, the grant-date fair value was estimated using a Monte Carlo simulation model, which factors in stock volatility and other market-based assumptions. The expense is recognized over the requisite service period, regardless of whether the market condition is ultimately met.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="f-573" continuedAt="f-573-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about restricted stock units during the years ended December&#160;31, 2024, and the three months ended March&#160;31, 2025:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-513-3" continuedAt="f-513-4"><ix:continuation id="f-573-1"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.092%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-112" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-574">962,849</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-112" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-575">2.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-113" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-576">2.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-577">1,858,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-114" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-578">2.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-579">956,679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-114" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-580">2.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-114" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-581">305,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-114" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-582">2.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-115" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-583">1,558,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-115" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-584">2.33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-114" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-585">2.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-107" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-586">47,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-587">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-107" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-588">167,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-589">2.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-107" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-590">188,958</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-107" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-591">2.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-116" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-592">1,249,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-116" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-593">2.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-107" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-594">1.3</ix:nonNumeric></span></td></tr></table></div></ix:continuation><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses recognized on restricted stock units issued to employees were $<ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:RestrictedStockExpense" scale="6" id="f-595">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="0" name="us-gaap:RestrictedStockExpense" scale="6" id="f-596">0.3</ix:nonFraction> million during the three months ended March&#160;31, 2025 and 2024, respectively. On March&#160;31, 2025, the fair value of the Company&#8217;s common stock was approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="c-116" decimals="2" name="izea:CommonStockFairValue" scale="0" id="f-597">2.10</ix:nonFraction> per share, and the intrinsic value of the non-vested restricted units was $<ix:nonFraction unitRef="usd" contextRef="c-116" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="f-598">2.6</ix:nonFraction> million. Future compensation related to the non-vested restricted stock units as of March&#160;31, 2025, is $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="0" name="izea:Fairvalueofcommonstockissuedforfutureservices" scale="6" id="f-599">2.5</ix:nonFraction> million, and it is estimated to be recognized over the weighted-average vesting period of approximately 1.25 years. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2011 Equity Incentive Plan, the Board determines the exercise price to be paid for the stock option shares, the period within which each stock option may be exercised, and the terms and conditions of each stock option. The exercise price of incentive and non-qualified stock options may not be less than <ix:nonFraction unitRef="number" contextRef="c-119" decimals="INF" name="izea:FairMarketValueOfIncentiveStockOptions" scale="-2" id="f-600">100</ix:nonFraction>% of the fair market value per share of the Company&#8217;s common stock on the grant date. If an individual owns stock representing more than <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="izea:Percentageofindividualownershipofcommonstock" scale="-2" id="f-601">10</ix:nonFraction>% of the outstanding shares, the exercise price of each share of an incentive stock option must be equal to or exceed <ix:nonFraction unitRef="number" contextRef="c-120" decimals="INF" name="izea:FairMarketValueOfIncentiveStockOptions" scale="-2" id="f-602">110</ix:nonFraction>% of fair market value. Unless otherwise determined by the Board at the time of grant, the exercise price is set at the fair market value of the Company&#8217;s common stock on the grant date (or the last trading day prior to the grant date, if it is awarded on a non-trading day). Additionally, the term is set at <ix:nonNumeric contextRef="c-121" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-603">ten years</ix:nonNumeric>, and the option typically vest on a straight-line basis over the requisite service period as follows: <ix:nonFraction unitRef="number" contextRef="c-122" decimals="INF" name="izea:Percentageofindividualownershipofcommonstock" scale="-2" id="f-604">25</ix:nonFraction>% <ix:nonNumeric contextRef="c-122" name="izea:StockOptionVestingPeriodFromGrantDate" format="ixt-sec:durwordsen" id="f-605">one year</ix:nonNumeric> from the date of grant with the remaining vesting monthly in equal increments over the following <ix:nonNumeric contextRef="c-123" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-606">three years</ix:nonNumeric>. The Company issues new shares for any stock awards or options exercised under its 2011 Equity Incentive Plan. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-607" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2011 Equity Incentive Plan during the year ended December&#160;31, 2024, and the three months ended March&#160;31, 2025, is presented below: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-124" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-608">343,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-609">9.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-125" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-610">5.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-126" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-611">65,154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-612">1.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-126" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-613">244,588</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-614">10.51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-126" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="f-615">520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-616">9.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-127" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-617">33,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-127" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-618">18.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-126" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-619">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-128" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-620">2,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-621">27.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-128" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="f-622">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-623">15.44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-129" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-624">31,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-625">18.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-128" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-626">3.8</ix:nonNumeric></span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-129" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-627">30,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-628">18.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-128" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-629">3.7</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025 and the three months ended March 31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-130" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="f-630"><ix:nonFraction unitRef="shares" contextRef="c-128" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:fixed-zero" scale="0" id="f-631">no</ix:nonFraction></ix:nonFraction> options were exercised. The fair value of the Company's common stock on March&#160;31, 2025, was approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="c-116" decimals="2" name="izea:CommonStockFairValue" scale="0" id="f-632">2.10</ix:nonFraction> per share, and the intrinsic value on outstanding options as of March&#160;31, 2025, was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="0" id="f-633">36</ix:nonFraction>. The intrinsic value of the exercisable options as of March&#160;31, 2025, was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="0" id="f-634">36</ix:nonFraction>. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-513-4" continuedAt="f-513-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock" id="f-635" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the nonvested stock option activity under the 2011 Equity Incentive Plan during the years ended December&#160;31, 2024, and March&#160;31, 2025, is presented below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.840%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Nonvested Options</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-124" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-636">26,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-637">8.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-125" name="izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-638">1.1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-639">24,728</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-640">18.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" scale="0" id="f-641">520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" scale="0" id="f-642">9.24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-127" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-643">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-127" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-644">18.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-126" name="izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-645">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-128" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" id="f-646">709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-128" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" scale="0" id="f-648">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-128" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" scale="0" id="f-649">9.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-129" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" scale="0" id="f-650">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-651">18.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-128" name="izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-652">3.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="c-129" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-653">31,147</ix:nonFraction> shares</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-654">18.01</ix:nonFraction> per share, of which options to purchase <ix:nonFraction unitRef="shares" contextRef="c-129" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-655">30,736</ix:nonFraction> shares were exercisable with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-129" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-656">18.10</ix:nonFraction> per share as of March&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses recognized on stock options issued to employees during the three months ended March&#160;31, 2025 and 2024 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:StockOptionPlanExpense" format="ixt:num-dot-decimal" scale="0" id="f-657">7,501</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:StockOptionPlanExpense" format="ixt:num-dot-decimal" scale="0" id="f-658">51,965</ix:nonFraction>, respectively. Future compensation related to non-vested awards as of March&#160;31, 2025, is $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="0" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="0" id="f-659">1,862</ix:nonFraction>, and it is estimated to be recognized over the weighted-average vesting period of approximately <ix:nonNumeric contextRef="c-126" name="izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" format="ixt-sec:duryear" id="f-660">3.7</ix:nonNumeric> years.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inducement Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2023, the Board of Directors adopted the IZEA Worldwide, Inc. 2023 Inducement Plan (the &#8220;Inducement Plan&#8221;) to accommodate equity grants to new employees hired by IZEA in connection with acquisition transactions, including the Hoozu acquisition. Under the Inducement Plan, IZEA may grant restricted stock units (&#8220;RSUs&#8221;), including performance-based and time-based RSUs, with respect to up to a total of <ix:nonFraction unitRef="shares" contextRef="c-131" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-661">1,800,000</ix:nonFraction> shares of IZEA common stock to new employees of IZEA or its subsidiaries. Pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules, the Inducement Plan was adopted without stockholder approval. In accordance with Rule 5635(c)(4) of the NASDAQ Listing Rules, awards under the Inducement Plan can only be made to individuals not previously employees or non-employee directors of IZEA (or following such individuals&#8217; bona fide period of non-employment with IZEA), as an inducement material to the individuals&#8217; entry into employment with IZEA or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the NASDAQ Listing Rules. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" id="f-662" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about inducement grant-related RSUs during the year ended December 31, 2024, and the three months ended March&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inducement Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Time-Based</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Based</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-132" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-663">10,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-133" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-664">328,354</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-134" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-665">338,354</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-135" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-666">219,355</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-136" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-667">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-668">219,355</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-135" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-669">179,355</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-136" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-670">328,354</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-137" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-671">507,709</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-138" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-672">50,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-139" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-673">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-140" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-674">50,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-141" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-675">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-142" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-676">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-143" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-677">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-141" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="f-678">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-142" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="f-679">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-143" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="f-680">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at March 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-144" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-681">50,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-145" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="f-682">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-146" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-683">50,000</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)<ix:footnote id="fn-4" continuedAt="fn-4-1" footnoteRole="http://www.xbrl.org/2003/role/footnote"> </ix:footnote></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="fn-4-1">Inducement shares forfeited in 2024 were related to the divestiture of Hoozu in December, 2024</ix:continuation>.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amended and restated IZEA Worldwide, Inc. 2014 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) provides for the issuance of up to <ix:nonFraction unitRef="shares" contextRef="c-147" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-684">125,000</ix:nonFraction> shares of the Company&#8217;s common stock to employees regularly employed by the Company for <ix:nonNumeric contextRef="c-148" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durday" id="f-685">90</ix:nonNumeric> days or more on a full-time or part-time basis (<ix:nonFraction unitRef="h" contextRef="c-148" decimals="INF" name="izea:MinimumhourrequirementforemployeesparticipationintheESSP" scale="0" id="f-686">20</ix:nonFraction> hours or more per week on a regular schedule). The ESPP operates in successive six-month periods commencing at the beginning of each fiscal year half. Each eligible employee who elects to participate may purchase up to <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="izea:Annualcompensationlimitpercentageemployeestockpurchaseplan" scale="-2" id="f-687">10</ix:nonFraction>% of their annual compensation in common stock, not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="0" name="izea:Annualcompensationlimitemployeestockpurchaseplan" format="ixt:num-dot-decimal" scale="0" id="f-688">21,250</ix:nonFraction> annually or <ix:nonFraction unitRef="shares" contextRef="c-148" decimals="0" name="izea:Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" format="ixt:num-dot-decimal" scale="0" id="f-689">2,000</ix:nonFraction> shares per offering period. The purchase price will be the lower of (i) <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="izea:Fairmarketvalueofsharesavailableforissuance" scale="-2" id="f-690">85</ix:nonFraction>% of the fair market value of a share of common stock </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-513-5" continuedAt="f-513-6"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the first day of the offering period or (ii) <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="izea:Fairmarketvalueofsharesavailableforissuance" scale="-2" id="f-691">85</ix:nonFraction>% of the fair market value of a share of common stock on the last day of the offering period. The ESPP will continue until January&#160;1, 2028, unless otherwise terminated by the Board. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock compensation expense on ESPP options was $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-692">10,789</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-693">1,010</ix:nonFraction> for the three months ended March&#160;31, 2025, and 2024, respectively. As of March&#160;31, 2025, there were <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP" format="ixt:num-dot-decimal" scale="0" id="f-694">77,931</ix:nonFraction> remaining shares of common stock available for future issuance under the ESPP. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Rights Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2024, the Board of Directors declared a dividend of one preferred share purchase right (a &#8220;Right&#8221;) for each share of the Company&#8217;s common stock as of June 7, 2024 (the &#8220;Record Date&#8221;), pursuant to a Rights Agreement between the Company and Broadridge Corporate Issuer Solutions, LLC, as Rights Agent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Right initially entitles the holder to purchase one one-thousandth of a share of Series A Junior Participating Preferred Stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-150" decimals="2" name="us-gaap:PreferredStockDividendRatePerDollarAmount" scale="0" id="f-695">8.25</ix:nonFraction>, subject to adjustment. The Rights are not exercisable until the earlier of (i) the tenth business day after a person or group acquires <ix:nonFraction unitRef="number" contextRef="c-150" decimals="INF" name="izea:ExercisableShareholderRightsPercentageHeld." scale="-2" id="f-696">15</ix:nonFraction>% or more of the Company&#8217;s common stock, or (ii) the tenth business day after a tender or exchange offer is announced that would result in such ownership (the &#8220;Distribution Date&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution Date, the Rights trade with the common stock and are not evidenced by separate certificates. Following the Distribution Date, the Rights will separate and be evidenced by Right Certificates mailed to the stockholders of record.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rights will expire on May 28, 2025, unless earlier redeemed, exchanged, or terminated under the terms of the Rights Agreement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary is qualified in its entirety by reference to the full Rights Agreement, filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on May 28, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock-based compensation cost related to all awards granted to employees is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the employee&#8217;s requisite service period utilizing the weighted-average forfeiture rates as disclosed in &#8220;Note 1 Company and Summary of Significant Accounting Policies.&#8221; <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-697" continuedAt="f-697-1" escape="true">Total stock-based compensation expense recognized on restricted stock, restricted stock units, stock options, and employee stock purchase plan issuances during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#8217;s consolidated statements of operations as follows: </ix:nonNumeric></span></div><ix:continuation id="f-697-1"><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.347%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-698">62,449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-699">51,571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="0" sign="-" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-700">10,270</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-701">56,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-702">232,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-703">246,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-704">285,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="0" id="f-705">354,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:footnote id="fn-5" footnoteRole="http://www.xbrl.org/2003/role/footnote">Stock-based compensation expense for the Sales and Marketing department due to the targeted workforce reduction that occurred in January 2025. This is due to the reversal of previously recognized expense for unvested awards that are forfeited upon termination. Because we recognize stock compensation on a straight-line basis over the vesting period&#8212;rather than when the shares actually vest&#8212;expenses related to unvested awards are recorded in advance of full service being rendered. When employees depart before completing their vesting schedules, any unrecognized expense is reversed</ix:footnote>.</span></div></ix:continuation><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize activity in other comprehensive income (loss) for unrealized gains and losses on securities and foreign currency translation adjustments.&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-706" continuedAt="f-706-1" escape="true">The activity in&#160;accumulated other comprehensive income&#160;(loss) for the three months ended 2025, and 2024, respectively, was as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><ix:continuation id="f-706-1"><ix:continuation id="f-513-6"><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation  Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassification of foreign currency translation adjustment to income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-707">12,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-708">127,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-709">34,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-710">105,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-711">250,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="f-712">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-713">250,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" sign="-" name="izea:UnrealizedGainOnSecuritiesHeld" format="ixt:num-dot-decimal" scale="0" id="f-714">13,903</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" sign="-" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-715">109,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="0" id="f-716">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="0" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="0" id="f-717">123,362</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="izea:UnrealizedGainOnSecuritiesHeld" format="ixt:num-dot-decimal" scale="0" id="f-718">58,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="0" id="f-719">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="0" id="f-720">62,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-721">1,694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-722">17,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-723">34,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-724">18,075</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-725">192,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="0" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-726">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="0" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="0" id="f-727">188,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_160"></div><div style="text-align:justify"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-728" continuedAt="f-728-1" escape="true">LOSS PER COMMON SHARE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-728-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing the net income or loss by the basic weighted average number of shares of common stock outstanding during each period presented. Although restricted stock is issued upon the grant of an award, the Company excludes restricted stock from the computations of the weighted average number of shares of common stock outstanding until the stock vests. Diluted loss per share is computed by dividing the net income or loss by the sum of the total of the basic weighted-average number of shares of common stock outstanding plus the additional dilutive securities that could be exercised or converted into common shares during each period presented less the amount of shares that could be repurchased using the proceeds from the exercises.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-729" escape="true"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:58.219%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.574%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-730">142,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="0" id="f-731">3,265,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic and diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-732"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-733">16,927,166</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-734"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-735">16,333,415</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted loss per common share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-736"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-737">0.01</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-738"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-739">0.20</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-740" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following weighted average items from the above computation of diluted loss per common share, as their effect would be anti-dilutive: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.518%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-161" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-741">31,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-162" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-742">343,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-163" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-743">1,249,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-164" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-744">1,374,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total excluded shares</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-745">1,280,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-746">1,717,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_163"></div><div style="text-align:justify"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-747" continuedAt="f-747-1" escape="true">REVENUE</ix:nonNumeric></span></div><ix:continuation id="f-747-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-748" continuedAt="f-748-1" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the Company&#8217;s revenue by product service type:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-749">7,907,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-750">6,696,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS Services Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-751">60,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-752">256,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-753">7,968,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-754">6,952,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed Services revenue is comprised of two types of revenue, Sponsored Social and Content. Sponsored Social revenue, which totaled $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-755">6.8</ix:nonFraction> million for the three months ended March&#160;31, 2025 and $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-756">5.9</ix:nonFraction> million for the three months ended March&#160;31, 2024, is recognized over time. Content revenue, which totaled $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-757">1.1</ix:nonFraction>&#160;million during the three months ended March&#160;31, 2025, and $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-758">0.8</ix:nonFraction> million for the three months ended March&#160;31, 2024, is recognized at a point in time.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SaaS Revenue is comprised of three types of revenue, License Fees, Marketplace Spend Fees, and Other Fees. License Fees revenue, which totaled $<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-759">28.7</ix:nonFraction>&#160;thousand for the three months ended March&#160;31, 2025 and $<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-760">217.0</ix:nonFraction> thousand for the three months ended March&#160;31, 2024, is recognized over time. Marketplace Spend Fees revenue totaled $<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-761">1.3</ix:nonFraction> thousand for the three months ended March&#160;31, 2025 and $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-762">13.1</ix:nonFraction> thousand for the three months ended March&#160;31, 2024, recognized over time. Other </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees revenue totaled $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-1" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-763">31.0</ix:nonFraction> thousand during the three months ended March&#160;31, 2025 and $<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-764">26.2</ix:nonFraction> thousand for the three months ended March&#160;31, 2024, recognized at a point in time.</span></div><ix:continuation id="f-748-1"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the Company&#8217;s revenues as determined by customer geographic region:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.110%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.636%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from North America</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-765">7,628,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-180" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-766">5,490,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from APAC</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-767">237,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-768">1,027,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from Other</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-769">102,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-770">434,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-771">7,968,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-772">6,952,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="f-773" escape="true"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about receivables, contract assets, and contract liabilities from contracts with customers reported in the Company&#8217;s consolidated balance sheet:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Billed Contract Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:ContractWithCustomerAssetGross" format="ixt:num-dot-decimal" scale="0" id="f-774">4,400,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerAssetGross" format="ixt:num-dot-decimal" scale="0" id="f-775">7,835,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled Contract Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-776">61,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:UnbilledContractsReceivable" format="ixt:num-dot-decimal" scale="0" id="f-777">151,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="0" id="f-778">192,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="0" id="f-779">205,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-780">7,095,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="0" id="f-781">8,188,651</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not typically engage in contracts longer than <ix:nonNumeric contextRef="c-1" name="izea:LengthOfContractWithCustomers" format="ixt-sec:durwordsen" id="f-782">one year</ix:nonNumeric>. Therefore, the Company will recognize substantially all of the contract liabilities recorded at the end of the year in the following year. The contract liability balance as of December&#160;31, 2024, was $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-783">8.2</ix:nonFraction> million. Of that balance, $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="f-784">5.1</ix:nonFraction> million was recognized as revenue during the three months ended March&#160;31, 2025. The contract liability balance as of March&#160;31, 2025, was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:ContractWithCustomerLiability" scale="6" id="f-785">7.1</ix:nonFraction> million. The Company expects to recognize the associated revenue during the next twelve months. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract receivables are recognized when the receipt of consideration is unconditional. Contract liabilities relate to the consideration received from customers in advance of the Company satisfying performance obligations under the terms of the contracts, which will be earned in future periods. Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized upon the Company meeting the performance obligations. As a practical expedient, the Company expenses the costs of sales commissions that are paid to its sales force associated with obtaining contracts that are less than <ix:nonFraction unitRef="number" contextRef="c-1" decimals="0" name="izea:ContractLengthForSalesCommissionsPayment" format="ixt-sec:numwordsen" scale="0" id="f-786">one</ix:nonFraction> year in length in the period incurred.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to most of the Company&#8217;s contracts being <ix:nonNumeric contextRef="c-1" name="izea:PerformanceObligationContractTerm" format="ixt-sec:durwordsen" id="f-787">one year</ix:nonNumeric> or less in length. As such, the remaining performance obligations at March&#160;31, 2025 and December&#160;31, 2024, are equal to the contract liabilities disclosed above. The Company expects to recognize the full balance of the unearned revenue from March&#160;31, 2025 within the subsequent twelve months.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 13. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-788" continuedAt="f-788-1" escape="true">SEGMENT DISCLOSURES</ix:nonNumeric></span></div><ix:continuation id="f-788-1"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#8220;Managed Services&#8221;). Our Chief Operating Decision Maker (&#8220;CODM&#8221;) is our Chief Executive Officer (&#8220;CEO&#8221;). We evaluate our financial performance based on the results of <ix:nonFraction unitRef="reportable_operating_segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" id="f-789">one</ix:nonFraction> reportable operating segment, as defined by ASC 280.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM monitors revenue growth and profitability trends to assess market demand, pricing strategies, new customer growth, current customer retention and expansion, and growth by market vertical. Personnel cost trends are studied to assess efficiency, efficacy of incentive programs, and to determine the need for headcount adjustments. Cash operating cost trends inform how non-payroll costs are impacting cash resources. Taken together, net income is the ultimate measure of performance, or investment in growth. Resource allocation decisions include funding new technologies, additional headcount to drive and manage growth, informing cost management strategies and evaluating financing needs. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="f-790" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table depicts reportable segment results reviewed by the CODM:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.363%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.375%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-791">7,968,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="0" id="f-792">6,952,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue-direct</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="izea:CostOfRevenueDirect" format="ixt:num-dot-decimal" scale="0" id="f-793">3,337,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="izea:CostOfRevenueDirect" format="ixt:num-dot-decimal" scale="0" id="f-794">2,753,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human capital costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="izea:HumanCapitalCosts" format="ixt:num-dot-decimal" scale="0" id="f-795">3,440,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="izea:HumanCapitalCosts" format="ixt:num-dot-decimal" scale="0" id="f-796">4,943,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other cash operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="izea:CashOperatingCosts" format="ixt:num-dot-decimal" scale="0" id="f-797">1,400,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="izea:CashOperatingCosts" format="ixt:num-dot-decimal" scale="0" id="f-798">2,757,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-799">160,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="0" id="f-800">204,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-801">285,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:EmployeeBenefitsAndShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-802">354,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="us-gaap:InterestIncomeOperatingAndNonoperating" format="ixt:num-dot-decimal" scale="0" id="f-803">490,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="us-gaap:InterestIncomeOperatingAndNonoperating" format="ixt:num-dot-decimal" scale="0" id="f-804">671,517</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred federal tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-806">18,782</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="0" id="f-807">22,145</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="0" id="f-808">104,158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Loss</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="0" id="f-809">142,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="0" id="f-810">3,265,850</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following descriptions provide additional details regarding certain components represented in the accompanying table, including cost of revenue, human capital costs, and cash operating costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue includes the direct costs associated with providing our services to customers. These costs primarily consist of influencer fees and other costs directly tied to the fulfillment of customer contracts. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human capital costs represent expenses related to our employees, including salaries, wages, bonuses, commissions, payroll taxes, and employee benefits.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other cash operating expenses refer to the recurring operating costs of running the business, excluding non-cash items such as depreciation, amortization, and stock-based compensation. These expenses include professional services, software subscriptions, travel, and other general business costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest expense, net realized gains (losses) on the sale of securities and cryptocurrency, as well as realized gains (losses) on foreign exchange transactions.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_1662"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-811" continuedAt="f-811-1" escape="true">INCOME TAX</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-811-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for interim periods is determined using an estimated annual effective tax rate in accordance with ASC 740-270, Income Taxes, Interim Reporting. The effective tax rate may be subject to fluctuations during the year as new information is obtained, which may affect the assumptions used to estimate the annual effective tax rate, including factors such as valuation allowances against deferred tax assets, the recognition or de-recognition of tax benefits related to uncertain tax position, if any, and changes in or the interpretation of tax laws in jurisdictions where the Company conducts business.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-812" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax expense and effective tax rate were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-814">18,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:fixed-zero" scale="-2" id="f-815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-816">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_175"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTE 15.&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-817" continuedAt="f-817-1" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div style="text-indent:47.25pt"><span><br/></span></div><ix:continuation id="f-817-1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has completed an evaluation of all subsequent events through May&#160;13, 2025, to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements and events that occurred but were not recognized in the consolidated financial statements. The Company has concluded that no subsequent event has occurred that requires disclosure.</span></div></ix:continuation><div style="text-indent:47.25pt"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_178"></div><div style="margin-bottom:9pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 2.&#160;  &#8212;  MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND &#160;&#160;&#160;&#160;RESULTS OF OPERATIONS</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_181"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (this &#8220;Quarterly Report&#8221;) contains &#8220;forward-looking statements&#8221; intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact contained in this report, including those contained in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and the notes to our consolidated financial statements, particularly those that utilize terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;can,&#8221; &#8220;could,&#8221; &#8220;continue,&#8221; &#8220;design,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;aims,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;believes,&#8221; &#8220;thinks,&#8221; &#8220;intends,&#8221; &#8220;likely,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;pursue,&#8221; &#8220;strategy,&#8221; &#8220;future,&#8221; &#8220;forecasts,&#8221; &#8220;goal,&#8221; &#8220;hopes,&#8221; or the negative of these words or other words or expressions of similar meaning, are forward-looking statements. Such statements are based on currently available operating, financial and competitive information, and are subject to inherent risks, uncertainties, and changes in circumstances that are difficult to predict and many of which are outside of our control. Future events and our actual results and financial condition may differ materially from those reflected in these forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause these differences include, but are not limited to, the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse economic or market conditions that may harm our business; including supply-chain issues, labor distribution, business closures, and inflationary pressures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a few of our customers accounting for a significant portion of our gross billings and accounts receivable, and the loss of, or reduced purchases from, these or other customers having a material adverse effect on our operating results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any erroneous or inaccurate estimates or judgments relating to our critical accounting policies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise the additional funding needed to fund our business operation in the future;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to satisfy the requirements for continued listing of our common stock on the Nasdaq Capital Market;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain effective internal control over financial reporting and effective disclosure controls and procedures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property and other proprietary rights; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain and grow our business; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">results of any future litigation and costs incurred in connection with any such litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition in the industry;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variability of operating results; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain and enhance our brand;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accuracy of tracking the number of user accounts; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any security breaches or other disruptions compromising our proprietary information and exposing us to liability;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our development and introduction of new products and services; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our reliance on, and compliance with, open-source software;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the successful integration of acquired companies, technologies, and assets into our portfolio of software and services; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">marketing and other business development initiatives; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general government regulation; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dependence on key personnel; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to attract, hire, and retain personnel who possess the technical skills and experience necessary to meet the service requirements of our customers; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential liability concerning actions taken by our existing and past employees; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any losses or issues we may encounter as a consequence of accepting or holding digital assets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impacts of the situation in the Middle East and the military conflict between Russia and Ukraine, and the global responses to them;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with doing business internationally; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other risks and uncertainties described in the Risk Factors section of this Annual Report.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All forward-looking statements in this document are based on current expectations, intentions, and beliefs using information available to us as of the date of this Quarterly Report; we assume no obligation to update any forward-looking statements, except as required by law.&#160;Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results to differ materially from any future results, performance, or achievements expressed or implied by such forward-looking statements.</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_184"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IZEA Worldwide, Inc. (&#8220;IZEA&#8221;, &#8220;Company,&#8221; &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) is a leading innovator in the creator economy, specializing in providing value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The Company&#8217;s mission is to make creator economy solutions for marketers. We offer solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. By fostering these connections, we light up the creator economy with IZEAs - social-first content, made by creators, that are culturally relevant and move at the speed of culture, champion the creators, empowering individuals to monetize their creativity, content, and influence.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IZEA made a significant mark in the industry by launching the first influencer marketplace, PayPerPost, in 2006, setting a precedent for the evolution of digital marketing platforms. Today, the Company caters to a diverse range of clients, including independent creators and Fortune 10 brands, offering services in influencer marketing, customer-generated content, and custom content creation. IZEA provides tech-enabled managed services and self-service software tools, accommodating the varying needs of its clientele and ensuring mutually beneficial collaborations within its ecosystem.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IZEA Flex is a robust suite of tools that enhance IZEA&#8217;s ability to manage influencer marketing at scale. Beyond enabling seamless campaign execution, Flex empowers IZEA&#8217;s internal teams to measure influencer marketing performance with precision. The platform boasts a suite of core modules, which together provide a comprehensive toolkit for optimizing influencer marketing campaigns. Flex is distinguished by its ability to quantify the ROI of marketing efforts at scale, complemented by the introduction of AI-powered tools that streamline content and creative campaign ideation.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On IZEA.com, the Company offers a dynamic environment where creators can showcase their work to marketers, and marketers can directly engage and hire influencers, simplifying the collaboration process. This platform, alongside the innovative use of generative AI tools in FormAI, underscores IZEA's commitment to facilitating content creation and enhancing the efficiency of digital marketing strategies.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Components of Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overall consolidated results of operations are evaluated based on Revenue, Cost of Revenue, Sales and Marketing expenses, General and Administrative expenses, Depreciation and Amortization, and Other Income (Expense), net. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue primarily from our managed services, when a marketer (typically a brand, agency, or partner) pays us to provide custom content, influencer marketing, amplification, or other campaign management services (&#8220;Managed Services&#8221;). Additionally, we generate revenue from subscription fees charged to access our software platforms, license and transaction fees from self-service customers, and fees from such as inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#8220;SaaS Services Revenue&#8221;). </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cost of revenue consists of direct costs paid to our third-party creators who provide the custom content, influencer marketing, or amplification services for our Managed Service customers, where we report revenue on a gross basis. It also includes internal costs for our campaign fulfillment and SaaS support departments. These costs include salaries, bonuses, commissions, stock-based compensation, employee benefit costs, and miscellaneous departmental costs related to the personnel responsible for supporting our customers and ultimately fulfilling our obligations under our contracts with customers.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales and marketing expenses consist primarily of salaries, bonuses, commissions, stock-based compensation, employee benefit costs, travel, and miscellaneous departmental costs for our marketing, sales, and sales support personnel. They also include marketing expenses such as brand marketing, public relations events, trade shows, marketing materials, and travel expenses.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative (&#8220;G&amp;A&#8221;) expense consists primarily of salaries, bonuses, commissions, stock-based compensation, employee benefit costs, and miscellaneous departmental costs related to our executive, finance, legal, human resources, and other administrative personnel. It also includes travel, public company, investor relations expenses, accounting, legal professional services fees, and other corporate-related expenses. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within G&amp;A, we incorporate technology and development costs, consisting primarily of our payroll costs for our internal engineers and contractors responsible for developing, maintaining, and improving our technology, as well as hosting and software subscription costs. These costs are expensed as incurred, except to the extent that they are associated with internal-use software that qualifies for capitalization, which is then recorded as software development costs in the consolidated balance sheet. When major software components are developed, we capitalize these as intangible assets. Depreciation and amortization related to these costs are separately stated under depreciation and amortization in our consolidated statements of operations and comprehensive loss. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">G&amp;A expenses include current period gains and losses on our acquisition costs payable and gains and losses from the sale of fixed assets. Impairments on fixed assets are included as part of G&amp;A expenses presented separately in our consolidated statements of operations and comprehensive loss when deemed material.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses consists primarily of amortization of our internal-use software and acquired intangible assets from our business acquisitions. To a lesser extent, we also have depreciation and amortization on equipment used by our personnel. Costs are amortized or depreciated over the estimated useful lives of the associated assets. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense is primarily related to the payment plans for purchasing computer equipment.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income consists primarily of interest income earned on investments, as well as realized gains and losses on foreign currency exchange transactions, primarily related to the Canadian and Australian Dollar.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_190"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations for the Three Months Ended March&#160;31, 2025 and 2024 </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of our consolidated statements of operations and the change between the periods:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,401,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,967,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,056,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,934,509)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,940,507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,783,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(842,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,834)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,624,215&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,011,538&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,387,323)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(655,852)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,058,655)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,402,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of digital assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,654)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,001)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,865&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155,159)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,052&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774,023&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,971)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,284,632)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,141,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,800)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265,850)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123,050&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(96)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates our revenue by type, the percentage of total revenue by type, and the change between the periods:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Managed  Services Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,907,410&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696,542&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210,868&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SaaS Services Revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(195,388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015,480&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed Services revenue during the three months ended March&#160;31, 2025 increased by $1.2 million, or 18% from the same period in 2024. Managed Services revenue for the three months ended March&#160;31, 2024 included $0.5 million from Hoozu, which was divested in December 2024. Excluding revenue attributable to Hoozu of $0.5 million in the first quarter of 2024, Managed Services revenue increased to $7.9 million, or 28%, during the quarter ended March&#160;31, 2025. Revenue from on-going customers increased year-over-year due to the addition of new customers in the current quarter and increased spend from one of our larger existing customers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SaaS Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> revenue is generated by the self-service use of our technology platforms by marketers to manage their own content workflow and influencer marketing campaigns. SaaS Service revenue decreased to $60,953 during the three months ended March&#160;31, 2025, compared to $0.3 million in the same period of 2024. The decrease is due to our shift away from SaaS products, including reduced marketing efforts and limited availability for new sign-ups</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of revenue for the three months ended March&#160;31, 2025 increased by $0.4 million, or approximately 11%, compared to the same period in 2024. The increase is primarily driven by higher costs associated with increased revenues from our recurring customer base this quarter which has a higher mix of lower margin customers.</span></div><div style="padding-right:13.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expense for the three months ended March&#160;31, 2025 decreased by $1.9 million, or approximately 63%, compared to the same period in 2024. This decrease is primarily due to lower payroll and related costs, following our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 2024 selective workforce reduction, a pause in current period advertising and promotional spending, and decreased general contractor fees.</span></div><div style="margin-top:9pt;padding-right:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:9pt;padding-right:13.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense for the three months ended March&#160;31, 2025 decreased by $0.8 million, or approximately 22%, compared to the same period in 2024. The decrease is primarily due to lower employee-related costs following our December 2024 selective workforce reduction, reduced use of external contractors, decreased professional service fees, and lower software licensing expenses.</span></div><div style="margin-top:6pt;padding-right:13.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization </span></div><div style="margin-top:6pt;padding-right:13.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense for the three months ended March&#160;31, 2025 decreased by $43,834, or approximately 21%, compared to the same period in 2024. Depreciation expense on property and equipment was $22,955 and $26,557 for the three months ended March&#160;31, 2025 and 2024, respectively. Amortization expense was $0.1 million and $0.2 million for the three months ended March&#160;31, 2025 and 2024, respectively. Amortization expense related to internal use software developments costs was $0.1 million and $0.1 million for the three months ended March&#160;31, 2025, and 2024, respectively. Depreciation and amortization expense decreased compared to the prior-year quarter primarily due to lower depreciation on computer equipment that became fully depreciated during the first quarter of 2025. Additionally, amortization expense declined due to the absence of expense related to legacy platforms that were sunset in 2024, for which amortization was accelerated in the fourth quarter of 2024.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense totaled $1,654 during the three months ended March&#160;31, 2025, compared to $2,001 in the prior year period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net, totaled $0.5 million during the three months ended March&#160;31, 2025, a decrease of $0.2 million compared to the same period in 2024, primarily from investment portfolio interest income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Loss</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss for the three months ended March&#160;31, 2025 was $0.1 million, compared to the net loss of $3.3 million for the same period in 2024.</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_196"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Metrics</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review the information provided by our key financial metrics, Managed Services Bookings, and gross billings, to assess the progress of our business and make decisions on where to allocate our resources. As our business evolves, we may change the key financial metrics in future periods. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Services Bookings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed Services Bookings is a measure of all sales orders received during a time period, less any cancellations received, or refunds given during the same time period. Sales order contracts vary in complexity with each customer and range from custom content delivery to integrated marketing services; our contracts generally run from several months for smaller contracts up to twelve months for larger contracts. We recognize revenue from our Managed Services contracts on a percentage of completion basis as we deliver the content or services over time, which can vary greatly. Historically, bookings have converted to revenues over a 6-month period on average. However, since late 2020, we have received increasingly larger and more complex sales orders, which, in turn, has lengthened the average revenue period to approximately 9-months, with the largest contracts taking longer to complete. During the latter half of 2023, the time between bookings and revenue improved to an average of 7.5 months. For this reason, Managed Services Bookings, while an overall indicator of the health of our business, may not be used to predict quarterly revenues and could be subject to future adjustments. Managed Services Bookings is useful information as it reflects the number of orders received in one period, even though revenue from those orders may be reflected over varying amounts of time. We use the Managed Services Bookings metric to plan operational staffing, to identify key customer group trends to enlighten go-to-market activities, and to inform its product development efforts. Managed Services Bookings for the three months ended March&#160;31, 2025 and 2024 was $7.5 million and $9.3 million, respectively.</span></div><div style="margin-top:12pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measure</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a &#8220;non-GAAP financial measure&#8221; under the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;). We define Adjusted EBITDA as operating income (or loss) from operations before depreciation and amortization, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">non-cash stock-based compensation, and other operating adjustments that are non-recurring or unusual to our core ongoing operations.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Adjusted EBITDA as a measure of operating performance, for planning purposes, to allocate resources to enhance the financial performance of our business and in communications with our Board of Directors regarding our financial performance. We believe that Adjusted EBITDA also provides valuable information to investors as it excludes non-cash transactions, and it provides consistency to facilitate period-to-period comparisons.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not consider Adjusted EBITDA in isolation or as a substitute for an analysis of our results of operations as under GAAP. Not all companies calculate Adjusted EBITDA similarly, limiting its usefulness as a comparative measure. Moreover, Adjusted EBITDA has limitations as an analytical tool, including that Adjusted EBITDA: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">does not include stock-based compensation expense, which is a non-cash expense, but has been, and will continue to be for the foreseeable future, a significant recurring expense for our business and an essential part of our compensation strategy; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">does not include stock issued for payment of services, which is a non-cash expense, but has been, and is expected to be for the foreseeable future, an important means for us to compensate our directors, vendors, and other parties who provide us with services; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">does not include depreciation and intangible assets amortization expense, impairment charges, and gains or losses on disposal of equipment, which is not always a current period cash expense, but the assets being depreciated and amortized may have to be replaced in the future; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">does not include non-operating activity, such as interest income and other gains, losses, and expenses that we believe are not indicative of our ongoing core operating results, but these items may represent a reduction or increase in cash available to us.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of these limitations, Adjusted EBITDA should not be considered a measure of discretionary cash available to us to invest in the operation and growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using these non-GAAP financial measures as supplements. In evaluating this non-GAAP financial measure, you should be aware that in the future, we may incur expenses similar to those for which adjustments are made in calculating Adjusted EBITDA. Our presentation of this non-GAAP financial measure should also not be construed to infer that our future results will be unaffected by unusual or non-recurring items.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a reconciliation from the GAAP measurement of net loss to our non-GAAP financial measure of Adjusted EBITDA for the three months ended March&#160;31, 2025, and 2024:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:58.391%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:18.780%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.782%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265,850)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment to fair market value of digital assets</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,159)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash stock issued for payment of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471,190)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(666,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="f-818">18,782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,850)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,421,661)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA as a % of Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.2)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:13.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2024 measure excludes interest income to ensure comparability with the Company&#8217;s revised definition of the metric, which no longer includes interest income beginning in 2025.</span></div><div style="margin-bottom:12pt;margin-top:5pt;padding-left:13.5pt;text-indent:-9pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_199"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Near-Term Liquidity and Capital Resources</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;The Company&#8217;s primary cash needs have historically been funding the development and integration of our technology platforms used in its business, marketing expenses, and G&amp;A expenses including salaries, bonuses, and commissions. The Company has incurred losses and negative cash flow from operations for most periods since inception, primarily the result of costs associated with third-party creators, salaries, bonuses and stock-based compensation, and other G&amp;A expenses, including technology and development costs, which has resulted in a total accumulated deficit of $104.4 million as of March&#160;31, 2025. While we have not achieved profitability, we believe we have sufficient resources to fund operations and planned investments for at least the next twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents of $50.6 million as of March&#160;31, 2025, as compared to $44.6 million as of December&#160;31, 2024. This increase of $6.0 million is the result of the maturing of certain investments, supplemented by cash provided by operating activities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.346%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used for)/provided by:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,341,872)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,715,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,971,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(618,804)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,233)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates on cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137,265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,414)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,967,880&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,588,604&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by operating activities was $2.0 million during the three months ended March&#160;31, 2025, primarily due to a decrease in accounts receivable. Net cash provided by investing activities was $4.7 million during the three months ended March&#160;31, 2025, primarily due to the maturity of marketable securities. Net cash used for financing activities during the three months ended March&#160;31, 2025 was $618,804, primarily due to payments for shares withheld for taxes and the repurchase of treasury stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Near-Term Liquidity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that our operating expenses will increase over time to support higher levels of revenue and required working capital financing as we continue to pursue the expansion of our business. We currently believe that we have adequate cash and long-term investments to fund our business growth for the next twelve months; however, should additional capital become necessary, we expect these funds would be financed predominately through proceeds from future equity, equity-based, or debt offerings, unless and until our operations are profitable and sustain our ongoing capital needs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Condition and Outlook</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Balance Sheet is strong, including $52.2 million in cash and short-term investments and no outstanding debt.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed Services revenue from ongoing operations increased 27.6% over the prior year quarter. Hoozu, which was divested in December 2024, contributed $0.5 million in revenue in the first quarter of 2024, and $3.4 million in the full year of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows were $2.0 million positive in the current period, including $1.6 million from net working capital changes and $0.4 million in cash income. Cash income was positive, reflecting lower structural human capital and administrative expenses associated with our December 2024 targeted workforce reduction and other cost reduction measures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net loss for the first quarter improved $3.1 million compared to the first quarter of 2024, mainly due to cost savings from the reduction in workforce and other restructuring efforts previously disclosed in our Annual Report on Form 10-K. These included exiting unprofitable international operations and reorganizing our go-to-market teams to support driving North American operations.</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has recorded operational losses to date. Alongside recent management and Board changes, we are conducting a comprehensive analysis of our business and exploring strategic alternatives. The Board of Directors established a Strategic and Capital Allocation Committee to, among other assignments, collaborate with management to review business strategies and formulate a plan to achieve sustainable and consistent profitability. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_202"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not engage in any &#8220;off-balance sheet arrangements&#8221; (as that term is defined in Item 303(a)(4)(ii) of Regulation S-K) as of March&#160;31, 2025.</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_205"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Use of Estimates</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;There have been no material changes to our critical accounting policies as set forth in Item 7, &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; included in our Annual Report on Form 10-K for the year ended December&#160;31, 2024. For a summary of our significant accounting policies, please refer to&#160;&#8220;Note&#160;1&#160;Company and Summary of Significant Accounting Policies&#8221;&#160;included in&#160;Item 1&#160;of this Quarterly Report.</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_208"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;Note 1. Company and Summary of Significant Accounting Policies,&#8221; under Part I, Item 1 of this Quarterly Report for information on additional recent pronouncements.</span></div><div><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_211"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 3.  &#8212;  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable to smaller reporting companies.</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_214"></div><div style="margin-top:6pt"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 4.  &#8212;  CONTROLS AND PROCEDURES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that the Company files or submits under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), is recorded, processed, summarized, and reported within the periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that the Company files under the Exchange Act is accumulated and communicated to management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Furthermore, controls and procedures could be circumvented by the individual acts of some</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">persons, by collusion of two or more people, or by management override of the control. Misstatements due to error or fraud may occur and not be detected on a timely basis.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Evaluation of Disclosure Controls and Procedures </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the preparation of this Quarterly Report on Form 10-Q for the period ended March&#160;31, 2025, an</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evaluation was performed under the supervision and with the participation of our management including our principal executive</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">officer and principal financial officer to determine the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March&#160;31, 2025. Based on this evaluation, our management concluded that, as of March&#160;31, 2025, our disclosure controls and procedures were effective as designed to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosures.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining effective internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Internal control over financial reporting is a process designed by, or under the supervision of, our principal executive officer and principal financial officer and effected by our Board of Directors, management, and other personnel, to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with GAAP. Internal control over financial reporting includes policies and procedures that:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the Company&#8217;s transactions; </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) provide reasonable assurance that transactions are recorded as necessary for the preparation of our financial statements in accordance with GAAP, and that receipts and expenditures are made only in accordance with authorizations of our management and directors; and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) provide reasonable assurance regarding prevention or timely detection of any unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement misstatements. Also, projections of any evaluation of internal control effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the fiscal quarter ended March&#160;31, 2025 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_229"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_232"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 1.  &#8212;  LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in lawsuits and various other legal proceedings that arise in the ordinary course of our business. Litigation is subject to inherent uncertainties and an adverse result in any such litigation that may arise from time to time that may harm our business. As of May&#160;13, 2025 we are not party to any legal proceedings or claims that we believe would or could have, individually or in the aggregate, a material adverse effect on us.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_235"></div><div><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 1A.  &#8212;  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully consider the factors discussed under Item 1A of Part I to our Annual Report on Form 10-K for the year ended December 31, 2024 regarding the numerous and varied risks, known and unknown, that may prevent us from achieving our goals.&#160;If any of these risks occur, our business, financial condition, or results of operation may be materially and adversely affected.&#160;In such a case, the trading price of our common stock could decline, and investors could lose all or part of their investment. These risk factors may not identify all risks that we face, and our operations could also be affected by factors that are not presently known to us or that we currently consider to be immaterial to our operations. There have been no material changes to the risk factors described under &#8220;Risk Factors,&#8221; included in our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024.</span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_238"></div><div style="text-align:justify"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 2.  &#8212;  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_241"></div><div style="text-align:justify"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 3.  &#8212;  DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_244"></div><div style="text-align:justify"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 4.  &#8212;  MINE SAFETY DISCLOSURES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_247"></div><div style="text-align:justify"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 5.  &#8212;  OTHER INFORMATION</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_250"></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#932576;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ITEM 6.  &#8212;  EXHIBITS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:4.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.707%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000152153611000468/q1100271_ex3-1.htm">Amended and Restated Articles of Incorporation of IZEA, Inc., filed with the Nevada Secretary of State on November 28, 2011 (Incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the SEC on November 23, 2011).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523112000019/exhibit31certificateofchan.htm">Certificate of Change of IZEA, Inc., filed with the Nevada Secretary of State on July 30, 2012 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on August 1, 2012).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523114000020/ex3-1articlesamendment2014.htm">Certificate of Amendment to Articles of Incorporation filed with the Secretary of State of the State of Nevada on April 17, 2014 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on April 18, 2014).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000146929911000365/izeaex31.htm">Certificate of Designation (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 27, 2011).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001495231/000149523124000102/izea-20240528.htm">Certificate of Designation (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on May 28, 2024).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523115000003/ex3-120150123nvcertificate.htm">Certificate of Withdrawal of Certificate of Designation filed with the Secretary of State of the State of Nevada effective January 23, 2015 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 29, 2015).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523116000071/ex31certificateofamendment.htm">Certificate of Amendment filed with the Secretary of State of the State of Nevada effective January 11, 2016 (Incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 12, 2016).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523123000104/exhibit31certificateofch.htm">Certificate of Change filed with the Secretary of State of the State of Nevada effective June 16, 2023 (Incorporated by reference to exhibit 3.1 to the Company&#8217;s Current Report on Form 8-k filed with the SEC)</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001495231/000149523124000117/izea-20240614.htm">Second Amended and Restated Bylaws of IZEA, Inc. (Incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the SEC on June 17, 2024).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523116000083/exhibit311nvmerger20160405.htm">Articles of Merger of IZEA Innovations, Inc. filed with the Secretary of State of the State of Nevada effective April 5, 2016 (Incorporated by reference to Exhibit 3.11 to the Company's Quarterly Report on Form 10-Q filed with the SEC on May 11, 2016).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.11</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523118000091/exhibit31izeaworldwidein.htm">Articles of Merger of IZEA Worldwide, Inc. filed with the Secretary of State of the State of Nevada effective August 20, 2018 (Incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the SEC on August 23, 2018).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.12</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523120000028/exhibit310izeanevadaarti.htm">Articles of Merger of IZEA Worldwide, Inc. filed with the Secretary of State of the State of Nevada effective December 17, 2019 (Incorporated by reference to Exhibit 3.10 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 30, 2020). </a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.13</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523121000058/exhibit311nvarticlesofme.htm">Articles of Merger of IZEA Worldwide, Inc. filed with the Secretary of State of the State of Nevada effective December 14, 2020 (Incorporated by reference to Exhibit 3.10 to the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March 30, 2021).</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1495231/000149523124000100/exhibit41rightsagreement.htm">Rights Agreement, dated May 28, 2024, between IZEA Worldwide, Inc. and Broadridge Corporate Issuer Solutions, LLC, as Rights Agent, which includes the Summary of Rights to Purchase Series A Junior Participating Preferred Stock as Exhibit B, and Form of Rights Certificate as Exhibit C (incorporated herein by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed on May 28, 2024).</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001495231/000149523124000172/izea-20240906.htm">Agreement and Release, dated September 6, 2024, between the Company and Edward H. (Ted) Murphy. (Incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the SEC on September 10, 2024).</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001495231/000149523124000172/izea-20240906.htm">Agreement and Release, dated September 6, 2024, between the Company and Ryan S. Schram. (Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the SEC on September 10, 2024).</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001495231/000149523124000193/izea-20240930.htm">10b5-1 Issuer Repurchase Instructions, dated September 27, 2024, between IZEA Worldwide, Inc. and Ladenburg Thalmann &amp; Co. Inc. (incorporated herein by reference to Exhibit 99.1 to the Company&#8217;s Current Report on Form 8-K filed on September 30, 2024)</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31120250331.htm">Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit31220250331.htm">Certification of Principal Financial and Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* (a)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32120250331.htm">Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* (a)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit32220250331.htm">Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:4.870%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.707%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* (b)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following materials from IZEA Worldwide, Inc.'s Quarterly Report for the period ended March 31, 2025 are formatted in XBRL (eXtensible Business Reporting Language): (i) the Unaudited Consolidated Balance Sheets, (ii) the Unaudited Consolidated Statements of Operations and Comprehensive Loss, (iii) the Unaudited Consolidated Statement of Stockholders' Equity, (iv) the Unaudited Consolidated Statements of Cash Flow, and (v) the Notes to the Unaudited Consolidated Financial Statements.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive File (formatted as inline XBRL and contained within Exhibit 101).</span></td></tr></table></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed or furnished herewith.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In accordance with Item&#160;601of Regulation&#160;S-K, this Exhibit is hereby furnished to the SEC as an accompanying document and is not deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In accordance with Rule&#160;406T of Regulation&#160;S-T, the XBRL related information in Exhibit&#160;101 to this Quarterly Report on Form 10-Q shall not be deemed to be &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i9682eec2a1c34cccbfbd9132fedc17cf_280"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,&#160;thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:67.176%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IZEA Worldwide, Inc.<br/>a Nevada Corporation</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Patrick J. Venetucci</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick J. Venetucci<br/>Chief Executive Officer<br/>(Principal Executive Officer)&#160;</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 13, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter J. Biere</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Peter J. Biere</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Principal Financial and Accounting Officer) </span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit31120250331.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ie2ccca5cd05644c7b766661abbd704b1_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certification by Principal Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pursuant to Section 302 of the Sarbanes Oxley Act of 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Patrick J. Venetucci, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of IZEA Worldwide, Inc.&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;May&#160;13, 2025</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:73.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Patrick J. Venetucci</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick J. Venetucci</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit31220250331.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib537abaf9f3c474cb9dcfdf47b354617_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certification by Principal Financial and Accounting Officer </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">pursuant to Section 302 of the Sarbanes Oxley Act of 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Peter J. Biere, certify that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Quarterly Report on Form 10-Q of IZEA Worldwide, Inc.&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;May&#160;13, 2025</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:379.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:129.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter J. Biere</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Biere</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit32120250331.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i7454eeb974af4a8da2ce5568cbb40ba8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of IZEA Worldwide, Inc., a Nevada corporation (the &#8220;Company&#8221;), on Form 10-Q for the period ended March&#160;31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Patrick J. Venetucci, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;May&#160;13, 2025</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:60.979%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Patrick J. Venetucci</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patrick J. Venetucci<br>Chief Executive Officer<br>(Principal Executive Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>exhibit32220250331.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib09b390602cb46cab00b0978c26d0879_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of IZEA Worldwide, Inc., a Nevada corporation (the &#8220;Company&#8221;), on Form 10-Q for the period ended March&#160;31, 2025, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Peter J. Biere, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;May&#160;13, 2025</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:512.25pt"><tr><td style="width:1.0pt"></td><td style="width:316.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:192.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Peter J. Biere</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:33pt"><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter J. Biere<br>Chief Financial Officer<br>(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>izea-20250331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:bad81cd4-934d-4330-9ea3-36401c97abe6,g:5878b1fc-f8cc-483b-8e63-779470b36094-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:izea="http://www.izea.com/20250331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.izea.com/20250331">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="izea-20250331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="izea-20250331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="izea-20250331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="izea-20250331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.izea.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.izea.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets - Parenthetical</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.izea.com/role/ConsolidatedStatementsofOperations">
        <link:definition>9952153 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>9952154 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>9952155 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.izea.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPolicies" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies">
        <link:definition>9952157 - Disclosure - Company and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitions" roleURI="http://www.izea.com/role/BusinessAcquisitions">
        <link:definition>9952158 - Disclosure - Business Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.izea.com/role/FinancialInstruments">
        <link:definition>9952159 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.izea.com/role/PropertyandEquipment">
        <link:definition>9952160 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssets" roleURI="http://www.izea.com/role/IntangibleAssets">
        <link:definition>9952161 - Disclosure - Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SoftwareDevelopmentCosts" roleURI="http://www.izea.com/role/SoftwareDevelopmentCosts">
        <link:definition>9952162 - Disclosure - Software Development Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://www.izea.com/role/AccruedExpenses">
        <link:definition>9952163 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayable" roleURI="http://www.izea.com/role/NotesPayable">
        <link:definition>9952164 - Disclosure - Notes Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesNotes" roleURI="http://www.izea.com/role/CommitmentsandContingenciesNotes">
        <link:definition>9952165 - Disclosure - Commitments and Contingencies (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.izea.com/role/StockholdersEquity">
        <link:definition>9952166 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossperCommonShare" roleURI="http://www.izea.com/role/LossperCommonShare">
        <link:definition>9952167 - Disclosure - Loss per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.izea.com/role/Revenue">
        <link:definition>9952168 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.izea.com/role/SegmentReporting">
        <link:definition>9952169 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.izea.com/role/IncomeTaxes">
        <link:definition>9952170 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.izea.com/role/SubsequentEvents">
        <link:definition>9952171 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Company and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Company and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.izea.com/role/FinancialInstrumentsTables">
        <link:definition>9955513 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.izea.com/role/PropertyandEquipmentTables">
        <link:definition>9955514 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SoftwareDevelopmentCostsTables" roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsTables">
        <link:definition>9955515 - Disclosure - Software Development Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://www.izea.com/role/AccruedExpensesTables">
        <link:definition>9955516 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayableTables" roleURI="http://www.izea.com/role/NotesPayableTables">
        <link:definition>9955517 - Disclosure - Notes Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesTables" roleURI="http://www.izea.com/role/CommitmentandContingenciesTables">
        <link:definition>9955518 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.izea.com/role/StockholdersEquityTables">
        <link:definition>9955519 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossperCommonShareTables" roleURI="http://www.izea.com/role/LossperCommonShareTables">
        <link:definition>9955520 - Disclosure - Loss per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.izea.com/role/RevenueTables">
        <link:definition>9955521 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.izea.com/role/SegmentReportingTables">
        <link:definition>9955522 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.izea.com/role/IncomeTaxesTables">
        <link:definition>9955523 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails">
        <link:definition>9955524 - Disclosure - Company and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails">
        <link:definition>9955525 - Disclosure - Company and Summary of Significant Accounting Policies - Accounts Receivable and Concentration of Credit Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails">
        <link:definition>9955526 - Disclosure - Company and Summary of Significant Accounting Policies - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails">
        <link:definition>9955527 - Disclosure - Company and Summary of Significant Accounting Policies - Software Development Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>9955528 - Disclosure - Company and Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails">
        <link:definition>9955529 - Disclosure - Company and Summary of Significant Accounting Policies - Advertising Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails">
        <link:definition>9955530 - Disclosure - Company and Summary of Significant Accounting Policies - Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessAcquisitionsAdditionalInformationDetails" roleURI="http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails">
        <link:definition>9955531 - Disclosure - Business Acquisitions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails" roleURI="http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails">
        <link:definition>9955532 - Disclosure - Financial Instruments - Marketable Securities by Significant Investment Category (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.izea.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>9955533 - Disclosure - Financial Instruments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails" roleURI="http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails">
        <link:definition>9955534 - Disclosure - Financial Instruments - Fair Value of Marketable Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails" roleURI="http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails">
        <link:definition>9955535 - Disclosure - Financial Instruments - Fair Value and Net Unrealized Gains (Losses) By Investment in OCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentDetails" roleURI="http://www.izea.com/role/PropertyandEquipmentDetails">
        <link:definition>9955536 - Disclosure - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNarrativeDetails" roleURI="http://www.izea.com/role/IntangibleAssetsNarrativeDetails">
        <link:definition>9955537 - Disclosure - Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails" roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails">
        <link:definition>9955538 - Disclosure - Software Development Costs - Schedule of Software Development Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SoftwareDevelopmentCostsAdditionalInformationDetails" roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails">
        <link:definition>9955539 - Disclosure - Software Development Costs - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails" roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails">
        <link:definition>9955540 - Disclosure - Software Development Costs - Schedule of Future Estimated Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesDetails" roleURI="http://www.izea.com/role/AccruedExpensesDetails">
        <link:definition>9955541 - Disclosure - Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayableAdditionalInformationDetails" roleURI="http://www.izea.com/role/NotesPayableAdditionalInformationDetails">
        <link:definition>9955542 - Disclosure - Notes Payable - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesPayableScheduleofFutureMaturitiesDetails" roleURI="http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails">
        <link:definition>9955543 - Disclosure - Notes Payable - Schedule of Future Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesRetirementPlansDetails" roleURI="http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails">
        <link:definition>9955544 - Disclosure - Commitments and Contingencies - Retirement Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAuthorizedSharesDetail" roleURI="http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail">
        <link:definition>9955545 - Disclosure - Stockholders' Equity - Authorized Shares (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareRepurchaseDetails" roleURI="http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails">
        <link:definition>9955546 - Disclosure - Stockholders' Equity - Share Repurchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityEquityIncentivePlanDetails" roleURI="http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails">
        <link:definition>9955547 - Disclosure - Stockholders' Equity - Equity Incentive Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityRestrictedStockDetails" roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockDetails">
        <link:definition>9955548 - Disclosure - Stockholders' Equity - Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofNonVestedRestrictedStockDetails" roleURI="http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails">
        <link:definition>9955549 - Disclosure - Stockholders' Equity - Schedule of Non-Vested Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityRestrictedStockUnitsDetails" roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails">
        <link:definition>9955550 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityRestrictedStockUnitsScheduleDetails" roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails">
        <link:definition>9955551 - Disclosure - Stockholders' Equity - Restricted Stock Units Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionsDetails" roleURI="http://www.izea.com/role/StockholdersEquityStockOptionsDetails">
        <link:definition>9955552 - Disclosure - Stockholders' Equity - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofOptionsOutstandingDetails" roleURI="http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails">
        <link:definition>9955553 - Disclosure - Stockholders' Equity - Schedule of Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofNonvestedStockOptionDetails" roleURI="http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails">
        <link:definition>9955554 - Disclosure - Stockholders' Equity - Schedule of Nonvested Stock Option (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityInducementPlanDetails" roleURI="http://www.izea.com/role/StockholdersEquityInducementPlanDetails">
        <link:definition>9955555 - Disclosure - Stockholders' Equity - Inducement Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityEmployeeStockPurchasePlanDetails" roleURI="http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails">
        <link:definition>9955556 - Disclosure - Stockholders' Equity - Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityShareholderRightsPlanDetails" roleURI="http://www.izea.com/role/StockholdersEquityShareholderRightsPlanDetails">
        <link:definition>9955557 - Disclosure - Stockholders' Equity - Shareholder Rights Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryofStockBasedCompensationDetails" roleURI="http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails">
        <link:definition>9955558 - Disclosure - Stockholders' Equity - Summary of Stock-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" roleURI="http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails">
        <link:definition>9955559 - Disclosure - Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossperCommonShareScheduleofDilutiveSharesDetails" roleURI="http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails">
        <link:definition>9955560 - Disclosure - Loss per Common Share - Schedule of Dilutive Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossperCommonShareScheduleofAntiDilutiveSharesDetails" roleURI="http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails">
        <link:definition>9955561 - Disclosure - Loss per Common Share - Schedule of Anti-Dilutive Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueDisaggregationofRevenueDetails" roleURI="http://www.izea.com/role/RevenueDisaggregationofRevenueDetails">
        <link:definition>9955562 - Disclosure - Revenue - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueContractBalancesDetails" roleURI="http://www.izea.com/role/RevenueContractBalancesDetails">
        <link:definition>9955563 - Disclosure - Revenue - Contract Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.izea.com/role/RevenueNarrativeDetails">
        <link:definition>9955564 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.izea.com/role/SegmentReportingDetails">
        <link:definition>9955565 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesEffectiveRateReconciliationDetails" roleURI="http://www.izea.com/role/IncomeTaxesEffectiveRateReconciliationDetails">
        <link:definition>9955566 - Disclosure - Income Taxes - Effective Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="izea_ChangeInTheFairValueOfDigitalAssets" abstract="false" name="ChangeInTheFairValueOfDigitalAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" abstract="false" name="AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_NatureOfBusinessPolicyTextBlock" abstract="false" name="NatureOfBusinessPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" abstract="false" name="FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="izea_CashCDICInsuredAmount" abstract="false" name="CashCDICInsuredAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_CustomerTwoMember" abstract="true" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_AccountsReceivableExcludingContractAsset" abstract="false" name="AccountsReceivableExcludingContractAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="izea_SignificantAccountPoliciesLineItems" abstract="true" name="SignificantAccountPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="izea_AmortizationPeriodOfSoftwareDevelopmentCosts" abstract="false" name="AmortizationPeriodOfSoftwareDevelopmentCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_InvoicePaymentTerms" abstract="false" name="InvoicePaymentTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" abstract="false" name="ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_HoozuHoldingPTYLtd.Member" abstract="true" name="HoozuHoldingPTYLtd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_LossOfDivesitureOfBusinessNetOfTransactionCosts" abstract="false" name="LossOfDivesitureOfBusinessNetOfTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_HoldingPeriodOfMarketableSecurities" abstract="false" name="HoldingPeriodOfMarketableSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_FinancialAssetsFairValueDisclosure" abstract="false" name="FinancialAssetsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_DepreciationandAmortizationExpenseMember" abstract="true" name="DepreciationandAmortizationExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_DigitalAssetsMember" abstract="true" name="DigitalAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" abstract="false" name="CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne" abstract="false" name="CapitalizedComputerSoftwareExpectedAmortizationYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo" abstract="false" name="CapitalizedComputerSoftwareExpectedAmortizationYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree" abstract="false" name="CapitalizedComputerSoftwareExpectedAmortizationYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour" abstract="false" name="CapitalizedComputerSoftwareExpectedAmortizationYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive" abstract="false" name="CapitalizedComputerSoftwareExpectedAmortizationYearFive" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CurrentPortionOfFinanceObligation" abstract="false" name="CurrentPortionOfFinanceObligation" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService" abstract="false" name="DefinedContributionPlanEmployersMatchingContributionYearsOfService" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_ActiveRepurchaseProgramMember" abstract="true" name="ActiveRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_ExpiredAndActiveRepurchaseProgramsMember" abstract="true" name="ExpiredAndActiveRepurchaseProgramsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_TheAmendedandRestatedMay2011PlanMember" abstract="true" name="TheAmendedandRestatedMay2011PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="izea_EmployeesMember" abstract="true" name="EmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_IndependentDirectorsMember" abstract="true" name="IndependentDirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_Numberofindependentdirectors" abstract="false" name="Numberofindependentdirectors" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="izea_CommonStockFairValue" abstract="false" name="CommonStockFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="izea_NonExecutiveEmployeesMember" abstract="true" name="NonExecutiveEmployeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_Fairvalueofcommonstockissuedforfutureservices" abstract="false" name="Fairvalueofcommonstockissuedforfutureservices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_VestingFrequencyAxis" abstract="true" name="VestingFrequencyAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="izea_VestingFrequencyDomain" abstract="true" name="VestingFrequencyDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_TotalvestingperiodMember" abstract="true" name="TotalvestingperiodMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_TwelveMonthsAfterGrantDateMember" abstract="true" name="TwelveMonthsAfterGrantDateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_MonthlyInEqualInstallmentsMember" abstract="true" name="MonthlyInEqualInstallmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_StockOwnershipPlanAxis" abstract="true" name="StockOwnershipPlanAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="izea_StockOwnershipPlanDomain" abstract="true" name="StockOwnershipPlanDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_IndividualStockOwnershipInExcessOf10PercentMember" abstract="true" name="IndividualStockOwnershipInExcessOf10PercentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_May2011AndAugust2011EquityIncentivePlansMember" abstract="true" name="May2011AndAugust2011EquityIncentivePlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_EquityIncentive2011PlanMember" abstract="true" name="EquityIncentive2011PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_Percentageofindividualownershipofcommonstock" abstract="false" name="Percentageofindividualownershipofcommonstock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="izea_FairMarketValueOfIncentiveStockOptions" abstract="false" name="FairMarketValueOfIncentiveStockOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="izea_StockOptionVestingPeriodFromGrantDate" abstract="false" name="StockOptionVestingPeriodFromGrantDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="izea_InducementGrantRelatedRSUsMember" abstract="true" name="InducementGrantRelatedRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_TimeBasedRSUsMember" abstract="true" name="TimeBasedRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_PerformanceBasedRSUsMember" abstract="true" name="PerformanceBasedRSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_PerformanceBasedAndTimeBasedRSUAwardsMember" abstract="true" name="PerformanceBasedAndTimeBasedRSUAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_HoozuHoldingsInc.Member" abstract="true" name="HoozuHoldingsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_A2014EmployeeStockPurchasePlanMember" abstract="true" name="A2014EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_MinimumhourrequirementforemployeesparticipationintheESSP" abstract="false" name="MinimumhourrequirementforemployeesparticipationintheESSP" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="izea_Annualcompensationlimitpercentageemployeestockpurchaseplan" abstract="false" name="Annualcompensationlimitpercentageemployeestockpurchaseplan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="izea_Annualcompensationlimitemployeestockpurchaseplan" abstract="false" name="Annualcompensationlimitemployeestockpurchaseplan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" abstract="false" name="Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="izea_Fairmarketvalueofsharesavailableforissuance" abstract="false" name="Fairmarketvalueofsharesavailableforissuance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="izea_ExercisableShareholderRightsPercentageHeld." abstract="false" name="ExercisableShareholderRightsPercentageHeld." nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="izea_UnrealizedGainLossOnSecuritiesMember" abstract="true" name="UnrealizedGainLossOnSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_CurrencyTranslationAdjustmentMember" abstract="true" name="CurrencyTranslationAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_UnrealizedGainOnSecuritiesHeld" abstract="false" name="UnrealizedGainOnSecuritiesHeld" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_SaaSServicesSegmentRevenueMember" abstract="true" name="SaaSServicesSegmentRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_ManagedServicesRevenueMember" abstract="true" name="ManagedServicesRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_SponsoredSocialRevenueMember" abstract="true" name="SponsoredSocialRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_ContentRevenueMember" abstract="true" name="ContentRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="izea_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_MarketplaceSpendFeesnetMember" abstract="true" name="MarketplaceSpendFeesnetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_OtherFeesMember" abstract="true" name="OtherFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="izea_LengthOfContractWithCustomers" abstract="false" name="LengthOfContractWithCustomers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_ContractLengthForSalesCommissionsPayment" abstract="false" name="ContractLengthForSalesCommissionsPayment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="izea_PerformanceObligationContractTerm" abstract="false" name="PerformanceObligationContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="izea_CostOfRevenueDirect" abstract="false" name="CostOfRevenueDirect" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_HumanCapitalCosts" abstract="false" name="HumanCapitalCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="izea_CashOperatingCosts" abstract="false" name="CashOperatingCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>izea-20250331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:bad81cd4-934d-4330-9ea3-36401c97abe6,g:5878b1fc-f8cc-483b-8e63-779470b36094-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3d1d1b78-c4ce-4c1b-a14b-4e2cf5850da2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_20a9f21c-ec19-496e-bba9-077271c9dbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3d1d1b78-c4ce-4c1b-a14b-4e2cf5850da2" xlink:to="loc_us-gaap_CommonStockValue_20a9f21c-ec19-496e-bba9-077271c9dbcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_f9df208d-b2a1-4682-b4b6-cbc29c34d481" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3d1d1b78-c4ce-4c1b-a14b-4e2cf5850da2" xlink:to="loc_us-gaap_AdditionalPaidInCapital_f9df208d-b2a1-4682-b4b6-cbc29c34d481" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ce546c43-2024-49da-82f8-97d9afe71c11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3d1d1b78-c4ce-4c1b-a14b-4e2cf5850da2" xlink:to="loc_us-gaap_TreasuryStockValue_ce546c43-2024-49da-82f8-97d9afe71c11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6be503f2-7e0b-4cc4-b126-bf135a302b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3d1d1b78-c4ce-4c1b-a14b-4e2cf5850da2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_6be503f2-7e0b-4cc4-b126-bf135a302b8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9efeafa0-ea8e-4c9e-a34a-913e797ed662" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3d1d1b78-c4ce-4c1b-a14b-4e2cf5850da2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9efeafa0-ea8e-4c9e-a34a-913e797ed662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_2790f2b0-2668-467f-a22d-73251931bda5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3d1d1b78-c4ce-4c1b-a14b-4e2cf5850da2" xlink:to="loc_us-gaap_PreferredStockValue_2790f2b0-2668-467f-a22d-73251931bda5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a7dcaf5e-7d99-4cff-ac32-e5f814845b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_800cf488-17aa-4747-81c6-c9476865e879" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7dcaf5e-7d99-4cff-ac32-e5f814845b7f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_800cf488-17aa-4747-81c6-c9476865e879" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e46f2b0e-f7e4-4b93-ae5f-e478b45a9f56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7dcaf5e-7d99-4cff-ac32-e5f814845b7f" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e46f2b0e-f7e4-4b93-ae5f-e478b45a9f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_7988a2f0-a899-41f4-9fe4-b28cef3036ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7dcaf5e-7d99-4cff-ac32-e5f814845b7f" xlink:to="loc_us-gaap_OtherAssetsCurrent_7988a2f0-a899-41f4-9fe4-b28cef3036ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_82656dad-9001-4edc-97a8-eceff70279c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7dcaf5e-7d99-4cff-ac32-e5f814845b7f" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_82656dad-9001-4edc-97a8-eceff70279c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_c2889854-aa24-495a-baa2-e44ee5ef74e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_a7dcaf5e-7d99-4cff-ac32-e5f814845b7f" xlink:to="loc_us-gaap_ShortTermInvestments_c2889854-aa24-495a-baa2-e44ee5ef74e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0c3d6eab-1e9f-4acc-a95e-f47132817215" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b8940feb-eca4-4382-9449-671161ae2268" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c3d6eab-1e9f-4acc-a95e-f47132817215" xlink:to="loc_us-gaap_AssetsCurrent_b8940feb-eca4-4382-9449-671161ae2268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7ec18c58-d70d-4943-a761-6c7e98fbdb32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c3d6eab-1e9f-4acc-a95e-f47132817215" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7ec18c58-d70d-4943-a761-6c7e98fbdb32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_9801b573-1dea-4ca2-80f7-26290df92dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_0c3d6eab-1e9f-4acc-a95e-f47132817215" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_9801b573-1dea-4ca2-80f7-26290df92dd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_afcf26fd-dfb4-41c4-90fe-584fdd75bb53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e3c0bf47-89ba-41fd-95f3-419c444bf3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afcf26fd-dfb4-41c4-90fe-584fdd75bb53" xlink:to="loc_us-gaap_Liabilities_e3c0bf47-89ba-41fd-95f3-419c444bf3ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_acf74426-6e39-415a-941c-49047a4b4ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afcf26fd-dfb4-41c4-90fe-584fdd75bb53" xlink:to="loc_us-gaap_StockholdersEquity_acf74426-6e39-415a-941c-49047a4b4ba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_58a35461-d423-48aa-9a93-fa1c226fc47c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afcf26fd-dfb4-41c4-90fe-584fdd75bb53" xlink:to="loc_us-gaap_CommitmentsAndContingencies_58a35461-d423-48aa-9a93-fa1c226fc47c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_7f90416c-9eed-4549-b405-699f4fa3822b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ddf727cb-0fc2-4d79-9fe9-c0b842381e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7f90416c-9eed-4549-b405-699f4fa3822b" xlink:to="loc_us-gaap_LiabilitiesCurrent_ddf727cb-0fc2-4d79-9fe9-c0b842381e3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4e2c8977-6d54-4a0f-96f1-5ff57f7830a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_7f90416c-9eed-4549-b405-699f4fa3822b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4e2c8977-6d54-4a0f-96f1-5ff57f7830a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ebe126e7-6049-4dfc-8573-1d9ee863dd56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_41475bc3-7d0d-49d2-8b96-2bd489efc65c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ebe126e7-6049-4dfc-8573-1d9ee863dd56" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_41475bc3-7d0d-49d2-8b96-2bd489efc65c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f40a922d-fa8c-4fa2-a40e-eac80475b0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ebe126e7-6049-4dfc-8573-1d9ee863dd56" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f40a922d-fa8c-4fa2-a40e-eac80475b0ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ad9d569b-fc32-4462-b6e4-23c6e059fe92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ebe126e7-6049-4dfc-8573-1d9ee863dd56" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ad9d569b-fc32-4462-b6e4-23c6e059fe92" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c1c3a339-e7d8-46af-a7b7-fd83d4d2fe03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_a8642cf1-dc8a-4c10-b933-68ab865935f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c1c3a339-e7d8-46af-a7b7-fd83d4d2fe03" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_a8642cf1-dc8a-4c10-b933-68ab865935f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9220a001-ea4d-45cf-97e2-47725b4dde62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_c1c3a339-e7d8-46af-a7b7-fd83d4d2fe03" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9220a001-ea4d-45cf-97e2-47725b4dde62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1e93ff1f-ff8c-4dc3-acef-af431e153cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea800f4b-5bf1-4b9c-96c2-774e0b5b6219" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1e93ff1f-ff8c-4dc3-acef-af431e153cbe" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ea800f4b-5bf1-4b9c-96c2-774e0b5b6219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_97f7175e-ab51-47eb-aff0-c7807688bce9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1e93ff1f-ff8c-4dc3-acef-af431e153cbe" xlink:to="loc_us-gaap_CostsAndExpenses_97f7175e-ab51-47eb-aff0-c7807688bce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_250d466d-4777-4cb4-b71f-ee397644da48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_33ba70f1-1161-48cc-8b2a-95d655c37c12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_250d466d-4777-4cb4-b71f-ee397644da48" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_33ba70f1-1161-48cc-8b2a-95d655c37c12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ffa3a1e4-8380-4121-8aee-4e59daa45ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossAttributableToParent_250d466d-4777-4cb4-b71f-ee397644da48" xlink:to="loc_us-gaap_OperatingIncomeLoss_ffa3a1e4-8380-4121-8aee-4e59daa45ae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5c312f06-0d97-4452-a8ee-fb122015aeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3acacc9e-6ec5-44ce-83da-888ecb9b6579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5c312f06-0d97-4452-a8ee-fb122015aeaf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3acacc9e-6ec5-44ce-83da-888ecb9b6579" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_727a8218-232d-47c4-a1a6-ec5d2c70ad29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5c312f06-0d97-4452-a8ee-fb122015aeaf" xlink:to="loc_us-gaap_CostOfRevenue_727a8218-232d-47c4-a1a6-ec5d2c70ad29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_c0d83a6e-94bc-4344-9e33-ebba2b1879fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5c312f06-0d97-4452-a8ee-fb122015aeaf" xlink:to="loc_us-gaap_SellingAndMarketingExpense_c0d83a6e-94bc-4344-9e33-ebba2b1879fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_60a12b8b-6b0f-4ecb-b957-0edfd572ceaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_5c312f06-0d97-4452-a8ee-fb122015aeaf" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_60a12b8b-6b0f-4ecb-b957-0edfd572ceaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d824fd8a-a781-4c85-bcd1-c4900916b16a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_887b095d-5c2e-4efa-9dfe-c85cceac9880" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_d824fd8a-a781-4c85-bcd1-c4900916b16a" xlink:to="loc_us-gaap_InterestExpenseNonoperating_887b095d-5c2e-4efa-9dfe-c85cceac9880" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6c6a6d1b-79a7-4fed-ae0f-9359a4bebb45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_d824fd8a-a781-4c85-bcd1-c4900916b16a" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6c6a6d1b-79a7-4fed-ae0f-9359a4bebb45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ChangeInTheFairValueOfDigitalAssets_c7424c91-a957-44c1-be18-96fd429398e5" xlink:href="izea-20250331.xsd#izea_ChangeInTheFairValueOfDigitalAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_d824fd8a-a781-4c85-bcd1-c4900916b16a" xlink:to="loc_izea_ChangeInTheFairValueOfDigitalAssets_c7424c91-a957-44c1-be18-96fd429398e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_109f127b-6e75-4637-8582-17442e6257de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_1fa84c8a-d45a-4dd9-9fa5-2becfb45d70d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_109f127b-6e75-4637-8582-17442e6257de" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_1fa84c8a-d45a-4dd9-9fa5-2becfb45d70d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7d050089-27d4-4cf8-8bd9-266397a28d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_109f127b-6e75-4637-8582-17442e6257de" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7d050089-27d4-4cf8-8bd9-266397a28d6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_51fe59d5-f432-41ae-8aaf-51bace58ac17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cac3eac9-3de5-4076-b1d1-6910bd7fb4da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_51fe59d5-f432-41ae-8aaf-51bace58ac17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cac3eac9-3de5-4076-b1d1-6910bd7fb4da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c85bba16-8393-4514-93ec-9d2777f1d2af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_51fe59d5-f432-41ae-8aaf-51bace58ac17" xlink:to="loc_us-gaap_NetIncomeLoss_c85bba16-8393-4514-93ec-9d2777f1d2af" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a86d079-f26b-4542-90a6-edf8601bcc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_5cc4b614-bd34-4e3d-bf69-edccfbddba59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a86d079-f26b-4542-90a6-edf8601bcc2a" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_5cc4b614-bd34-4e3d-bf69-edccfbddba59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_288de32b-b71d-4b9b-8ceb-60b31dde49b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a86d079-f26b-4542-90a6-edf8601bcc2a" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_288de32b-b71d-4b9b-8ceb-60b31dde49b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1c331c4a-ff91-4f63-8692-e92cbde6a5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4a86d079-f26b-4542-90a6-edf8601bcc2a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1c331c4a-ff91-4f63-8692-e92cbde6a5f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_700182dc-dba9-4b89-944c-7f36d103334e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_9bdc96f4-57fd-4634-8e2f-edd45ae86e90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_700182dc-dba9-4b89-944c-7f36d103334e" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_9bdc96f4-57fd-4634-8e2f-edd45ae86e90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_14d9e411-6025-42c9-bf8b-33aecb3fe067" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_700182dc-dba9-4b89-944c-7f36d103334e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_14d9e411-6025-42c9-bf8b-33aecb3fe067" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9319e865-a4bc-4c9d-ba8a-eebbd0b4e557" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9319e865-a4bc-4c9d-ba8a-eebbd0b4e557" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets_6248f254-9099-4d03-ad0f-4277f85c271d" xlink:href="izea-20250331.xsd#izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets_6248f254-9099-4d03-ad0f-4277f85c271d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_570aa53f-d6b7-4725-ac38-ca1c9f589adc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_570aa53f-d6b7-4725-ac38-ca1c9f589adc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3d8423c0-962a-451f-ab9f-256240b8e06e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_NetIncomeLoss_3d8423c0-962a-451f-ab9f-256240b8e06e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9a169902-dfa9-484c-9ec9-a8726afb68c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_Depreciation_9a169902-dfa9-484c-9ec9-a8726afb68c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_e2556c52-49c1-482a-9437-ded0258622f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_e2556c52-49c1-482a-9437-ded0258622f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7bda2604-e12e-4e67-96bc-e0c82c5c6e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_7bda2604-e12e-4e67-96bc-e0c82c5c6e6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_7fcda183-f5ed-4e06-afc1-6efb233bbc07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_7fcda183-f5ed-4e06-afc1-6efb233bbc07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a90d237c-989a-4f74-9838-8c288721cd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a90d237c-989a-4f74-9838-8c288721cd1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_bc5e58a5-d4c1-435e-a988-edbfd2fb39f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_AdjustmentForAmortization_bc5e58a5-d4c1-435e-a988-edbfd2fb39f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_7f7729d5-eaf0-4912-9e41-002c22bceba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_7f7729d5-eaf0-4912-9e41-002c22bceba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f1eb0c97-a457-408d-9855-bd5a0b511558" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_64fd81b3-d5b6-4575-97f2-ca9bb78fe3fd" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f1eb0c97-a457-408d-9855-bd5a0b511558" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8cd34855-ba8b-454c-9fae-ac828aae8ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e77b8910-b6c4-4e0e-9ff5-53b6615b1284" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8cd34855-ba8b-454c-9fae-ac828aae8ce5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e77b8910-b6c4-4e0e-9ff5-53b6615b1284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8ef17030-7062-41f0-a26b-535d707a01db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8cd34855-ba8b-454c-9fae-ac828aae8ce5" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8ef17030-7062-41f0-a26b-535d707a01db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a0c9a3c8-a595-4923-8447-9822f459dd23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8cd34855-ba8b-454c-9fae-ac828aae8ce5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a0c9a3c8-a595-4923-8447-9822f459dd23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_44a1fcff-4f14-4d66-956f-826eaf59a3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8cd34855-ba8b-454c-9fae-ac828aae8ce5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_44a1fcff-4f14-4d66-956f-826eaf59a3f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_ce4b5d37-8cee-4e0f-ac95-de544d40cd58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4686f8a2-0f62-4039-b1d3-62abb0bed033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_ce4b5d37-8cee-4e0f-ac95-de544d40cd58" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4686f8a2-0f62-4039-b1d3-62abb0bed033" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.izea.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#PropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5ff02c78-9ae9-4a8c-8978-ca0c1b7c7dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7bd601df-3f85-4c18-9893-8b22a3895a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5ff02c78-9ae9-4a8c-8978-ca0c1b7c7dcc" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7bd601df-3f85-4c18-9893-8b22a3895a1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8ea47246-dc4c-47e9-9cff-4e7cc2ad04a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5ff02c78-9ae9-4a8c-8978-ca0c1b7c7dcc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8ea47246-dc4c-47e9-9cff-4e7cc2ad04a5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.izea.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#AccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0c96a2bf-659e-4981-80c9-bc914cdef00b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_80581ef6-e8ba-4016-bfd9-b71c99c86ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0c96a2bf-659e-4981-80c9-bc914cdef00b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_80581ef6-e8ba-4016-bfd9-b71c99c86ed9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CurrentPortionOfFinanceObligation_72c4c54d-55e2-423a-a09b-e4d06d411766" xlink:href="izea-20250331.xsd#izea_CurrentPortionOfFinanceObligation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0c96a2bf-659e-4981-80c9-bc914cdef00b" xlink:to="loc_izea_CurrentPortionOfFinanceObligation_72c4c54d-55e2-423a-a09b-e4d06d411766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrentAndNoncurrent_1bcae0e1-70fc-4ca7-bdce-83e14ffa732e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0c96a2bf-659e-4981-80c9-bc914cdef00b" xlink:to="loc_us-gaap_AccruedSalariesCurrentAndNoncurrent_1bcae0e1-70fc-4ca7-bdce-83e14ffa732e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_da5b337c-3519-4079-87d7-b1e871622e25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_0c96a2bf-659e-4981-80c9-bc914cdef00b" xlink:to="loc_us-gaap_AccruedIncomeTaxes_da5b337c-3519-4079-87d7-b1e871622e25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#NotesPayableScheduleofFutureMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d659e77e-0600-483f-99d4-dcf7da566025" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_39fd35b3-0485-40e4-bb64-5675fd4466a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_d659e77e-0600-483f-99d4-dcf7da566025" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_39fd35b3-0485-40e4-bb64-5675fd4466a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_c3d57aef-0a43-4049-8bd5-0fee58d76b52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_d659e77e-0600-483f-99d4-dcf7da566025" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_c3d57aef-0a43-4049-8bd5-0fee58d76b52" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>izea-20250331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:bad81cd4-934d-4330-9ea3-36401c97abe6,g:5878b1fc-f8cc-483b-8e63-779470b36094-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d9d292f-bab7-4318-80fa-fa7b5eb948d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4b350bd-ca56-400a-96b1-c7f4c643052c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1d9d292f-bab7-4318-80fa-fa7b5eb948d9" xlink:to="loc_us-gaap_StatementTable_b4b350bd-ca56-400a-96b1-c7f4c643052c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d919b560-fb13-4fb2-80f9-f59b18b3e1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b4b350bd-ca56-400a-96b1-c7f4c643052c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d919b560-fb13-4fb2-80f9-f59b18b3e1ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d919b560-fb13-4fb2-80f9-f59b18b3e1ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d919b560-fb13-4fb2-80f9-f59b18b3e1ba" xlink:to="loc_us-gaap_EquityComponentDomain_d919b560-fb13-4fb2-80f9-f59b18b3e1ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d919b560-fb13-4fb2-80f9-f59b18b3e1ba" xlink:to="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fbbff478-ed81-40c0-9d5e-788e15ebd612" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_CommonStockMember_fbbff478-ed81-40c0-9d5e-788e15ebd612" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a94f9c74-f417-40d6-b57e-52630c39d7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a94f9c74-f417-40d6-b57e-52630c39d7e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fd34c2df-1004-4056-be56-cdc7bce7a90d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fd34c2df-1004-4056-be56-cdc7bce7a90d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2fb49ecd-2b7e-41fd-af6e-d0951e7da194" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_RetainedEarningsMember_2fb49ecd-2b7e-41fd-af6e-d0951e7da194" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_195cec00-f6bc-44fa-a443-9779e7382890" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_195cec00-f6bc-44fa-a443-9779e7382890" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1d9d292f-bab7-4318-80fa-fa7b5eb948d9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b458eeeb-3e8d-40c6-a211-d627fb7665ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b458eeeb-3e8d-40c6-a211-d627fb7665ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e612968-e3e4-49c7-a0e7-0fcc296a584d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockholdersEquity_5e612968-e3e4-49c7-a0e7-0fcc296a584d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_0a589ef8-2c0a-48ed-8aab-6f973e93d7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_0a589ef8-2c0a-48ed-8aab-6f973e93d7e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_5c6929b2-666c-436e-904c-d5da902b8f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_5c6929b2-666c-436e-904c-d5da902b8f0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_651b9003-bd14-4a4a-b0d2-9d3fbe5e2baa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_651b9003-bd14-4a4a-b0d2-9d3fbe5e2baa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cc686b87-f51e-4ec8-8484-64e7d6c31788" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cc686b87-f51e-4ec8-8484-64e7d6c31788" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c4628f8e-9578-4add-8eb7-13b5c0613ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c4628f8e-9578-4add-8eb7-13b5c0613ffe" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7b2e7d3e-5941-47e4-9a95-150645e85315" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7b2e7d3e-5941-47e4-9a95-150645e85315" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_905da84f-8a83-46f3-9528-cca72da45bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_905da84f-8a83-46f3-9528-cca72da45bb8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f610d9a7-133d-4930-84c4-17881dcd38ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f610d9a7-133d-4930-84c4-17881dcd38ce" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5295a6a3-0a7b-4fab-bf50-fabc4bd944b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5295a6a3-0a7b-4fab-bf50-fabc4bd944b7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d18d77d4-ec67-4a16-8207-70d20b987bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_NetIncomeLoss_d18d77d4-ec67-4a16-8207-70d20b987bf9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_def31748-f6a7-497a-8fcf-d0f32190b1be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d06dd438-fded-4be4-8165-f8ea47a62891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ae62aba-00da-4418-b676-1ecd0e549280" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ae62aba-00da-4418-b676-1ecd0e549280" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5ae62aba-00da-4418-b676-1ecd0e549280_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ae62aba-00da-4418-b676-1ecd0e549280" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_5ae62aba-00da-4418-b676-1ecd0e549280_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ae62aba-00da-4418-b676-1ecd0e549280" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_17b5765e-11f9-4ef9-ae74-ad6251496bba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:to="loc_us-gaap_AccountsReceivableMember_17b5765e-11f9-4ef9-ae74-ad6251496bba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_41923c60-845d-4058-b1c9-c7c4a2529289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:to="loc_us-gaap_SalesRevenueNetMember_41923c60-845d-4058-b1c9-c7c4a2529289" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_47117644-1fe4-4dc3-a843-cfcb725df760" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_47117644-1fe4-4dc3-a843-cfcb725df760" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_47117644-1fe4-4dc3-a843-cfcb725df760_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_47117644-1fe4-4dc3-a843-cfcb725df760" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_47117644-1fe4-4dc3-a843-cfcb725df760_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_604b9b06-d79f-4d16-96f7-616c2457a1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_47117644-1fe4-4dc3-a843-cfcb725df760" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_604b9b06-d79f-4d16-96f7-616c2457a1a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_804ba542-bb37-4c77-b72a-40528c703170" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_604b9b06-d79f-4d16-96f7-616c2457a1a4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_804ba542-bb37-4c77-b72a-40528c703170" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_132cfce5-ce30-491a-8a89-cbcaa35e4ea7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:to="loc_srt_MajorCustomersAxis_132cfce5-ce30-491a-8a89-cbcaa35e4ea7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_132cfce5-ce30-491a-8a89-cbcaa35e4ea7_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_132cfce5-ce30-491a-8a89-cbcaa35e4ea7" xlink:to="loc_srt_NameOfMajorCustomerDomain_132cfce5-ce30-491a-8a89-cbcaa35e4ea7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_132cfce5-ce30-491a-8a89-cbcaa35e4ea7" xlink:to="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CustomerOneMember_701fcbdc-ec1a-42bc-b44b-4927d3b7032a" xlink:href="izea-20250331.xsd#izea_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:to="loc_izea_CustomerOneMember_701fcbdc-ec1a-42bc-b44b-4927d3b7032a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CustomerTwoMember_bb742f5a-09b4-4b1f-9f4c-6966dc7c68ec" xlink:href="izea-20250331.xsd#izea_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:to="loc_izea_CustomerTwoMember_bb742f5a-09b4-4b1f-9f4c-6966dc7c68ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_894e9376-1902-4866-ac1f-59f242a4bfbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_894e9376-1902-4866-ac1f-59f242a4bfbe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_41bde52b-33bd-41f4-847f-7342af45a1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_41bde52b-33bd-41f4-847f-7342af45a1bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_9524dcb7-a82f-40b6-bc30-77db758686f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_9524dcb7-a82f-40b6-bc30-77db758686f7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_09459cb5-da56-4232-a209-06a5e81b2906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_09459cb5-da56-4232-a209-06a5e81b2906" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AccountsReceivableExcludingContractAsset_d386e250-ca77-4ae5-9454-0d926d8d7ed1" xlink:href="izea-20250331.xsd#izea_AccountsReceivableExcludingContractAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_izea_AccountsReceivableExcludingContractAsset_d386e250-ca77-4ae5-9454-0d926d8d7ed1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_7a332058-c666-415e-abde-83540c57e6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_7a332058-c666-415e-abde-83540c57e6f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_cfc255b8-99e9-4737-b66a-8c93dbf02f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_cfc255b8-99e9-4737-b66a-8c93dbf02f7f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_7d82ffbf-b168-4e46-91a1-9dc7644f5948" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_7d82ffbf-b168-4e46-91a1-9dc7644f5948" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_e5afdfd8-b461-4b77-ba00-29541e732d87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_e5afdfd8-b461-4b77-ba00-29541e732d87" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePercentPastDue1_6d6f116b-bedb-4233-a72c-78f5312bd7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablePercentPastDue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_FinancingReceivablePercentPastDue1_6d6f116b-bedb-4233-a72c-78f5312bd7d1" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountPoliciesLineItems_e43d90ec-fa61-4a25-b228-44947e9501d2" xlink:href="izea-20250331.xsd#izea_SignificantAccountPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:href="izea-20250331.xsd#izea_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_e43d90ec-fa61-4a25-b228-44947e9501d2" xlink:to="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_41fa803a-48c1-4560-8161-f246163b5b68" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:to="loc_srt_RangeAxis_41fa803a-48c1-4560-8161-f246163b5b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_41fa803a-48c1-4560-8161-f246163b5b68_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_41fa803a-48c1-4560-8161-f246163b5b68" xlink:to="loc_srt_RangeMember_41fa803a-48c1-4560-8161-f246163b5b68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_41fa803a-48c1-4560-8161-f246163b5b68" xlink:to="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_393095a8-b327-40c8-9888-4e84d0473991" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:to="loc_srt_MinimumMember_393095a8-b327-40c8-9888-4e84d0473991" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_55dbc23e-aafa-455a-ad3c-3a7ec3e330c8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:to="loc_srt_MaximumMember_55dbc23e-aafa-455a-ad3c-3a7ec3e330c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4557e7b3-8f9d-4e37-9589-1e51683e5f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4557e7b3-8f9d-4e37-9589-1e51683e5f9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4557e7b3-8f9d-4e37-9589-1e51683e5f9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4557e7b3-8f9d-4e37-9589-1e51683e5f9a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_4557e7b3-8f9d-4e37-9589-1e51683e5f9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4557e7b3-8f9d-4e37-9589-1e51683e5f9a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_9422840e-4df7-41f6-8cd2-9abfbdf348f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:to="loc_us-gaap_ComputerEquipmentMember_9422840e-4df7-41f6-8cd2-9abfbdf348f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_57829c5c-7aab-48f8-b44d-225fcd57d48f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:to="loc_us-gaap_OfficeEquipmentMember_57829c5c-7aab-48f8-b44d-225fcd57d48f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_bcbb3a88-5d57-40db-922e-b01780ef3e40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_bcbb3a88-5d57-40db-922e-b01780ef3e40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1aa46f2-ee41-49fa-bc42-783bcd72482a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_e43d90ec-fa61-4a25-b228-44947e9501d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1aa46f2-ee41-49fa-bc42-783bcd72482a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountPoliciesLineItems_466761df-f49d-4477-895e-d6c844660d82" xlink:href="izea-20250331.xsd#izea_SignificantAccountPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountingPoliciesTable_8a696c2a-1afb-49df-8041-95301b0d957a" xlink:href="izea-20250331.xsd#izea_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_466761df-f49d-4477-895e-d6c844660d82" xlink:to="loc_izea_SignificantAccountingPoliciesTable_8a696c2a-1afb-49df-8041-95301b0d957a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f3aeeadb-0a3e-4f31-b37d-24c4f7896862" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a696c2a-1afb-49df-8041-95301b0d957a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f3aeeadb-0a3e-4f31-b37d-24c4f7896862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f3aeeadb-0a3e-4f31-b37d-24c4f7896862_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f3aeeadb-0a3e-4f31-b37d-24c4f7896862" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f3aeeadb-0a3e-4f31-b37d-24c4f7896862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6df3fa12-12ed-4db8-992c-95d1aa1a261e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f3aeeadb-0a3e-4f31-b37d-24c4f7896862" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6df3fa12-12ed-4db8-992c-95d1aa1a261e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_04f19e0f-3cac-406a-b9ee-5838094572ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6df3fa12-12ed-4db8-992c-95d1aa1a261e" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_04f19e0f-3cac-406a-b9ee-5838094572ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_c4ea339a-bab8-4fe9-9e3d-c822f5f0b184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_466761df-f49d-4477-895e-d6c844660d82" xlink:to="loc_us-gaap_AdvertisingExpense_c4ea339a-bab8-4fe9-9e3d-c822f5f0b184" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountPoliciesLineItems_6bbb6d1d-7b5d-4495-9bbb-b47001ce981f" xlink:href="izea-20250331.xsd#izea_SignificantAccountPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountingPoliciesTable_0a78ba3a-c4de-4f45-be67-074981ffacea" xlink:href="izea-20250331.xsd#izea_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_6bbb6d1d-7b5d-4495-9bbb-b47001ce981f" xlink:to="loc_izea_SignificantAccountingPoliciesTable_0a78ba3a-c4de-4f45-be67-074981ffacea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09aacb9b-470e-4722-89f7-fa35e537dc66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_izea_SignificantAccountingPoliciesTable_0a78ba3a-c4de-4f45-be67-074981ffacea" xlink:to="loc_us-gaap_AwardTypeAxis_09aacb9b-470e-4722-89f7-fa35e537dc66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09aacb9b-470e-4722-89f7-fa35e537dc66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_09aacb9b-470e-4722-89f7-fa35e537dc66" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_09aacb9b-470e-4722-89f7-fa35e537dc66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57ec9dc5-635f-4512-938c-fa936e5edab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_09aacb9b-470e-4722-89f7-fa35e537dc66" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57ec9dc5-635f-4512-938c-fa936e5edab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e8eb64eb-fa9a-4a78-b1cb-13e6aa6b131c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57ec9dc5-635f-4512-938c-fa936e5edab5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e8eb64eb-fa9a-4a78-b1cb-13e6aa6b131c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5d7f634-2d6a-4dff-94f6-e7106e7b3a72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_6bbb6d1d-7b5d-4495-9bbb-b47001ce981f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5d7f634-2d6a-4dff-94f6-e7106e7b3a72" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#BusinessAcquisitionsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c19c4def-99e7-4a2f-9acf-a4ad484bad92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c19c4def-99e7-4a2f-9acf-a4ad484bad92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c19c4def-99e7-4a2f-9acf-a4ad484bad92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c19c4def-99e7-4a2f-9acf-a4ad484bad92" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c19c4def-99e7-4a2f-9acf-a4ad484bad92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fbd71afd-deb0-4a35-a9e7-5186eda43e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c19c4def-99e7-4a2f-9acf-a4ad484bad92" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fbd71afd-deb0-4a35-a9e7-5186eda43e2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoozuHoldingPTYLtd.Member_3cc3f7f2-12a7-4d9d-a886-286dfaf3e61f" xlink:href="izea-20250331.xsd#izea_HoozuHoldingPTYLtd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fbd71afd-deb0-4a35-a9e7-5186eda43e2e" xlink:to="loc_izea_HoozuHoldingPTYLtd.Member_3cc3f7f2-12a7-4d9d-a886-286dfaf3e61f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_f4590a2f-0591-4bdc-8b0a-3d7b7a0150c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_f4590a2f-0591-4bdc-8b0a-3d7b7a0150c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_893c7c36-23d2-4038-bbaa-43b3c9f3cb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_f4590a2f-0591-4bdc-8b0a-3d7b7a0150c7" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_893c7c36-23d2-4038-bbaa-43b3c9f3cb7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fd4bf35-1c9a-47fa-b884-0593ff7ac35f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fd4bf35-1c9a-47fa-b884-0593ff7ac35f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22e3f4e2-9a3b-4ed2-96e8-eaad7885453e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22e3f4e2-9a3b-4ed2-96e8-eaad7885453e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_3eb92319-5d2d-4fb7-8056-5125e0c3a776" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_3eb92319-5d2d-4fb7-8056-5125e0c3a776" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts_e594cc47-e4a3-47bc-a088-c00afc66e455" xlink:href="izea-20250331.xsd#izea_LossOfDivesitureOfBusinessNetOfTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts_e594cc47-e4a3-47bc-a088-c00afc66e455" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_328dcceb-0c11-4fc3-9b58-e6989ff77eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_328dcceb-0c11-4fc3-9b58-e6989ff77eb1" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593f820b-0df5-4ec5-9918-44f3c964a6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593f820b-0df5-4ec5-9918-44f3c964a6dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_593f820b-0df5-4ec5-9918-44f3c964a6dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593f820b-0df5-4ec5-9918-44f3c964a6dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_593f820b-0df5-4ec5-9918-44f3c964a6dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593f820b-0df5-4ec5-9918-44f3c964a6dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b5d869f3-04c5-42f1-bf7e-5c2816400e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b5d869f3-04c5-42f1-bf7e-5c2816400e5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b4f763ca-f3eb-4c40-b516-2f83c85f0e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b4f763ca-f3eb-4c40-b516-2f83c85f0e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_652e5e33-b7e0-4901-92f5-514cf930d658" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_652e5e33-b7e0-4901-92f5-514cf930d658" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_652e5e33-b7e0-4901-92f5-514cf930d658_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_652e5e33-b7e0-4901-92f5-514cf930d658" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_652e5e33-b7e0-4901-92f5-514cf930d658_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_652e5e33-b7e0-4901-92f5-514cf930d658" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7d140061-e2ce-4a31-8588-ae12be08036b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7d140061-e2ce-4a31-8588-ae12be08036b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b06a3d98-468f-4734-bde7-bf94d966b72d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_CommercialPaperMember_b06a3d98-468f-4734-bde7-bf94d966b72d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_18ec7687-aea0-41ce-8e90-0549888133c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_MoneyMarketFundsMember_18ec7687-aea0-41ce-8e90-0549888133c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7a67a07d-8bf4-45e5-9684-5b3cc06e3f86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7a67a07d-8bf4-45e5-9684-5b3cc06e3f86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_1e595e03-6ff4-4aad-992e-1e9a273d9672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_1e595e03-6ff4-4aad-992e-1e9a273d9672" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ae3447f9-9738-4f12-b6ec-4b846404c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ae3447f9-9738-4f12-b6ec-4b846404c89e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_187b2013-8d8b-4d6e-81e5-5640af53d83e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_187b2013-8d8b-4d6e-81e5-5640af53d83e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3dff9e73-8474-4e57-b544-60a0dd9b9d61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3dff9e73-8474-4e57-b544-60a0dd9b9d61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_267fe177-b3b3-4956-93d8-5b0c080e76ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_267fe177-b3b3-4956-93d8-5b0c080e76ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_de541e22-8cb7-44ee-922c-bb8e1fe79f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_de541e22-8cb7-44ee-922c-bb8e1fe79f0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30efc068-f23a-4d7f-bf46-6508bba45c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30efc068-f23a-4d7f-bf46-6508bba45c4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4d5730d8-c191-4e6a-a096-a5b79c884bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4d5730d8-c191-4e6a-a096-a5b79c884bb7" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_9be1e3ba-d250-4585-9704-3e394deef6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:to="loc_us-gaap_MarketableSecuritiesTable_9be1e3ba-d250-4585-9704-3e394deef6c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9be1e3ba-d250-4585-9704-3e394deef6c4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_32066f06-315a-40df-8212-cffcf6aca88a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_32066f06-315a-40df-8212-cffcf6aca88a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0395220e-3b32-44bf-b30c-e81bf6dd1f67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0395220e-3b32-44bf-b30c-e81bf6dd1f67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ff800b12-8d35-40e4-853f-29b7680ee362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ff800b12-8d35-40e4-853f-29b7680ee362" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_08aead9b-4d6b-4067-b995-657bfd3b00a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_08aead9b-4d6b-4067-b995-657bfd3b00a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FinancialAssetsFairValueDisclosure_532e89f1-cd07-4bb0-9395-0ed80b8c0ef0" xlink:href="izea-20250331.xsd#izea_FinancialAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:to="loc_izea_FinancialAssetsFairValueDisclosure_532e89f1-cd07-4bb0-9395-0ed80b8c0ef0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_c489b9c0-261e-4973-bd2b-0857f629e7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_c489b9c0-261e-4973-bd2b-0857f629e7ee" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#PropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6bee79d0-52aa-4bb7-a306-8421c00d8e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6bee79d0-52aa-4bb7-a306-8421c00d8e5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6bee79d0-52aa-4bb7-a306-8421c00d8e5b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6bee79d0-52aa-4bb7-a306-8421c00d8e5b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6bee79d0-52aa-4bb7-a306-8421c00d8e5b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6bee79d0-52aa-4bb7-a306-8421c00d8e5b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5602d157-f0c8-4602-94ba-8c24abb0711f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5602d157-f0c8-4602-94ba-8c24abb0711f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_7591d129-d7d6-4c44-b813-94945b9756db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:to="loc_us-gaap_OfficeEquipmentMember_7591d129-d7d6-4c44-b813-94945b9756db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_26e4383e-734d-4e90-8052-5eb097cdd599" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:to="loc_us-gaap_ComputerEquipmentMember_26e4383e-734d-4e90-8052-5eb097cdd599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1039a143-bea4-40b6-877c-6d334cde33de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1039a143-bea4-40b6-877c-6d334cde33de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1039a143-bea4-40b6-877c-6d334cde33de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1039a143-bea4-40b6-877c-6d334cde33de" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1039a143-bea4-40b6-877c-6d334cde33de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_76927557-a604-4c86-bdb2-fe80cf05795c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1039a143-bea4-40b6-877c-6d334cde33de" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_76927557-a604-4c86-bdb2-fe80cf05795c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DepreciationandAmortizationExpenseMember_256cabc3-d9f8-43b2-a1d5-9ea2e4b35754" xlink:href="izea-20250331.xsd#izea_DepreciationandAmortizationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_76927557-a604-4c86-bdb2-fe80cf05795c" xlink:to="loc_izea_DepreciationandAmortizationExpenseMember_256cabc3-d9f8-43b2-a1d5-9ea2e4b35754" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fa3b8526-4503-4264-b387-cd4f1baed013" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fa3b8526-4503-4264-b387-cd4f1baed013" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5ff9b0c-0878-4d70-9cc6-7c6e0ed6cef3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5ff9b0c-0878-4d70-9cc6-7c6e0ed6cef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_13adc461-69e4-40b5-be34-3e08d6f1e20c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_13adc461-69e4-40b5-be34-3e08d6f1e20c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a7812e1e-a0ed-49e6-bbe5-4c5bc57edba4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_Depreciation_a7812e1e-a0ed-49e6-bbe5-4c5bc57edba4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fecb5e10-24f8-4ba3-a963-f143a5c61d31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fecb5e10-24f8-4ba3-a963-f143a5c61d31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fecb5e10-24f8-4ba3-a963-f143a5c61d31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fecb5e10-24f8-4ba3-a963-f143a5c61d31" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fecb5e10-24f8-4ba3-a963-f143a5c61d31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_df05c2b1-9163-4ed4-8c54-016782efebfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fecb5e10-24f8-4ba3-a963-f143a5c61d31" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_df05c2b1-9163-4ed4-8c54-016782efebfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DepreciationandAmortizationExpenseMember_f763cb10-aa33-4c7b-b9e0-9f89e6bc2431" xlink:href="izea-20250331.xsd#izea_DepreciationandAmortizationExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_df05c2b1-9163-4ed4-8c54-016782efebfd" xlink:to="loc_izea_DepreciationandAmortizationExpenseMember_f763cb10-aa33-4c7b-b9e0-9f89e6bc2431" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5fdf879c-7d9d-4744-9084-5f92636cae8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5fdf879c-7d9d-4744-9084-5f92636cae8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5fdf879c-7d9d-4744-9084-5f92636cae8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5fdf879c-7d9d-4744-9084-5f92636cae8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_5fdf879c-7d9d-4744-9084-5f92636cae8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad674bfa-5833-465d-8275-1787c6fad39b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5fdf879c-7d9d-4744-9084-5f92636cae8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad674bfa-5833-465d-8275-1787c6fad39b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DigitalAssetsMember_2c73e322-ce13-4e46-857b-faa72b77691f" xlink:href="izea-20250331.xsd#izea_DigitalAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad674bfa-5833-465d-8275-1787c6fad39b" xlink:to="loc_izea_DigitalAssetsMember_2c73e322-ce13-4e46-857b-faa72b77691f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_446d4112-74f4-4e17-bb6d-e32982c42d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_446d4112-74f4-4e17-bb6d-e32982c42d3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_99f18665-8f88-4ee5-8b80-09b5769be2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_99f18665-8f88-4ee5-8b80-09b5769be2f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_16fd73a4-0d8d-4497-bf82-8d92ecc55ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_16fd73a4-0d8d-4497-bf82-8d92ecc55ea2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#SoftwareDevelopmentCostsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ca49e573-d38d-40e8-9f7e-5f0adabb7a56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ca49e573-d38d-40e8-9f7e-5f0adabb7a56" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2513307e-9b32-457a-9031-5b8763b4ce44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ca49e573-d38d-40e8-9f7e-5f0adabb7a56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2513307e-9b32-457a-9031-5b8763b4ce44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2513307e-9b32-457a-9031-5b8763b4ce44_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2513307e-9b32-457a-9031-5b8763b4ce44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2513307e-9b32-457a-9031-5b8763b4ce44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96a4d788-ca79-4d74-b20b-6192bdb57084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2513307e-9b32-457a-9031-5b8763b4ce44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96a4d788-ca79-4d74-b20b-6192bdb57084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_d24694af-9d06-49d3-aa12-76200ca00ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96a4d788-ca79-4d74-b20b-6192bdb57084" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_d24694af-9d06-49d3-aa12-76200ca00ef7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_a7e2c57f-bc9a-43e9-8718-125579d5a0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_a7e2c57f-bc9a-43e9-8718-125579d5a0cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_1c236c31-db25-4e35-b5ce-683096620fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_1c236c31-db25-4e35-b5ce-683096620fb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3edbac0a-1a95-4f3f-a16c-5bcff6537176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3edbac0a-1a95-4f3f-a16c-5bcff6537176" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3eaddcd0-f99e-4cc2-90d4-4925b4e8ba14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3eaddcd0-f99e-4cc2-90d4-4925b4e8ba14" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#AccruedExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b506eb19-3fe3-46c0-b5ea-802941db738f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b506eb19-3fe3-46c0-b5ea-802941db738f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_ec8ce980-08a7-473d-9dee-8383ba762cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b506eb19-3fe3-46c0-b5ea-802941db738f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_ec8ce980-08a7-473d-9dee-8383ba762cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_ec8ce980-08a7-473d-9dee-8383ba762cd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ec8ce980-08a7-473d-9dee-8383ba762cd5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_ec8ce980-08a7-473d-9dee-8383ba762cd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2d23da5a-d8df-4dc8-b3f7-747e46e4133f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ec8ce980-08a7-473d-9dee-8383ba762cd5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2d23da5a-d8df-4dc8-b3f7-747e46e4133f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_b5414faf-d553-41c9-aa54-1acbd0b099f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2d23da5a-d8df-4dc8-b3f7-747e46e4133f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_b5414faf-d553-41c9-aa54-1acbd0b099f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_617c5215-445d-4c87-875f-7f238e4e4829" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_617c5215-445d-4c87-875f-7f238e4e4829" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_aa745979-0f24-4ee9-9913-8558b909292c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:to="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_aa745979-0f24-4ee9-9913-8558b909292c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CommitmentsandContingenciesRetirementPlansDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_1dee4d2f-825d-4632-9d5f-5ff6e7c03e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_OtherCommitmentsTable_1dee4d2f-825d-4632-9d5f-5ff6e7c03e5f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_43e258d5-95c7-44b7-86d4-39e59c95f660" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_1dee4d2f-825d-4632-9d5f-5ff6e7c03e5f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_43e258d5-95c7-44b7-86d4-39e59c95f660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_43e258d5-95c7-44b7-86d4-39e59c95f660_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43e258d5-95c7-44b7-86d4-39e59c95f660" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_43e258d5-95c7-44b7-86d4-39e59c95f660_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43e258d5-95c7-44b7-86d4-39e59c95f660" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_5047de31-3d3d-4f55-97e3-728f53b64812" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:to="loc_us-gaap_CostOfSalesMember_5047de31-3d3d-4f55-97e3-728f53b64812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_2a081e2f-b3de-4f5b-8855-22e949ebd76f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_2a081e2f-b3de-4f5b-8855-22e949ebd76f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_96959269-1459-49ec-98a1-d58b3f919d19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_96959269-1459-49ec-98a1-d58b3f919d19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_541be15f-02c3-492b-919f-1beadb1dcd87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_541be15f-02c3-492b-919f-1beadb1dcd87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5beba1be-62ce-4daa-b5db-0470fe52fc60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5beba1be-62ce-4daa-b5db-0470fe52fc60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_918c4702-2d5b-4707-9e19-e59aba703645" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_918c4702-2d5b-4707-9e19-e59aba703645" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService_52ba1b12-d928-43e1-bab7-a99695dd6a01" xlink:href="izea-20250331.xsd#izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService_52ba1b12-d928-43e1-bab7-a99695dd6a01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_54f4b8eb-c1e5-4b35-af98-dd635174b349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_54f4b8eb-c1e5-4b35-af98-dd635174b349" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityAuthorizedSharesDetail"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_333cbe20-3789-4f55-9f37-0eb667b74f36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dda6f782-564f-4ae4-ac7e-1a089ab516b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_333cbe20-3789-4f55-9f37-0eb667b74f36" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dda6f782-564f-4ae4-ac7e-1a089ab516b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fb155814-da5c-468f-a501-e514b4c2cbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dda6f782-564f-4ae4-ac7e-1a089ab516b0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fb155814-da5c-468f-a501-e514b4c2cbd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fb155814-da5c-468f-a501-e514b4c2cbd4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fb155814-da5c-468f-a501-e514b4c2cbd4" xlink:to="loc_us-gaap_ClassOfStockDomain_fb155814-da5c-468f-a501-e514b4c2cbd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fa47078b-c029-4b47-b884-8c177d00def3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fb155814-da5c-468f-a501-e514b4c2cbd4" xlink:to="loc_us-gaap_ClassOfStockDomain_fa47078b-c029-4b47-b884-8c177d00def3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_6d8ca7fb-d29f-4f83-950f-b0ed8bdf7dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_fa47078b-c029-4b47-b884-8c177d00def3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_6d8ca7fb-d29f-4f83-950f-b0ed8bdf7dc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3261705c-255a-4f8c-99c0-4075abd8ef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_333cbe20-3789-4f55-9f37-0eb667b74f36" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3261705c-255a-4f8c-99c0-4075abd8ef1e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityShareRepurchaseDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f4e34a1-ec3e-448f-8a57-2c6ce5b8cadf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f4e34a1-ec3e-448f-8a57-2c6ce5b8cadf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_517e3a19-cb84-482b-844e-52a61063f39e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f4e34a1-ec3e-448f-8a57-2c6ce5b8cadf" xlink:to="loc_srt_ShareRepurchaseProgramAxis_517e3a19-cb84-482b-844e-52a61063f39e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_517e3a19-cb84-482b-844e-52a61063f39e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ShareRepurchaseProgramAxis_517e3a19-cb84-482b-844e-52a61063f39e" xlink:to="loc_srt_ShareRepurchaseProgramDomain_517e3a19-cb84-482b-844e-52a61063f39e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ShareRepurchaseProgramAxis_517e3a19-cb84-482b-844e-52a61063f39e" xlink:to="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ActiveRepurchaseProgramMember_a9773bf9-81b2-4157-9c46-62733585ef8a" xlink:href="izea-20250331.xsd#izea_ActiveRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:to="loc_izea_ActiveRepurchaseProgramMember_a9773bf9-81b2-4157-9c46-62733585ef8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ExpiredAndActiveRepurchaseProgramsMember_058d3961-266d-4df1-acd2-8001843e8b2f" xlink:href="izea-20250331.xsd#izea_ExpiredAndActiveRepurchaseProgramsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:to="loc_izea_ExpiredAndActiveRepurchaseProgramsMember_058d3961-266d-4df1-acd2-8001843e8b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_504ae195-2080-403c-a7ce-77f23bf21278" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_504ae195-2080-403c-a7ce-77f23bf21278" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_d975ea4b-46a8-402c-aed5-53890561e786" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_d975ea4b-46a8-402c-aed5-53890561e786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1f6ee1d1-3b31-4a17-aa80-80c62c9a7c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_1f6ee1d1-3b31-4a17-aa80-80c62c9a7c4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38810c6d-71d2-4cf0-b96f-9e7c0de96a60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38810c6d-71d2-4cf0-b96f-9e7c0de96a60" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityEquityIncentivePlanDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_088ea770-95ec-40f0-9d44-77035e54c9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_088ea770-95ec-40f0-9d44-77035e54c9ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_088ea770-95ec-40f0-9d44-77035e54c9ae" xlink:to="loc_us-gaap_PlanNameAxis_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf" xlink:to="loc_us-gaap_PlanNameDomain_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4859426f-7c0e-45df-b1c8-3ae652faab72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf" xlink:to="loc_us-gaap_PlanNameDomain_4859426f-7c0e-45df-b1c8-3ae652faab72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TheAmendedandRestatedMay2011PlanMember_27cb737b-d43f-45e9-b122-eebed62ed425" xlink:href="izea-20250331.xsd#izea_TheAmendedandRestatedMay2011PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4859426f-7c0e-45df-b1c8-3ae652faab72" xlink:to="loc_izea_TheAmendedandRestatedMay2011PlanMember_27cb737b-d43f-45e9-b122-eebed62ed425" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease_3381a14c-ece8-4508-b24b-7c324d696b01" xlink:href="izea-20250331.xsd#izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:to="loc_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease_3381a14c-ece8-4508-b24b-7c324d696b01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0ad3b634-78b5-4274-b482-ad30978e228d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0ad3b634-78b5-4274-b482-ad30978e228d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_f9538107-6a9c-4940-b359-cf969cb9a7aa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:to="loc_srt_TitleOfIndividualAxis_f9538107-6a9c-4940-b359-cf969cb9a7aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f9538107-6a9c-4940-b359-cf969cb9a7aa_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_f9538107-6a9c-4940-b359-cf969cb9a7aa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_f9538107-6a9c-4940-b359-cf969cb9a7aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_f9538107-6a9c-4940-b359-cf969cb9a7aa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_8b119e7c-8b0d-4c47-9a24-f474c810def8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:to="loc_srt_DirectorMember_8b119e7c-8b0d-4c47-9a24-f474c810def8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EmployeesMember_7c9552d6-13df-4825-8cd7-a27ea859c18f" xlink:href="izea-20250331.xsd#izea_EmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:to="loc_izea_EmployeesMember_7c9552d6-13df-4825-8cd7-a27ea859c18f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_IndependentDirectorsMember_a0597b3c-3e92-4516-b4c4-4c95f7e241e0" xlink:href="izea-20250331.xsd#izea_IndependentDirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:to="loc_izea_IndependentDirectorsMember_a0597b3c-3e92-4516-b4c4-4c95f7e241e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_50021572-9c84-4b30-a151-8e9941634a57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:to="loc_us-gaap_AwardTypeAxis_50021572-9c84-4b30-a151-8e9941634a57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50021572-9c84-4b30-a151-8e9941634a57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_50021572-9c84-4b30-a151-8e9941634a57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_50021572-9c84-4b30-a151-8e9941634a57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74c39d92-b0bf-405d-82f2-79dd766e6e19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_50021572-9c84-4b30-a151-8e9941634a57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74c39d92-b0bf-405d-82f2-79dd766e6e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_854b2bc7-7b68-4e70-b42a-9cb8af34005e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74c39d92-b0bf-405d-82f2-79dd766e6e19" xlink:to="loc_us-gaap_RestrictedStockMember_854b2bc7-7b68-4e70-b42a-9cb8af34005e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Numberofindependentdirectors_d1361e20-5c48-4d63-bfcc-2ea3fc4dfb12" xlink:href="izea-20250331.xsd#izea_Numberofindependentdirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_izea_Numberofindependentdirectors_d1361e20-5c48-4d63-bfcc-2ea3fc4dfb12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdeee7d6-f3cb-4c12-8ce0-f17a6bf3ee0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdeee7d6-f3cb-4c12-8ce0-f17a6bf3ee0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_f59ad274-9c0b-44c7-974d-b635f9cfa948" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_f59ad274-9c0b-44c7-974d-b635f9cfa948" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_4d503110-a4b5-4d81-9e5d-cfab22fe9589" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_RestrictedStockExpense_4d503110-a4b5-4d81-9e5d-cfab22fe9589" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockFairValue_1691b3cb-b402-46da-a8f4-a5d3f5f33755" xlink:href="izea-20250331.xsd#izea_CommonStockFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_izea_CommonStockFairValue_1691b3cb-b402-46da-a8f4-a5d3f5f33755" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_d14cb4c7-bcf7-4239-8f97-b2c2fd9d13c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_d14cb4c7-bcf7-4239-8f97-b2c2fd9d13c1" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityScheduleofNonVestedRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5fac9a6-0e57-4f78-837c-901fdfcbe378" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5fac9a6-0e57-4f78-837c-901fdfcbe378" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8e41998d-9c3d-4328-a858-1dbd88ae6e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5fac9a6-0e57-4f78-837c-901fdfcbe378" xlink:to="loc_us-gaap_AwardTypeAxis_8e41998d-9c3d-4328-a858-1dbd88ae6e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e41998d-9c3d-4328-a858-1dbd88ae6e8d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8e41998d-9c3d-4328-a858-1dbd88ae6e8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8e41998d-9c3d-4328-a858-1dbd88ae6e8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a558757-8e98-44f3-bf90-d552c2f7f40f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8e41998d-9c3d-4328-a858-1dbd88ae6e8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a558757-8e98-44f3-bf90-d552c2f7f40f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_91000957-a108-4d84-863c-0820a42f0038" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a558757-8e98-44f3-bf90-d552c2f7f40f" xlink:to="loc_us-gaap_RestrictedStockMember_91000957-a108-4d84-863c-0820a42f0038" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67357d56-7142-4b14-bb64-ff131411646a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67357d56-7142-4b14-bb64-ff131411646a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4a33fc7d-1fe0-4832-8f5b-7027d8e431ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4a33fc7d-1fe0-4832-8f5b-7027d8e431ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03547ef2-30ab-404c-8205-5a5a3ba2704b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03547ef2-30ab-404c-8205-5a5a3ba2704b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_be33299f-ef48-459e-ac54-99dc1ccbb6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c2dbda0-6cd1-4c74-99ad-27c4939aa382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c2dbda0-6cd1-4c74-99ad-27c4939aa382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_587fb732-9926-425f-9cdd-f079f0a64b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_587fb732-9926-425f-9cdd-f079f0a64b4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_900d7157-3c21-444a-ad60-ea3bd9ea2bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_900d7157-3c21-444a-ad60-ea3bd9ea2bf4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f9cedb02-94e3-4716-bb8b-c13048b8a688" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_13a08195-e4dc-41ca-b9a2-3b9bf3e2b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_13a08195-e4dc-41ca-b9a2-3b9bf3e2b05f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_91f64959-3f50-4046-9ed1-f8d3b3255495" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:to="loc_srt_TitleOfIndividualAxis_91f64959-3f50-4046-9ed1-f8d3b3255495" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_91f64959-3f50-4046-9ed1-f8d3b3255495_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_91f64959-3f50-4046-9ed1-f8d3b3255495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_91f64959-3f50-4046-9ed1-f8d3b3255495_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_91f64959-3f50-4046-9ed1-f8d3b3255495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EmployeesMember_ac67bab7-a8b2-45ae-837f-6653761ff573" xlink:href="izea-20250331.xsd#izea_EmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:to="loc_izea_EmployeesMember_ac67bab7-a8b2-45ae-837f-6653761ff573" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_238dce03-881e-449e-9176-b4209c9833eb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:to="loc_srt_ExecutiveOfficerMember_238dce03-881e-449e-9176-b4209c9833eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_NonExecutiveEmployeesMember_e42b5a61-041b-460f-987a-e6a7362db6a4" xlink:href="izea-20250331.xsd#izea_NonExecutiveEmployeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:to="loc_izea_NonExecutiveEmployeesMember_e42b5a61-041b-460f-987a-e6a7362db6a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bec37d91-32dc-43f2-b9d2-ea08ca6979c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:to="loc_us-gaap_AwardTypeAxis_bec37d91-32dc-43f2-b9d2-ea08ca6979c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec37d91-32dc-43f2-b9d2-ea08ca6979c1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_bec37d91-32dc-43f2-b9d2-ea08ca6979c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec37d91-32dc-43f2-b9d2-ea08ca6979c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a77c9fc-6abc-40e2-9da7-40fe7697624c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_bec37d91-32dc-43f2-b9d2-ea08ca6979c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a77c9fc-6abc-40e2-9da7-40fe7697624c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c05d52c9-3fe2-43bc-8a52-8c426199c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a77c9fc-6abc-40e2-9da7-40fe7697624c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c05d52c9-3fe2-43bc-8a52-8c426199c4ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e38059f3-9158-4c2a-9792-94787918f484" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:to="loc_srt_RangeAxis_e38059f3-9158-4c2a-9792-94787918f484" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e38059f3-9158-4c2a-9792-94787918f484_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e38059f3-9158-4c2a-9792-94787918f484" xlink:to="loc_srt_RangeMember_e38059f3-9158-4c2a-9792-94787918f484_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e38059f3-9158-4c2a-9792-94787918f484" xlink:to="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a3a5f4b6-5677-460c-8615-45b88a1c51cf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:to="loc_srt_MinimumMember_a3a5f4b6-5677-460c-8615-45b88a1c51cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b337cf4-258d-41d3-9bb2-40551a792d8c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:to="loc_srt_MaximumMember_6b337cf4-258d-41d3-9bb2-40551a792d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3be8a2df-1413-46e0-abce-87a5cb6c702e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3be8a2df-1413-46e0-abce-87a5cb6c702e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1d5a46f8-302f-46b4-9ae1-4bc8699389ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1d5a46f8-302f-46b4-9ae1-4bc8699389ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e678cdae-c371-41f6-8b0d-3cfa1fc1630a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e678cdae-c371-41f6-8b0d-3cfa1fc1630a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockFairValue_e3796817-d66d-4e6f-8adb-b9642c08ed68" xlink:href="izea-20250331.xsd#izea_CommonStockFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_izea_CommonStockFairValue_e3796817-d66d-4e6f-8adb-b9642c08ed68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_e923f155-6bbf-4a84-93fa-519b1d3c52eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_RestrictedStockExpense_e923f155-6bbf-4a84-93fa-519b1d3c52eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_5f213951-dd69-4f75-accc-e9e218171ece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_5f213951-dd69-4f75-accc-e9e218171ece" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Fairvalueofcommonstockissuedforfutureservices_8f75f291-6d04-406c-b319-7cce9b172d4b" xlink:href="izea-20250331.xsd#izea_Fairvalueofcommonstockissuedforfutureservices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_izea_Fairvalueofcommonstockissuedforfutureservices_8f75f291-6d04-406c-b319-7cce9b172d4b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_75da5c8e-f035-4126-9159-0f4fa4e4444a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_75da5c8e-f035-4126-9159-0f4fa4e4444a" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityRestrictedStockUnitsScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc36e087-4ee5-48c0-a0c0-64ff40ea24c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc36e087-4ee5-48c0-a0c0-64ff40ea24c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c009d8ce-5014-4471-bf11-87635453e8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc36e087-4ee5-48c0-a0c0-64ff40ea24c0" xlink:to="loc_us-gaap_AwardTypeAxis_c009d8ce-5014-4471-bf11-87635453e8b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c009d8ce-5014-4471-bf11-87635453e8b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c009d8ce-5014-4471-bf11-87635453e8b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c009d8ce-5014-4471-bf11-87635453e8b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fcf28fd-5c99-4a97-b434-be724c11d5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c009d8ce-5014-4471-bf11-87635453e8b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fcf28fd-5c99-4a97-b434-be724c11d5b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_38485bef-2c23-4bba-a254-8dbd5dfc7393" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fcf28fd-5c99-4a97-b434-be724c11d5b0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_38485bef-2c23-4bba-a254-8dbd5dfc7393" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20aa2398-e45d-4996-8a5b-2b8683f2d200" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20aa2398-e45d-4996-8a5b-2b8683f2d200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_25c530be-599b-4cdd-a822-f06472d78da9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_25c530be-599b-4cdd-a822-f06472d78da9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_08dccea6-f421-47d1-916d-f9640941a0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_08dccea6-f421-47d1-916d-f9640941a0f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_16177f53-031f-448d-8045-bb5850f253d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_16177f53-031f-448d-8045-bb5850f253d5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8589072-2996-40f0-a021-898a7a9ce44e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_710ea12c-06b0-4a1b-ad69-ddef8b809a48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_710ea12c-06b0-4a1b-ad69-ddef8b809a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9df2d0c8-b91c-4b8a-b80e-cb8f1763bb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9df2d0c8-b91c-4b8a-b80e-cb8f1763bb0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52127a26-bd98-4e90-a23f-8c092430c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52127a26-bd98-4e90-a23f-8c092430c9ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6df2977a-dedf-43ab-a1b3-102a3fda8513" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6df2977a-dedf-43ab-a1b3-102a3fda8513" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_342a27f4-3a95-4a58-951d-cebb480bc096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1b1c2131-9820-48ac-b977-2603a1286e37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1b1c2131-9820-48ac-b977-2603a1286e37" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityStockOptionsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_VestingFrequencyAxis_3644f5dd-87c8-489e-9268-4236041d76ab" xlink:href="izea-20250331.xsd#izea_VestingFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_izea_VestingFrequencyAxis_3644f5dd-87c8-489e-9268-4236041d76ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_VestingFrequencyDomain_3644f5dd-87c8-489e-9268-4236041d76ab_default" xlink:href="izea-20250331.xsd#izea_VestingFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_izea_VestingFrequencyAxis_3644f5dd-87c8-489e-9268-4236041d76ab" xlink:to="loc_izea_VestingFrequencyDomain_3644f5dd-87c8-489e-9268-4236041d76ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:href="izea-20250331.xsd#izea_VestingFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_izea_VestingFrequencyAxis_3644f5dd-87c8-489e-9268-4236041d76ab" xlink:to="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TotalvestingperiodMember_8ed48004-6773-497e-b5e5-543acd306c6c" xlink:href="izea-20250331.xsd#izea_TotalvestingperiodMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:to="loc_izea_TotalvestingperiodMember_8ed48004-6773-497e-b5e5-543acd306c6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TwelveMonthsAfterGrantDateMember_970b97f5-6ba3-4f9e-825f-95b567035fa0" xlink:href="izea-20250331.xsd#izea_TwelveMonthsAfterGrantDateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:to="loc_izea_TwelveMonthsAfterGrantDateMember_970b97f5-6ba3-4f9e-825f-95b567035fa0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MonthlyInEqualInstallmentsMember_fe357174-681f-4153-b3df-87fd1180e2e7" xlink:href="izea-20250331.xsd#izea_MonthlyInEqualInstallmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:to="loc_izea_MonthlyInEqualInstallmentsMember_fe357174-681f-4153-b3df-87fd1180e2e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOwnershipPlanAxis_ccc921d1-6c9b-407c-94b6-52790c8e482f" xlink:href="izea-20250331.xsd#izea_StockOwnershipPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_izea_StockOwnershipPlanAxis_ccc921d1-6c9b-407c-94b6-52790c8e482f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOwnershipPlanDomain_ccc921d1-6c9b-407c-94b6-52790c8e482f_default" xlink:href="izea-20250331.xsd#izea_StockOwnershipPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_izea_StockOwnershipPlanAxis_ccc921d1-6c9b-407c-94b6-52790c8e482f" xlink:to="loc_izea_StockOwnershipPlanDomain_ccc921d1-6c9b-407c-94b6-52790c8e482f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOwnershipPlanDomain_f51cbb6b-a363-4693-81b1-63da8fcf95d9" xlink:href="izea-20250331.xsd#izea_StockOwnershipPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_izea_StockOwnershipPlanAxis_ccc921d1-6c9b-407c-94b6-52790c8e482f" xlink:to="loc_izea_StockOwnershipPlanDomain_f51cbb6b-a363-4693-81b1-63da8fcf95d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_IndividualStockOwnershipInExcessOf10PercentMember_79abf7a1-a4a4-4f6f-958f-1f9e3f132677" xlink:href="izea-20250331.xsd#izea_IndividualStockOwnershipInExcessOf10PercentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_StockOwnershipPlanDomain_f51cbb6b-a363-4693-81b1-63da8fcf95d9" xlink:to="loc_izea_IndividualStockOwnershipInExcessOf10PercentMember_79abf7a1-a4a4-4f6f-958f-1f9e3f132677" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b11b6bd2-a24e-40b1-a22b-9128542352d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_us-gaap_AwardTypeAxis_b11b6bd2-a24e-40b1-a22b-9128542352d4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b11b6bd2-a24e-40b1-a22b-9128542352d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b11b6bd2-a24e-40b1-a22b-9128542352d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b11b6bd2-a24e-40b1-a22b-9128542352d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93b80627-ec68-475c-8618-fe0bb726510b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b11b6bd2-a24e-40b1-a22b-9128542352d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93b80627-ec68-475c-8618-fe0bb726510b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fed2b449-e874-4749-b92b-29b4e8e14b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93b80627-ec68-475c-8618-fe0bb726510b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fed2b449-e874-4749-b92b-29b4e8e14b6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ce954e1c-41dd-4a11-aa81-62700eebdb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_us-gaap_PlanNameAxis_ce954e1c-41dd-4a11-aa81-62700eebdb0f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ce954e1c-41dd-4a11-aa81-62700eebdb0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ce954e1c-41dd-4a11-aa81-62700eebdb0f" xlink:to="loc_us-gaap_PlanNameDomain_ce954e1c-41dd-4a11-aa81-62700eebdb0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ce954e1c-41dd-4a11-aa81-62700eebdb0f" xlink:to="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_May2011AndAugust2011EquityIncentivePlansMember_d029a36a-8935-48d2-a956-af9f3d6964e0" xlink:href="izea-20250331.xsd#izea_May2011AndAugust2011EquityIncentivePlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:to="loc_izea_May2011AndAugust2011EquityIncentivePlansMember_d029a36a-8935-48d2-a956-af9f3d6964e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EquityIncentive2011PlanMember_c7e53918-a69f-457e-83a5-ce921d5624fb" xlink:href="izea-20250331.xsd#izea_EquityIncentive2011PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:to="loc_izea_EquityIncentive2011PlanMember_c7e53918-a69f-457e-83a5-ce921d5624fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Percentageofindividualownershipofcommonstock_c365e3ef-8c30-4e41-9247-e1ebb0d1f917" xlink:href="izea-20250331.xsd#izea_Percentageofindividualownershipofcommonstock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_Percentageofindividualownershipofcommonstock_c365e3ef-8c30-4e41-9247-e1ebb0d1f917" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FairMarketValueOfIncentiveStockOptions_56e77bb6-4612-4ff7-85bc-ad1cacd3a86f" xlink:href="izea-20250331.xsd#izea_FairMarketValueOfIncentiveStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_FairMarketValueOfIncentiveStockOptions_56e77bb6-4612-4ff7-85bc-ad1cacd3a86f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2e96798-acd8-4680-8a45-02ca02ba80d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2e96798-acd8-4680-8a45-02ca02ba80d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOptionVestingPeriodFromGrantDate_f57ebee7-c670-47a4-aee7-a6f12ce305e4" xlink:href="izea-20250331.xsd#izea_StockOptionVestingPeriodFromGrantDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_StockOptionVestingPeriodFromGrantDate_f57ebee7-c670-47a4-aee7-a6f12ce305e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockFairValue_d7770417-b68f-486f-9ba6-e9ea03e58c3e" xlink:href="izea-20250331.xsd#izea_CommonStockFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_CommonStockFairValue_d7770417-b68f-486f-9ba6-e9ea03e58c3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_34102a38-1e3d-4426-9ed0-b7f2ed5ee382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_34102a38-1e3d-4426-9ed0-b7f2ed5ee382" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ece6253a-6a96-45d9-b1bd-5283cd0d598b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ece6253a-6a96-45d9-b1bd-5283cd0d598b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a0c5975b-d1d9-4dfb-98c6-b09d8bbf0c75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a0c5975b-d1d9-4dfb-98c6-b09d8bbf0c75" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7966c522-9616-49e5-8a3d-d4e9c2c403e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7966c522-9616-49e5-8a3d-d4e9c2c403e9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7e5b262e-6291-408e-8f5e-1b6aae2b1cff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7e5b262e-6291-408e-8f5e-1b6aae2b1cff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_59f3924d-e783-4fab-8d3e-da875543cce8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_59f3924d-e783-4fab-8d3e-da875543cce8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense_81da66de-bbea-42ec-a981-31215327b334" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_StockOptionPlanExpense_81da66de-bbea-42ec-a981-31215327b334" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cbe86e43-cd6f-4b6f-a341-893f029c2d63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cbe86e43-cd6f-4b6f-a341-893f029c2d63" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_db42a4cc-1ee7-40cd-9f34-bcba029a8d04" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_db42a4cc-1ee7-40cd-9f34-bcba029a8d04" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6427f04b-df38-4b78-a0d8-7736aaba7caf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6427f04b-df38-4b78-a0d8-7736aaba7caf" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityScheduleofOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6e8e815a-1bc5-4b85-83ff-c6219733aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6e8e815a-1bc5-4b85-83ff-c6219733aab6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4afb1ee4-cc20-4850-8d81-31318972f8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6e8e815a-1bc5-4b85-83ff-c6219733aab6" xlink:to="loc_us-gaap_PlanNameAxis_4afb1ee4-cc20-4850-8d81-31318972f8e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4afb1ee4-cc20-4850-8d81-31318972f8e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4afb1ee4-cc20-4850-8d81-31318972f8e9" xlink:to="loc_us-gaap_PlanNameDomain_4afb1ee4-cc20-4850-8d81-31318972f8e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_828a7af7-b28a-4b9e-9743-524b6810a90b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4afb1ee4-cc20-4850-8d81-31318972f8e9" xlink:to="loc_us-gaap_PlanNameDomain_828a7af7-b28a-4b9e-9743-524b6810a90b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EquityIncentive2011PlanMember_937f9c41-b30c-4cc0-a47a-5fcb53dae0c1" xlink:href="izea-20250331.xsd#izea_EquityIncentive2011PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_828a7af7-b28a-4b9e-9743-524b6810a90b" xlink:to="loc_izea_EquityIncentive2011PlanMember_937f9c41-b30c-4cc0-a47a-5fcb53dae0c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c3f59bdb-d180-4257-a114-806f2d50ac31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c3f59bdb-d180-4257-a114-806f2d50ac31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae7ca259-2ec5-441a-810c-01be3a7bbed8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae7ca259-2ec5-441a-810c-01be3a7bbed8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2c9cac47-3b4d-44e9-9a41-efc88b31655c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2c9cac47-3b4d-44e9-9a41-efc88b31655c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_419675d9-08f6-4fb2-8563-54eb77ba4e43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_419675d9-08f6-4fb2-8563-54eb77ba4e43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3e902692-eb75-4750-8ef6-3e3f5cd70a79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14ea619f-1b27-4a2a-b082-270adf59862b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14ea619f-1b27-4a2a-b082-270adf59862b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0dabe7f5-32b2-4e5a-9b47-ec68af5b7311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0dabe7f5-32b2-4e5a-9b47-ec68af5b7311" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eecda31d-2498-436d-a46c-61ce195cd6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eecda31d-2498-436d-a46c-61ce195cd6fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ed5367f8-f8fb-43b9-a82d-9ee17f77fae2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ed5367f8-f8fb-43b9-a82d-9ee17f77fae2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dd1e8fd4-2f1a-4092-8279-1925c35df9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_38e57bf1-aa86-4a44-9589-fa65dc9b2e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_38e57bf1-aa86-4a44-9589-fa65dc9b2e5d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_78d2b74b-78d7-4f52-93f6-ac8b34bc5658" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_78d2b74b-78d7-4f52-93f6-ac8b34bc5658" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ada9fe8-9b96-4753-8f9e-9372eb64ac6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ada9fe8-9b96-4753-8f9e-9372eb64ac6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b2d7ded7-a290-437f-964a-45da96efe1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b2d7ded7-a290-437f-964a-45da96efe1aa" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityScheduleofNonvestedStockOptionDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_081baa4e-94c9-4a34-a626-aa119124e070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_081baa4e-94c9-4a34-a626-aa119124e070" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8b42ca91-a118-4ee9-9479-703a8ed0fdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_081baa4e-94c9-4a34-a626-aa119124e070" xlink:to="loc_us-gaap_PlanNameAxis_8b42ca91-a118-4ee9-9479-703a8ed0fdd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8b42ca91-a118-4ee9-9479-703a8ed0fdd6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_8b42ca91-a118-4ee9-9479-703a8ed0fdd6" xlink:to="loc_us-gaap_PlanNameDomain_8b42ca91-a118-4ee9-9479-703a8ed0fdd6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_588d7b24-2f93-4f44-8b93-22d1a9985fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_8b42ca91-a118-4ee9-9479-703a8ed0fdd6" xlink:to="loc_us-gaap_PlanNameDomain_588d7b24-2f93-4f44-8b93-22d1a9985fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EquityIncentive2011PlanMember_180f49bf-9225-4655-8bf0-0dc572d84285" xlink:href="izea-20250331.xsd#izea_EquityIncentive2011PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_588d7b24-2f93-4f44-8b93-22d1a9985fdb" xlink:to="loc_izea_EquityIncentive2011PlanMember_180f49bf-9225-4655-8bf0-0dc572d84285" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_9685c675-b814-4878-839f-cfe2c1fef4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_9685c675-b814-4878-839f-cfe2c1fef4bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_8c252a77-2948-4629-a18e-8686e88c80b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_8c252a77-2948-4629-a18e-8686e88c80b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6cc2fb96-81e0-4575-87ef-29e6c9cdcd17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6cc2fb96-81e0-4575-87ef-29e6c9cdcd17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2a657c58-b5b9-4a47-9ee5-9f90412ea1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:to="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c60b2d54-cf40-469e-94bc-bd9624060360" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c60b2d54-cf40-469e-94bc-bd9624060360" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3c736b5a-7a93-48fd-b4a2-3941aff0575f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3c736b5a-7a93-48fd-b4a2-3941aff0575f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_4ba55dd6-a77f-4959-94f8-2782e007e4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_4ba55dd6-a77f-4959-94f8-2782e007e4c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_a138b2fd-ca73-4b46-94aa-c6dc50593fed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_c695d3d1-8fc1-4267-aeb8-b6dfcef6e53d" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:to="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_c695d3d1-8fc1-4267-aeb8-b6dfcef6e53d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityInducementPlanDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityInducementPlanDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityInducementPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c59c9f1a-7932-46c2-a406-ffc069e8efb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:to="loc_us-gaap_AwardTypeAxis_c59c9f1a-7932-46c2-a406-ffc069e8efb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c9f1a-7932-46c2-a406-ffc069e8efb9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c59c9f1a-7932-46c2-a406-ffc069e8efb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c59c9f1a-7932-46c2-a406-ffc069e8efb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c59c9f1a-7932-46c2-a406-ffc069e8efb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ff774a18-1cf5-4ad4-8575-68a3fb27d85a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ff774a18-1cf5-4ad4-8575-68a3fb27d85a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_InducementGrantRelatedRSUsMember_240ea1ff-4431-4bab-9678-ed1cf57a3bd2" xlink:href="izea-20250331.xsd#izea_InducementGrantRelatedRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:to="loc_izea_InducementGrantRelatedRSUsMember_240ea1ff-4431-4bab-9678-ed1cf57a3bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fd746215-fe3a-40a9-b3e1-740ebf73596d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:to="loc_us-gaap_PlanNameAxis_fd746215-fe3a-40a9-b3e1-740ebf73596d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fd746215-fe3a-40a9-b3e1-740ebf73596d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_fd746215-fe3a-40a9-b3e1-740ebf73596d" xlink:to="loc_us-gaap_PlanNameDomain_fd746215-fe3a-40a9-b3e1-740ebf73596d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_fd746215-fe3a-40a9-b3e1-740ebf73596d" xlink:to="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TimeBasedRSUsMember_d71188f1-d089-4759-8d25-0d278959e1c9" xlink:href="izea-20250331.xsd#izea_TimeBasedRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:to="loc_izea_TimeBasedRSUsMember_d71188f1-d089-4759-8d25-0d278959e1c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceBasedRSUsMember_613f53fe-c0f5-4d8c-ad01-29aea0b23188" xlink:href="izea-20250331.xsd#izea_PerformanceBasedRSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:to="loc_izea_PerformanceBasedRSUsMember_613f53fe-c0f5-4d8c-ad01-29aea0b23188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceBasedAndTimeBasedRSUAwardsMember_c0ce9b92-92b6-4fff-b483-f9458ed32aa7" xlink:href="izea-20250331.xsd#izea_PerformanceBasedAndTimeBasedRSUAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:to="loc_izea_PerformanceBasedAndTimeBasedRSUAwardsMember_c0ce9b92-92b6-4fff-b483-f9458ed32aa7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7d353292-6119-4bc8-91b1-75e87b3c25fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7d353292-6119-4bc8-91b1-75e87b3c25fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7d353292-6119-4bc8-91b1-75e87b3c25fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d353292-6119-4bc8-91b1-75e87b3c25fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_7d353292-6119-4bc8-91b1-75e87b3c25fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9756e303-3f5c-4869-a9ec-7f8956cdcd91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d353292-6119-4bc8-91b1-75e87b3c25fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9756e303-3f5c-4869-a9ec-7f8956cdcd91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoozuHoldingsInc.Member_016960cb-afb3-43db-948a-62532169f506" xlink:href="izea-20250331.xsd#izea_HoozuHoldingsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9756e303-3f5c-4869-a9ec-7f8956cdcd91" xlink:to="loc_izea_HoozuHoldingsInc.Member_016960cb-afb3-43db-948a-62532169f506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b75c42e9-4893-4d3b-9874-56671489ebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b75c42e9-4893-4d3b-9874-56671489ebe5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1717271d-d655-4e62-a32a-e77c9107088a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1717271d-d655-4e62-a32a-e77c9107088a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c4fb2b48-3a85-4837-b1c7-e9bbfe7af6da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c4fb2b48-3a85-4837-b1c7-e9bbfe7af6da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_03d5d481-1931-48e4-9776-8267734c0f19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_03d5d481-1931-48e4-9776-8267734c0f19" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_42953d91-7214-40ad-9b00-fead841ffbff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:to="loc_us-gaap_PlanNameAxis_42953d91-7214-40ad-9b00-fead841ffbff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_42953d91-7214-40ad-9b00-fead841ffbff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_42953d91-7214-40ad-9b00-fead841ffbff" xlink:to="loc_us-gaap_PlanNameDomain_42953d91-7214-40ad-9b00-fead841ffbff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aedd0bb8-94de-4e85-977f-f5090167189e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_42953d91-7214-40ad-9b00-fead841ffbff" xlink:to="loc_us-gaap_PlanNameDomain_aedd0bb8-94de-4e85-977f-f5090167189e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_A2014EmployeeStockPurchasePlanMember_7d5a8600-fdde-4266-8a58-b0baaa2afef8" xlink:href="izea-20250331.xsd#izea_A2014EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_aedd0bb8-94de-4e85-977f-f5090167189e" xlink:to="loc_izea_A2014EmployeeStockPurchasePlanMember_7d5a8600-fdde-4266-8a58-b0baaa2afef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_65cf8573-ee4e-402a-8303-309dca71035a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:to="loc_us-gaap_AwardTypeAxis_65cf8573-ee4e-402a-8303-309dca71035a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65cf8573-ee4e-402a-8303-309dca71035a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_65cf8573-ee4e-402a-8303-309dca71035a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_65cf8573-ee4e-402a-8303-309dca71035a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34a0158b-94e6-4369-b368-4b5ef26c912e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_65cf8573-ee4e-402a-8303-309dca71035a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34a0158b-94e6-4369-b368-4b5ef26c912e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_40ec639b-b80a-4e13-9021-bd1155e8b19a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34a0158b-94e6-4369-b368-4b5ef26c912e" xlink:to="loc_us-gaap_EmployeeStockMember_40ec639b-b80a-4e13-9021-bd1155e8b19a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c954e6f9-a8f1-48c0-baa9-5062f4602b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c954e6f9-a8f1-48c0-baa9-5062f4602b3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4e6dd6d-240d-46a6-ad63-522d0520e86f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4e6dd6d-240d-46a6-ad63-522d0520e86f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MinimumhourrequirementforemployeesparticipationintheESSP_e6826eef-ebf6-4d7a-8898-92b06aba92d9" xlink:href="izea-20250331.xsd#izea_MinimumhourrequirementforemployeesparticipationintheESSP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_MinimumhourrequirementforemployeesparticipationintheESSP_e6826eef-ebf6-4d7a-8898-92b06aba92d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan_837de824-1957-4cd9-9c93-940cdb4ed663" xlink:href="izea-20250331.xsd#izea_Annualcompensationlimitpercentageemployeestockpurchaseplan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan_837de824-1957-4cd9-9c93-940cdb4ed663" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Annualcompensationlimitemployeestockpurchaseplan_47279c9a-af28-4b4d-92ce-31d617b24482" xlink:href="izea-20250331.xsd#izea_Annualcompensationlimitemployeestockpurchaseplan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Annualcompensationlimitemployeestockpurchaseplan_47279c9a-af28-4b4d-92ce-31d617b24482" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan_7308f1cf-6490-4561-8603-a414ecd9fd97" xlink:href="izea-20250331.xsd#izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan_7308f1cf-6490-4561-8603-a414ecd9fd97" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Fairmarketvalueofsharesavailableforissuance_7141c998-f20d-4a95-8424-cd2ee4550886" xlink:href="izea-20250331.xsd#izea_Fairmarketvalueofsharesavailableforissuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Fairmarketvalueofsharesavailableforissuance_7141c998-f20d-4a95-8424-cd2ee4550886" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_05e272af-dfaf-4e48-b3c6-be4452646377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_05e272af-dfaf-4e48-b3c6-be4452646377" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_22f95e05-e210-48a0-a679-a32011579006" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_22f95e05-e210-48a0-a679-a32011579006" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquitySummaryofStockBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b98cb1e-b733-4286-b543-c70f86b52cee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8873ad7a-cef3-4ddb-b72e-f56de5cbeec3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b98cb1e-b733-4286-b543-c70f86b52cee" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8873ad7a-cef3-4ddb-b72e-f56de5cbeec3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_56b70dbd-bacc-424c-99b5-d6c6f46fe88e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8873ad7a-cef3-4ddb-b72e-f56de5cbeec3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_56b70dbd-bacc-424c-99b5-d6c6f46fe88e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_56b70dbd-bacc-424c-99b5-d6c6f46fe88e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_56b70dbd-bacc-424c-99b5-d6c6f46fe88e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_56b70dbd-bacc-424c-99b5-d6c6f46fe88e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_56b70dbd-bacc-424c-99b5-d6c6f46fe88e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0066b1b5-1e2e-4bfc-a023-686ac6c6007d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:to="loc_us-gaap_CostOfSalesMember_0066b1b5-1e2e-4bfc-a023-686ac6c6007d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_cdae46b9-8c5a-4fdb-a1b4-b591c9457837" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_cdae46b9-8c5a-4fdb-a1b4-b591c9457837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f74fe206-8093-4f00-abdb-a7fb721f8f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f74fe206-8093-4f00-abdb-a7fb721f8f4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6019236d-3d42-4ac2-a74f-88a52e509987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b98cb1e-b733-4286-b543-c70f86b52cee" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6019236d-3d42-4ac2-a74f-88a52e509987" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67629d2a-9f7e-401e-b21f-59165c8ca2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67629d2a-9f7e-401e-b21f-59165c8ca2c4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67629d2a-9f7e-401e-b21f-59165c8ca2c4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6" xlink:to="loc_us-gaap_EquityComponentDomain_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6" xlink:to="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e24311-b3e0-45f5-9ba5-a51147c8ad22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e24311-b3e0-45f5-9ba5-a51147c8ad22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_UnrealizedGainLossOnSecuritiesMember_9b68e645-b0b6-4611-b3fb-50af02a995fe" xlink:href="izea-20250331.xsd#izea_UnrealizedGainLossOnSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_izea_UnrealizedGainLossOnSecuritiesMember_9b68e645-b0b6-4611-b3fb-50af02a995fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13fe5341-6612-4622-b307-433f953b6c33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13fe5341-6612-4622-b307-433f953b6c33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CurrencyTranslationAdjustmentMember_15038214-ec2b-4051-8c0c-30934681359f" xlink:href="izea-20250331.xsd#izea_CurrencyTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_izea_CurrencyTranslationAdjustmentMember_15038214-ec2b-4051-8c0c-30934681359f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_039a95f6-3f55-4ea2-87a4-f4f847aaaee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_StockholdersEquity_039a95f6-3f55-4ea2-87a4-f4f847aaaee7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_ea3c306d-fd7a-4ec1-b4a0-c2f98f8478d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_ea3c306d-fd7a-4ec1-b4a0-c2f98f8478d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e7e9f8b0-bd46-4359-8bc3-6ae5c0b551dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e7e9f8b0-bd46-4359-8bc3-6ae5c0b551dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_UnrealizedGainOnSecuritiesHeld_07500d09-b284-4e25-95fe-ca75efc992aa" xlink:href="izea-20250331.xsd#izea_UnrealizedGainOnSecuritiesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_izea_UnrealizedGainOnSecuritiesHeld_07500d09-b284-4e25-95fe-ca75efc992aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_5d353633-1ead-4dbf-a8a7-4fd13ffaee1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_5d353633-1ead-4dbf-a8a7-4fd13ffaee1c" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#LossperCommonShareScheduleofAntiDilutiveSharesDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ea48ce39-44ab-4fe0-9d77-956dcaad7270" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_72a1e09a-8c59-4dbd-afa7-bab8f4e08e79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ea48ce39-44ab-4fe0-9d77-956dcaad7270" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_72a1e09a-8c59-4dbd-afa7-bab8f4e08e79" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_72a1e09a-8c59-4dbd-afa7-bab8f4e08e79" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0c1dbb18-9465-4372-a3b6-3e8baa003d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0c1dbb18-9465-4372-a3b6-3e8baa003d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_735f9e54-ff2f-4313-9121-b4a489ac1ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_735f9e54-ff2f-4313-9121-b4a489ac1ab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ea16f42b-4706-4d2f-8913-1417d418a624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ea48ce39-44ab-4fe0-9d77-956dcaad7270" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ea16f42b-4706-4d2f-8913-1417d418a624" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a9a98ed4-dc20-4bdf-b4c2-767ad3bab430" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a9a98ed4-dc20-4bdf-b4c2-767ad3bab430" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c779b099-fb5d-4636-b5ee-6d9ee29a74d6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:to="loc_srt_ProductOrServiceAxis_c779b099-fb5d-4636-b5ee-6d9ee29a74d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c779b099-fb5d-4636-b5ee-6d9ee29a74d6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c779b099-fb5d-4636-b5ee-6d9ee29a74d6" xlink:to="loc_srt_ProductsAndServicesDomain_c779b099-fb5d-4636-b5ee-6d9ee29a74d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c779b099-fb5d-4636-b5ee-6d9ee29a74d6" xlink:to="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SaaSServicesSegmentRevenueMember_65b029cf-3fed-44e6-aad1-1e8c28776c32" xlink:href="izea-20250331.xsd#izea_SaaSServicesSegmentRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:to="loc_izea_SaaSServicesSegmentRevenueMember_65b029cf-3fed-44e6-aad1-1e8c28776c32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ManagedServicesRevenueMember_e1d886dc-1ca7-48a0-9484-8023d0d5ad34" xlink:href="izea-20250331.xsd#izea_ManagedServicesRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:to="loc_izea_ManagedServicesRevenueMember_e1d886dc-1ca7-48a0-9484-8023d0d5ad34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34f58d74-9ed9-4c69-9045-577cd71a0a44" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:to="loc_srt_StatementGeographicalAxis_34f58d74-9ed9-4c69-9045-577cd71a0a44" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_34f58d74-9ed9-4c69-9045-577cd71a0a44_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_34f58d74-9ed9-4c69-9045-577cd71a0a44" xlink:to="loc_srt_SegmentGeographicalDomain_34f58d74-9ed9-4c69-9045-577cd71a0a44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_34f58d74-9ed9-4c69-9045-577cd71a0a44" xlink:to="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_24fe4ddb-2dbf-4525-885a-a8847c475feb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:to="loc_srt_NorthAmericaMember_24fe4ddb-2dbf-4525-885a-a8847c475feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_762b645e-6387-45f3-bbf6-ddf6c117c3d8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:to="loc_srt_AsiaPacificMember_762b645e-6387-45f3-bbf6-ddf6c117c3d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_OtherMember_74f677fd-6002-4971-a0da-a290d4050113" xlink:href="izea-20250331.xsd#izea_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:to="loc_izea_OtherMember_74f677fd-6002-4971-a0da-a290d4050113" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f9fedade-6fce-4ac9-84cc-37d58b97e290" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a9a98ed4-dc20-4bdf-b4c2-767ad3bab430" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f9fedade-6fce-4ac9-84cc-37d58b97e290" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_103cb4a9-11fc-47d0-89d4-32ba4da6eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_103cb4a9-11fc-47d0-89d4-32ba4da6eecc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f959708b-13c2-48e9-aa1b-c50a065b4874" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_103cb4a9-11fc-47d0-89d4-32ba4da6eecc" xlink:to="loc_srt_ProductOrServiceAxis_f959708b-13c2-48e9-aa1b-c50a065b4874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f959708b-13c2-48e9-aa1b-c50a065b4874_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f959708b-13c2-48e9-aa1b-c50a065b4874" xlink:to="loc_srt_ProductsAndServicesDomain_f959708b-13c2-48e9-aa1b-c50a065b4874_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f959708b-13c2-48e9-aa1b-c50a065b4874" xlink:to="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SponsoredSocialRevenueMember_d23baf39-b36b-45f7-9fe5-2f90f2926512" xlink:href="izea-20250331.xsd#izea_SponsoredSocialRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_SponsoredSocialRevenueMember_d23baf39-b36b-45f7-9fe5-2f90f2926512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContentRevenueMember_aa330126-c048-49e1-b570-a76f66bb1f32" xlink:href="izea-20250331.xsd#izea_ContentRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_ContentRevenueMember_aa330126-c048-49e1-b570-a76f66bb1f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LicenseFeesMember_508d8639-61e1-4eff-8596-cb7acbbc19ad" xlink:href="izea-20250331.xsd#izea_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_LicenseFeesMember_508d8639-61e1-4eff-8596-cb7acbbc19ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MarketplaceSpendFeesnetMember_ce260c82-dfc8-41cc-950b-89712cde5d93" xlink:href="izea-20250331.xsd#izea_MarketplaceSpendFeesnetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_MarketplaceSpendFeesnetMember_ce260c82-dfc8-41cc-950b-89712cde5d93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_OtherFeesMember_7220dafc-3785-48df-8e28-51cb258989e6" xlink:href="izea-20250331.xsd#izea_OtherFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_OtherFeesMember_7220dafc-3785-48df-8e28-51cb258989e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ac21797-2708-49fb-b61a-bbc35b5bfd44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ac21797-2708-49fb-b61a-bbc35b5bfd44" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LengthOfContractWithCustomers_c8e6db70-ed1f-41a2-9516-9afe17831dd4" xlink:href="izea-20250331.xsd#izea_LengthOfContractWithCustomers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_izea_LengthOfContractWithCustomers_c8e6db70-ed1f-41a2-9516-9afe17831dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_64eb7015-768b-4a8c-8548-4c1b5848c6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_us-gaap_ContractWithCustomerLiability_64eb7015-768b-4a8c-8548-4c1b5848c6d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_10907691-0daf-4f15-8e37-25afb4160bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_10907691-0daf-4f15-8e37-25afb4160bb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContractLengthForSalesCommissionsPayment_2249ac4b-9853-494d-a0ae-5fdf3937f66f" xlink:href="izea-20250331.xsd#izea_ContractLengthForSalesCommissionsPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_izea_ContractLengthForSalesCommissionsPayment_2249ac4b-9853-494d-a0ae-5fdf3937f66f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceObligationContractTerm_b0b052c6-4a61-4fc0-a7a8-2edabad24fbe" xlink:href="izea-20250331.xsd#izea_PerformanceObligationContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_izea_PerformanceObligationContractTerm_b0b052c6-4a61-4fc0-a7a8-2edabad24fbe" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.izea.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.izea.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_282f1f7a-a4c6-4056-91f5-bf615ff1ea17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_282f1f7a-a4c6-4056-91f5-bf615ff1ea17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c2774c6e-9ba6-4c5e-9436-9306e3478ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_282f1f7a-a4c6-4056-91f5-bf615ff1ea17" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c2774c6e-9ba6-4c5e-9436-9306e3478ce1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c2774c6e-9ba6-4c5e-9436-9306e3478ce1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c2774c6e-9ba6-4c5e-9436-9306e3478ce1" xlink:to="loc_us-gaap_SegmentDomain_c2774c6e-9ba6-4c5e-9436-9306e3478ce1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0026425a-72b0-439b-86da-5814fd9be7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c2774c6e-9ba6-4c5e-9436-9306e3478ce1" xlink:to="loc_us-gaap_SegmentDomain_0026425a-72b0-439b-86da-5814fd9be7c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember_b398eabd-328e-4b30-8ffc-9752da53e374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0026425a-72b0-439b-86da-5814fd9be7c8" xlink:to="loc_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember_b398eabd-328e-4b30-8ffc-9752da53e374" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2ba2317-fffe-45be-ae1a-0b55627fbb76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2ba2317-fffe-45be-ae1a-0b55627fbb76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CostOfRevenueDirect_4f827e8e-0a28-4956-bf64-ac2b0ad22695" xlink:href="izea-20250331.xsd#izea_CostOfRevenueDirect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_izea_CostOfRevenueDirect_4f827e8e-0a28-4956-bf64-ac2b0ad22695" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HumanCapitalCosts_1507643b-ea1c-4c0b-b693-32c311f7e662" xlink:href="izea-20250331.xsd#izea_HumanCapitalCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_izea_HumanCapitalCosts_1507643b-ea1c-4c0b-b693-32c311f7e662" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CashOperatingCosts_5145d2c7-75bc-4544-9cf5-d526ef6a7848" xlink:href="izea-20250331.xsd#izea_CashOperatingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_izea_CashOperatingCosts_5145d2c7-75bc-4544-9cf5-d526ef6a7848" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3ab737d5-f6ee-4e35-92c9-69bb2fd4f4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3ab737d5-f6ee-4e35-92c9-69bb2fd4f4fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_1e7d2d76-0578-4845-a57d-1cdd43887299" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_1e7d2d76-0578-4845-a57d-1cdd43887299" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating_49eb09bd-488f-42f2-acb7-e16823f524b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_InterestIncomeOperatingAndNonoperating_49eb09bd-488f-42f2-acb7-e16823f524b3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d9cf59ba-7b00-4dce-b845-2b456f185d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d9cf59ba-7b00-4dce-b845-2b456f185d8a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_e3db6ded-11b6-4785-847c-88996b05b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_OtherIncome_e3db6ded-11b6-4785-847c-88996b05b82f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_429bde16-d8ff-49a3-a44d-14328a9b722e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_429bde16-d8ff-49a3-a44d-14328a9b722e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3b307f70-8748-469d-8021-842c3eb4f735" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_NumberOfReportableSegments_3b307f70-8748-469d-8021-842c3eb4f735" xlink:type="arc" order="10"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>izea-20250331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:bad81cd4-934d-4330-9ea3-36401c97abe6,g:5878b1fc-f8cc-483b-8e63-779470b36094-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59910508-703e-455d-bfa7-9e35b4fc8ece_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used for operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_6c70601f-05f7-457a-8b90-f268a50d750c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a4f03533-085c-4db5-bee2-85ca7678a2d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_74441c6e-d1b8-473c-a18e-358163042653_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_0654cd3b-bc81-432a-acaa-2ec45d6cce8d_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_759d227e-f5d8-40b7-b63c-2ed2aa24baa4_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_6fb4da49-d6fe-491c-acff-81ccc582bd6c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTerm_584ee276-3f6d-4418-9573-ae9c32de13e1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment plan</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTerm_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTerm" xlink:to="lab_us-gaap_LongTermDebtTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8713a718-01a9-4814-9c32-d9fa3d6a5d3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_050d40c7-1a33-4ae4-a125-556a49697830_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1f2acb8b-0d4b-4231-8cbc-9210672a2586_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, award vesting period (in days)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_IndividualStockOwnershipInExcessOf10PercentMember_030056a8-0026-486c-a477-5aa84b8ac4e8_terseLabel_en-US" xlink:label="lab_izea_IndividualStockOwnershipInExcessOf10PercentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual Stock Ownership in Excess of 10 Percent</link:label>
    <link:label id="lab_izea_IndividualStockOwnershipInExcessOf10PercentMember_label_en-US" xlink:label="lab_izea_IndividualStockOwnershipInExcessOf10PercentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual Stock Ownership in Excess of 10 Percent [Member]</link:label>
    <link:label id="lab_izea_IndividualStockOwnershipInExcessOf10PercentMember_documentation_en-US" xlink:label="lab_izea_IndividualStockOwnershipInExcessOf10PercentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Individual Stock Ownership in Excess of 10 Percent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_IndividualStockOwnershipInExcessOf10PercentMember" xlink:href="izea-20250331.xsd#izea_IndividualStockOwnershipInExcessOf10PercentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_IndividualStockOwnershipInExcessOf10PercentMember" xlink:to="lab_izea_IndividualStockOwnershipInExcessOf10PercentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_AccountsReceivableExcludingContractAsset_ed18856c-44a1-4be9-962a-7be048e22dcf_terseLabel_en-US" xlink:label="lab_izea_AccountsReceivableExcludingContractAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable excluding Contract Asset</link:label>
    <link:label id="lab_izea_AccountsReceivableExcludingContractAsset_label_en-US" xlink:label="lab_izea_AccountsReceivableExcludingContractAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable excluding Contract Asset</link:label>
    <link:label id="lab_izea_AccountsReceivableExcludingContractAsset_documentation_en-US" xlink:label="lab_izea_AccountsReceivableExcludingContractAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable excluding Contract Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AccountsReceivableExcludingContractAsset" xlink:href="izea-20250331.xsd#izea_AccountsReceivableExcludingContractAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_AccountsReceivableExcludingContractAsset" xlink:to="lab_izea_AccountsReceivableExcludingContractAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_19cde3aa-e620-45da-9aba-46157f158c3a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_21c085f1-8671-4860-877f-2d370842d48b_terseLabel_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:label id="lab_us-gaap_CashDivestedFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Divested from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashDivestedFromDeconsolidation" xlink:to="lab_us-gaap_CashDivestedFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b6a0ef5e-ce0c-474c-bd56-2c567339e171_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_35e98aaf-82dd-405b-8aab-dd2c43316d36_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_930a5f6a-ad36-4be9-80a0-5ca8157aaee6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0c5fbcfc-dc04-455b-9e01-c19f1fc230c2_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7808ad05-5c50-4d2f-8620-0d097cf52459_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_10315e28-bb56-4c9f-9402-5ce66e414311_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_7674ab49-7c79-4762-a8c8-ff300e643e42_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1fe2c75c-4050-437d-9ae5-3e60e0083ecf_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_393fe805-33d1-417c-b4af-1f9b56fc9f28_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_461a547e-64ca-4cb7-b708-626706dc696d_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_2c45f5c6-167f-4e9a-9009-51569f5d506b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_0b33f928-fc06-4609-b5fc-3fb9209eb615_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, nonvested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_271c0362-ec1b-4122-b05d-99e2861c550a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_NatureOfBusinessPolicyTextBlock_1aa04fba-ef17-4c81-85e4-13b0e1421dc8_terseLabel_en-US" xlink:label="lab_izea_NatureOfBusinessPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nature of Business</link:label>
    <link:label id="lab_izea_NatureOfBusinessPolicyTextBlock_label_en-US" xlink:label="lab_izea_NatureOfBusinessPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nature Of Business [Policy Text Block]</link:label>
    <link:label id="lab_izea_NatureOfBusinessPolicyTextBlock_documentation_en-US" xlink:label="lab_izea_NatureOfBusinessPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Nature of Business [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_NatureOfBusinessPolicyTextBlock" xlink:href="izea-20250331.xsd#izea_NatureOfBusinessPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_NatureOfBusinessPolicyTextBlock" xlink:to="lab_izea_NatureOfBusinessPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_92649cbe-0144-47c0-a3d2-04d8d183c971_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_7e48e0c7-3280-4c6c-a5c4-70e879adfb23_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_70bc2743-7849-4e77-a549-c4cc1b53eb8a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ChangeInTheFairValueOfDigitalAssets_bf3cbd64-8637-45e4-9178-514190d110f3_terseLabel_en-US" xlink:label="lab_izea_ChangeInTheFairValueOfDigitalAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in the fair value of digital assets</link:label>
    <link:label id="lab_izea_ChangeInTheFairValueOfDigitalAssets_label_en-US" xlink:label="lab_izea_ChangeInTheFairValueOfDigitalAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in the fair value of digital assets</link:label>
    <link:label id="lab_izea_ChangeInTheFairValueOfDigitalAssets_documentation_en-US" xlink:label="lab_izea_ChangeInTheFairValueOfDigitalAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Change in the fair value of digital assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ChangeInTheFairValueOfDigitalAssets" xlink:href="izea-20250331.xsd#izea_ChangeInTheFairValueOfDigitalAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ChangeInTheFairValueOfDigitalAssets" xlink:to="lab_izea_ChangeInTheFairValueOfDigitalAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3c5319b3-f816-4368-8a50-b3dca934c2ab_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_4b7b2b48-207c-4a68-adb1-5c8da029abe1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_524e799a-f86b-4dcb-8cd5-6a362c2ca7df_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">US Treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_888e70ba-ffb7-49de-8902-2ee949c82703_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_e7df14dc-8afd-47c1-af63-9319842aab49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Performance Shares, Outstanding Activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a8a195ce-0c08-4535-b410-d65c9e869fa6_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_3bf84d56-5bca-4112-8b64-6a0610043a8e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_4b739532-684f-4bec-bafb-9f8dc374116e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_6b98c457-83e4-4fd8-a092-88154b7de790_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_273dba07-7f7c-4b49-b968-48a07b88ae98_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Office equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_77cf2e22-bf97-40d9-92b5-3d569845ed38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares expected to vest weighted average</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_9498c1d7-9c2c-4083-9d28-55a09ea90fd9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9b883296-aed9-4e93-9e32-f94583aa7751_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_97c3700f-14ad-474c-b21c-74c3958d37f3_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_InvoicePaymentTerms_67aaca1b-0654-4d76-af9f-4c334543eccf_terseLabel_en-US" xlink:label="lab_izea_InvoicePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Invoice payment terms</link:label>
    <link:label id="lab_izea_InvoicePaymentTerms_label_en-US" xlink:label="lab_izea_InvoicePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Invoice Payment Terms</link:label>
    <link:label id="lab_izea_InvoicePaymentTerms_documentation_en-US" xlink:label="lab_izea_InvoicePaymentTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Invoice Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_InvoicePaymentTerms" xlink:href="izea-20250331.xsd#izea_InvoicePaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_InvoicePaymentTerms" xlink:to="lab_izea_InvoicePaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_872d8894-37f8-433b-a70f-5a5e8709852f_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_e2c5f271-3cf7-46b6-914f-b12fb173665e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment for divestiture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_4a91d987-d4f3-4afe-b0bb-d5af58d994ab_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_d01f9e00-207f-414e-949c-b25cb05faef5_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4f725145-58ef-4ce1-84f2-7b6a2608eba9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_830f8dc1-fd17-4b8b-a709-726096681b93_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_869c002f-32d7-47ae-a8e3-c7a9ee1a5d93_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_1c81633f-2e85-41f8-bd52-83c6c8902e07_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental non-cash activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b6236345-b3df-4c78-811a-c4485029e53f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts_a743b87e-bd7c-4e1c-b78b-032901b482a7_terseLabel_en-US" xlink:label="lab_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss of divesiture of business net of transaction costs</link:label>
    <link:label id="lab_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts_label_en-US" xlink:label="lab_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss of divesiture of business net of transaction costs</link:label>
    <link:label id="lab_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts_documentation_en-US" xlink:label="lab_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss of divesiture of business net of transaction costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts" xlink:href="izea-20250331.xsd#izea_LossOfDivesitureOfBusinessNetOfTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts" xlink:to="lab_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_551942bb-e7af-45bf-a37f-572697cfa71d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_2fdc05ae-f95a-4d81-811e-9b93d6f464bc_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_DepreciationandAmortizationExpenseMember_0e16682b-b10f-43cb-940c-8e0de8e15efb_terseLabel_en-US" xlink:label="lab_izea_DepreciationandAmortizationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and Amortization Expense</link:label>
    <link:label id="lab_izea_DepreciationandAmortizationExpenseMember_label_en-US" xlink:label="lab_izea_DepreciationandAmortizationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation and Amortization Expense [Member]</link:label>
    <link:label id="lab_izea_DepreciationandAmortizationExpenseMember_documentation_en-US" xlink:label="lab_izea_DepreciationandAmortizationExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Depreciation and Amortization Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DepreciationandAmortizationExpenseMember" xlink:href="izea-20250331.xsd#izea_DepreciationandAmortizationExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_DepreciationandAmortizationExpenseMember" xlink:to="lab_izea_DepreciationandAmortizationExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_eecd1fd9-a802-41e2-9ac9-a3b065c06ccc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_96a9d27a-cb74-4ac0-9c49-91af1611c54a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing (1)</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f433595e-9c33-4070-a924-eabec496ae11_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_034cbad8-c835-4c5f-81f3-524e7b7ddb70_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_466bfb1e-74d4-4547-bf11-13f04f55e972_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_Fairvalueofcommonstockissuedforfutureservices_828f3414-5888-437b-96b4-7dbd0c44bfb3_terseLabel_en-US" xlink:label="lab_izea_Fairvalueofcommonstockissuedforfutureservices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common stock issued for future services</link:label>
    <link:label id="lab_izea_Fairvalueofcommonstockissuedforfutureservices_label_en-US" xlink:label="lab_izea_Fairvalueofcommonstockissuedforfutureservices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair value of common stock issued for future services</link:label>
    <link:label id="lab_izea_Fairvalueofcommonstockissuedforfutureservices_documentation_en-US" xlink:label="lab_izea_Fairvalueofcommonstockissuedforfutureservices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value of common stock issued for future services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Fairvalueofcommonstockissuedforfutureservices" xlink:href="izea-20250331.xsd#izea_Fairvalueofcommonstockissuedforfutureservices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_Fairvalueofcommonstockissuedforfutureservices" xlink:to="lab_izea_Fairvalueofcommonstockissuedforfutureservices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_73c2e46f-0d1f-450c-8e58-e3a3dd44fca9_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:to="lab_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9cf26352-6fed-48aa-a522-14ec89b7a5ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c487bf31-903b-4080-b2eb-f3aff8480a78_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_221acf37-0c26-40cc-aa69-610d1a288af6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_385d27f1-c731-4fdf-bd5a-436a7c8dccb1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee service share-based compensation, nonvested awards, compensation cost not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CashCDICInsuredAmount_464b7bd3-2c9b-4bf6-9ff6-43c67b763a3b_terseLabel_en-US" xlink:label="lab_izea_CashCDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, CDIC Insured Amount</link:label>
    <link:label id="lab_izea_CashCDICInsuredAmount_label_en-US" xlink:label="lab_izea_CashCDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, CDIC Insured Amount</link:label>
    <link:label id="lab_izea_CashCDICInsuredAmount_documentation_en-US" xlink:label="lab_izea_CashCDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash, CDIC Insured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CashCDICInsuredAmount" xlink:href="izea-20250331.xsd#izea_CashCDICInsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CashCDICInsuredAmount" xlink:to="lab_izea_CashCDICInsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_7e17a379-d9f0-4e89-b7ec-ab51ab64bd53_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashUninsuredAmount_2cf891a9-4283-4a7d-98f9-59888544a6cc_terseLabel_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, uninsured amount</link:label>
    <link:label id="lab_us-gaap_CashUninsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashUninsuredAmount" xlink:to="lab_us-gaap_CashUninsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_5ee0265d-075e-469f-87d3-042c12a75474_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_2ef37ca2-c785-45f9-a7bc-8ddaf0715cec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_08050c8f-156a-4464-a65f-436d44ab14cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments on shares withheld for statutory taxes</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_90e17a06-e6ff-4e69-8695-73e58f033ab0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_Annualcompensationlimitemployeestockpurchaseplan_31472c99-06a2-45e9-9254-9496e2c9127d_terseLabel_en-US" xlink:label="lab_izea_Annualcompensationlimitemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual compensation limit, employee stock purchase plan</link:label>
    <link:label id="lab_izea_Annualcompensationlimitemployeestockpurchaseplan_label_en-US" xlink:label="lab_izea_Annualcompensationlimitemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Annual compensation limit, employee stock purchase plan</link:label>
    <link:label id="lab_izea_Annualcompensationlimitemployeestockpurchaseplan_documentation_en-US" xlink:label="lab_izea_Annualcompensationlimitemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Annual compensation limit, employee stock purchase plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Annualcompensationlimitemployeestockpurchaseplan" xlink:href="izea-20250331.xsd#izea_Annualcompensationlimitemployeestockpurchaseplan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_Annualcompensationlimitemployeestockpurchaseplan" xlink:to="lab_izea_Annualcompensationlimitemployeestockpurchaseplan" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8a05dc75-14a0-4ed0-abd3-1b0be18ab963_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_1fd2f5f9-8b9e-415e-bbab-f62853b6d0a3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e70005d7-230f-47e3-853b-664198ea7d2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units , nonvested vested in period, weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_3e5adabd-dd9e-4741-b476-881f34a11f27_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_6b37fd8c-81e0-4235-a49f-c1464dfd0212_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_fb54b75c-9fc1-419c-8583-a0f252445f36_verboseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Due in 1 year or less</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0143afe6-f6c6-4be1-82e1-5d414eb1e06e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_45bbeefc-9d77-4d12-aa5d-4f4e7d226644_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_2c20ce6b-8548-47dd-ad51-fe271f53d1f4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_630ff424-c7b5-46f9-a700-94a879fbd117_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e5806f83-81f7-4d32-8094-52ee88555fde_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_cb2c334d-ff8b-401a-bb8f-5541cd6d869a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_bc1689f1-d496-436c-846f-b91f970486a3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_18cf322a-dcc9-4e81-83ce-c1b610539441_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software Development Costs</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_9a81268d-7acd-45dc-85d6-6a904b3e73e8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e568fd67-4807-42dc-ac7e-551ac1204e40_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1bbf8e87-403b-4702-b8b7-4a582f6e4be2_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionPlanExpense_17bc5590-6b43-4103-9170-77ac585a3c2a_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionPlanExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option plan expense</link:label>
    <link:label id="lab_us-gaap_StockOptionPlanExpense_label_en-US" xlink:label="lab_us-gaap_StockOptionPlanExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock or Unit Option Plan Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionPlanExpense" xlink:to="lab_us-gaap_StockOptionPlanExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_03f36bbc-23ec-41f6-a2ee-04dd8283cde0_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_TheAmendedandRestatedMay2011PlanMember_b189a2e6-5c7d-49a6-bc8a-be9264101008_terseLabel_en-US" xlink:label="lab_izea_TheAmendedandRestatedMay2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Amended and Restated May 2011 Plan</link:label>
    <link:label id="lab_izea_TheAmendedandRestatedMay2011PlanMember_label_en-US" xlink:label="lab_izea_TheAmendedandRestatedMay2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Amended and Restated May 2011 Plan [Member]</link:label>
    <link:label id="lab_izea_TheAmendedandRestatedMay2011PlanMember_documentation_en-US" xlink:label="lab_izea_TheAmendedandRestatedMay2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The Amended and Restated May 2011 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TheAmendedandRestatedMay2011PlanMember" xlink:href="izea-20250331.xsd#izea_TheAmendedandRestatedMay2011PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_TheAmendedandRestatedMay2011PlanMember" xlink:to="lab_izea_TheAmendedandRestatedMay2011PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_fe57f2b7-808f-4ec7-bd7a-acfc8bb4e71c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_61d0c310-7b88-437b-9085-1dfa78f43d2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_00aa2ee1-93ec-491a-bcd4-aa4fd177b9c3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_36ee1d65-1964-4be9-b1ea-d9fd9e63af15_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_cc070945-1b19-4b79-99c5-e4f1ac48b284_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, Reclassified to Receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, Reclassified to Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:to="lab_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4e2dfe1d-9b78-401e-bc32-24b9cd8d2fe9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares, issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CommonStockFairValue_cf7ab08a-6d8c-4e5f-989e-4b609b22b0ad_terseLabel_en-US" xlink:label="lab_izea_CommonStockFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, fair value</link:label>
    <link:label id="lab_izea_CommonStockFairValue_label_en-US" xlink:label="lab_izea_CommonStockFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Fair Value</link:label>
    <link:label id="lab_izea_CommonStockFairValue_documentation_en-US" xlink:label="lab_izea_CommonStockFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockFairValue" xlink:href="izea-20250331.xsd#izea_CommonStockFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CommonStockFairValue" xlink:to="lab_izea_CommonStockFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_4edba172-8c10-46ae-8c99-84fde897eb96_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_ba335342-49b8-4ebf-852c-63999b87597f_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_722322be-43eb-4c3e-9ec6-b055c0ff8d7c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on currency translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_76d80229-4b27-49eb-a191-b073dbae8505_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_NonExecutiveEmployeesMember_0cfc3417-bcb9-4ef1-b842-cefbce27b655_terseLabel_en-US" xlink:label="lab_izea_NonExecutiveEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non Executive Employees [Member]</link:label>
    <link:label id="lab_izea_NonExecutiveEmployeesMember_label_en-US" xlink:label="lab_izea_NonExecutiveEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non Executive Employees [Member]</link:label>
    <link:label id="lab_izea_NonExecutiveEmployeesMember_documentation_en-US" xlink:label="lab_izea_NonExecutiveEmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non Executive Employees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_NonExecutiveEmployeesMember" xlink:href="izea-20250331.xsd#izea_NonExecutiveEmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_NonExecutiveEmployeesMember" xlink:to="lab_izea_NonExecutiveEmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8c0f66c5-0cc5-4694-9d9e-a29699bd9bc1_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_6fa278ed-78eb-4e69-aa1f-cd411ae6bc6d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_dd937f3b-b97b-441e-89ae-875e1736b4fb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Options, exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ManagedServicesRevenueMember_841a2dbf-a83b-4ebb-98f4-1c9b5b7d0746_terseLabel_en-US" xlink:label="lab_izea_ManagedServicesRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Managed Services Revenue</link:label>
    <link:label id="lab_izea_ManagedServicesRevenueMember_label_en-US" xlink:label="lab_izea_ManagedServicesRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Managed Services Revenue [Member]</link:label>
    <link:label id="lab_izea_ManagedServicesRevenueMember_documentation_en-US" xlink:label="lab_izea_ManagedServicesRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Managed Services Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ManagedServicesRevenueMember" xlink:href="izea-20250331.xsd#izea_ManagedServicesRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ManagedServicesRevenueMember" xlink:to="lab_izea_ManagedServicesRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_60f4243c-0403-4aa6-96a2-2823b38cc7cb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0b2dcc27-11de-4715-86cc-9a5573318716_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_UnrealizedGainOnSecuritiesHeld_291651de-c054-4849-9385-4a8bf9a6ac6f_terseLabel_en-US" xlink:label="lab_izea_UnrealizedGainOnSecuritiesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain on securities held</link:label>
    <link:label id="lab_izea_UnrealizedGainOnSecuritiesHeld_label_en-US" xlink:label="lab_izea_UnrealizedGainOnSecuritiesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized gain on securities held</link:label>
    <link:label id="lab_izea_UnrealizedGainOnSecuritiesHeld_documentation_en-US" xlink:label="lab_izea_UnrealizedGainOnSecuritiesHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrealized gain on securities held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_UnrealizedGainOnSecuritiesHeld" xlink:href="izea-20250331.xsd#izea_UnrealizedGainOnSecuritiesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_UnrealizedGainOnSecuritiesHeld" xlink:to="lab_izea_UnrealizedGainOnSecuritiesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_bc2b3e8e-237d-4d79-a097-d0f28daff9c7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on securities held</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_cec8f748-ff38-4d7d-859f-fbd2e512fe63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on securities held</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_71dd3faf-5639-4909-8d68-bff9ff2be151_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_5ec53a05-72ad-4968-81b6-8a0ff87bd5de_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_TwelveMonthsAfterGrantDateMember_33976d69-3b9c-474f-8e72-f74d41d20233_terseLabel_en-US" xlink:label="lab_izea_TwelveMonthsAfterGrantDateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Twelve Months After Grant Date</link:label>
    <link:label id="lab_izea_TwelveMonthsAfterGrantDateMember_label_en-US" xlink:label="lab_izea_TwelveMonthsAfterGrantDateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Twelve Months After Grant Date [Member]</link:label>
    <link:label id="lab_izea_TwelveMonthsAfterGrantDateMember_documentation_en-US" xlink:label="lab_izea_TwelveMonthsAfterGrantDateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Twelve Months After Grant Date [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TwelveMonthsAfterGrantDateMember" xlink:href="izea-20250331.xsd#izea_TwelveMonthsAfterGrantDateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_TwelveMonthsAfterGrantDateMember" xlink:to="lab_izea_TwelveMonthsAfterGrantDateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b68247d8-1f49-4a30-bd12-00eec5d9557a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_6fa2cd3c-29bc-45b6-a1e5-7dc1d8c628a4_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_91555d00-12fc-481d-b4b8-e93f16d7318d_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_29473370-1c78-44c8-b1b4-fc3c8f38d333_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CurrentPortionOfFinanceObligation_5fd5cec6-5967-4068-b5f7-c63146d5a19f_terseLabel_en-US" xlink:label="lab_izea_CurrentPortionOfFinanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of finance obligation</link:label>
    <link:label id="lab_izea_CurrentPortionOfFinanceObligation_label_en-US" xlink:label="lab_izea_CurrentPortionOfFinanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current portion of finance obligation</link:label>
    <link:label id="lab_izea_CurrentPortionOfFinanceObligation_documentation_en-US" xlink:label="lab_izea_CurrentPortionOfFinanceObligation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Current portion of finance obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CurrentPortionOfFinanceObligation" xlink:href="izea-20250331.xsd#izea_CurrentPortionOfFinanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CurrentPortionOfFinanceObligation" xlink:to="lab_izea_CurrentPortionOfFinanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_May2011AndAugust2011EquityIncentivePlansMember_1c88d80b-f665-4063-885d-20226cce7f82_terseLabel_en-US" xlink:label="lab_izea_May2011AndAugust2011EquityIncentivePlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">May 2011 and August 2011 Equity Incentive Plans</link:label>
    <link:label id="lab_izea_May2011AndAugust2011EquityIncentivePlansMember_label_en-US" xlink:label="lab_izea_May2011AndAugust2011EquityIncentivePlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2011 and August 2011 Equity Incentive Plans [Member]</link:label>
    <link:label id="lab_izea_May2011AndAugust2011EquityIncentivePlansMember_documentation_en-US" xlink:label="lab_izea_May2011AndAugust2011EquityIncentivePlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2011 and August 2011 Equity Incentive Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_May2011AndAugust2011EquityIncentivePlansMember" xlink:href="izea-20250331.xsd#izea_May2011AndAugust2011EquityIncentivePlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_May2011AndAugust2011EquityIncentivePlansMember" xlink:to="lab_izea_May2011AndAugust2011EquityIncentivePlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets_cef2cd6c-27a8-4dfc-9c5f-7ecbe4f1f83a_negatedTerseLabel_en-US" xlink:label="lab_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to fair market value of digital assets</link:label>
    <link:label id="lab_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Fair Market Value of Indefinite Lived Intangible Assets</link:label>
    <link:label id="lab_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets_documentation_en-US" xlink:label="lab_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustment to Fair Market Value of Indefinite Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" xlink:href="izea-20250331.xsd#izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" xlink:to="lab_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_e1f2ee72-58e2-4628-b8ed-984abe08c4fc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock at cost: 767,335 and 586,849 shares at March&#160;31, 2025 and December&#160;31, 2024, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePerDollarAmount_8091d673-62b9-4e68-bb7a-8561a160978d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred Stock, Dividend Rate, Per-Dollar-Amount</link:label>
    <link:label id="lab_us-gaap_PreferredStockDividendRatePerDollarAmount_label_en-US" xlink:label="lab_us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Dividend Rate, Per-Dollar-Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePerDollarAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:to="lab_us-gaap_PreferredStockDividendRatePerDollarAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_3f2747ae-e604-4e12-89c1-84f57ba42437_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:to="lab_us-gaap_FinancialInstrumentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_4900d6a8-dacf-4e10-adb7-a2c93292b6fd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_b93aeea3-6be7-4292-9a81-8166bcc5abf3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_a275a9d0-f565-41f0-a36f-740e2878bf6d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_a6bbf1fe-cc5c-463d-8afc-92aa1804c8a0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from investment maturities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_ec93c328-f780-4116-81e5-92ded1c89c1e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Total contribution expense</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_b2f1945b-64ca-43a7-9ecf-e3b64fe6aec5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_81f0d19a-451d-4e21-817a-85eae5e85156_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_eaa536b2-545f-4848-9033-9651fbb5d999_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8c77442a-bb66-45ba-ac05-fa249a47ad54_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_EmployeesMember_4750eaee-2a81-4656-a7b8-b70ecf49f19a_terseLabel_en-US" xlink:label="lab_izea_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employees</link:label>
    <link:label id="lab_izea_EmployeesMember_label_en-US" xlink:label="lab_izea_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employees [Member]</link:label>
    <link:label id="lab_izea_EmployeesMember_documentation_en-US" xlink:label="lab_izea_EmployeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EmployeesMember" xlink:href="izea-20250331.xsd#izea_EmployeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_EmployeesMember" xlink:to="lab_izea_EmployeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_7ecd0f45-578e-4c11-832c-2b9618eb42e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_bff204fb-be1e-4f83-8119-72f221221c5e_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_12c3c828-4a4d-4094-9062-d9250244e8e9_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f7aaae21-bfe3-4248-a8b3-f282479f3f65_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_MarketplaceSpendFeesnetMember_2578d86e-00e7-4c7b-80d9-46a8f4fdeca4_terseLabel_en-US" xlink:label="lab_izea_MarketplaceSpendFeesnetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketplace Spend Fees</link:label>
    <link:label id="lab_izea_MarketplaceSpendFeesnetMember_label_en-US" xlink:label="lab_izea_MarketplaceSpendFeesnetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketplace Spend Fees, net [Member]</link:label>
    <link:label id="lab_izea_MarketplaceSpendFeesnetMember_documentation_en-US" xlink:label="lab_izea_MarketplaceSpendFeesnetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Marketplace Spend Fees, net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MarketplaceSpendFeesnetMember" xlink:href="izea-20250331.xsd#izea_MarketplaceSpendFeesnetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_MarketplaceSpendFeesnetMember" xlink:to="lab_izea_MarketplaceSpendFeesnetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_ce5e8c5a-c877-437d-86b9-bde8df5a1947_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company contribution percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_e4f22088-a2dc-454f-94ba-e4114f3d0674_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining life (years), outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_20642f41-8256-4aac-9f2d-585e53c21753_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_51307c90-bd16-4ce5-84a5-3b7e45a36321_terseLabel_en-US" xlink:label="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining years to vest (in years)</link:label>
    <link:label id="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_label_en-US" xlink:label="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Nonvested, Weighted Average Remaining Contractual Term</link:label>
    <link:label id="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_documentation_en-US" xlink:label="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Nonvested, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" xlink:to="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f6beb620-dd69-4e13-b128-613fb4992cb6_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b402bf7c-2707-41c6-9b86-0b7ce4c53cac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Imputed interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_fa46b4c2-2fe6-468e-8df3-afde68f1a223_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_IndependentDirectorsMember_2ef0d7fe-5066-4f60-a177-2c76a9bfbd3d_terseLabel_en-US" xlink:label="lab_izea_IndependentDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Independent Directors</link:label>
    <link:label id="lab_izea_IndependentDirectorsMember_label_en-US" xlink:label="lab_izea_IndependentDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Independent Directors [Member]</link:label>
    <link:label id="lab_izea_IndependentDirectorsMember_documentation_en-US" xlink:label="lab_izea_IndependentDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Independent Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_IndependentDirectorsMember" xlink:href="izea-20250331.xsd#izea_IndependentDirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_IndependentDirectorsMember" xlink:to="lab_izea_IndependentDirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_a8ac13c9-a12d-4018-be61-635c15ca1b31_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares repurchased during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_StockOptionVestingPeriodFromGrantDate_97f5467e-0e1d-41a2-9e02-efa8a867e53b_terseLabel_en-US" xlink:label="lab_izea_StockOptionVestingPeriodFromGrantDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock option vesting period from grant date (in years)</link:label>
    <link:label id="lab_izea_StockOptionVestingPeriodFromGrantDate_label_en-US" xlink:label="lab_izea_StockOptionVestingPeriodFromGrantDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Option Vesting Period From Grant Date</link:label>
    <link:label id="lab_izea_StockOptionVestingPeriodFromGrantDate_documentation_en-US" xlink:label="lab_izea_StockOptionVestingPeriodFromGrantDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Option Vesting Period From Grant Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOptionVestingPeriodFromGrantDate" xlink:href="izea-20250331.xsd#izea_StockOptionVestingPeriodFromGrantDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_StockOptionVestingPeriodFromGrantDate" xlink:to="lab_izea_StockOptionVestingPeriodFromGrantDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_240a7c2a-bc8b-443a-91f1-9ba0897a5a0d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_6d0807ba-6fb6-4a55-a7d9-a05ec7a2c2ae_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested vested in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8e40d28b-4742-4947-8e8b-aa43bff92c82_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested vested in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_cff71ca5-5508-4934-8d53-d38137faef4c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjusted Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2fc3604f-ff6e-4cbd-8187-da328d129720_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Contract with Customer</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_df6403f6-adcb-4a82-96c3-9c11b548a11f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_552cacfb-81e7-4b2a-93dc-e5d4e72aed41_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9a362482-d6df-46d8-a08a-1bf36708a6e5_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_878ad009-9d9c-4a4c-903c-2e8aa998efef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_65fbecbc-24b3-4c14-ba0e-4f1280da7baa_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_79fed178-c655-4594-8104-a4ce9a3b9976_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_8558cfeb-e4ed-4712-89d0-e5d54d526b45_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_54de7cff-b594-4f19-8b1e-82839c18c1db_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock_804392ed-7a57-487e-bf60-0df936dedaf1_terseLabel_en-US" xlink:label="lab_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of Investments in Marketable Debt Securities</link:label>
    <link:label id="lab_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock_label_en-US" xlink:label="lab_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Investments in Marketable Debt Securities [Table Text Block]</link:label>
    <link:label id="lab_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock_documentation_en-US" xlink:label="lab_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value of Investments in Marketable Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" xlink:href="izea-20250331.xsd#izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" xlink:to="lab_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_eb3bc250-4fef-4ce2-89c3-dab03177d95f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_a23471ae-912a-4962-9e73-06e540dd69b8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_49c1bd3c-7f4f-4cea-a027-48a91062ad2f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_b39ff59d-e4ed-485d-b7fb-f5b934040718_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9ff32905-c148-49e3-9e96-5b26313d66d6_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1776eec0-6f45-4090-9a6f-51892092c2a1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_SignificantAccountingPoliciesTable_088e6c25-2314-4799-a5d6-26c7bfb96ce7_terseLabel_en-US" xlink:label="lab_izea_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_izea_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_izea_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_izea_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_izea_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountingPoliciesTable" xlink:href="izea-20250331.xsd#izea_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_SignificantAccountingPoliciesTable" xlink:to="lab_izea_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember_1e97f23e-3f84-4efc-a43b-6ef378f26120_terseLabel_en-US" xlink:label="lab_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment, Aggregation before Other Operating Segment</link:label>
    <link:label id="lab_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember_label_en-US" xlink:label="lab_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment, Aggregation before Other Operating Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember" xlink:to="lab_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_6c6d3fdb-9c50-49e2-b275-873d4b1ca616_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_3d3a3cdf-1cb9-4f7a-ba41-d14437fd8952_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_380f4c9f-9e37-4dac-acf3-1ac23bf5f0a6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_17b136bc-a0f1-4a37-a79b-6388c1a77372_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_c87fb118-4b9d-41c5-a1fe-d0976737b991_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_91465d26-4068-4073-a5c1-43c880b348ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c1b493ab-daeb-4609-bc68-d4fc65e7d944_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_e6c199ae-4f77-459f-8ff4-e119941ce463_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance obligation, less current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_77fea092-a519-420d-aa39-fb4ef508f43a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capitalized computer software, amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_ae01cdaa-6962-40bd-b7d6-4d8b2496dce5_terseLabel_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_GainOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_GainOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainOnSaleOfInvestments" xlink:to="lab_us-gaap_GainOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_3748a02b-4787-4aa6-b655-2cbdd1ffd19d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_18935107-9e09-4a41-87e1-7cf47137dd8f_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled receivables</link:label>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledReceivablesCurrent" xlink:to="lab_us-gaap_UnbilledReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f85d1f28-a1bd-4e5e-a37a-8d41d16c2e10_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_395c9f20-5ea3-4a28-8b16-9af4410e31b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common shares, forfeited</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_58bf28b9-0de0-4e0b-8de1-b8ab62c81c12_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series A Junior Participating Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_ea291650-c27e-4633-9836-9c95bb5750c2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_2ad7f047-6bd1-48d5-9fbc-e8838ce5d3d6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted loss per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_5743215e-6b64-4306-ac6d-b7627e98ecad_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5a2ff060-ac9d-48e4-b08b-c196fa6e4ba1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ContentRevenueMember_55cd191c-8b08-4d08-a5a4-792ddbddbc57_terseLabel_en-US" xlink:label="lab_izea_ContentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Content Revenue</link:label>
    <link:label id="lab_izea_ContentRevenueMember_label_en-US" xlink:label="lab_izea_ContentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Content Revenue [Member]</link:label>
    <link:label id="lab_izea_ContentRevenueMember_documentation_en-US" xlink:label="lab_izea_ContentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Content Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContentRevenueMember" xlink:href="izea-20250331.xsd#izea_ContentRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ContentRevenueMember" xlink:to="lab_izea_ContentRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_71dfbfb4-250a-4c4f-b838-eabd1dbad218_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a5a080f3-078e-4367-9e6a-a772643dca93_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_VestingFrequencyAxis_7497e82c-6237-438c-87ee-1e5bd8787304_terseLabel_en-US" xlink:label="lab_izea_VestingFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Frequency [Axis]</link:label>
    <link:label id="lab_izea_VestingFrequencyAxis_label_en-US" xlink:label="lab_izea_VestingFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Frequency [Axis]</link:label>
    <link:label id="lab_izea_VestingFrequencyAxis_documentation_en-US" xlink:label="lab_izea_VestingFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_VestingFrequencyAxis" xlink:href="izea-20250331.xsd#izea_VestingFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_VestingFrequencyAxis" xlink:to="lab_izea_VestingFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_55f4a8aa-2f2b-4abc-a797-e3c25852b9b8_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_63a76493-363e-423e-bc1e-88fa33871b2c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_b1778b2c-2835-4e97-811a-bd07ee8def6b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementOperatingActivitiesSegmentAxis_label_en-US" xlink:label="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Activities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="lab_us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2f4466c4-513c-47c7-ab4e-1d789595b924_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining useful life exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_OtherFeesMember_d2f02d4e-00d9-4cb9-a545-faaf5955cb7b_terseLabel_en-US" xlink:label="lab_izea_OtherFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Fees</link:label>
    <link:label id="lab_izea_OtherFeesMember_label_en-US" xlink:label="lab_izea_OtherFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Fees [Member]</link:label>
    <link:label id="lab_izea_OtherFeesMember_documentation_en-US" xlink:label="lab_izea_OtherFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Fees contract revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_OtherFeesMember" xlink:href="izea-20250331.xsd#izea_OtherFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_OtherFeesMember" xlink:to="lab_izea_OtherFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_1abf768b-ba92-42d3-91df-1c57dcdc8af6_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Finite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:to="lab_us-gaap_IntangibleAssetsFiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_731017e6-8745-47a5-997c-c08284537daf_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percent of employees' gross pay</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_26118b60-3f9e-4955-9792-00b0ff4eb290_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_714155a3-a735-4f2e-af7e-e0b8257fd627_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share repurchase program, remaining authorized, number of shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Remaining Authorized, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_7d36fde3-fd51-4bc6-9ae9-df3415be4cb3_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_14de2cc2-c768-4089-bfd3-2bb7ec68a01d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_ef4401d6-1b97-4a0d-8fcb-f01dd019da0f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Severance</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2dd5be72-b30b-4b05-b43f-b823c67f375b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_814b929e-945a-4dae-9e67-2b6a37a80c0c_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, nonvested beginning of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_3fc81653-343e-4e85-87ed-50b5da8a1e74_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, nonvested end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_3e440187-82f9-4dc0-a461-9d6fa965c653_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset back securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_c276f1c5-5a88-4e55-8cce-0f2260cf37b4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_48828448-749c-4d23-b16a-9401c5df2c91_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_45637c0b-4e36-424f-a671-6bc1a63af57f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6c0498fe-e533-44b9-8c7d-708e51e9df26_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_0137cfc1-6ec0-42a3-8a0c-228d1ad825a8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_PerformanceObligationContractTerm_3cdb14e5-cc63-4548-898c-f30ca0db125e_terseLabel_en-US" xlink:label="lab_izea_PerformanceObligationContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance obligation contract term</link:label>
    <link:label id="lab_izea_PerformanceObligationContractTerm_label_en-US" xlink:label="lab_izea_PerformanceObligationContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Obligation Contract Term</link:label>
    <link:label id="lab_izea_PerformanceObligationContractTerm_documentation_en-US" xlink:label="lab_izea_PerformanceObligationContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Obligation Contract Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceObligationContractTerm" xlink:href="izea-20250331.xsd#izea_PerformanceObligationContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_PerformanceObligationContractTerm" xlink:to="lab_izea_PerformanceObligationContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7cf87f67-3550-49a4-a8c4-101701223bd3_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_61efc8f3-4fdc-4d36-be6f-6aedeb8be08a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_7555732e-2f4b-455a-b485-4d38eea764ec_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_1678da65-1ac8-47fa-9640-63d03078717c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_58dccfcd-f0c4-4e35-bce9-4a9fb629f349_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes at effective rates</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b6597d3-9809-4d2a-a4ce-dac33f56a2f2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_031b7058-efef-4dee-935b-ad8bcda175d1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_1031abc9-03a2-479d-b3c9-adb83cc4ac3c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e463af44-3f48-44be-b086-8e60f0bbf58b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a5b88124-3feb-45e0-b8f0-82e132a24f19_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_473613e7-075b-4b7c-8c53-748fd199bf97_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_95512118-8f0c-4fa8-ab1f-0f16cec3b4ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_87f26d5e-ab9b-452f-a21a-626e8a0c0454_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_fd809546-b47f-4951-b743-504c98beaeeb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_57a3e402-31bc-4317-aee0-04c14ff56656_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_HoldingPeriodOfMarketableSecurities_8f2dc5a3-4966-484e-9566-83d42383fed1_terseLabel_en-US" xlink:label="lab_izea_HoldingPeriodOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Holding period of marketable securities</link:label>
    <link:label id="lab_izea_HoldingPeriodOfMarketableSecurities_label_en-US" xlink:label="lab_izea_HoldingPeriodOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Holding period of marketable securities</link:label>
    <link:label id="lab_izea_HoldingPeriodOfMarketableSecurities_documentation_en-US" xlink:label="lab_izea_HoldingPeriodOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Holding period of marketable securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoldingPeriodOfMarketableSecurities" xlink:href="izea-20250331.xsd#izea_HoldingPeriodOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_HoldingPeriodOfMarketableSecurities" xlink:to="lab_izea_HoldingPeriodOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2c0c623f-5c7f-43a0-9745-e974b1e740d7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c8fadd0c-9c05-42bf-93c4-b322d0bcdedd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_b997829f-1fb7-4c3f-a738-332b0da5bf9b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares withheld to cover statutory taxes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_734044a3-bacf-429a-8cff-f32bdbe6becc_terseLabel_en-US" xlink:label="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]</link:label>
    <link:label id="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_label_en-US" xlink:label="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] [Roll Forward]</link:label>
    <link:label id="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_documentation_en-US" xlink:label="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" xlink:to="lab_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e66735f5-bcea-4317-ab82-11ede1e0a941_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2f6a4500-ac29-46bb-9571-03252fc899eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_c5f9f88a-d602-47fa-bea6-3e2f9effad25_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_af137c32-8f7c-4cab-ad27-440836f2fd6c_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b99bca6f-2193-4446-a632-79cbda1c6002_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_3e32d15f-ab0d-4275-a64a-bb5ad13a7639_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_f96b4c75-721c-46f6-ac2d-09730f38c967_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_e1e58dd8-e10b-48c5-9d72-1f120ed542c5_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_42427035-8904-4d10-8ee4-e0faf59479bf_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Shares in ESOP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Shares in ESOP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ContractLengthForSalesCommissionsPayment_efcba482-b54e-46de-8757-c5692588661f_terseLabel_en-US" xlink:label="lab_izea_ContractLengthForSalesCommissionsPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract length for sales commissions payment</link:label>
    <link:label id="lab_izea_ContractLengthForSalesCommissionsPayment_label_en-US" xlink:label="lab_izea_ContractLengthForSalesCommissionsPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Length For Sales Commissions Payment</link:label>
    <link:label id="lab_izea_ContractLengthForSalesCommissionsPayment_documentation_en-US" xlink:label="lab_izea_ContractLengthForSalesCommissionsPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Length For Sales Commissions Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContractLengthForSalesCommissionsPayment" xlink:href="izea-20250331.xsd#izea_ContractLengthForSalesCommissionsPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ContractLengthForSalesCommissionsPayment" xlink:to="lab_izea_ContractLengthForSalesCommissionsPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_2b75d555-6c8a-4809-a0ab-3b45ed59dbd4_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CashOperatingCosts_42b536c8-a6cd-4ebc-95b2-1f7610e1c7bc_terseLabel_en-US" xlink:label="lab_izea_CashOperatingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other cash operating costs</link:label>
    <link:label id="lab_izea_CashOperatingCosts_label_en-US" xlink:label="lab_izea_CashOperatingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash operating costs</link:label>
    <link:label id="lab_izea_CashOperatingCosts_documentation_en-US" xlink:label="lab_izea_CashOperatingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash operating costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CashOperatingCosts" xlink:href="izea-20250331.xsd#izea_CashOperatingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CashOperatingCosts" xlink:to="lab_izea_CashOperatingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ea3f4df2-2213-48fe-bd1c-f4ff36f27b03_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ccd3d4b0-de5f-4c88-bedd-4f3246d36d79_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1fe99609-19d7-45e3-b74e-d9ad15c9d6f1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_fd5527d1-6cdb-41e5-a701-1c1c6f9cf100_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software Development</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_5048acd7-f0cb-4e0a-94c9-4368716aa4f4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Benefits and Share-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:to="lab_us-gaap_EmployeeBenefitsAndShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_3fab6a48-6b0b-4b1c-91e7-6ce1ee076e8a_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from APAC</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_0ac00224-6904-4952-b263-875072af789b_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_571f6974-fd00-4f6d-adeb-7582584af2d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_967e2029-7bf5-4084-8d7b-91e3c092d579_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b21083f3-a0d8-403a-a51f-5cbf01f4217a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6dbe2e78-08ae-49cf-bead-2a33338d7657_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a077f94a-60e3-40eb-ac0b-31be74c02f48_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_78cbd12e-4f6e-4d30-9644-5c46dd380896_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_be3a8280-7bf9-4382-b54b-2321b1227ffa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grants outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_62d6d3df-8668-4cb4-952a-79187a4920bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_309aa9e0-9ad2-46ea-9a29-274f1af4adae_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, end of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_b61c6c2e-6765-4c0a-a281-6ba94bd65df3_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized computer software, additions</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_cd697a37-9602-409f-a3e6-9c3bd4dc49db_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6a098a85-5da2-4a96-9e9b-01728c0ef008_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_92465c2c-e43e-4dc3-a92c-ee85e70ae379_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_7c651eac-48e9-4672-8a80-3994fc4d18e7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued other (1)</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_b6be62bc-873a-4861-898f-ede3f9e65746_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_6476430e-85ba-40d2-a640-d140c2bad56b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_SegmentDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDiscontinuedOperationsMember" xlink:to="lab_us-gaap_SegmentDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_c9c8aed3-aafb-4341-89a0-6abf00d08bd8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_bf9f1dc6-ab34-40db-9bee-bb1cc0afd138_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_dfb8aec5-04e7-4997-9fba-16225cd98b9f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e8180235-4d7c-42d6-b6d5-62507aa83b22_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested grants in period, weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_ca39aa04-a3b9-4351-80fc-3c67dbefa734_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_9d84db02-9825-456e-a226-b4ffc4b03996_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_c477e3d4-efde-466f-8950-9146eef9d268_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_7c5cd198-50ba-48eb-bcf0-da1e49e80125_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExecutiveOfficerMember_1fd2d9cf-adb6-4dad-af19-04bb17b068fb_terseLabel_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Officer</link:label>
    <link:label id="lab_srt_ExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExecutiveOfficerMember" xlink:to="lab_srt_ExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2927fa33-baec-451c-a3ff-f5822e46c68f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_LicenseFeesMember_32c81570-8f82-4a41-b58a-487fb83807de_terseLabel_en-US" xlink:label="lab_izea_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_izea_LicenseFeesMember_label_en-US" xlink:label="lab_izea_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_izea_LicenseFeesMember_documentation_en-US" xlink:label="lab_izea_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License Fees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LicenseFeesMember" xlink:href="izea-20250331.xsd#izea_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_LicenseFeesMember" xlink:to="lab_izea_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivablePercentPastDue1_91d96b8d-c5b7-49f9-96b8-fc20f1773efb_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivablePercentPastDue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing Receivable, Percent Past Due</link:label>
    <link:label id="lab_us-gaap_FinancingReceivablePercentPastDue1_label_en-US" xlink:label="lab_us-gaap_FinancingReceivablePercentPastDue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Percent Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePercentPastDue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablePercentPastDue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivablePercentPastDue1" xlink:to="lab_us-gaap_FinancingReceivablePercentPastDue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f77130c7-b08f-4393-a341-cffea2de5103_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_0f91bdff-0bb1-4da0-8490-717ae8473e83_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_d67cae82-d1ad-4ff3-afae-be98efde5463_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_495906f0-056a-413a-b016-d734ceeeb1e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_2f603092-7cd3-4857-84ce-755658e995ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_3ed28364-aed2-475d-96d1-25a6e5ab7bef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capitalization of software development costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Develop Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_fd219581-4e06-48c3-b067-ace0ee7872d0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_abb844d7-d80d-4368-9108-9587da36481d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfEquity" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_MinimumhourrequirementforemployeesparticipationintheESSP_6c84d88d-a33d-4115-9875-8fead0573947_terseLabel_en-US" xlink:label="lab_izea_MinimumhourrequirementforemployeesparticipationintheESSP" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum hour requirement for employees participation in the ESSP (hours)</link:label>
    <link:label id="lab_izea_MinimumhourrequirementforemployeesparticipationintheESSP_label_en-US" xlink:label="lab_izea_MinimumhourrequirementforemployeesparticipationintheESSP" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum hour requirement for employees participation in the ESSP</link:label>
    <link:label id="lab_izea_MinimumhourrequirementforemployeesparticipationintheESSP_documentation_en-US" xlink:label="lab_izea_MinimumhourrequirementforemployeesparticipationintheESSP" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum hour requirement for employees participation in the ESSP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MinimumhourrequirementforemployeesparticipationintheESSP" xlink:href="izea-20250331.xsd#izea_MinimumhourrequirementforemployeesparticipationintheESSP"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_MinimumhourrequirementforemployeesparticipationintheESSP" xlink:to="lab_izea_MinimumhourrequirementforemployeesparticipationintheESSP" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_86fc0c61-ae2b-42e4-a4a0-cfd042e38b5e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value of common stock issued for services</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_360afeaf-db40-4e17-aef1-5d7317c5ace1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, capital shares reserved for future issuance (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_UnrealizedGainLossOnSecuritiesMember_dd57f252-de68-4502-b22e-34143ca6101d_terseLabel_en-US" xlink:label="lab_izea_UnrealizedGainLossOnSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Securities</link:label>
    <link:label id="lab_izea_UnrealizedGainLossOnSecuritiesMember_label_en-US" xlink:label="lab_izea_UnrealizedGainLossOnSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Securities [Member]</link:label>
    <link:label id="lab_izea_UnrealizedGainLossOnSecuritiesMember_documentation_en-US" xlink:label="lab_izea_UnrealizedGainLossOnSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss) on Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_UnrealizedGainLossOnSecuritiesMember" xlink:href="izea-20250331.xsd#izea_UnrealizedGainLossOnSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_UnrealizedGainLossOnSecuritiesMember" xlink:to="lab_izea_UnrealizedGainLossOnSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_5690e0ea-0927-47cc-b3a1-b4af00385bbd_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_DigitalAssetsMember_ebd9c285-26e1-4fe1-993b-bea9dcc1896e_terseLabel_en-US" xlink:label="lab_izea_DigitalAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Digital Assets</link:label>
    <link:label id="lab_izea_DigitalAssetsMember_label_en-US" xlink:label="lab_izea_DigitalAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Digital Assets [Member]</link:label>
    <link:label id="lab_izea_DigitalAssetsMember_documentation_en-US" xlink:label="lab_izea_DigitalAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Digital Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DigitalAssetsMember" xlink:href="izea-20250331.xsd#izea_DigitalAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_DigitalAssetsMember" xlink:to="lab_izea_DigitalAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_1d71df9f-1e50-4e97-84e1-e02979664f43_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_987da250-2d1a-4608-b557-31b37de4f7c4_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares authorized for repurchase</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:to="lab_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_MonthlyInEqualInstallmentsMember_9908f7bf-73bc-4020-9286-05f9f1b537fe_terseLabel_en-US" xlink:label="lab_izea_MonthlyInEqualInstallmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monthly in equal installments</link:label>
    <link:label id="lab_izea_MonthlyInEqualInstallmentsMember_label_en-US" xlink:label="lab_izea_MonthlyInEqualInstallmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Monthly in equal installments [Member]</link:label>
    <link:label id="lab_izea_MonthlyInEqualInstallmentsMember_documentation_en-US" xlink:label="lab_izea_MonthlyInEqualInstallmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Monthly in equal installments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MonthlyInEqualInstallmentsMember" xlink:href="izea-20250331.xsd#izea_MonthlyInEqualInstallmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_MonthlyInEqualInstallmentsMember" xlink:to="lab_izea_MonthlyInEqualInstallmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_ea599bed-46c0-4bd7-ae02-4f4f322a7d5a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:to="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_d4d22d9b-8e0b-4740-9df5-cc25cbf9d7c6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares repurchased during the period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_StockOwnershipPlanAxis_4569f632-1641-4376-a044-500c2873f95b_terseLabel_en-US" xlink:label="lab_izea_StockOwnershipPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Ownership Plan [Axis]</link:label>
    <link:label id="lab_izea_StockOwnershipPlanAxis_label_en-US" xlink:label="lab_izea_StockOwnershipPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Ownership Plan [Axis]</link:label>
    <link:label id="lab_izea_StockOwnershipPlanAxis_documentation_en-US" xlink:label="lab_izea_StockOwnershipPlanAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Ownership Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOwnershipPlanAxis" xlink:href="izea-20250331.xsd#izea_StockOwnershipPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_StockOwnershipPlanAxis" xlink:to="lab_izea_StockOwnershipPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_A2014EmployeeStockPurchasePlanMember_30384b41-22a9-4868-9103-0e27b8702d2b_terseLabel_en-US" xlink:label="lab_izea_A2014EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2014 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_izea_A2014EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_izea_A2014EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2014 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_izea_A2014EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_izea_A2014EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2014 Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_A2014EmployeeStockPurchasePlanMember" xlink:href="izea-20250331.xsd#izea_A2014EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_A2014EmployeeStockPurchasePlanMember" xlink:to="lab_izea_A2014EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_Numberofindependentdirectors_5a26f504-62e8-467b-8262-a825f1a2c14d_terseLabel_en-US" xlink:label="lab_izea_Numberofindependentdirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of independent directors</link:label>
    <link:label id="lab_izea_Numberofindependentdirectors_label_en-US" xlink:label="lab_izea_Numberofindependentdirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of independent directors</link:label>
    <link:label id="lab_izea_Numberofindependentdirectors_documentation_en-US" xlink:label="lab_izea_Numberofindependentdirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of independent directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Numberofindependentdirectors" xlink:href="izea-20250331.xsd#izea_Numberofindependentdirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_Numberofindependentdirectors" xlink:to="lab_izea_Numberofindependentdirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_83bcd5d0-025a-4e07-935b-8163b2410cbe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_a4b872f8-2e89-4004-9124-bd23e1458c2e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e23485d7-33fe-48c1-94d3-e2f4d5d9751f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred federal tax</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_ee4e17e0-b9a6-4f0c-b9bf-626a24de594b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_e46257ab-fe8c-4f79-9462-386945812e66_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2c212897-35f3-491e-98a9-6d5fad20a177_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_6a220c35-24e1-4b1b-97af-912a4b0cf5b7_terseLabel_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, FDIC insured amount</link:label>
    <link:label id="lab_us-gaap_CashFDICInsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashFDICInsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, FDIC Insured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFDICInsuredAmount" xlink:to="lab_us-gaap_CashFDICInsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_54d5e2ba-0a30-4e4a-b305-f5173ac0fa8e_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramDomain" xlink:to="lab_srt_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_68edef4b-085c-4c7f-bb41-bfbff20a36ec_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_2f1f1cb2-8562-47cc-b849-051a64ab5207_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_e8915803-aff1-4647-a299-4e62655bb1f5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued for payment of services, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_4e019ad8-c71b-4e12-a195-5530185ef371_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_edb05a6a-7308-493d-aa86-87e444a259f1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2eec8114-a117-4650-b224-fffbd53222af_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_FinancialAssetsFairValueDisclosure_08c81ab0-6f32-4642-b50d-95a8497fbf24_terseLabel_en-US" xlink:label="lab_izea_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_izea_FinancialAssetsFairValueDisclosure_label_en-US" xlink:label="lab_izea_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_izea_FinancialAssetsFairValueDisclosure_documentation_en-US" xlink:label="lab_izea_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Financial Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FinancialAssetsFairValueDisclosure" xlink:href="izea-20250331.xsd#izea_FinancialAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_FinancialAssetsFairValueDisclosure" xlink:to="lab_izea_FinancialAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_2f9c215f-947f-417c-8fbf-f713ebbe6a76_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_8440d0f0-ba64-4120-a411-dc0da91333f4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_c71fde50-d258-4b81-b6d9-6adf0a6dfb73_verboseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Software development costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_0a69035e-f1fe-4540-9041-63cdb43f0baf_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized computer software, gross</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_11741370-1826-42b3-ba99-74a16751f32e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_42bd9328-db9a-4d6e-adc3-b34fcda2e7a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Share withheld to cover statutory taxes (shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0cca5cfc-f4e9-4788-9567-5ff0c398f461_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_93d7c580-02d7-4cda-8354-09d4e0c8ab0e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Net Loss</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_bdd868ee-94d8-41fa-a7ef-8f2e3a8f8c32_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_HoozuHoldingsInc.Member_49824b36-a90f-4ff0-a836-27297ea33fe8_terseLabel_en-US" xlink:label="lab_izea_HoozuHoldingsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hoozu</link:label>
    <link:label id="lab_izea_HoozuHoldingsInc.Member_label_en-US" xlink:label="lab_izea_HoozuHoldingsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hoozu Holdings, Inc. [Member]</link:label>
    <link:label id="lab_izea_HoozuHoldingsInc.Member_documentation_en-US" xlink:label="lab_izea_HoozuHoldingsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hoozu Holdings, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoozuHoldingsInc.Member" xlink:href="izea-20250331.xsd#izea_HoozuHoldingsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_HoozuHoldingsInc.Member" xlink:to="lab_izea_HoozuHoldingsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_PerformanceBasedRSUsMember_6458642a-73e3-4f0b-baa6-bb4708f28de5_terseLabel_en-US" xlink:label="lab_izea_PerformanceBasedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Based</link:label>
    <link:label id="lab_izea_PerformanceBasedRSUsMember_label_en-US" xlink:label="lab_izea_PerformanceBasedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Based RSUs [Member]</link:label>
    <link:label id="lab_izea_PerformanceBasedRSUsMember_documentation_en-US" xlink:label="lab_izea_PerformanceBasedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance Based RSUs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceBasedRSUsMember" xlink:href="izea-20250331.xsd#izea_PerformanceBasedRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_PerformanceBasedRSUsMember" xlink:to="lab_izea_PerformanceBasedRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_f87e124e-8231-4e7f-8a03-5e30067e5413_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_d291b256-304b-4acb-a817-cc7e16e1e9f0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value, forfeited</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_d17e0ef6-09fe-499e-b3d9-25e309d47021_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax benefit, divestiture</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_28ec8738-b90c-4397-8382-a73902b0256a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b3ccca3d-5356-4b15-891d-9292b85ed272_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_a620dea0-a8ea-4ae1-8b72-dd18f410182f_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_6c42819c-0e87-4f72-ad61-986df386dbd0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_86117c7a-1d28-4f14-8f62-0a5478e46c66_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_829b7d1f-ac22-454c-bc19-035ee683c435_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_InducementGrantRelatedRSUsMember_9a4aa33a-5d48-4c96-aa8f-41f2cda72c26_terseLabel_en-US" xlink:label="lab_izea_InducementGrantRelatedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement grant-related RSUs</link:label>
    <link:label id="lab_izea_InducementGrantRelatedRSUsMember_label_en-US" xlink:label="lab_izea_InducementGrantRelatedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inducement grant-related RSUs [Member]</link:label>
    <link:label id="lab_izea_InducementGrantRelatedRSUsMember_documentation_en-US" xlink:label="lab_izea_InducementGrantRelatedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inducement grant-related RSUs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_InducementGrantRelatedRSUsMember" xlink:href="izea-20250331.xsd#izea_InducementGrantRelatedRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_InducementGrantRelatedRSUsMember" xlink:to="lab_izea_InducementGrantRelatedRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour_d66ba631-4787-4075-bdb4-5407f847a0f9_terseLabel_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour_label_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Four</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour_documentation_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour" xlink:to="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_5c5d0051-3bfc-420c-a452-41743fba98ba_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_93768ede-c39f-4be5-b89f-682b0df843af_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f48b293c-9a7a-466b-a733-d398779a9548_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_TotalvestingperiodMember_9fee18f8-4528-461f-9331-7ba31621e1cb_terseLabel_en-US" xlink:label="lab_izea_TotalvestingperiodMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total vesting period</link:label>
    <link:label id="lab_izea_TotalvestingperiodMember_label_en-US" xlink:label="lab_izea_TotalvestingperiodMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total vesting period [Member]</link:label>
    <link:label id="lab_izea_TotalvestingperiodMember_documentation_en-US" xlink:label="lab_izea_TotalvestingperiodMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total vesting period [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TotalvestingperiodMember" xlink:href="izea-20250331.xsd#izea_TotalvestingperiodMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_TotalvestingperiodMember" xlink:to="lab_izea_TotalvestingperiodMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_80b37475-4b10-4f3d-bd29-3a8308724f20_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_866c843e-586e-46b5-b6e4-89b7e112f0d2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_VestingFrequencyDomain_5cf33061-7a45-47d9-b003-9a9539752db0_terseLabel_en-US" xlink:label="lab_izea_VestingFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Frequency [Domain]</link:label>
    <link:label id="lab_izea_VestingFrequencyDomain_label_en-US" xlink:label="lab_izea_VestingFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Frequency [Domain]</link:label>
    <link:label id="lab_izea_VestingFrequencyDomain_documentation_en-US" xlink:label="lab_izea_VestingFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_VestingFrequencyDomain" xlink:href="izea-20250331.xsd#izea_VestingFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_VestingFrequencyDomain" xlink:to="lab_izea_VestingFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_63758c8c-4bd2-4805-bea3-9de61b89c8f9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_323bcae2-e694-41eb-ba6d-86ece31c3d1e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_1d7ce0df-99a7-4cd3-93d9-23210eeaa667_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_57d83bf7-5b7d-4c52-8b5b-876063c933ef_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ActiveRepurchaseProgramMember_7a4af5b7-ed81-4a67-a828-7d799fb8d684_terseLabel_en-US" xlink:label="lab_izea_ActiveRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Active Repurchase Program</link:label>
    <link:label id="lab_izea_ActiveRepurchaseProgramMember_label_en-US" xlink:label="lab_izea_ActiveRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Active Repurchase Program [Member]</link:label>
    <link:label id="lab_izea_ActiveRepurchaseProgramMember_documentation_en-US" xlink:label="lab_izea_ActiveRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Active Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ActiveRepurchaseProgramMember" xlink:href="izea-20250331.xsd#izea_ActiveRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ActiveRepurchaseProgramMember" xlink:to="lab_izea_ActiveRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ac6ae2b0-3467-4904-b34a-3077d65aa121_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_FairMarketValueOfIncentiveStockOptions_c92e9083-1a8a-466b-ad4f-74ca101b0b96_terseLabel_en-US" xlink:label="lab_izea_FairMarketValueOfIncentiveStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair market value of incentive stock options</link:label>
    <link:label id="lab_izea_FairMarketValueOfIncentiveStockOptions_label_en-US" xlink:label="lab_izea_FairMarketValueOfIncentiveStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Market Value of Incentive Stock Options</link:label>
    <link:label id="lab_izea_FairMarketValueOfIncentiveStockOptions_documentation_en-US" xlink:label="lab_izea_FairMarketValueOfIncentiveStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Market Value of Incentive Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FairMarketValueOfIncentiveStockOptions" xlink:href="izea-20250331.xsd#izea_FairMarketValueOfIncentiveStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_FairMarketValueOfIncentiveStockOptions" xlink:to="lab_izea_FairMarketValueOfIncentiveStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_c322ad74-0c87-4a5c-b249-3e3937500897_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_bd043b92-4201-4a60-ab78-c38e2e1cdd13_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_LengthOfContractWithCustomers_45f97c97-3b1c-4399-aad8-4c1eafcb1384_terseLabel_en-US" xlink:label="lab_izea_LengthOfContractWithCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Length of contract with customers</link:label>
    <link:label id="lab_izea_LengthOfContractWithCustomers_label_en-US" xlink:label="lab_izea_LengthOfContractWithCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Length of Contract With Customers</link:label>
    <link:label id="lab_izea_LengthOfContractWithCustomers_documentation_en-US" xlink:label="lab_izea_LengthOfContractWithCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Length of Contract With Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LengthOfContractWithCustomers" xlink:href="izea-20250331.xsd#izea_LengthOfContractWithCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_LengthOfContractWithCustomers" xlink:to="lab_izea_LengthOfContractWithCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_623d5318-b98d-45cd-bb09-e8d9232c2ae4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_1c2fa9d7-8a5a-4e43-83e9-f9b8bc0d51be_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e3413f16-df20-4c52-b114-17fc82c12ae9_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_9ff4f06c-a69a-4a84-998d-83ce61988d09_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CurrencyTranslationAdjustmentMember_680d69bb-fd9f-4e0b-a079-360780783738_terseLabel_en-US" xlink:label="lab_izea_CurrencyTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Currency Translation Adjustment</link:label>
    <link:label id="lab_izea_CurrencyTranslationAdjustmentMember_label_en-US" xlink:label="lab_izea_CurrencyTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Currency Translation Adjustment [Member]</link:label>
    <link:label id="lab_izea_CurrencyTranslationAdjustmentMember_documentation_en-US" xlink:label="lab_izea_CurrencyTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Currency Translation Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CurrencyTranslationAdjustmentMember" xlink:href="izea-20250331.xsd#izea_CurrencyTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CurrencyTranslationAdjustmentMember" xlink:to="lab_izea_CurrencyTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_69453088-7f73-4a8c-8a62-84d3897eb9cb_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CustomerOneMember_bd5f2eff-dffa-4527-8b2a-c9a32505f25b_terseLabel_en-US" xlink:label="lab_izea_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_izea_CustomerOneMember_label_en-US" xlink:label="lab_izea_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_izea_CustomerOneMember_documentation_en-US" xlink:label="lab_izea_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CustomerOneMember" xlink:href="izea-20250331.xsd#izea_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CustomerOneMember" xlink:to="lab_izea_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_baea60e9-8bae-419a-8a5d-d61a966deaed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0464b35d-802e-4adf-b7a1-b6ca568b263c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_311e9bdf-f6af-45e8-80de-f4e5a246d657_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperatingAndNonoperating_f63f644f-9bdc-40ec-bf1c-2407fca79c8c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperatingAndNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Operating and Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:to="lab_us-gaap_InterestIncomeOperatingAndNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3f9febb2-1252-4821-92dd-072e9d677e1e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_SponsoredSocialRevenueMember_c1a0d997-b4bd-46d2-885e-128025f773f4_terseLabel_en-US" xlink:label="lab_izea_SponsoredSocialRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sponsored Social Revenue</link:label>
    <link:label id="lab_izea_SponsoredSocialRevenueMember_label_en-US" xlink:label="lab_izea_SponsoredSocialRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sponsored Social Revenue [Member]</link:label>
    <link:label id="lab_izea_SponsoredSocialRevenueMember_documentation_en-US" xlink:label="lab_izea_SponsoredSocialRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sponsored Social Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SponsoredSocialRevenueMember" xlink:href="izea-20250331.xsd#izea_SponsoredSocialRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_SponsoredSocialRevenueMember" xlink:to="lab_izea_SponsoredSocialRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_be1b8045-5e5e-4740-9e09-428aa20b7c73_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease_8a7400f3-d55e-4e58-8bc5-a0bf22def2e5_terseLabel_en-US" xlink:label="lab_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase in number of plan shares (in shares)</link:label>
    <link:label id="lab_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease_label_en-US" xlink:label="lab_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Period Increase (Decrease)</link:label>
    <link:label id="lab_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" xlink:href="izea-20250331.xsd#izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" xlink:to="lab_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_2ab0390c-ebb2-4822-9b26-b37529c36caf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Share Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Share Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_dbe140ed-e8ec-4952-ab96-4ce6f4cf6edb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_7d4a2a16-95fe-4daa-81f0-c7d120dd25d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price, expired</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_86f7cd23-654a-4785-bd71-95c7eae2b761_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_6da91327-ee7d-47ea-b271-cef80b647481_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_f81ab301-663b-4469-b921-01dd28dc7cb6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_PerformanceBasedAndTimeBasedRSUAwardsMember_72635ca2-458c-455c-abff-540a2194aa15_terseLabel_en-US" xlink:label="lab_izea_PerformanceBasedAndTimeBasedRSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_izea_PerformanceBasedAndTimeBasedRSUAwardsMember_label_en-US" xlink:label="lab_izea_PerformanceBasedAndTimeBasedRSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance-based and time-based RSU awards [Member]</link:label>
    <link:label id="lab_izea_PerformanceBasedAndTimeBasedRSUAwardsMember_documentation_en-US" xlink:label="lab_izea_PerformanceBasedAndTimeBasedRSUAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Performance-based and time-based RSU awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceBasedAndTimeBasedRSUAwardsMember" xlink:href="izea-20250331.xsd#izea_PerformanceBasedAndTimeBasedRSUAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_PerformanceBasedAndTimeBasedRSUAwardsMember" xlink:to="lab_izea_PerformanceBasedAndTimeBasedRSUAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_StockOwnershipPlanDomain_73f4a5e8-8c44-4191-b1c0-8fd82473ca5d_terseLabel_en-US" xlink:label="lab_izea_StockOwnershipPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Ownership Plan [Domain]</link:label>
    <link:label id="lab_izea_StockOwnershipPlanDomain_label_en-US" xlink:label="lab_izea_StockOwnershipPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Ownership Plan [Domain]</link:label>
    <link:label id="lab_izea_StockOwnershipPlanDomain_documentation_en-US" xlink:label="lab_izea_StockOwnershipPlanDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Ownership Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOwnershipPlanDomain" xlink:href="izea-20250331.xsd#izea_StockOwnershipPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_StockOwnershipPlanDomain" xlink:to="lab_izea_StockOwnershipPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_Fairmarketvalueofsharesavailableforissuance_ee67acda-a4b6-4260-ba68-2084db901c54_terseLabel_en-US" xlink:label="lab_izea_Fairmarketvalueofsharesavailableforissuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair market value of shares available for issuance (percentage)</link:label>
    <link:label id="lab_izea_Fairmarketvalueofsharesavailableforissuance_label_en-US" xlink:label="lab_izea_Fairmarketvalueofsharesavailableforissuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair market value of shares available for issuance</link:label>
    <link:label id="lab_izea_Fairmarketvalueofsharesavailableforissuance_documentation_en-US" xlink:label="lab_izea_Fairmarketvalueofsharesavailableforissuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair market value of shares available for issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Fairmarketvalueofsharesavailableforissuance" xlink:href="izea-20250331.xsd#izea_Fairmarketvalueofsharesavailableforissuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_Fairmarketvalueofsharesavailableforissuance" xlink:to="lab_izea_Fairmarketvalueofsharesavailableforissuance" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo_1a6a465f-6464-4fb4-88e9-4260775951a9_terseLabel_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo_label_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Two</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo_documentation_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo" xlink:to="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5a947bc5-381a-4d82-9faf-4edc7cac7a80_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_a50f605b-8d30-4488-99e7-36cf6e555dbb_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debt</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_d6d20b45-de48-4183-9bda-edf91d04fa01_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosures</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_177f09e4-9db1-4877-867b-78778eec4640_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_01b01447-3d95-43c6-9cc2-119d45a33f68_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_3ebfd9f3-5653-4dd4-b2bd-acba8b2aea03_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_39b2cf89-bc52-4767-a54f-52197123e750_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_7d66e822-8046-408e-b084-8fd8146a30fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:to="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_07303bee-2c8f-4386-a4e1-071ab51e0462_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_14025c39-9137-407e-b5b2-338fbcc2d519_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_6577e035-2cb1-49d1-991c-e3345d76ea7d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_37667e05-9be9-48d0-ac0d-8d02b3212c6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes Payable</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_dccd3dd7-f8be-4999-9abe-1d163be3eaed_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_bc21d98b-e1b5-4409-93c9-04db222d9b35_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_bffdbb03-3222-4263-a434-b773b6bfa3df_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Common shares, nonvested beginning of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_d63a7187-d742-43fc-8950-61f37f7e7be5_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Common shares, nonvested end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive_285c5317-ed23-4b9b-9f3f-ef5ff430cd89_terseLabel_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2030</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive_label_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Five</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive_documentation_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive" xlink:to="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_1d7c05cb-0fe2-4f41-9018-a898235594a7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_8885b503-59b3-41fa-bcfd-9324e2ef5b18_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_4bdba390-21a2-409b-8641-3334ee6b0e0f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_cef259e4-193b-40f9-a7d6-52044e000338_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_2776416b-5eff-47ac-8748-685d2074b2de_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_eb791cf4-9071-4699-b4b5-04ea28b264e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Cost [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_HumanCapitalCosts_780be7f2-0ce1-422a-88c6-fdeab6bcd344_terseLabel_en-US" xlink:label="lab_izea_HumanCapitalCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Human capital costs</link:label>
    <link:label id="lab_izea_HumanCapitalCosts_label_en-US" xlink:label="lab_izea_HumanCapitalCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Human capital costs</link:label>
    <link:label id="lab_izea_HumanCapitalCosts_documentation_en-US" xlink:label="lab_izea_HumanCapitalCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Human capital costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HumanCapitalCosts" xlink:href="izea-20250331.xsd#izea_HumanCapitalCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_HumanCapitalCosts" xlink:to="lab_izea_HumanCapitalCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_9cc66aa0-5a78-4bcf-a674-b0ef3f2c8644_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_fe5d8380-5032-42c6-bcc1-6897d0cb57cd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6d779ec4-1a38-41c1-be5e-d1d6611c3deb_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common stock; $0.0001 par value; $50,000,000 shares authorized; shares issued: $17,661,220 and $17,518,018, respectively, shares outstanding: $16,893,885 and $16,931,169, respectively.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockExpense_74c5bdd3-9c6e-465a-9b61-9eb98160ba0a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock or unit expense</link:label>
    <link:label id="lab_us-gaap_RestrictedStockExpense_label_en-US" xlink:label="lab_us-gaap_RestrictedStockExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock or Unit Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockExpense" xlink:to="lab_us-gaap_RestrictedStockExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4501b1b7-bb52-461e-8e31-d170df49960b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_AmortizationPeriodOfSoftwareDevelopmentCosts_09f15ada-fc72-4c29-9f85-957a65186459_terseLabel_en-US" xlink:label="lab_izea_AmortizationPeriodOfSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization period of software development costs (in years)</link:label>
    <link:label id="lab_izea_AmortizationPeriodOfSoftwareDevelopmentCosts_label_en-US" xlink:label="lab_izea_AmortizationPeriodOfSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Period Of Software Development Costs</link:label>
    <link:label id="lab_izea_AmortizationPeriodOfSoftwareDevelopmentCosts_documentation_en-US" xlink:label="lab_izea_AmortizationPeriodOfSoftwareDevelopmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization Period Of Software Development Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AmortizationPeriodOfSoftwareDevelopmentCosts" xlink:href="izea-20250331.xsd#izea_AmortizationPeriodOfSoftwareDevelopmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_AmortizationPeriodOfSoftwareDevelopmentCosts" xlink:to="lab_izea_AmortizationPeriodOfSoftwareDevelopmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6c59a236-f8f9-452e-8c25-e891141cea73_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_c718ea64-a124-4b11-90e6-80576980dbfa_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossAttributableToParent_label_en-US" xlink:label="lab_us-gaap_IncomeLossAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) Attributable to Parent, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossAttributableToParent" xlink:to="lab_us-gaap_IncomeLossAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_c5438dc9-5cd1-4c43-aa50-04b9eaf3a5c0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_26de3c40-d0f5-492e-ad0b-657c773d77d2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employers annual vesting percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:to="lab_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_187bd289-b0e3-4fe6-abe2-81c0d5179544_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested forfeited in period, weighted average grant date fair value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan_81153dae-366a-416d-b4ab-3ffcb3535609_terseLabel_en-US" xlink:label="lab_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual compensation limit percentage, employee stock purchase plan (percentage)</link:label>
    <link:label id="lab_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan_label_en-US" xlink:label="lab_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Annual compensation limit percentage, employee stock purchase plan</link:label>
    <link:label id="lab_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan_documentation_en-US" xlink:label="lab_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Annual compensation limit percentage, employee stock purchase plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan" xlink:href="izea-20250331.xsd#izea_Annualcompensationlimitpercentageemployeestockpurchaseplan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan" xlink:to="lab_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8fc81a04-fc0a-4fee-8d27-f0ab104de28a_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_09129f74-b416-4885-9032-eac683b3e774_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_6bd6224d-b857-402d-87e8-d6cb0b2715ae_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock; $0.0001 par value; $10,000,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan_2ade6d3f-723e-44ca-b06d-e8781aa33dc7_terseLabel_en-US" xlink:label="lab_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issuance limit per offering period, employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan_label_en-US" xlink:label="lab_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares issuance limit per offering period, employee stock purchase plan</link:label>
    <link:label id="lab_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan_documentation_en-US" xlink:label="lab_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Limit on stock issued during period, employee stock purchase plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" xlink:href="izea-20250331.xsd#izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" xlink:to="lab_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_c775c5bb-214a-4944-9a86-172272043288_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment, useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2af7baab-9038-4587-81b8-5be17bf8510b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_3e9a965e-94de-4e3d-b2bb-8ce0430de7da_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_68679dfe-1412-4202-a7a8-726681077c7a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental Unemployment Benefits, Severance Benefits</link:label>
    <link:label id="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_label_en-US" xlink:label="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Unemployment Benefits, Severance Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:to="lab_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_5ce6623c-a4f4-4afc-8450-5572cbdebcae_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic loss per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService_a7cb6693-3722-4636-80f7-dda5882a3af1_terseLabel_en-US" xlink:label="lab_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employers matching contribution, service period (in years)</link:label>
    <link:label id="lab_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService_label_en-US" xlink:label="lab_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employers Matching Contribution, Years of Service</link:label>
    <link:label id="lab_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService_documentation_en-US" xlink:label="lab_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employers Matching Contribution, Years of Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService" xlink:href="izea-20250331.xsd#izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService" xlink:to="lab_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_641e38fa-5408-47bf-a068-60d0a2fc29ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_16f31ac7-8a35-4ca6-a9c1-d80e7a1504d2_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_8778298d-d781-4eef-aea5-56e482ba31be_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_af14528d-c39c-4f39-b866-215e7cf06bef_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested weighted average remaining contractual terms</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_20d36804-8560-427d-aed4-237e84246096_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_52d00629-0243-45c7-9017-647d54f7944d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_a9cb37fb-20a1-46be-b452-ca56b2c6a027_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramAxis" xlink:to="lab_srt_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_8f23bf2c-9629-4b3e-938c-9082b47bdd3f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Assets, Total</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_d4b814e2-11d7-4b2a-8dc3-d70d8816b92d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_5293ad39-918c-4019-85e7-319a1c871d48_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_b2b36d9e-4a22-4360-b4cf-5bc35e12b3bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_807f358c-de4f-411f-9ea9-0d3f6c619620_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested grants in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_f7ba9afe-36e7-4e2c-8d0c-8c3f2f76173b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_ec17fc4f-965a-45c0-9ffb-14d20b336045_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Value of stock issued or to be issued for payment of services</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_fa0d4abb-4461-47d5-9b4a-dd13e7cfbbb9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies (Note 9)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0f861b71-f64e-4228-a3d5-85f077e3d886_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_OtherMember_78a3888e-79a5-4b82-8901-7044b993ca95_terseLabel_en-US" xlink:label="lab_izea_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Other</link:label>
    <link:label id="lab_izea_OtherMember_label_en-US" xlink:label="lab_izea_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_izea_OtherMember_documentation_en-US" xlink:label="lab_izea_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_OtherMember" xlink:href="izea-20250331.xsd#izea_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_OtherMember" xlink:to="lab_izea_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_4dffe620-dde7-4af4-825c-6a2716e9c2d8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Combinations Policy</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f5d605d5-8ad9-45f2-87e1-46530106c21d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CustomerTwoMember_1ddced11-1dc8-4f3c-bfce-a418dca6a3bd_terseLabel_en-US" xlink:label="lab_izea_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Two</link:label>
    <link:label id="lab_izea_CustomerTwoMember_label_en-US" xlink:label="lab_izea_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer two [Member]</link:label>
    <link:label id="lab_izea_CustomerTwoMember_documentation_en-US" xlink:label="lab_izea_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CustomerTwoMember" xlink:href="izea-20250331.xsd#izea_CustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CustomerTwoMember" xlink:to="lab_izea_CustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_8b668001-db31-4ffb-a43f-5407ffd7e2ad_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentOperatingActivitiesDomain_label_en-US" xlink:label="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Activities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain" xlink:to="lab_us-gaap_SegmentOperatingActivitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_SaaSServicesSegmentRevenueMember_bf0a1e33-57c9-4230-8c0c-0b9726a6340e_terseLabel_en-US" xlink:label="lab_izea_SaaSServicesSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SaaS Services Revenue</link:label>
    <link:label id="lab_izea_SaaSServicesSegmentRevenueMember_label_en-US" xlink:label="lab_izea_SaaSServicesSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SaaS Services Segment Revenue [Member]</link:label>
    <link:label id="lab_izea_SaaSServicesSegmentRevenueMember_documentation_en-US" xlink:label="lab_izea_SaaSServicesSegmentRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">SaaS Services Segment Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SaaSServicesSegmentRevenueMember" xlink:href="izea-20250331.xsd#izea_SaaSServicesSegmentRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_SaaSServicesSegmentRevenueMember" xlink:to="lab_izea_SaaSServicesSegmentRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_EquityIncentive2011PlanMember_0d59f246-84a1-4fbf-bb80-095f83839cce_terseLabel_en-US" xlink:label="lab_izea_EquityIncentive2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Incentive 2011 Plan</link:label>
    <link:label id="lab_izea_EquityIncentive2011PlanMember_label_en-US" xlink:label="lab_izea_EquityIncentive2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Incentive 2011 Plan [Member]</link:label>
    <link:label id="lab_izea_EquityIncentive2011PlanMember_documentation_en-US" xlink:label="lab_izea_EquityIncentive2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Incentive 2011 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EquityIncentive2011PlanMember" xlink:href="izea-20250331.xsd#izea_EquityIncentive2011PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_EquityIncentive2011PlanMember" xlink:to="lab_izea_EquityIncentive2011PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_c8f8c0ba-d65c-4fd1-b6e0-7c4cfda1f248_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_HoozuHoldingPTYLtd.Member_894b51b2-e601-4599-a44c-047a779a7c61_terseLabel_en-US" xlink:label="lab_izea_HoozuHoldingPTYLtd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hoozu Holding PTY Ltd.</link:label>
    <link:label id="lab_izea_HoozuHoldingPTYLtd.Member_label_en-US" xlink:label="lab_izea_HoozuHoldingPTYLtd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hoozu Holding PTY Ltd. [Member]</link:label>
    <link:label id="lab_izea_HoozuHoldingPTYLtd.Member_documentation_en-US" xlink:label="lab_izea_HoozuHoldingPTYLtd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hoozu Holding PTY Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoozuHoldingPTYLtd.Member" xlink:href="izea-20250331.xsd#izea_HoozuHoldingPTYLtd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_HoozuHoldingPTYLtd.Member" xlink:to="lab_izea_HoozuHoldingPTYLtd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_aa50d68f-ef97-4ab1-8a8e-b66d3681e6ff_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_dce37e3d-ebd0-4c27-a243-003a31ebb242_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_dc4ddd95-410b-44ee-86f1-88ad588d55b5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued for payment of services, net (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_5863f336-0ac8-4c72-9e41-7e9258a97e17_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_0391a60c-b37d-4974-97f7-e8172e4ed60f_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_4fb2ecfd-e50b-40ec-9ade-f1a4624f633b_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_1fa378e1-54df-4a19-bd74-1d756e884de1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e4942070-e452-49cc-a044-2cbe7537d26f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_5f28be67-2703-46c7-bfd6-d3f964964c72_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_6ab4470d-06ff-4c90-b6de-2dbcf41a7c8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_54060c7b-c172-4a1a-a1bf-727814ba3f67_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b94d960b-1e7c-4f76-b87a-929a611575b3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_0d4f0e18-a6f6-45fd-adeb-f681818f44b7_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_565306b2-ee21-4696-a921-f3f47deb42d5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_7bfc2bd9-59eb-4dd1-bcd3-85b49f5fc20d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_Percentageofindividualownershipofcommonstock_1712e425-04fd-4228-86a9-6f88a2c68bef_terseLabel_en-US" xlink:label="lab_izea_Percentageofindividualownershipofcommonstock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of individual ownership of common stock (percentage)</link:label>
    <link:label id="lab_izea_Percentageofindividualownershipofcommonstock_label_en-US" xlink:label="lab_izea_Percentageofindividualownershipofcommonstock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Percentage of individual ownership of common stock</link:label>
    <link:label id="lab_izea_Percentageofindividualownershipofcommonstock_documentation_en-US" xlink:label="lab_izea_Percentageofindividualownershipofcommonstock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage of individual ownership of common stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Percentageofindividualownershipofcommonstock" xlink:href="izea-20250331.xsd#izea_Percentageofindividualownershipofcommonstock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_Percentageofindividualownershipofcommonstock" xlink:to="lab_izea_Percentageofindividualownershipofcommonstock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7a424c8f-72c9-41e4-bef2-2f2b492ad26a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d0b5ea78-8411-4cfb-b381-d19b770ed030_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_d5c8e997-13b3-4706-a09f-1352fa68f143_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_d4207650-67f9-4ed1-98fa-d9b40687badd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_161d27f0-b18d-4e46-bc24-646b303cb23c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6fdaeadf-a060-414a-a42d-689a155d9888_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_0965d62c-4400-4708-b51a-6fc24445d8b0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear_6edd52b2-00a7-4a27-a966-923e8dfbbd2e_terseLabel_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear_label_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" xlink:to="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CostOfRevenueDirect_d2fc3b0d-d2d7-4395-828f-aeffb857cc3a_terseLabel_en-US" xlink:label="lab_izea_CostOfRevenueDirect" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue-direct</link:label>
    <link:label id="lab_izea_CostOfRevenueDirect_label_en-US" xlink:label="lab_izea_CostOfRevenueDirect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of revenue-direct</link:label>
    <link:label id="lab_izea_CostOfRevenueDirect_documentation_en-US" xlink:label="lab_izea_CostOfRevenueDirect" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cost of revenue-direct</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CostOfRevenueDirect" xlink:href="izea-20250331.xsd#izea_CostOfRevenueDirect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CostOfRevenueDirect" xlink:to="lab_izea_CostOfRevenueDirect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1f8e07de-826c-4ce5-a879-68596af8ddea_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested beginning of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3e6e9aa6-c7d6-44bb-b0c3-d77aaa433c24_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units, nonvested ending of period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_024e3e6b-a8df-4f82-8f1e-9055882fe217_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Options, expired</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_7bb6291b-42a8-4121-b870-57ef884a0571_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_6cd55a65-50eb-4e72-b6c4-77cf87f3390d_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_a9ccefeb-4155-40a8-9611-bfd2146ee2eb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_6f7270e7-c002-4e0d-90b2-65324fbe8c43_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities, revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_2b680cac-54cd-4260-af9f-127bf60b8b16_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_68b2cd1f-7bdd-4026-b4d8-d952af07a21e_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_734bd37c-62d6-42de-8d99-7d37b66b5e46_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_6aed569c-1294-4dcb-8575-98ce8f37c562_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8e0a053e-c9c4-46d6-8a07-dbd220873310_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e78a56b2-8142-46c6-b9cd-ba6faee83d7c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_27ef768e-9ca7-4aa0-b321-0ea0ed6179c6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers_305b5020-2795-4bad-b166-d54e81a99b78_terseLabel_en-US" xlink:label="lab_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract assets and contract liabilities length of agreement with customers</link:label>
    <link:label id="lab_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers_label_en-US" xlink:label="lab_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Assets And Contract Liabilities Length Of Agreement With Customers</link:label>
    <link:label id="lab_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers_documentation_en-US" xlink:label="lab_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Assets And Contract Liabilities Length Of Agreement With Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" xlink:href="izea-20250331.xsd#izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" xlink:to="lab_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0c9f7f91-6273-4e03-8f98-0ea1af2eb055_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ExercisableShareholderRightsPercentageHeld._4c333214-32cb-4a65-b6c3-1ec60438dd69_terseLabel_en-US" xlink:label="lab_izea_ExercisableShareholderRightsPercentageHeld." xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable shareholder rights percentage held.</link:label>
    <link:label id="lab_izea_ExercisableShareholderRightsPercentageHeld._label_en-US" xlink:label="lab_izea_ExercisableShareholderRightsPercentageHeld." xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercisable shareholder rights percentage held.</link:label>
    <link:label id="lab_izea_ExercisableShareholderRightsPercentageHeld._documentation_en-US" xlink:label="lab_izea_ExercisableShareholderRightsPercentageHeld." xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercisable shareholder rights percentage held.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ExercisableShareholderRightsPercentageHeld." xlink:href="izea-20250331.xsd#izea_ExercisableShareholderRightsPercentageHeld."/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ExercisableShareholderRightsPercentageHeld." xlink:to="lab_izea_ExercisableShareholderRightsPercentageHeld." xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_014a6000-0bec-4713-ae07-f1e3e057a704_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_4c9af54e-c0bc-45dd-b26d-2ebc495bb2e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common shares, vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_SignificantAccountPoliciesLineItems_f9864b11-7fd5-477f-9718-12087d7b49bf_terseLabel_en-US" xlink:label="lab_izea_SignificantAccountPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_izea_SignificantAccountPoliciesLineItems_label_en-US" xlink:label="lab_izea_SignificantAccountPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Account Policies [Line Items]</link:label>
    <link:label id="lab_izea_SignificantAccountPoliciesLineItems_documentation_en-US" xlink:label="lab_izea_SignificantAccountPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Significant Account Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountPoliciesLineItems" xlink:href="izea-20250331.xsd#izea_SignificantAccountPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_SignificantAccountPoliciesLineItems" xlink:to="lab_izea_SignificantAccountPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_a09fa5d0-310a-40c2-85f2-026596b8d057_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareNet" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareNet" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree_f4d3fc61-250f-4373-9960-9bb2db8b1097_terseLabel_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree_label_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Three</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree_documentation_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree" xlink:to="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_850009b4-c3bc-4c39-a46d-449425b1adaa_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NorthAmericaMember_97a6112b-6d42-4741-8573-d2afeec8f79c_terseLabel_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from North America</link:label>
    <link:label id="lab_srt_NorthAmericaMember_label_en-US" xlink:label="lab_srt_NorthAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">North America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NorthAmericaMember" xlink:to="lab_srt_NorthAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2c7f30c8-6bce-49a1-b9d3-703ca2860c40_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_ExpiredAndActiveRepurchaseProgramsMember_c2284aaa-5a99-4771-bf9d-0d11d7227026_terseLabel_en-US" xlink:label="lab_izea_ExpiredAndActiveRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expired and Active Repurchase Programs</link:label>
    <link:label id="lab_izea_ExpiredAndActiveRepurchaseProgramsMember_label_en-US" xlink:label="lab_izea_ExpiredAndActiveRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expired and Active Repurchase Programs [Member]</link:label>
    <link:label id="lab_izea_ExpiredAndActiveRepurchaseProgramsMember_documentation_en-US" xlink:label="lab_izea_ExpiredAndActiveRepurchaseProgramsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expired and Active Repurchase Programs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ExpiredAndActiveRepurchaseProgramsMember" xlink:href="izea-20250331.xsd#izea_ExpiredAndActiveRepurchaseProgramsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_ExpiredAndActiveRepurchaseProgramsMember" xlink:to="lab_izea_ExpiredAndActiveRepurchaseProgramsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_980c3816-8ada-40d5-8ced-5562bcf5e476_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1ad8364a-366d-48f2-8743-9c599833169b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Options, forfeited</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_e3f3380d-a2cf-46d7-8695-d4f203b6eb12_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxes" xlink:to="lab_us-gaap_AccruedIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_TimeBasedRSUsMember_2af64eaa-d8d5-4428-8307-aeb425e27612_terseLabel_en-US" xlink:label="lab_izea_TimeBasedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Time-Based</link:label>
    <link:label id="lab_izea_TimeBasedRSUsMember_label_en-US" xlink:label="lab_izea_TimeBasedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Time Based RSUs [Member]</link:label>
    <link:label id="lab_izea_TimeBasedRSUsMember_documentation_en-US" xlink:label="lab_izea_TimeBasedRSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Time Based RSUs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TimeBasedRSUsMember" xlink:href="izea-20250331.xsd#izea_TimeBasedRSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_TimeBasedRSUsMember" xlink:to="lab_izea_TimeBasedRSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_934dc1ac-b759-47f5-aa81-75ead1342bd9_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrentAndNoncurrent_5b36166c-1fe8-4990-9294-83a5eddd7183_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payroll liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Salaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_02c3052a-2dc2-46d0-bc51-9edf87251951_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne_2d465c95-ed65-49ce-bdf8-2a4750a05978_terseLabel_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne_label_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year One</link:label>
    <link:label id="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne_documentation_en-US" xlink:label="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne" xlink:to="lab_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>izea-20250331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:bad81cd4-934d-4330-9ea3-36401c97abe6,g:5878b1fc-f8cc-483b-8e63-779470b36094-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.izea.com/role/Cover" xlink:type="simple" xlink:href="izea-20250331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c9cb7505-dcec-4de4-bbde-fb22eeade785" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_DocumentType_c9cb7505-dcec-4de4-bbde-fb22eeade785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c3638728-dcf0-4c13-9f6a-0fd16f788dbd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_CurrentFiscalYearEndDate_c3638728-dcf0-4c13-9f6a-0fd16f788dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_b9b38e4c-4f0e-4e14-ba8a-75e62e529b71" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_DocumentTransitionReport_b9b38e4c-4f0e-4e14-ba8a-75e62e529b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0d79b527-f190-4028-858c-f91fa354fac5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityFileNumber_0d79b527-f190-4028-858c-f91fa354fac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_032b21e5-98b1-448e-ab56-72c427d26021" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityRegistrantName_032b21e5-98b1-448e-ab56-72c427d26021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_098b86bb-df5c-48fb-a2ca-f7c5cdba9b05" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_098b86bb-df5c-48fb-a2ca-f7c5cdba9b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_071baf42-9400-4c4f-aed1-ee6b29b3e922" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityTaxIdentificationNumber_071baf42-9400-4c4f-aed1-ee6b29b3e922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_db4894d7-d3e9-4a28-918d-653916070704" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityAddressAddressLine1_db4894d7-d3e9-4a28-918d-653916070704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_a34c77ee-35ad-4c1e-945a-84685654bcfb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityAddressAddressLine2_a34c77ee-35ad-4c1e-945a-84685654bcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_8443fe7e-faa6-416b-88e0-a0c160f15433" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityAddressCityOrTown_8443fe7e-faa6-416b-88e0-a0c160f15433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_181c2b5b-3b23-4cba-aafa-13f8284ee3fa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityAddressStateOrProvince_181c2b5b-3b23-4cba-aafa-13f8284ee3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9d349685-1ddd-4869-9a88-4d4a8dbf42a4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityAddressPostalZipCode_9d349685-1ddd-4869-9a88-4d4a8dbf42a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d0cc4399-f8f9-406c-8241-6db477e5691b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_CityAreaCode_d0cc4399-f8f9-406c-8241-6db477e5691b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_66aa0b14-b246-4e7d-b756-40c8fc266cd3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_LocalPhoneNumber_66aa0b14-b246-4e7d-b756-40c8fc266cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e1d6d2ab-2feb-468f-8191-db9925e172bc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_Security12bTitle_e1d6d2ab-2feb-468f-8191-db9925e172bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5c71adc6-d008-4dbd-94b4-f420f2119440" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_TradingSymbol_5c71adc6-d008-4dbd-94b4-f420f2119440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b66f02d4-a237-4d94-84da-bc9c92318c91" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_SecurityExchangeName_b66f02d4-a237-4d94-84da-bc9c92318c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_65bfe225-b757-43e6-98ad-e070c5fed857" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityFilerCategory_65bfe225-b757-43e6-98ad-e070c5fed857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_92d4b073-c691-43e8-9b3b-0f01a37d87ff" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntitySmallBusiness_92d4b073-c691-43e8-9b3b-0f01a37d87ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_7d1fbb61-44c5-463c-9e2e-641c3d8b0a6d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityEmergingGrowthCompany_7d1fbb61-44c5-463c-9e2e-641c3d8b0a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_00cd123d-dc1e-4600-9a5f-e3fa3cbee3bd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_00cd123d-dc1e-4600-9a5f-e3fa3cbee3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_429d3909-8f43-4b20-8214-5051b18fd1ef" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityCentralIndexKey_429d3909-8f43-4b20-8214-5051b18fd1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_7ed00b9a-3039-40ce-97b7-e75b54668e3f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_DocumentFiscalYearFocus_7ed00b9a-3039-40ce-97b7-e75b54668e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_4eaf93db-0ee6-4f6a-aa28-36ee571cdc06" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_DocumentFiscalPeriodFocus_4eaf93db-0ee6-4f6a-aa28-36ee571cdc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8f1ccb1d-ec1d-4604-9039-96cbcadefffe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_AmendmentFlag_8f1ccb1d-ec1d-4604-9039-96cbcadefffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f3e9eb04-f319-4ba0-844f-383d56790265" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityCurrentReportingStatus_f3e9eb04-f319-4ba0-844f-383d56790265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d79d7310-b848-4f13-b356-701617973729" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_DocumentPeriodEndDate_d79d7310-b848-4f13-b356-701617973729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1527fa66-e92a-49dc-88d8-eaed0751cd31" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityInteractiveDataCurrent_1527fa66-e92a-49dc-88d8-eaed0751cd31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_1f6ced81-f9b1-4c09-8321-77d33bb1c35c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_DocumentQuarterlyReport_1f6ced81-f9b1-4c09-8321-77d33bb1c35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_7d34477a-6b92-418c-9f5c-edf3ddf384f6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4549a115-f0ff-45db-ad4d-0e94b71cf9a1" xlink:to="loc_dei_EntityShellCompany_7d34477a-6b92-418c-9f5c-edf3ddf384f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4e6f4233-06c6-4993-93e0-53c8697dc622" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4e6f4233-06c6-4993-93e0-53c8697dc622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_09a58ed0-cc37-4db0-8337-058dcd954ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_09a58ed0-cc37-4db0-8337-058dcd954ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_d1578a8a-eedd-4324-a624-432939881df8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_d1578a8a-eedd-4324-a624-432939881df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_a98f707a-842c-47d9-93f1-9314e10be828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:to="loc_us-gaap_ShortTermInvestments_a98f707a-842c-47d9-93f1-9314e10be828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_50d667c2-cfc3-401d-bcd5-38eee26ec9e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:to="loc_us-gaap_OtherAssetsCurrent_50d667c2-cfc3-401d-bcd5-38eee26ec9e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8c65f3b1-56c9-4b76-9869-fd72c1d6e79c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8dfe5c8f-e987-494e-8211-93a90cac12e2" xlink:to="loc_us-gaap_AssetsCurrent_8c65f3b1-56c9-4b76-9869-fd72c1d6e79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_203aadcb-a25d-40c0-9563-10f18312cf55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_203aadcb-a25d-40c0-9563-10f18312cf55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_d5bb561d-4c2d-4a48-9781-e153a9ef0413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_d5bb561d-4c2d-4a48-9781-e153a9ef0413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4393ca4b-4c41-4c6b-8ca2-2aadd5efe2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_Assets_4393ca4b-4c41-4c6b-8ca2-2aadd5efe2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_39e3633b-9fc5-4234-bd1f-e932dad153af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_39e3633b-9fc5-4234-bd1f-e932dad153af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_b2621b00-bf67-45ed-9742-f4e584a3b556" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_39e3633b-9fc5-4234-bd1f-e932dad153af" xlink:to="loc_us-gaap_AccountsPayableCurrentAndNoncurrent_b2621b00-bf67-45ed-9742-f4e584a3b556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_3038e482-9b36-46ea-9fb2-75877631611e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_39e3633b-9fc5-4234-bd1f-e932dad153af" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_3038e482-9b36-46ea-9fb2-75877631611e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22095fcb-5157-4883-8c86-f4f425910c67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_39e3633b-9fc5-4234-bd1f-e932dad153af" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_22095fcb-5157-4883-8c86-f4f425910c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6598866e-ff9f-4547-9213-ed55a343546b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_39e3633b-9fc5-4234-bd1f-e932dad153af" xlink:to="loc_us-gaap_LiabilitiesCurrent_6598866e-ff9f-4547-9213-ed55a343546b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0a906cab-1798-43ab-9266-c5e2051847a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_0a906cab-1798-43ab-9266-c5e2051847a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_30be68bc-2cb3-4267-b620-52b5a868e347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_Liabilities_30be68bc-2cb3-4267-b620-52b5a868e347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_980fcd41-e933-49a6-9af5-94f67d4867d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_CommitmentsAndContingencies_980fcd41-e933-49a6-9af5-94f67d4867d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_82899598-c841-47fb-96b3-b01037170294" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:to="loc_us-gaap_PreferredStockValue_82899598-c841-47fb-96b3-b01037170294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_01a9576e-4bdd-4301-8183-1a789d4618f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:to="loc_us-gaap_CommonStockValue_01a9576e-4bdd-4301-8183-1a789d4618f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_479a5131-dc02-4197-84ee-b946dc97e444" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:to="loc_us-gaap_TreasuryStockValue_479a5131-dc02-4197-84ee-b946dc97e444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_aea2052e-cb0e-47e7-8d51-a3e013ac2cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:to="loc_us-gaap_AdditionalPaidInCapital_aea2052e-cb0e-47e7-8d51-a3e013ac2cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27e45498-7aec-4f60-a262-f0bada648ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_27e45498-7aec-4f60-a262-f0bada648ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f75729d3-f6e1-45d8-81a9-c5104e00fd8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f75729d3-f6e1-45d8-81a9-c5104e00fd8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1154e3f7-5593-4c35-88db-f42c3cd64845" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8a9d75dc-1b6a-4424-91ad-b210d2cf31a0" xlink:to="loc_us-gaap_StockholdersEquity_1154e3f7-5593-4c35-88db-f42c3cd64845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_2495b503-2371-487c-b98f-546f02a329d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d9b984f4-63b3-40ac-964b-013e7509eb67" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_2495b503-2371-487c-b98f-546f02a329d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6d810681-5c1b-42cb-84b3-21e4a7c590e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_6d810681-5c1b-42cb-84b3-21e4a7c590e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_402941a9-56d6-481b-a0be-6043e4d9bed0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_402941a9-56d6-481b-a0be-6043e4d9bed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_d7c7f029-ef4b-43e0-9d2d-be6f23b70f51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_PreferredStockSharesIssued_d7c7f029-ef4b-43e0-9d2d-be6f23b70f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_d28b9a50-d560-44af-908a-9574b1501073" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_d28b9a50-d560-44af-908a-9574b1501073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f2948336-5532-4a9e-809f-0f7f0362a234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f2948336-5532-4a9e-809f-0f7f0362a234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0bcdc051-b656-4f21-b478-df07e189946b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0bcdc051-b656-4f21-b478-df07e189946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a3aae770-948f-4ec1-9bf4-50991b16201d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_CommonStockSharesIssued_a3aae770-948f-4ec1-9bf4-50991b16201d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_cd8ff860-c59d-463e-b81c-5a89f1d629f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_cd8ff860-c59d-463e-b81c-5a89f1d629f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_6676d8e8-99b8-4343-b8a1-8cb09221f9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_73017a05-c552-4b3f-82f3-a10e641ec415" xlink:to="loc_us-gaap_TreasuryStockCommonShares_6676d8e8-99b8-4343-b8a1-8cb09221f9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ca6112c-962c-443d-97ed-2bda5602c589" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2ca6112c-962c-443d-97ed-2bda5602c589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_1cdd409a-c799-49d9-87c7-8cc2200ab822" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_1cdd409a-c799-49d9-87c7-8cc2200ab822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_91f84b99-c5bb-4061-80ae-98c4bc71fbb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1cdd409a-c799-49d9-87c7-8cc2200ab822" xlink:to="loc_us-gaap_CostOfRevenue_91f84b99-c5bb-4061-80ae-98c4bc71fbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_b1b62901-f0cd-4440-b733-36de67d42df6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1cdd409a-c799-49d9-87c7-8cc2200ab822" xlink:to="loc_us-gaap_SellingAndMarketingExpense_b1b62901-f0cd-4440-b733-36de67d42df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c5c41be8-5f6b-4ace-ba79-73af49c02394" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1cdd409a-c799-49d9-87c7-8cc2200ab822" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c5c41be8-5f6b-4ace-ba79-73af49c02394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_22e54a4b-ebf9-4e7e-99ca-ca9a565dc0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1cdd409a-c799-49d9-87c7-8cc2200ab822" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_22e54a4b-ebf9-4e7e-99ca-ca9a565dc0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_63a8afa3-7444-4f9a-8fb8-1f9c80f05869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_1cdd409a-c799-49d9-87c7-8cc2200ab822" xlink:to="loc_us-gaap_CostsAndExpenses_63a8afa3-7444-4f9a-8fb8-1f9c80f05869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_866c40be-f80b-477e-bc35-c711469e0fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_OperatingIncomeLoss_866c40be-f80b-477e-bc35-c711469e0fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ChangeInTheFairValueOfDigitalAssets_aaa7d418-f246-45fa-b1d9-6376d3b6fd84" xlink:href="izea-20250331.xsd#izea_ChangeInTheFairValueOfDigitalAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:to="loc_izea_ChangeInTheFairValueOfDigitalAssets_aaa7d418-f246-45fa-b1d9-6376d3b6fd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_c0ae75b2-6f16-4f3b-aafd-15819df1b3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:to="loc_us-gaap_InterestExpenseNonoperating_c0ae75b2-6f16-4f3b-aafd-15819df1b3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_587f3f77-b862-4ffc-b911-72096a581643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_587f3f77-b862-4ffc-b911-72096a581643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_83c654ed-a333-4379-a582-ac00607cc575" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_83c654ed-a333-4379-a582-ac00607cc575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossAttributableToParent_189e2549-85cd-4162-bd52-9251274a7cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:to="loc_us-gaap_IncomeLossAttributableToParent_189e2549-85cd-4162-bd52-9251274a7cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4451006b-28ed-4e8e-abac-2b00ab024017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_d5fabe39-6359-4e84-b483-ad815f46cf6c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4451006b-28ed-4e8e-abac-2b00ab024017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_db85147c-69d1-4b42-89c6-07dcee54514f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_NetIncomeLoss_db85147c-69d1-4b42-89c6-07dcee54514f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd88be5e-4871-4afb-88ad-e46366f6a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd88be5e-4871-4afb-88ad-e46366f6a1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4b746ff5-22ab-4859-b7d6-d7b79c9d6303" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4b746ff5-22ab-4859-b7d6-d7b79c9d6303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_83948ba3-69cf-4254-bea8-b725d1157162" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_EarningsPerShareBasic_83948ba3-69cf-4254-bea8-b725d1157162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_13e08fb6-0bf5-4914-bfd3-9bb001528f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_3f7f665e-282f-4be9-804d-aa68efe12c38" xlink:to="loc_us-gaap_EarningsPerShareDiluted_13e08fb6-0bf5-4914-bfd3-9bb001528f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fe3ffe4-f945-4f0f-bf77-f286de674ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8976354f-4b7b-4bb6-aa68-98073fdce94a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fe3ffe4-f945-4f0f-bf77-f286de674ac0" xlink:to="loc_us-gaap_NetIncomeLoss_8976354f-4b7b-4bb6-aa68-98073fdce94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f11c604e-a851-4ade-8dda-7304742ca60a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fe3ffe4-f945-4f0f-bf77-f286de674ac0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f11c604e-a851-4ade-8dda-7304742ca60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_f58474ea-e5eb-4e69-899e-97a416eb1c35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fe3ffe4-f945-4f0f-bf77-f286de674ac0" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax_f58474ea-e5eb-4e69-899e-97a416eb1c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_acb2c262-cfed-4233-8e3c-a39da7ecbc45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fe3ffe4-f945-4f0f-bf77-f286de674ac0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_acb2c262-cfed-4233-8e3c-a39da7ecbc45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f947ffd0-c1ee-4173-bea7-27cf46b7cc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2fe3ffe4-f945-4f0f-bf77-f286de674ac0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f947ffd0-c1ee-4173-bea7-27cf46b7cc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ffc78e4e-85c5-44c9-8bcd-e72c38b612b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b4b350bd-ca56-400a-96b1-c7f4c643052c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ffc78e4e-85c5-44c9-8bcd-e72c38b612b5" xlink:to="loc_us-gaap_StatementTable_b4b350bd-ca56-400a-96b1-c7f4c643052c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d919b560-fb13-4fb2-80f9-f59b18b3e1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4b350bd-ca56-400a-96b1-c7f4c643052c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d919b560-fb13-4fb2-80f9-f59b18b3e1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d919b560-fb13-4fb2-80f9-f59b18b3e1ba" xlink:to="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fbbff478-ed81-40c0-9d5e-788e15ebd612" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_CommonStockMember_fbbff478-ed81-40c0-9d5e-788e15ebd612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a94f9c74-f417-40d6-b57e-52630c39d7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a94f9c74-f417-40d6-b57e-52630c39d7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_fd34c2df-1004-4056-be56-cdc7bce7a90d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_TreasuryStockCommonMember_fd34c2df-1004-4056-be56-cdc7bce7a90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_2fb49ecd-2b7e-41fd-af6e-d0951e7da194" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_RetainedEarningsMember_2fb49ecd-2b7e-41fd-af6e-d0951e7da194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_195cec00-f6bc-44fa-a443-9779e7382890" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17960280-6c37-4b90-bac1-694bc079c056" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_195cec00-f6bc-44fa-a443-9779e7382890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1d9d292f-bab7-4318-80fa-fa7b5eb948d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b4b350bd-ca56-400a-96b1-c7f4c643052c" xlink:to="loc_us-gaap_StatementLineItems_1d9d292f-bab7-4318-80fa-fa7b5eb948d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1d9d292f-bab7-4318-80fa-fa7b5eb948d9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_b458eeeb-3e8d-40c6-a211-d627fb7665ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_b458eeeb-3e8d-40c6-a211-d627fb7665ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5e612968-e3e4-49c7-a0e7-0fcc296a584d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockholdersEquity_5e612968-e3e4-49c7-a0e7-0fcc296a584d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_0a589ef8-2c0a-48ed-8aab-6f973e93d7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_0a589ef8-2c0a-48ed-8aab-6f973e93d7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_5c6929b2-666c-436e-904c-d5da902b8f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_5c6929b2-666c-436e-904c-d5da902b8f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_651b9003-bd14-4a4a-b0d2-9d3fbe5e2baa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_651b9003-bd14-4a4a-b0d2-9d3fbe5e2baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cc686b87-f51e-4ec8-8484-64e7d6c31788" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cc686b87-f51e-4ec8-8484-64e7d6c31788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c4628f8e-9578-4add-8eb7-13b5c0613ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c4628f8e-9578-4add-8eb7-13b5c0613ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7b2e7d3e-5941-47e4-9a95-150645e85315" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_7b2e7d3e-5941-47e4-9a95-150645e85315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_905da84f-8a83-46f3-9528-cca72da45bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_905da84f-8a83-46f3-9528-cca72da45bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f610d9a7-133d-4930-84c4-17881dcd38ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f610d9a7-133d-4930-84c4-17881dcd38ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5295a6a3-0a7b-4fab-bf50-fabc4bd944b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_5295a6a3-0a7b-4fab-bf50-fabc4bd944b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d18d77d4-ec67-4a16-8207-70d20b987bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_NetIncomeLoss_d18d77d4-ec67-4a16-8207-70d20b987bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_def31748-f6a7-497a-8fcf-d0f32190b1be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_def31748-f6a7-497a-8fcf-d0f32190b1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d06dd438-fded-4be4-8165-f8ea47a62891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2444a9f-59d7-4522-ab86-2ebce88c3bcd" xlink:to="loc_us-gaap_StockholdersEquity_d06dd438-fded-4be4-8165-f8ea47a62891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="izea-20250331.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bbb5d618-3a58-4fe5-9584-000aa00709c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bbb5d618-3a58-4fe5-9584-000aa00709c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_22da96a5-ce2a-4ff3-b19a-d824fd828f59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bbb5d618-3a58-4fe5-9584-000aa00709c5" xlink:to="loc_us-gaap_NetIncomeLoss_22da96a5-ce2a-4ff3-b19a-d824fd828f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bbb5d618-3a58-4fe5-9584-000aa00709c5" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets_c24fed9b-f1f1-40ec-9462-987efe42ee0c" xlink:href="izea-20250331.xsd#izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:to="loc_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets_c24fed9b-f1f1-40ec-9462-987efe42ee0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c708409b-d0e4-4d74-90b3-1526717160ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:to="loc_us-gaap_Depreciation_c708409b-d0e4-4d74-90b3-1526717160ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_dcc10b28-40b9-4900-8dc1-31ddace6ab1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:to="loc_us-gaap_AdjustmentForAmortization_dcc10b28-40b9-4900-8dc1-31ddace6ab1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_540b312a-6c28-46e0-9eb2-bd0b12689ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems_540b312a-6c28-46e0-9eb2-bd0b12689ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_d9a5f42c-ce6e-4df0-bc04-de12e97bdbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_d9a5f42c-ce6e-4df0-bc04-de12e97bdbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_976fda4e-5688-4fb6-852e-110858822fd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_976fda4e-5688-4fb6-852e-110858822fd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e4abd1ba-bb93-416a-b7e9-12f6c8fca6f6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b24c028c-c6fb-47b0-9f29-fae85c70e169" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b24c028c-c6fb-47b0-9f29-fae85c70e169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dd596b33-3c53-4dab-a4ba-cd0c2da225a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_dd596b33-3c53-4dab-a4ba-cd0c2da225a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c6a3f41-ea0a-4278-9932-4cc35a6ccf87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c6a3f41-ea0a-4278-9932-4cc35a6ccf87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_22c0c4cc-5e9b-4f6f-a9c7-4f63d19f9d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_22c0c4cc-5e9b-4f6f-a9c7-4f63d19f9d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_41a0aa65-a3cc-427f-8c7b-32a1ed14e360" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_41a0aa65-a3cc-427f-8c7b-32a1ed14e360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d94510b-8fe7-4ed1-aaa8-3eedde0d5dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d338ce95-8ec6-4b2b-8615-14299bce7b77" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8d94510b-8fe7-4ed1-aaa8-3eedde0d5dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e553ce14-2226-44bc-ba14-84fc86f860d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e553ce14-2226-44bc-ba14-84fc86f860d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1984ee8d-42d5-4147-a55a-0fd5756817a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e553ce14-2226-44bc-ba14-84fc86f860d7" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1984ee8d-42d5-4147-a55a-0fd5756817a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6a4ce618-a91b-4996-8058-4de76e8ea1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e553ce14-2226-44bc-ba14-84fc86f860d7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6a4ce618-a91b-4996-8058-4de76e8ea1ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_08cdb451-26d1-414c-bbd4-981622918d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e553ce14-2226-44bc-ba14-84fc86f860d7" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_08cdb451-26d1-414c-bbd4-981622918d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_96679a11-ab9f-4e32-985b-15d7c66885d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_e553ce14-2226-44bc-ba14-84fc86f860d7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_96679a11-ab9f-4e32-985b-15d7c66885d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2635562f-5a02-477d-9095-e991f1bc907f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2635562f-5a02-477d-9095-e991f1bc907f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfEquity_290a3bac-bc1a-4451-80a1-e637a612ee26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2635562f-5a02-477d-9095-e991f1bc907f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfEquity_290a3bac-bc1a-4451-80a1-e637a612ee26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a39ca0cb-4fed-4c3c-b0f9-17847cdf91e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2635562f-5a02-477d-9095-e991f1bc907f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a39ca0cb-4fed-4c3c-b0f9-17847cdf91e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_61eadbd9-01cb-44ff-99c1-36fe5a49fb57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2635562f-5a02-477d-9095-e991f1bc907f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_61eadbd9-01cb-44ff-99c1-36fe5a49fb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23cbb562-4961-4787-b761-7fda5e2898fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23cbb562-4961-4787-b761-7fda5e2898fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7a833e3e-182d-4d05-90fd-4e0b97df6cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7a833e3e-182d-4d05-90fd-4e0b97df6cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f95ed673-7cee-40b7-9508-46c3a007cac1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f95ed673-7cee-40b7-9508-46c3a007cac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48723b70-7260-4604-a8e0-b97912b861c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48723b70-7260-4604-a8e0-b97912b861c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_2b42bdfb-79b2-4df8-85ac-42caa1bd4569" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_2b42bdfb-79b2-4df8-85ac-42caa1bd4569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2a0b9016-cd0a-4995-aff4-a4d6d167547a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_2b42bdfb-79b2-4df8-85ac-42caa1bd4569" xlink:to="loc_us-gaap_InterestPaidNet_2a0b9016-cd0a-4995-aff4-a4d6d167547a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e149240d-3f4e-4f40-88fc-f82b11f0f180" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a74d60af-da63-4d86-a396-9082c1ce6237" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e149240d-3f4e-4f40-88fc-f82b11f0f180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_b8c91108-4183-4120-b545-49c4c1f2ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e149240d-3f4e-4f40-88fc-f82b11f0f180" xlink:to="loc_us-gaap_StockIssued1_b8c91108-4183-4120-b545-49c4c1f2ef56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f494e19d-f992-498e-84ee-dccd8992ec58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_36970a86-912a-4cff-b8f9-347d0567738c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f494e19d-f992-498e-84ee-dccd8992ec58" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_36970a86-912a-4cff-b8f9-347d0567738c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/BusinessAcquisitions" xlink:type="simple" xlink:href="izea-20250331.xsd#BusinessAcquisitions"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/BusinessAcquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_58f5dbcf-f55c-4b50-a2d4-c894abe6112d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_16ab07ba-d729-4b04-a250-54f94b29b626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_58f5dbcf-f55c-4b50-a2d4-c894abe6112d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_16ab07ba-d729-4b04-a250-54f94b29b626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstruments" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d22a536-31d0-4a82-880b-19a0379bb461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_15b17630-4728-403e-84b9-4d3b11752c63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d22a536-31d0-4a82-880b-19a0379bb461" xlink:to="loc_us-gaap_FinancialInstrumentsDisclosureTextBlock_15b17630-4728-403e-84b9-4d3b11752c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="izea-20250331.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bd05080b-b422-4362-b49b-e5e6121a3b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7ee2a7e2-248a-425e-86a3-a39e0b8136bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_bd05080b-b422-4362-b49b-e5e6121a3b2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7ee2a7e2-248a-425e-86a3-a39e0b8136bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/IntangibleAssets" xlink:type="simple" xlink:href="izea-20250331.xsd#IntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/IntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e6323f23-13b7-4064-8ad1-6952bfb5c754" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_9e0d7bf1-18e5-4501-9c36-3395dcb53823" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e6323f23-13b7-4064-8ad1-6952bfb5c754" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_9e0d7bf1-18e5-4501-9c36-3395dcb53823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SoftwareDevelopmentCosts" xlink:type="simple" xlink:href="izea-20250331.xsd#SoftwareDevelopmentCosts"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SoftwareDevelopmentCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_41936793-9d93-4b3f-b8ac-7899534f4793" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_6bbd50fe-1595-479d-ade9-74af39e43e71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_41936793-9d93-4b3f-b8ac-7899534f4793" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_6bbd50fe-1595-479d-ade9-74af39e43e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/AccruedExpenses" xlink:type="simple" xlink:href="izea-20250331.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_e05cbf51-850c-4959-b874-f125eee252bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_0e537e0d-0384-419d-a878-fd38f4c26a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_e05cbf51-850c-4959-b874-f125eee252bf" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_0e537e0d-0384-419d-a878-fd38f4c26a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/NotesPayable" xlink:type="simple" xlink:href="izea-20250331.xsd#NotesPayable"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/NotesPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c98f1465-781f-4c2f-b655-85bc242e14c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_694f7229-808f-4d02-a15a-560c8100e3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c98f1465-781f-4c2f-b655-85bc242e14c0" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_694f7229-808f-4d02-a15a-560c8100e3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CommitmentsandContingenciesNotes" xlink:type="simple" xlink:href="izea-20250331.xsd#CommitmentsandContingenciesNotes"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CommitmentsandContingenciesNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_73ca041d-1636-4f10-857b-a6cbe28aa0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_15c62fa5-7080-4ce5-bc2e-7f41ef6261be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_73ca041d-1636-4f10-857b-a6cbe28aa0b4" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_15c62fa5-7080-4ce5-bc2e-7f41ef6261be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquity" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f9d4d61f-3be4-41e1-84e4-c455ee10e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_37b879a0-b164-41dd-b0ff-54de17a56926" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f9d4d61f-3be4-41e1-84e4-c455ee10e2d8" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_37b879a0-b164-41dd-b0ff-54de17a56926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/LossperCommonShare" xlink:type="simple" xlink:href="izea-20250331.xsd#LossperCommonShare"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/LossperCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a8b96caf-6080-45d2-bf58-79e93d4e5fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7aeff7fa-e5fa-4e20-994f-1a99a393083d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a8b96caf-6080-45d2-bf58-79e93d4e5fc3" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7aeff7fa-e5fa-4e20-994f-1a99a393083d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/Revenue" xlink:type="simple" xlink:href="izea-20250331.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_496fc7b7-d92d-4e81-aa41-9e935fe61d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f8e3db22-2b26-4c73-8aee-483e7150d9b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_496fc7b7-d92d-4e81-aa41-9e935fe61d5e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_f8e3db22-2b26-4c73-8aee-483e7150d9b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SegmentReporting" xlink:type="simple" xlink:href="izea-20250331.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_02e96464-50ee-4266-9a69-463e70e7f0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_c3efbc59-5ec6-4368-9013-59e31f90b458" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_02e96464-50ee-4266-9a69-463e70e7f0e0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_c3efbc59-5ec6-4368-9013-59e31f90b458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/IncomeTaxes" xlink:type="simple" xlink:href="izea-20250331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_35f1273a-f031-4a96-a4e7-4e372c3a067a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6d6b88d6-1093-4deb-a65f-de122cdf986a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_35f1273a-f031-4a96-a4e7-4e372c3a067a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6d6b88d6-1093-4deb-a65f-de122cdf986a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SubsequentEvents" xlink:type="simple" xlink:href="izea-20250331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_c9e55dab-e51f-42f6-999c-33b87ecac4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_38039cc2-3538-47c4-a38a-636b9cae245b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_c9e55dab-e51f-42f6-999c-33b87ecac4b5" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_38039cc2-3538-47c4-a38a-636b9cae245b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_NatureOfBusinessPolicyTextBlock_0f4c95ce-72e0-4ad0-80cc-6e6bdc83db79" xlink:href="izea-20250331.xsd#izea_NatureOfBusinessPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_izea_NatureOfBusinessPolicyTextBlock_0f4c95ce-72e0-4ad0-80cc-6e6bdc83db79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_cb5f15e7-c2a7-4a87-bf1f-ec4e822c4ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_cb5f15e7-c2a7-4a87-bf1f-ec4e822c4ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1401fba4-c483-4a79-a24c-6758e74f86ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_UseOfEstimates_1401fba4-c483-4a79-a24c-6758e74f86ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9e44fe2f-5355-438b-9595-49d4fa9a2457" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9e44fe2f-5355-438b-9595-49d4fa9a2457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_58150e94-f9e5-43e9-a6a2-ad3183efcf10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_58150e94-f9e5-43e9-a6a2-ad3183efcf10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_2cfba21a-3430-4a0b-aa88-683d43b7dec1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_2cfba21a-3430-4a0b-aa88-683d43b7dec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_dc610352-3e83-4dbf-b12b-e291a3b10f67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_dc610352-3e83-4dbf-b12b-e291a3b10f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_7493ba7f-2176-4cad-ab5e-f6222b4314bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsFiniteLivedPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_IntangibleAssetsFiniteLivedPolicy_7493ba7f-2176-4cad-ab5e-f6222b4314bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_f5615221-d7fe-4618-ba89-59216edab38f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_f5615221-d7fe-4618-ba89-59216edab38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_96b14b7f-3b11-44e7-976b-a36bdd132f95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_96b14b7f-3b11-44e7-976b-a36bdd132f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_32664008-5133-452b-a81e-55f002d4dfea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_32664008-5133-452b-a81e-55f002d4dfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_f112b228-a1c0-491b-ade2-baa594d5d238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_f112b228-a1c0-491b-ade2-baa594d5d238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_621a0efd-2230-400e-bd81-a1832c54b019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_621a0efd-2230-400e-bd81-a1832c54b019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1f154b43-bf7e-43ba-a632-8d323debb840" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_1f154b43-bf7e-43ba-a632-8d323debb840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3d62fa34-8163-4cf3-a6ac-72c94a60e656" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_3d62fa34-8163-4cf3-a6ac-72c94a60e656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_d0d08d2b-94f1-4c86-81f3-0d3bd79365d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_d0d08d2b-94f1-4c86-81f3-0d3bd79365d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_523054cc-5964-4107-bb90-1f3c517e7f37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0a3f0d29-8916-43d9-bab8-c49ce35c51b6" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_523054cc-5964-4107-bb90-1f3c517e7f37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6bc1ac56-8af4-4126-b448-1e37d6b3cb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_65aa398e-49b7-4973-a188-32023734fc42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6bc1ac56-8af4-4126-b448-1e37d6b3cb8e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_65aa398e-49b7-4973-a188-32023734fc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_00bc2fa5-9313-4dc3-b009-e0f56bd6c8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_7ca88ab3-bcd0-4b44-b671-9b1879fa4c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_00bc2fa5-9313-4dc3-b009-e0f56bd6c8a9" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_7ca88ab3-bcd0-4b44-b671-9b1879fa4c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock_213debc7-87d2-4251-9e8c-c037ea92481d" xlink:href="izea-20250331.xsd#izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_00bc2fa5-9313-4dc3-b009-e0f56bd6c8a9" xlink:to="loc_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock_213debc7-87d2-4251-9e8c-c037ea92481d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_23ee18f3-8584-43b3-831e-328f3b2918c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_00bc2fa5-9313-4dc3-b009-e0f56bd6c8a9" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_23ee18f3-8584-43b3-831e-328f3b2918c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="izea-20250331.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_96b13a80-031f-405c-96a2-3758d193db2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d273a4f9-294e-4411-a1fa-d33971925aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_96b13a80-031f-405c-96a2-3758d193db2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_d273a4f9-294e-4411-a1fa-d33971925aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsTables" xlink:type="simple" xlink:href="izea-20250331.xsd#SoftwareDevelopmentCostsTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SoftwareDevelopmentCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_0e544baf-408b-45e0-9d8e-7faa8ab92f82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1b0dbd2e-94d8-48c3-907b-f2f75ef87368" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0e544baf-408b-45e0-9d8e-7faa8ab92f82" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1b0dbd2e-94d8-48c3-907b-f2f75ef87368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_9f8c648e-34b3-480d-ad7d-a2f8462d9fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_0e544baf-408b-45e0-9d8e-7faa8ab92f82" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_9f8c648e-34b3-480d-ad7d-a2f8462d9fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="izea-20250331.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_60c4810a-91dd-4e08-b750-23d0f37636a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6ec591ad-a9a1-4c19-9698-454fe9fdda86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_60c4810a-91dd-4e08-b750-23d0f37636a3" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_6ec591ad-a9a1-4c19-9698-454fe9fdda86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/NotesPayableTables" xlink:type="simple" xlink:href="izea-20250331.xsd#NotesPayableTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/NotesPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ea35fb50-4daf-40d9-bcd3-4f676b28dfdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_03635fea-2e77-4ed1-87f7-9f077f4b9d83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea35fb50-4daf-40d9-bcd3-4f676b28dfdd" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_03635fea-2e77-4ed1-87f7-9f077f4b9d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="izea-20250331.xsd#CommitmentandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CommitmentandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6fdc6617-da81-44b7-9354-701e090bdb37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_e07e200f-9b0c-4044-a325-7021897396a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6fdc6617-da81-44b7-9354-701e090bdb37" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_e07e200f-9b0c-4044-a325-7021897396a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_28034fd1-935b-48da-b45b-98db6de9e7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_28034fd1-935b-48da-b45b-98db6de9e7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f399a79e-6fc3-4d3a-b8ef-ecd217ff8d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f399a79e-6fc3-4d3a-b8ef-ecd217ff8d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_41c58aa0-035a-4802-bd12-3469fe1302bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_41c58aa0-035a-4802-bd12-3469fe1302bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_4df19b8b-b507-46e6-88ca-e93600c4b722" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:to="loc_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock_4df19b8b-b507-46e6-88ca-e93600c4b722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_494cc4c4-edbe-4a3e-82db-225512912792" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:to="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock_494cc4c4-edbe-4a3e-82db-225512912792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_b62d294d-87da-4cfd-b8ad-00571eda34d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_b62d294d-87da-4cfd-b8ad-00571eda34d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9689ea9c-9c23-4f0e-b478-e7c17f88aeab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19e1cf5e-308c-416f-9bf9-6b10a1200db9" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9689ea9c-9c23-4f0e-b478-e7c17f88aeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/LossperCommonShareTables" xlink:type="simple" xlink:href="izea-20250331.xsd#LossperCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/LossperCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e775327b-d9e0-41c5-a96c-67af62001d13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1f91ae7d-a03f-4cdf-971b-a4e05207b111" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e775327b-d9e0-41c5-a96c-67af62001d13" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1f91ae7d-a03f-4cdf-971b-a4e05207b111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d79fef45-e162-491d-8bce-04647cf1adb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e775327b-d9e0-41c5-a96c-67af62001d13" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d79fef45-e162-491d-8bce-04647cf1adb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/RevenueTables" xlink:type="simple" xlink:href="izea-20250331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ac8f7f91-d1f3-4645-8a54-e0b213977419" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_74b103ac-60d4-4d8b-81fa-855a14623b95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ac8f7f91-d1f3-4645-8a54-e0b213977419" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_74b103ac-60d4-4d8b-81fa-855a14623b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_518afc79-25b0-49ce-81bb-9a90f8910ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ac8f7f91-d1f3-4645-8a54-e0b213977419" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_518afc79-25b0-49ce-81bb-9a90f8910ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="izea-20250331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bafd8daa-3333-4530-afef-87de16d5abfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_266e4b77-4ed9-4871-b27c-76335bb866a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bafd8daa-3333-4530-afef-87de16d5abfe" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_266e4b77-4ed9-4871-b27c-76335bb866a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="izea-20250331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_728102ae-85b4-46f9-8248-b5a1228d9568" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_df5e9780-5d16-4dc9-8f80-f570a452de23" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_728102ae-85b4-46f9-8248-b5a1228d9568" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_df5e9780-5d16-4dc9-8f80-f570a452de23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6bfcf93d-ae7d-4a6d-952a-442ef25ef6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_618ae2f6-373f-4cf0-ae71-d65b846ac0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashUninsuredAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6bfcf93d-ae7d-4a6d-952a-442ef25ef6e2" xlink:to="loc_us-gaap_CashUninsuredAmount_618ae2f6-373f-4cf0-ae71-d65b846ac0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFDICInsuredAmount_cc1ce413-ec7e-4fce-aa12-71f328b85600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashFDICInsuredAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6bfcf93d-ae7d-4a6d-952a-442ef25ef6e2" xlink:to="loc_us-gaap_CashFDICInsuredAmount_cc1ce413-ec7e-4fce-aa12-71f328b85600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CashCDICInsuredAmount_96a7a6de-9153-4cc9-b11a-9e58afd0a5c9" xlink:href="izea-20250331.xsd#izea_CashCDICInsuredAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6bfcf93d-ae7d-4a6d-952a-442ef25ef6e2" xlink:to="loc_izea_CashCDICInsuredAmount_96a7a6de-9153-4cc9-b11a-9e58afd0a5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_614c6769-5c2d-4755-84cf-1ab01dc6cef5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_614c6769-5c2d-4755-84cf-1ab01dc6cef5" xlink:to="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ae62aba-00da-4418-b676-1ecd0e549280" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ae62aba-00da-4418-b676-1ecd0e549280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_5ae62aba-00da-4418-b676-1ecd0e549280" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_17b5765e-11f9-4ef9-ae74-ad6251496bba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:to="loc_us-gaap_AccountsReceivableMember_17b5765e-11f9-4ef9-ae74-ad6251496bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_41923c60-845d-4058-b1c9-c7c4a2529289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c323aaea-c997-4a3b-b647-1db68227933b" xlink:to="loc_us-gaap_SalesRevenueNetMember_41923c60-845d-4058-b1c9-c7c4a2529289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_47117644-1fe4-4dc3-a843-cfcb725df760" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_47117644-1fe4-4dc3-a843-cfcb725df760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_604b9b06-d79f-4d16-96f7-616c2457a1a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_47117644-1fe4-4dc3-a843-cfcb725df760" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_604b9b06-d79f-4d16-96f7-616c2457a1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_804ba542-bb37-4c77-b72a-40528c703170" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_604b9b06-d79f-4d16-96f7-616c2457a1a4" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_804ba542-bb37-4c77-b72a-40528c703170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_132cfce5-ce30-491a-8a89-cbcaa35e4ea7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:to="loc_srt_MajorCustomersAxis_132cfce5-ce30-491a-8a89-cbcaa35e4ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_132cfce5-ce30-491a-8a89-cbcaa35e4ea7" xlink:to="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CustomerOneMember_701fcbdc-ec1a-42bc-b44b-4927d3b7032a" xlink:href="izea-20250331.xsd#izea_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:to="loc_izea_CustomerOneMember_701fcbdc-ec1a-42bc-b44b-4927d3b7032a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CustomerTwoMember_bb742f5a-09b4-4b1f-9f4c-6966dc7c68ec" xlink:href="izea-20250331.xsd#izea_CustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_9006bf13-f50b-413c-929f-b8575e5664ea" xlink:to="loc_izea_CustomerTwoMember_bb742f5a-09b4-4b1f-9f4c-6966dc7c68ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_299b93de-9b1e-4490-8b29-6f15d88bb3b3" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_894e9376-1902-4866-ac1f-59f242a4bfbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_894e9376-1902-4866-ac1f-59f242a4bfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_41bde52b-33bd-41f4-847f-7342af45a1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_41bde52b-33bd-41f4-847f-7342af45a1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_9524dcb7-a82f-40b6-bc30-77db758686f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease_9524dcb7-a82f-40b6-bc30-77db758686f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_09459cb5-da56-4232-a209-06a5e81b2906" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_09459cb5-da56-4232-a209-06a5e81b2906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AccountsReceivableExcludingContractAsset_d386e250-ca77-4ae5-9454-0d926d8d7ed1" xlink:href="izea-20250331.xsd#izea_AccountsReceivableExcludingContractAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_izea_AccountsReceivableExcludingContractAsset_d386e250-ca77-4ae5-9454-0d926d8d7ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_7a332058-c666-415e-abde-83540c57e6f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetReclassifiedToReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable_7a332058-c666-415e-abde-83540c57e6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_cfc255b8-99e9-4737-b66a-8c93dbf02f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_cfc255b8-99e9-4737-b66a-8c93dbf02f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_7d82ffbf-b168-4e46-91a1-9dc7644f5948" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_7d82ffbf-b168-4e46-91a1-9dc7644f5948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_e5afdfd8-b461-4b77-ba00-29541e732d87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue_e5afdfd8-b461-4b77-ba00-29541e732d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivablePercentPastDue1_6d6f116b-bedb-4233-a72c-78f5312bd7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancingReceivablePercentPastDue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_6d8fa125-823e-41ff-9681-458f0140f03c" xlink:to="loc_us-gaap_FinancingReceivablePercentPastDue1_6d6f116b-bedb-4233-a72c-78f5312bd7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c4193d72-e31b-4db1-8015-4df1608123ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:href="izea-20250331.xsd#izea_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c4193d72-e31b-4db1-8015-4df1608123ec" xlink:to="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_41fa803a-48c1-4560-8161-f246163b5b68" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:to="loc_srt_RangeAxis_41fa803a-48c1-4560-8161-f246163b5b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_41fa803a-48c1-4560-8161-f246163b5b68" xlink:to="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_393095a8-b327-40c8-9888-4e84d0473991" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:to="loc_srt_MinimumMember_393095a8-b327-40c8-9888-4e84d0473991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_55dbc23e-aafa-455a-ad3c-3a7ec3e330c8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8bb26a87-05b1-40b3-8c98-fd72fe6298a7" xlink:to="loc_srt_MaximumMember_55dbc23e-aafa-455a-ad3c-3a7ec3e330c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4557e7b3-8f9d-4e37-9589-1e51683e5f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4557e7b3-8f9d-4e37-9589-1e51683e5f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_4557e7b3-8f9d-4e37-9589-1e51683e5f9a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_9422840e-4df7-41f6-8cd2-9abfbdf348f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:to="loc_us-gaap_ComputerEquipmentMember_9422840e-4df7-41f6-8cd2-9abfbdf348f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_57829c5c-7aab-48f8-b44d-225fcd57d48f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:to="loc_us-gaap_OfficeEquipmentMember_57829c5c-7aab-48f8-b44d-225fcd57d48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_bcbb3a88-5d57-40db-922e-b01780ef3e40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c220e2cb-a102-4ee4-ba51-9bfa96a35c34" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_bcbb3a88-5d57-40db-922e-b01780ef3e40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountPoliciesLineItems_e43d90ec-fa61-4a25-b228-44947e9501d2" xlink:href="izea-20250331.xsd#izea_SignificantAccountPoliciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a169376-d877-46f6-bf02-5c2b5fb714ec" xlink:to="loc_izea_SignificantAccountPoliciesLineItems_e43d90ec-fa61-4a25-b228-44947e9501d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1aa46f2-ee41-49fa-bc42-783bcd72482a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_e43d90ec-fa61-4a25-b228-44947e9501d2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d1aa46f2-ee41-49fa-bc42-783bcd72482a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_88abfaef-8ccb-4b59-a97c-9b70ecbb4710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_AmortizationPeriodOfSoftwareDevelopmentCosts_46870a1f-a5b8-4415-aec5-26d52d3a84c9" xlink:href="izea-20250331.xsd#izea_AmortizationPeriodOfSoftwareDevelopmentCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_88abfaef-8ccb-4b59-a97c-9b70ecbb4710" xlink:to="loc_izea_AmortizationPeriodOfSoftwareDevelopmentCosts_46870a1f-a5b8-4415-aec5-26d52d3a84c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_79b7c844-167f-464f-8148-7cc98eaa3ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_InvoicePaymentTerms_f4cc9d3d-7165-43de-abcb-3b144d1c49c6" xlink:href="izea-20250331.xsd#izea_InvoicePaymentTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79b7c844-167f-464f-8148-7cc98eaa3ea1" xlink:to="loc_izea_InvoicePaymentTerms_f4cc9d3d-7165-43de-abcb-3b144d1c49c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers_5841f673-f6bb-43eb-b6d4-2155e3736a09" xlink:href="izea-20250331.xsd#izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_79b7c844-167f-464f-8148-7cc98eaa3ea1" xlink:to="loc_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers_5841f673-f6bb-43eb-b6d4-2155e3736a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8f720a16-670d-4861-88d4-85114fa8baf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountingPoliciesTable_8a696c2a-1afb-49df-8041-95301b0d957a" xlink:href="izea-20250331.xsd#izea_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8f720a16-670d-4861-88d4-85114fa8baf5" xlink:to="loc_izea_SignificantAccountingPoliciesTable_8a696c2a-1afb-49df-8041-95301b0d957a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_f3aeeadb-0a3e-4f31-b37d-24c4f7896862" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a696c2a-1afb-49df-8041-95301b0d957a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_f3aeeadb-0a3e-4f31-b37d-24c4f7896862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6df3fa12-12ed-4db8-992c-95d1aa1a261e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_f3aeeadb-0a3e-4f31-b37d-24c4f7896862" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6df3fa12-12ed-4db8-992c-95d1aa1a261e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_04f19e0f-3cac-406a-b9ee-5838094572ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6df3fa12-12ed-4db8-992c-95d1aa1a261e" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_04f19e0f-3cac-406a-b9ee-5838094572ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountPoliciesLineItems_466761df-f49d-4477-895e-d6c844660d82" xlink:href="izea-20250331.xsd#izea_SignificantAccountPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountingPoliciesTable_8a696c2a-1afb-49df-8041-95301b0d957a" xlink:to="loc_izea_SignificantAccountPoliciesLineItems_466761df-f49d-4477-895e-d6c844660d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_c4ea339a-bab8-4fe9-9e3d-c822f5f0b184" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_466761df-f49d-4477-895e-d6c844660d82" xlink:to="loc_us-gaap_AdvertisingExpense_c4ea339a-bab8-4fe9-9e3d-c822f5f0b184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7ab8e382-f4a5-4b74-a005-60abf2e79124" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountingPoliciesTable_0a78ba3a-c4de-4f45-be67-074981ffacea" xlink:href="izea-20250331.xsd#izea_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7ab8e382-f4a5-4b74-a005-60abf2e79124" xlink:to="loc_izea_SignificantAccountingPoliciesTable_0a78ba3a-c4de-4f45-be67-074981ffacea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_09aacb9b-470e-4722-89f7-fa35e537dc66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountingPoliciesTable_0a78ba3a-c4de-4f45-be67-074981ffacea" xlink:to="loc_us-gaap_AwardTypeAxis_09aacb9b-470e-4722-89f7-fa35e537dc66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57ec9dc5-635f-4512-938c-fa936e5edab5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_09aacb9b-470e-4722-89f7-fa35e537dc66" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57ec9dc5-635f-4512-938c-fa936e5edab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e8eb64eb-fa9a-4a78-b1cb-13e6aa6b131c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57ec9dc5-635f-4512-938c-fa936e5edab5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e8eb64eb-fa9a-4a78-b1cb-13e6aa6b131c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SignificantAccountPoliciesLineItems_6bbb6d1d-7b5d-4495-9bbb-b47001ce981f" xlink:href="izea-20250331.xsd#izea_SignificantAccountPoliciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountingPoliciesTable_0a78ba3a-c4de-4f45-be67-074981ffacea" xlink:to="loc_izea_SignificantAccountPoliciesLineItems_6bbb6d1d-7b5d-4495-9bbb-b47001ce981f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5d7f634-2d6a-4dff-94f6-e7106e7b3a72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_SignificantAccountPoliciesLineItems_6bbb6d1d-7b5d-4495-9bbb-b47001ce981f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b5d7f634-2d6a-4dff-94f6-e7106e7b3a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#BusinessAcquisitionsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3ab0a78f-71ee-4019-b77a-64b823aed6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3ab0a78f-71ee-4019-b77a-64b823aed6d0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c19c4def-99e7-4a2f-9acf-a4ad484bad92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c19c4def-99e7-4a2f-9acf-a4ad484bad92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fbd71afd-deb0-4a35-a9e7-5186eda43e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c19c4def-99e7-4a2f-9acf-a4ad484bad92" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fbd71afd-deb0-4a35-a9e7-5186eda43e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoozuHoldingPTYLtd.Member_3cc3f7f2-12a7-4d9d-a886-286dfaf3e61f" xlink:href="izea-20250331.xsd#izea_HoozuHoldingPTYLtd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_fbd71afd-deb0-4a35-a9e7-5186eda43e2e" xlink:to="loc_izea_HoozuHoldingPTYLtd.Member_3cc3f7f2-12a7-4d9d-a886-286dfaf3e61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:to="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentOperatingActivitiesDomain_f4590a2f-0591-4bdc-8b0a-3d7b7a0150c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentOperatingActivitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOperatingActivitiesSegmentAxis_24a8fef9-5ec3-47d9-8dfb-1c71c661f63e" xlink:to="loc_us-gaap_SegmentOperatingActivitiesDomain_f4590a2f-0591-4bdc-8b0a-3d7b7a0150c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDiscontinuedOperationsMember_893c7c36-23d2-4038-bbaa-43b3c9f3cb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentOperatingActivitiesDomain_f4590a2f-0591-4bdc-8b0a-3d7b7a0150c7" xlink:to="loc_us-gaap_SegmentDiscontinuedOperationsMember_893c7c36-23d2-4038-bbaa-43b3c9f3cb7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9debe371-b14f-4547-af96-bf7ab74a1c2b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fd4bf35-1c9a-47fa-b884-0593ff7ac35f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_9fd4bf35-1c9a-47fa-b884-0593ff7ac35f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22e3f4e2-9a3b-4ed2-96e8-eaad7885453e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22e3f4e2-9a3b-4ed2-96e8-eaad7885453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashDivestedFromDeconsolidation_3eb92319-5d2d-4fb7-8056-5125e0c3a776" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashDivestedFromDeconsolidation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_CashDivestedFromDeconsolidation_3eb92319-5d2d-4fb7-8056-5125e0c3a776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts_e594cc47-e4a3-47bc-a088-c00afc66e455" xlink:href="izea-20250331.xsd#izea_LossOfDivesitureOfBusinessNetOfTransactionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts_e594cc47-e4a3-47bc-a088-c00afc66e455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_328dcceb-0c11-4fc3-9b58-e6989ff77eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_e0bb4e1d-601f-40f3-8aa6-7b42071d9eeb" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_328dcceb-0c11-4fc3-9b58-e6989ff77eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bf645b0d-be06-4747-b9a1-8155aa789d64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bf645b0d-be06-4747-b9a1-8155aa789d64" xlink:to="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593f820b-0df5-4ec5-9918-44f3c964a6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593f820b-0df5-4ec5-9918-44f3c964a6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_593f820b-0df5-4ec5-9918-44f3c964a6dc" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b5d869f3-04c5-42f1-bf7e-5c2816400e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b5d869f3-04c5-42f1-bf7e-5c2816400e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_b4f763ca-f3eb-4c40-b516-2f83c85f0e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b285317c-d5f9-4bd0-9b4e-4159e4e2ef9e" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_b4f763ca-f3eb-4c40-b516-2f83c85f0e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_652e5e33-b7e0-4901-92f5-514cf930d658" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:to="loc_us-gaap_FinancialInstrumentAxis_652e5e33-b7e0-4901-92f5-514cf930d658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_652e5e33-b7e0-4901-92f5-514cf930d658" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7d140061-e2ce-4a31-8588-ae12be08036b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7d140061-e2ce-4a31-8588-ae12be08036b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b06a3d98-468f-4734-bde7-bf94d966b72d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_CommercialPaperMember_b06a3d98-468f-4734-bde7-bf94d966b72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_18ec7687-aea0-41ce-8e90-0549888133c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_MoneyMarketFundsMember_18ec7687-aea0-41ce-8e90-0549888133c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_7a67a07d-8bf4-45e5-9684-5b3cc06e3f86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_7a67a07d-8bf4-45e5-9684-5b3cc06e3f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_1e595e03-6ff4-4aad-992e-1e9a273d9672" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_1e595e03-6ff4-4aad-992e-1e9a273d9672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ae3447f9-9738-4f12-b6ec-4b846404c89e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3738a0d-955e-4967-a726-4a97d47b0d96" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ae3447f9-9738-4f12-b6ec-4b846404c89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9f5f2a72-8fb4-4332-bb8e-1424eab1ad3d" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_187b2013-8d8b-4d6e-81e5-5640af53d83e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_187b2013-8d8b-4d6e-81e5-5640af53d83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3dff9e73-8474-4e57-b544-60a0dd9b9d61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3dff9e73-8474-4e57-b544-60a0dd9b9d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_267fe177-b3b3-4956-93d8-5b0c080e76ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_267fe177-b3b3-4956-93d8-5b0c080e76ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_de541e22-8cb7-44ee-922c-bb8e1fe79f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_de541e22-8cb7-44ee-922c-bb8e1fe79f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30efc068-f23a-4d7f-bf46-6508bba45c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_30efc068-f23a-4d7f-bf46-6508bba45c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_4d5730d8-c191-4e6a-a096-a5b79c884bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_bcefa60f-c9c9-4190-9af0-c0f7b6857760" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_4d5730d8-c191-4e6a-a096-a5b79c884bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c977846b-f50b-47bb-9ad1-d852a45b332a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoldingPeriodOfMarketableSecurities_bed5e90a-1258-4a0f-859c-06a7e3f86636" xlink:href="izea-20250331.xsd#izea_HoldingPeriodOfMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c977846b-f50b-47bb-9ad1-d852a45b332a" xlink:to="loc_izea_HoldingPeriodOfMarketableSecurities_bed5e90a-1258-4a0f-859c-06a7e3f86636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainOnSaleOfInvestments_8c7d4436-980b-47c3-8f28-724084f7d525" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainOnSaleOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c977846b-f50b-47bb-9ad1-d852a45b332a" xlink:to="loc_us-gaap_GainOnSaleOfInvestments_8c7d4436-980b-47c3-8f28-724084f7d525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d4cbcb4e-d981-4718-bdbc-8b538c16924c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_77360618-453f-485e-bdc8-526347ad6360" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d4cbcb4e-d981-4718-bdbc-8b538c16924c" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_77360618-453f-485e-bdc8-526347ad6360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_a6a418ac-fa03-4e3d-8f8d-428a8aee3d80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d4cbcb4e-d981-4718-bdbc-8b538c16924c" xlink:to="loc_us-gaap_MarketableSecurities_a6a418ac-fa03-4e3d-8f8d-428a8aee3d80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c3950e3f-6c0e-4035-aa1e-a9d01e7d4789" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_9be1e3ba-d250-4585-9704-3e394deef6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c3950e3f-6c0e-4035-aa1e-a9d01e7d4789" xlink:to="loc_us-gaap_MarketableSecuritiesTable_9be1e3ba-d250-4585-9704-3e394deef6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9be1e3ba-d250-4585-9704-3e394deef6c4" xlink:to="loc_us-gaap_FinancialInstrumentAxis_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_bec9daf5-cb56-4c2f-b74a-0bfa59a9afa0" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_32066f06-315a-40df-8212-cffcf6aca88a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_32066f06-315a-40df-8212-cffcf6aca88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_0395220e-3b32-44bf-b30c-e81bf6dd1f67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_0395220e-3b32-44bf-b30c-e81bf6dd1f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ff800b12-8d35-40e4-853f-29b7680ee362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ff800b12-8d35-40e4-853f-29b7680ee362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_08aead9b-4d6b-4067-b995-657bfd3b00a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1a4fd0ff-511e-4b9c-bff0-2c98268023c5" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_08aead9b-4d6b-4067-b995-657bfd3b00a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_9be1e3ba-d250-4585-9704-3e394deef6c4" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FinancialAssetsFairValueDisclosure_532e89f1-cd07-4bb0-9395-0ed80b8c0ef0" xlink:href="izea-20250331.xsd#izea_FinancialAssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:to="loc_izea_FinancialAssetsFairValueDisclosure_532e89f1-cd07-4bb0-9395-0ed80b8c0ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_c489b9c0-261e-4973-bd2b-0857f629e7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_8792961d-b5de-4665-808b-e79efaa28b58" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax_c489b9c0-261e-4973-bd2b-0857f629e7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/PropertyandEquipmentDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#PropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/PropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f5316538-7ba3-486a-87de-def9da46e068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f5316538-7ba3-486a-87de-def9da46e068" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6bee79d0-52aa-4bb7-a306-8421c00d8e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6bee79d0-52aa-4bb7-a306-8421c00d8e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6bee79d0-52aa-4bb7-a306-8421c00d8e5b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_5602d157-f0c8-4602-94ba-8c24abb0711f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_5602d157-f0c8-4602-94ba-8c24abb0711f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_7591d129-d7d6-4c44-b813-94945b9756db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:to="loc_us-gaap_OfficeEquipmentMember_7591d129-d7d6-4c44-b813-94945b9756db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_26e4383e-734d-4e90-8052-5eb097cdd599" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_24bb4160-3469-45cd-9f8c-9658f65d3ce4" xlink:to="loc_us-gaap_ComputerEquipmentMember_26e4383e-734d-4e90-8052-5eb097cdd599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1039a143-bea4-40b6-877c-6d334cde33de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1039a143-bea4-40b6-877c-6d334cde33de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_76927557-a604-4c86-bdb2-fe80cf05795c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1039a143-bea4-40b6-877c-6d334cde33de" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_76927557-a604-4c86-bdb2-fe80cf05795c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DepreciationandAmortizationExpenseMember_256cabc3-d9f8-43b2-a1d5-9ea2e4b35754" xlink:href="izea-20250331.xsd#izea_DepreciationandAmortizationExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_76927557-a604-4c86-bdb2-fe80cf05795c" xlink:to="loc_izea_DepreciationandAmortizationExpenseMember_256cabc3-d9f8-43b2-a1d5-9ea2e4b35754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b479d01-734a-42e6-bfa5-51062ef2d681" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_fa3b8526-4503-4264-b387-cd4f1baed013" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_fa3b8526-4503-4264-b387-cd4f1baed013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5ff9b0c-0878-4d70-9cc6-7c6e0ed6cef3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a5ff9b0c-0878-4d70-9cc6-7c6e0ed6cef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_13adc461-69e4-40b5-be34-3e08d6f1e20c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_13adc461-69e4-40b5-be34-3e08d6f1e20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a7812e1e-a0ed-49e6-bbe5-4c5bc57edba4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1d6ec44b-2d37-42be-a1dc-3613a45d221e" xlink:to="loc_us-gaap_Depreciation_a7812e1e-a0ed-49e6-bbe5-4c5bc57edba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/IntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#IntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/IntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ee108dc6-6387-4ea6-86d2-a815042c3b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ee108dc6-6387-4ea6-86d2-a815042c3b4d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_fecb5e10-24f8-4ba3-a963-f143a5c61d31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_fecb5e10-24f8-4ba3-a963-f143a5c61d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_df05c2b1-9163-4ed4-8c54-016782efebfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_fecb5e10-24f8-4ba3-a963-f143a5c61d31" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_df05c2b1-9163-4ed4-8c54-016782efebfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DepreciationandAmortizationExpenseMember_f763cb10-aa33-4c7b-b9e0-9f89e6bc2431" xlink:href="izea-20250331.xsd#izea_DepreciationandAmortizationExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_df05c2b1-9163-4ed4-8c54-016782efebfd" xlink:to="loc_izea_DepreciationandAmortizationExpenseMember_f763cb10-aa33-4c7b-b9e0-9f89e6bc2431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5fdf879c-7d9d-4744-9084-5f92636cae8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5fdf879c-7d9d-4744-9084-5f92636cae8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad674bfa-5833-465d-8275-1787c6fad39b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5fdf879c-7d9d-4744-9084-5f92636cae8d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad674bfa-5833-465d-8275-1787c6fad39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DigitalAssetsMember_2c73e322-ce13-4e46-857b-faa72b77691f" xlink:href="izea-20250331.xsd#izea_DigitalAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ad674bfa-5833-465d-8275-1787c6fad39b" xlink:to="loc_izea_DigitalAssetsMember_2c73e322-ce13-4e46-857b-faa72b77691f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_919cd5bb-cf8d-4333-acad-85198b946d40" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_446d4112-74f4-4e17-bb6d-e32982c42d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_446d4112-74f4-4e17-bb6d-e32982c42d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_99f18665-8f88-4ee5-8b80-09b5769be2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_99f18665-8f88-4ee5-8b80-09b5769be2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_16fd73a4-0d8d-4497-bf82-8d92ecc55ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ae465ac9-0fbe-413d-be02-84551c889cdd" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_16fd73a4-0d8d-4497-bf82-8d92ecc55ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_7d289c5e-dc79-4d08-b56d-3138fdb0888d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_2e926227-cd2b-4804-9110-756ae2e5739c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_7d289c5e-dc79-4d08-b56d-3138fdb0888d" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_2e926227-cd2b-4804-9110-756ae2e5739c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_8b98a3e5-420a-402c-b1c2-dd2c20867dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_7d289c5e-dc79-4d08-b56d-3138fdb0888d" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization_8b98a3e5-420a-402c-b1c2-dd2c20867dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_e7cf1b7e-e424-4b3e-b694-9dfac3d71853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_7d289c5e-dc79-4d08-b56d-3138fdb0888d" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_e7cf1b7e-e424-4b3e-b694-9dfac3d71853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#SoftwareDevelopmentCostsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_835c7128-49e2-4acb-9137-c3dc215e8d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ca49e573-d38d-40e8-9f7e-5f0adabb7a56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_835c7128-49e2-4acb-9137-c3dc215e8d4b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ca49e573-d38d-40e8-9f7e-5f0adabb7a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2513307e-9b32-457a-9031-5b8763b4ce44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ca49e573-d38d-40e8-9f7e-5f0adabb7a56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2513307e-9b32-457a-9031-5b8763b4ce44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96a4d788-ca79-4d74-b20b-6192bdb57084" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2513307e-9b32-457a-9031-5b8763b4ce44" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96a4d788-ca79-4d74-b20b-6192bdb57084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_d24694af-9d06-49d3-aa12-76200ca00ef7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_96a4d788-ca79-4d74-b20b-6192bdb57084" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_d24694af-9d06-49d3-aa12-76200ca00ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ca49e573-d38d-40e8-9f7e-5f0adabb7a56" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_a7e2c57f-bc9a-43e9-8718-125579d5a0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_a7e2c57f-bc9a-43e9-8718-125579d5a0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_1c236c31-db25-4e35-b5ce-683096620fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_1c236c31-db25-4e35-b5ce-683096620fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3edbac0a-1a95-4f3f-a16c-5bcff6537176" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3edbac0a-1a95-4f3f-a16c-5bcff6537176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3eaddcd0-f99e-4cc2-90d4-4925b4e8ba14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_e53277da-f870-42fa-a850-e9a5cf8be576" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3eaddcd0-f99e-4cc2-90d4-4925b4e8ba14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear_86fe476c-d946-4769-8593-6434741e8a78" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:to="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear_86fe476c-d946-4769-8593-6434741e8a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne_f41c242e-a994-4502-ab0e-5d9fda5cf9bb" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:to="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne_f41c242e-a994-4502-ab0e-5d9fda5cf9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo_accc9f46-a5f1-4af7-a922-312d95cda19d" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:to="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo_accc9f46-a5f1-4af7-a922-312d95cda19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree_2f774f1f-d831-4779-bf94-e29bc06ef4df" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:to="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree_2f774f1f-d831-4779-bf94-e29bc06ef4df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour_75110d63-1f8f-4298-8211-f87d1c19e49e" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:to="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour_75110d63-1f8f-4298-8211-f87d1c19e49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive_e1730ca3-7bee-41ce-a80b-024da44d45fa" xlink:href="izea-20250331.xsd#izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:to="loc_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive_e1730ca3-7bee-41ce-a80b-024da44d45fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareNet_f654d3e8-e933-4da2-9ae2-06d86f9bfc06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedComputerSoftwareNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_ac4e6dfe-07d6-46fe-8db9-c83aaa6ca4b4" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareNet_f654d3e8-e933-4da2-9ae2-06d86f9bfc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/AccruedExpensesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#AccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/AccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ef8e4c75-1162-4f5e-9978-cde7a1fd7f68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrentAndNoncurrent_fc7a1d78-8bfa-49ed-95af-cd95f8c16016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedSalariesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ef8e4c75-1162-4f5e-9978-cde7a1fd7f68" xlink:to="loc_us-gaap_AccruedSalariesCurrentAndNoncurrent_fc7a1d78-8bfa-49ed-95af-cd95f8c16016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxes_26c8793a-57bd-44fb-8fd5-d7404a285086" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ef8e4c75-1162-4f5e-9978-cde7a1fd7f68" xlink:to="loc_us-gaap_AccruedIncomeTaxes_26c8793a-57bd-44fb-8fd5-d7404a285086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CurrentPortionOfFinanceObligation_97c7367e-2d53-4379-b3d4-0a5a2bced6a7" xlink:href="izea-20250331.xsd#izea_CurrentPortionOfFinanceObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ef8e4c75-1162-4f5e-9978-cde7a1fd7f68" xlink:to="loc_izea_CurrentPortionOfFinanceObligation_97c7367e-2d53-4379-b3d4-0a5a2bced6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_ab75f1e3-bb1f-4d51-828f-ecec3e9cf260" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ef8e4c75-1162-4f5e-9978-cde7a1fd7f68" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent_ab75f1e3-bb1f-4d51-828f-ecec3e9cf260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_bf99d1fc-1f62-43f1-ba01-f302b74fd226" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ef8e4c75-1162-4f5e-9978-cde7a1fd7f68" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_bf99d1fc-1f62-43f1-ba01-f302b74fd226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b506eb19-3fe3-46c0-b5ea-802941db738f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ef8e4c75-1162-4f5e-9978-cde7a1fd7f68" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b506eb19-3fe3-46c0-b5ea-802941db738f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_ec8ce980-08a7-473d-9dee-8383ba762cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b506eb19-3fe3-46c0-b5ea-802941db738f" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_ec8ce980-08a7-473d-9dee-8383ba762cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_2d23da5a-d8df-4dc8-b3f7-747e46e4133f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_ec8ce980-08a7-473d-9dee-8383ba762cd5" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_2d23da5a-d8df-4dc8-b3f7-747e46e4133f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_b5414faf-d553-41c9-aa54-1acbd0b099f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_2d23da5a-d8df-4dc8-b3f7-747e46e4133f" xlink:to="loc_us-gaap_EmployeeSeveranceMember_b5414faf-d553-41c9-aa54-1acbd0b099f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_b506eb19-3fe3-46c0-b5ea-802941db738f" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_617c5215-445d-4c87-875f-7f238e4e4829" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_617c5215-445d-4c87-875f-7f238e4e4829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_aa745979-0f24-4ee9-9913-8558b909292c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_a99efdac-f83f-46a5-a762-f375896f6970" xlink:to="loc_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits_aa745979-0f24-4ee9-9913-8558b909292c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/NotesPayableAdditionalInformationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#NotesPayableAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/NotesPayableAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9c15501e-b50f-491a-8448-aae739dcf7ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_28953ba3-1cad-418f-84f0-288d816804e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c15501e-b50f-491a-8448-aae739dcf7ab" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_28953ba3-1cad-418f-84f0-288d816804e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTerm_622106e2-5e7b-42af-aa24-c2d5c7470903" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c15501e-b50f-491a-8448-aae739dcf7ab" xlink:to="loc_us-gaap_LongTermDebtTerm_622106e2-5e7b-42af-aa24-c2d5c7470903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d5f7c55d-0f9d-44dc-8890-895b5b19a75a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c15501e-b50f-491a-8448-aae739dcf7ab" xlink:to="loc_us-gaap_LongTermDebt_d5f7c55d-0f9d-44dc-8890-895b5b19a75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_dc834417-bd59-435b-b0ed-94a55287d303" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c15501e-b50f-491a-8448-aae739dcf7ab" xlink:to="loc_us-gaap_LongTermDebtCurrent_dc834417-bd59-435b-b0ed-94a55287d303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_51dcab80-138e-40d7-875c-8efc2464e7d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9c15501e-b50f-491a-8448-aae739dcf7ab" xlink:to="loc_us-gaap_InterestExpenseDebt_51dcab80-138e-40d7-875c-8efc2464e7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#NotesPayableScheduleofFutureMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_728c725d-6bfa-46b0-bdbb-ff1fdcce91f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_e5a577cb-a75e-4d2e-b741-aed1b1c1a5db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_728c725d-6bfa-46b0-bdbb-ff1fdcce91f6" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_e5a577cb-a75e-4d2e-b741-aed1b1c1a5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2d818b44-e865-41ab-b99c-04e3b9fd02ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_728c725d-6bfa-46b0-bdbb-ff1fdcce91f6" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_2d818b44-e865-41ab-b99c-04e3b9fd02ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_020cc0c5-44b4-434e-9d84-28402cc3fea4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_728c725d-6bfa-46b0-bdbb-ff1fdcce91f6" xlink:to="loc_us-gaap_LongTermDebt_020cc0c5-44b4-434e-9d84-28402cc3fea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#CommitmentsandContingenciesRetirementPlansDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_458ff2a8-299f-418b-b765-cadc57d36634" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_1dee4d2f-825d-4632-9d5f-5ff6e7c03e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_458ff2a8-299f-418b-b765-cadc57d36634" xlink:to="loc_us-gaap_OtherCommitmentsTable_1dee4d2f-825d-4632-9d5f-5ff6e7c03e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_43e258d5-95c7-44b7-86d4-39e59c95f660" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1dee4d2f-825d-4632-9d5f-5ff6e7c03e5f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_43e258d5-95c7-44b7-86d4-39e59c95f660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_43e258d5-95c7-44b7-86d4-39e59c95f660" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_5047de31-3d3d-4f55-97e3-728f53b64812" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:to="loc_us-gaap_CostOfSalesMember_5047de31-3d3d-4f55-97e3-728f53b64812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_2a081e2f-b3de-4f5b-8855-22e949ebd76f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_2a081e2f-b3de-4f5b-8855-22e949ebd76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_96959269-1459-49ec-98a1-d58b3f919d19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_16c1dbc8-8de7-4866-9689-0be0039622f4" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_96959269-1459-49ec-98a1-d58b3f919d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_1dee4d2f-825d-4632-9d5f-5ff6e7c03e5f" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_541be15f-02c3-492b-919f-1beadb1dcd87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_541be15f-02c3-492b-919f-1beadb1dcd87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5beba1be-62ce-4daa-b5db-0470fe52fc60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_5beba1be-62ce-4daa-b5db-0470fe52fc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_918c4702-2d5b-4707-9e19-e59aba703645" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_918c4702-2d5b-4707-9e19-e59aba703645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService_52ba1b12-d928-43e1-bab7-a99695dd6a01" xlink:href="izea-20250331.xsd#izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService_52ba1b12-d928-43e1-bab7-a99695dd6a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_54f4b8eb-c1e5-4b35-af98-dd635174b349" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_f1d25ba5-df1e-40c6-8372-c68e5fc6c228" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_54f4b8eb-c1e5-4b35-af98-dd635174b349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityAuthorizedSharesDetail"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c864fca-3b5f-4d30-9d8f-df46030d3b67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9679e6b9-e0ce-486f-94cf-59fc1f224484" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c864fca-3b5f-4d30-9d8f-df46030d3b67" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9679e6b9-e0ce-486f-94cf-59fc1f224484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_54f58a45-1489-4260-b63e-ff96c17d0ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c864fca-3b5f-4d30-9d8f-df46030d3b67" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_54f58a45-1489-4260-b63e-ff96c17d0ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2d05938b-1ffe-4fc9-9c38-5998893b07d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c864fca-3b5f-4d30-9d8f-df46030d3b67" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2d05938b-1ffe-4fc9-9c38-5998893b07d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dda6f782-564f-4ae4-ac7e-1a089ab516b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0c864fca-3b5f-4d30-9d8f-df46030d3b67" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dda6f782-564f-4ae4-ac7e-1a089ab516b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fb155814-da5c-468f-a501-e514b4c2cbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dda6f782-564f-4ae4-ac7e-1a089ab516b0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fb155814-da5c-468f-a501-e514b4c2cbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fa47078b-c029-4b47-b884-8c177d00def3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fb155814-da5c-468f-a501-e514b4c2cbd4" xlink:to="loc_us-gaap_ClassOfStockDomain_fa47078b-c029-4b47-b884-8c177d00def3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_6d8ca7fb-d29f-4f83-950f-b0ed8bdf7dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_fa47078b-c029-4b47-b884-8c177d00def3" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_6d8ca7fb-d29f-4f83-950f-b0ed8bdf7dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_333cbe20-3789-4f55-9f37-0eb667b74f36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dda6f782-564f-4ae4-ac7e-1a089ab516b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_333cbe20-3789-4f55-9f37-0eb667b74f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_3261705c-255a-4f8c-99c0-4075abd8ef1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_333cbe20-3789-4f55-9f37-0eb667b74f36" xlink:to="loc_us-gaap_PreferredStockSharesIssued_3261705c-255a-4f8c-99c0-4075abd8ef1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityShareRepurchaseDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_99f27a40-1bc4-4cca-84a3-c8e0a0ec78f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f4e34a1-ec3e-448f-8a57-2c6ce5b8cadf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_99f27a40-1bc4-4cca-84a3-c8e0a0ec78f9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f4e34a1-ec3e-448f-8a57-2c6ce5b8cadf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_517e3a19-cb84-482b-844e-52a61063f39e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f4e34a1-ec3e-448f-8a57-2c6ce5b8cadf" xlink:to="loc_srt_ShareRepurchaseProgramAxis_517e3a19-cb84-482b-844e-52a61063f39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramAxis_517e3a19-cb84-482b-844e-52a61063f39e" xlink:to="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ActiveRepurchaseProgramMember_a9773bf9-81b2-4157-9c46-62733585ef8a" xlink:href="izea-20250331.xsd#izea_ActiveRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:to="loc_izea_ActiveRepurchaseProgramMember_a9773bf9-81b2-4157-9c46-62733585ef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ExpiredAndActiveRepurchaseProgramsMember_058d3961-266d-4df1-acd2-8001843e8b2f" xlink:href="izea-20250331.xsd#izea_ExpiredAndActiveRepurchaseProgramsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_a70d146d-c2a4-468d-bfef-f1b1c8bdeabc" xlink:to="loc_izea_ExpiredAndActiveRepurchaseProgramsMember_058d3961-266d-4df1-acd2-8001843e8b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8f4e34a1-ec3e-448f-8a57-2c6ce5b8cadf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_504ae195-2080-403c-a7ce-77f23bf21278" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased_504ae195-2080-403c-a7ce-77f23bf21278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_d975ea4b-46a8-402c-aed5-53890561e786" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased_d975ea4b-46a8-402c-aed5-53890561e786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1f6ee1d1-3b31-4a17-aa80-80c62c9a7c4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_1f6ee1d1-3b31-4a17-aa80-80c62c9a7c4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38810c6d-71d2-4cf0-b96f-9e7c0de96a60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d4fb6962-ed4c-472a-a83b-9860cf44703a" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_38810c6d-71d2-4cf0-b96f-9e7c0de96a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityEquityIncentivePlanDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_079b2321-111e-4fcb-ae4e-9183b18f4686" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_088ea770-95ec-40f0-9d44-77035e54c9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_079b2321-111e-4fcb-ae4e-9183b18f4686" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_088ea770-95ec-40f0-9d44-77035e54c9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_088ea770-95ec-40f0-9d44-77035e54c9ae" xlink:to="loc_us-gaap_PlanNameAxis_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4859426f-7c0e-45df-b1c8-3ae652faab72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8ec7a7ea-a2d0-46fc-b1ea-eb6d8b2aaedf" xlink:to="loc_us-gaap_PlanNameDomain_4859426f-7c0e-45df-b1c8-3ae652faab72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TheAmendedandRestatedMay2011PlanMember_27cb737b-d43f-45e9-b122-eebed62ed425" xlink:href="izea-20250331.xsd#izea_TheAmendedandRestatedMay2011PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4859426f-7c0e-45df-b1c8-3ae652faab72" xlink:to="loc_izea_TheAmendedandRestatedMay2011PlanMember_27cb737b-d43f-45e9-b122-eebed62ed425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_088ea770-95ec-40f0-9d44-77035e54c9ae" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease_3381a14c-ece8-4508-b24b-7c324d696b01" xlink:href="izea-20250331.xsd#izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:to="loc_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease_3381a14c-ece8-4508-b24b-7c324d696b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0ad3b634-78b5-4274-b482-ad30978e228d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f37ef1a3-5f48-4c82-9162-fdb051d603a2" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_0ad3b634-78b5-4274-b482-ad30978e228d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b429579d-40bc-4e26-bd8a-f155d2b21005" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b429579d-40bc-4e26-bd8a-f155d2b21005" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_f9538107-6a9c-4940-b359-cf969cb9a7aa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:to="loc_srt_TitleOfIndividualAxis_f9538107-6a9c-4940-b359-cf969cb9a7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_f9538107-6a9c-4940-b359-cf969cb9a7aa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_8b119e7c-8b0d-4c47-9a24-f474c810def8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:to="loc_srt_DirectorMember_8b119e7c-8b0d-4c47-9a24-f474c810def8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EmployeesMember_7c9552d6-13df-4825-8cd7-a27ea859c18f" xlink:href="izea-20250331.xsd#izea_EmployeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:to="loc_izea_EmployeesMember_7c9552d6-13df-4825-8cd7-a27ea859c18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_IndependentDirectorsMember_a0597b3c-3e92-4516-b4c4-4c95f7e241e0" xlink:href="izea-20250331.xsd#izea_IndependentDirectorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8312e512-f96c-485d-8e19-e3002618efeb" xlink:to="loc_izea_IndependentDirectorsMember_a0597b3c-3e92-4516-b4c4-4c95f7e241e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_50021572-9c84-4b30-a151-8e9941634a57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:to="loc_us-gaap_AwardTypeAxis_50021572-9c84-4b30-a151-8e9941634a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74c39d92-b0bf-405d-82f2-79dd766e6e19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_50021572-9c84-4b30-a151-8e9941634a57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74c39d92-b0bf-405d-82f2-79dd766e6e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_854b2bc7-7b68-4e70-b42a-9cb8af34005e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_74c39d92-b0bf-405d-82f2-79dd766e6e19" xlink:to="loc_us-gaap_RestrictedStockMember_854b2bc7-7b68-4e70-b42a-9cb8af34005e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5d3c36c4-a03a-4549-b1c9-793da16e5cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Numberofindependentdirectors_d1361e20-5c48-4d63-bfcc-2ea3fc4dfb12" xlink:href="izea-20250331.xsd#izea_Numberofindependentdirectors"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_izea_Numberofindependentdirectors_d1361e20-5c48-4d63-bfcc-2ea3fc4dfb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdeee7d6-f3cb-4c12-8ce0-f17a6bf3ee0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_cdeee7d6-f3cb-4c12-8ce0-f17a6bf3ee0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_f59ad274-9c0b-44c7-974d-b635f9cfa948" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_f59ad274-9c0b-44c7-974d-b635f9cfa948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_4d503110-a4b5-4d81-9e5d-cfab22fe9589" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_RestrictedStockExpense_4d503110-a4b5-4d81-9e5d-cfab22fe9589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockFairValue_1691b3cb-b402-46da-a8f4-a5d3f5f33755" xlink:href="izea-20250331.xsd#izea_CommonStockFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_izea_CommonStockFairValue_1691b3cb-b402-46da-a8f4-a5d3f5f33755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_d14cb4c7-bcf7-4239-8f97-b2c2fd9d13c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a2b18df-3f68-46d9-85d7-a81dbd9ccaf5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_d14cb4c7-bcf7-4239-8f97-b2c2fd9d13c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityScheduleofNonVestedRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47a9ae11-4807-4e42-9a74-d111f7b08903" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5fac9a6-0e57-4f78-837c-901fdfcbe378" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_47a9ae11-4807-4e42-9a74-d111f7b08903" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5fac9a6-0e57-4f78-837c-901fdfcbe378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8e41998d-9c3d-4328-a858-1dbd88ae6e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5fac9a6-0e57-4f78-837c-901fdfcbe378" xlink:to="loc_us-gaap_AwardTypeAxis_8e41998d-9c3d-4328-a858-1dbd88ae6e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a558757-8e98-44f3-bf90-d552c2f7f40f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8e41998d-9c3d-4328-a858-1dbd88ae6e8d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a558757-8e98-44f3-bf90-d552c2f7f40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_91000957-a108-4d84-863c-0820a42f0038" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a558757-8e98-44f3-bf90-d552c2f7f40f" xlink:to="loc_us-gaap_RestrictedStockMember_91000957-a108-4d84-863c-0820a42f0038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5fac9a6-0e57-4f78-837c-901fdfcbe378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67357d56-7142-4b14-bb64-ff131411646a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_67357d56-7142-4b14-bb64-ff131411646a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4a33fc7d-1fe0-4832-8f5b-7027d8e431ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4a33fc7d-1fe0-4832-8f5b-7027d8e431ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03547ef2-30ab-404c-8205-5a5a3ba2704b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_03547ef2-30ab-404c-8205-5a5a3ba2704b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_be33299f-ef48-459e-ac54-99dc1ccbb6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cbd2b8d9-b525-47a4-8f8f-2fcd68429215" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_be33299f-ef48-459e-ac54-99dc1ccbb6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c2dbda0-6cd1-4c74-99ad-27c4939aa382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_5c2dbda0-6cd1-4c74-99ad-27c4939aa382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_587fb732-9926-425f-9cdd-f079f0a64b4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_587fb732-9926-425f-9cdd-f079f0a64b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_900d7157-3c21-444a-ad60-ea3bd9ea2bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_900d7157-3c21-444a-ad60-ea3bd9ea2bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f9cedb02-94e3-4716-bb8b-c13048b8a688" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4eee2ca8-0232-4006-af7f-affdabe47dbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f9cedb02-94e3-4716-bb8b-c13048b8a688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_13a08195-e4dc-41ca-b9a2-3b9bf3e2b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13e1a251-1443-457d-b8f1-7d702f069946" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_13a08195-e4dc-41ca-b9a2-3b9bf3e2b05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4182fd3f-b66f-407b-82d4-0bf871e07d08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4182fd3f-b66f-407b-82d4-0bf871e07d08" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_91f64959-3f50-4046-9ed1-f8d3b3255495" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:to="loc_srt_TitleOfIndividualAxis_91f64959-3f50-4046-9ed1-f8d3b3255495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_91f64959-3f50-4046-9ed1-f8d3b3255495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EmployeesMember_ac67bab7-a8b2-45ae-837f-6653761ff573" xlink:href="izea-20250331.xsd#izea_EmployeesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:to="loc_izea_EmployeesMember_ac67bab7-a8b2-45ae-837f-6653761ff573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExecutiveOfficerMember_238dce03-881e-449e-9176-b4209c9833eb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ExecutiveOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:to="loc_srt_ExecutiveOfficerMember_238dce03-881e-449e-9176-b4209c9833eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_NonExecutiveEmployeesMember_e42b5a61-041b-460f-987a-e6a7362db6a4" xlink:href="izea-20250331.xsd#izea_NonExecutiveEmployeesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_5abb065e-51b0-45c3-b4d1-7dcb6b9ea7a1" xlink:to="loc_izea_NonExecutiveEmployeesMember_e42b5a61-041b-460f-987a-e6a7362db6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_bec37d91-32dc-43f2-b9d2-ea08ca6979c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:to="loc_us-gaap_AwardTypeAxis_bec37d91-32dc-43f2-b9d2-ea08ca6979c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a77c9fc-6abc-40e2-9da7-40fe7697624c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_bec37d91-32dc-43f2-b9d2-ea08ca6979c1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a77c9fc-6abc-40e2-9da7-40fe7697624c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c05d52c9-3fe2-43bc-8a52-8c426199c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7a77c9fc-6abc-40e2-9da7-40fe7697624c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c05d52c9-3fe2-43bc-8a52-8c426199c4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e38059f3-9158-4c2a-9792-94787918f484" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:to="loc_srt_RangeAxis_e38059f3-9158-4c2a-9792-94787918f484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e38059f3-9158-4c2a-9792-94787918f484" xlink:to="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a3a5f4b6-5677-460c-8615-45b88a1c51cf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:to="loc_srt_MinimumMember_a3a5f4b6-5677-460c-8615-45b88a1c51cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6b337cf4-258d-41d3-9bb2-40551a792d8c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ac7a3667-c304-4893-b615-e3cddf62e678" xlink:to="loc_srt_MaximumMember_6b337cf4-258d-41d3-9bb2-40551a792d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f93c16d0-725b-4d58-8b5a-12636c689d18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3be8a2df-1413-46e0-abce-87a5cb6c702e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3be8a2df-1413-46e0-abce-87a5cb6c702e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1d5a46f8-302f-46b4-9ae1-4bc8699389ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_1d5a46f8-302f-46b4-9ae1-4bc8699389ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e678cdae-c371-41f6-8b0d-3cfa1fc1630a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e678cdae-c371-41f6-8b0d-3cfa1fc1630a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockFairValue_e3796817-d66d-4e6f-8adb-b9642c08ed68" xlink:href="izea-20250331.xsd#izea_CommonStockFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_izea_CommonStockFairValue_e3796817-d66d-4e6f-8adb-b9642c08ed68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockExpense_e923f155-6bbf-4a84-93fa-519b1d3c52eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_RestrictedStockExpense_e923f155-6bbf-4a84-93fa-519b1d3c52eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_5f213951-dd69-4f75-accc-e9e218171ece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_5f213951-dd69-4f75-accc-e9e218171ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Fairvalueofcommonstockissuedforfutureservices_8f75f291-6d04-406c-b319-7cce9b172d4b" xlink:href="izea-20250331.xsd#izea_Fairvalueofcommonstockissuedforfutureservices"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_izea_Fairvalueofcommonstockissuedforfutureservices_8f75f291-6d04-406c-b319-7cce9b172d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_75da5c8e-f035-4126-9159-0f4fa4e4444a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a7cbfd3a-006c-4031-b17f-131d11c666d3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_75da5c8e-f035-4126-9159-0f4fa4e4444a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityRestrictedStockUnitsScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3be696e5-b3dc-4974-9f02-3a013dd7f964" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc36e087-4ee5-48c0-a0c0-64ff40ea24c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3be696e5-b3dc-4974-9f02-3a013dd7f964" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc36e087-4ee5-48c0-a0c0-64ff40ea24c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c009d8ce-5014-4471-bf11-87635453e8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc36e087-4ee5-48c0-a0c0-64ff40ea24c0" xlink:to="loc_us-gaap_AwardTypeAxis_c009d8ce-5014-4471-bf11-87635453e8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fcf28fd-5c99-4a97-b434-be724c11d5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c009d8ce-5014-4471-bf11-87635453e8b3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fcf28fd-5c99-4a97-b434-be724c11d5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_38485bef-2c23-4bba-a254-8dbd5dfc7393" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9fcf28fd-5c99-4a97-b434-be724c11d5b0" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_38485bef-2c23-4bba-a254-8dbd5dfc7393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bc36e087-4ee5-48c0-a0c0-64ff40ea24c0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20aa2398-e45d-4996-8a5b-2b8683f2d200" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20aa2398-e45d-4996-8a5b-2b8683f2d200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_25c530be-599b-4cdd-a822-f06472d78da9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_25c530be-599b-4cdd-a822-f06472d78da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_08dccea6-f421-47d1-916d-f9640941a0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_08dccea6-f421-47d1-916d-f9640941a0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_16177f53-031f-448d-8045-bb5850f253d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_16177f53-031f-448d-8045-bb5850f253d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8589072-2996-40f0-a021-898a7a9ce44e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_38604ae6-9348-47ec-8596-9fda5bf4f20d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a8589072-2996-40f0-a021-898a7a9ce44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_710ea12c-06b0-4a1b-ad69-ddef8b809a48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_710ea12c-06b0-4a1b-ad69-ddef8b809a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9df2d0c8-b91c-4b8a-b80e-cb8f1763bb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9df2d0c8-b91c-4b8a-b80e-cb8f1763bb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52127a26-bd98-4e90-a23f-8c092430c9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_52127a26-bd98-4e90-a23f-8c092430c9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6df2977a-dedf-43ab-a1b3-102a3fda8513" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6df2977a-dedf-43ab-a1b3-102a3fda8513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_342a27f4-3a95-4a58-951d-cebb480bc096" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2c60e80c-b488-4d70-98f7-65d2b0d0f9bd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_342a27f4-3a95-4a58-951d-cebb480bc096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1b1c2131-9820-48ac-b977-2603a1286e37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_edd1cfdf-1a7e-438a-b43c-c2e148ca3f4d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_1b1c2131-9820-48ac-b977-2603a1286e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityStockOptionsDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd74414d-8ee9-43d0-8420-d9f989c624b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dd74414d-8ee9-43d0-8420-d9f989c624b0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_VestingFrequencyAxis_3644f5dd-87c8-489e-9268-4236041d76ab" xlink:href="izea-20250331.xsd#izea_VestingFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_izea_VestingFrequencyAxis_3644f5dd-87c8-489e-9268-4236041d76ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:href="izea-20250331.xsd#izea_VestingFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_VestingFrequencyAxis_3644f5dd-87c8-489e-9268-4236041d76ab" xlink:to="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TotalvestingperiodMember_8ed48004-6773-497e-b5e5-543acd306c6c" xlink:href="izea-20250331.xsd#izea_TotalvestingperiodMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:to="loc_izea_TotalvestingperiodMember_8ed48004-6773-497e-b5e5-543acd306c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TwelveMonthsAfterGrantDateMember_970b97f5-6ba3-4f9e-825f-95b567035fa0" xlink:href="izea-20250331.xsd#izea_TwelveMonthsAfterGrantDateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:to="loc_izea_TwelveMonthsAfterGrantDateMember_970b97f5-6ba3-4f9e-825f-95b567035fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MonthlyInEqualInstallmentsMember_fe357174-681f-4153-b3df-87fd1180e2e7" xlink:href="izea-20250331.xsd#izea_MonthlyInEqualInstallmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_VestingFrequencyDomain_4ebe696b-e24e-414c-87f4-e8363a4a09af" xlink:to="loc_izea_MonthlyInEqualInstallmentsMember_fe357174-681f-4153-b3df-87fd1180e2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOwnershipPlanAxis_ccc921d1-6c9b-407c-94b6-52790c8e482f" xlink:href="izea-20250331.xsd#izea_StockOwnershipPlanAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_izea_StockOwnershipPlanAxis_ccc921d1-6c9b-407c-94b6-52790c8e482f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOwnershipPlanDomain_f51cbb6b-a363-4693-81b1-63da8fcf95d9" xlink:href="izea-20250331.xsd#izea_StockOwnershipPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_StockOwnershipPlanAxis_ccc921d1-6c9b-407c-94b6-52790c8e482f" xlink:to="loc_izea_StockOwnershipPlanDomain_f51cbb6b-a363-4693-81b1-63da8fcf95d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_IndividualStockOwnershipInExcessOf10PercentMember_79abf7a1-a4a4-4f6f-958f-1f9e3f132677" xlink:href="izea-20250331.xsd#izea_IndividualStockOwnershipInExcessOf10PercentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_StockOwnershipPlanDomain_f51cbb6b-a363-4693-81b1-63da8fcf95d9" xlink:to="loc_izea_IndividualStockOwnershipInExcessOf10PercentMember_79abf7a1-a4a4-4f6f-958f-1f9e3f132677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b11b6bd2-a24e-40b1-a22b-9128542352d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_us-gaap_AwardTypeAxis_b11b6bd2-a24e-40b1-a22b-9128542352d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93b80627-ec68-475c-8618-fe0bb726510b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b11b6bd2-a24e-40b1-a22b-9128542352d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93b80627-ec68-475c-8618-fe0bb726510b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fed2b449-e874-4749-b92b-29b4e8e14b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_93b80627-ec68-475c-8618-fe0bb726510b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fed2b449-e874-4749-b92b-29b4e8e14b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ce954e1c-41dd-4a11-aa81-62700eebdb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_us-gaap_PlanNameAxis_ce954e1c-41dd-4a11-aa81-62700eebdb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ce954e1c-41dd-4a11-aa81-62700eebdb0f" xlink:to="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_May2011AndAugust2011EquityIncentivePlansMember_d029a36a-8935-48d2-a956-af9f3d6964e0" xlink:href="izea-20250331.xsd#izea_May2011AndAugust2011EquityIncentivePlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:to="loc_izea_May2011AndAugust2011EquityIncentivePlansMember_d029a36a-8935-48d2-a956-af9f3d6964e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EquityIncentive2011PlanMember_c7e53918-a69f-457e-83a5-ce921d5624fb" xlink:href="izea-20250331.xsd#izea_EquityIncentive2011PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9d70ea12-7796-4575-9b04-884c53325629" xlink:to="loc_izea_EquityIncentive2011PlanMember_c7e53918-a69f-457e-83a5-ce921d5624fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_43f25065-15b7-4136-b055-e539f03b430b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Percentageofindividualownershipofcommonstock_c365e3ef-8c30-4e41-9247-e1ebb0d1f917" xlink:href="izea-20250331.xsd#izea_Percentageofindividualownershipofcommonstock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_Percentageofindividualownershipofcommonstock_c365e3ef-8c30-4e41-9247-e1ebb0d1f917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_FairMarketValueOfIncentiveStockOptions_56e77bb6-4612-4ff7-85bc-ad1cacd3a86f" xlink:href="izea-20250331.xsd#izea_FairMarketValueOfIncentiveStockOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_FairMarketValueOfIncentiveStockOptions_56e77bb6-4612-4ff7-85bc-ad1cacd3a86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2e96798-acd8-4680-8a45-02ca02ba80d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2e96798-acd8-4680-8a45-02ca02ba80d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_StockOptionVestingPeriodFromGrantDate_f57ebee7-c670-47a4-aee7-a6f12ce305e4" xlink:href="izea-20250331.xsd#izea_StockOptionVestingPeriodFromGrantDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_StockOptionVestingPeriodFromGrantDate_f57ebee7-c670-47a4-aee7-a6f12ce305e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CommonStockFairValue_d7770417-b68f-486f-9ba6-e9ea03e58c3e" xlink:href="izea-20250331.xsd#izea_CommonStockFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_CommonStockFairValue_d7770417-b68f-486f-9ba6-e9ea03e58c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_34102a38-1e3d-4426-9ed0-b7f2ed5ee382" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_34102a38-1e3d-4426-9ed0-b7f2ed5ee382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ece6253a-6a96-45d9-b1bd-5283cd0d598b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ece6253a-6a96-45d9-b1bd-5283cd0d598b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a0c5975b-d1d9-4dfb-98c6-b09d8bbf0c75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a0c5975b-d1d9-4dfb-98c6-b09d8bbf0c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7966c522-9616-49e5-8a3d-d4e9c2c403e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7966c522-9616-49e5-8a3d-d4e9c2c403e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7e5b262e-6291-408e-8f5e-1b6aae2b1cff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7e5b262e-6291-408e-8f5e-1b6aae2b1cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_59f3924d-e783-4fab-8d3e-da875543cce8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_59f3924d-e783-4fab-8d3e-da875543cce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionPlanExpense_81da66de-bbea-42ec-a981-31215327b334" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockOptionPlanExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_StockOptionPlanExpense_81da66de-bbea-42ec-a981-31215327b334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cbe86e43-cd6f-4b6f-a341-893f029c2d63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cbe86e43-cd6f-4b6f-a341-893f029c2d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_db42a4cc-1ee7-40cd-9f34-bcba029a8d04" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_db42a4cc-1ee7-40cd-9f34-bcba029a8d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6427f04b-df38-4b78-a0d8-7736aaba7caf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_afb41f2e-764b-4df4-9376-7bb6a822dbf5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_6427f04b-df38-4b78-a0d8-7736aaba7caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityScheduleofOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_51395177-61ad-459e-8ea4-8ad7c6623836" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6e8e815a-1bc5-4b85-83ff-c6219733aab6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_51395177-61ad-459e-8ea4-8ad7c6623836" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6e8e815a-1bc5-4b85-83ff-c6219733aab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4afb1ee4-cc20-4850-8d81-31318972f8e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6e8e815a-1bc5-4b85-83ff-c6219733aab6" xlink:to="loc_us-gaap_PlanNameAxis_4afb1ee4-cc20-4850-8d81-31318972f8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_828a7af7-b28a-4b9e-9743-524b6810a90b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4afb1ee4-cc20-4850-8d81-31318972f8e9" xlink:to="loc_us-gaap_PlanNameDomain_828a7af7-b28a-4b9e-9743-524b6810a90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EquityIncentive2011PlanMember_937f9c41-b30c-4cc0-a47a-5fcb53dae0c1" xlink:href="izea-20250331.xsd#izea_EquityIncentive2011PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_828a7af7-b28a-4b9e-9743-524b6810a90b" xlink:to="loc_izea_EquityIncentive2011PlanMember_937f9c41-b30c-4cc0-a47a-5fcb53dae0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6e8e815a-1bc5-4b85-83ff-c6219733aab6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c3f59bdb-d180-4257-a114-806f2d50ac31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c3f59bdb-d180-4257-a114-806f2d50ac31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae7ca259-2ec5-441a-810c-01be3a7bbed8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ae7ca259-2ec5-441a-810c-01be3a7bbed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2c9cac47-3b4d-44e9-9a41-efc88b31655c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2c9cac47-3b4d-44e9-9a41-efc88b31655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_419675d9-08f6-4fb2-8563-54eb77ba4e43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_419675d9-08f6-4fb2-8563-54eb77ba4e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3e902692-eb75-4750-8ef6-3e3f5cd70a79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_7fade7f9-ce21-4e9a-ac0f-1c542d1b470b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3e902692-eb75-4750-8ef6-3e3f5cd70a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14ea619f-1b27-4a2a-b082-270adf59862b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_14ea619f-1b27-4a2a-b082-270adf59862b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0dabe7f5-32b2-4e5a-9b47-ec68af5b7311" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0dabe7f5-32b2-4e5a-9b47-ec68af5b7311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eecda31d-2498-436d-a46c-61ce195cd6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eecda31d-2498-436d-a46c-61ce195cd6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ed5367f8-f8fb-43b9-a82d-9ee17f77fae2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_ed5367f8-f8fb-43b9-a82d-9ee17f77fae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dd1e8fd4-2f1a-4092-8279-1925c35df9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_a14544a7-e540-4e04-b853-4f244e7160fd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dd1e8fd4-2f1a-4092-8279-1925c35df9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_38e57bf1-aa86-4a44-9589-fa65dc9b2e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_38e57bf1-aa86-4a44-9589-fa65dc9b2e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_78d2b74b-78d7-4f52-93f6-ac8b34bc5658" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_78d2b74b-78d7-4f52-93f6-ac8b34bc5658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ada9fe8-9b96-4753-8f9e-9372eb64ac6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ada9fe8-9b96-4753-8f9e-9372eb64ac6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b2d7ded7-a290-437f-964a-45da96efe1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0681bd2e-ef0b-4434-b582-e4d1112dba9c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_b2d7ded7-a290-437f-964a-45da96efe1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityScheduleofNonvestedStockOptionDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2ed5d2a8-29f7-44c5-b9d5-1b1148cc948e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_081baa4e-94c9-4a34-a626-aa119124e070" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2ed5d2a8-29f7-44c5-b9d5-1b1148cc948e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_081baa4e-94c9-4a34-a626-aa119124e070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_8b42ca91-a118-4ee9-9479-703a8ed0fdd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_081baa4e-94c9-4a34-a626-aa119124e070" xlink:to="loc_us-gaap_PlanNameAxis_8b42ca91-a118-4ee9-9479-703a8ed0fdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_588d7b24-2f93-4f44-8b93-22d1a9985fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_8b42ca91-a118-4ee9-9479-703a8ed0fdd6" xlink:to="loc_us-gaap_PlanNameDomain_588d7b24-2f93-4f44-8b93-22d1a9985fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_EquityIncentive2011PlanMember_180f49bf-9225-4655-8bf0-0dc572d84285" xlink:href="izea-20250331.xsd#izea_EquityIncentive2011PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_588d7b24-2f93-4f44-8b93-22d1a9985fdb" xlink:to="loc_izea_EquityIncentive2011PlanMember_180f49bf-9225-4655-8bf0-0dc572d84285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_081baa4e-94c9-4a34-a626-aa119124e070" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_9685c675-b814-4878-839f-cfe2c1fef4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_9685c675-b814-4878-839f-cfe2c1fef4bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_8c252a77-2948-4629-a18e-8686e88c80b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_8c252a77-2948-4629-a18e-8686e88c80b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6cc2fb96-81e0-4575-87ef-29e6c9cdcd17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_6cc2fb96-81e0-4575-87ef-29e6c9cdcd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2a657c58-b5b9-4a47-9ee5-9f90412ea1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward_1d7779e4-caa2-40a6-8fa9-e5b66d8ea289" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_2a657c58-b5b9-4a47-9ee5-9f90412ea1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:to="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c60b2d54-cf40-469e-94bc-bd9624060360" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_c60b2d54-cf40-469e-94bc-bd9624060360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3c736b5a-7a93-48fd-b4a2-3941aff0575f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_3c736b5a-7a93-48fd-b4a2-3941aff0575f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_4ba55dd6-a77f-4959-94f8-2782e007e4c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_4ba55dd6-a77f-4959-94f8-2782e007e4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_a138b2fd-ca73-4b46-94aa-c6dc50593fed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward_2e03f0d0-e347-490d-bd13-dbb9b6416f95" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_a138b2fd-ca73-4b46-94aa-c6dc50593fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_c695d3d1-8fc1-4267-aeb8-b6dfcef6e53d" xlink:href="izea-20250331.xsd#izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b0864ba-4f8a-46a9-b1e5-9fbf1c29ee78" xlink:to="loc_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm_c695d3d1-8fc1-4267-aeb8-b6dfcef6e53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityInducementPlanDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityInducementPlanDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityInducementPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4f42337b-054c-4e72-bded-7a224a325cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4f42337b-054c-4e72-bded-7a224a325cf3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c59c9f1a-7932-46c2-a406-ffc069e8efb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:to="loc_us-gaap_AwardTypeAxis_c59c9f1a-7932-46c2-a406-ffc069e8efb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c59c9f1a-7932-46c2-a406-ffc069e8efb9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ff774a18-1cf5-4ad4-8575-68a3fb27d85a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ff774a18-1cf5-4ad4-8575-68a3fb27d85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_InducementGrantRelatedRSUsMember_240ea1ff-4431-4bab-9678-ed1cf57a3bd2" xlink:href="izea-20250331.xsd#izea_InducementGrantRelatedRSUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_359c9684-4ed6-4bd3-a522-dd3b6fa5e212" xlink:to="loc_izea_InducementGrantRelatedRSUsMember_240ea1ff-4431-4bab-9678-ed1cf57a3bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fd746215-fe3a-40a9-b3e1-740ebf73596d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:to="loc_us-gaap_PlanNameAxis_fd746215-fe3a-40a9-b3e1-740ebf73596d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_fd746215-fe3a-40a9-b3e1-740ebf73596d" xlink:to="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_TimeBasedRSUsMember_d71188f1-d089-4759-8d25-0d278959e1c9" xlink:href="izea-20250331.xsd#izea_TimeBasedRSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:to="loc_izea_TimeBasedRSUsMember_d71188f1-d089-4759-8d25-0d278959e1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceBasedRSUsMember_613f53fe-c0f5-4d8c-ad01-29aea0b23188" xlink:href="izea-20250331.xsd#izea_PerformanceBasedRSUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:to="loc_izea_PerformanceBasedRSUsMember_613f53fe-c0f5-4d8c-ad01-29aea0b23188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceBasedAndTimeBasedRSUAwardsMember_c0ce9b92-92b6-4fff-b483-f9458ed32aa7" xlink:href="izea-20250331.xsd#izea_PerformanceBasedAndTimeBasedRSUAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_aeca8774-ed61-4e5a-a1c6-27cf7c046a1d" xlink:to="loc_izea_PerformanceBasedAndTimeBasedRSUAwardsMember_c0ce9b92-92b6-4fff-b483-f9458ed32aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_7d353292-6119-4bc8-91b1-75e87b3c25fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_7d353292-6119-4bc8-91b1-75e87b3c25fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9756e303-3f5c-4869-a9ec-7f8956cdcd91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_7d353292-6119-4bc8-91b1-75e87b3c25fa" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9756e303-3f5c-4869-a9ec-7f8956cdcd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HoozuHoldingsInc.Member_016960cb-afb3-43db-948a-62532169f506" xlink:href="izea-20250331.xsd#izea_HoozuHoldingsInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9756e303-3f5c-4869-a9ec-7f8956cdcd91" xlink:to="loc_izea_HoozuHoldingsInc.Member_016960cb-afb3-43db-948a-62532169f506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9a2e6ea2-eca6-46c3-a7e5-dab77a7525f5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b75c42e9-4893-4d3b-9874-56671489ebe5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b75c42e9-4893-4d3b-9874-56671489ebe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1717271d-d655-4e62-a32a-e77c9107088a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1717271d-d655-4e62-a32a-e77c9107088a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c4fb2b48-3a85-4837-b1c7-e9bbfe7af6da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c4fb2b48-3a85-4837-b1c7-e9bbfe7af6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_03d5d481-1931-48e4-9776-8267734c0f19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bef84571-c478-44bf-93c2-e735cb909332" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_03d5d481-1931-48e4-9776-8267734c0f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4aedd02-f0c1-48a7-979b-f78d9bfe8b6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b4aedd02-f0c1-48a7-979b-f78d9bfe8b6c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_42953d91-7214-40ad-9b00-fead841ffbff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:to="loc_us-gaap_PlanNameAxis_42953d91-7214-40ad-9b00-fead841ffbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_aedd0bb8-94de-4e85-977f-f5090167189e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_42953d91-7214-40ad-9b00-fead841ffbff" xlink:to="loc_us-gaap_PlanNameDomain_aedd0bb8-94de-4e85-977f-f5090167189e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_A2014EmployeeStockPurchasePlanMember_7d5a8600-fdde-4266-8a58-b0baaa2afef8" xlink:href="izea-20250331.xsd#izea_A2014EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_aedd0bb8-94de-4e85-977f-f5090167189e" xlink:to="loc_izea_A2014EmployeeStockPurchasePlanMember_7d5a8600-fdde-4266-8a58-b0baaa2afef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_65cf8573-ee4e-402a-8303-309dca71035a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:to="loc_us-gaap_AwardTypeAxis_65cf8573-ee4e-402a-8303-309dca71035a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34a0158b-94e6-4369-b368-4b5ef26c912e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_65cf8573-ee4e-402a-8303-309dca71035a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34a0158b-94e6-4369-b368-4b5ef26c912e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_40ec639b-b80a-4e13-9021-bd1155e8b19a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_34a0158b-94e6-4369-b368-4b5ef26c912e" xlink:to="loc_us-gaap_EmployeeStockMember_40ec639b-b80a-4e13-9021-bd1155e8b19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_09920de4-8469-47b8-9823-e9a48c9a9665" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c954e6f9-a8f1-48c0-baa9-5062f4602b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c954e6f9-a8f1-48c0-baa9-5062f4602b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4e6dd6d-240d-46a6-ad63-522d0520e86f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c4e6dd6d-240d-46a6-ad63-522d0520e86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MinimumhourrequirementforemployeesparticipationintheESSP_e6826eef-ebf6-4d7a-8898-92b06aba92d9" xlink:href="izea-20250331.xsd#izea_MinimumhourrequirementforemployeesparticipationintheESSP"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_MinimumhourrequirementforemployeesparticipationintheESSP_e6826eef-ebf6-4d7a-8898-92b06aba92d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan_837de824-1957-4cd9-9c93-940cdb4ed663" xlink:href="izea-20250331.xsd#izea_Annualcompensationlimitpercentageemployeestockpurchaseplan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan_837de824-1957-4cd9-9c93-940cdb4ed663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Annualcompensationlimitemployeestockpurchaseplan_47279c9a-af28-4b4d-92ce-31d617b24482" xlink:href="izea-20250331.xsd#izea_Annualcompensationlimitemployeestockpurchaseplan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Annualcompensationlimitemployeestockpurchaseplan_47279c9a-af28-4b4d-92ce-31d617b24482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan_7308f1cf-6490-4561-8603-a414ecd9fd97" xlink:href="izea-20250331.xsd#izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan_7308f1cf-6490-4561-8603-a414ecd9fd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_Fairmarketvalueofsharesavailableforissuance_7141c998-f20d-4a95-8424-cd2ee4550886" xlink:href="izea-20250331.xsd#izea_Fairmarketvalueofsharesavailableforissuance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_izea_Fairmarketvalueofsharesavailableforissuance_7141c998-f20d-4a95-8424-cd2ee4550886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_05e272af-dfaf-4e48-b3c6-be4452646377" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_05e272af-dfaf-4e48-b3c6-be4452646377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_22f95e05-e210-48a0-a679-a32011579006" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c31aa8ea-fe62-41f2-a610-a69435d91a9d" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP_22f95e05-e210-48a0-a679-a32011579006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityShareholderRightsPlanDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityShareholderRightsPlanDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityShareholderRightsPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2852bc08-5788-4715-9efe-ddbeb1f2fc85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePerDollarAmount_6d416185-9245-4948-82de-128e4a726f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockDividendRatePerDollarAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2852bc08-5788-4715-9efe-ddbeb1f2fc85" xlink:to="loc_us-gaap_PreferredStockDividendRatePerDollarAmount_6d416185-9245-4948-82de-128e4a726f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ExercisableShareholderRightsPercentageHeld._3c6c40e6-b5b8-4492-aa73-66b6e9aa9a40" xlink:href="izea-20250331.xsd#izea_ExercisableShareholderRightsPercentageHeld."/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2852bc08-5788-4715-9efe-ddbeb1f2fc85" xlink:to="loc_izea_ExercisableShareholderRightsPercentageHeld._3c6c40e6-b5b8-4492-aa73-66b6e9aa9a40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquitySummaryofStockBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0077ddb-6ef2-43f3-a2d5-64e808b8a604" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8873ad7a-cef3-4ddb-b72e-f56de5cbeec3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c0077ddb-6ef2-43f3-a2d5-64e808b8a604" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8873ad7a-cef3-4ddb-b72e-f56de5cbeec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_56b70dbd-bacc-424c-99b5-d6c6f46fe88e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8873ad7a-cef3-4ddb-b72e-f56de5cbeec3" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_56b70dbd-bacc-424c-99b5-d6c6f46fe88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_56b70dbd-bacc-424c-99b5-d6c6f46fe88e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0066b1b5-1e2e-4bfc-a023-686ac6c6007d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:to="loc_us-gaap_CostOfSalesMember_0066b1b5-1e2e-4bfc-a023-686ac6c6007d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_cdae46b9-8c5a-4fdb-a1b4-b591c9457837" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_cdae46b9-8c5a-4fdb-a1b4-b591c9457837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f74fe206-8093-4f00-abdb-a7fb721f8f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c8ab5b35-b564-4193-9059-ef9d4385ad44" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_f74fe206-8093-4f00-abdb-a7fb721f8f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b98cb1e-b733-4286-b543-c70f86b52cee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8873ad7a-cef3-4ddb-b72e-f56de5cbeec3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b98cb1e-b733-4286-b543-c70f86b52cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6019236d-3d42-4ac2-a74f-88a52e509987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b98cb1e-b733-4286-b543-c70f86b52cee" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6019236d-3d42-4ac2-a74f-88a52e509987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb065873-f508-4946-b00b-99210f4be56e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67629d2a-9f7e-401e-b21f-59165c8ca2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fb065873-f508-4946-b00b-99210f4be56e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67629d2a-9f7e-401e-b21f-59165c8ca2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67629d2a-9f7e-401e-b21f-59165c8ca2c4" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_be1b56a6-7e2e-4f74-ae8d-02606c22a9a6" xlink:to="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e24311-b3e0-45f5-9ba5-a51147c8ad22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d3e24311-b3e0-45f5-9ba5-a51147c8ad22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_UnrealizedGainLossOnSecuritiesMember_9b68e645-b0b6-4611-b3fb-50af02a995fe" xlink:href="izea-20250331.xsd#izea_UnrealizedGainLossOnSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_izea_UnrealizedGainLossOnSecuritiesMember_9b68e645-b0b6-4611-b3fb-50af02a995fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13fe5341-6612-4622-b307-433f953b6c33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_13fe5341-6612-4622-b307-433f953b6c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CurrencyTranslationAdjustmentMember_15038214-ec2b-4051-8c0c-30934681359f" xlink:href="izea-20250331.xsd#izea_CurrencyTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0ec5b903-188a-48e7-9ace-4e3a71878c72" xlink:to="loc_izea_CurrencyTranslationAdjustmentMember_15038214-ec2b-4051-8c0c-30934681359f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_67629d2a-9f7e-401e-b21f-59165c8ca2c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_039a95f6-3f55-4ea2-87a4-f4f847aaaee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_StockholdersEquity_039a95f6-3f55-4ea2-87a4-f4f847aaaee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_ea3c306d-fd7a-4ec1-b4a0-c2f98f8478d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_ea3c306d-fd7a-4ec1-b4a0-c2f98f8478d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e7e9f8b0-bd46-4359-8bc3-6ae5c0b551dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e7e9f8b0-bd46-4359-8bc3-6ae5c0b551dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_UnrealizedGainOnSecuritiesHeld_07500d09-b284-4e25-95fe-ca75efc992aa" xlink:href="izea-20250331.xsd#izea_UnrealizedGainOnSecuritiesHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_izea_UnrealizedGainOnSecuritiesHeld_07500d09-b284-4e25-95fe-ca75efc992aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_5d353633-1ead-4dbf-a8a7-4fd13ffaee1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_448b4546-3d6b-4f76-972e-606f9942fc92" xlink:to="loc_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease_5d353633-1ead-4dbf-a8a7-4fd13ffaee1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#LossperCommonShareScheduleofDilutiveSharesDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5c9b3f26-a590-4f4a-86d7-0ce3299ad688" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d3c86d0a-4b2a-4304-bac1-008f8be0490c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5c9b3f26-a590-4f4a-86d7-0ce3299ad688" xlink:to="loc_us-gaap_NetIncomeLoss_d3c86d0a-4b2a-4304-bac1-008f8be0490c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_747856ec-ec6d-4e32-85b5-1337ff60a5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5c9b3f26-a590-4f4a-86d7-0ce3299ad688" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_747856ec-ec6d-4e32-85b5-1337ff60a5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b4b6fc66-b83e-4b02-a40b-bb5900ee4cee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5c9b3f26-a590-4f4a-86d7-0ce3299ad688" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b4b6fc66-b83e-4b02-a40b-bb5900ee4cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9a3459b6-2fdd-4940-8975-5c95a8c7f6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5c9b3f26-a590-4f4a-86d7-0ce3299ad688" xlink:to="loc_us-gaap_EarningsPerShareBasic_9a3459b6-2fdd-4940-8975-5c95a8c7f6ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9009496c-83d7-4c69-a736-41b401434011" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5c9b3f26-a590-4f4a-86d7-0ce3299ad688" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9009496c-83d7-4c69-a736-41b401434011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#LossperCommonShareScheduleofAntiDilutiveSharesDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_596570ba-4bea-4c03-a85d-9705637b05d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_72a1e09a-8c59-4dbd-afa7-bab8f4e08e79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_596570ba-4bea-4c03-a85d-9705637b05d7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_72a1e09a-8c59-4dbd-afa7-bab8f4e08e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_72a1e09a-8c59-4dbd-afa7-bab8f4e08e79" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac3fd0bc-92ff-4f3a-a39f-f583e99535ba" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0c1dbb18-9465-4372-a3b6-3e8baa003d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0c1dbb18-9465-4372-a3b6-3e8baa003d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_735f9e54-ff2f-4313-9121-b4a489ac1ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_87788ddc-0d5c-4977-8d3b-920b742092fd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_735f9e54-ff2f-4313-9121-b4a489ac1ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ea48ce39-44ab-4fe0-9d77-956dcaad7270" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_72a1e09a-8c59-4dbd-afa7-bab8f4e08e79" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ea48ce39-44ab-4fe0-9d77-956dcaad7270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ea16f42b-4706-4d2f-8913-1417d418a624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_ea48ce39-44ab-4fe0-9d77-956dcaad7270" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ea16f42b-4706-4d2f-8913-1417d418a624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#RevenueDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/RevenueDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_368ae4fb-09c8-457d-ba46-784d5c7577cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_368ae4fb-09c8-457d-ba46-784d5c7577cc" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c779b099-fb5d-4636-b5ee-6d9ee29a74d6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:to="loc_srt_ProductOrServiceAxis_c779b099-fb5d-4636-b5ee-6d9ee29a74d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c779b099-fb5d-4636-b5ee-6d9ee29a74d6" xlink:to="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SaaSServicesSegmentRevenueMember_65b029cf-3fed-44e6-aad1-1e8c28776c32" xlink:href="izea-20250331.xsd#izea_SaaSServicesSegmentRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:to="loc_izea_SaaSServicesSegmentRevenueMember_65b029cf-3fed-44e6-aad1-1e8c28776c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ManagedServicesRevenueMember_e1d886dc-1ca7-48a0-9484-8023d0d5ad34" xlink:href="izea-20250331.xsd#izea_ManagedServicesRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b356203a-f972-4c19-9073-68be54b42683" xlink:to="loc_izea_ManagedServicesRevenueMember_e1d886dc-1ca7-48a0-9484-8023d0d5ad34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_34f58d74-9ed9-4c69-9045-577cd71a0a44" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:to="loc_srt_StatementGeographicalAxis_34f58d74-9ed9-4c69-9045-577cd71a0a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_34f58d74-9ed9-4c69-9045-577cd71a0a44" xlink:to="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NorthAmericaMember_24fe4ddb-2dbf-4525-885a-a8847c475feb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NorthAmericaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:to="loc_srt_NorthAmericaMember_24fe4ddb-2dbf-4525-885a-a8847c475feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_762b645e-6387-45f3-bbf6-ddf6c117c3d8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:to="loc_srt_AsiaPacificMember_762b645e-6387-45f3-bbf6-ddf6c117c3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_OtherMember_74f677fd-6002-4971-a0da-a290d4050113" xlink:href="izea-20250331.xsd#izea_OtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_c4372f8a-ee6c-489c-94de-9af3b743dd66" xlink:to="loc_izea_OtherMember_74f677fd-6002-4971-a0da-a290d4050113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_a9a98ed4-dc20-4bdf-b4c2-767ad3bab430" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_752aa1a0-3d2a-4742-a24e-06cfef3d2fad" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_a9a98ed4-dc20-4bdf-b4c2-767ad3bab430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f9fedade-6fce-4ac9-84cc-37d58b97e290" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_a9a98ed4-dc20-4bdf-b4c2-767ad3bab430" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f9fedade-6fce-4ac9-84cc-37d58b97e290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/RevenueContractBalancesDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#RevenueContractBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/RevenueContractBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0908a750-19ea-4208-bea1-879b4c790b71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_8a930402-211c-475e-8928-0f624ceb0b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0908a750-19ea-4208-bea1-879b4c790b71" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_8a930402-211c-475e-8928-0f624ceb0b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_13c22ce7-f445-4c37-94fa-889e25fbfcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0908a750-19ea-4208-bea1-879b4c790b71" xlink:to="loc_us-gaap_UnbilledContractsReceivable_13c22ce7-f445-4c37-94fa-889e25fbfcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_c57412ef-717f-4395-a62a-eea8becb0569" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0908a750-19ea-4208-bea1-879b4c790b71" xlink:to="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_c57412ef-717f-4395-a62a-eea8becb0569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_8400ad8c-2c88-4f8b-8d2e-de813b3cd9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0908a750-19ea-4208-bea1-879b4c790b71" xlink:to="loc_us-gaap_ContractWithCustomerLiability_8400ad8c-2c88-4f8b-8d2e-de813b3cd9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_991cafff-b167-4509-8e17-348654be9060" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_103cb4a9-11fc-47d0-89d4-32ba4da6eecc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_991cafff-b167-4509-8e17-348654be9060" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_103cb4a9-11fc-47d0-89d4-32ba4da6eecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f959708b-13c2-48e9-aa1b-c50a065b4874" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_103cb4a9-11fc-47d0-89d4-32ba4da6eecc" xlink:to="loc_srt_ProductOrServiceAxis_f959708b-13c2-48e9-aa1b-c50a065b4874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f959708b-13c2-48e9-aa1b-c50a065b4874" xlink:to="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_SponsoredSocialRevenueMember_d23baf39-b36b-45f7-9fe5-2f90f2926512" xlink:href="izea-20250331.xsd#izea_SponsoredSocialRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_SponsoredSocialRevenueMember_d23baf39-b36b-45f7-9fe5-2f90f2926512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContentRevenueMember_aa330126-c048-49e1-b570-a76f66bb1f32" xlink:href="izea-20250331.xsd#izea_ContentRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_ContentRevenueMember_aa330126-c048-49e1-b570-a76f66bb1f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LicenseFeesMember_508d8639-61e1-4eff-8596-cb7acbbc19ad" xlink:href="izea-20250331.xsd#izea_LicenseFeesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_LicenseFeesMember_508d8639-61e1-4eff-8596-cb7acbbc19ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_MarketplaceSpendFeesnetMember_ce260c82-dfc8-41cc-950b-89712cde5d93" xlink:href="izea-20250331.xsd#izea_MarketplaceSpendFeesnetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_MarketplaceSpendFeesnetMember_ce260c82-dfc8-41cc-950b-89712cde5d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_OtherFeesMember_7220dafc-3785-48df-8e28-51cb258989e6" xlink:href="izea-20250331.xsd#izea_OtherFeesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_85779a0e-b50b-49c7-a3f4-41df4c87f25b" xlink:to="loc_izea_OtherFeesMember_7220dafc-3785-48df-8e28-51cb258989e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_103cb4a9-11fc-47d0-89d4-32ba4da6eecc" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ac21797-2708-49fb-b61a-bbc35b5bfd44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ac21797-2708-49fb-b61a-bbc35b5bfd44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_LengthOfContractWithCustomers_c8e6db70-ed1f-41a2-9516-9afe17831dd4" xlink:href="izea-20250331.xsd#izea_LengthOfContractWithCustomers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_izea_LengthOfContractWithCustomers_c8e6db70-ed1f-41a2-9516-9afe17831dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_64eb7015-768b-4a8c-8548-4c1b5848c6d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_us-gaap_ContractWithCustomerLiability_64eb7015-768b-4a8c-8548-4c1b5848c6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_10907691-0daf-4f15-8e37-25afb4160bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_10907691-0daf-4f15-8e37-25afb4160bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_ContractLengthForSalesCommissionsPayment_2249ac4b-9853-494d-a0ae-5fdf3937f66f" xlink:href="izea-20250331.xsd#izea_ContractLengthForSalesCommissionsPayment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_izea_ContractLengthForSalesCommissionsPayment_2249ac4b-9853-494d-a0ae-5fdf3937f66f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_PerformanceObligationContractTerm_b0b052c6-4a61-4fc0-a7a8-2edabad24fbe" xlink:href="izea-20250331.xsd#izea_PerformanceObligationContractTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_115378ff-7df1-432f-8739-3aa6fbaa5810" xlink:to="loc_izea_PerformanceObligationContractTerm_b0b052c6-4a61-4fc0-a7a8-2edabad24fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_942a2132-a4f8-439c-9577-aa7cddba8a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_282f1f7a-a4c6-4056-91f5-bf615ff1ea17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_942a2132-a4f8-439c-9577-aa7cddba8a3e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_282f1f7a-a4c6-4056-91f5-bf615ff1ea17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c2774c6e-9ba6-4c5e-9436-9306e3478ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_282f1f7a-a4c6-4056-91f5-bf615ff1ea17" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c2774c6e-9ba6-4c5e-9436-9306e3478ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0026425a-72b0-439b-86da-5814fd9be7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c2774c6e-9ba6-4c5e-9436-9306e3478ce1" xlink:to="loc_us-gaap_SegmentDomain_0026425a-72b0-439b-86da-5814fd9be7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember_b398eabd-328e-4b30-8ffc-9752da53e374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0026425a-72b0-439b-86da-5814fd9be7c8" xlink:to="loc_us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember_b398eabd-328e-4b30-8ffc-9752da53e374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_282f1f7a-a4c6-4056-91f5-bf615ff1ea17" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2ba2317-fffe-45be-ae1a-0b55627fbb76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2ba2317-fffe-45be-ae1a-0b55627fbb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CostOfRevenueDirect_4f827e8e-0a28-4956-bf64-ac2b0ad22695" xlink:href="izea-20250331.xsd#izea_CostOfRevenueDirect"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_izea_CostOfRevenueDirect_4f827e8e-0a28-4956-bf64-ac2b0ad22695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_HumanCapitalCosts_1507643b-ea1c-4c0b-b693-32c311f7e662" xlink:href="izea-20250331.xsd#izea_HumanCapitalCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_izea_HumanCapitalCosts_1507643b-ea1c-4c0b-b693-32c311f7e662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_izea_CashOperatingCosts_5145d2c7-75bc-4544-9cf5-d526ef6a7848" xlink:href="izea-20250331.xsd#izea_CashOperatingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_izea_CashOperatingCosts_5145d2c7-75bc-4544-9cf5-d526ef6a7848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3ab737d5-f6ee-4e35-92c9-69bb2fd4f4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3ab737d5-f6ee-4e35-92c9-69bb2fd4f4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_1e7d2d76-0578-4845-a57d-1cdd43887299" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeBenefitsAndShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_EmployeeBenefitsAndShareBasedCompensation_1e7d2d76-0578-4845-a57d-1cdd43887299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperatingAndNonoperating_49eb09bd-488f-42f2-acb7-e16823f524b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeOperatingAndNonoperating"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_InterestIncomeOperatingAndNonoperating_49eb09bd-488f-42f2-acb7-e16823f524b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d9cf59ba-7b00-4dce-b845-2b456f185d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d9cf59ba-7b00-4dce-b845-2b456f185d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_e3db6ded-11b6-4785-847c-88996b05b82f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_OtherIncome_e3db6ded-11b6-4785-847c-88996b05b82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_429bde16-d8ff-49a3-a44d-14328a9b722e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_429bde16-d8ff-49a3-a44d-14328a9b722e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_3b307f70-8748-469d-8021-842c3eb4f735" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_58473f3e-87f4-491f-b927-872ba878f72c" xlink:to="loc_us-gaap_NumberOfReportableSegments_3b307f70-8748-469d-8021-842c3eb4f735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.izea.com/role/IncomeTaxesEffectiveRateReconciliationDetails" xlink:type="simple" xlink:href="izea-20250331.xsd#IncomeTaxesEffectiveRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.izea.com/role/IncomeTaxesEffectiveRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fcd29eb2-0de1-4b09-a91a-6993769a830c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4b6500b9-5713-46b9-b26b-653c91b50a17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fcd29eb2-0de1-4b09-a91a-6993769a830c" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4b6500b9-5713-46b9-b26b-653c91b50a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_47826c6c-9354-417b-a0a6-bd6824c21487" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fcd29eb2-0de1-4b09-a91a-6993769a830c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_47826c6c-9354-417b-a0a6-bd6824c21487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>izea-20250331_g1.jpg
<TEXT>
begin 644 izea-20250331_g1.jpg
M_]C_X1<+17AI9@  34T *@    @ # $   ,    !!P@   $!  ,    !!AT
M  $"  ,    $    G@$&  ,    !  4   $2  ,    !  $   $5  ,    !
M  0   $:  4    !    I@$;  4    !    K@$H  ,    !  (   $Q  (
M   F    M@$R  (    4    W(=I  0    !    \    2@ "  (  @ "  M
MQL   "<0 "W&P   )Q!!9&]B92!0:&]T;W-H;W @0T,@,C Q-2XU("A-86-I
M;G1O<V@I #(P,3<Z,#(Z,34@,#@Z,S(Z,#@   20   '    !# R,C&@ 0 #
M     0 !  "@ @ $     0  !PB@ P $     0  !P@         !@$#  ,
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MRZ><4]Z9SRN8 'AORU>P265A_6GZNYL?9^H4%QT#'N%;_P#MJ_T[/^BM0$$
M@R#P0FD$;BF&491TD"/,4NDDD@A22222E))))*4DDDDI22222E))))*4DF)
M$DP!R2LS,^M'U>PI^T=0H#AH6,>+'_\ ;5/J6?\ 11 )V%IC&4M(@GR%NHDN
M/S?\9?2:I;A8]^6X<.(%-9_M6_IO_9=9N+_C'ZI;U*AEN+0W#MM96^MI>;0'
MN%>]MQ+:W.9NW;?0]Z<,4^S,.5S$$\->>C__T,;J'_*.9_X9O_\ /MB C]0_
MY1S/_#-__GVQ 5T;.['8>2Q <(<)'@=43'NOQ7;L6VS'=XTO=6?_  )S%!))
M3J8_UJ^LN-I5U*XCPMV6_P#MPRQROT?XP?K-5]-^/?\ \941_P">+*5SB2!A
M$] L.'&=X1^QZ^K_ !F=7;_/86/9_4<]G_5>LK+?\:%GY_2Q\6Y'_DL=JX=)
M#VH=EAY7 ?T!]LGO&_XT*?S^FVC^K:P_E#$0?XS\'OT_(_SJ_P#R:\_20]J'
M9'W/!^[^,GT _P",_![=/R/\ZO\ \FAN_P :%/YG3;3_ %K6#\@>N#22]J'9
M7W/!^[^,GN'?XT+/S.ECXNR/_(X[E6M_QF=7=_,X6/7_ %W/?_U/HKD$D?:A
MV2.5P#] ?;)Z2_\ Q@_6:T>Q^/1_Q=1)_P#!K+50R/K5]9<D1;U*X#PJV5?^
M>&5N64DB(1'0+QAQC:$?L9Y%U^4[=E769#O&Y[K/_/KG(8 :(: !X#1.DBO4
MC87].Q?_  Q3_P"?&(*-A?T[%_\ #%/_ )\8D=E'8O\ _]'&ZA_RCF?^&;__
M #[8@(_4/^4<S_PS?_Y]L0%=&SNQV'DI));'U4Z)C]<ZL["R;+*ZF4/N)J(#
MB6NJJ:W<]K_]-N^BD2 +/1$I",3([#5QTEO_ %M^K%/U?LQC1D/OJRMX#;0W
M<TLV'Z=88U^[?_HU3Z/]7.J]:9?9@-K+<<AK_4?LESANV,]K_P W]Y 2%<5Z
M+1E@8"=U$]3I_5<Q);5GU+^M-<D]/+P.[+:G?AZK7_\ 151_0.OUF'],RO[-
M3G_^>MZ7%'N/M2,F,[3B?\(-!)3OHR,>ST<FJS'MC=Z=K'5N@_G;+ UVU0 )
M<&M!<YVC6M!))_DM;[G(KE)(HQ,P\8UY^%5G_D$1G2^JO^A@93OA1:?_ $6E
M85Q#N&LDG>Q['NKL:6/82U[' M<UPT<U['>YKFJST[I74>J7.HZ=CNR'L -A
M$-:P'Z/JVO+:V;MOM_/>E:B0!9-#N6JDNHI_Q<_6*P V68M /(+WO</[+*MO
M_@B/E?XM.J54&S&S*<FT"32YCJIC\UEN^[W?UV,3?<AW#%]YPW7&'D$E*RNR
MJQ]5K#7;6XLLK<(<UPT<UP44YE4C87].Q?\ PQ3_ .?&(*-A?T[%_P##%/\
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M\S#R4C87].Q?_#%/_GQB"C87].Q?_#%/_GQB<=F4[%__UL;J'_*.9_X9O_\
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MXG1%Q\?)RS&)1;DGPIK?9_YZ:Y)7BC26MC_5/ZS9 FOIMK1XVEE7_1NL8_\
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M_P#V[5LL_P"FM-)$$C8TD2E'6)(\GD<W_%KT>W<["OOPW'Z+=PMK']FZ;O\
MP=9F+_BWZE3U.A]F72_#JM98Y[0]MI#'"S8VD[ZV[]NW?]H]B]!23AEGW9AS
M68"N*_/5_]G_[1ZV4&AO=&]S:&]P(#,N,  X0DE-! 0      !<< 5H  QLE
M1QP!6@ #&R5'' (   (    X0DE-!"4      !#'71?E=+5N]=N^.93 Z7E<
M.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
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M;       0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6)
M;^            !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M        0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M            4G-L=%5N=$8C4'AL0'+            *=F5C=&]R1&%T86)O
M;VP!     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2
M;'0               !4;W @56YT1B-2;'0               !38VP@56YT
M1B-0<F- 60           !!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O
M<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M  UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M   X0DE- ^T      ! !+     $  0$L     0 !.$))300F       .
M         #^    X0DE-! T       0   !:.$))3009       $    'CA"
M24T#\P      "0           0 X0DE-)Q        H  0         !.$))
M30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       !
M #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M  !P  #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@  #A"24T$"       $     $   )
M   "0      X0DE-!!X       0     .$))300:      -?    !@
M       '"   !P@    5 $P ;P!G &\ = !Y '  90!? %  =0!R '  ; !E
M "T 3 !! %( 1P!%     0                         !
M  <(   '"                      !                         !
M   !        ;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q
M    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL
M;VYG   '"     !29VAT;&]N9P  !P@    &<VQI8V5S5FQ,<P    %/8FIC
M     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O
M=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN
M#6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !)
M;6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !P@     4F=H
M=&QO;F<   <(     W5R;%1%6%0    !        ;G5L;%1%6%0    !
M    37-G951%6%0    !       &86QT5&%G5$585     $       YC96QL
M5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $       EH;W)Z
M06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E
M<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +
M8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4
M   )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F<
M#&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P
M.$))300H       ,     C_P        .$))3004       $     SA"24T$
M#      5F0    $   "@    H    >   2P    5?0 8  '_V/_M  Q!9&]B
M95]#30 !_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ H "@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
M         0 " P0%!@<("0H+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:  P# 0 "$0,1 #\ ]527GV9_C'ZI3U3(KJQ:'8E-KZFL<7BP
MBMQK+S<T^FW>YN[;]G]BT<+_ !E])MAN;C7XCCRYH%U8_M5Q=_[+IYQ3WIG/
M*Y@ >&_+5[!)96']:?J[FQ]GZA07'0,>X5O_ .VK_3L_Z*U 00"#(/!":01N
M*891E'20(\Q2Z222"%))))*4DDDDI22222E))))*4DDDDI228D 23 ')*S,S
MZT?5["G[1U"@.&A8QXL?_P!M4^I9_P!%$ G86F,92TB"?(6ZB2X_-_QE])JE
MN%CWY;APX@4UG^U;^F_]EUFXO^,?JEO4J&6XM#<.VUE;ZVEYM >X5[VW$MK<
MYF[=M]#WIPQ3[,PY7,03PUYZ/__0QNH?\HYG_AF__P ^V("/U#_E',_\,W_^
M?;$!71L[L=AY+$!PAPD>!U1,>Z_%=NQ;;,=WC2]U9_\  G,4$DE.IC_6KZRX
MVE74KB/"W9;_ .W#+'*_1_C!^LU7TWX]_P#QE1'_ )XLI7.)(&$3T"PX<9WA
M'['KZO\ &9U=O\]A8]G]1SV?]5ZRLM_QH6?G]+'Q;D?^2QVKATD/:AV6'E<!
M_0'VR>\;_C0I_/Z;:/ZMK#^4,1!_C/P>_3\C_.K_ /)KS])#VH=D?<\'[OXR
M?0#_ (S\'MT_(_SJ_P#R:&[_ !H4_F=-M/\ 6M8/R!ZX-)+VH=E?<\'[OXR>
MX=_C0L_,Z6/B[(_\CCN5:W_&9U=W\SA8]?\ 7<]__4^BN021]J'9(Y7 /T!]
MLGI+_P#&#]9K1['X]'_%U$G_ ,&LM5#(^M7UER1%O4K@/"K95_YX96Y922(A
M$= O&'&-H1^QGD77Y3MV5=9D.\;GNL_\^N<A@!HAH '@-$Z2*]2-A?T[%_\
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MTL;J'_*.9_X9O_\ /MB C]0_Y1S/_#-__GVQ 5T;.['8>2EU/^+?_P 45O\
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MV("/U#_E',_\,W_^?;$!71L[L=AY*74_XM__ !16_P#A.S_S[C+EEU/^+?\
M\45O_A.S_P ^XR;D^0^3%S'\S/R='_&C_P!Y?]:_\E2XS P;>HYV/T^F19E6
M"O<-=K3[K;?^M4MLL79_XT?^\O\ K7_DJ5?_ !:=.KMSLOJ3X+L9HIJ;I(=9
M[[;/Y/L:RMG_ %Y-C+AQ7Y_FQ8LGM\H)=A*O/BT>QZIF8_0>AVY%; VO"I#*
M*M8D 4XU/]5UGIUKQPE[B7V.+['$N>\\N<X[GO/]9R]IZITG ZMC#%ZA5ZU(
M>+ T.<SW-^B=U3F._.6<SZC_ %59QT]COZ[GO_\ /CW*/'DC$&[LM?EN8QXH
MRXA(RD>CY.NX_P 5W\[U7X8W_NRH?7_HG2.FX&';@8M6-:^\UN-8VES#78\A
MP'T_>QG]11_Q99-%>9U#'>\-NO92ZIAY<*S?ZNS^IZM:DG+BQDC^6K8S9!EY
M:<H@ZU_S9M;_ !E$?M_'_P#"C?\ SY:N57M>7TKI><\69N'1DO:-K775LL('
M.UKK&N51_P!5OJV_GI>*/A4QO_4M"9',  *.C%BYR,(1B8GTBGQYWT3\"O9O
MJ_\ \@]-_P#"E'_GMB\H^L6+CX?6NH8N,WTZ*;2VM@,AH+6/VC^TY>K_ %?_
M .0>F_\ A2C_ ,]L1S&XQ/==SQO'C(ZF_M#3_P">WU5F/VC7IIH''_OBO=,Z
MWTKJPL/3LEN1Z) MVR"W=.R=P;]+:O%JOYMOP7=_XK_I=4_]!_R7H3Q1C$D$
MZ+<_*0QXY3!D3&M_.FA_C)_\4-/_ (39_P"?<A<JNI_QD_\ BAI_\)L_\^Y"
MY92X_D'DVN7_ )F'DI&POZ=B_P#ABG_SXQ!1L+^G8O\ X8I_\^,3CLRG8O\
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M ', : !O '     9 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P "
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M4D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M86-S<$U31E0     245#('-21T(               $  /;6  $     TRU(
M4" @
M       18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP
M=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D     4
M9&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0
M   D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M!#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG
M:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M    $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV
M-BTR+C$
M             %A96B        #S40 !     1;,6%E:(
M      !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:
M6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W
M=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                        9&5S
M8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A
M8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'
M0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &1E
M<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V
M,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ                                  !V
M:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,
M"58 4    %<?YVUE87,          0                        */
M G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *  M
M #( -P [ $  10!* $\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H
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M :(    & @,!              <(!@4$"0,* @$ "P$   8# 0$!
M    !@4$ P<"" $)  H+$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R(
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MQ0H/J&DE8?,*OY*!4?[T>I[VG[M'(%D@.Y27-Z_XM4@C0_Z58U5U^PR,?GT
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M%Z?^3?Q[^0%"F0Z4[FZX[-C: U$M)M+=N&RF9H8@;,<K@(Y174;#@LE53QL
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MW7O?NO=>]^Z]U[W[KW7'6+7_ -?Z<_3ZCCWX9X?ZO]7SZ]]N.N)D4?4'ZV_
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M#R92I_F!U%NY;+O.SR>#NUI-:MZ2Q/&?RUJ.A,#@@G^G^M<_[#_>.?:?4/\
M5_J_P\//HL.,'KK6O^//T%N3Q?Z#GW:N*GK=">N]8(N.1_46^G]?>M0/6N'7
M+WOKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N
MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[
MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K
MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z
M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7$L
M!^?Q?@$\#_6]ZJ.O==:Q^000+D<$V_UA?\\>_5%:=>.!4]>\BVOS;CZ F]_H
M1;Z_[#W[4.'^K_B^O=(W>G9/7?6V,_C?8N_-F[ PUW7^+[VW/A-J8S5& TB_
M?YZ>GBNH()]? ()^H]NQ12SMI@5G/HH)/RP!Y^7KY=+;+;=QW*7P-NMY+A_X
M8T:1OV(">JX.VOYT_P#+GZE6IAE[YI>QLM3R-&N'ZEV_G-]&J9#8FEW'1PQX
M-A>P!.5%[W%P"0)+3DWF.[[A;&,>LA"4_(G5_+J3=F]CO<S>J&/;6ME];AEA
M(^U&/B_]4^JO.W/^%+^RJ,5E'T5\9]SY]F9EHMP=K;OQ6UHX]*^FHGVIM&++
MM+<_2,9B.P^K7X]B>R]LKI\W]RJ "E$4L3\JMH _8?LZEC9?NK[G,!+S!NL<
M*CBMO$TI/V/(8J'YF,_9U6#V[_/Q_F$=EBMI=L[KV%TMBJM6A%)UGL;'RUZ4
MW"JHSV_7S=7'*1^N:EDA-_T!/8IL_;WEZV ,RO.:9UL0*^NE-./D21Y=2QLO
MW=?;?:BKWD<U^P\YY2!7Y+#X51\F+?.O57W:GR*[[[QJWK>X>Y>S>S)7=76+
M>V]]Q;BH*?QMJC2BQN2J)*>G13^B.")54W(4>Q59[5MFWJ%L;>.*G#2B@_[U
M0DU^?\^I9V?E?EKE] FR6$%K0<8XT5C]K !F^UB3ZUZ!KZ\GFUKV^I %^";_
M ))_'M?0'B/]7\AT?DC_ %#'Y4_P5ZZ_-[V )O;\"W( 'O=>/G7_ %?ZL=>+
M5&?]7YUK^SKHV-U^GTMS?_6L/>NJ==VU#FQY_!]^Z]UZX!/^PY (!L?K[]U[
MKO\  YL3_A_Q'OW7NN%A?Z&PO?Z_U]^Z]UV"#^./]8VX_)'T_P!Y]^Z]U[ZF
MY4_['_;?I]^Z]UXFQM_K#Z7_ ,1S?W[KW7=B/I?ZVY^G X_V'OW7NO?ZW%R.
M1QQ]??NO==\_T_I_3\GGW[KW7B;#_#^OYO[]U[KH7('%BOTN/]IM[]U[KPX!
M_%K_ .]?[S[]U[KU^0!^!R/]?\7'OW7NO7)_KQ]2./Q^/S[]U[KW!-P+FP/U
M_J/IS[]U[K>+_P"$Y^?J\U\"=S8^5G:':?R.["P%%K-U2FJ-E;9W2ZH+G@S9
M.4D<<W/N"?<:'P^81(N/$B1C^3,O^!1^76 WWF;1+?W&28<9[.%S]HDFB_P1
MC^77_]/:9_GA?]NN_D]_K]*_[S\A]I>Q;R-_RM-K_P W?^K,G4P^P7_3VMJ_
MZBO^T*XZ^?$.?Q;F]QQ?_7'O(3KH]UX_7^G!%Q^+?6_^M[]U[KL<_P"'U^GY
MYN#[]U[KKDWM<?XV-S^/K[]U[KUS_2YM<6'T!X'OW7NN@U_J+_[#\G_7/OW7
MNN^/R#];\_[R?QQ[]U[KQ%S8_P!#]/\ @W'OW7NNBH'X/'^Q^O''^]^_=>ZY
M$?Z_'X^H/^P]^Z]UU>QN;@'@7OQ_KCW[KW75P>!S]>+BQYO_ ,B]^Z]UXFYM
M>W^M?ZW_ .*>_=>Z[^GJ/]?\>![]U[KW!^HN>2+?T!M:_OW7NO"WX^MN+"UA
M_L??NO=>)^O/'T/T_P!<V]^Z]UX6/];<B_XYY]^Z]UX\_P!1^.+_ -/R![]U
M[KWU!O\ EK?[X^_=>Z[L1<CZ_P!/Q];_ %]^Z]UU?ZVM]?P;\'_C?U]^Z]UT
M;B_T!/\ L#]+?U^GX^G^V]VJ,8X?ZATX'X<<?/\ V!7\^G'&Y;*8:MI\IB,E
M78G)4C^6ER.,K*B@K:>2_$E/64KK(C?C4K#Z^VI(XI5*2J'7T(!'YU!_G7[.
MF)X;>YB,-Q&KHV&5@&!'H0P-?SQT>3J?^:!\^^EOLH]E_*3M"HQV/T1TV&WO
MEH.S<+%3J?\ @'%B^Q(<I%%':X40A"O]DJ>?9#=\J<NWM3-:H"1Q2L9K_M*
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M=5I-)$?1M+C_  *?MSGY=1ONOW7^3;NK[5>7-JQX!C',@_(JC?M<]6!=<?\
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M\@G\$VO8?7Z?3W[KW7N3P/Q]?R?]YM[]U[KH@7!/^%A<?[S_ (>_=>Z[^O\
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M^G-O]?\ Q]^Z]UX?4_7_ !6XX_UO?NO=>M]2?S^+\?6][^_=>Z[YO;D_GZ6
M_I;_ )'[]U[KB#R+_6UKW' _K?\ K[]U[KES:WXM8\'^G^!]^Z]U[5?^E_\
MDKZ?ZWOW7NO#U?4<7/\ KV(_K?W[KW7N?K8"_P#2Y/UO^/?NO=>/]>#P?]>W
MT-O?NO=>N;@'@_6X^EK?F_OW7NO?G_7)X_-]/OW7NO7X'(N#]>;?T^OO>*_+
MKW7AR+#Z6_/UY//O77NO6MS^/Q]+"_U-_?NO==\_X&YN+CZ?X\>_=>ZW;?\
MA-G_ -D,]J_^+7[Y_P#?0;%]PC[EYWZ(_P#"%_ZN2]8(_>B_Z>!:?]*^+_M)
MN^O_T=IC^>%_VZ[^3W^OTI_\$/M+V+>1O^5IM?\ F[_U9DZF'V"_Z>UM7_45
M_P!H5QU\^,D\#\_T!^O]?J/>0G71[KKG\?C\#Z?7F]_?NO=>O_7CF_-KV/!
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MZY X_K[]U[KI>;?7@"P_UQ;W[KW79%[7YL;V_P!Z]^Z]UUZ;VO\ G5>XM?\
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M>!]?]?Z_X?CW[KW75QQ?\\'\?CD\^_=>Z]_O?]++?3_J??NO=>Y!MSR/R?\
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M^FEM[9/,7/YNPM_A[,X_;GE] -;3/3U<9_WE1T*K3[M7MQ;T\<W<_KKF4?\
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M_OO]?WO'^KRZJ#04'I_J].O?2_U-OR+@\BW.GZ_U]^KC(ZN'IP)_PU_S=*?
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M=:EL2"#8VXYY_IQ[WU[KK6O'UY_(!M_L3]/?O.G7NDUG-[[,VP"VY=V[9V\
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MOW7NNC<C_#FX_)L>??NO=>_P''ZK?GZ'\W]^Z]UX$$<?BPM:]K\'W[KW7O\
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M_BGOW7NN/T/U( )*@_FWU]^Z]UR_(%B/J1S_ +'FWOW7NN@+_A;?Z_\ A?\
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MB0;?3GZ>_=>Z[MP3^+7X)Y/U'U]^Z]USN/\ 8_TN+^_=>ZX'@WL2;'D VO\
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MC[]6GS_(=;\3A7_-_EZY#^M^/Z_GCZV/U'^P/OU>/S^W_.>M!N'']M!^S/\
MAZZ_-_Z6/Y)-_P#%??B<4'6PRCA4?8 /\_78#7Y/'%C^>/\  _7_ &/O>KC_
M ,5UK4M.'^7KK@\$V M8W)(7Z@C5^?=?(_ZO]7\^O>(WD:?L/^;I7XCL#?F
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M@?V1592LM[2'VQL*56ZD'VJI_P &GHIE^ZURPW]AN=TG^F6)_P# J=+G'_\
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M (*]/5/_ #-/Y?E45$7R^Z'75J'^4;]Q%);0+G5]VZ6_PO\ 7\>ZGEKF ?\
M$.;\HV/^ =)V]KO<5..RWGY0.?\  #T^P?S$_@94@&/YC?&I;JK 5'<VP:0V
M;Z _=UR6/]0>1^?=#R[O_P#RA3_\XW_S=,'VV]PE_P"6'?G[+2<_X$/2@B^=
MGPBG4O#\Q_BM*HX)C^0G4C@'^A*Y<^Z'8M[7XK.<?\VI/^@>F#R!SX/BV2_'
MVV=P/^L?4^/YK_#:;3X?EG\:)2P!01=[=7.7O]-&G*\W_P /;1VG=1QM9?\
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M/^<$O_0/7O\ 9EOCE_S_ /Z3_P#1J[%_^K_>_H;W_?+_ .\-_FZ]_5WF#_E
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MPZ3]3_.4_EHTG^=^4^V6L;'[;9G:5;;@G_E"P4G]#]/\/ZB[J\H<RM\-F_\
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M?]7Y]=6"\\_U^I/T^EK?T]^U']O'JQDXT_+KLV)O8ZKDWYYOQ]??JYU?ZO\
M#_DZH".&:?ZOLZZYY^GT(Y_(']H_U]ZZKUV.0;_DF_\ 3^G'OW7NNCQP.+?T
ML3_7Z'W[KW7OU?[ VY_P^MK?U]^Z]U[5]!<?4<W'(_WWX]VT_,=>Z[!/T_VQ
MXOR+_3W7KW77)O\ UOQ?Z@WOS;_;>_=>ZZN!_CS];$7//'T_Q]^Z]UW<?X\\
M_P!;CZ<^_=>Z]^;\'\?7Z?U ]^Z]U[CZ$CC^I'_$W]^Z]U[_ %^+VO?C]/\
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M?C@V_P![]^Z]UQ!N;_BQOR.+&X)]^Z]UV ?K^#]1:WU'OW7NO6/!^OT_V/\
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M2?P/ZF]R03]#<CZ^]U],?ZORZM4'B3UXWYM].>3];7N+_6X_I[\#UX28H?\
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M['WZOICK54TTI_('KUVL1];6!MQQ_3WH];#"N!I'RZ['X)%OI^6!%CQQ]/\
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M>YX^O'^\\?[Q[]U[KD+VY_I_O/Y]^Z]UP'U'UX^HXO\ 7_'_ 'OW[KW7=O\
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M?NO==\&UN;?3^E_?NO==?3Z _7G@G_;$^_=>Z['/U_V%C?BUKW]^Z]UUS?\
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M>=7^O>WYM^??NO=>^AY!(-B+VX/].??NO==?2PXN?Z 'Z>_=>Z\;#\&PL/\
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M.18#Z6/OW7NO#\FW^V//^P"^_=>ZYC@?U_/ M_K<>_=>ZXBP%Q_M[<VM]?\
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MR+#ZCBWU_//OW7NO BYY_I:]Q8#_ %_?NO==7X_/TU?4W_V_OW7NN[BWX/\
MP8CW[KW77XN?ZG_7N. ;>_=>Z['^MP2"/P 1_7W[KW7OK]!;_7#"W-_?NO=<
MK_X'_>/?NO=;M?\ PFS_ .R&>U/_ !:_?/\ [Z#8O]/<(>Y7_)=B_P":"_\
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M%R!]3SS_ (VY]^Z]U[@$?TYL""/]<^_=>Z]?_#\ _FW N+>_=>Z]<VO^+_\
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MW<_[W8_U(XY]^Z]UU_9 ^G-O\1S:U_\ >/?NO=>_UEYY'U'U_P!?W[KW7?\
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MU)%S[]U[KJP^@'UN.?ZZ;BWOW7NNQ]2>>3S>W  _/O;&IKU[KWUL#];W%O\
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M_0_4C\_D\\^_=>ZZ'T_V/XN#R;7N??NO=<B;#\#\#D_[SQ[]U[KH6XL;7!
MY%_Z^_=>Z]S;_57X_I_KFP'OW7NNM0_!MSS86O[]U[KE8V/TY_P//%O?NO==
M?UL!?Z_7\GZ^_=>ZZ (!-[G\$<_[Q[]U[KNX)_'YMP+FS7X]^Z]UZXMS>Q(!
M/T_V _P]^Z]UU87L.".>#>_/T-_?NO==_3_#FPY_586_'OW7NN[_ (YO>_\
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M<?CZ "UO?NO=<K_3Z&_Z?Z_3ZGW[KW75OR+\Z>?ZW//^/OW7NN5_^*?7F_\
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MUUR#]3_K6^OXO?W[KW7?X_/]>?\  W%_I[]U[KB"/Z?07/-[ ?2WOW7NN_\
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M +5:_P#7CW[KW77]+'C_ &_U^AY]^Z]UZ_-OH0>+_GBWU]^Z]UT;CGZV%O\
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M]."?K[]U[KR@?T_XH;<:O?NO==D'\_3F_P"+<W!]^Z]UQY-C<W! ' M_B?\
M6]^Z]UV3]1;^R?\ &X_'/OW7NNK<GZ@<-];&YXM[]U[KU[?[W_AS]1I-O?NO
M==CD#^G^V/'Y%O\ 'W[KW7=_I];_ %'!-C;Z<>_=>ZZL?KP;BU_\/];W[KW7
MB; '_;?U/']?Q[]U[KL\$'_8?XF_]#[]U[KJ]_H1]#< 7_P]^Z]UX?FUKW!/
MU/ZOQ^/?NO=>_ -K ?CGCD'GW[KW71O^H _X@'DV^G/OW7NN0_/Y_']+_P"%
MC[]U[KCR?J%_&G_'F_!]^Z]U[_8K?G]-@3_3D^_=>ZZYL /\?IP3I%N??NO=
M=_7FPY%OQQS]0?>ZTX=>Z[N+?D_Z_'XOR3[UU[KN_P!.!;\M<6O:WOW7NN+&
MP^G] /Z<&XY]^Z]UV=(YM8_@_3\?6Q]^Z]U[^GY^G-C<V-_Z>_=>Z]<?2_IM
M8V(X!-@??NO=>'!M_C^!_P 5_P!?W[KW7OK_ $;\'Z?[V/?NO=>OP?\ >#<>
MFXL/?NO==6/U-KV_3^/^1?X>_=>Z['_$$_\ )1N/?NO=>L+_ .Q-_KP2/?NO
M==$V_/T^H'U)M;W[KW7OH+6X_P!8_P!;W^O_ !/OW7NNN#]1>U_H&%K?0>_=
M>ZYK]/I^?ZWX_KS[]U[KC87(/UL#_06 MS;W[KW7?Z=5K?[3?_'Z@?\ %/?N
MO=>_WN]_\0-7X'U]^Z]UU8_TM]!Q]+:OK[]U[KE?\\V_WJW' ]^Z]UQ_Q)Y^
MH^I%C^0/?NO=<O\ 8'_7XN+_ ('OW7NNN#_MB;?4?7Z^_=>ZZN/SR?\ 5?3B
M]OJ/?NO=>L.>#P;_ -+ &_I]^Z]UW^?]C8&_T-K<#W[KW76GZDWMS^?\;WX]
M^Z]UV/\ 8?6][$<'ZVO^??NO==G_ & '-_\ 8_GW[KW71)'//^M^/Z?6WOW7
MNO7//'X!'X_V]_?NO==?BUP1SQ8 _3^A]^Z]UV ;\G_6M;B_Y'_&_?NO=>/T
M_P!8?FQM;Z_['W[KW7KD?XF]K7_K_K^_=>ZXV!XO;\WO_C;\?G_'W[KW78-O
MZ\ GBP!']2/?NO==CC^I_P  .!_A_P C]^Z]UZU["Q'];6L??NO=>%QQS]23
MR+\_2_OW7NO'_'@6^AL?H>/?NO==B_Y _%^?\.2??NO=>L!] /\ >O\ >??N
MO=>!/^O8@'_B3[]U[KK_   -OP1S8V_']??NO==$7(_V ^HM8?4>_=>Z]8"U
MB!^#>W-C8^_=>Z[N+6O]0?K_ (\?7W[KW7OK]686_/"CW;3\QU[KQ^MB3^?P
M>?\ 6TV]UZ]UWQ]?\#<C_#_'W[KW7'4;&X'U(_VW^'OW7NNQP?Z?3Z$'@?0\
M_CW[KW7K#3^2">/ZC_6]^Z]UW_M^/];G_8>_=>ZXW^IY'^Q_UA?_ 'G\>_=>
MZ[YL +C_ !L/Z7^GOW7NNQ;Z@#\\\#Z?U]^Z]UU;Z\_6_P"1S?\ V'OW7NN[
M_P"/U-O]8_X<?[W[]U[KJY')/'^\_2W^]^_=>Z]^+<$_T!M]/\ ??NO=>L?J
M?\>.2.18>_=>Z]_L/I]/I_2UN/?NO=>'UXX^H/\ 2_X-A;W[KW7KCGFQ_)_K
M8?T/_$>_=>Z[)-P!;_8_[[_B/?NO==$WX^A^MO\ 6/'OW7NO6'!M].!:YX_V
M'OW7NN[_ /%?]?\ ''OW7NO#@?2P_'Y'/^/OW7NN/X_J0#Q9;#^MK#W[KW7?
MX/!//IOS_@+7]^Z]UV>/]L>?R/P/?NO==&QY%[CC\?DV]^Z]UX_BXY'/'T^O
M^/OW7NN_]N3S_K_7^GOW7NNOK_A^+?CGZ&QM^??NO=>'^V%@/\1>WT/OW7NN
MA_K7X)XO^3^!^/?NO==\'Z6MQ?BWT-^??NO==?U_Q-B?J?K:W%O>Z]U>O==W
M^A^GXL;@6'TY]ZZ]UW;Z_7GZ@?3_ %[V]^Z]UQYL0?Z7!('%_J/?NO=<C^3^
M/3_O!O[]U[KKZ?7Z:1S]1_C[]U[KW!!^IM?Z_4>_=>Z]];GZW%B+_3^OOW7N
MN^;?07X_UN?\/?NO==6)O^ ?\.3_ (GZ>_=>ZZM;_;@6^HL!?Z<^_=>Z[L/J
M.;_0'D:OK^??NO=>O>_ Y-N/R+?FWOW7NO6^GI']. /K_7_6]^Z]U[_8?6XO
M^ H_K[]U[KNUOR?J#]2>+>_=>ZZ _P!C>W^%K"XL#[]U[KB6_H?S_C]/Q^/?
MNO=<B38_GZ7 )%O]<7]^Z]UX_P!.+?T-B#_0?Z_OPI7/7NNS].0/J/K]/]?G
MW[KW71X)-B;_ -#_ ,1[]U[KJ]N /\1<?T%R3[]U[KO\_P"-@3_3@_B_OW7N
MNP/U<?7_ !/OW7NN//T/-[CD6X'OW7NN[F_U+&P%B;?X_3W[KW7N P)'U_/^
M/TM[]U[KP_(_/%S_ +#@B_OW7NN^?K<6_ MQ_AS[]U[KW/\ 0?[<_P#%/?NO
M=="UP?\ $_X?7^@]^Z]UX\"W];@?\1[]U[KPN/\ $?[!;?ZUOZ^_=>Z[)  X
MX_I]3Q]/?NO=<0./I<D\WO\ 2_X]^Z]UV#P#_A:WYO>WOW7NO?2_^PNQX!M]
M?K_Q'OW7NO6'X_(X_P"CO]?W[KW794'_ (J;D?[:_OW7NN/Y'^#-?^G)_-_?
MNO==_D'GD\GCCFUOI[]U[KH@W/Y_UO\ 8W'Y_K[]U[KL"Q-AQ_M^0?\ "_OW
M7NN[<:;_ ('^''T_Q]^Z]UX \WOS?\W_ -MQ[]U[KC_K?T%OZ<_U'OW7NN[V
M%Q^+G^I/^/\ M_?NO=>(^GTX)X ^H_(M[]U[KW_$\6_'^%K^_=>Z]^/R1QQQ
M_K#GW[KW71!Y/^M:W^M_3W[KW78O?5^+?3\_X<>_=>Z]_0_X^JW/T%K<?CW[
MKW7N+\?4?[U?_'W[KW7K7OP..+<6!_J/?NO=>X^MN; GZVN?IQ[]U[KPO<C\
MWO\ 7\7M;Z>_=>Z]S>_T/T%Q_L;W]^Z]U[\$"_''^-Q]/?NO==!OKJ]7^P!_
MV/'OW7NO&_\ L;<G_"_UO[]U[KD1_@?J/IQ;_$>_=>ZZ(XM];6L#8?3ZV]^Z
M]U[\<\"UK?7_ &(_/OW7NO7-A^3]"1;@_CW[KW7OI>X)-Q^#S;Z?3W[KW7OP
M0/J/ZV_/^MQ_K>_=>Z]>W'/T  OS_A_QOW[KW7K$7_X-?\\C\@^_=>ZZOR#_
M *Q_Q^EN3[]U[KLB_'XL?R>>>/?NO=>O_L+WMR.;F_U]VT_,=>Z]86N2!_L!
M;Z6M[KU[KQ'U//(M]./]M]??NO==?4< &WTY)_Q_/OW7NN5C_L/Z7-[?Z]_>
MZT-1U[KK5_KWO_O%_P"@]ZZ]UUQR/K]+BUOI_4CW[KW79N+<\GB_/^PL/I[]
MU[KWYM_3_;M8<&_OW7NNOZV]-^"#_4_T]^Z]UWS;\_G\F_UXY%_?NO=>YY^H
M%O\ ;6_I_P 5]^Z]UXWO].#P;"]_QR??NO=>/]J_^W/^(M^![]U[KUC^+'CZ
M?FW^ ^G^\>_=>Z\?Z@#_ %[<VM]??NO=>N..>"+?X7M^3[]U[KW^O<%K<C_
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MZ)L.0;\G_7_K>WOW7NNQ^>#>Y-CSR?S[]U[KH6/YM?\ L\@6^@M[]U[KUO\
M$6O_ %YTG^S_ +X^_=>Z[_K]./\ B>21[]U[KUOHMS_A_7C^GOW7NO'ZW_UA
M>]K&_P!/?NO=>_-^>!;Z_P"%^?\ D?OW7NO7M_7_ &Q%^/J>/?NO=<_?NO=<
M/^-@<_VAQ^?K[]U[KWUXOP/R./IP?\/?NO==7L?I;_8<G^MC[]U[KQ//T!!-
M[6N?\3QQ[]U[KLGFUQ_K_0'C_'_'W[KW7K6-A^3R+&UK?CW[KW77T/UO8&UV
M^G];^_=>Z[L/R3^>">.?P??NO==FUC_C?_BOOW7NNK_X_FW^Q_I]/I_C[]U[
MKL?2UR2/ZW_WOW[KW75_]8V^G(OR/ZW]^Z]U[Z\FY'/T_P +<>_=>Z[%[_Z_
M)/\ L+6'OW7NN.D?4W)OR>0?Z"P'OW7NN[?X#@^G_B>/?NO=>OP" +$W_P"-
MGW[KW7>G_>]7^Q]^Z]UX?X<V-K_D7^OU]^Z]UT!SS^KZW^HM]/IQ[]U[KU_S
MP.;$6/UO_4V]^Z]UXC\V_-_SS;@<6]^Z]UX_Z]K?XC_8W]^Z]UZ_U-OQ?Z<\
MC@WO[]U[KOZ?4@#\#_6-QR??NO=<2;_AK?U%P/\ ;>_=>Z[(//\ KW_P%OIP
M?]8>_=>Z]_A]1Q>Y_'^/OW7NO#DDWN/Z<V!/^'OW7NN/^L!;C\W)YX'OW7NN
M1/XX!!%[VY'U'OW7NO'Z?2W-^1QQS^/?NO=>X(N?I<GZG^EOK_K^_=>Z\?H1
MSS_L.2?I_P 5]^Z]UZW^/YO]?]B!^??NO=>Y/U''/'%_H3:W^V]^Z]UUZ@/P
M!?\ V-KW_'OW7NN_ZGZ#ZDCF_P#L#[]U[KWX_'U^MOS]+V_K[]U[KHG\ \_[
M&Q_/U%S[]U[KE^;\_P"W_/\ 2W]??NO=<;<\-<C_ !Y/^N?I_O'OW7NNS>W^
ML#]#:W]#[]U[KU[?2PX^G'!M?GW[KW7K?7\#GZ<7O_K^[=GSZ]UT!>UN!_@2
M ?\ &_NO7NO7_P /Q]2>?KR+DW_Q'OW7NNQ?Z#D@_7Z$!N3P??NO=>!_K_3\
M<?@W^G^M[]U[KUA^?Q]3] =0L3[]U[KVD_7\W4G_ & ]^Z]UX$_D_P!K\7/^
MP]^Z]UW_ ("UO\/Z'Z$>_=>ZX\?U_( MQ:_]+>_=>Z[_ #_C]>>#R+?4>_=>
MZ[NH_H/]M_Q'OW7NN)'^'-P-5^?]?W[KW7OR;\_2P^O^%Q?W[KW7OI_9('UX
MXX_V'OW7NO ?FW-@/J.1_7CW[KW7*WU^AY_/^/)]^Z]UU_4CZ6/^Q(/OW7NN
M5^+\_P#$_6WOW7NN/T _KZ1?^H_P]^Z]UT #8_J/%_Z"Y]^Z]UT2+WU&UKC\
M\WM^??NO=<A]?];Z6Y)'TN??NO==7/)L?Q=?J#?^GOW7NN_[5[\6_P!X]^Z]
MUU8?U_'YN;+^+>_=>Z[/)M_M7U_Y ]^Z]UV?^(OP?K8W%O?NO==#BX4\#F]_
MS;\?[W[]U[KW']/I]?2;6^MK7]^Z]UZX  _I;^E[_P" _K[]U[KW^]DV)!'^
M\7O[]U[KHZ;B_)^G^O\ X^_=>ZY @\7/T_XU>_OW7NNOP1^/K_2U_P"E_?NO
M=>_K87Y)_/X_XW[]U[KOFW'/_(5_]8^_=>Z]?Z#ZFUR".;?[Q[]U[KHW(/\
M4_\ 0O\ 3W[KW73?4#@WM];_ ->/?NO==WY*_P"  ^OXY'/OW7NNK6M_4_7@
M<_FQ]^Z]UV;_ (_H3<GG_8'W[KW7@?I8_BUOZ&U[\^_=>Z]_K'B]K?7GZ#C_
M %_?NO=>^GT^EO3_ (D\^_=>ZZ+ ?3ZFQ-K"_P#A<>_=>Z[^IX^A^MR/ZZ>/
M?NO=>_Q/']1:][?0^_=>ZZ'U/'-[:O\ :O\ 6]^Z]UR(/]?S_O%OH?I[]U[K
MKZ<_[ _U M?GW[KW71_VJ]N1^.#]1]/\/?NO=>(/]#]>;?D#Z6'OW7NO7/\
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MU_\ 'W[KW7OP?SR;D\6L+?CW[KW7N;<<<?2][#_#_'W[KW7=C_3_ &-A>_\
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MO#\'_8<?C\?3W[KW7O\ #Z7Y^O\ A^/\?]A[]U[KHWN?\;<WX!'OW7NN5_\
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M-K>_=>Z[/-K&W]/];_6/OW7NNN;6XN+7^IX(_-O?NO=>%N#] ;6%AR?J#?\
MK[]U[KHB_P!+7%A<&W^\>_=>Z]^?H?R";?6_]3[]U[KE8\<GCZ_3G_#W[KW7
M&Q_Q/.KG_>K>_=>ZY7O<#Z@V_P!;GW[KW7&P-N/I<<?D VMS[]U[KUC<@?C^
MO%^?]IM[]U[KOF]KW(YM]+<<6_XW[]U[KH"_-A?_  )O_A>_OW7NN_K;D_[
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M_H"?5QQ;\?ZX]^Z]UUZ>?IS_ (\_X\W]^Z]UWQ_0?7_HGDV]^Z]UXB]KB_\
MK?7Z_P!#[]U[KP)MRIXY/T'^N??NO==GD'\#FQY%^/R/?NO=<5/X_P !:_Y-
M[^_=>Z\.?IS;^EA]?\"/?NO==FW/UXYN#^;_ $M]/?NO==FPMQ_07 N??NO=
M=?TMSS^1R?Z$?3W[KW7K'GZ\_DD?T_H/?NO=>(^EQQ]2 !R??NO=>Y^M_P#8
MVYTGW[KW7@#^?ISS<6-S_3W[KW7O]>_TM_6_^N?^*^_=>ZZ]/^MR;<D?ZY%O
M?NO==GZ $C\$W_H#S[]U[KHW(XX(^O\ @+7M?W[KW79Y/XYY(XN?Q[]U[KOC
MZW)L3^/]X]^Z]UZ]_P ?[V/H?IS[]U[KH\GZV'^PYXN??NO=>_-KF]K6^E^+
MW]^Z]UX?D'\CCF]Q_7W[KW7K_P!+#U?6X-_Z^_=>ZXGGD_ZH"W_%2/>Z]M.O
M=<K#C_?6N+D>]=>Z];@?UN ?Q>WTY/OW7NO&UEO?\_[U;\^]U[J]>Z]8W^IM
M?_??[#WKKW7=[?6Y/^ ^H_J+>_=>ZX_3Z?J_J>#_ $'U]^Z]UX \D$@7XX)%
MC_A[]U[KE?Z<?7_;?[Q[]U[KC^+'CZBX'XYO_O7OW7NNS_KFWYX(^O'%_P#;
M^_#..O==GGG@CZ'CFW^O[]U[KJW]+6M>]BWU^OU]^Z]U[D6^G^N?QP!_Q7W[
MKW7A]!;C^MK'\7_Q]^Z]UUS:YY%OR!;_ %_Z_P"\>_=>Z[N>?^->G_;>_=>Z
M]P"1<?4DW_XCW[KW7K\C\GBP_IQSR?K[]U[KK_C1O8@_U%_Q[]U[KOZ<FWU_
MU/Y_K]??NO=="X^A']0O^'^O[]U[KO\ V%UX_J;W_P!?W[KW7FN1>W^-S>XM
M_A[]U[KWJO\ @?X \_Z_/OW7NO6XO;\&X Y-_I]/^*^_=>Z]8_[3];_D?C\6
M]^Z]UU>UOJ.-/]0#^/I^??NO==_U_-P38G_'C@^_=>Z\I_IS?\WY^MN;^_=>
MZ\/Z_6X^O MQ^/?NO=> Y_WBW^%N+^_=>ZZM^+GFY(_Y%[]U[KL\_P"W_P!Y
MM>]P??NO=>)Y_H;7!_PM].??NO=>'(%A<?G5R?\ 8>_=>Z\?]C_C]#]?[-C;
MW[KW7OH+G^O'!O\ 6]N??NO=>YY%SS].+?CW[KW7OZC4; <_ZJ]_K[]U[KQU
M'D?UMP?\?K8^_=>Z]S:_'UO_ *PM]?\ 7]^Z]UU8FWTX_'(X(L/?NO==_P!+
M@'FU[?D&WU)]^Z]UZQ-B1].1_3_8_GW[KW7E^I_V-Q_L>/?NO==_[$_\F_TO
M[]U[KKG_ !_5?\_3^GOW7NO?6_'UL>?Z#BY'OW7NO?7ZG\G^H(Y_J??NO==&
MW];&Y_WAK\^_=>ZY<6_J+7YYO^?S[]U[KJ]SR+?4$<&Y'T%_?NO=>/\ A<?B
MPY (^G'/OU,TZ]UZY_U^6_V ']??NO=='Z6_I<7;_'\^_=>Z[Y_KS_K_ .%O
M][]^Z]UQL"#<F_T_Q_P'OW7NN0XO;ZB_X_VPN??NO==:;W/U/^^XL+>_=>Z[
ML3_5?ZVMS_L??NO=>X^O M_C]#?^@]^Z]U[\W/\ K>D$D?F]_?NO==6N#]/K
M<^K@B]O?NO=<^?Z#_;G_ (I[]U[KJ_\ 7_;#Z_6U[^_=>ZZ'Y/\ CS?Z6_IQ
M_A[]U[KUR;DBUN1?_>>/?NO=>^HL1;FW'/OW7NN[7MR./J/U?[R??NO==?3Z
M7_P!)^G]0!?W[KW7?U'%Q]#>W]??NO=>_P!C]/\ 'ZV%C?W[KW7OS?\ UQ?^
MOY'^\>_=>ZXBQ^@O]+<#CBWJ]^Z]UW]?Z<G^MKV^G(/OW7NO'D@$"QO];WX_
MI[]U[KUUM<V''^\$?CW[KW7AJX%N.?ZWX^G/OW7NO7' _K<_C\F_)]^Z]U[Z
M#Z@_X#\W//\ Q/OW7NN[\VOS_4#Z?Z][^_=>ZX\<?XB_T'X%[?3W[KW7=[6'
M].3]/P+>_=>Z]<6O8<'BQ''^O_3W[KW7C8C_ %OK]!]1<_7W[KW7C<_0D?TL
M"O\ O/OW7NN@Q)_PO]>/H!];?Z_OW7NN1YX)%P;@?ZW]??NO==:N;$_GZ6/Y
M^@]^Z]U[_I$FY^G-[>_=>ZZ/!MJ(_P 3R/?NO=<KCZV_!-[#\<?7W[KW77^P
MO^#<_P"'U/\ C[]U[KQ'^U&_X%P/]Z]^Z]UU:]N.2OYY _V_OW7NNQ]23_CS
M;^AL?S[]U[KK\?FP!'!_ _(_Q]^Z]UV/K?\ '/-K_4\6]^Z]UX<$FWU/)OQ]
M+W^GOW7NO#BX_H1?_&XM[]U[KH?G@$ '\6Y^A]^Z]UV"";?D'\\WXM[]U[KQ
M_P![^OX_L?3GW[KW77/]?Z_EK_U'YM[]U[KOGZ6X_I_K-?WN@]>O=>-P.>;G
MGFWXM;WKKW75SSPO'/\ L?ZCW[KW7K6-S_O%P/K^??NO==C_  ^E[FWJ^OXX
M]^Z]U[_$_7_#\<_6WOW7NNK\?4CFW/)X%KV_U_?NO==WL #S_2WYM]/?NO=>
MXY'%@.?J.3_C[]U[KKZG\&W^U?D&U[>_=>Z[_P 1S<\_FX_H;^_=>Z\?Q:_U
MO>_U_P ![]U[KL_G_>#?]((^OOW7NN/U_P!C?_&_]1?\>_=>Z\#?Z7X%K_6W
MXO[]U[KE;DF]OI?_ &!_K[]U[KC8?TL1;D#@&USS[]U[KOC5?G^EOI_O?^O[
M]U[KKG_DD6M_3_$>_=>Z[L?];_'\VU7M<'W[KW7OPO\ K<C^O'Y]^Z]UU<#_
M  ^MCS?D^_=>Z[_VFW'Y_P !_A_L1[]U[KOZZO\ >_SR+^_=>ZZ^FHGZV)_U
MA^!Q[]U[KWX-^?I>_P!?]X_'OW7NO<\_3C\VXM_3Z^_=>Z\/I<?ZG_>OI]/?
MNO=> MP?Q8W_ #<_ZWOW7NNAS<_4BUOH".+BX]^Z]UWZ38VO_@.;?[ <>_=>
MZZ/(XX/^!%KW'_%??NO=>);Z#ZBUR.?K_A;W[KW7K"]^=0-_]Y]^Z]UV2; W
M/-A^#_O'OW7NO?5O\%_WO^OOW7NO7^@^@ !M^3Q]![]U[KWU'] /]?Z#Z<GW
M[KW78^EC<?7ZFYX_-S[]U[KH<&PN3?DGGW[KW70'*W'T %[\<<@CW[KW7?\
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ME]+\VY/-_JQ'Y]^Z]UW?Z_@@7_UK_P"M[]U[KH\BW'U%K\6_P'OW7NO$7-B
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MA]^Z]U[_ !_J/\2#Q?@>_=>Z[L?K^?\ #^E[_G\^_=>ZZ_WCBU[B_P#3Z_\
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M?Z_7BW!]^Z]UW<\<?TYO;_>#[]U[KH?G^IL;C_'@?6_OW7NO$G_;?7_BE_\
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MUX?D\@?4BQ' 7Z>_=>ZX@ \&Q-B;@W_/OW7NN7YY^IX ('^O^/?NO=='GGZ
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M_P"??NO=<=)_I?\ /]D<_P!/I[]U[KL\7-_]M^/]8'W[KW7?^)X(M< G^O\
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MAP/S^?\ 8>_=>ZZ^@O\ CC\6M8WM;_>/?NO==D_\&%_]A:W-Q[]U[KQ'^O\
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M<FYL??NO=='ZC@_7DVN>/H>/?NO==\?X<?0D7L%X/T]^Z]UU<'GGGT@_2_\
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M^/\ 8^_=>Z\..0?JPN?Z\V/OW7NNR3]+7_Q'X_V_Y]^Z]UUR/K]+_P"'%_\
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M#_>?>0O71[KQXLHN>00/I:W/U]^Z]UWR+FU[$V_QN>;>_=>ZZXXX!!^IO?\
MP])/U_V'OW7NN[V%A]>1]3^/K8V]^Z]UZ_Z?I_47YO;Z?6WOW7NNB?I8_2W'
M(U7_ *W]^Z]UR_Q_'T)-S]#8>_=>ZZN3Q_L?S;ZW7GW[KW7OS_@.#_0&]R??
MNO==<\\_6WUNPX^O/OW7NO$\6:X)^MK<\V^OOW7NNQ;_ &]SP;D-^;'W[KW7
M@.;VX(!_V/OW7NO$<6^OU(MQ;_6 ^OOW7NO VO?Z7L+7/%KCW[KW7A_O9/\
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M_P!IMSI_UN/I;W[KW7=Q_MK+Q?BW];^_=>ZZ_L\V_P 3]!]?]A[]U[KJ]_\
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M<<VY_H??NO==7_J;7/X_K;GGW[KW7C>UC^+&XXL3_A[]U[KE_A]?ZGBQ]/\
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M?W[KW77Y^@-_P?Z_2]O]Y]^Z]UX\?UY8W'U!_K]1[]U[K=N_X39?]D,=J_\
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ML<_[:PO^?]?W[KW77Y^O^'-KB_X!'OW7NNOJ?Q]+6XL2/H+7]^Z]UV/IR/\
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M 'G^G()Y^GOW7NNB!^1_KF_]?\3[]U[KW]>1P /]?\>J_OW7NN_Z#3Z3^?\
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M<CZV'OW7NNOP2>;#\BUB1_Q/OW7NN7-P>;$#C_&_Y]^Z]UQ^E@.+V^@O>_\
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M-K?GCZ<6]^Z]UUP#8@W-@;WM<#_'W[KW7AR !_O-C?G@'W[KW75["X^EK7_
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MR2?H5^O^Q_Q_WKCW[KW7OZ#Z6LW/^W('OW7NNP?J!:Q) XX^E[>_=>Z[_P
M..1SS>WX'/OW7NNOJO%Q]+?C_?#W[KW7B2+\?3D?T_QY]^Z]UT.>1_6]S^"?
MK;W[KW7?Y''TX'^/I^E_?NO=>^@''-K"W/X]^Z]U[FWUYY/T)M_A[]U[KP_I
M;D^JW^%_J?\ 'W[KW77'^V;5^/I_M_?NO==G\?T'-Q;_ &WOW7NO$F_X(L;
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M^OU!X-OH#[]U[KQ //\ :_P-C_3_ (U[]U[KW^W_ #>P_J; ^_=>Z\>/K?\
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MQ^O]?[7OW7NNA?Z#D@ '^@/Y]^Z]UU<<FYN01_K<7_P]^Z]UXD&XO_C^./\
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M'Y^GT^G]??NO=>_(_H; ?T_K]/?NO=>^O!_P^GXN+&_OW7NN@?Z7/^ %@/\
M7/U]^Z]UV;?ZW/\ K^K\"P]^Z]UX6(O]?\+&W^M8^_=>Z\>/S:QL"3?D\\^_
M=>ZZYX_/ (O^#_KCW[KW7=["YN?\;_@GC_8^_=>Z\QX_H.?K^21Q;W[KW7?'
M]/P!?^H/OW7NN/TN!?@&W L+\_7W[KW7*]N/]X_J/Z >_=>ZZ' X%N0.1_L+
M_P"O[]U[KKG^O/!M_B3:W^M[]U[KNQY_-_H>"+ <>_=>Z\"1R2?]B+?4V]^Z
M]UYK\ 'D_P#$?X^_=>Z]:P_%O38\_P!;_GW[KW7?^PYX^G^\ #W[KW77^'^L
M+7_!X_V_OW7NO7NM_H1_O/YM[]U[KUASR;V(Y_I_7W[KW78O^?\ >/?NO=>_
MPMQQ^..?\/?NO=>)(_UO];_8GC_6]^Z]UZ_^'U-C^/\ 6_U_?NO=<;$?D\7(
MM;@_TY][QU[KN_(YM8<WXO\ TX/O77NNE_'YX-K<?X6]^Z]UX_0C^A%N+?[W
M[W7NKU[KQO\ 6WY'XLQ_K?WKKW7?];6O:W''J]^Z]UUQR/ZCCD6N!P!_M_?N
MO==_BPY!!M_L!_Q7W[KW75B.3I -K\<?[$'W[KW7=B!8D'Z_6_T_//OW7NN-
MS]#<$FYMQ8?U]^Z]UR_US< #4!^3:]R??NO==6/^WO<?U/\ 7GZ'W[KW79%Q
MR.;$\?U_(]^Z]UU<?4\@VM8'ZCW[KW7?X!_U^/\ 7^EQQ[]U[KW^L?J?^- <
M?X^_=>ZW;?\ A-G_ -D,]J?^+7[Y_P!XZ@V+[A'W+QOL0_X0O_5R7K!'[T7_
M $\"T_Z5\7_:3=]?_]?:8_GA?]NN_D]_K]*?_!#[2]BSD;_E:;7_ )N?]69.
MIA]@O^GM;5_U%?\ :%<=?/CM_:N1:Q-OH;"_O(7KH]U[Z 7 M^!_L/R?I[]U
M[KP'U_)L?K<$_P"W_'OW7NO<_11;Z'^O^N+'\^_=>Z]?CFPN.+_ZWYO[]U[K
MUSJ^HM^!QS_K>_=>ZZ/(O?@<7/\ O8_U_?NO==F_X/\ 3\&Y_P!<CW[KW75[
M$?BW-A>QO]+V_P"*>_=>ZY6-K'^EO\ /\?S_ +S[]U[KW-OS>UC<D?CZ^_=>
MZZ-R!S8WM<7]^Z]U[ZW_ -AR#R;<C@CW[KW77U^@_P ./P3]2/?NO==\6XX%
M[\7/T-_K[]U[KUO\">>?IR1Z??NO==W('T/^Q/\ C;W[KW7$_6Q'/]DC\#Z#
MW[KW7(6'^/XN.?I_K>_=>ZZMQ]!>_P#0?2]O]Z]^Z]UX \WM^?\ 8W^OOW7N
MNK?G@&P-A]?\>+^_=>Z[M:_UY-R21^.;^_=>Z];_ (GC\?6XMQ[]U[KW^U6N
M#;Z_BWY]^Z]UU;_'^I_K;\-]?Q[]U[KOD?[<_P#0U_\ >O?NO=>_I]18C_#Z
M_P"O^/?NO=>6X'T/^QMQ[]U[KO\ PX!XX_UOQQ[]U[KC;\#Z,!^"1_AS[]U[
MKQ!%SS:Y)YMP1_O?OW7NNQ_3\GZV^O\ @3?Z>_=>Z\?Q];7U7^H'^'OW7NNO
MI];_ .'T^BCB_P#K>_=>Z[)/T_K_ +Z_^'^\^_=>Z]IM].#8#_6YN?K[]U[K
MHCZVX_K_ $_P(/\ O?OW7NN0M];7X%S?^GT_V/OW7NNA]+CC]5[_ .O^3[]U
M[KPL!Q8_UN;?Z_OW7NO?X\_U^O\ O8-O?NO=>O\ T^NGGCGCCZ\>_=>ZZXM_
M:_'];"W/U]^Z]UW>]^#^+6YO;^EO?NO==,P( _!^O^'Y]^Z]UV/J?H?I]/\
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MNO==V^IO:_\ C_L!<'WNO;3KW75Q>Q^H_(%^;?7CWKKW7K$\W_VY_!'^T_\
M%??NO=<2+_4B_%S_ *_(X]^Z]URO]+'\6/%[6_/'OW7NO6M>_P!.?K]"?K>W
MOW7NN[_[[_"]K^_=>ZX_2WUT\_UL01^;>_=>ZY?["X/U M^?KR??NO=< /\
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M/'^\_P"N/K[]U[KUOH3^ #Q?Z#Z\_7W[KW7OR/\ 7;\<7_%_?NO=>!_///\
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MC^!P2+BXL1_@?K[]U[KOG^G]#8+_ $-_Z^_=>ZZM;D6YY''-_KQ[]U[KPO8
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MDD?TX]^Z]UW]+?['Z<#Z?D>_=>ZZ_P ;>JU@>.3_ (>_=>Z\#Q?D?UO]0?\
M4_3W[KW77&K\"P_PM<_\C]^Z]UW]+7-P;_XWO]/I[]U[KW-KV'X L!]/S[]U
M[KW/YM]18\?6WU]^Z]UT;6M?\:O\3[]U[KUK\\<7O;@&X_K[]U[KE_Q)_/\
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M_]+:8_GA?]NN_D]_K]*__!#[2]BWD;_E:;7_ )N_]69.IA]@O^GL[5_U%?\
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M_P <?X'B_P"?I_QOW[KW7*W^P-K?6]OZ>_=>ZZ-Q_4\\6MP/I[]U[KW/^N+
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MVUK?[#_;>_=>ZX "W]?I^+#Z6L2/]?W[KW6[?_PFR_[(9[5M?_LJ_?/U_/\
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MW']/?NO==6O<#TV'('-_R.?]O[]U[KL7)^MQP1<#_??[Q[]U[KJ]N?\ @MR
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M%Y^MK'CCW[KW7K_ZPL=(!%^1].?>\=>Z]<6('T%N"/Q^?>NO==_T-S8"Y/\
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MS_7W[KW7F-P"/\;-SQ_L/?NO==\_B_X^G'^V!]^Z]UUP21^2+'_7''OW7NO
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MWW^Q]^Z]U[^U_C;_ &Q^ER+_ -/?NO=>_K>XM_K"_P#L?^-^_=>Z\0!]>;D
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M7NO:?Z_[$_[U];^_=>ZZXO;BX^M[BXM_C_O7OW7NN^;?2W-N/^*'\>_=>ZZ
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M5R?Z#C_7;^@]^Z]UU_4_3_"Q!X-R?]?W[KW7?U_U[_X?@W_'Y]^Z]U[ZB_\
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M/U]^Z]UR(^GX'-_]C_3W[KW77T!M_34 ;\#W[KW7?'!X/]DG_B@]^Z]UU?\
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MUM^0>?\ 6(]^Z]UQ N"+\<?\;]^Z]UR']"+FW^/(_P!C[]U[KWY ^EC>PO\
M2W//OW7NO<_UYX_U_P#$D#W[KW70YL+<'G\ ?[&W^P]^Z]UVI/\ 3\CZ<  ^
M_=>ZXG_>!]!<<V/-_P#&WOW7NN^/]@ +BU^!R+D>_=>Z[_ M8#CZW_WOW[KW
M71M^1^=/]/S]1[]U[KO^USS<$ ?ZWX]^Z]UZ_P! ?Q8_U/'U/'OW7NNO5_3_
M (U^/3S[]U[KOGZ6_I<?BQ_I[]U[KOBW%C?ZFW!M^2/?NO=>_H+CZ#GZ<#Z>
M_=>Z\#Q^?R.3<W'X]^Z]UP(']+'G_;<W_P"->_=>Z[L;"Y_/')'%N!Z;>_=>
MZ]P ;6N+ FW]3^??NO==FW]JXO\ BY_XCW[KW7AQ>_-OS_A:]K>_=>Z\2./K
MR1_K<-[]U[KU['D?7@'^O]+>_=>ZZM^21;FP-O\ 86_K[]U[KEP1?ZV/^)%[
M>_=>ZZ-_K]/K^2/\?S_Q3W[KW7KW^K#^MP1?_6]^Z]U[F][ C^MA?_#Z>_=>
MZ]];#^EKG\'^H]^Z]UUSZO\ 'Z'\^]TS3KW78/\ 3\#G@_7_ %O>NO==ZA_C
MQ:_YY/XX]^Z]UQX_'UN?Z"]N+<6]^Z]UW8_XW_2?IP+W_P!O[]U[KW(O;FYL
M?P1_3W[KW7K\7_ N./I];#W[KW75[7)YO]?\+?IO;W[KW7?Y) Y M>_ _P #
M[]U[KU[BY!MP>+_ZXL![]U[KU_IS86'^N+CCZ^_=>Z[_ -8?0'Z6^OX'OW7N
MN)M;ZCDWY_%Q:_OW7NN["UK\@?X$V_I[]U[KQOR?K_1;?X_U'OW7NO?[4+'Z
M?BY_Q]^Z]UX?FQ_-S^;W]^Z]UX$6/TX^H-R!_M_?NO=>'/YO<?G_ *-]^Z]U
M[\&_T!_%P..+>_=>Z[-[_51^+GZ^_=>ZZY'-N!<\VXXX M[]U[KUC]/ZVN/Q
M8<$ >_=>Z[_QN1?GG\?[?W[KW75^.#_B;"Y/^']/?NO==@?X6_V-_K]3S[]U
M[KKD\<6O];_C^EE]^Z]U[3^;+^>+?4_CGW[KW77(/U)_US]+\"_OW7NN_J.;
M\6O]>?\ >+^_=>Z]]/\ 6 X_IQ^DW]^Z]U[Z_4<#_>/P>??NO=>^@-[6_P!:
MP/\ MO?NO=>_PXM]/]C>U[6_K[]U[KW-[$VX_)YM;Z_Z_P#L/?NO=>N+@<D_
MZPX_//OW7NO#_C5K_P"Q)O[]U[KBW^-C<$VX'U_V/OW7NN1X_K:X_H-(O;W[
MKW7(D"U_S]/?NO=<#?ZFW'X//ZCS[]U[KD3;ZGF_^\7_ .*>_=>ZX6/TORW^
M\CZ\CW[KW7?'UL 1;GD<G\6/OW7NO J.?I?^IO\ 7\V%_?NO=<KV-O\ "YX_
MWGCW[KW77^)O:PL;_P"W'OW7NO?U/TMQS_7^OI_US[]U[KQN?K:P_5;G\7^A
M]^Z]U[@?0 "XYO8<?X>_=>ZZ'T!_K]"3]"?P/K[]U[KOD_XCZB]U(_UO?NO=
M=_[#Z\GZ<_X'W[KW70^OYX^MSQ];@\>_=>Z\1R387/Y^@_V _P /?NO=>/-U
M'^%O\.;'W[KW70X_QN;#\6-['CW[KW7*X_ -_P#6L;7_ ,??NO=<;\#D\_0\
M\FUA[]U[KO\ %_K_ *UR?K_7_6]^Z]UZY_5Q_L1:W']??NO=>(LMN;<?X'Z\
M\'W[KW71(%OQ:]@+_G_7'OW7NN[<WYO_ ,1?_>[<>_=>ZZ-^1_AP/J>3];?X
M^_=>Z[!'%P;CZ<&_^V'OW7NO?T!)YOP!_7^OOW7NO6/];'_#Z?[8^_=>ZZO_
M (\_2QN1_P 1[]U[KE^KZ?UL?S_KCW[KW7?/^]_U_P!A[]U[KCR+_6P _IQQ
M_C[]U[KNW(/ ;\_F_OW7NN.H6_K_ &?Q]/R??NO=>(XY8'_8?7^@X]^Z]UW_
M +?DBYM;\<6!]^Z]U[_6M8V_ ]1/U]^Z]UZW]1?_ %P#]!^+^_=>Z[U _3_?
M?G\^_=>ZZ_%KCZ6^OT']2/?NO=>O_C^1:X_QM?\ V_OW7NN^+_2U@.;6Y_//
MOW7NNAR6_'^'T/\ 2]_?NO==V_V(_H?^*^_=>Z];Z?X?0_["W/OW7NN-O]:X
MM?Z_["_^/^/OW7NO?3GZ7Y(/)-OQS[]U[KL>G^OYYXMQ_K>_=>Z]]3]#_L1P
M/ZV/OW7NNN;?@?CG@VO;Z^_=>Z[']!_07_I_C?\ Q]^Z]UUR#]?K:_ _UOS[
M]U[KU[@_BUN+V_/]3[]U[KE:PXX/]?K?_7]^Z]UU^+DZN+V/ M_6P]^Z]U[Z
M@WO]?R?\;$>_=>ZZ_!'^' 'UX%C];_GCW[KW7OQQ^"/T_2_^\^_=>Z[!O^/I
MP?ZV_P!?W[KW71%[D$&_T'^P^O\ K^_=>Z]?_6N2/SJO;\V'OW7NNRUK_P"V
M_KS[]U[KW]3]"0;'Z?3_ %_?NO==?BUB1_KW/]?Q?W[KW78)/'('-C^+?CZ^
M_=>Z]_3_ !-QR?ZWM;W[KW77J)'^%_I^+CZ^_=>Z]S<6O]+Z2>+7M]??NO==
MBWT!X-_\#_CS[]U[KWTX^HT_0_7_ 'CW[KW70XO;GU?U ^H^@]^Z]UW_ $!!
M%K'Z7^GXX]^Z]UXV'I)-M/\ L?K8>_=>Z]_A?ZZOZ?ZJWOW7NO'C^O\ R41<
M_P"%_?NO=>XM;@"QXOP;_3GW[KW7@/K^+V^AY'']??NO=;MO_";+_LAGM7_Q
M:_?7_OH=B^X1]R_^2]%_S07_ *N2]8(_>B_Z>!:?]*^+_M)N^O_7VF/YX7_;
MKOY/?Z_2G_P0^TO8MY&_Y6FU_P";O_5F3J8?8+_I[6U?]17_ &A7'7SXB2#]
M;<<#BW^W-O>0G71[KOAKV-_Z?X<6]^Z]UUJX)^E[?T/^!X]^Z]UV3S;G_$_X
M?U'OW7NO<\ $?[#GCZ<_ZWOW7NNBOYMS_0'C_&YX]^Z]UV;F_!']#QQ_L1[]
MU[KU^.>?K?D?UM_A[]U[KPN%O;Z\V']2?K?W[KW7OP+?0F_U-_K<CCW[KW7C
M8_4<\?[S]!<>_=>ZZX^M[ -<W'U/^'OW7NNP018$V'U/T(%OQ[]U[KU[WM_M
MQQ?GCGW[KW7B6XL/\3_Q3_'_ 'CW[KW7K#ZV')O_ *]_]?W[KW71/U'X!%K@
M"_'T(-O]?W[KW79_(X)^@_U7TM<GW[KW7K&]K7_QO;\W'T]^Z]UT/I<V'-Q^
M+V''U]^Z]UWP#SP--N?I_7Z^_=>Z]?\ /Y_K]./Z FX]^Z]U[ZW'XN?ZW/-_
M]M[]U[KO^AM]!QS]./S?W[KW7$W%['Z?\4_/^/OW7NN[6-@2+_[S_4\^_=>Z
M]>_]/3<C\?0<7!]^Z]UUSR">#P.".?\ 8>_=>Z['U_V'/JO;\\W]^Z]UT/QP
M;_V0?]N?Z>_=>Z[/X/X7C_B/?NO=>Y]7]/Q_A;Z6'OW7NO"QM]1?Z7)_XK[]
MU[KL$<?T_%_KQ]3[]U[KWX^@^@)/X-O\??NO=<;\DV/X_P!<<>_=>Z[(^O\
MC<V^ES_OO\??NO=>'T^A^O\ K?F_OW7NO?0<7U&W)']?ZGW[KW75N0!_9O\
MX_7_ &WOW7NNQ];#]/UO:W^]6]^Z]UX@_7Z'Z"WXMS8?\;]^Z]UU<\6!_H;C
MCZV^GOW7NN[_ ) /^WO;FWT'^M[]U[KWTN/K^JX'^/(O[]U[KUN>;C\#Z#Z_
M4CW[KW7O]86Y'/UN!_K>_=>ZZL1:P_VW%_\ 7^OOW7NNR3].!?Z'W[KW7OQ?
MZ?ZPY^MCQ[]U[KNX)OS<7X_WCW[KW70-S8\&W]1]?];W[KW7N?K]!]>/R3]
M??NO=>M^?]8DWX/IMQ[]U[KN_P"1R+?3_$'_ !]^Z]UT;V%[VXOP#^/K^??N
MO==DGCC\V(XY'^%_?NO=<;<7_H+C_#\@7]^Z]UW87 L;$DV_ /OW7NO?0<D<
M"QMSS^/I_3\>_=>Z]8V/+?3CZ?2W]/?NO==7'U!'%[ D<<6MQ[]U[KP!Y!_/
MU'!:WT^OOW7NNQ?CGZG^G/TYX_U_?NO=<6^O'UX_QM;^GOW7NN5QZ?\ >OIR
M.+ GW[KW7>D<<?[R??NO==#\7_'^P_P^K>_=>Z[-[C\<'_C7OW7NO6-[W/\
MM^#_ %X]^Z]UQO;A>3Q?B]A:WX]^Z]UW]!_3D_4\_7\>_=>Z]]>;&]KC_#_#
M\>_=>ZZL"-/&KZ7M^?\ 7]^Z]UX'\&Y/'%N;VL??NO==_P"L/K;4+G@'W[KW
M7@P_+7_V%O?NO=>(_)')^O\ C_A]?K[]U[KL<FXO;_7X_P!M[]U[KJXMS]"
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MY_I]/?NO==?U7BPM]1];_P"M[]U[KN_^VYY_'!M]??NO==?CZ$?6_'/^-O\
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M0N!<_P"]C^OOW7NN@?K]1]#_ *]^/Z>_=>Z\.1]#_2]K&UOZ^_=>Z[^O(/\
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MT_[ 'Z6M8^_=>Z\MQ];_ (O?@#_;^_=>Z[_!XL3<'_7_ -A[]U[KHGZWX!_
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M[KWY7CZ7^@/Y-O\ D?OW7NO7_/''Y^I^MOI[]U[KNQ%N>!;\<\>_=>Z]>_\
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M=>Z]_:O]>+<7/Y_P]^Z]U[ZVMS_MSR/I:_OW7NO7Y%B+<WY%K?CCW[KW7O\
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M7' 'U7\_XWY]^Z]UW?\ PO\ I_V-_P"I'OW7NN_\?Z_BW/T^E_\ >??NO==
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M."+?U X^GOW7NO<\C\ 6N>/Q8?[S[]U[KN]_I<_T/]/]N/\ BOOW7NNKBXN
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M\)L_^R&>U3_7Y7[Y_P#?0;%'N$?<O&^Q#_A"_P#5R7K!'[T7_3P+3_I7Q?\
M:3=]?__2VF/YX7_;KOY/?Z_2G_P0^TO8LY&_Y6FU_P";G_5F3J8?8+_I[6U?
M]17_ &A7'7SXB+@GZ?3Z\_BX_P!;_8>\A>NCW7?^P(X(O;Z6_-_?NO==  &]
M_I] >+\<_7W[KW7?XL#;\6^H^ER.??NO=>Y_))_UN!^>/Z_CW[KW7N#_ (V^
MMUY_XCW[KW71XN3_ %O8D<\?@>_=>Z\3;DC^@'TM_MK_ .O[]U[KD>/H+W^I
M'^]\>_=>ZZMQ_KVU?XW_ *?[?W[KW7E('!^M_P#'^G]??NO==_[#ZBWTY/\
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M/^*^_=>Z[M^!Q;Z?X<V_K[]U[KW ^EA_K\_47_K[]U[KWI_1<_[[GW[KW70
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MZWX_/^Q/OW7NO$_GZCFUA>W')]^Z]UX#CZ<<\?ZYN./?NO=>_2#_ %_WC^O
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MKUO5]/Q<?7GF_/OW7NN[\?2PM>_'^O[]U[KHDVX //X_VXX]^Z]UXVYU<?4
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MLTW8OQB[LVY04S.LV;/7^X<KMU&0V8?WDP<-30'^HM4FXY%Q[$5KS#L=X/\
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M $O[]U[KRCBQY%[6(^GO9I7'7NO&XO<_4\6_']+_ /$^]=>Z]_A?\&W L?\
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MQO>W/^)]^Z]U[\DV/-^;D_G_  ]^Z]UZP_I^#;C^GY_Q]^Z]UXVY_P 3:_\
M3BW/OW7NO#ZW^O%AR.>;FWOW7NO&XL2?R;'^EQ8<>_=>Z]SP?\/R;#G_ &'O
MW7NO?T-K<&WYY(O?W[KW7K$Z@> ?I_OA[]U[KU_H0>/KSSZ?S]![]U[KQ/U
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M_P##W[KW7E'Y_%CS_3^OOW7NN7-OZ<_ZD<_X6]^Z]U[^@_I]3Q8W'/\ L/\
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M?['\_P"Q]^Z]UR^@YY_U_P#6M_C]??NO=<>%^IO:P/\ 3GD&WOW7NNQ87O\
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M[]U[KW^VY^GU_LF_OW7NN_Q^+#\W^O\ K^_=>ZX_5N0+_P"N1]/S[]U[KO\
M-OQ]?J;_ .WO[]U[KW(^A/U%S]3S^.??NO==6Y(^G /']1]+>_=>ZY6/YYYN
M/IQ_2_OW7NO _P!3]/K]/R;"_OW7NN/ O8M?Z\V^G]??NO==V!'%[VO?\\_X
M^_=>Z]:Y(_WW/^^_WCWL4KGKW7KMQ<_X\"]_]M[UU[KKZF_-OZ?7D?ZWOW7N
MN_H>/]B18"X-Q>WOW7NO <?UL?\ 7M;Z 6^A]^Z]U[]7UO;_ 'LCZW]^Z]UZ
MY_H2?K_J;CZ>_=>Z[Y_V']+<6O\ \4]^Z]UU_3^HOQ;\D7]^Z]U[\6-R2+V^
MA/\ A8>_=>Z\#_6Q^GTN>!^3[]U[KQOR;6X^O%_]O[]U[KWT-[7](X /X-^/
M?NO=>Y/^//!%K"QX]^Z]UZXYX^G)OS8_['_B/?NO=>O_ %']1?Z"WOW7NNC>
MXYN;$'\CW[KW7?Y!X^O)_P ;6^OOW7NO$V']."18W_V_OW7NNEX/]!>UO\?]
MM[]U[KH$7L!?Z<GGCZ^_=>Z[^HXL?R;&WXM;W[KW7=QR;<<7XX/Y]^Z]UT ?
MSJY-C_C_ (V]^Z]U[GZ<\#Z7Y-Q]3S[]U[KO_8  ?C\?F]O]O[W3-.O=>O;Z
M\7:_^PM;\>]=>ZZNO^^O^?U>_=>Z]<$\\$?[8C_"_OW7NN7X'T/%C^3;_8>_
M=>ZX<D"WU7_7_P!ZM[]U[KD./KP!>WT_)O;G\^_=>Z\#:Y/'U)-C_7^OOW7N
MN^>1]/Z'BWT_I[]U[KUQS_K\_7\_3W[KW7OR2.?P!?B]OZ>_=>ZZL0+?@?GC
M@#Z'Z>_=>Z]J'^L./Q_C_OK>_=>Z]8_3FQ%A?\?FQ'OW7NO#^US?FPO_ %_I
M[]U[KH\_X<_2]KW_  0/?NO==_5;'D_X?7GZ>_=>Z]]+ \@\BW-["Y!/OW7N
MO!1^>?\ $_U^EO?NO=<O?NO=<3P+B]@!Q_K'G@^_=>Z]^;_\; OR2/?NO=<K
M_CGZ?6W_ !3W[KW7'G\FPL+< ?[#GW[KW7@+_P!>0.;\<<_CW[KW7K&QXM<@
MBQ_K_CS[]U[KP^MOS:]CR;?T!]^Z]U[_ (@_@D\7^A'OW7NNN;D7^O( M8_[
M>_OW7NNQQP/^*GG\V'X]^Z]UZQ^E@>/R!?Z?DW]^Z]UW_3C_  _WP'X]^Z]U
MU^+BPN/R+?[S[]U[KUB+GD_7_@OT_I[]U[KW^'T''%_]NO/OW7NO7%R+_7_;
M ^_=>Z]^1^;V_P!>P_M>_=>Z]_L!I_I:QO;_ !]^Z]UU;@#D 'Z#ZD6U<_X^
M_=>Z[-A:_P!;DW_'UO8^_=>ZZM^+M?\ QL>/ZV]^Z]U[Z_7Z@<C@ 7')N/?N
MO=<O]O\ 3^OU']1_C[]U[KW(M8#G_8?[<>_=>ZZ'^'X/(/XO]0+>_=>Z]]/P
M1];'Z\V^O//OW7NO$BX-[?[$7(//-_?NO=<?I:][ @_ZY/-_?NO=<O\  \#Z
M 'D_7W[KW7OS]#S]";?TO8_T]^Z]UX\?7Z?JXMQ_1>/>P*BO5@I+:1U[^O/U
MMQ]2!]+V]Z]*>?6RC#CUX'^IO]?H/IS8 V][IU[0WY^GGUV 2?Z7X%_H&_PO
M_M_]M^>/=3CKVBH)!X?;_FZZ-OS]?[/]DV/]/I?W:E20#P^WK6GT-?\ 5_+\
M^ECM/KSL#?U1]GL;8F\=Z59<1"FVGMG-[BJ"YX$?BP\$S:OZ"WM-/=V=MFYF
M2/\ TS!?\)'1=?;KM>V"NY7,-OY_JR)'CU[F I\^'1QMB?RN?YA78TE,NW?B
M5W!1K6!&@EWI@8NM:<I+^B22J[&FQ2(I'J#.P%N?I[)9^;.7+8D27:$C^&K_
M /' W0(W#W<]M-K+"ZWFW.GCX3&?_JPLE?RZ.]U__P )Z/G]NUXCNINFNK*9
MM+S#=?84V:K(P>2D4'7M!F(G=?P&G5?]K]D5Q[D;!%B%99&!QI4+^?<P-/RZ
M NX_>7]N[+4+);J[/D4B"*?M,LD;#\E/1W>O_P#A,IDI%CJ.T_EE0TC73SXG
MK_JV:O# ?J,6X=R9>GM;Z#5BS_7_  ]DEQ[G,12UM,^KO_D5!_Q[H!;C]ZL4
M*[1LV3P::?\ Y\2/_K)T=K8?_"=/X*[9C@?=VX>\^R*M=)J4S&]L)M[$3,/J
MD-%M'$T=3&A_HU<[?[7[([CW$Y@E-(!%"/Z*5_X^6Z >X_>8]P[MB;)+6T'E
MHA+M^V5W!_)0/ET;3;_\FG^6KMN&.*B^+NVJYHU75/N#=_9FY9IG46+RG/YN
MI7D\E455_H +#V42\X<S2L6-VXKY#2H_XRH_;Q^?0,N?>OW1NWUR[O(I_P"%
MI#'_ -6XUZ7?_#5G\N[1X_\ 91^H--@-7\%J_+Q^?-]QKO\ XZK^T_\ 6;F'
M_E,E_P!Z/2#_ %VO<K_H]77_ #DQ^RE.D;GOY.G\MC<44L5=\5]H4HE5E+X'
M='8VV'CU?VH&VWF*4H1^-)'MZ+F[F6$AENW-/XM+5^W4IK^=>EUM[U>Z%HP>
M/>)6(X:UBE'_ %41NBF]A?\ "=SX';LAJ6V?D.Z.KJUPYI/[O;YH=PXN"5CZ
M?N*'?&.R51+&/]0E;&_T_<%N3BV]P^8H&!E,<P_I)I/Y%"M/V'H8;;]Y7W&L
MW!O?IKP>?B1%&/YPO& ?G0CY=5I=T_\ ":SN+"15=?T'\@MC]@PQJ\T.W^QL
M!D^N\RZHW%%2YG"R9RDJ)2/TR3I1I?@Z1S[$MA[G6TA"W]NR5XM&=0_8VDBG
M^F;J4]A^]-L\Q5.8MLEMS2A>!Q,OVE'$95?D&D/5*'R&^!GRZ^*[U4W=_16]
M=J8&GG,!WI1TD6Y]A3L3>'Q[VVP]9C5:1?4D,M2DOX,88$ ;[;S%LV[4%E.K
M,?PDZ6_WEJ$_E4?/J=>6?<;DKF\*NP[A%+*?]"8F.84X_I2!7-/,J"OH>BB:
M3_AQR01P1_6_^M_Q7Z<^SOY?ZO\ 5Y9Z&]/4_P"K\NN@&N/IJ;ZJ>1R+_P"O
MP"./>Z'_ %?ZOV=>TFE>O"_#?T' ^I/%C?WKJO7?^'U/U)'!M>_%O?NO==CC
M_6_PM;_7%N?>Z9IU[KJWZ?I];\"W^Q]ZZ]UZQO\ 6Y%P. .2+^_=>Z]P>?S_
M %_WBXO[]U[KUS_0?X6M^/I?GW[KW77]>00#?_8-]?I[]U[KNP_Q_3;_ &'^
MO[]U[KU_]J'T%V'XY_/OW7NNOS:_!^@'YXM]??NO==VOZ3^+6X(_UP/?NO==
M'C^G'-^;$WM?_C7OW7NO$_3ZV+#_ &W]+>_=>Z]8'@B_YX):]^#S[]U[KD0.
M?]Y_QM]/?NO=='@$_P")/]?J+>_=>Z];G\CG_>?]Y_Q]^Z]UT3_K'U?VOQ<?
MT/OW7NN5K7/^);C@&_OW7NN*\@WMS_3C@<6/OW7NO<_["_.GZ"UK6M?W[KW7
M=_Q]?3^D<_[S[]U[KUS8@_BPN.3_ *Y'OW7NO<7']#ZOS>X_)]^Z]UW_ (VY
MX^H_)_Q]^Z]U[G^@_P!O_P :]^Z]UQ'_ !().K^O^ ]^Z]UX?4GD_P"L187Y
M-N??NO=<K_6W)^G^M_3_ (W[]U[KC8?U^ER!^GZ_CGW[KW7OH0!_B03] ".?
M]\??NO=>(')_'Y_V!Y_WP]^Z]UZRFP'X(-C?_8\'W[KW7K7_ %#\ 7!^OYM[
M]U[KO\#3_7D ?\5]^Z]UWR/Q^?H..+V%O?NO==7!OR/R/K^"??NO=>MI^G^\
MD_G_  'OW7NNN1]#8?2Y^A_QL??NO==_2PN;VXYXXX/'OW7NO"Q+'_6^OXM_
M7W[KW7N>?J/]<CZ \_3W[KW71-C?_6_U[?ZQ_P ??NO==F]P.?S8\?4?ZWOW
M7NMVW_A-E_V0QVK_ .+7[Z_]]#L7W"/N7C?8A_PA?^KDO6"/WHO^G@6G_2OB
M_P"TF[Z__];:9_GA?]NN_D]_K]*?_!#[2]BWD;_E:;7_ )N_]69.IA]@O^GM
M;5_U%?\ :%<=?/@^@!O>W"\"P/O(3KH]UR_J;%3];V'TM].??NO=>%OS:XL3
MQ8_2]_?NO==<V-S?Z7N"./S;W[KW7?/Y']1Q_0_XGW[KW7N&_P"-?T^EK_T]
M^Z]UU8&UQ_T-8?BP'OW7NN_Z?06N.?\ B/I[]U[KPN!8#B__  8$'W[KW77'
MX!-A<6_'^!Y]^Z]UW]/J#^>38V_K:WOW7NN)''^/^L.+_2_]/?NO==DD<$V^
MMC:YL/Z^_=>Z]P?J/H?K]18_G_BGOW7NO *;?X?U%@0/S[]U[KOZ&QL#;CDV
M_P!M[]U[KC<@VYM]/]>YY)/OW7NN_H?KQS8'\#_@WOW7NN_3;Z>FWUYO];^_
M=>Z\;6N.?KR>/J;>_=>Z[N/\;BU_H#SS;GCW[KW7$\<?ZUK<V_I:_OW7NNR.
M#]>;_DG\<>_=>Z]]>1_2Q'T'^(-[^_=>ZZ_3;\"_T!-S_K^_=>Z[7\\D\V_U
MK>_=>ZY7/]/S_7\?U]^Z]UQ%C]+?G_6X/^IO[]U[KW^')M;@_P"WN3[]U[KH
MV/X!YN+7(_Q%P/\ 7]^Z]UW_ %N0?ZC@ ?Z_OW7NNN#^KG_'^G^'XY]^Z]UR
MMS_O7TXX]^Z]UP /_(-S_2UK^_=>ZY'3:]_J>>3_ $O[]U[KPO>_)N+V L/]
M[]^Z]UX<7L+DW)XMR?I];<>_=>Z]Q_J?I9>>.+_CW[KW71%[_CFPN.3Q;Z^_
M=>Z%KH4?\9UZ6)_Y^QUV?Z_\QA1_\5]H=V_Y)5S_ ,TI/^.'HFYG/_(<W+_G
MGG_ZM/U]2/WBYUR9Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NB4?S',+19KX$?,2DR$234]/\<^V,Q&C#7IK]O;-J\]BYAJ_,=530R G\KQ
M8^S?EUF3?[-J_P"CQ#'S<#_ :'CCH<^V,C0^XFQF/!-];*?F'E5#^U20>OFL
MGD<< GGZDD_7CWDUUU&Z]SP>;?C\<?7FU_?NO=<B/]ZM_K7_ #[]U[KB1PQX
MO8@V-_\ 7]^Z]UW>WU L.>  0?Q?W[KW7K'Z\$_U(''^O8^_=>Z\;CGZ_7\G
M^GY'T]^Z]UU?\?3Z<FW%Q;@>_=>Z[L#^+D6_PO;C\>_=>Z]]2+WO_4#@6-_J
M??NO=>7ZCG_"_P#4GGG_ 'CZ_P!??CCC@G_5_J^T5ZMI)X9_R_9_J_R]&K^.
M/PC^5'RTJI8>@NF=V;ZQE+4_:9#=?BH\!LC&50&MZ>OWKN66CQBS(OK-,M4T
MY6Q6-KBY/N>_[1LX_P!V$X1J5TY+'\@"1]IH/G3H&\T<_<H<F*/ZQ7T<$A%5
MB%7E8>1$489Z'R8@+ZD=6(2?\)]?YB QJURX3J*2J8:CAD[/HQDD.B_C:62E
M6C)/TNM61_C[#0]QN72VG]7[?#_Z&K_+J,Q]Y'VV,NBMU3^+P!I_X_J_XST7
MW>W\F_\ F1[%+O7_ !DW#G*9072LV5NC8&]Q*@_MI0[8RM55K?\ "RTZL?Z>
MS.#G7EJ< BY"GT974_S6G\Z="2Q]\/:Z_4:=U6(GREBFCI]I:,)^QCT4S>OQ
M)^4_6[.-_?&[O79\: L:G<'5&^,90NB_62'(55"L$B?[7'(R_P"/LW@WK9[D
M5@NHF^R1:_LK4?GT,K'G7DW<P/W?NUI,3P"W$1;_ 'G54?80#T %12U-)/+2
MU=/-254+^*:GJ(G@GBD!_P W+&X#*P'U5@#[,E974,I!!\QD?MX="5&65!)$
M0X/"F<>OS'S'6#C\#Z"Z\_4?X?U][\J].%2!4XZ[&H_@_6WTO]#_ (?U_'OW
M7M!_;_J_U>775K?EK@WM?ZW/T_XU_M_?J$]:TGA_J'7?(_%A8CZ&WUXO;WNA
MX^77@I/#/V9_P==?4<'_ !_IIOQP/S;WZGIG_5Z]>"DUIY==_BQ'XL?]\/>N
MJ]=<'\V8CZ<V_J/?NO==_P"P.FUOI_OC[]U[KK_;\'GZ_P!+>_=>Z]_7CZFQ
M%^/I<VM[]U[KQ%N0.;6TGGC_ &'OW7NNK%N3QR-/]0/\??NO==WL;_ZXL.2U
MOZV]^Z]UX<_C^@YN"2/S?W[KW75_I>][W_Q4'ZV]^Z]UWQQP.?KQ]?\ 6]^Z
M]UUQ:WY-K_CZ?D7_ ,??NO=>''TYM];\6/Y//OW7NN5N/]C_ +Q>]O?NO==!
M1<_ZXM_A;_7]^Z]U[F][7) MR#;^OOW7NNQJ_P!Y/_&C^/?NO==?[T;DWX/^
M/OW7NN_K:_\ K\_@_@<>_=>ZZ'^W^IY!')_I?W[KW7'Z?X &]OQ8-^#[]U[K
MGP;\@W_5;F_'OW7NNO\ B/\ ;_I_WOW[KW7A]+CU$?3^MB/H??NO=>U<?4$_
MX_G_ &]O?NO==7^HX_%S]1ZOK]??NO==G_&W/!)XOZ>+_P#&O?NO=>^IX'T/
MUO\ [$\>_=>ZZT_06'^V_P /S[]U[KUQ_7GZ\?3ZV^G^\^_=>Z[/(XN/Z'Z_
M[#T^_=>Z]<?2XM>][C_7_P![]^Z]UV/IR!]!?\_3_#W[KW70OQ8D@G^@^GOW
M7NN(//\ 7F]_Z$G^O^M[]U[KG8_ZPM:WU'^Q/OW7NNO\;FWX/%O]B!;W[KW7
M6D?ZG\G^OT'X_P!?W[KW7?'''UX_-[_T/OW7NO?UY'U%A_K&QX][Q3Y]>ZY'
M_ CC\6N?]X]^ J:=>ZZNM[<7^G^P_I[UU[KJ]_J.5_WCCZ^_=>Z]Q;_6L.;&
MUCQ]/?NO=>/X')MP>; W]^Z]UZP'X'UM]+\G_$^_=>Z];ZD?G_>K?U%S_O/O
MW7NO <7XO];@6_LV]^Z]U[Z6^O\ A>Y_V!_Q/OW7NN_]B>..>!_6Y]^Z]UU?
M_ _3BPX_V%O?NO=>^@O_ (<V%CQ]!;GW[KW7=^"?]MP>./R/?NO=<>+<W(O?
MZ'_>2/?NO=<N1<D #Z_DFY_K[]U[KC<?3]7-_KS?_8>_=>Z[!'T7\6_K_7GZ
M^_=>Z]S_ +"Y/^/#7^GOW7NNOI_L#8 <<G\L![]U[KL<DDBQXM]0?Z?3W[KW
M79N.?Q_3\6_UOZ^_=>ZZ^@M;ZZOQ>P_V'OW7NO6_!^GU)O\ 4CZV]^Z]UX$\
M\@\V!_QM?W[KW7N/Z6X(_P"00;>_=>Z];ZB_UY(_I?ZB_OW7NNM/UO\ G\WX
M'-_\/?NO==@$'@?T^MN!?Z"WOW7NO7N#;FYM?^O%_P##W[KW7>D6/ OS^/Z_
M3W[KW75[?0ZOQ;Z\?G@>_=>Z]<"PL+\?UMR?Q]??NO=>M;D6^C&]N?\ ;>_=
M>ZZO;^I_///'];CW[KW79-C:UQ]+#Z_[;W[KW7N.>?\ @Q_V' ]^Z]U[Z#\_
M[8_ZG_8^_=>Z[.D&Y^OU_P"(O[]U[KH?7^G  '^PO]??NO=>M^>=7XO^;"]N
M/Q[]U[KHW^A(%B. #8GZ\^_=>Z[%OP/\/[7_ !3_  'OW7NN7]?KS_M_I;\>
M_4S3KW7$G@6%O]B./QP/>RI&?]7\^KZ#Y9X?SZ]<G_7YXL;_ $YL1?\ WW^'
MOQ%,''5:4XFG\NNB"+7O:P']FZDVYM_MO>O\G^JOV=;TG_57KWZ;B]N1<\?6
M_/'_ !KW[_+U[2:T&>A1V=T=W7V(T$?7O3_:.^7J=(@39W7^[-SO+K/H\(PE
M).6O^+ _X>T4NY;= :3W$:?Z9U'^$]$MYS%R[MVK]X;A;0:>/B3Q)3_>F'\^
MC:[._E4?S$M\O3QX7XD]M41G*B,[QQ>.Z\0:A8>:3?\ 4XQ8_P#$R%0/S;V4
MR\W<M0FCWB'_ $NIO^.J>@=>^\'MEMY(GWF!J?[[US?]6D>OY5Z-KLK_ (3[
M?S$-U21)GL'U%UPDFGR2;R[-HL@*=6%RLJ]>TN=8D?[0&]D\WN)R]%\'BR>F
ME *_[TR]!"]^\G[:V:D6K75R1_ON"E?L\9XNCB['_P"$R_:E9)$W9/RHZ_VW
M%93/%L?KS<.]I&M<M%'-GJ[  7^GD:,V^I1OI[)Y_<Z  BVM&;_32!1^856K
MT"-P^]5M:@KMFS2R?.6=$_DL<N/Z-?SZ.!L;_A-7\7,4T<O8/>G>.\I(P"8=
MMQ[(V-03/?U">*KQ^:J-!_HE4K?[7[)I_<O>9 5AAA3YD.Q_X\!_+\N@3?\
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MKW7OK8<W_-OR/ZW]^Z]UNV_\)LO^R&>U?_%K]\_^^@V+?W"/N7G?HC_PA?\
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M=4.#Z?ZO]7#KQ]./2)W=UEUUO^+P[[V!LG>L0C,2Q;MVK@MR1",_[K"9JGG
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MB3,83/5VL_XBA6WXO[-X/<^@_P 8L\^JR8_85/\ AZ%ME]ZR(@+N>RG'G'<
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M-[_B]R/]<#W[KW7K#CZCD#Z?73[]U[KWYN>1>P%QP??NO=>%^."1;Z<7O?\
MQM[]U[KA>W!TG_;FU_K]??NO=<K\VL;G_6N.+&Q]^Z]UZX_I^;_6W/\ K'W[
MKW7@;  ?4B][_F_OW7NN5SQ_O0_UO\??NO=='CG\?TO_ $-Q]??NO=>_J?R;
M7%[6_P!<^_=>Z[L?\!_K?TM_Q7W[KW75QQR?\3;^@YN/?NO=>)M]+6X/^W_P
M]^Z]U[@ 6_/-OZ\<CW[KW7N?]YO];#Z<CW[KW7?T)-CS;\C_ (GW[KW77^PO
M_B/SI^ES[]U[KU@!^/Z\@7_VW'OW7NO6Y _HMS_7Z_2_OW7NO?D_6Q^O!^EK
M6]^Z]UU<< G@#D6^A^GOW7NN7X_K_MC<?7\?[Q[]U[KH#@@<C_&QY_I[]U[K
MQO<_T/%C8$_ZWOW7NO<6-^?R>?J/J+V]^Z]UW<_X'Z?0_3^M[^_=>ZZ_M?UL
M/S^+^_=>ZZ6WU''^!M];?U]^Z]UW?^O%_I8'\_T/OW7NO?[4+'BW!)_-[>_=
M>ZZN20K ?XGFU[7X]^Z]UW^0/S]?]8C@$D>_=>Z]_O%B+D_D7O:Y]^Z]U[BQ
M']!S]??NO=;MO_";+_LACM7_ ,6OWU_[Z'8ON$?<O&^Q#_A"_P#5R7K!'[T7
M_3P+3_I7Q?\ :3=]?__0VF/YX7_;KOY/?Z_2G_P0^TO8LY&_Y6FU_P";G_5F
M3J8?8+_I[6U?]17_ &A7'7SY!Q?_ !MR >;_ .M[R%ZZ/==<"PXY)_VQ]^Z]
MU[\<<7 _Q_/I/OW7NN_I^"/P#]3;^@]^Z]UQ)!%K<_3\<$?07]^Z]UW_ (7%
M_P _\%_U-_?NO==7_P!C?Z@?3Z6_UQ[]U[KL\$<GZ_TYM:Y_V'OW7NO7Y!_'
MT_KS_6P]^Z]UW?@G_@W]+C_#W[KW75[?U^@L+6/UL+GW[KW7N3?Z<?@B_P#K
M7-_?NO=>XO>Y_21?_6/UO[]U[KW^'^/^'Y/%K^_=>Z]<<'^G!+<$>_=>ZZ/T
MYYY/)N;"]K>_=>Z[%E_%S>UP.?I?W[KW7KVL/\?SR0#SR/K[]U[KQ(M]#_K?
MTX^@_P"*>_=>Z[M;Z?X#Z_@>_=>ZXDW%K7_KP1I]^Z]UW_L./K_7_8?\3[]U
M[KP%^2+$<"X(M_O/OW7NO#ZG\7OJ-^1^1[]U[KL_U_WC^M^ #[]U[KW%P?S]
M/QZO?NO==76]_P _\:^E_I[]U[KH?[#Z$6MP.>+_ /&_?NO=>XX_QL;\WL6O
M]??NO==WX_U[<?07/-^.??NO=>Y_K<?2Q7_>3]/?NO=>-_Q8C_5?T_V-_?NO
M=>!_QY-OI;Z:K?4#W[KW7CSQ_C;_ %S]?]M_L??NO==?X_0<G@FW/T]^Z]UW
M]?TC\&_^!/OW7NN^?];\<D?3^O\ K^_=>Z];_?6-O]M?W[KW7'@WM_7FU^;_
M %]^Z]T+/0G'>?2I^G_&6>N3SZO^8QHO:#=?^25<_P#-*3_CAZ)>9_\ E6]R
M_P">>?\ ZM/U]23WB[UR:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NB?_S!_P#LA'YE?^*O]Z?^^UR7LWY?_P"2]8_\]$/_ %<7H:^VW_3P
M]C_Y[[3_ *OIU\T*RW^G'^Q_V/Y]Y-==2NN[>J_U//']/Z6]^Z]UUQ;U"UO]
MMZC]1[]U[KUQ86Y(_P!?\#W[KW7O\/Z_CC^M_P#6_P!X]^Z]UX7-K7XN!>PM
MQ;W[KW78(  _P^O^'TO_ ,4]^Z]UX'C@\< ?BP^GOW7NNN0+CDW/TYO<_GW[
MKW7?.GZ\W^OZO\/Q[]U[K?R_D4]9XK8'\N3J3,T4,,>4[4W#V'V+N6:*%4:H
MR4F]*O9V*+2CEM&+PV/3G])! X^N/7/5U)<\RS(:TBTH,^04$X(_B)/7.GW_
M -UGW+W/OHY&)2T6*",'R58E=OVR22'YU\NKBO83ZA;KWOW7NO>_=>Z][]U[
MKWOW7NO>_=>Z][]U[KWOW7NO>_=>ZQZ#]-5QQP03]/\ $F_^W/O5"1GCZ_\
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MX][IY'_5_J^=.O:3Y4_:.NA?BXMSI-_J">0+^]'KQ6G$T_;_ )NN0!)L ?\
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M[K^VJ_\ +;M?RDK_ ).G"+^5O_,+FMI^(O=%SZQY=LM!Z2 ?5YY%L?ZK]?\
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M3]?XGV3C(M=O]6</AZ6U_P Z;>T;^X?,C?"Z+]B#_*3T4R?>3]RG_LVM8_\
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MWY-P.1:]_K?\>_=>ZW;?^$V?_9#/:G_BU^^?]XZ@V*/<(>Y7_)=B_P":"_\
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M^K+_ &<I[B3H<DL^*1?K:][G5:WY'^Q]CSJ>>O<V/^/YOQ]/?NO==_CCZ6/
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MKW7@?[5K<<B_X!]^Z]UU]6'JY'U_'^N!Q[]U[KE_A^/^(M_4>_=>ZZ %M/\
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MZ]UW^.?^3A_L?I[]U[KH?4BY-OP;<BWOW7NNP.  ?H>?S_K^_=>ZZ']>+#Z
MBP_U_?NO=>Y_-_\ 6MQS]?IS[]U[KO\ UK7^MOZW_P!M[]U[KC];\6-C?_6/
M//OW7NNQ<@GB]Q^#^!_C[]U[KUK_ .'']!]+?3_C7OW7NO<_7DVN3]!R/I]/
M]M[]U[KK_?$?4'\FU_\ 6/OW7NN_Z6_M?\4N3[]U[KJQM]>+\7%S_@1;W[KW
M7(BXM?\ I?\ Q_K[]U[KQ-@?KP/K_P ;/OW7NNN/Z?X_J_M?T]^Z]UUR+_FX
M/U_Z%M[]U[KL@<?D ?4_X_3W[KW7A_6QM]?K;Z#CCZ>_=>ZZ %[?UY_'I/\
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M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^;_\
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M+:O\??NO=>M^?TC_ 'G_  O_ (?X>_=>Z]8<<_5;?ZX_J/?NO=>'T'!_P^G
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MR;_07_-CQ]??NO=>N";$#CC\'G\ $^_=>Z[_ ,?Q^+?47%C[]U[KK_>U-_\
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MU_\ 9$?F5;_O%[O4_P"VZTR7LWY?_P"2[9?\UXO^KB]#7VV_Z>'L7_/?:?\
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M]U[KUQ_C<?XW^IM[]U[KQM>]B+$&_/\ L??NO=>_%K?[:]OK?\>_=>ZW;?\
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M ,:]^Z]UX\BWXM>YO_OK^_=>Z]]#]!<W(_J..3S[]U[KC^2+_4G\\_7Z<?\
M%/?NO==@6/UM_0<?2]_S[]U[KO\ -S]"+?T_/-[^_=>ZZ_%QQ:Q( 'U N>#[
M]U[KWYOSP"!P;G_'Z>_=>Z\6']?]AS_7@W]^Z]UV>!S^3S]0/\?\??NO==GZ
M7YX_QM_O7OW7NNN+ _[>YO\ X?4^_=>Z[Y*CD_2_'Y]^Z]UU?Z'\&Y^E[?D?
M3W[KW7OQ_L!;_$#GZ?U]^Z]UX_DGC]/U_P #?W[KW77I/T]5_K^#];WO[]U[
MKNW"WN?Z?C_6O;W[KW7K?[:]_I^/Z6_WCW[KW77I_H?^)M_3W[KW7=CS< \
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M_>MN')&SWO$R6=L3_IO!4/\ EJ!_S=%E'TX/-OR?S] ./Q[->A/UWS?F]K\
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MKJQ/)_2.0/\ #W[KW7*QO_L?Z<V^MK_T]^Z]UNV?\)L_^R&>U?\ 'Y7[X_\
M?/[$'N$?<O._1'_A"_\ 5R7K!'[T7_3P+3_I7Q?]I-WU_]':8_GA?]NN_D]_
MK]*__!#;2]BWD7_E:;7_ )N_]69.IA]@O^GL[5_U%?\ :%<=?/C_  #_ %L/
M]B>;V_U_>0G71[KQ%_S_ %^I^HO<\C\>_=>Z]:_'U!)_UN#R;CW[KW7KW_21
M_K6_Q][QU[KJUQQJ-_S^>#?\^]=>Z['T%QZ;#^@'];_X\^_=>Z\?I>WJ^E[?
M4_X>_=>Z]_M7%K?3_:?K[]U[KUN>; ?4\6'^L3?W[KW71/ ^H_UQ<\?U_P"1
M>_=>Z['/^]7(O<?[Q[]U[KI0/]C;D?U'^Q]^Z]UW]2P/(%O^*_CW[KW71Y_'
M]0">00/S_2_OW7NN[:?H"+<6YXY_PO[]U[KUA_L>;?X$\V ^GOW7NO<6M^+V
M^H%O?NO==_C@#G^O _V(]^Z]UT+7X_V ^A_WG_7/OW7NO?VKW'/ X^O^Q]^Z
M]UXC^EQ_K'G^O_%??NO==?D@K^+_ %' '_$>_=>ZY7^@_)YXY_WGW[KW71_K
M]+'58_FWUM[]U[KJYXOQ;\"X'!X^MA[]U[KJX_I]+?3G]/YO[]U[KE]0&%_Z
M?X_7\#GW[KW71)_QL?\ #_'Z>_=>Z\>.+\GZDCZ6^G'OW7NN1%_P+'Z_U_P]
M^Z]UU?@ VY^GUM_A[]U[KWX-K'BQL+DD_P"M[]U[KQ/'-K\<'GZ^_=>Z]]+#
M@"]N#?G^G/OW7NO?4FQM8#ZCZ?ZXO[]U[KQY^OX(^A_)_))]^Z]UU:XX_P
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M! X/T!YO[]U[KW/UL;@G_;?T/OW7NNB"/R?ZV _)-S[]U[KUK*>?K]2?]?\
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M_P !;_6_U_I[]U[KWU(!_'/%_K^/?NO==@7'U/XX/^'OW7NN/]0+@W)^J_[
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M'VAXSM/L#>VV/%;Q';NZL]AO'SQXCC:B*W^PM[32V5C.=4\*.3QU*I_PC/\
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M]^Z]U[W[KW7O?NO=>]^Z]UC$BD7Y'^O];_TM_7_#WK4"*CKU.M #^=E\I/\
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MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^<5_-=_[>*_+;_Q*M?\
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M H_PUZ71_=:Y4_T;<[MOL6%?^?&Z0V4_X4@_.6L#)0=<_&/$J==F@V3V765
M!:ZW>NW?)&;#C_-#ZGZ\>U:>VNQJ.Z6<G_3(/^L?1A%]V#D%#66[OG_YN0 ?
ML%N#_/H.\I_PH-_F'Y'7]KE>G<(&MI&+ZQBD"?UT',5M6?\ DJ_M]?;KEY?.
M4_:X_P BCHQA^[9[:Q_V@NI/]-,/^?43H/LC_/;_ )F%=J%-W;MS#@Z@/X;U
M!U1(4)-[#^,8BKO;\7O[41\@\M)\43-]LC?Y".C.'[O?M9&:R64DG^FN)_\
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M+NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K47_X4X>G>OQ
M'Y.U^YB#:]@,KMW^O^O?W+GM:"(KT5X&+_!)_F_U4ZS+^ZE7Z/>R/X[7]NFX
MIUJU?\F_0$?JL#]+^Y5ZRTZ\.;"_U4C_ &(XO[]U[KD >+_@?CZ$VL;CW[KW
M77T^G^]@ D_D?7W[KW79OQ8"]_S^/];W[KW7?^W^@_WGW[KW75^!] #;_;6N
M??NO==7YL3S>_!/^V^GT]^Z]UXGCC^MS;\C\GCGW[KW71L0 "1?Z @V_V_OW
M7NN[6^@(X^E[\V_I[]U[KHGZ7N+7Y_/^/'T]^Z]UR^G)/%OI:]O]C[]U[KHW
M_!_QM:QM^?K[]U[KU[6']1QQ:Q''%_?NO=>/)_Q7F_X'YY]^Z]U] W^1A_V[
M"^.O_4?W-_[_ #W)[Q]Y\_Y6FX^R/_JU'USF^\#_ -/9W3[+7_M$@ZMO]A#J
M&>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KYQ7\UW_MXK\M
MO_$JU_\ [K*3WD=R?_RK-H/Z)_X\W73GV8_Z=ALW_-$_\??JOC@_@?X?U-OJ
M.?8CZD;KE;_$_2WU_P!Y_P!?W[KW7 D"PY'YXX(%O^*^]@5Z]UXD< W_ -@3
M?@\7'O77NNQQ_9(_WF_^O;W[KW7K?X<&WXY'X ]^Z]UZX)!N.+\7%^>/Q[]U
M[KNQM^!]#8#B_OW7NN/T_P!B=0_U_?NO==\#G\D_GGB]S:W^W]^Z]UW_ (_6
MP-KVN?\ 6(]^Z]UT&^GU^@O]/J?I[]U[KH<<GC\<W_H+_P"]>_=>Z[_-_P"H
MOS^/];W[KW7O[0(X/Y!X_P ![]U[KW'TOP> ..>?J#[]U[KH B]Q>WT_/U_5
M[]U[KL\7O8 B]_H??NO=>' XN>>;D?D?7CW[KW7B3^#_ +T>+7X]^Z]UZP_K
M]?U?BXM:Y'OW7NO&XM:WUYM].>!S[]U[KWY']/P;$FQ'Y/OW7NO7O]>?Q?Z"
MQY]^Z]U[\?XK]"./Q?W[KW7>KZ<'GZ?3^E_?NO==<?FWZAP.>;6L;>_=>Z]^
M!_B +VXXY^GOW7NO$C@\6OR2+G^G'OW7NNQ_R;]!;Z6^@Y_K[]U[KB/];Z7/
M] ?ZVM<>_=>Z]8\G^FF_^) O]??NO==W-S_O N/^)]^Z]UX?0$\BP'_%3S[]
MU[KK_8#\W_KQ^;^_=>Z[X_I]/Z6&G_ F_OW7NO $7O\ 7^IYX]^Z]UX_U_QX
M/X^MK'_8\^_=>Z]?DD\Z;_3_ !]^Z]UNV_\ ";+_ +(9[4_\6OWS_P"^@V+[
MA#W*_P"2[%_S07_JY+U@C]Z+_IX%I_SP1?\ :3=]?__4VF/YX8O_ "N_D]_Y
M14?[?Y#[2]BWD;_E:;7_ )N_]69.IA]@O^GL[5_U%?\ :%<]?/B )_)_!L0#
MP?H;^\A.NCW7?X^H)'YX^@-_Q[]U[KH?@&_(N.;G^OUM[]U[KE:]OI<7M_2_
MOW7NN)/^\_I%VY'^W]^Z]UR-_P 7'T_ _K]/?NO==<_DG_$ 7MS]"?>S3RZ]
MU[_8'A3]>>3_ $_K[UU[KUP/[1_W@_3_ %A[]U[KPY^G^U6/UX+?D>_=>ZZ_
M/ %P;\'^O!Y]^Z]UWS^3]0 >!]3QP??NO==6XN/\#?ZDV_U_]X]^Z]URM^GC
MZ?7C_8W ]^Z]UU?\?4_TN/Z6M[]U[KI;#Z DV_V'^\^_=>Z[%OP+'_ ?X?DD
M>_=>Z]S_ (C_ &Q_M?T%_P >_=>ZZ%_P?K_K<7-^??NO==_0<_BW^\?2Y'OW
M7NNN+WM8?4'^M_J#[]U[KUP =/%O]C>X_'OW7NN[<?CZ6/\ L3ZO?NO=>M_A
M;@?6Y^OX]^Z]UX6^B_CZ_7^O//OW7NN[@V_/Y _V-K^_=>ZZ-BMSQ_B1S_MO
M?NO=>'))_ -@/Z$>_=>Z\!^?J+#Z<BX^EK>_=>Z\+DW%^./^##_#_'W[KW7?
MU^@^GT_'X_H??NO=="P_(O\ GF]_?NO==%OH./\ 8"X_P]^Z]UWQ]/J?\?K^
MJWU]^Z]UV#;_ %N+?2P_V/OW7NO"WT^MOZ?BW^'OW7NN(U#\GZV_UO\ $7OQ
M[]U[KL<C^IYY_P!<\FWOW7NN(Y_M?U"_@?2WT]^Z]T+/08MWITM^;]L=<&P/
M_9XT7M!NW_)*N1_PJ3_CAZ)^:,<M[E_SSS_]6GZ^I+[Q=ZY,=>]^Z]U[W[KW
M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1/_P"8/_V0C\RO_%7^]/\ WVN2
M]FVP?\EVR_YKP_\ 5Q>AM[;?]/#V/_GOM/\ J^G7S0CS^#^1?_8V/^W]Y-]=
M2>N^5_UOJ0!]!?\ J3[W6G#KW7K7O<?[<V MQ^/>NO==?X&Q-N"1S_L;^_=>
MZ[!Y-S_06O\ [<V]^Z]UU?3?5]#]/I_MO?NO==\<<<V'T^OT_K[]U[KU^/SS
M;\$_BW^'OW7NO6U<W-OJ/]?_  ]^Z]UU_0'FWT*\VM[]U[KU@+V)!_)_-K_X
M_P#$>_=>ZY?F^KBU[6_%OK[]U[KKZ_X6(O8\?UN1[]U[KP^G]3QQ<6%O];W[
MKW7=Q:]OJ>/IR;V]^Z]UT 1S;^I)XMS_ (GD>_=>Z\?S8V)MQ?GZW/OW7NO<
MAK6_5^;_ -/S]/?NO=>L1^;C^AX_WD>_=>ZZO_M+6M_C?GZ\W]^Z]UW]?I].
M.;_T/ %_?NO=>_V_Y!/^(^I_XW[]U[KKZ'Z_UXX_I<_7W[KW7+D_0D?[#_BO
MOW7NNN>#;@_7_8<K]??NO=>)^GUO]+$?7\>_=>Z\;\\_@G38'\?\5]^Z]UW?
M_>_K^+?6_OW7NN)('U%OQP;\6M_OK^_=>Z[OZN.1^KZ6/TMQ?W[KW7O]?FYM
MS_M^/Q[]U[KW%[6X^AM]>. #_A[]U[J^W_A.]U-GMY?-W,=GTT+IMGICJW<U
M;FLCHD-/_&-](-I[=PNM 0LM1#)DJI YL4I'M<@>X]]R;N.+9([0Y>:0:?L4
M5)_:5&?,]8[_ 'F=XMK+D2+:'(\6]N$T+7(6 :W?[ ?#7[7ZWC_<(=8$=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=:=O_  H[^4AW
M/VAUC\2MNY MB.L,?'V9V-3PN_CDWONR@-/M#&UL1('EQV&>6KC(!!3)CDE;
M"7_;7:C'!+O$PS)^FA_HC+&GS:@_VOKUFM]U_E(6VUWO.=RG?<DV\)./THR#
M*1\GD"K7R,1\CUK+6_IQ]/\ &X'X]REUE3UU;_ 7^O!M]#QQ[]U[KW -["UO
MJ>.?]8^_=>Z[/U_I_AQ<V^EO?NO==?ZQ/ZO]?\?3W[KW7OQ^/SSS?D7O[]U[
MKL?T%[_XD_[?\^_=>ZZ'(_#?Z]A^?Z>_=>ZZXX((7\?UX^OY]^Z]UWS_ (\:
MB/KR3].#[]U[KWT'XX_P^G%^??NO=*?8W_'Z[-/_ &=&WP?IQ_N5A_P_U_;%
MYBRE_P!(_P#-3TDW7_DEW?\ S2D_XZW7U5?>*O7(OKWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z:\SF<9M_$97/9FKCQ^'PF-KLOELA4:EIZ
M'&XVF:LKJR=K7"1Q(SL0#P#[\H+L$45)X?GTY#%)/*L$(U.Y"J!Q+$T 'S)-
M.OF_?S /G#V/\Y>]]Q]A[FRF2INO<7E,EC>HMA/52_P?9FS5J&&/*T2D1-DZ
MZ-$J,I6%-<LIT B"*"*/)+EO8;?8=O6V11XSC]1J9+'^6D9 'VFE2>NGGMK[
M?[9R!R]#86R*UW(H-Q+I[Y)2.[/'PT)TQKBBBNG6S$D8-_\ 7Y)''^\&W/\
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M[L!]+C^NGGD<VY]^Z]UX?X?T%O3].;^_=>Z]]+?U X ^HX]^Z]UX7_'^JO\
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MOW7NO>_=>Z][]U[HG_\ ,'_[(0^9?_BK_>O_ +[3)>S?E_\ Y+ME_P UXO\
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M_P![%N>.;^_=>ZZ^A'^OP!P+VYO[]U[KOFPY^MOQ_46_XW[]U[KB;FQ/T'U
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MX^G]1ZK_ -;VXM_7V(^I&Z[ 'X_U_P#;BW/U]^Z]UWR/];G^OY/''OW7NO<
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M^.G_ 'OW[KW79'U!YO\ 3Z_T_/OW7NN)(L">>+?GDG]7OW7NN[_T '/YXO\
MZP]^Z]UZUK ?X_UY_/ O[]U[KVKZC\W('%OQ>_/OW7NNK_7_ &U[6(Y_/_(O
M?NO=>^A!'-R;VL?K_C[]U[KOZ'GDDGG^@'OW7NO7^G -_I_T4>??NO==<7 (
MX%R>1IN/KQ[]U[KN_%K?X6O]!]/K[]U[KUN+W-_K?CZ6_I[]U[KS?2_(YO;Z
M\CZ#CW[KW7O\#SP2?I_7CZ>_=>Z\#<WX_P!?_8@6]^Z]UNV_\)LO^R&.U?\
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MOIU\T2QN?Z6M]?\ >;>\FNNI771_QN;6-O\ >OI[]U[KUK7_ ,!S_K&P_/\
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M_2XM_A8FUC];CW[KW7K@G\L/]8\<<<?X^_=>Z\>/Q:][%1^/P"??NO=>_-K
MD6N3QR/SQ[]U[KES_O/^\?[;W[KW7"W]2?5P 3<\_DCW[KW7?/UXO_7FUOK[
M]U[KN_\ 2_YYMQ_KW][%*YZ]UUSZN ?]8V)M_6WO77NO?UU<#_#Z #\<>_=>
MZZ%O\#P !:Q(/U^MO?NO=<@;BXY_WBYM[]U[KL&_^Q_V/^\CW[KW7'CZVYM]
M>/K_ $M_7W[KW7OI]+7_ "3;\F_/OW7NO<W )_U_Z?3Z?\3[]U[KWT^HL;?6
MZWO_ *]_?NO==_Z_/I%_Z^_=>ZZ_H?KP.!_O!"^_=>Z]R.";CGZCZ#_$^_=>
MZ]];CG@_V>+ ?BY]^Z]U[_7XYX_/YO\ C_'W[KW7*_\ R+_B/?NO=<#?ZD_X
M6/!%_K8^_=>Z]^=5KBWXM_6_T]^Z]U[FUO\ >>?KQ_Q6_OW7NNK"U["P)^I(
M/^L;^_=>ZYCBW];#Z#ZV_P ??NO==7/T'U^G^MQ];^_=>Z]^?S_B+#GC\GZ>
M_=>Z]Q>Y^I' MR!;GW[KW7FN0;C^O^/^L01[]U[KN_\ K_0G_;?Z_OW7NN)Y
MX^O-A;Z@_P!/Z>_=>ZW;O^$V8M\&>U1_X%?OK_WT.Q?Z^X1]R\;[$/\ A"_]
M7)>L$?O1?]/ M/\ I7Q?]I-WU__1VF?YX7_;KSY._P#E%?\ X(?:5O8MY%_Y
M6FU_YN_]69.IA]@_^GL[5_U%?]H5SU\^+^S^0>/J>>3_ %]Y"=='NN//TO;\
M#@_G\GW[KW7+@WY/) X_%N1[]U[KP_VUOKJ')O\ 2Y]^Z]U[DW%R+6!O_O)O
M[]U[KQ_4#<B]^/QQ[]U[KHV-S=>+?@_0G^OOW7NN_IP+"UO]<W^MK^_=>Z]Q
MS_4FQ%_K<\GW[KW75N!]?K<@_4\_F_OW7NNBH L2/]MS_O?OW7NN8O\ 4_UX
M']/Q]??NO=<;?6XORQX_VW_(O?NO==^C_#ZV^GY]^Z]U[\?ZXN0/I8_4^_=>
MZ]<7 /U'Y_QMR/?NO==?7Z<6^I'!^G.J_OW7NN[#_:3]/HM_K^>#[]U[KJWX
M^M[VO?\ '];?ZP]^Z]UW_C<6N/\ B#[]U[KD3;Z_3^OOW7NN'_$$:2+_ $O8
M7;GW[KW7+D_X7^O'J_WCW[KW7B;W']/Z_C_$>_=>ZX@@@&UA^?\ C8'OW7NN
M=_\ C?XL/Q>_OW7NNB?ZV_(Y^I X')]^Z]UQM_L?]<@\_P!/]X'OW7NNS_AQ
M8VOP +_4>_=>ZY"P L+?[[\^_=>ZX6XO_OKG@_[[_>O>Z9IU[KL7!/U_QM8V
M/^^_P]ZZ]U[C_;_3DFY(M]/?NO==$VX_L\_[U]/^*>_=>Z[!^I')/^P-Q_C]
M/?NO=>('^L#P?Q]/I]??NO==_C^OUYXO]??NO==V_P!ZM_A_MO?NO=<#_P A
M?3\ V_V(/OW7NA9Z"O\ Z=.EC]3_ *6>NB/_ $,**_T]H-V_Y)=R?^%2?\</
M1/S/_P JWN/_ #SS_P#5I^OJ2>\7>N3'7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]
MU[W[KW7O?NO=>]^Z]T3_ /F#<_!'YE_^*O\ >O\ O'6F2/LWY?\ ^2]9?\UX
M?^KB]#7VV_Z>'L?_ #WVG_5].OFA!>"#>WU_UOS[R:ZZE==VY' M]>;GZ?UO
M_K^_=>Z[_)_%_P# WX_Q/'OW7NN-Q_6YO_4$G_6(]^Z]UW<?UO\ J^G)'/%K
M>_=>Z]>_TM_9'!O8@WO;W[KW7B?Z<\_UM^+^_=>Z[46'UN/]OS?GW[KW7&P_
MH;&_%C?\?\4]^Z]UW]0?ZCTW_P![X]^Z]U[@<<_IN3Q>W]/?NO=>YM_@+V ^
MIMQ[]U[KL"P'^%_S_CQ[]U[KJP'-C];BUN>/H/?NO==?0 '\&XY']>"??NO=
M=C^I'()^@/'Y/U]^Z]UW^1;\DG^GT'^/OW7NO6_K_C_O)O[]U[KKGZ@<D#C\
M7OSP??NO=>)_/XXXX_!O?Z^_=>ZZ-F_#<VYMQ_A?W[KW7=^3_A?4;<V_!%_?
MNO=> _UAS:X ''T_WOW[KW7OZ6_!YM^;BY)O[]U[KWJX/)^G'%O\?I[]U[KP
MXN!_K\D6 /Y'OW7NNP?Z<_7_ &%A]+GW[KW77'TMQQ<_ZW(!]^Z]UZ_YYL?]
MB+?X\>_=>Z]^;W%_]?CZ?3_;^_=>ZV _^$]GQ:_TL_*;/?(#<>.%1L[XZ8-:
MC#25,"O3579^]J>HQ.W$42V#F@QZ9.N+*"T-0*1_263W'7N-NHMMK3;8CWW!
MJWKH6A(_-J9] ?+K'+[RW-O[HY4BY:MGI-N3]].(@B*LU:?QN47YA9!Z];O/
MN$^L#>O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KAK7F]QIO
M>X^EO]]?WJO\^O=:2?\ PH7^4A[5^3^V_CSM[(K/M'X[8)VSR4TZ24U5V?OF
MFI\KF_(T5Q(<=C4QM& QO%.U;'I4ZP9K]N-K%MMC[F_Q3FB_Z1<8^UJ\*?".
ML[_NT\I?NGE6;FBZ2DNY-1"1D01%E%/]-)J8^3!8SPH>M?&U[?6]@?Z<7^G'
MN1^LD.NQ>W%^.+?UM];>_=>Z[' '^M^/^(]^Z]UT";7_ !^!]+6]^Z]UUR/R
M/H#Q>P'YX'U]^Z]UXF_!_J2+?T'^Q]^Z]UW]!?D_Z]OI];^_=>Z]Q^?Q_KVX
M-OI[]U[KQX&D?C@_X7_/OW7NN@%O]>?]J'^/^-O?NO==V]-OS:W^WX]^Z]U[
M\<CBW^O]/ZW]^Z]UZ_\ 7\_1>#?_ !O[]U[I4;'(&]MG6L?]_1M^_P">3E8>
M?;%[_N%-_I&_XZ>DFZ_\DN[_ .:<G_'6Z^JI[Q5ZY%]>]^Z]U[W[KW7O?NO=
M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW1;OF/_V2)\JC_3XX=X_^^QR?M?M7_)4M
MO^:L?_'QT(^3?^5PVK_GLMO^KT?7S%/H/KS]>2+V_P!?WE%UU<Z[L>.>.?R?
M]AS[]U[KCQ=3]/\ 86_%A_O7OW7NN_\ 'FW!^I_US[]U[KUSSS];V/IL/\?K
M[]U[KW_$?DAK_6_U]^Z]U[_'B_TL2/K_ *X]^Z]U[Z7/^\WX;_'W[KW7A]!?
MG^A^G^%O?NO==:OP>3_7A2+C_'W[KW7K\\CU7X_UB;6'OW7NNP>+_P!;6_(O
M_0#W[KW7C].>/^)/^/UX]^Z]UU;@#F_-K_C^O]/?NO=<OQ_M_P#'D"UA?W[K
MW71)_P /Z7/^M?W[KW71(_K8VM?G\?7W[[>O=>_!'U_U^?J>/\??NO=>!^M[
MF_XL>!_A<>_=>ZY ?ZJQM]./?NO=<>+&W!%[L1?\_P!??NO=>!^OU!U'^G/^
M/_$>_=>Z[_P'^L1_O9]^Z]UXG^G'U_V%_P#'_7]^Z]UU8WO].+?T^I_V/OW7
MNO'@WM_R%Q?]/]/?NO==V/UO^;\"W^W]^Z]U[\F]R ?SSS_L/?NO=>/T-P3^
M?KQ_L#[]U[KJX'(^A/-_R/Z@>_=>ZV>_^$R?_,UOE;?Z_P"C[K?G\?\ 'R9*
M_N+?<[_<>S_TTG^!>L4_O6_\DG9?^:MQ_P <BZW O<0=86=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6HQ_PIQYWM\0?Z_W4[GX_/\ Q=MN
M>Y=]KO[.^^V+_!+UF9]U'_<+>_\ FI:?\=N.M6G@W_/-A?G_ 'L^Y4ZRSZ[O
M] #?3]?ZFW''OW7NO6^GUX-@#>UP.#[]U[KP_P"3OK;D?C^A]^Z]UW<#_#_7
MN/J;GZ^_=>ZX7!M^2W&DGZ?C_'W[KW7(?CG^MOH+_P"(!]^Z]U[4#^/]Z_'/
MOW7NNOJPM?CZG\V/-O?NO==V%K_3CZ_G_D?OW7NNK+:]K?Z]Q_O)]^Z]UU]-
M/!X_UOH>/]O_ (>_=>ZY?@FW!^O_ !4#Z_[Q[]U[KC]/S:Y(-OQ;^GOW7NN5
M_P# $C\?T_UO?NO==7_QX)O;ZCCZCW[KW7T#OY&'_;L+XZ_]1_<W_O\ /<GO
M'WGS_E:;C[(_^K4?7.;[P/\ T]G=/LM?^T2#JV_V$.H9Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOG$_S7?^WBWRVM:Y[6KQ;_ ,AE(?>1
MW)__ "K=I_I#_P >;KIS[,?].PV;_FB?^/OU7R?K_6]R!^+C_>O]?V(^I&Z]
M^"?I?Z FUK?3W[KW72\?U_/%S_O (]^Z]UW_ %'Y_IP;<6X_XW[]U[KH?[U:
MW_(1^HO?W[KW7KCGZ_C\L?SS?WNF:=>ZY?0< _ZUR>1]!Q[UU[KJUK7MQ>UN
M /\ 7/OW7NO#\M^#_KWXX'OW7NO!5(O;_>_?NO=>6X^HOR?Z?['W[KW7K%K7
MXM_0^_=>Z]<_U_(N+?07L??NO=>/]/ZWN;7^GXX]^Z]UU;_8K:WT^AM<GW[K
MW7N?SR3:UQQ_KCW[KW7?T'!-[B]^?K_7_C7OW7NNKCC\6-B+VY_Q'OW7NO6_
M']KZWMS>_P#3W[KW79Y ^MKV_P 6'OQ%#3KW7=N;_CZ_XWM;W[KW7N1_C_KV
M'^PX]^Z]UT#Q]#8BPL/H /KS_7\>_=>Z['^%_J?J>>#:PO[]U[KJY ]0N/I_
MC_3F_OW7NNCP;VN!<_TM?_>_?NO==_FX-@3S^;\_D_CW[KW7OJ.+'Z\\WY^O
M'OW7NO<@_P"#6^A'U_)%_?NO==\?6W^QMR?\>/?NO==6_P #?_87_'^%O?NO
M==\W^OXM_L?ZV]^Z]UT>1;D_B_T^GOW7NO6-[7]-OI_O'U]^Z]UT.;<\VYL2
M!]??NO==G@"]SS^#8_X?3W[KW7OZCD\@"XN#[]U[KJW]0"?H/J"?P;GW[KW7
M?_%/P1>Y_-O^-^_=>ZW;?^$V?_9#/:MO^\K]]?\ OH=B^X1]R_\ DO1?\T%_
MZN2]8(_>B_Z>!:?]*^+_ +2;OK__TMIG^>%_VZ[^3W^OTI_\$/M+V+>1O^5I
MM?\ F[_U9DZF'V"_Z>UM7_45_P!H5QU\^'CD_4 F]_\ &WO(3KH]U[\V'-_K
M;_'Z_P"W]^Z]UZY/%KV/Y%QQ_K>_=>Z\+#CZ7M]+_P!;?GW[KW7;7)TC_7/_
M "+W[KW7@ >?K]+'_6_I[]U[KQ-KWL+WMP?]A[]U[KWYO?ZV  YO;Z_0>_=>
MZ[^O/!(/'^M_0^_=>ZZ^AOS?3;^I_P!?CW[KW7N+6O\ 3^AL.>?J?^*^_=>Z
MZX)L1]#8"_XM^??NO=<@!R1^2+\_D&_OW7NNAR2?Z<?['W[KW7OKQ_C]2"?]
MC[]U[KW^Q/UOSP+_ $_//OW7NNM0''(M]+?[U[]U[KODVMQ<6XYX_']/?NO=
M>/Y_P!(L>>?J??NO==6%CS]+7_/-K?3W[KW79 _5:Y^@!_U[>_=>Z]S;Z$"P
M_'T(/^I]^Z]UX\BQO?Z\6%_?NO==?ZW-N2>/TGFQO[]U[KN_-K'ZGD_0&UQ[
M]U[KH_J_I8<D?G_&Q]^Z]UR' _/]>?QQ_L??NO=>_'/'YO8?7_6_K[]U[KC]
M/R/I]+CZ?ZGG_>_?NO==V/%^?ZV_-OI[]U[KJUS8W_!YN0"/\/\ 'W[KW78_
MWF_XY(XX%_S_ +'W[KW7K_2Q_4#;Z<'W[KW7$_[$?2WI'XYXY][ J:=>Z]Q]
M.;GGBU@W]![UU[KE?Z<&]N/H3_L&)]^Z]U[GFUOZV_QO?Z^_=>Z[O;_'@F_T
M_P!;GZ>_=>ZZ! ^@(OS_ (_[S[]U[H6.@_\ F>G2Q!'/;'7-Q_3_ ']]%]!_
ML/:#=O\ DE7/_-*3_CAZ)^9_^5<W'_GGG_ZM/U]23WB[UR8Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB@?S!O^R$?F7_XJ]WK_ .^SR7LW
MY?\ ^2]9?\UX?^KB]#7VV_Z>'L?_ #WVG_5].OFA6OP1_O/XM;WDUUU*Z]S8
MW/U/ /''U//OW7NO?U#&]@#^?P.??NO=>^O_ !7Z"X_-^/\ ;^_=>ZZN+6 ^
MH_H3<?T_'OW7NN_I]+VL!R0!_K^_=>Z]IM:P'];$_P!18CW[KW7CZ@/H 2+?
MG_>[>_=>Z[)(')%_]8VO[]U[KHD$?6W()Y^H/^M[]U[KQYXY%^!]+6^OT]^Z
M]UT2+<_4?6_Y_K]/]Z]^Z]UWS];\:K_7^S[]U[KWY(/]1_C8D_CW[KW71/T_
MKR"UN18?T'OW7NN_Z_U*CZ'_ !L?Z^_=>Z]^+GF_TN/I?Z>_=>Z\MP+'^MOK
M_A[V:5QU[KOG\6M_L3S_ %YM[UU[KQ/^O]?Z?7_#W[KW75[?46%[ ?[#_7]^
MZ]UT!R+'Z 'Z?C_7]^Z]UW];_CF_-Q]!^??NO=>OQ;ZC^A_I]/[/OW7NN)%_
MZG\CZD?3\W]^Z]UR_/UL!]2>+W' 'OW7NO7_ ,;_ %_H+_X#W[KW7N?S?Z\#
M5_C_ +[Z^_=>Z\38F]_\/Z#\?3W[KW75CQR;&_YL/]AQ_K7]VU-2M?\ 56G6
MRM"0?+[>OHA_RD/BY_LJGP@ZLVQEJ#^'=@=C4S]O=D+-"J546XM\4<55CL17
M J&5\7B8L=CYXV=@)X9F4V>WO&[FW=?WQO<TZ$F-#H3/X5)R.&&)9OL-.N:'
MO%S:><.?+R^B;5;VY^GA]/#B)4L/42/KD!I6C &E.K.O8=ZB[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z!#Y$=T[;^.O1W:O>6[64X+K+9
M6;W5-323>)LG6T5*1AMOT\BJQ$^1KG@H:?4MA+*E^.0HV^RDO[R*Q@KJE8#[
M*\3\A2I)/D.COES8[KF7?K38+/,EW*D8-*Z0Q[G/]%%JQ^0)\NOF1]A[\W-V
MEOS>W96\\A)EMV[^W3G]X;ER$C,S5>;W'DY<KDI@DA:RF65RBW](LHX4>\H[
M6WBL[9+6 42)0JC' "GIQZZL;3M]GLVVV^TV*Z(;:-(D \E10JY\SC)\_/TZ
M1G^]GDD>FP)O]#[>Z6=<OZ<GZ7N"/Q];CW[KW77)M_L"/Q]/KP/?NO==GD6)
M'^W^@O<7]^Z]UU>]C:P/TYM_A;CW[KW7CP!;_#^T?]X]^Z]U[\VM^;@?U/UN
M#_Q'OW7NN^?ZD?7\7_-_K[]U[KOGZ6_J ?Z#\<>_=>ZZ)_JMS^;BWY_J??NO
M==6'XN/R;?3Z_3\^_=>Z[^G];7%K'Z_U^OOW7NO6/]/Z"U_H!_C[]U[I4;&O
M_?;9MN+[HV];D<#^+0^V+[_<*;_2-_QT])-U_P"27=_\TI/^.MU]53WBKUR+
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NBV_,?_ +)#^5?_
M (KAWE_[['*>S#:O^2I;?\U8_P#CZ]"/DW_E;]K_ .>RU_ZO1]?,5^@T\W_P
MY-K_ %^GO*'KJYUR!O\ @C_7]^Z]UQM>Q_VUOSQ<?7_8^_=>Z]8\6O\ 2W^%
MOS]?^*>_=>ZZM;\?ZPOP=7X'OW7NN_Q?\&]R!:U_J;G_ (I[]U[KNW^PYOP?
MK_B>/?NO==?7D@'Z\_C_ & ]^Z]UV+ \VO:YM?Z7^I'T]^Z]UU_3\?@#CBQM
MQ<>_=>ZZ-QQ]!S].;<\GZ>_=>Z];T\<W_P!Y_%^?S[]U[KL_X_T/Y'Y-A>Q]
M^Z]U[\ ?4\\_G_$"_OW7NO'G\'\\V/'^(]^Z]UT+G]7]&^@M]?H!?W[[.O=<
MK'_#Z_\ $W]^Z]UUQ].?Q_L/R./I[]U[KKDV(_WC@$?2WO9%#3KW7KV-OZ<C
M\#U"YN#_ $]ZZ]UW<WMP+_[Q8<G_ (I[]U[KJQ/UN#]/S_K@_P"W]^Z]UW^0
M3:WU^GU_US]/?NO==<<6*\?X\?[;_>??NO==\_3_ !O<_3ZW%K>_=>ZZMS8L
M2?Z7_P!C_O7OW7NN^?H>>3_AS^/I_M_?NO==_BW%S_3CG_8>_=>ZZ!XN2?\
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M^GUO>XN;?ZWX]^Z]UT&)/%_I]./K_K^_=>Z\/]<?JOP;W!^O ]^Z]UVI^O\
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M>ZW;/^$V?_9#/:G_ (M?OG_>.H-BCW"'N5_R78O^:"_]7)>L$?O1?]/ M/\
MG@B_[2;OK__4VF/YX7_;KOY/?X'I4_\ LP^TO8MY&_Y6FU_YN_\ 5F3J8?8+
M_I[6U?\ 45_VA7'7SXKW-KBY_'I ^MC<F_O(3KH]UXCZ<+S:_P!?S^??NO=>
ML; ?FYM_L/?NO=<O\+&W(MQ^/?NO=>_K^+"W(-_]@??NO==6_'T_U@?Z\G5[
M]U[KODB][?[87'X/-_?NO=>XM?\ %K?\:O\ 7W[KW75[?4?ZP'%_]@#[]U[K
MWX!%OQ:XN;WM]??NO=>^O^VN#_3BWU]^Z]UT3Z^!?BW_ !/OW7NO7_P_2;#\
M_P"QL/?NO=<A?^M_]AQ;^MQ[]U[KQY_-A]+6^O-OK[]U[KB>/ZW_ %7M^?\
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MV'^\>_=>Z\>/[ _V'/\ Q'OW7NN5N.>.#^?R3_OK>_=>ZXGZ_GD7-C>X^GT
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M\#];W_']+<_0C@>_=>Z]^;_UM_L /U7/OW7NNS86O_6POS]3?W[KW75A_7Z
MC\7O_4GW[KW2HV,+;VV<3]#N?;WT_P ,I#>_MB^_W"F_TC?\=/23=?\ DEW?
M_-*3_CK=?54]XJ]<B^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[HMWS'_P"R0_E7_P"*X=Y?^^QRGLPVK_DJ6W_-6/\ X^O0CY-_Y6_:_P#G
MLM?^KT?7S% I%K'B_-_S^./>4/75SKKZ 7Y-K6L;&QX]^Z]U[CZ<6_/%N!]
M2??NO=>YO?\ WBX_5I]^Z]UV.!_O/)'TM]>/?NO=>!X//^ _K?\ VWOW7NN@
M%_H1IO>_^W%_?NO==@6_US_4D7]^Z]UX\?D6/X;Z7O?W[KW7@?ZG\D?4?Z]^
M/?NO==7YM]+?GZ#_ &WOW7NO7N"./\+&W ^AN?>Z9IU[KO\ P''TY-S_ *W!
M]ZZ]UX_\C!NW^Q]^Z]UUS:PN.;6^H_U^?Q[]U[KQ_P!8@<FWTN;7Y]^Z]UV>
M3;\"UQ^+?7D>_=>ZZ'U)_%N"?^*GW[KW7? M]2;< \G_ %_]?W[KW7OZC\@W
M)^G)Y'OW7NO<G^J\_7ZC@6/U]^Z]UT&'] O^]_['CW[KW7?]G\&WZ?\ 8?2_
MOW7NN_S?FUO\?]O[]U[KCS<W/(MI/^N;?CW[KW77^I^GT%[&UU_QO[]U[KO\
MVU'_ &__ !KW[KW7=^"1S86!O<_TN1[]U[KU@;'\_CZV%O\ 6/OW7NO#FQ_V
M!!X_-]0'^\^_=>ZV>_\ A,H?^,K?*T?]^_ZW/^%O[QY+W%ON?_N/9_Z:3_ G
M6*?WK?\ DD[+_P U;C_CD76X#[B#K"SKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>ZU%_^%.7_'Z_$#DBVU>Y_P#6(.6VY]?<N^U_]E>GYQ?X
M)/\ /UF9]U+_ '#WO_FI:?\ ';CK5LL;W']+?[S?W*G66?77]0;GCZGZ?\1[
M]U[KVK_ _6WTX^O]??NO==D7X)^G)'_&_?NO==<@6'] 0/H?KS[]U[KUC^3]
M#?\ H +_ -??NO=>OQ;D<6^AY_'OW7NN[<6N3_KGZC^A/OW7NO7Y_P!O_3FW
MOW7NNK#\W_2!;_6_UO\ BOOW7NO6-[_U%OJ;@?X'W[KW70^G)Y' %_S^GD>_
M=>Z[)L%/T'^\6M]/]?W[KW7OZ$_FP/\ KCZ>_=>ZZMS<'ZDFX%^/]?W[KW7O
MZ7MQ]+$\ ?7_ &/OW7NOH'?R,/\ MV%\=?\ J/[F_P#?Y[D]X^\^?\K3<?9'
M_P!6H^N<WW@?^GL[I]EK_P!HD'5M_L(=0SU[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]U[W[KW7O?NO=?.*_FN_]O%?EMR/^9K5X_K;_ '%TG-O>1W)__*MV
MG^D/_'FZZ<^S/_3L-F_YH_\ /[]5\$<W%K$"]_Z7^OL1]2-U[D?4C^G/T/\
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M_OA[]U[KH#_ <?G3S]+_ .W]^Z]UZYM^?2?]C]?\/]Z]^Z]UW_3CZF_]>?\
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MQ]^Z]UX?2_(XN?S?C_'\^_=>Z\>;<\@ WO\ T/UM]/?NO=>YM;G_ %_KS>W
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MWYN;_0@V!_K[]U[KH BYT_4CCZ?3Z'W[KW7N?J>0/H3Q_O'OW7NN_P#6YO\
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M 'XL?]8G_>3[]U[K9[_X3)BW:WRM_P#$?=;6/];;CR0]Q;[G_P"X]G_II/\
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MO<@&_P#7CZM^/?NO=>_/TO\ 53_K?4?3W[KW7K_0?4G\@V/]>/?NO=>!_/\
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M[KUSP" /Z#_6_I;_  ]^Z]U[GZ?G5SR?Z7X/OW7NMGK_ (3)_P#,UOE;S?\
MXQ]UO_L?]_)DN?<6^YW^X]G_ *:3_ O6*?WK?^23LO\ S5N/^.1=;@7N(.L+
M.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K48_X4Y?\ 'Z_$
M#_PU>Y__ ';;;M[EWVO_ +*^^V+_  2]9F?=1_W"WO\ YJ6G_';CK5I//-^.
M3_0V M>X_P"*>Y4ZRSZ[OZOKQ_QJ_P#3W[KW7K@?0?['\?6UKB_OW7NO"Q)
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M["'4,]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SBOYKO\
MV\5^6_\ XE:OY_I_N,I#[R.Y/_Y5FT']$_\ 'FZZ<^S'_3L-F_YHG_C[]5\<
M\W-R/];\\?0_GV(^I&Z[YO\ 06//T^A_J??NO==$_7_#BW];_3GW[KW70'!Y
M)X(/YY_I8^_=>Z[OQ;^EK?T_PN??NO=>_P!:X'//'T)N3_Q3W[KW7?X/]3Q?
M\\\"]O?NO==?3D#\VX)47O;Z#W[KW7O\/R>>?P;6X]^Z]UZ_'T(X(MSQ_0W]
M^Z]UXG\?4_C^HN/?NO=='@$?C_'GCZ>_=>Z[X-AR".!]#_9_(]^Z]UU?@ >F
M_P!+>J_^'OW7NO<_J_VUSP./K;W[KW79XXL;7_XB]EM[]U[KD#?Z?[?\?T]^
MZ]UQ-@;WYXY']/\ 8_X^_=>ZZX%A8?XBW']+W]^Z]UW;\"U_\+ _ZU[GW[KW
M7OJ!R0/]A?GZ<^_=>ZZX)/'^M^#Q]"#[]U[KOF_'X^O'UM_3W[KW71N;6^E[
M>K\\V^GOW7NO#_7/-PO /YMR??NO=>LO'U^MA_@;WM[]U[KP''U/ZKC_ !'U
ML/\ 8>_=>Z[))^AMS;Z?G\7]^Z]U[CZCDBW))_/TO[]U[KWT_ _QO?D+P>/?
MNO=>_P >1P+\?T_WW]/?NO==?ZW/]?KR?IS_ %Y]^Z]U[\CZB_X'UY'_ !H>
M_=>ZY6_V'UX' Y^GOW7NO?@ <?[S;_;^_=>ZZ*@%>#Q_OA<^_=>ZZ_%S]+'B
M[7-A[]U[KU_38$?3_>+?7W[KW7A8 _@B][7M_A]??NO=;MW_  FS_P"R&>U?
M_%K]\_[SU#L4^X1]R_\ DO1?\T%_ZN2]8(_>B_Z>!:?]*^+_ +2;OK__T-IC
M^>%_VZ[^3W^OTI_\$/M+V+.1O^5IM?\ FY_U9DZF'V"_Z>UM7_45_P!H5QU\
M^0\_U7_$<FW]+CWD+UT>ZZM^?]B?Z<VO[]U[KU^2/J?^-^G_ 'OW[KW7C]#R
M#8W!/'/]/?NO== 7'''^'U'^V/OW7NO7O]+_ %O<C4!_K>]T'KU[KNQMSSQ]
M".;^]=>ZZ])_K^?\/SJ_/OW7NN_TG^M_]N?]C[]U[KWY (N?]MQ>]Q[]U[KO
M\'_C:CW[KW70%OK?FW]!R/H /?NO==?UL/Z7L+?0W^GOW7NN7T_WWU)^O'OW
M7NNC^3^>;<<WM<&_OW7NO$VM>X_I:W''T]^Z]UWSP3R1<_TY_P!:WOW7NO?U
M_P 2!?\ I<6]^Z]UUSQ;_#Z_[5QS_C?W[KW7N;WO>WU'''-_H?\ #W[KW7A_
M6WY)^EK\>_=>ZZN./IR!^1Q^1_MO?NO=<OS?\<6_P%N3[]U[KQO]>;C\?4'_
M & ]^Z]UX\_C\7^G/T_'^/OW7NNO[/\ K<_UX^MO^(]^Z]UV;G_6M]" 1?W[
MKW7OQ8@CZ_X_[R/?NO==6^M^;FP)_P!:_OW7NO:5M<"_^Q_QM[]U[KQL1;Z_
M[[ZW ]^Z]U[Z7/\ M[ \\V_/^'OW7NO607^G'^V'^P]^Z]UX 6(T_DW_ .(Y
M/OW7NNN&')_(L?ZG_6]^Z]UWR2+@"Q_K]?\ 6]^Z]UZVG_8?ZY_K];?Z_OW7
MNN-F^H%OI;\'@6]^Z]UVP%KG\?ZU_P"@Y]^Z]T+/0G_,]>EC]3_I8ZY^M_\
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M^+<"]C]>2+_GCV(^I&Z[) ^M['_;#W[KW77)/T_I>X_H?Q[]U[KW%B?P3?\
M-Q^"??NO==6//UM_KE1_L!;W[KW7?^PU#4/J;#_"UO?NO==_BWU-@?\ 7/\
ML??NO==,?3QQSS^+6/OW7NO<W^A^M_Q_2WOW7NN^+?Z]_P#8G_C?OW7NNN0/
MK_7DVN?Z6]^Z]UT;$V-OI?@_ZWY]^Z]UV 0?P?Z"_/'T/^O[]U[KUP/Z7/\
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M\]]I_P!7TZ^:%P?]N2/\2/K[R:ZZE== 7Y)YYM_@1];>_=>Z[_WG\&Q8V/\
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MZ[/_ !(/_!@/H![]U[KU[W'/T)_Q^MB/>Z8KU[KH<6MR.+F_ N?Z>]=>Z[
M^@/(^O\ K^_=>Z4^QP#O79I_KNC;_P#R;E8?;%]_N%-_I&_XZ>DFZ_\ )+N_
M^:4G_'6Z^JK[Q5ZY%]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW4"OQM)E**LQN1IX*V@R%'4T-;1U,:34U525D)IZJFG@<%6CD1F5U:X8$@
MBWO2U4AAQ' _ZOV]61WC<21DJRD$$<00:@CYCRZ^=E_,D_E[=E?!7NK<6-GP
M65R/1NZ,WD*_J'L:&GJ:K$5N!K)C54FT\WDE&B#,XZ,BGJ:>9E>94^YA4PR
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M4.+#C_ 7L#_K>_=>Z]Q<<?\ )I_'TMQ[]U[KQX-S^+"YY%OS;\^_=>ZW;?\
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M/Z7O]?I[]U[KKFW/UN%O]?H?K[]U[KE^?IS]#R>/S8^_=>ZXD\\_7FUOK?\
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MFO:WUN;$_3Z_ZWOW7NN[DVMR/R?S[]U[KKFW^O;Z BW];6]^Z]UW_L2>"/\
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MK!'[T7_3P+3_ )X(O^TF[Z__T]IC^>%_VZ[^3W^OTI_\$/M+V+.1O^5IM?\
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M'KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZX%P+7N 1>Y](
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ML/0XH>OF8=C;$S_5W8>^>L]TTXI-S=>;QW+LG<-,H($&;VKF9L%E$74+Z1-
M^EB.18@>\H+6YCO+6*[C^"55;\F%?Y<#\^NJVU;E!O.UV^[69K'<QI*AP*I(
MH=2?G0C&?3I%_0WNW];7X'^'M[I7UU?ZV'].+,0/S<\>_=>ZY<<G_>_]I_(]
M^Z]UT+C_ %O]3P;?UY]^Z]UXB_U_H2#_ +'^G'OW7NO?0?4<?3_'BW/OW7NO
M<7L..20;BQ(X_'OW7NO<'_$C\'Z_ZUO?NO==:OQ8W'Y^MN+7]^Z]UL^?\)D_
M^9J?*S_Q'W6Y_P!ON/)#_B/<6^YW^X]G_II/\"]8I_>M_P"23LO_ #5N/^.1
M=;@/N(.L+.O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K48_X
M4X_\?M\0/P?[J]S?XGC+;<-K>Y=]KO[.^^V+_!+UF9]U+_</>S_PRT_X[<=:
MM5A?Z#Z_[V#[E3K+/KW'^'U ^A^H_'OW7NO'BW)X/)N1]>1?_#W[KW7O]AR"
M;<$?B_T'OW7NO?[>W%O5?Z"]A[]U[KQXM_M(_P!Y _(]^Z]UUSS?A1Q_B?QR
M??NO=>'X^IL;_DD77W[KW7?//UO?^H^E_P >_=>Z[)M^/]C_ *YL/?NO=<20
M/H;_ %''/^MS]?\ >?=NSY]>Z[/ )'%_\?\ >;'\^Z]>Z[ /U)/U/'X_H/?N
MO=<20;\WX^GX'-N??NO==GZ7_P !:P)/^P-Q[]U[KW^-CSS_ *]CQ]+^_=>Z
M^@;_ ",/^W8?QV_QK^YO_?Y[D]X^\^?\K3<?9'_U:CZYS?>!_P"GL[I]EK_V
MB0=6W^PAU#/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\XK
M^:Y_V\6^6W_B5:__ &_\,I+<>\CN3_\ E6[3_2'_ (\W73KV9'_,,-F_YH_\
M_OU7U?\ U_8CZD7KBO\ B!?\$#ZC^OOW7NNOK;Z@ <7_ *_3GWO%?EU[KWYO
M?@WMP+#4+^]=>Z[Y)'U_V(X/%_I?W[KW7CSZ3]=-[\<'_'W[KW7=SQ]./U?[
M:_'OW7NO?7\W']!;Z_Z_OW7NNOJ;V/\ 7Z'\?C_;^_=>Z[O_ %M_9^A_-_?N
MO=='ZW'-N/K<\_6_OW7NO \"W 'U_P!:WOW7NO#GD ?D?6UA_3CW[KW7@18F
MQ%[7-_Z_X^_=>Z]]!]+V-^./][]^Z]UU8"]S8?3_ 'C\7_US[]U[KNP_K8VT
MW_WD>_=>ZZMR/];_ &XO]#;W[KW7N1R1S_JOZ7X%_?NO=>O?TWL1^1Q]#^/?
MNO==CB]_J;<@$_3^H'OW7NO7_P!OZN/SSR/?NO=>X_U*_G_>/K^/?NO==?07
M!_-_Z"Q'T]^Z]UZUS?@<DW!^EA^;_P"/OW7NNR3P;?Z]P?J?I[]U[KWU)!)-
MB/Q]/]M[]U[KJS#GGZWM]";_ -0![]U[KL_G5]+\7!'U%QS[]U[KW/\ 0CF_
M]+_X&U_?NO==&_UMS<6X(Y-N??NO=>_(_P"0K<$?7\7_ *^_=>Z[_I_@;?[8
MV''OW7NO<_U^O]+?CB_-_?NO==_T!OS^!?GG^IY]^^SKW75K\_4VL;BW^O;Z
M>_=>Z\1]3^?ZV_PM^/?NO=>!!MP>1;Z<6_/'OW7NO7 ' -OZG@<G_'W[KW6[
M;_PFR_[(9[5^@_YRPWS:W]/]$&Q?<(^Y>-]B'_"%_P"KDO6"/WHO^G@6G_2O
MB_[2;OK_U-IC^>&;?RN_D]_K]*G_ &WR'VE[%G(W_*TVO_-S_JS)U,/L%_T]
MG:O^HK_M"N.OGQ_\57G\\_4?Z_O(7KH]UX'TW-K7_(O^?\;^_=>ZZMJM<$BQ
MYO\ X_T'OW7NN_H#P ./];ZV/OW7NO \\\6XYM<@CBY]^Z]UU:W %C?Z_7_>
MQ_O7OW7NNQ_B#;A?]M^?];W[KW7OTBP_%[7_ -O[]U[KL\VY^A_WG^GOW7NN
MO^)Y_P!?C^GOW7NNOT\F_/U_XU]/?NO==_@_J_UKFP_''OW7NN[6/I M_OOS
M[\<FO7NNAQ?BU[V-O\;"Y]^Z]U[D6']018?2_P#6WOW7NO*!]?\  #_#@?CW
M[KW75@. /Z7N#S<V^A]^Z]UW]!:Y')M?F]A[]U[KW#7 N0>";D6_UO?NO==_
M[ ?])?U]^Z]UT0. ;#G^GUL>![]U[KQ/^)_K86^E_K[]U[KI>+W!M^!8GW[K
MW7?TL!QR;?ZP^M[^_=>Z]ZOZC_;?[Q_K>_=>Z]]/]B ...?\+^_=>Z]8_7_'
M^@_I;^OOW7NNK7/UL+_0"W/^O_7_  ]^Z]UZX%Q<#_6!^O\ L??NO==BY_'^
M\C\'CZ>_=>Z[X(/%[WO;_#W[KW7$Z@?ZW-K?0<GW[KW7OK]1?^S] +?U/OW7
MNN[ CZ?G\ ?ZQM[]U[KC8_\ !1>UA_7_ &%O?NO==D7_ ,#QR2?]Z^GOW7NO
M?2]N/][^OX^OY_P]^Z]UV1?F_/'-C;Z\^_=>Z]9?I;\_X_[W_O-O?NO="ST'
MQWITK_AVQUS]./\ F,:&_M!NW_)*N?\ FE)_QP]$_,__ "KFX_\ ///_ -6G
MZ^I'[Q=ZY,=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10/Y
M@W_9"/S+_P#%7N]?]YZTR0]F_+__ "7K'_GHA_ZN+T-?;;_IX>Q_\]]I_P!7
MTZ^:'?\ I_C_ +Q_A]?>3774KKB3<C\V_P +K?\ V'OW7NN5_KP>+?T_/Y]^
MZ]UQ_IJ %P;7'TM_K^_=>Z[ M:W%[\?G_>?]Y]^Z]UX?F]^;7_ISQQ[]U[KO
MGD<_FQX^GT_'OW7NNK+>Y^OUX/'^!]^Z]U[^EOK^/J!;_6]^Z]UXDD'Z?0_U
M_!L??NO==<?DD#U?4?U_I[]U[KO^O' ^O'!/]??NO=>Y'XOR0/SR3<?[#W[K
MW70X!(-O\/U#^EQ[]U[KN_TO<:?]YX]^Z]UU;@VX;\6]-_\ 8>_=>Z[-N>/U
M#ZCFY_P'OW7NO V _P!;ZW'/^M_A[]U[KJUSR;@\6N?J/K[]U[KO_"Q^E@1S
M_A[]U[KQ!_'!N?S<<_7W[KW7?^V_K<<<_P"M[]U[KJ_!!_ M:WY47-K^_=>Z
M\3<?2_(')Y)!^AM[]U[KOZCZV/\ AS_L1;W[KW3QMS;N9W=N'!;4V]CI\MN+
M<^:Q>WL%BJ1==5E,UF:U,=BL?2(3ZI)IY$B0?ZHCW2:2.")IY314!8GY#B?V
M=,W5S!96DM]=,$BA1G=CP54!9B?D%!/V=?3,^(7QZPOQ:^-73_0F%%.Z]>;.
MQV.S==2@"+,[OKF?,;US@]*FU;E*FLJ5#KJ".JG]/O&#=K^3==QFOY>,KEJ>
M@X*O^U  _P %.N5?./,=QS=S->\Q7%0UU(S*#Q1!18T\QV(JK\Z5\^C+^T'0
M:Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NB"_S+?E OQ&^&
M?;_;%!7+0;UJL*=A]9!79*F3L'>L;XG!5E$RWU/C8VJ<PX)%XZ20 W(]G/+>
MUG>-ZALF%5KJ?Y*O$'_3<!\R./4@^UW*?]=.=['9G!:WUB6>G^^(B'<$^6O$
M8/D7!Z^<!)(\SR23/)++([2/(Y9Y&D>[L[NQN68FY/UOS<>\F!@4'EPZZ@KH
M4:%%%QC[. _U?[/7#^OTX_.G_'G\^_=4Z]R!]#^+6 -N/I[]U[KP_I:QXO:P
MM[W3%>O==#EC]+D \B]N/>NO=> O?CZ#^@%[CZ?3W[KW7+_7'Y)^O^/!]^Z]
MUQ'U_P ;\W_)M>Y_I[]U[KGS_0?[<_\ %/?NO=<3_K#Z#ZB_Y^@/OW7NNKVN
M;6-S8D_6Y_ ]^Z]UW^+?TN/TGC\&WOW7NNK#GZ_U'^'YN+>_=>Z]]!Q<W) -
MQ]3_ *WOW7NN^;#D_4<_ZY^H/OW7NO?7CD$6_P ?J/S[]U[KUOKQ^H G\#_'
MGW[KW70/X-_\/K_MN /?NO=*G8_.]=FB_/\ >C;_ -/K_P 76'C_ &WMB]_W
M"F_TC?\ '3TDW7_DEW?_ #3D_P".MU]53WBKUR+Z][]U[KWOW7NO>_=>Z][]
MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO
M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U
M[KWOW7NO>_=>Z][]U[KWOW7NOF\_S1H(*/\ F%?+F&GC$2-W1NBH=$ 56GK)
M$K*J72.+O+([F][DF_U]Y'\H:FY<M-1K1,5SP8T!/F.NGGM S2>V6S%\D6ZB
MOYE0/L  I]@Z(2/S]3JO_MOI;V(NI#Z]?Z<D6O\ 7B]O]?W[KW7OJ.;'Z\CF
MW'T'OW7NNOZBY_%OQ]/I:_U]^Z]UR_Q^HM;^O^Q]^Z]UT+$7Y/'^%A_K7X]^
MZ]UXG@_6_P#B+?\ %/?NO=>/%R /K]3^3^0/?NO==<&Y']+G@GZ_4?7W[KW6
MSY_PF4_YFK\K!_3KWK;_ -Z3)GW%ON?_ +CV?^FD_P "=8I_>M_Y).R_\U;C
M_CD76X#[B#K"SKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZU
M&/\ A3C_ ,?M\0/_  U>Y_\ W:[<^GN7?:[^SOOMB_P2]9F?=2_W#WL?\,M/
M^.W'6K3S^?KP3]> /I]?]C[E3K+/KNP_V-]5KB]_Z>_=>Z\>?]@>1R;C_$#W
M[KW7O]XYN!_K<$<>_=>Z]<\$_3^U_MO?NO=>/^Q^H(-OR186]^Z]UT!>Q%N/
MR.#].1;_ %_?NO=<N3^?Z V_P-_K[]U[KKFU[FWX^@_V]Q[]U[KQ%_J.>;"_
M^'OW7NNK$<6%_P#$G^MKG^OOW7NN_P#8'ZWN/I]+?X^_=>ZZXYX^E[\_T'T_
MUO?NO==C_"YYM;^ESR??NO=>/)O_ (C_  ^GTM_7W[KW7N;?[$\_X7_P]^Z]
MU] W^1A_V["^.O\ U'=S?^_SW)[Q\Y\/_(JN!\H_^K4?7.;[P'_3V=T^RU_[
M1(.K;_81ZAGKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^<3
M_-=_[>*_+?\ \2K7_P#NKI/Z>\CN3_\ E6[3_2'_ (\W73KV9/\ S##9O^:/
M_/S]5]6)^MC_ +P1_K'_ %_8CZD7KHD7/X_K<?J_'OW7NN/TOQ]!S];?7\C_
M 'GW[KW7(G\_7FXY^EQ87'OW7NO'FW)X_H#?Z?U]^Z]UX&YO_0$<\'CZW]^Z
M]UX_[R/H/]<6]^Z]UZUP/S;Z_P"Q^MB/S[]U[KUS>YTCG\_6W^O?W[KW7OS<
M#^@_(XO_ $/OW7NNOK_AS>X_Q%SS[]U[KL&WUO<6')Y('T-S;W[KW7=N?]?Z
MG^U_L/?NO=<2.+'3^. +?3_7/OW7NN1O8 6!_/OW7NO"_P#0#_D?^'OW7NN/
MJ_K_ $^H_J+7]^Z]UW<W']3?CZ7(M]?]M[]U[KWT'' YOP;_ .'U]^Z]UX?@
MCC\'C\?@CW[KW7OQ_P 0/3_C?Z^_=>Z[^O\ L/S^?]XM[]U[KJXO^+6^G^+'
MGW[KW7B!;F_UOP;\G@CW[KW75[<'Z6;\@D_GGW[KW7K6/' -^>3;BX-_?NO=
M=V-QR+<?[<"W^V]V%6.>O=>"V''TM:W/_$_\4]UZ]U[\6 L ;?7F_P!+\6]^
MZ]UX\7L3Q];\_P"PN??NO=>%OH/S9O\ 87_V/OW7NO<#G\W X_U7^^_Q]^Z]
MUU;\\_4_D:>&^G]??NO==_3ZD7_VY^G]/]M[]U[KU^2#?_#\7X^EQ[]U[KW'
MU(N1].&'OW7NN@&N;7-C^3Q>W-[>_=>Z]86_WKZ_VOH./?NO==@@W^H/ )^G
M(_'/OW7NMVW_ (39?]D,=J_^+7[Z_P#?0[%]PC[EYWZ(_P#"%_ZN2]8(_>B_
MZ>!:?]*^+_M)N^O_U=IC^>&+_P KOY/?^45'^W^0^TO8MY&_Y6FU_P";O_5F
M3J8?8+_I[.U?]17_ &A7/7SXR>!?B]Q_K7^A]Y"=='NO?0?6]OK]2?K^?]A[
M]U[KW/(%O\?J>&/%K>_=>Z]>W^-K?7C\?0$^_=>Z]:_UL3<#Z6^G/^]>_=>Z
M]]+V_!-[_3CZZ??NO==W-P..3_O'OW7NNO\ 7_! 'Y^HL0??NO==<_7U<_3U
M?7C_ %O?NO=>L>?ZW-OQQ:W'OW7NNR1:Y!'/^QO_ (>_=>Z[XN1Q<\?GZ6]^
MZ]UQ:]QR!^?Q]?\ 8^_=>Z[_ #;ZD6_WKZ\^_=>Z]< \_G_8'GZW/OW7NNP+
M'Z?06!_P_ _U_?NO==7O_B?]M]#QQ[]U[KK^@X!_V]K_ -+_ /$>_=>Z]IMQ
M_7\?4FWUYX]^Z]UXDFWT_5Q_C_2UOZ>_=>Z]<BX ( ^OT)''^/\ C[]U[KL
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MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\W_P#FH?\
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M/]/Z<?TM[]U[KE;_  46^GYM_7W[KW75OQ_J2+?@<?[?W[KW7OI?ZW(N2/\
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MW10/Y@W_ &0C\R__ !5[O4?[?K3)#V;\O_\ )>LO^:\/_5Q>AK[;?]/#V/\
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MW7O]8?D7Y-V%K_GW[KW6SY_PF4_YFO\ *[_Q'W6WT^G&X\E[BWW._P!Q[/\
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MQ<?\:]^Z]UR_%K'^O''Y^G'OW7NNK_C_  _/Y_%C?_'W[KW7OZ\V-K<D7O\
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MS;G_ (W[]U[KH'@'ZC_"_P"38?7W[KW7C?@ &W _UA].??NO=<K_ .OR>/\
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M0_T/^?CUT[]G/^G9;/\ \T%_X^W1 [$\_P!?K_3Z6M<'V(NI$Z[L/Z7N!?\
M%P?Z7]^Z]UV2"/\ 8CG\?U]^Z]UT."1^HVY/^O\ BWOW7NNR?]O:]K$G_>/?
MNO=>_%CS?_?"]O>P*FG7NNN;?4WO]1S8@V/ ]ZZ]U[Z7M_M-KDG\\<'Z>_=>
MZ]Q]>6(^EC?\?X>_=>ZV>_\ A,GQVK\K1_W[[K;\6_YB/)>XM]SO]Q[/_32?
MX%ZQ3^];_P DG9?^:MQ_QR+K<!]Q!UA9U[W[KW7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=:C'_"G&_\ ?7X@&]K;5[F_I_SMMN?U]R[[7?V=]]L7
M^"7K,S[J/^X6]_\ -2T_X[<=:M5AQ:_X8?XV]RIUEGUV!;Z ?7_&]OSS[]U[
MKW//-N+_ $^G'OW7NO$>DV^O/^\\D>_=>ZZ-C_4WL1_Q/OW7NO<"P^@Y)'X_
MWGW[KW78O^+@?C@<?C_C?OW7NN('UY^GTL!P?S^/?NO=>O?D#D6L;W_5];_Z
MWOW7NNS]/]C^>/\ "_JO[]U[KNYYX/\ AQ_A]./?NO==6']?K<VO]2>/K[]U
M[KW^L >;_6]B?S[]U[KP_/YO_7_6OSQ[]U[KHB_^WLUKFX'];?GW[KW7=K?4
M _A?]8FUC[]U[KZ!O\C#_MV%\=?^H_N;_P!_GN3WC[SY_P K3<?9'_U:CZYS
M?>!_Z>SNGV6O_:)!U;?["'4,]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>
M]^Z]U[W[KW7SB?YKG/\ ,6^6X^@_TK5]S_Y"J3_8^\CN3O\ E6[3_2'_ (\W
M73GV8_Z=ALW_ #1/_'WZKYX(/^Q'TY(M< >Q'U(W7'_8?T#6X%Q]3_K'W[KW
M7(D$6_J#;C\^_=>ZZY]0_-@+'_6_VWOW7NNP1<<ZOZ7^H_KS[]U[KB?K_:-K
M&W^/OW7NN7^/UOP;GGDVL#_3W[KW79Y N 2?ISQ_K^_=>Z]<@?\ $_\ $VL/
M?NO=<0?I^?IQ8FP-_P#B/?NO=>)!!_VPY-C87Y'OW7NN_P V#?[U^#8_CW[K
MW7O]<'\<_P"L?]C^??NO==GG_$BQX/Y_V/OW7NNA<W/]?H?^D??NO==6L !Q
MIL23>QXYY]^Z]UV1?^GY_'/T_J?\??NO=>_VUM1N3]?K;CW[KW7C8?46^AN/
MI<?CW[KW70)X_);ZF_\ 0^_=>ZY#ZGBW]?Z?7\'W[KW79-OQ[]U[KUO]C];?
MCZ_X^_=>ZX_G@@_7@6%O?NO==:3;ZF_/]+?[;_'W[KW7?'TM]>3<_G^E_P"O
MOW7NO$6!(')N?]O]0+>_=>ZZ_P + "]B"?J?Q8^_=>Z\+_[ W)((M_K_ $]^
MZ]UW<G_6O?\ KP.+>_=>Z\OTXY_Q'ZO]C?W[KW7M(YNO^\WO_L3[]U[KQO>X
M^G]/SQ]/J![]U[KU_I^;GZ\7_P ;6]^Z]UX?X?UY^HN3];W'OW7NO?U!N+7^
MG]"?K[]U[KUS^?Z_[4OX]^Z]U[^H_'Y)XN3Q<7]^Z]UT18 <*/\ 8D_2WOW7
MNMV[_A-G_P!D,]J_C_G*_?/^/UZ@V+[A#W*_Y+L7_-!?^KDO6"/WHO\ IX%I
M_P \$7_:3=]?_]#:8_GA?]NN_D[_ *_2O_P0^TO8MY%_Y6FU_P";O_5F3J8?
M8/\ Z>SM7_45_P!H5SU\^,_0W-_]XOS8CCWD)UT>ZZXYTCZ#FX/(^MO?NO=>
MMI7\$6//^N/]Z]^Z]U[_  _-O]Z:P_VWOW7NNS8D<WMS8"_YM]??NO=>N?R?
MH+GC_'^OOW7NO <<6_V'U^M_KS[]U[KLG^G^'/\ K_X?T]^Z]UUS_L#R+V(O
M?5^/?NO=>/)'TL?I;_:?\??NO=<;DD@_[;\"QO;W[KW7+D #ZD_BUOQ]/?NO
M==#\"PO_ %((Y'(_I[]U[KUKB_U'-@/Q_K>_=>Z\/]B/\2">!_6WOW7NN[_U
M)7_8?XWO?W[KW70N?\?ZW'T-_P >_=>Z[^IL?KIL?]C_ $]^Z]UXBW^(_"V_
MV''OW7NO?X"_%C]2?K]!^>/?NO== <?J/'U -[<?X>_=>Z\6M8<CZ7OZO?NO
M=<N/Z?6Y%Q_7ZCW[KW7&W(X'^!O?C\<7]^Z]UR_)_(X%K<?6WOW7NNA< \_X
M@G_B??NO=>N#:UN#_K\#C\>_=>ZZN?\ 'ZC^M[E;_6_O>.O==BQ-P?H+?XG_
M !-_>NO==7O_ +  @CZV_-[\>_=>Z[M:W]JW'TYO_B??NO=>^JV_'XM_0'CZ
M^_=>Z[_V!_UK\\?3W[KW70^A_!%Q<#CZ_B_OW7NO6Y!_KR/K_KV^OOW7NO?U
ML+7-K\#GW[KW7K#B]S];!O\ >??NO==_TO<W/^'!!X_I[]U[KUKVOS;Z\VO?
MZ_3W[KW0K]!_\STZ5 _';/7/]?\ GL*(CZ_X^T.[?\DJY_YI2?\ '#T3\S_\
MJYN7_///_P!6GZ^I)[Q<ZY,=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]
M^Z]U[W[KW1/_ .8/_P!D(_,O_P 5?[T_]]IDO9OR_P#\EZQ_YZ(?^KB]#7VV
M_P"GA['_ ,]]I_U?3KYH7'T(XN=(Y_'UN?>3774KKOZ_@CZ7YO<'\_[P/?NO
M==-?_C8!N.;<6]^Z]URY _Q_WO\ H/?NO== @_07%_\ ;<7N/?NO=>OS]3:R
MG^OYY)M[]U[KJ^F_];@?[;_7_%O?NO=<A?\ I_OOQ[]U[KB1^?I^;7 -S^K^
MOOW7NO"_]?S]0M_KP>??NO==\_['5>U^=/\ 3W[KW7?YOQ]./Z_[?W[KW77X
MXXL;$6O_ +?W[KW7K$?@6^GY^A^@U>_=>Z]P?Q_M/U_LVO[]U[KH K_4_CZ'
MZ_U]^Z]UWP/]B.;W%_Z_7W[KW7A?^G];_2_)N>>/?NO==6N/\/\ #BX_QO\
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MY_V)M[]U[KW!N/U'^O!^OT^GO8%33KW79%P;W/Y ^A''TX]ZZ]UUS<<<#D6
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M M_C_KV'^\>_=>Z]8_G_ %N;FXM^/I[]U[KQO_C:Y!N ?K_A_3W[KW75N/\
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MW//!  ^GO=>ZO7NO?0&W!%OS?_>_>NO=>!O<CD$"WX/^W]^Z]UU_4'U?2P)
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M/T-OJ![]U[KWT/\ 0$BW^P7Z'W[KW7K_ . /UL0+CG^OOW7NO$'Z"XM;^O\
MO'_(_?NO="QT)QWITJ#]?]+'71_PO_?"BM>W^M[0[MC:KG_FE)_QP]$W-'_*
MM[E_SSS_ /5I^OJ2>\7.N3/7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?
MNO=>]^Z]T3_^8/\ ]D(?,O\ \5?[T_\ ?:Y+V;;!G?;(?\/A_P"KB]#;VV_Z
M>'L?_/?:?]7TZ^:&UQ;_ 'OZDV^@/O)P"IIUU)ZZ'^VYO;_:5^GO77NN1/\
MQKGDF]K6]^Z]UZXO;G^GY_I?W[KW7$D#Z"^K_>[_ ./OW7NN^?I_6XL;<C^O
M'OW7NN_3_0?X?3G_ %O?NO=<;BU@/H"38V'^W]^Z]U[4/I]./]?BU_S[]U[K
MOD7XO>]R2/\ 8?[#W[KW7BW-N0?QQ_A[]U[KQ Y_PO?_ !'ZK>_=>Z\03?C@
MV'X_'-_?NO==_C@@6X//T]^Z]UQMR03:]CP1S?\ Q]^Z]USO_O5_];W[KW7
M _T)X_)O^>;7_P /?NO==_X_@"PN.?\ $^_=>Z\3_JA>Q'T^GTOS[]U[KWUN
M/H18\'_B#[]U[KUSQ_C?_$?X#\>_=>Z[O_MC]#Q[]U[KL LP Y9K*%'+$WL
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M! N;_D?T/OW7NN_]L3;Z\?ZXX]^Z]UQN/IQQ;CBQ/Y()]^Z]UR!N>.;_ .\
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M/^#K+[MU[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZU6_\
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M_6'/%_\ 'W[KW7=^ +?4#_>?QS?W[KW7A<_VKV^M@.??NO==:@;?4<BW^O\
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M_P!/^\BNX&M?Z7_W,_CW[]P;%_RA0?\ .&/_ *!Z]_K>^W__ $8K#_LCMO\
MK5U[_9\_G+^?F?\ + 7^@_V8KN"Y_P#6S[]^X-B_Y0H/^<,?_0/7O];WV_\
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M-N/?NO=>%R.;G^O^N#<7'OW7NO'CZC_>2W/X%C[]U[KZ!G\C ?\ 8L/X[?\
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M;_PFSM_LC/:MOI_LU^^?_?0[%]PC[EXWV(?\(7_JY+U@C]Z+_IX%I_TKXO\
MM)N^O__5VF/YX7_;KOY/?^45'_LP^TO8MY%_Y6FU_P";O_5F3J8?8/\ Z>SM
M7_45_P!H5SU\^/Z_[?Z_6X7Z>\A.NCW7K&XMP+$?CCCW[KW7@;W^M^"+@?ZX
M''OW7NO?46M?Z_7@\?FWOW7NN[<WXY!'T^M^??NO==?UN+VY_P ;WX_WCW[K
MW77^L2?\;GZCZKJ]^Z]URN+V_P +^_=>ZZ!)^H%K#_8D\\>_=>Z\+GZ@_7^O
M' _WK_#W[KW7$M>_U'IYL+_Z_'OW7NN1Y!'UN2!]/]<<^_=>Z]_3@'GCD?\
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M'ZN2/]A[]U[KQ'!)/]#Q^+?T]^Z]UUSS?\6/^N;?GW[KW7O^)O\ 7FQ/]/\
M#W[KW70%_P ?XV].F]K?CW[KW7K\FY-K#_87/YM[]U[I4;'-]Z[._'^_IV^.
M/R/XM#^![8O?]PIO](W_ !T])-U_Y)5Y_P TY/\ CK=?55]XJ]<B^O>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H%/D=NO+;!^/7?&^L#.:;-
M[)Z9[0W9AJE.)*?*;<V/79C'S1GZ I-"C#_$?CVIL84GOX86&'D13\P6 _RG
MHYY<M(MPYAL+"?*3W$,;?Z5Y44_R/7R\I)Y)Y9)YG>>>5WFEEE9I))9)#>22
M1W.IF))+$FY_/O*@4   H!P'Y4_+@.NM"Z$4*HI3\N' 4] , >0QGK'IM?\
MQ_Q(X_I_QOW[JO7FY_UQ].1^/K>_OW7NN[_FQ_WCZWM;W[KW77Y'YN?^(M?W
M[KW75C:WXX( /UX]0'OW7NNOH?S;T_7CZ'BWOW7NN7^^O]"."+W/^P][U&FG
MKW7A^%_PYN/K8?B_O77NN['G^AX_V'^^O[]U[KHWMQ;FW/T)_P!C[]U[KO\
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MY!]^Z]UW>_\ MOI>UO\ $7'OW7NNR3Z>!?\ U_S;W[KW77))/(X/U%A_4?\
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M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NM1?\ X4Y?\?K\0/\
MPU>Y_P#W;;;]R[[7?V=]]L7^"7K,S[J/^X6]_P#-2T_X[<=:M=Q<\'_'_;7]
MRIUEGUT  ;GCZ@ _7Z^_=>Z\?H./I;F]P.+\@>]XI\^O==@^KDC]/_&_>NO=
M>_I]/H.2.>3:W'OW7NNOH2>/2+"Q!L/?NO==_3BU_P V']=7^]>_=>Z[O_O?
M ^A(^GY_Q]^Z]U[\>KG^O_&K>_=>ZZY '^'U_H./Z#_BOOW7NN[_ /&OQ>YX
M]^Z]U[GZGZ?CBY_WCW[KW7$7'T/&HBQ'OW7NNV-Q^0>>1^"!S[]U[KWT'T_
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MQ_3D?G\<?[Q[]U[KP/%_Q]>.+D<&_OW7NO$_U^G/^QO]/I[]U[KN]K\<_P"
M/^PY]^Z]UQM<W-[?@ZOI_K>_=>Z[)_ Y!_H1]2>?K[]U[KJWY^@!)/)_V'^Q
M]^Z]URO]?IP;#G_"_-_?NO==?X@V%OIQ]+<<^_=>Z\>2./I<V_K;BU_?NO=>
M(_-B38_ZW^V/OW7NO'^OTO\ AN1SS]/]X_UO?NO=>M>WUM_CS_T-S_O'OW7N
MN[_['\_7Z"_!M_K>_=>ZVAO^$WWQ;;,[T[7^7>Y,;?'[,I6ZCZSGJ(7,<FY\
M]3Q93?N7HI"5 DH\:]#0*WJ#)D)UX9/<4^YFZT2+9HCW-^H],4I54!^1RWY
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MO_9('^W)O[E3K+/KJW/]!>YL>+_TM_K^_=>Z\+FQYOIM^+'\_CW[KW7OS^+
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M]I-WU__1VF/YX7_;KOY._P#E%?\ X(?:7L6\B_\ *TVO_-W_ *LR=3#[!_\
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M/%_ZGW[KW7K\VU#^GXX/^^X]^Z]U[_6N>;'Z_4?3W[KW7B0?Z\VMP>>>2/\
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M=D#CC@'\\\6N??NO=>N3_J?Q_7\_I]^Z]UX&P'U/^)-Q_MQ?W[KW7OK^"?\
M8<?Z_-N??NO==7-Q^"?Z\_3D#W[KW7=[$V()O>UB?Q;\>_=>Z[_PO_4:C;ZD
M_3W[KW7OZ<_0VY_K;\6]^Z]UQXX_PM]3;Z"_Y]^Z]UW:YL;7^OT_XF_OW7NN
M5_Z\?[;Z?U]^Z]UQO;@@V/ ']/QR??NO=<O]B?\ 7X]^Z]UQO;2.?]B?]XX]
M^Z]U[ZC_ !'^V!]^Z]UQ_P")-OZ6O]"?Z_['W[KW7/Z7/UO_ +;^GT]^Z]UT
M03^3]0/]>W^'OW7NO$<W YY_I]?IS[]U[KN_'XOP/ZW/Y''OW7NN/)Y N.!8
M@?2U^/?NO=<OK;_>?J!_K:??NO=>^@YX_P!;T_[#Z^_=>ZZ(N?Q<?6XO[]U[
MKPM<@7/X(O?_ &]_^(]^Z]UV+W8V_I;_ !M[]U[KK@?46U?7GW[KW7OZGGC^
MOT^GUY_-O?NO=>O_ %YL>/J+GW[KW6[;_P )LO\ LAGM7_Q:_?/^\]0;%/N$
M?<O_ )+T7_-!?^KDO6"/WHO^G@6G_2OB_P"TF[Z__]+:8_GA?]NN_D]_K]*_
M_!#[2]BWD7_E:;7_ )N_]69.IA]@O^GL[5_U%?\ :%<=?/B_J?KP. .3<?DV
M]Y"=='NN^ 0/H?\ ;CGZCGW[KW75C_4_\E'_ (I[]U[KUR/I?@VY!N;\GG_C
M7OW7NO?U('XO_@ !86]^Z]UZXM8G\?47!L.1[]U[KO\ 'XY(!-OK^#<>_=>Z
M\/I<D_T_U^?Z?U]^Z]U[\?07_ (L"?\  'W[KW7OJ1]=7];&P_PL??NO==_Z
M_P">+?[#\>_=>ZZM?ZW/UXX_'^/_ !OW[KW7K\7/''U!_J>?I[]U[KVGC]-O
MSP>0??NO==&Y%O\ $CZG_C?OW7NO6 '/U_%[G_8$C_>O?NO=>N+C@7)_U-OS
M_4^_=>Z[_K]1?\\V'^Q-O?NO==V'X_I;Z_0?X>_=>ZZ)(_Q/-OR;_P"PM[]U
M[KOZ?G_8DB]OH#[]U[KC<^H'D<$7!^E_\+>_=>Z[_)YY O\ X_ZW^M_A[]U[
MKUC8"QM;DW'^\>_=>Z\M@!_3DW_UOK[]U[KW'/\ O=^3IX/OW7NO?@CFX_QY
M/].??NO=>_)-C^/P>/\ 6/\ O?OW7NO GF_-^1:_T/\ C[]U[KQ-K?G^FGCZ
M?@^_=>Z[(!_U_P#7L;7^OOW7NO?CZ-_KW7W[KW71X!%OQ^/\?K;W[KW7OZG\
M?@#\?\D^_=>ZXF_-Q].?QR";V)]^Z]UZ_)_'TO?\W_J/^1>]TS3KW7*W-[L>
M 1:W_$^]=>ZZ_P!3_A^#^?Q?W[KW78_/%OR>+7XX'OW7NA8Z$X[TZ5/_ ']C
MKFW]0/[XT?X_KS]?:#=O^27<G_A4G_'#T3<T&O+>Y?\ ///_ -6GZ^I)[Q=Z
MY,]>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW10/Y@W_9"/S+
M_P#%7^]?_?:9+V;\O_\ )>L?^>B'_JXO0U]MO^GA['_SWVG_ %?3KYH8(M;\
M_P!.+\?['WDUUU*Z[]^Z]UQ-[?2W/]!^#8?GW[KW7A_AS:W X7G\^_=>Z\/P
M/[2K]/\ &WOW7NNA^/Z%;&P_V')/OW7NO D\E>?]M].!]?S[]U[KUQ8?G^O]
M38W^E_?NO==\VN>!SP+K;GZV'OW7NO$$_7^O^-OZV_Q]^Z]UX$ZK'C^@_P"-
MCW[KW7?/^'U_WBWOW7NO?T'TYX_/T'Y]^Z]UQN#]+_0"_P";_@>_=>ZY?XV_
M)_']#;\?FWOW7NNOZ<7 L;#_ &WUO[]U[KQ_K^/3].?H;W]^Z]UZ_I)^H_Q'
M-B;$<>_=>Z]_QJ_^/IM^?\>/?NO==_FW]1Q?@DL;\$_[Q;_>_?O\G5M)''_5
M_J\^M]7^1=\7#\>OA/M_>^>QK4N__D77Q=JYIZB%H:N#9TM**#K+%,)-),7\
M,U9>,:>&R,J$\"V/W/.[#<]]>)#6.V_3'IJSK((J,MBH\J=<[??[FW^LO/TU
ME;-6VVVMNGH9 29V]*^(2E?-8E/5TWL']0AU[W[KW7O?NO=>]^Z]U[W[KW7O
M?NO=>]^Z]U[W[KW7O?NO=(W?^_=L]8[%WEV/O&N&+VGL+;&?WAN3(,$;[3![
M:QDN7RM0B,PU,L,+Z4N"6LOU]N0Q27$R6\(U/(0J@>98@ ?M/2S;["ZW2^AV
MVR4O-<.D:+G+NP51^9(Z^8[\B^[=R?([O3M;O+=C.N;[-WIFMT2TKRM*F*QU
M94&/"8"F=[DP8ZB2FH8+FXCB7Z^\GMLL8]LVZ+;XN$:A:^IK5C^9J:?/RZZK
M\K[#:\K<N6?+UG\%I$J5&-3#+O\ :[DN?F?GT"WT'IXYO?\ ! ^MO:_H\Z[M
M8FPY_(!MQ_7W[KW7A8?2Y_P'(O[]U[KUP+WXMP+_ -"/?NO=>/\ 3TC^HO:_
M^\>_=>Z[N;GZ_P" M_Q/_&_?NO==?BQM]0 !<#G^I]^Z]UX$$G^HXY/U_P !
M[]U[KH$D?0VY%OZBW'OW7NN^;_0_3@<6_P!C[]U[KO\ 'YXX_P >/\.??NO=
M<1Q;^A-OSQQ8$7]^Z]UR/X/'X'^(OQP??NO==< #_:?K;\7_ *^_=>ZZ"\W%
M[ _3_6X/Y_/OW7NNS<GZ< _ZX-_ZCW[KW7K?ZQ_K8<V_!O[]U[KUQ>_'].20
M?]M[]U[KQ/\ K?X<7-OZWO[]U[KUP+C@7-OK];B_/OW7NO'BX_) X -AQ;CW
M[KW7@#_A]/I8?GZ_3W[KW7O\.;V_J?Z6O;W[KW2HV/SO79M[?\?3M_Z_]K:'
M_6]L7O\ N%-\T;_CIZ2;K_R2[O\ YI2?\=;KZJGO%7KD7U[W[KW7O?NO=>]^
MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=%N^8__9(?RK_\5P[R_P#?8Y3VOVK_
M )*EM_S5C_X^.A'R;_RN&U?\]EK_ -7H^OF*?ZKZW^GYX_UO>4775SKH#C4>
M?Z _@?ZWOW7NNQ]!R0!^3:]_IR/?NO=>M_A_O/!O]1[]U[KK_87L?IJ)_%_S
M[]U[KL7NQYM_C_Q'OW7NO"P_-K<6O>W-K^_=>Z]S?ZVY/! %P/Z>_=>ZZ_Y!
M]7^%@/\ 6O\ \1[]U[KNQM^;B_-Q8_TO[]U[KOFPYY/YL/\ 7^GOW7NNA<<?
MUO\ @_CC^OOW7NN[_P#$<_@7X'OPSU[KH#@F_-[\6'/]#[\10TZ]UZWUXO\
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MO==\V^G^PMP;GCCW[KW7T#?Y&'_;L+XZ_P#4?W-_[_/<GO'WGS_E:;C[(_\
MJU'USF^\#_T]G=/LM?\ M$@ZMO\ 80ZAGKWOW7NO>_=>Z][]U[KWOW7NO>_=
M>Z][]U[KWOW7NO>_=>Z^<3_-=O\ \.*_+8_]_6K_ .G%L92>\CN3O^5;M/\
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MX6.G^GOW7NNB2?\  VO_ +#_ (-[]U[KO_'\7N/S]38_3W[KW7O]8?47%_\
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M/H+7_P #[]U[KW'UXM_KDWL>/?NO=> )'^O]0?SQ8W]^Z]U[@WO_ +$\7'/
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M7($D<6_/Y/OW7NNB;6L/Q;_&WYY']/?NO=>O]?\ "_X_Q]5B??NO==BW%O\
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MZ^_=>Z\+\V_I;^O/X-S^/?NO=="YY_KP+\@#Z&_OW7NO <C@6 ^M^.?K]?\
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M<?X$_C_7O;_7M[]U[KWUX^I_UQ] WY'OW7NMGO\ X3)_\S6^5W'_ #3[K?\
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MWY?_ .2]8_\ /1#_ -7%Z&OMM_T\/8_^>^T_ZOIU\T.W^T_4?6]OK]?I]/\
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MO 6%KWO^/T\>_=>Z]Q];?IN!S]+?6_OW7NNA<6X^@M_M_P#8\\^_=>Z[M?\
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M:GK(';^E3HJ7_0,QTS_WE%V;_L-B;4'YO]?N?9M_KF[C_P HT?[6_P _0O\
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M%Z&OMM_T\/8_^>^T_P"KZ=?-#(O_ (CDCBUC^+_\B]Y-==2NN_QS8L/K^/\
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MJ?,YX](BU_\ ;@C^E[6_K[4=+NNC<?U/-A_@#_OOS[]U[KJW-OH+?I!/]?\
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MZ<?46^@XO?F_'OW7NN0_/]?QR3:_]3S[]U[KH<<6Y/%P?R!Q[]U[KN_U'/!
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M<_['W[KW7K$?G_7_ #>YMR/?NO=>N?IQ^/KQ<_FWOW7NNK'_ &WZ?I;^O/\
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M/I?\<_3^GOW7NA2Z4ZGW/WMVYUMTWLR 3[H[,WIM_9N)NA>&EFSE?'1R9*K
M(TT])&S54[W $4;,2 I/M+N%[%MUA+N$OPPH6/Y>0^;</MZ+>8=YM>7-DN]]
MOL16D3RMFA.D84?-SVC^ECSZ^G)U+UAMGI?K#K_J795,*/:G6^T-O[-P,+*B
MRG';>QT>.AJ*DQ!0T\P0RSRVN\C,YN6)]XNW5Q/=W,EU,:O(Q8_:22?L'7*+
M=]SN][W2XWB_;5-<RO*Y_I2,6/Y"M /(4'ET(WMKHOZ][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NJ@_YUORD_P!EJ^#^^<5A<F:'?_>TO^AS
M9X@E*5E/C=Q44DN_,W"JC6%@PJ55,LR%?%45-,00;7%7)6T_O3?HO$%8X/U&
M\QVDZ1^;4QG%<4ZF3V*Y2'-?/]LTZZK:PK<R^A,9'A+Z=TI4D?B57'D>M #Z
M"]B3?_7XOR3]"3^?]?WD14^6/^+KUT>+*3P_R>M/\/7'Z\,>?J.!;Z>]=4Z[
M^@^I'UXO]/3_ ,1_A[]U[KWU)')M]?J/Z?T]^Z]U[G_$\WX(^O\ J??NO==W
M-_\ 7O\ 3^S;W[KW7$?@+8VO?G_>?K[]U[KWT!)X)/(_J/?NO==WN2!_A_L+
M'^A]^Z]UZYN1_0?C^O\ 2_T]^Z]UX_TX)X_UA_L/?NO=>X_V]N;\FW(]^Z]U
MXBPN2?\ 7''Y_I]/?NO==6O_ +8 7_V_^]>_=>Z[M]1?D\GZ\@<#GZ^_=>ZZ
MM^/J!]>?ZCF_^]^_=>ZY <WM;\6'^O[]U[KVI?Z_[[_8^_=>ZZ_H/[6D'G_
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M5^/Z_P#(7OW7NNQ;Z#G@\'_7L?I[]U[KWTXN;_7^I//YX_I[]U[KH_0?46/
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M?]Y]^Z]UU<7L/ZV/''U_K[]U[KL7X)N3JM?_  (^H]^Z]UU8<\?TO^+<7O\
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MA/%N+B_]?=^G.NSP1I N;_C^G^M[]U[KWXMI'^%S?_>/>Z9IU[KQXXY):_\
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M<7O^2/?NO==_CZ#ZV/X']#_O/OW7NNKVX!'T^O\ 3FU@3?W[KW7M)_!X^O\
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MKW7N/R ?J.;$_6PN??NO=>_Q_// ^A_Q(/\ O?OW7NA8Z$_YGITJ/S_I8ZZ
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M_=>Z][]U[KWOW7NO>_=>Z)__ #!_^R$/F7_XJ_WI_P"^TR7LWY?_ .2]9?\
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M\7XXO_L?I[]U[KUO];ZW_P!>WT]^Z]UUP#_AIOQP+?D^_=>Z\1_L3_0F]O\
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M]^Z]U[\$#FUOZ<W/(M[]U[KWUN!]1:WTX(_I[]U[KPM^/Q^G_8_ZY]^Z]UT
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M6/ '!(_KS[]U[KE;_6_WG_>?Z^_=>ZX_DD\_4 ?3C\WO[WBGSZ]UV3:W^/\
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M?NO=;/?_  F4_P"9K?*W\_\ &/NMN>/^>CR7N+?<[_<>S_TTG^!>L4_O6_\
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M/('//!O_ *_Y]^Z]UU>UQ?@G_'@-]/\ BOOW7NN_K_L;$<'Z_3\>_=>Z[O\
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M>=%I\SQZRYY8^Z[;M:I<<XW\BRL*F*UT 1FE:&61) Q!PQ6,*#A2PST5L_\
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M +V/OW^MMR]_'/\ [VG_ %JZ]_P,/MY_RE;A_P Y;?\ [9NN_P#H(_\ G?\
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M;LY!(M[E3)'O(,/\"#Q_C[J?;78:$"6>OKJ3_!X?5&^[![?$4%UN _YO6_\
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MKVN/I]/?NO=<6L;<@?[R0?\ 7'OW7NN0 !O_ + ?BQ M:Y]^Z]UU_K'5:_\
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M0.?Z'C\V]^Z]UXW)M_L?I<'^E_?NO==7!'TO^/I?_8\^_=>Z]]2?Q_L;V/\
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M6[3_ $A_X\W73GV8_P"G8;-_S1/_ !]^J^?H22; ?7C@D_G\^Q'U(W7B2?\
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M;W[KW2HV+SO;9O%O]_3@+V_K_%8?I[3WO^X4W^D;_CIZ2;K_ ,DN[_YI2?\
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MA'-OZ?0<>]=>Z]<77Z?T '^)M>_OW7NO6'-^>>2?]J%K ^_=>ZZT\_47_/\
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M_P!";DG\6]^H?/KP0GCC[<=../Q&7R\OCQ6*R&3EN%\=!15-:_JO;TTZL?\
M>/=))8HO[5@OVFG^'IB:>WMAJN9%C'])@/\ #T(F)Z+[OSP48/IOM7-,P&@8
MGKS=V2+W^A3[.C>_^P]I&W/;4^.XB'VR*/\ +T53<R<N6W^Y&X6R?Z:>)?\
MCS#H6,)\$_FSN +)AOB'\F*Z%S9:F/HWLN.A)']*R?&+$/\ DOVFDW_8HOCO
M(?RD4G]@->BBX]PN0K45GWJQ4^GU4)/[%<GH2<9_*X_F&99?\D^(W=,>NVD9
M/;)PQ%_]5_&)(+?[&WM&W-O+:<;M/RU'_ #T4R^[OMI#\>\V_P#M69O^.J>A
M)Q/\F;^9CFM/V?Q8W# &^G\6WWU)@0.>-39S<%,!_L?;+<Z<L+QNA^22'_ A
MZ+9O?/VI@^/=U/\ I8+IO^.P'H1L=_(@_F7UUC4=+[9PY903_$>W>K)=%O[)
M.*RU4"?]:_M&WN!RTIHLCM]D;#_CP'15-]X;VNC%4O)9/]+;S#_CZ+TO<5_P
MGQ_F'5X056*Z<PH-]393LZ*4)_P;^#T-7?\ V%_:=O<;EY:XE-/Z _RL.B^7
M[R7MO'\)NG_TL '_ !Z1>GG-_P#"=[Y_8K&-7X_(=!;GJ@A9<'@NR,Y!E'*W
M*QK+N7!X^BU'BQ-8!R+D<VTGN/L#&C),H]2BT_DY/\NF(/O+^W<THCDCO(@?
MQ-#&5^VB3.U/]K7Y=51=_?%OY!_%G<J;4[^ZIW7UMEJHS-C)LS1QU&#ST5,V
MB>;;NZ,6\^,R*(;!VHJN4*2 UB1[%FW;OMN[1^+M\JR <0*A@?0J0&'YBGSZ
MF'EOF[EKF^U-WRY>QW2K34%)#I7AKC8*Z?[917RZ +FP^@O]"#QS_A[,Z9I]
MO\O]1_9]E1,4(X\?3SZZNW-_K:_'T'^O[UU3KOB]N/I_2Y/Y-Q[]U[KQX'^)
M_%N3Q_A[]U[KKDD_[?@?2WT!(_/OW7NO#B]A]"?I^2?\/?NO==_[3]/^*7_X
MI[]U[KI1Q?\ )OR/J?\ ;^_=>ZY#Z<?3\?F_Y_K[]U[KA8BXX!X()-C_ (^_
M=>Z56QN-[;.YY_O3M^]_Q?*PF_MB]_W"F_TC?\=/23=?^27=_P#-.3_CK=?5
M4]XJ]<B^O>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N@
MU[.Z@ZS[IVE7;#[;V'M+L;9V0LU1MW=^#H<YC?.B-'#6P0UZ/X:F(.QAJH2D
ML9-XW4\^W[>ZN;.87%F[1NO!E8@CTX?S^6,UZ,=JW?==CO4W'9[F2VG3@\;%
M&IC%5(J#05!J#Y]5QYC^1Y_+)R]3/5CXY-C)JA_(Z8GMCNJBI4>Y9O!1+N)H
M(E/T"11JH^J@'V(X^=^:(U"BZJ!ZI&3^TI7]M>I1@]_/=:",1_O36!COM[5C
M3YDPDG[2:_/I+U/\AG^6K.;P]0;KH_4S6@[<[,<6/T3_ "K)R&P_!O?_ !]O
M#GSF?SG'_../_H'I4OWAO=4?%?H?^H:W'^"(=,<_\@/^7',!X]C]DTI (#4_
M:NYV-R>&_P K:47']+6_P]W_ *_<R_[]7_G&G^;I]?O%^Z(^*[B;[;>+_(HZ
M8JC_ (3V?R\YM7CH.YZ/5JM]OV;KT7-Q;[S'RWM]!>_^Q]W'N!S)YNG^\#IY
M?O'^Y@^*6W;[;=?\A'3%4?\ "=;X"S\QYKY!TA))O3]C;;?3<_0?=[?EOQQS
M?_&Y]W'N%S%^,QM]J?YCTI3[RWN0G_*(WVP$?X)!TFJW_A-S\&:@,:/LKY18
MY[>D0[XZOGB!_P!J6KV9(Q'_ "%[>3W(W]34QP-]J/7]HD'^#I9%]Y_W C^.
MVL7^V*?_ "7 Z1E=_P )I_BJ]_X;WQ\@*3_4_?/UQ7@<W]7V^$IK^U ]S-Y\
MX8?R#C_G_I=']Z;G1?[2PLV^P3C_  S-TDZO_A,WT>__   ^3?:M-R2/O-G;
M0KK<_0^*2GO[N/<S<Q_Q'B_:_P#GZ5I]ZGF3_1-KMO\ :O*O^$MTF:O_ (3(
M[!<'['Y<[PI3S;[GJ/"5@_P)$6=@]O?ZY]\?CM4/V,P_R=*H_O6;N/[79H6^
MR>0?X4;I(Y#_ (3#H49L3\TF60!C'#D/CXK*S'](>II-Z*5'^M$?:B/W1<"D
MMD#]DM/\,9Z7Q?>ODI2?8ZGU6\(_D;8_X>D#DO\ A,IVA'J_A/RQV'7 7T?Q
M'K'<.*O;Z:A396LTW_-B?;_^NA PH]FWY2_]"=+X?O6;;6LNRR+_ *6X5O\
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M[KW7C>W'UN>3^!?W[KW7T#?Y&'_;L+XZ_P#4?W-_[_/<GO'WGS_E:;C[(_\
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MQ5+AD HOC*@+ZU  UJ&U\7 8%FIPHOY3/\QG(USX^#XF]FQU".8FDKEV_BZ
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M!J!KVY@>R?O=?7E]#R=SG-XK2D+;7+TUE_*&9OQZ\!'/=J[6)U!EU72.?ZW
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M]UW]#R3_ %MQ_O?OW7NO6N/S_JN>>?Z6]^Z]UX?ZQY'/U_'%O?NO==$$ZO\
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M_L/I]/I_K6X]^Z]UUQ:QN3<VOSR/K_OC[]U[KKC_ %1(/X^M[<_4>_=>Z]]
M"38<?C_;C_8_GW[KW7*_^!_)_P"-?\:]^Z]UT+"_XOSQR.?I;W[KW7K?4B]B
M;\'GZ_@#W[KW77^PO;FQ^OTL/]X^OOW7NN](_I>YYO\ T_P]^Z]UW<V/X(MS
M:X]^Z]UQX( )-K?[U_0^_=>Z[ //'!YOQ]?Z?ZWOW7NO#C_:?I];7)O<\^_=
M>Z]]/Q:[?3_D&WX]^Z]UQ() )/J_U[?GW[KW7*WU^O/UN>/\?KS[]U[KW^O?
MZ6(NOY_-K^_=>Z\>!_K6_P ;<6M[]U[KOC_7X /)^AX_'OW7NN%FXN;?BQ(
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ML+_@#\GZ>_=>ZZM8BU[6_%N3_L??NO=>OQ8CG_%?K;D6 ]^Z]UW_ +R1:_\
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M:CS_ ##_ )<#_O\ %G^3_P L(#[R/Y0SRW:#^A_S\>NG?LY_T[+9_P#F@O\
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MX]^Z]U[Z?\1_B?\ 6_K_ (^_=>Z]87O;_&_/]+_3^OOW7NNOR .#_2_ YO\
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M3O\ K]*__!#[2]BWD;_E:;7_ )N_]69.IA]@O^GL[5_U%?\ :%<]?/C%AP;
M<_['_;^\A.NCW7OQ;^GU/^POJ]^Z]UXFUOP3QQ_0?@>_=>Z]S?\ 'X/ ^O\
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MR^OUX_'U/OW7NNK_ (O^"/U?4GZ&_OW7NO$_XV_QO8_[U[]U[KK38?Z]^/\
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M_>/S?^G/^N??NO==6)(!%P+F_P!"?\./?NO==_3_ !'-SP;&][\>_=>Z[O\
MFQ_'X_K[W3-.O==?I_J?]:YOQ]2#[UU[KH?7@?@\_@CZ#W[KW78XU'Z6M_K?
M3BWOW7NO7(_I^.>;7_)X'OW7NNA8'D6O>Q/^!_/_ !KW[KW7?_)-AQ]+VL/S
MS[]U[KU_5R?\#Q^ +W)]^Z]UX$G_ %QP3]/]M[]U[KKG@\\-8<WO?@@>_=>Z
M%GH,D=Z=+ 6(_P!+/71O8_\ /84?]#[0[M_R2KD?\*D_XX>B?FC_ )5O<O\
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M'_3L-F_YHG_C[]5\V_H1P.+?U/%S[$?4C=>^M["U_KJ!'T_Q'OW7NNOJ+?I
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MU[KO4#_MK_C_ &UO?NO=>)-O]<_4<_['W[KW7$FW^O\ [<\#C41[]U[KOG\
M?D_DD'_8_P"'OW7NMVW_ (39F_P9[4_\6OWS_O'4&Q?<(^Y>=^B/_"%_ZN2]
M8(_>B_Z>!:?]*^+_ +2;OK__T]IC^>%_VZ[^3W^OTK_\$/M+V+>1O^5IM?\
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M^@%N>+G^E[#W[KW7AR+?[WR3_4D>_=>Z\/\ 4WN;7O\ 7Z_X^_$4Z]UZPO\
MT)(N#R#;\"_OW7NNKV_KR/J+'Z?G_BOOW7NNQ?ZGC\?0CCZ_D^_=>Z[N+\<W
M^IO_ $]^Z]UU?Z?7G@<_C^O^O[]U[KH'_ CGZ_7B]K$G_'W[KW7?]?ZBPO\
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MTM?FUOI[]U[KG?W[KW0K]!FW>O2QL.>U^N/]O_?"B_I_K^T.Z8VJY_YI2?\
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M6II<?-21T.VL<?BYL.1S_7\^T?1#PSUR]ZJ.O==7!^A!_P!8CWZN:=>IUT6
M_P!C]/\ '_8GWZM./7NN7O?7NN'D6U[\<7^G%_H"/>J\?EUX9X=>UJ3;_"YY
M%@/]\#]/]C[WY5'7NO:UXY^OYXM]+\_T_P!C[U4=;H>O:UO]?]<_T_WW/OU:
M5^77J'KO5P#8\_BX_P"*^]TZUUWJ!^AO_K>_=>ZZU6_'''-Q;DV'U/\ OO\
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M\+N@4^NE23^7<,]9L?=6L98MAW;<7%$EN(HP?4PQEFI]GC#\SUK0_AN/]?\
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M$WXOS^+>_=>Z]]1>]_\  $6_V-Q[]U[KJQN?I<@ 'Z$\<\?U]^Z]UV;#BPL
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M['ZD&E%O\?:^/VVWU^Z22)/D2Y/\H_\ +T(+/[K_ #W,/\:N[*'Y>),S?L$
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M?X_7WH'&<=:U\<D?S_P]<OK:XNH/J'%N/J!J'^V]^KBG\_/^=>O:A2@Q\_\
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M\?DV/U-N+>_=>Z]<'_7'U_%O\+D?3W[KW7@; #DW/'^/^)]^Z]UZW];G\<<
M_P"^_P!?W[KW7AR21>WYX^MOZ>_=>Z]_4#Z?IY)_XW[]U[KW//UYL/K]./\
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M_/T_U7OW7NNK<?0 ?6]KFWUO<G_B/?NO=<O]L ?I;_BGOW7NNOQ?FP^@%_\
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MCZ$V_K;\>_=>Z\+ V_)^A_)_K<^_=>ZZY]0O_2PMQS]>/?NO==_[QR?I_K\
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MXO\ 3B&3_CJ1?X>E'N__ (4N=]5V+FI]B_&[J;:V8: Q1Y/<>YMV[RI*>1U
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MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z*!_,&_[(1^9?\
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M'\_[Q_3W[KW7&]^!].5M_6P_K[]U[KNYMQR>#]/P3_C[]U[KKFQ'U)OP>/\
M7^GOW7NN[?[?\>HG_7M[]U[KJY_I<W/U/TOS[]U[KO\ J?\ "QOR/I?W[KW7
MK&WTYM]>+W]^Z]UZUN>1Q>_UO_K^_=>Z[M_L/U#CBPO[]U[KK^OXM;C]-O\
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MY-A]3QI^GOW7NO?2VJ_T /(M_4<#W[KW7(FUO\>/Q_M_?NO==$V^@'^M^?\
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MV-_Z^_=>Z\3<7!M_L;?FW/OW7NA8Z#L>].E;_P#/V.NKV/\ V=]%]?:#=O\
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MY]^Z]UUP+_7Z?T(L+7X]^Z]UZP_UQ>W'XO\ G^G^\>_=>Z[N3]2!SP?KR?\
M8_7W[KW7'2#_ $/IL1_B/I]/?NO==\_G_$G^HY_K_P 1[]U[KOZ\\?GZ&_XM
M^?S[]U[KH"QOR./Z$W/]3;W[KW7A_0 _X&Q''^O_ +S[]U[KUS?\$<6Y_P!X
M'^/OW7NMV[_A-IQ\&>U1_P"!7[Y_]]!L7W"'N5_R78O^:"_]7)>L$?O1?]/
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M_P!1]1^.#?Z'WKKW7O\ ;CCZW_K_ *_OW7NNOR..?ZDD_2_X_P!A[]U[KN_
MX^I%K\CG\\^_=>Z\.#8?2Y)_WH"_OW7NNKBU[?46O^2?I8#W[KW7?TXL6/\
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MO=$__F#_ /9"'S+_ /%7^]/_ 'VN2]FVP?\ )=LO^:\/_5Q>AM[;?]/#V/\
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M\GG\^_=>ZZ''U'Y_IQ>]K ^_=>Z]]!>U_K<#Z\FXY]^Z]UT01;_;#DGF]_\
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MW]^Z]UUS] 18'^E[<?[[_8^_=>Z^@=_(P_[=A?'7_J/[F_\ ?Y[D]X^\^?\
M*TW'V1_]6H^N<WW@?^GL[I]EK_VB0=6W^PAU#/7O?NO=>]^Z]U[W[KW7O?NO
M=>]^Z]U[W[KW7O?NO=>]^Z]U\XG^:X?^QBWRWY^G:U?^/I_N+I/>1W)W_*MV
MG^D/_'FZZ<^S'_3L-F_YHG_C[]5\WO<\ @?X$_U-C[$?4C=>'&H<_C^I-[<\
M^_=>Z]]5Y_/]/I_7W[KW75S?Z D_0@?["Y//OW7NO#^H%[&URQ_I];>_=>Z[
M%S^3^?R/Z\_CW[KW75QSR.;<#^OYX/\ Q3W[KW7?!'%S8CG\\<_GW[KW7O\
M>O5?_8<7/]??NO=>_P"(^G)^M[$7/OW7NO<<V(MQ?\\#ZBWOW7NO<_[S8_BX
M^E_^1>_=>Z]_A_2Q'(N>+6/OW7NO#D@FX%OJ?H+_ %]^Z]UQL3;GZ?06/X^E
M_?NO=<E%A_4DW%OSQ]"??NO=<;<6&JQN!_2X-_H??NO==@#Z?D?3ZK?\7/OW
M7NO?C_'Z$_XWLI]^Z]U[^G'^'%B+?3Z<_P"V]^Z]UW_K?X#D6LO]>??NO=>
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M)_S/3I7Z?\S8ZZ!%_P#L\*/C_>?:#=O^27<G_A4G_'#T3<SC_D-[E_SSS_\
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M_P#L3?Z?4C_$>_=>Z[O;Z?7GZW'^)Y/OW7NO?ZWX! /Y])]^Z]UU_2_/-O\
M&_T%_P#>??NO==C\?T'^/'TMQ_7W[KW7@>"+F_\ CQ_A>_OW7NNB2;6)^I']
M.;<?3W[KW7?U^O/-[?TL?Z?[W[]U[KW)'U-_Q] #_K7]^Z]UT;_6]B.+CD?[
MS[]U[KD?IS?ZG_C0X_'OW7NNB!P+?X 7_P!B2/?NO=>N1^.#Q;\7O_7W[KW7
MK\V_)^H_'TN>/^-^_=>ZZ^G^M^+VY'' 'OW7NN0)N?S_ *W^MR+^_=>ZXV'/
M'TO8W/%OZ_\ &O?NO==_T_3]>3?@FW]/?NO=>)L+?J/]+V)]^Z]U[_"_-N2.
M#_AQ[]U[KO\ XCB_YX_%K>_=>Z]?@"QO;_ V]^Z]UQU _@_[Q:Q-C[]U[KE8
M_P#$?X$?T]^Z]UU_4_0BW-B >;_3W[KW7C_1;#B_]/\ B/?NO==<7O\ FXO^
M+$GZ_G_;>_=>Z[' ]/\ A]3QS[]U[KH?@@<7MP3QS]??NO==_C^JVO\ T_%O
M?NO==?7\D7L+V)^AXY]^Z]UW<\\_TMQ;\VYX]^Z]UU_4<\_7@W/%K@GW[KW7
M?TL2;<_X?07_ *?Z_OW7NO&P_P!5_KW-O][]^Z]U[\FWXMS^?Z_J-_?NO=>(
M_K;Z'Z_U/U^GOW7NO']/'J_H3R>?]?W[KW73'_7_ #<?X?3GW[KW7=[CG\ZK
M6_I[]U[KUB+CDCBQX/\ K_7W[KW78)-Q^?Q_A?Z7]^Z]UT+6^EA]/ZDW_K[]
MU[KC]+:;\G_6!_'(]^Z]UVQ(M;B_OW7NN_\ #Z_@D@@D?GW[KW7@/]YN./R!
MQ?G_ (BWOW7NO L?][_IP?Q]#[]U[KU^;<_0?T_U5K^_=>Z]8_X_F_T%[?3_
M %O?NO=>^MQ^!_@>/Z?3Z^_=>ZZ_38@<GC\_G_"_OPSCKW79O>_-A_0_6W^'
MOW7NO6/X_%_I;\_T)^GOW7NO6/)XN?\ ;>_=>Z\3>XMQ8V/UY_V'OW7NO7(/
M) '^(_WFU_?NO==<C_8V_P"*#Z6]^Z]UX#\&WTN.>5_KS;W[KW7OQ^" HM<<
M7/'U]^Z]UW?\:A]";_['W[KW7K\ VN"+\#Z'Z\^_=>ZZ!^M[WMJM]!>WOW7N
MN0-_Q_M_\>2![]U[KH@<#B]P;<7/'Y'OW7NO _4?6W].?]O_ (^_=>Z];_$\
M<CGFQ^IM;W[KW7O\+<?3Z_D\D>_=>Z[YM];&_P!?I;G_ &/OW7NNK7'^V_/)
MM]+GW[KW7?UX(_VXXO[]U[KB/]I!_I<\\ ?CW[KW7(7'U_K_ %)]^Z]UUS:U
M@-7_ !3\\>_=>ZZ_M \$?BUS]/J./?NO==_IO_C]"3R?]<^_=>Z\> /Z<<\?
M@\ _X>_=>Z]P;\?U/U(YM:X/OW7NN@"?]C>X-_R;\>_=>Z[/(X%_Q:XMQ_6W
MOW7NO?3_ &-S?@W'U/OW7NO"VG@7!)X_V-OS[]U[KN]OS_M[?UL#[]U[KH7M
M_A8<GZ\&]_?NO==\6(Y YO;\?G\^_=>ZZ'UOSS];_P"'']![]U[KN_\ O/UM
M<'^EP/?NO==<BU^;G_&X ^E_?NO=>YM?\"_!^I_U_?NO=> O8C\<#^EOK^?\
M/?NO=>Y_UQ;Z&Y_-_P _X>_=>Z]<?[>_T%]5N.>/?NO=>O\ 4V^H/T^MP;>_
M=>Z]]3_0?FWYU'CW[KW7B3];_P"]6M?^I_/^Q]^Z]UXW']3ZK\7/']/?NO=>
M_/T'T^O-QQ_JC[]U[KW^%A8@_3Z?[$^_=>Z]^ /[)'^V/UY]^Z]UX_X_1?ZW
MY/T!/'OW7NO'@?FW'YX%CQ_L??NO=?0-_D8?]NPOCK_U']S?^_SW)[Q]Y\_Y
M6FX^R/\ ZM1]<YOO _\ 3V=T^RU_[1(.K;_80ZAGKWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z^<3_-=N/YBWRU_'_&5J_\ V)_AE)_ON?>1
M_*'_ "K-H/Z)_P"/-UTY]F?^G8[-_P T?^?GZKYL.>;$WOS>_-N0?8BZD;KR
MD'Z:;?[&_P!;CZ^_=>ZZ4<D_GZ_0CZ_7W[KW7+^GYY-S_2PL3[]U[KCIY(MZ
M?]<_[?G\^_=>Z[M<B_%_H/SQS]1[]U[KB>"#^+W^IO?_ &/OW7NN0O\ G^O^
MM?BW'OW7NN-A;Z\7'U^H/YXX]^Z]UR_QL?Z7_-K_ -+>_=>ZZM8<ACP!_6_Y
M^G^'OW7NNP38<?T_Q^GY%O\ 'W[KW7N1QS>U_K?_  /]3[]U[KQ'^M8_X$D_
MZ]O?NO=>^@Y  M_OO3[]U[KU[V^GY%K\V/T]^Z]UX<C_ !#'^MN#S_O'OW7N
MNKWM_5;W!_+?BP'OW7NO?CZ<CD#Z_@<>KW[KW7C_ %L+D\_FPM8W]^Z]UR_-
MO]I/T^GU_H??NO=>_##ZV_XI]/?NO==7_P!;Z7N3_JC].?\ #W[KW7O];^@%
MK\$?X>_=>ZZ!_!M_CQ_3^OOW7NN^"+'_  -OZ7-K>_=>ZZM_BP^GTL!SQ]![
M]U[KOZD\\_FQY/\ 0_Z_OW7NO<C\_P"L!R+#BW^O[]U[KN]OJ.387_K_ (V]
M^Z]UTQX^E^?S_K_0>_=>ZZ^BW %QSS]>/]M[]U[KE_7^A Y_KQ^??NO==?U(
MX]-Q8\?ZY'OW7NO7Y_/UXX^HM^/?NO==?U/^LP%_]N??NO=<K?[$W^OT-OZ7
M'OW7NNB;&W^ /^L+\^_=>Z]_0?4F_P#R(C^GOW7NMVW_ (39BWP:[5O]?]FO
MWS]/I_S*'8ON$?<O&^Q#_A"_]7)>L$?O1?\ 3P+3_I7Q?]I-WU__T=IG^>%;
M_AKOY/7_ *]*_P#P0VTO8MY&_P"5IM?^;O\ U9DZF'V"_P"GM;5_U%?]H5QU
M\^.XM]3R?KQQQ?WD)UT>ZZ/%A_4V^G^P]7]??NO==7 /U^MOS?\ V]_^*^_=
M>Z[%^#SQ>USR?\#[]U[KH&_]3;_;C^O/'U]^Z]URL?\ H7^I/')O[\:5QU[K
MKD?3_5?3_>;>_=>ZZ_UB#:W(N2/5P/?NO=>) '^W!4&_U//OW7NN5OQ_K7_Q
MM;GW[KW71YX^MA?_ %S_ *P/OW7NO*>!>Y_)-[C_ &_OW7NNN;\\B]^+FQ_'
MT]^Z]UXD'\?0_4\6/^M[]U[KOT\\W_)MS?W[KW7K\D#@W_P//YX/OW7NO<D
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M[KQY_I_B2/H#P/K[]U[KH_XB]C;_ %R/Z#W[KW7K\W^H'TL1_K<W]^Z]UV;
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M)^A'(YO>_P!/>NMZ?4@?ZOEUU_M)-P?S;2!S^+^]T]<=;\-NN_\ #^FKZ7!
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M)S[RRGPS,_V1O_S\HZ*)_O >UD/P;@\O^DMKC_GZ)>A)Q7_"??\ F)9'2*O
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MQB/K_C_UG^_?7WW^_I/][;_/U3^LW,O_ $<;K_G/+_T%U('QI^.BBR]!=*
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M4/\ $T^)K+?["_M]?<W;R>^UD'V,I_S=&<?WJ.5V_MMKN5^PQ-_A9.@TS/\
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MGA;_ &AL'6U(;_D&_M6O.'++<+M/S#C_  J*?GT;P^\GMA<?V>\P#_3"1/\
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MKW10/Y@W_9"/S+_\5>[U_P#?9Y+V;\O_ /)>L?\ GHA_ZN+T-?;;_IX>Q_\
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ME]\;EN/^;@W'E:K7_P A7]H9.;.9)/BO)/R('^ "GY=$%Q[S>Z%U_:[S./\
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M $ _-S<_['WXCT _U?EUOSZYZ>+#C_6N/]Z]^S_JSUJ@Z]I_P'^P)'^WM[T
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MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\XG^:[_ -O%?EM_7_2K7_\
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MH<\W_J#8\>]]5Z\?K^3;Z7!)_P!:X]^Z]U[U?X<#G\_C\^_=>ZZ_U_5S>Y(
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MZ[_-[G_@MQQ_K^_=>ZZ!(Y)OS;Z7)_P!]^Z]UV/J2!^.!]/H;<W]^Z]UZ_\
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M/'(_K[]U[KUC?]1-^>./Q_A[]U[KNY/TM_MB>?QS[]U[K=N_X3:<_!KM4_\
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M'^AY'I'OW7NO?2WT%OH+_BW(]^Z]UZ_Z3^>>!Q>_^O[]U[KQ !_I<V_X-?\
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M\?T_U_\ 6M_C[]U[KJW'/^Q_V]SP/?NO==V(M;G^O]2?Z\^_=>Z\+#_8D_\
M%-(O[]U[KC^2";?7BU^#^??NO==GZ7'^N0?Z?D>_=>ZZM<6XM:X)Y/\ O/OW
M7NO?JO;\'^I^MOZ$>_=>Z[_J01QQ;\"WOW7NNN+_ $%^?K<7 _-C[]U[KO\
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M?NO=>M]2?S^+\?6][^_=>Z[YO;D_GZ6 _I;_ )'[]U[KB#R+_6UKW' _K?\
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MHD7/T'^'OW7NO->U_P# _P"Q'OW7NN-C>XM^>+?TX/'OW7NN1XM^H\\6_/\
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M/OW7NO#GZ@?4VN.?\/?NO=>_UR.+GDVY)N+@>_=>Z%GH/GO7I:UQ?MCKDV!
M_P"8PHOH?:'=<;5<_P#-*3_CC=$_-'_*N;C_ ,\\_P#U:?KZD?O%SKDQU[W[
MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$__F#_ /9"'S+_ /%7
M^]?_ 'VF2]F_+_\ R7;+_FO%_P!7%Z&OMM_T\/8_^>^T_P"KZ=?-$L?Z?U^A
M/Y]Y-==2NNOZW_/T(N>/Z?GW[KW70_H/T_@'B_%["_OW7NO'F_XM^0/I_3\^
M_=>Z[-[?[W_B!]??NO==\@<_7GGZ#D^_=>ZXW ('' L38W_WCW[KW7?)'/\
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MNR./IS].>; \$^_=>ZZ('))8#ZGG\W_H/?NO=> %[VYYM_7^A_P]^Z]U[C_
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MU-O?NO8K3KHNH^I'^^_K;W[KW7@ZFYN+ V)N+?TO_P 1[]U[KNX^IX_U^/\
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MK5_/^(QE)[R.Y/\ ^59M!_1/_'FZZ<^S./;'9O\ FC_S^_5?']3^; ?TM?\
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MV6R7@_TT+I_Q\+T%69_G/_RS<&LAJ_E%@ZDQ@DIA]@=MYUF(_LI_!L!.#?\
M!O;_ !]J8^3N9I31+1OS*+_QYAT<6_L=[J7)I'L\B_Z>2!/^/RKT$.8_GZ_R
MX,87%'V#V'N#1]#B.J-WP"3_ ()_'XJ'_DZWM<O(/,YIJA5:^LB?Y&/1Q#]W
MCW0E^.TBC_TUQ$?^.,W0:97_ (48_ C'Z_M=L?([-Z 2!C.O=EP%[&WI_CFY
MZ/\ Y.M[4Q^W7,,A /A+7U<G_CJMT;6_W9O<>8T=[.+_ $T[G_CD3]!)E_\
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MZ?[#=;A?MBB;_ 5Z$/%_\*<-Y0&/^._$#;61 /[@Q/=&5PK./]H:KVU7Z?\
M8AO;+>U\5>R](^V.O_60=%\OW5+,_P!AO;K_ *:T5O\ !<+T)&-_X4X[4F &
M9^'.X:"_ZQC>[L9E@#_M/W6UZ*_^QM[2/[87(Q%=J1\T(_Y^;HIF^ZK?J?\
M%]ZC?_36S)_@F?H0L7_PI@^/\Q3^-?&[N/'\@2'%[@V5F-/Y.D5<U#?_ &-O
M:=O;+=:=ES%^8?\ Z!Z+)?NM<T+_ &&YVK?Z99E_P*_0H8G_ (4@_!RO5$RO
M6_R:PLI7UO-LOK>OHP2; ))1;M:4\_\ -A?:>7VVWZ,$QO"WV,X_X]&.BV?[
ML/N!$!X5S8R5\A+,K?SMP/Y]"=B?^%!G\N[(E!69OM_ ![7;+=7U<ZI?\/\
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MKY/TN>/H1_KC_>_8CZD;KQ)'^'^)Y_W@>_=>Z]8GZ<?DCZW/^/OW7NNC>_\
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M8^;D_LT*>A-9_=F]P[DCQY;2#_32R,?^,0N/Y]%ZW!_PIGZGIA(=J_%;L3-
M7,3;@[$VUMEG%^/(,=C\MH_QMJ_P]F$?MCN!_MKJ,?8I:GV5"]"*W^ZQOK4^
MKW:"/UT122?X6BZ '<__  IH[,JG?^YGQ/V)@HBQ$2[E[.W!NN2/BP,C8K$X
M8-Q^-(]F,?M?;C^UNR?LC _PN:="2V^ZKMJT^MWJ5_71;HG_ !Z:3H ]S_\
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M1^]%_P!/ M/^>"+_ +2;OK__U]IG^>"+_P KOY/?Z_2I_P!M\AMI'V+>1O\
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M[KW71-K7L+D_ZUA_3W[KW0K]!_\ ,].EN3_S-CKGGBY_W^-$!?VAW7.U7/\
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MV1DF:W *9+(8NDH&N>!:K_Q^G/LV@Y)YFG&KZ;0/Z3HO\M5?Y=#"Q]A?=.^
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MOQ]!S_A]/?NO=>Y_I;^MK<\?CW[KW7N?[-AR>;#Z7M[]U[KW'-A^JUN/K?\
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M7_-B?J/?NO=>_P!<_D6Y-CQQ87_K[]U[KK2>>?J #Q]0!8\GW[KW7@/TV/\
M7Z?X\V_/OW7NNQ;Z$DWM;U7/U_%O?NO==WX_QM?D$#W[KW7$7%_5]#S?^G^Q
M_/OW7NNQ];_UM8?ZP_%_?NO=;MO_  FS_P"R&>U/_%KM\?\ OH-B^X0]RO\
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MNO?J-P?I;CD?[?W[KW7N?H!]21QQ]#87/OW7NNOJ+#G3_AP;'CW[KW7?]?\
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M_=>Z][]U[KWOW7NB,_S*]SX_:?P!^8.3RLB14U7T%V/MJ)G-E.1WG@)=G8=
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MW7NN5[\?G_B#[]U[KKC^@(%@.?IQS>_OW7NO?X_CG^T=/)]^Z]UUR?ZVYYU
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MNO=<OP;6Y_IQ_O(]^Z]UUI_IZ2/I8W_V]_?NO==<#@\CZ <'D?UM[]U[KO\
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M@FW/XX_VX)]^Z]URY_-B+@?3Z_@W'OW7NN^?K^+?3Z\_[#W[KW71 (/Y(O\
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M4UM=43U=;63S5-56U4SU-15551(TT\]343EG=W=B[NQ+%B23?GW(:JB!504
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MO:JI/\%8Z?,:2!7Y4I\CU'VY^SGMENU3<;/"A/G#J@I_SA9!_*GR/1].N/\
MA1G\V-K^.GW[LKH_M"D4KYJRKVUGMH;@D"&S*M=MG(QT"@@DF^+;GZ6%Q[(+
MGVUV:45MIIHC\RK+^R@/_&NH[W/[L7(MT-6VW-W:-Z:XY4'^U:,.?^<@Z/\
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MRJJ2SR2R2$N[N2S,223<^Y&1(XU"1@*!3 &!3% !3%/\W62T216\2PVZ!$0
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MT]IC^>%_VZ[^3O\ K]*__!#[2]BWD;_E:;7_ )N_]69.IA]@O^GL[5_U%?\
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MJ386XMS_ +S[]U[KGS;_ !O_ +Q>]O\ ;>_=>ZXGC_6Y)O\ 2Y/'OW7NO6)
MN0.?\3R#^+GW[KW7A8"YMR>3].;_ ./OW7NO7/\ O/\ 1OI[]U[KQO\ X\_T
MM_MO?NO==#@\6^O].?I<@$>_=>ZZ'/\ K< <$C_$BWOW7NN8(^@'^V((]^Z]
MUT20/H;?0F_/^OS^??NO==7-U'!_V/\ A^?K[]U[KWT_X+8?7\ _7GZW]^Z]
MU[ZVX/X(N+6_KS^??NO==_CZ< @KS]??NO==W)_I;_"Y)YOS;_#W[KW71%@0
M>>>!]3_06O[]U[KW]!<@<<@VN#_A[]U[KJ_T^I^@(/T;^M@?S[]U[KLD#Z_T
M-K7_ .0OI[]U[K=M_P"$V7_9#':O_BU^^O\ WT.Q?<(^Y>=^B/\ PA?^KDO6
M"/WHO^G@6G_2OB_[2;OK_]3:9_GA?]NN_D]_K]*__!#[2]BWD7_E:;7_ )N_
M]69.IA]@O^GL[5_U%?\ :%<=?/B_-QR+W'_)'O(3KH]UXFX-OIS<C^EO][]^
MZ]UW;Z_3FW^P_P!A[]U[KQM:YOQ<?4C_  YM[]U[KKD6L/R>#_B>#[]U[KQ7
MZFY_K]3_ $^I]^Z]UQ/)X^O(O^./SQ[]U[KE_@;DG@_47'T_WCW[KW70;C\?
M7_6_']+^_=>Z[YO]>;7_ -AQ^/I_7W[KW71^EN>/J2">0;<>_=>Z['^/YO\
MZ]SS_L/?NO==?UX_I<#ZWO?Z^_=>Z\#8D*+V_P ?]Z]^Z]U[^@_US<_0?V@
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M]Y_J+?4_X^_=>ZY'D?['\\6(/!]^Z]UQ ^MQ]2>;?2_^^_K[]U[KL'])^G^
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MCZD7/^\>_=>Z]>WU_38VM^;\_3W[KW7*_P#@?]N/SQQS[]U[KB#?TCD<@V_
M_'/OW7NN_P CD_ZUOKQ?W[KW7@22;?[2?Q]#S[]U[KVH\\<_C^EOZW]^Z]U[
M\_D_46^G'OW7NNA>_P"#?@CDV^GU_P!Y]^Z]UW8FQ_M V/X! /OW7NNAP+<?
MTY_U5[>_=>Z['T_-OQ8W_/XX]^Z]UQ_KS?ZV%KVOR>/?NO=<OZ7YM]"/H=1M
M?W[KW7A]+?0C_6X'U/U/OW7NNN!]/\?]AZ;_ $/U]^Z]UV+C_>./H!S;_'W[
MKW7N>;WO^. +7X'T]^Z]U[Z6M]>;D"_XN??NO==:?\3<?2QL =-O?NO==ZN;
M6_K]#_O7OW7NNC8'ZGZ?GG\6N+_GW[KW7+G_ &'UMS]0?Z^_=>Z]]>;WY_P(
M'^VM[]U[KC;Z\ ?7ZB_ %KCW[KW7=@. O/-KVY_WGW[KW70_ ^AN2.#Q[]U[
MKLK<_P!/^-?0^_=>Z\>/Q?BW'/T^GTM[]U[KPX/ L/I;_'ZW_P!M[]U[KW-^
M#_0V_'/]#[]U[KUOS?Z_3@?GZ?CW[KW7K$_75SQ^/]<_3W[KW7N>.1;Z'GZ_
MZQ_K[]U[KQ//!L>!>U^#^/?NO=>Y-K_CZVO>XX/OW7NO<\\_0W_KQ;\ ^_=>
MZ[_V(_V%S^;_ (_P]^Z]UT.+FW]?^3>/?NO=='\_X_0'_6Y-A_A[]U[KNX]-
MK_FWX'']??NO=>N>!R2;\D ?3W[KW70%^+'_  )^@_V]O?NO==_GZ?GD_P"-
MK\>_=>ZZXL +F_T_K8'GGW[KW7?U_ _K;4>/]M[]U[KWXL/S?D6('];6_P!X
M]^Z]UT2 ;"]_K];<_7GZ#W[KW79-S_4 7N.3?_"WOW7NO?X_6]K \_BYM[]U
M[KOZ _7\G_6_K;W[KW75KV_XCB]_K?W[KW6[;_PFR_[(9[5']/E?OG_>>H-B
MGW"/N7C?8A_PA?\ JY+U@C]Z+_IX%I_TKXO^TF[Z_]7:8_GA?]NN_D]_K]*_
M_!#;2_I[%O(W_*TVO_-W_JS)U,/L%_T]K:O^HK_M"N.OGQ@D_P"'_(_I_MO>
M0G71[KQ_&H_ZPY _V/OW7NN^.!_7CZC_ &/OW7NN-S<V'TMP.?S<^_=>ZY<_
M7U?UMQ]?S_L/?NO==?[ F][WM?CCZ'W[KW75K?I()L?SR;^_=>Z[_/U/^L6'
MY'-_?NO==6'T_!XY!!N/\??NO==_[U8BWT M_4^_=>ZZ_(^IMP1?\C@'_;^_
M=>Z[/-P1_K ?7ZVO[]U[KR\#D@_3Z<VO_7W[KW7&PN3<@'Z&_P#C;GW[KW7=
MOH#]%Y-_H>;_ .M[]U[KU_P;\_0<$_7_ %O?NO==GCZW_P!Y/'Y)M[]U[KN_
M'^/TOQ:]KW]^Z]UQ %R 2+_3@?0C^OOW7NN_J#J^E[@_2W]![]U[KOC_ !_3
M_7\?[?\ WGW[KW7$FUN;W86L?]N/?NO==Z@-/^/^\ _T]^Z]UX_[V1>P*WOQ
MS[]U[KUEL>!Q_M_Z_7W[KW7OQSQQ>X;G_;^_=>Z]]#_CR;7XL3]??NO=>_(-
MR;_3CZ7^GOW7NNK\VY/]1<6M_A[]U[KUE!_WG\GBUO?NO==GZJ!QS?Z?T_''
MOW7NNB.;WO\ CCZ@'Z&_OW7NO'G_ 'LC5S?_ %O?NO=>6XX-SQ^+6L?\3[]U
M[KL_CZWYTV_WKGW[KW77^ !M8<@<DC_'W[KW78O_ %T\V'%A_MC[W3-.O=>!
M')M_L;@W_P!A[UU[KK\_ZP+?4?FY(_WKW[KW79L.-3?[Q?ZV]^Z]UW;^AM>W
MTY''T]^Z]UZ_^O\ [=?Q]?S[]U[KHZ1Z2+#Z_GW[KW7B!R?S?Z_6W^P]^Z]U
MX?4_U_UQ?_6'^'OW7NN[6%O]<'_8^_=>ZXV(Y'UYO;ZV)O>WOW7NN?\ L3]/
M]\??NO=<3]/Z\G_6XX_M7]^Z]U[Z\'@A2/IQS^1[]U[KQ-K'CZ\_ZY'U]^Z]
MUW<#Z?@Z1_K_ -/?NO=='C3P/J!^1]/I[]U[KB.+_P!+&U^5)OQ[]U[KE^1^
M3:Q_K]+_ $^GOW7NN_\ 8?[U^?J??NO==&Q^G^PY L1^FP_Q]^Z]UU_C]?\
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MU_H+<WO[]U[KUN1_C^;D<?[#^I]^Z]U[GZ &UB/\00/?NO=>XO?^OU_H>/\
M??3W[KW7AQQ_M1_' XO[]U[KJU^/R/K_ (?ZFW]/]A[]U[KD+_0?X?U:Y)OQ
M[]U[KW-C].!QQ]#;Z6]^Z]UQOQ^/KZ>?KQ^??NO=>XXMS8D'TZK_ )N??NO=
M=_B_^\6O]../?NO=>YX^M^?J#^6^A]^Z]U[GF_-K?CGZWM[]U[KW^U6YY! ]
M5Q>W^'OW7NO?4&_!/U/^QX]^Z]U[G^U_M[<#^H_V/OW7NO?7Z 'ZV(_%OIP?
M?NO=>Y_K<<BQ^I_K^/?NO=>X_P .;$ CZ_X_Z_OW7NO?X64V_%RQ'^\>_=>Z
MZO\ [#])/^-Q<_CW[KW7(\\<"_%[_C_ >_=>ZZ M_M[G^MK?\5]^Z]UZX_K]
M2+VL3_K7'OW7NO<7N./P1>PX']/?NO==6XXL>?J.;<W_ $^_=>Z[Y' %N1S^
M+'\\^_=>Z\;<CZ#CB_/]3?\ /OW7NN]7]01_K_Z]O?NO==?46_'^!L?]:W^/
MOW7NNR3^!_4?TY_'U]^Z]U[^A_ISP?S;_#W[KW77I6Y_V']>?Z>_=>Z]_:/)
MYX'^'%_?NO=>_P 1_3ZGZ:;7^@]^Z]UU>X_%@!];$W_V_OW7NN^?S8?T^@)_
MP_/OW7NO?ULMN#].#]>+^_=>Z]];V-[6MQ?_ &Q/O=!Z]>Z\3;Z@?6_^P^E_
M>NO==?U(_P!CQP>+_3W[KW7(GCGBQ_!!_P /S[]U[KK^GTX(M]!<?FW/OW7N
MNP/]<_3_ '@_T]^Z]UU8&_Y/JM_L>/?NO== :O\ 6YXYL?Z#W[KW7=[?7CG^
MO]?K_OA[]U[KNUA_0_[2/^1^_=>ZXD%@.!;\7_''XM[]U[KOB]_Z:K?U)OS8
M>_=>ZZ_3];_0?ZUA^#Q[]U[KE?Z7_P .?K]?];W[KW7$WYN3;@_D6YXL/?NO
M==VU<@D _P"/OW7NNN/K]+<C@7(_K]/?NO=<OQ]"/K_O/U/%_?NO==#^GX%P
M?QS_ *WOW7NNO4>?];BQ^H]7/OW7NO&X(Y'_ !(_%K>_=>Z[//Y_J;_T'T-K
M6]^Z]U[GCZ6/^P//]/?NO=>.D\G\_0\W/^P]^Z]UZXY^G M^;W_I<^_=>Z]^
M1R21>P/^(^I]^Z]U[B]_J1]; <WX%K^_=>Z]?\#C\V^AY-[<^_=>ZXW/%^.>
M2+CD#@'W[KW7*Y''!)_Q )X_WOW[KW7C^&'U'%CQ_L.??NO=>_U1L/K_ (_@
MWY_Q]^Z]UU]/K]2;$W(^GTM;W[KW7?)^H/Y_/U_']??NO=>_'YN?\"#P?R1_
MA[]U[KKZ_G^GUN?J.!;Z>_=>Z[_I_K<$\D'Z^_=>Z\+<VX_P^HN1?\>_=>Z\
M2;VX'^N1]?\ 6]^Z]U[_ &!^M_\ 7L;W_P!?W[KW79_/^QOSQ]/S_3_8>_=>
MZXW'U'/(N3Q;BW/OW7NN[_ZW^/(Y'T)M^/?NO==#C^JC^O'/'YO[]U[KOF_T
M'%OK>_)_J??NO=>_I_4CC^G!NMQ[]U[KW^V/YMQQ<_7_ &'OW7NO?@7-P2 +
M77W[KW7C:WX!'/T_H; ^_=>Z[M_L+7L/QS]/?NO=="X']; <6(_V/OW7NO<_
MX?[R?TFQ]^Z]UUQ]!?AOQ^#>P^OOW7NNS];$_@'C_>1[]U[KOBQ_USS;]-Q?
MCW[KW7$\FQL?Z"Q'^OR/?NO=<[_[[_B??NO==7_I;\_7Z6'!^GOW7NNOI];"
MY-[CB]K<>_=>Z\.!_L"0?Z#_  _P]^Z]UW?FW^^//!'OW7NN-VY_%A];<7!_
M'^P]^Z]UX"]K$D#Z6XY_V/OW7NN7-OK^ ;_C_'CW[KW77^I/YN;_ .QX_K[]
MU[KK3<WOS8CZ?T])/OW7NNP .!?^S_3Z?U'OW7NNKDW_ .2> ?J!R3;W[KW7
M=OZ_FW)/)YY'_(O?NO=>_H38_7\V^OOW7NO'GBPO^/H;?[ V]^Z]UU];6_-_
M\/H?S]>/\/?NO==VX_%_K>_XO_7Z^_=>Z]>W'T'^%N/R>/?NO==DC\<_BPY_
MV_OW7NO'^A'' _']?\/?O//7NNN?H0/Q_B!^!;W[KW7OI^/Q8>_=>Z\387XO
MQ]/S_K?[#W[KW79/!_UC?Z<?Z_OW7NNK$_2P/TX_"_T]^Z]UNV_\)L_^R&>U
MOS_SE?OG_>.G]B#W"/N7G?HC_P (7_JY+U@C]Z+_ *>!:?\ 2OB_[2;OK__6
MVF/YX?'\KKY/_P#E%?\ X(?:7L6<C?\ *TVO_-S_ *LR=3#[!?\ 3V=J_P"H
MK_M"N.OGQ@V_'U//!_I]1[R%ZZ/==&Q_)Y_%^/\ 7'_&_?NO==V^G^N?Q]=1
M]^Z]UT ;D@<'Z7_XK]??NO==G@ZC?CZ#^E_][]^Z]UUQ_MO[1X)Y^@)]^Z]U
MWQ^3_3U!;6_V/OW7NO?U'T_%K_4GZCG_ 'CW[KW7OK]>#>]K@_3W[KW70_J"
M3>]R !]. #?W[KW78!O^/I^/J>/R??NO=>Y//(M^.;?6]P??NO=>T_U_V)_W
MKZW]^Z]UUQ>W%Q];W%Q;_'_>O?NO==\V^EN;<?\ %#^/?NO== ?0_0_D_J_U
MR2?I[]U[KL?UYMZ3>]_K_K^_=>Z]]3;^A!^G^VM_L/?NO==#ZDG_ %/X_P"B
M1[]U[KO_ &YYX# D?UX]^Z]UW>QM_O/X_P!O[]U[KB>01;C@C^H!_H![]U[K
MQY_%K%;'ZFUK^_=>Z[O_ $/X!_V'Y-C;W[KW70 M?_"P/].-/ ]^Z]UROS;_
M (D?[U[]U[KK_>OI;Z\_TN/Q[]U[KWT''(YM^;?T'OW7NN^+?ZG_ (C_ &/O
MW7NN-[<\V_I:P_U^+^_=>Z]P;B_))X-[7_V/OW7NN_ZV_%A;\V'OW7NO6X''
MUYO?FWU^O^O[]U[KQL0 ?Z@6O_C;W[KW7B#Q]>+<7'X'X/OW7NNO5]/QP+#Z
M&_U]^Z]UR^I-KC^OU%S_ +'WNO=7KW77];<<#Z6OS]/IS[UU[KVDWU?[QQ]?
MZ>_=>Z]>_P!"/S^?]O\ CW[KW7M0X'^M_K"X_P ??NO=>XM>WT!/XXN+GCW[
MKW78' _V'/\ K#Z^_=>ZZM];@<F_^ _U[^_=>ZZ]-O\  6X_'^V_XU[]U[KN
M_P"-7YO>X_VW/OW7NO _D_7BX'^!]^Z]UU8_X?4 _6W/Y ^G^\>_=>Z['^TG
M^G%C;^I^OOW7NO <GCZ_TU#_ &_X]^Z]UT#Q<W)O^!S]/Z>_=>Z[X_Q///!^
MH_(M[]U[KLDBY_%N"+?7W[KW70/)^OIO_3\?X_7WNM.'7NO?[?\ U_5<_P"N
M;>]=>Z\.?Q^+?7^S[]U[KQ_I^?J!QS;Z?[?W[KW7N./J+?@ _P!+?7W[KW7K
MBW^L;#F_(^GT]^Z]UZY_K^;?0\'_ !Y]^Z]UX?6WT-K\\D?C@GW[KW70Y_'^
M))N!<_46]^Z]UR/-S^ "/\?\??NO==?[ _7^OUTBP]^Z]UX?UM=N#?\ U_\
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MF^GT^E_?NO=>OJ%C?^O].+?7GW[KW79X_!%_J1_M/(M[]U[KH7_(-KWY!/\
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MA<C^EK6O_B??NO==\VL/]Z_U)M[]U[KUC_K6/!_I_L![WBGSZ]UX?2_Y_/\
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MB!>Q-[W_ .->_=>Z[O;_  %O]A;_ &DCW[KW7K\?X\\_X@?T]^Z]UWQ>]^;
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MOR/]M_O7OW7NNQS>_P!;VN!8C_6/OW7NN[C\_P"W-A].?S;W[KW77U^H^O\
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M8N.+_P"-OJ!_A[]U[KKZ<_0W/^)N3>UQ[]U[KH<?0 ?CGZW^OU]^Z]UV./\
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ML?K:W  M8_FYX]^Z]UU?^OY'TL;<'_'_  ]^Z]UWS;\<AB?]C_3W[KW7?/\
M0&Q_'U_WUO?NO==#BX')OS^+?[W[]U[KQ'TN?IP?KS?\?7W[KW7OKROYY/\
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MY!M_O7%N;>_=>ZXV/]#;Z"_Y-_U&WOW7NNQ]23^/IP;V)MR/?NO=>L;WY/\
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MZZO;@GZZKBXX_P!;W[KW7=^?S:_^/Y]/OW7NNC_JK\VM:UKG^A ]^Z]UW?Z
M<?D<$_3ZW]^Z]UU:PL2+FY/]/];BWOW7NN[_ .\6Y_K_ %Y]^Z]U[^U>W X'
MT^I%S[]U[KQYYX!XM>W];BQ_WOW[KW75N 2?J>/]B?Z?X^_=>Z[]7TMP?R.+
M?U_K[]U[KKZG@G_$7_IQ^/?NO==_6_'YO]?]]S[]U[KW%^/KQP?\#;\>_=>Z
M]_@!>Q(Y_P!X(]^Z]UZ]P>.#^3]/?NO==%0>?]M:PO?_ %_S[]U[KO\ UN+"
MU_S?\#GW[KW77%@!I/ZN>"?\/?NO=<OQ_K@\_@ _Z_OW7NNN?IP#_7\W^GT]
M^Z]U[_"XX(O>]_KQ[]U[KW/U^IM] ; '_'GW[KW7@0+VOQQS<_3W[KW77]?P
M01P#_0?3C_'W[KW7@+7)^EK<?4<W_L^_=>Z[_I]!<&W'TOS[]U[KNY^E_K]#
MQ_3_ &'OW7NN-KW(/)!M;B_-_?NO==WY(L3^#>PX'Y'OW7NNB?\ 7^I^C?3\
M?G\7]^Z]UW_OOTM_MO\ C7OW7NO&Y_!']+$?G_7]^Z]U[_78?7BUO]A_MO?N
MO=>MQ:W'/'^QN/?NO=>L>/I];G@_7^O'OW7NO$_@W^HY_P +_G^GOW7NN(53
M_7\6)XO?^GOW7NN7]/3^1>UKCW[KW70 -['^GT!7Z>_=>Z[MS:_/UMZC_P 3
M[]U[KW^!8D\V XO[]U[KS?T _P!XN![]U[KN_P!0>/K8GZ?X<^_=>ZZ7Z6M]
M"1?W[KW7&Q_LD<B]N!_MK>_=>Z[MP2?]3R/\1]/?NO==F_\ C_A8\_[$GW[K
MW7K?U-P+\@_3^MS]?]Y]^Z]U[\V_)%R3_AP+#W[KW7N0/]<W/XM<6_/OW7NO
M7  _KI_U_I_K?CW[KW7=O]3Q^;\<_P"]^_=>ZZ-[_7B_^QXYX]^Z]UU?\W]-
MP.; 6_/U]^Z]UW8WO;\?X<<_06/OW7NNAR/RWJM_L/\ B/?NO=<[_3@_\4_U
M_?NO=<?ZW!YM<6O_ (?4>]T'KU[KB"HO_6Q_J/\ 8<^]=>ZY?XF]C<<\6'_&
MS[]U[KH_@_2]^?\ 8W'^'U]^Z]UWJ_U[VU<_D?[#W[KW7O\ #G@WOS_6]O?N
MO==$?X\#Z<\C\?Z_U_Q]^Z]UX6 _KS:_/)'(M[]U[KOD_P"WOQ]" >+GW[KW
M7OZ&W('^Q_/'OW7NO 'U'@$_G\@?X^_=>Z]^H?0WM^>.??NO==F]_I_A_B!_
M4'W[KW7#_6M^H?GZ_GGD^_=>ZY7-K\_7CZ?UM;W[KW7N00 ./R;6'^P]^Z]U
MZ][W^EK@?7C^OOW7NN7T''OW7NN!^I/^TL/\;CW[KW7@PY]5_P"G^V]^Z]U[
M_6'TL>!_A<_[Q[]U[KE_L>>/H/Z\#Z^_=>Z]8_ZPX^G^W-_?NO==7_5P?]?F
MW'OW7NNA>Y O_6YO_2WT]^Z]UWQ_3Z^KZWY_UO?NO=>^FGBUK#_7X^@]^Z]U
MZP/(O^FP/!_WCW[KW7OR>#POT/OW7NNOK<\_ZGT_T_UC[]U[KL_X\DV_KS;\
MW'OW7NO _CBWT^M[_GW[KW7O\#P/H0>+_FXM[]U[KNW^VM]/Q?\ KI]^Z]UT
M./\ 5'FUC_K7_/OW7NNR/I>_^N/]Y]^Z]U[C_8BY ^MN.1Q[]U[KQ_%O]]?@
M<>_=>ZZ'UM?@?ZW^M;W[KW76J]C_ (_7\7//_&O?NO==W) _U[\?3@_F_OW7
MNNK_ (N+7YL+@"_Y(]^Z]UV1_L.+_P#%;_6_OW7NNK?X&Y^I^A^O]/?NO==G
MD<7M<7N+W'^ /OW7NO<_3Z7O:QTGCZ#GW[KW7C8&XO<_CZ _Z_OW7NO?U_/^
M'T_-F^GOW7NO?@D$FY'X/X/^'OW7NO?7ZBXO_B+?[#_B??NO==\V-CS_ %(_
MVWOW7NNO]M_C86^G/]??NO=>-A_R5>W^/T]^Z]UW<'GG@7_VXO[]U[KHV_U^
M;<F]OS^??NO=>Y%OQ<\'\@G_  Y]^Z]UZX^AN;_7_#FWX_Q]^Z]U[21>UB/[
M(-[?UY]^Z]UZW^W^MP?R?]?\>_=>Z[-^+?X_2W^P/Y]^Z]UU]5M<_CD_XG_'
MW[KW7A]./Q]&/)_VWOW7NN_J!<#GZ<C_ %O?NO=>YO:_]GZV_/\ 7W[KW7&P
M^@X]7^O8@>_=>ZY6^EOQ?ZW]^Z]UQMZO\2 ;_P!+<&P]^Z]UX<C_  !'U_/]
M;^_=>Z\3Q^;C\V(_-[<^_=>Z\/Z?X@7_ "+&]N?Q[]U[KOZD\#@6-B?S^/I[
M]U[KP/!YN1]?H"!_L/?NO=>(/^'/!^I_P%O?NO==DV^O^M^/Z7O]/?NO=<;W
MO<'\VX)_X,![]U[KE:U_SSJYXM[]U[KCQ?\ 'UYY((-OI?W[KW796_U)_P!:
M_ ]^Z]U[GZ&XO^20>!]0;^_=>ZZX/)4_[$V'^'U]^Z]UXD<\WO8$C_6_/_&O
M?NO==\M]/IS_ ,:/^W]^Z]UU_7_#4?ISP;?4>_=>Z[)!_P!Z_P!N;&W_ !KW
M[KW7C]+_ %%B>/\ 7N/I[]U[KQL3PUK<'\?ZWOW7NO7^H/XY/^'-_P##W[KW
M77T/'/)/!Y']1:WOW7NN['_"QO?\?BP'OW7NMVW_ (39_P#9#/:O_BU^^?\
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M%[WO_K!CS?W[KW75B?Z$_P"(M_M['W[KW7N>!_K@'_6%N1[]U[KNW'Y_J/\
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M[KW7M0Y^O'U'Y^MO?NO=>^G^QX/XN?P./?NO==7'T^ESR#?F_!Y]^Z]UV?\
M6O<6O_4'^MO?NO==$?X^FX!'^V'U_P!A[]U[KL"WT^MO^(_P]^Z]UW?Z_P!/
MZ_[#ZCW[KW70^E[@W/\ K?X@<>_=>Z\2O]?Z<<D#_8#W[KW7C<&Q/]H$#Z?G
MD>_=>Z[_ !_JKW_UOK[]U[KH?['\6XM].> ??NO=>_!/)O:P^GU^@!_WOW[K
MW72@CGZ@\6'UO_C[]U[KO\%K<GC\_2]OQ[]U[KQ%N2";?UM_L#Q[]U[KK_;
M WO?B]OI[]U[KUS>QL/Q<CZCZV'OW7NN[?F[<_7F_P"+?CW[KW70///Y%_IR
M?S8'W[KW71Y%N+<6YY'OW7NNQ];D_G\D<BUK@>_=>Z[O_L3]/K].+W M[]U[
MKWY_/X%OZ7^EA;W[KW7A:UO]<<\GDV-Q[]U[KJWTL+W)N0?Z\$>_=>Z]QR+<
MGFU[W-^+^_=>Z[L+'@$7O8?CC\'W[KW79%[7_P!]Q_3GW[KW71 L>/2>1;_6
MM]/?AG'7NNB;K_9_Q^O^M>WOW7NN^3_KWY_VGCFWOW7NN_Z_4W_Q'I]^Z]UT
M1_7F_P";VY_V'^L/?NO=>Y_-S].?TVXY]^Z]UX&UOKS?BX/^V)]^Z]UU]; D
M@_@#@CCZ_GW[KW7?X/UN.3S;_8?[;W[KW78_']3P?]M?D>_=>ZXF_P!3];7Y
MM<<?X?\ %/?NO==@<W/UL;_T-C]??NO=>#<<_4?4?3_>_?NO=>/'XOS>]_S_
M +#_ &WOW7NO'ZDW_!%SP;?U_P!>_OW7NO"][\6-KC\C\7'OW7NO  \\GFW^
MOSJ_/OW7NO'^H%Q_6_\ L?\ >_>Z9IU[KWUXM_K_ ( YO]/\?>NO==6%B2!^
M"/J#S_4>_=>Z['/]0;?[#GDG_?'W[KW7OZ_47M]>+<?C_'W[KW7KC@VY/ Y'
MOW7NO#^A^OYX/(' (/OW7NNQ_0VO;\?T]^Z]UPX^E@?\+ 7'UO<'W[KW7=^"
M+@6MJ/(-_P V]^Z]UX'FR\?2_%[6XYY]^Z]UZWY/TN"!Q;^@'O=,TZ]UW;\\
M6M:W-]/].#[UU[KUPWU_J.?P#^/?NO==?XV ^A_Q]7!Y]^Z]UZY&D#CBY_ /
M'^M[]U[KOZ@W^HN2/K^;CW[KW7OI;\?4<\WM[]U[KNY_KP+W^A_V!_UO?NO=
M=#@G_7 _Q'%A>_OW7NN_J/\ 7^I ('T_!][IBO7NO?0?7Z"U_P 7'%[>]=>Z
MZ^AO]/J=)_K[]U[KW/\ L;W/-R/R /?NO=>%@+ _X@G_ 'P]^Z]U[3_R+^GY
M_P!M_A[]U[KL#^OU_J/S_KCW[KW7$ 6^EC:W(MQ?]7OW7NO?0$&Y_-Q?@_FW
MOW7NN_IR ;\_[&PM<^_=>Z\!S?\ I^?21Q_L/?NO=>N/Z$?[#\WL/K^??NO=
M="Q)6PX_PO\ BQ_/OW7NN[$:;'\6Y_I]?I[]U[KKZ?TM_L/K^1J^O^M[]U[K
MOCD@7L;<?CBWOW7NO#Z_Z_)/Y_' /]/?NO=>  '/(X(']/?NO=>-_K>P_H0"
M#?\ I;W[KW76G_&UOI].;?G_ (W[]U[KES_K_P!;GC_6]^Z]UQ-A?_ DG_8_
MBQ_P]^Z]UW_Q MP2.?Z#W[KW7N?]ZL#:]Q_3_B??NO=>_P!N3SS:QX/OW7NO
M?73_ &1_3\D_T/OW7NO6X_K<W'_(OZ>_=>Z]_4'_  'TX(O_ (W]^Z]U[FYY
MX_ MS_MO?NO=>-_S:P(Y_K8V-_?NO=>_K<6_Q^H_U[>_=>Z[YL?Q:UOZ?ZP]
M^Z]UU^;76XM:_)^G)]^Z]UW<?Z_-N+>_=>ZZ'^'U 6_]/?NO=>_'^ N#:W(M
MQS[]U[KW'Y"CG\VY'^'OW7NO%AQ]#?\ K_O?T]^Z]UZ_UXMQ^+?G\W]^Z]UX
MW_I^;G_'FW_&_?NO=>'U%O\ 8_0GD_DCW[KW7N/\+_6^G_>??NO=>)L03Q_O
MO[5O]X]^Z]UX 7_Q YM8#_8V]^Z]UT0&N1^H'_B;>_=>ZY6_/^M]/H?ZFWOW
M7NN)/!OP"2+?X_U)]^Z]UX$7^I_/'/YY''OW7NNQ]+'_ %O]X_''OW7NN_\
M'GU?[Q[]U[KKZ<\"_P"6M?Z?2W'^]^_=>Z]J-A]/Q?\ /UXX ]^Z]UX?UL/K
M^.2+_7D>_=>Z]^+#CTG@_7GW[KW7KWN!^+W'];>_=>ZXDW/Y(O\ TMS_ $O]
M??NO=<OK]?P?ZD@6_J./?NO=>X^FJ_U_U_Z^_=>Z]_2WYO\ X7L/J;^_=>Z[
MOQ<?3\'Z#^G/OW7NNC]+GB]KVYOQ[\!4TZ]UW?\ )O\ 7C_>K<>_=>ZZ_P!?
MZ?[S<<VX]^Z]UT.+\7NUKCZ\_BY]^Z]UWR/KQSP1Q<_X_7W[KW7N%^G]0#>Y
MY_'OW7NNC_6W^TV/%[_CW[KW7=A?_'Z_4C_ >_=>ZZ)N+\VL;6''^Q'OW7NN
M=_\ C7^/YX]^Z]UP(N0#]0.2#_O=Q[]U[KNYL>/]M;_6XM[]U[KP(%_I^/KQ
MQ:P_'OW7NNOJ+^D?3FW^'/U]^Z]UWS_4_P"MS_K_ *K>_=>Z[_Q'T%S_ *]^
M?K[]U[KKU?4'Z_T'T_V]O?NO==WY^AO;_$#W[KW77-B1?ZW /)_UK>_=>Z\.
M?\=5SSR+C^O^\>_=>Z\2;@<CZ_T-[#W[KW7?TY(O86N/]YX]^Z]U[FWU_P!<
M$7-[7^HM[]U[KP_I>W]  !_C_C[]U[KKD_BWU_V%S8'W[KW7@/SP#<V_UK6_
MP]^Z]UZY!YN?]@.3?ZW]^Z]UZPN+_P"L!_K<W/OW7NN[_3^IO8?U_P!?W[KW
M7$FS?[W]+V(^G/OW7NN['_8$#Z@GD#\CW[KW7OQ<\?Z_.FW'^Q/OW7NO _@W
MX%[WOQ_4V]^Z]UXBX'TN.>;^_=>ZZY'T(XO]3<#^@]^Z]UWQ^;?VN1R!<^_=
M>Z]R!>]Q_0\'_;^_=>Z\;_UX'T/%_I;DG_BGOW7NNOP?\;$L1>X_P!_WCW[K
MW78Y_)%]5O\ 8_\ %/>Z9IU[KPY%OJ1]01?G_8^]=>Z\/]2;W OQ^;'BWOW7
MNN_R!_3D?X "W/OW7NN!O];*MCQ^/I[]U[KE>PYL;_2W-_P0 ??NO=;MO_";
M+_LAGM7_ ,6OWU_[Z'8ON$?<O_DO1?\ -!?^KDO6"/WHO^G@6G_2OB_[2;OK
M_]#:8_GA&W\KOY/'_'I7_P""'VE[%O(W_*TVO_-W_JS)U,/L%_T]K:O^HK_M
M"N.OGQC_ &_Y/^%^?\/>0G71[KH\\WX^IT_6]K<GW[KW79XY_(XY/U'^Q]^Z
M]UX<#Z7YTBY^O/'OW7NO?ZD_@:C_ + \^_=>Z];Z<GD'Z6'-K@_CW[KW76H'
M_'D6'X!]^Z]UW<_TY%O\?K_2WOW7NO #Z?7D_4BUQ];#W[KW7A<WY/X(Y_K^
M#;W[KW7?^L#QP#_3C_'W[KW7AR+V'UX_P'T]^Z]UU<C\%O\ ;?[#W[KW7N>?
M\1];&]_IS;W[KW7OP>+6L?5>U_\ 8^_=>Z\;BP'T^G]3?\'W[KW7@6/]?]C8
M?[#Z>_=>Z]]" 1_0 ^_=>ZZ!_%N?Q]."%_U_?NO==\\_4_7_ !^O!!O?W[KW
M75OZD\?BX"\"_P!#[]U[KWY_)_K?BW'UM_K>_=>Z]RQ/]!<?[Q:WOW7NN[#\
MB_Y&HCFWX%O?NO=<1_4\V( /'X%[?T]^Z]USY_UO]:W_ !(]^Z]UT?ZF_P#K
MG\?GZ#_B??NO==?DDDV!(^G^POQ[]U[KNQ_WUO\ 6X_I_7W[KW7OIS?GC5;W
M[KW7OZ<<#Z?[:]_?NO=>L?\ BM^3;ZZ3?W[KW7OJ>1_A_7\:OH??NO=<;7'
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M0W!_PY'OW7NN^+7'T^GU-B/I_M_?NO=>%A]+<G\?[S_7W[KW7N+DD?ZW#?\
M%/?NO==?F]S_ (6^GTL;6O[]U[KUA_0?07/XM^>![]U[KNUAQQ^"/K<?XV]^
MZ]UZYL;\<\$\6'OW7NO?2Q)^AM_O'YM[]U[KO@<_2_YX/^PO[]U[KIN1Z?\
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MW7NO$_2_-[BXYM<^_=>Z]_:/UX '^O?\^_=>Z]<C_8<M>_Y-_P >_=>Z\/\
M#G^S_L1]>/?NO=>/TLQ)O8?CD_X?\;]^Z]UX_6Y'%R2>?QPOOW7NO?@_U T_
M7C_8>_=>ZZX''Z3^?ZW_ -<^_=>Z\"".?\2"23R!<<CW[KW7.XL#_7Z?['W[
MKW7$?D?47(%OQ<7/OW7NO<BW^ -[_D#Z<^_=>Z[!X_K_ *W_ !/OW7NN-_\
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M(W'/_$GD6]^Z]UQ_U@;7^O)/^TGGW[KW7=CQ_@.#_L+ GW[KW75P;7!(//\
MK<V_'OW7NNP>.+W'%N.#_4V]^Z]UZ]OR+']/X]^Z]UT/R.#?G^OJ_/(X]^Z]
MUW_3CBWT'/#?X^_=>Z\/S;_&Q%N/Z#W[KW7OJ+GFRFY_U_QQ[]U[KK4?]4O'
M^\C_ !_H??NO==_\FZC?_$\W''OW7NO?4@7L?S;_ (+]??NO==6N;V%Q]0>/
M]:YY]^Z]UXA2?SQ?@ V_WCW[KW78^IM].+#\C\?0^_=>ZZOQ<W/X_'TO_0?G
MW[KW7=OZ<<_G^I'ZO^->_=>ZXEA]..;WMS]?I[]U[KEJX!M]?K8?4G^GOW7N
MO:@/]8"_%O\ ;>_=>Z]IYX'UO<_Z_OW7NO7Y M]23_C];CW[KW7OZ_X'G@\V
M^G^^'OW7NO7_ *\<@\?\3_Q/OW7NO6_Z% ^@YO\ [[Z>_=>ZZ_IQ>WTM^./]
M?^OOW7NN5OR?Z6-_Z7Y^GOW7NNOQSQS];\_2U[C\^_=>Z]_C_A_4@W'!O[]U
M[KQ_WCDMSR.+V]^Z]U[\?3^IM^?I8_3W[KW75K?4#^G /T^G^W]^Z]UW;\?B
MWT%B03S?W[KW7?)M]2#_ *WY_P /^-^_=>ZXW'T_P^@OR?\ 7'OW7NNS9O2>
M?I_7_8W]^Z]U[_>M('YM<FWOW7NNSQ;Z#^G^'^M[]U[KH\_32;?@\_[Q[]U[
MKJ_(-B0+CCFWXO[]U[KLGZ#Z<7-C8<>_=>ZW;?\ A-E_V0SVJ?Z_*_?/^\=/
M[$'N$?<O._1'_A"_]7)>L$?O1?\ 3P+3_I7Q?]I-WU__TMIC^>%_VZ[^3W^O
MTK_\$/M+V+>1O^5IM?\ F[_U9DZF'V"_Z>SM7_45_P!H5QU\^,\@?ZX_J ?\
M/>0M:&HZZ/==_P"]\\&WT)N?>NO=<?K:_-K\&Y/(O[]U[KVD#D'_ &/]/Q_O
M?OW7NN5_]?ZZ?J?I_7W[KW71M<W'U N;_P!>/?NO==$ &_J_WW^O[]U[KL6L
M>!8&YN;GCZGW[KW7M7^M_7@WM_MA[]U[KPN ?S_0CD\GGW[KW7KDD&UOJ"?]
MC:WOW7NN-K\\'DVN/2;_ %X]^Z]US^GT_J;_ -??NO=="P^G]!8_UN?S[]U[
MKUA^K_8?J-K?UO[]U[KHB]OZ_P"))(YY-C[]U[KLVN!]+7_WP_'OW7NNK'ZV
MY_PM_6]_]X'OPSU[KNW ^@']#S?_ &]O?NO=>M_2]C_2P_'U/^/OW7NO'\K^
M;?["U[6]^Z]UZWT!M<WL;7_%S]??NO=>YX'TYL0+?TO^??NO=>O_ +PPO_AQ
MI_/OW7NNN#R/]X_PL?\ B/?NO==\\W/]1;^EQ?Z^_=>Z['T'Y')Y_P!>X]^Z
M]U[\V''I/^P_I]/?NO== FYX/XL/S;\GGW[KW75B?Z7X_(-K\W']/?NO==_4
M7_P-N;_3Z6O^?\??NO==V_)^OTX)''^'OW7NO7/]#^?Z?[#CW[KW71^G^I_V
M(_'TN??NO==$<7'/(^G^O:X_Q_Q]^Z]UW^+?0FWU((Y/-A[]U[KRW^HO8GZ'
M_'\W]^Z]UT+7O^/IS8?C\CW[KW79L1]#_O%[?UY]^Z]UXGBYM]?I^2O]+'W[
MKW7CS8@\ \\BP_U_?NO=>)M:Y'X_XW;W[KW7OH+?4B]OI<?@>_=>ZZMQ_0VO
M8?\ &^??NO==KP!?^MA;G_>O?NO==?0:OS8G_8D\>_=>Z[U'_:?K_7\$V^OO
MW7NNQ;\#_'@>_=>ZZ_-K?G5_0"WT]^Z]UX7)^MO5^;\#^EO?NO==G_$_X<?X
MG@?[;W[KW7#\WXO8$?3DG\^_=>ZY$7^MR+BPM:W]3?W[KW7A<6'/'U^G-_\
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M_P!MS;Z7O[]U[KC;D$< CFW]/]?W[KW79XU'FW^!O_A_L/?NO=>OQ?BUS?\
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M];_3^@'OW7NN[_6W)L/I^"1_C[]U[KJP^MN+#\<\?X'W[KW71L".#^.?S?\
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MO_L./?NO=>/')^G^N6O^?I[]U[KWX)M]06'XM_QO_'W[KW7OZ'ZBQY/TY/\
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M7O38C\+_ (GZ_P"/OW7NO7/XY']+#C_#CW[KW75KFX)X/'^V^@!]^Z]UR'I
M!_K;C_'W[KW7'GZW)L2"#^?]M[]U[KL<?\38'^MOK[]U[KQ^I!O9K6_H/?NO
M=>OS>Y_UK^F]KGD>_=>Z]]/S;\FY_ ^@]^Z]U[G^GXM>]S;_ &'OW7NN[6^E
MK6_UN?\ >??NO==&WUXN?H;WOQ_3_BGOW7NO "]["_YYO_OC[]U[KO\ 'T'^
MM^+V^EO]?W[KW77_ !%P/^( O]3[]U[KW( Y_(_4?Q^1[]U[KJQ!-OP0=/\
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M+-^/S>WOW7NN5S_0_P"\_C^G'OW7NO6Y/UYO?_:K_2U_?NO==?DCB_\ K?X
M_3W[KW78"\7/(_Q-OI>_OW7NO6M?\<W(/^!N2/?NO=>!)'^'(YYOS87_ .)]
M^Z]UX #\CGZ#\?[:_OW7NO7X^ATV_P!C_3W[KW7A<\_@'BWY^O/OW7NO:?S^
M>;_XW]^Z]UU;\?46!-^&(OS8^_=>Z[X_U]-^3^+?0<>_=>Z[M<W^H-K'^GOW
M7NO<_P"\@?F_/'Y_XK[]U[KB+\!N1?\ /UO]+>_=>Z[_ ,0!?D_I-_\ ;^_=
M>Z]R3]+BWY^G^Q7CW[KW7AS^3];?7@\WX]^Z]URN/^*?F_\ K6]^Z]UQ)('/
M^\_[;Z#W[KW75A>Y'Y^M[$D?T ]^Z]URM_MA]!<C_;GW[KW7N#^.0+$?X'W[
MKW7$C\\<6YY'%K_CW[KW7B1S]?\ $V(^GTU?\:]^Z]UV/Z_C2!8_2WUO[]U[
MKQXO_K_BX_%@+^_=>Z]S^>#>QM]6_P!B??NO== <7)!'^U<_[W;W[KW79_%O
M]L"!Q_6X]^Z]UW8W/TL1]/\ B+^_=>ZZM_K?[8_[?Z_7_'W[KW7KDW_PO_M_
MP#_R/W[KW7CR2!]1S_0_[?GW[KW70LH/U_U_I^;?7W[KW7('Z_7ZV'^V]^Z]
MUQ'/-^?]>WT_J/\ ;^_=>Z[M>Q'X_(XXO]+>_=>ZZ^@O;GZ7_))-C_C_ +S[
M]U[KL"_T/!OJ^GU/^M[]U[KLBX_'U_I_C[]U[KW(^IO_ *PY/^P]^Z]UT./K
M>XN3_P ;'^]>_=>Z]S<7('-K#Z?3W[KW77T%N?ZC3QP/S]??NO=>(O;CZ&Q_
M-Q?^OOW7NNQP3_JB3:_]+^_=>ZZ_-K #\W(Y'XO_ *WOW7NN^>.+7)O^?]N?
M?NO=>_WGZ!KD<6-O?NO=>-FYXM_4_P#$>_=>Z[%A_KV%_P#8#CCW[KW71M>]
MK\CD$_[U[]U[KUP#<D?GZ?7_  ^G^'OW7NNK@&]SSJ'^L;_@#W[KW7@3;A?S
M_2PM[]U[KN]OJ/I:Q^I_H;_ZWOW7NO6Y_%O]8?7_ (K[]U[KLVY^@/XO;_;^
M_=>ZZ%B?SQ_06_IP?]M[]U[KUR./]Z_ _I_QOW[KW7@/\ 1_K6Y_K8^_=>Z\
M6-SQP/K]3_QKW[KW7K?UYY-O\ ?K>WOW7NO?2_'/)%_K_K>_=>Z[' _K:QO_
M %X^M_?NO=>_UO\ C?)Y/OW7NNOJ2#;D#_6L#_O?OW7NN[GZ<_7ZVXM?Z7_U
MO?NO=<;'BPM;D#Z@GW[KW7=N3QP?\!S_ (W]^Z]UT1S;_:;#\B_] ??NO=>X
M4C^OU_//%A]/?NO=<KW^@_-OI^?ZV]^Z]UUQ:_\ P4W/X/\ 6WOW7NNR";?3
M\W!Y'/\ Q3\>_=>ZZ']+'_> /]?W[KW7O]I/^W^EP>3P/?NO=>XO]  1;^A_
MUO?NO==6/%OP3]20+C@<7]^Z]U[\V OS9O\ '_$^]U[J]>Z[_'(%KV^G _QM
M?WKKW7OZ<_4<<?GZWM[]U[KUQS;\7) _/^Q]^Z]UT+C^MN/S8<<?GW[KW7+C
M_6^E^1Q;Z ^_=>Z\#?\ K;^O'/\ K>_=>ZX@@"_/UL2;^_=>Z[_K]+?@G\BU
M^+_C_#W[KW7A]3QS^1?C_7^GOW7NO&S?7\?FXO\ ZW'OW7NO7_/XM9K_ (L/
M]A[]U[KW XX _'-C_MC[]U[KH?0M?DW^G'^P'OW7NO6(-[$CD_XW/U^GOW7N
MN_K_ (?U /)N.;_ZWOW7NN_]B?\ #]//OW7NNA_L;W!)''/^M_O?OW7NO"P)
M'/T!_K]/?NO=>O8_X <#\FPOQ[]U[KJY'U^I%A]+?7D\#W[KW78(OP.;GZ ?
M@?GW[KW7=QQ];_ZQ^MOI[]U[KH"US?G\_P!!_L./?NO=>O8"US<\7/OW7NO<
MFP'T!6]K'_>?>Z8KU[KQYX/'%N>>3]+>]=>Z[YMS^/H3^?Z>_=>Z[O\ CG_?
M?C_7]^Z]UUJ_-C:_UXM];>_=>ZZ^AXX%KG_#_6]^Z]UU]"1;Z@D\V^IL/?NO
M==@BWU^O^QN;6_/OW7NO"VJ_(/Y%_?NO==$GD'BWU(O^?I[]U[KD/\!]+ D_
M6]K#CW[KW7']-_S]18_@'_#W[KW7OZV-A]#>]O\ 8 \>]D4-.O==GZ<<'\'@
M#GZ@ ^]=>ZZL; _CZ\^K\?[#W[KW7?T*\"W-N>!?D_\ &O?NO==_X_[R!?C^
MG'OW7NNC;\\ ?0^KCW[KW7AR;D?2UK'Z$?@_X^_=>Z[%R+?0<?ZY_KP/?NO=
M=7/)])/^''/^/OW7NO?X'D7Y-K #\?3W[KW7N+_G5_6W/^O_ $]^Z]UX<\_D
M_6_^''T_U_?NO=>_%Q8'CFW^W^OOW7NNO]MSZAJ _H/Z>_=>Z]^;>K@ ?3CC
MD'W[KW7=^3R2/Z6_K^+^]TQ7KW7@ ;VYM_4?DGGWKKW7@/K8GF_//Y^AM[]U
M[KH7L/I;\WO^>3R?Q[]U[KUOJ/R0O'-_Z&Y]^Z]URYYY-[_T''%_?NO==66P
MX//TYYM_3W[KW7OJ"+\G_7/ZOH![]U[KNQO]2/\ "_\ O7OW7NO6^G^N/T\?
M[?W[KW7&QO:Y^ES];:K6^OOW7NN_\3^+V _ M]"/?NO=>YX_'TN +?FQ_P!]
M?W[KW7OKP1QP#S;Z?X?\4]^Z]UW^/Z<_7_"]_P >_=>Z];_B./QQ^/?NO=<?
MJ;\@>G@_0W]^Z]U[D<_3_8\\_P"^_P"1^_=>ZY?7D <?2]Q_O'OW7NNOS:WY
M^MN+'D^_=>ZY7^OXM_7_ 'OW[KW7'5S:Q^O^\WM>WOW7NO6O;GZ?GZG_ %K^
M_=>Z[^G!N0> +?3W[KW7B+_3_'_87%O?NO=<?S^?[1OSZ>/?NO==\$?CCZWN
M?]Y:WOW7NNN+_P"M8#Z?2U[^_=>Z['^'XXN?JO%O?NO==$7L3_K<VO\ [:WO
MW7NN5A_7_'_8?T_UO?NO== \_4&Y/U(O;\!??NO=>_2/]O;\W/X'OW7NO$&Q
M_/\ 2W//T_-_?NO==6X^I'^QX(_UC^??NO==V-[\_P"/]#_A_OA[]U[KQ_-O
M]2.>;<?XCW[KW71L  >"/^*\V]^Z]UV0+7X%B#]/I_KV]^Z]UZ_^\+]/^-#_
M (K[]U[KW%A>US]#;_;'W[KW7K@_FY^G]+@GW[KW7?\ 3B_^(YM[]U[KCP18
M?0<7/^\6_P ??NO==_X_XCCZL>+ W_'OW7NO$7L;FP'U_P")]^Z]UT/KQP"!
M]!]/Z$G^OOW7NN[W_M$7^GTY_''OW7NNR#:WU_']>/Z_Z_OW7NNEX^GT)L+F
MU_\ ;#W[KW7OP3P./Z$'Z?U/OW7NNP/Z<<\_DW'^)]^Z]UV3;_?6_P![]^Z]
MUQL.#?ZV_P!CQ;Z?\4]^Z]UX  V_V(%CP?\ 7]^Z]U[@$WM;ZB]OS^KZ^_=>
MZ]^KBW]/KQ_L1[]U[KJ_)%^;7N/S;_;^[:?F.O==_1A;\_6_)/\ K>Z]>Z\3
M;\ *3]?P1;Z6'OW7NO$CZ&UC>_!O<?4^_=>Z];\V/U)^MC<^_=>ZZ^GU%N;#
MU-S_ *UO?NO=<K?U/TL?Q^/S[]U[KP-[6)XM>XO]1^??NO==7^G'];<7 YX)
M/OW7NN[_ .]V_'U_I[]U[KH$?X#Z@D "UOZD^_=>Z]Q_O']>/]A^/Q[]U[KW
M%C^?Z_D_ZPM[]U[KJX^O/UN3R+?CW[KW7=N>;V_ _P"(LOOW7NO'ZG_'^MQR
MO(][H/7KW6[;_P )L_\ LAGM7_#Y8;Y'%_\ GT&Q?Z^X0]R_^2]%_P T%_ZN
M2]8(_>B_Z>!:?]*^+_M)N^O_U=IC^>%_VZ[^3W^OTI_\$/M+V+>1O^5IM?\
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MZ'Z\_4V_!][IFG7NN^/Q]3>Q^I/%_J?>NO=<>?J.2+C^G^WO_O7OW7NN[?U
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M3C_B??NO=>!U?0D6O^!^?I[]U[KL'@6_QY^HX/\ 4^_=>ZZL?R0;\&XMQ?\
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M?]]_7W[KW71_-OH0US^/I]>/?NO==\&_U^GTY _V /OW7NN-_P##_&W'TO\
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M 6^@O_A?W[KW7B  ?I<_@<&WOW7NO7 O]./K]2.3SQ[]U[KWUN.3>QYX_-R
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M<'^G'^Q)L??NO=>O^/R>2+$FWT^J^_=>ZZ)M_L>#R0+GZD7'OW7NN_\ 7N"
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M (?3ZV_XCW[KW78'-[BW^'//^^/OW7NNM-CS].3Q]/\ ;'W[KW7?XY_!Y/\
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MOW7NO?32+V^O%_K_ $'/OW7NO<_0$G_&XXMR.!_O/OW7NO6YX'Y_'''^P/\
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M/T_46'^\'D>_=>Z]86 -R+\?U /]??NO=>N+6X-F '_$'W[KW7@?]L/KJ_M
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M_P!?Q]1>QO\ 7BX]^Z]UW<W_ !P>?\/]\/?NO=<0#;FWY)XO<_ZW'OW7NO$
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M7NO<<@D7-K_B_P#3W[KW7OI87)/XY_H;GW[KW7C<#3_5;#_7]^Z]UZUO\?H
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M_3Z@<?XB_OW7NNSR?R+<&P%Q?_'W[KW7C;^UQP?S];_7CW[KW7OK]?K8\G\
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M[KW7?TY^G-C_ $/''OW7NNKCZ _7\'CZMSS[]U[KE]>;"_\ K$?[R??NO==
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M?4W%B;_FY^GOW7NNK\_1OI:Y!/Y]^Z]URM].2;<BQ'/^O[]U[KH?3D?DD?[
M_P!3[]U[KPN?S;_#\\_U_P"*^_=>Z\2.#?D6X^GU_P!<>_=>ZZL.>>!]";\?
MXCW[KW78X_Y)'^MQ_B/?NO=>O];CZ6//XO[]U[KW]2 #Q;^G/^-_?NO=<_?N
MO=</K;_6N.?H;?A??NO=> -_SQ8#G\6_I[]U[KL#^M^?J/J/]Z]^Z]UQ_P ;
M\7U7/T(/%O?NO=<@ .+ 6_Q)^OOW7NN-O[1OQ8_X\?UX]^Z]UW;^S8:?]?\
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M'_$^_=>Z\;"][_IY(X'U^O'Y]^Z]UZ_U^G^%C^+VN3[]U[KU[\#C3]3]1;_
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MS]?J ?K_ +U_Q3W[KW75B 0/IQ;FQ^OOW7NN[&U["]]5N?K[]U[KL_2WZ?\
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M7=_Q8\?T'_%/?NO=>]7]../R=0'Y!]^Z]UX"]^+ _06''%K^_=>Z]S_B.?\
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M)MQ].!;G_'W[KW7/_6)_UN/Q]1S[]U[KUK?T_P!C_O'/OW7NN/'UL;CZD?\
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M/U/^Q ]^Z]UWQ_L+?BQ']/?NO=<>.3]5)O;_ &JUS]?>S2N.O==GGC^OTO\
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M^@'-_K:_OW7NNSQ?C_8BPLH_I;W[KW7'C_&_')^M_P >_=>ZYV_P_-_K^?\
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M;CF]O?NO=>O]/Q>U[_GCFX/T]^Z]U[Z\?2_X'YL>;\>_=>Z[!)_J.;<6-_\
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MF_OW7NN('U_.JUK_ .M?GW[KW7N3:X_VQXX;GCW[KW7+GZ@\?T_V'OW7NNK
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M)L.1S_Q3W[KW71Y_/^QYM_CS]+?X>_=>Z[_%OI:P-[<\7(]^Z]UU]+_BUO\
M6_P-_P"G^'O8%33KW7?^/^-B#]#_ (\^]=>ZY7_WWU-_]8>_=>ZXW-[7'^/'
MT_U^??NO==$?3@<_0CTD'Z_X^_=>Z[^G 'Y_WGZGD_X>_=>Z]_A]>;D?TO\
M3CW[KW7&W^+?7_7]7^P]^Z]UV/K]>"2>#_3^OOW7NO &UOJ/PRFQ_P!Y]^Z]
MURN/\1S87!]^Z]UPM;@V%S?\<6/^Q]^Z]UR)'T ^C?3Z<_CGW[KW70_V_!7C
M@?U(]^Z]UZ_^VYY!LO/YO[]U[KD.;$$GC@_4?3Z^_=>ZZ^O^ M>U[7_Q-O?N
MO==  ?0_C\$$_6_T]^Z]UX_J^I%Q8_@6_'/OW7NO"Q'T_P"-<6_/^'OW7NN^
M;GFP%OQQS]>??NO=>_J2!?\ K:_^M_C[]U[KUOKP"1;ZCG_"Y]^Z]U[G@V_I
MR?J/]]_K^_=>Z\/]:_-^?I_L#[]U[KQN/R3]./S>_-K>_=>Z];D<"XXOSR/\
M/?NO=>;^O]/ZD_GCZ>_=>Z[XL+?U%O\ $ _[U[]U[KKZBWT(-[?3_;>_=>Z\
M?\.!QR.18_FWOW7NO<%?5_QN_P#Q7W[KW7A^01];<#C_  X]^Z]UZY^O]?\
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M_/OW7NNS>U['@W^I)]^Z]UX'FQ^OU_Z)]^Z]UZP_WG_B;6]^Z]UT3S?D@?0
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MCZ$<'_ <_P!1[]U[KK_6"G\<W^H^@_WWU]^Z]UW>XX_(('X^G'OW7NO7%_\
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MXC@\_7ZG^OOW7NN@+?4"WT))X-O\/Z^_=>Z[/%[GZ\#^G^V]^Z]UX7''TO\
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M_P#K6^OOW7NN_P#8$<V !^OY]^Z]UU]#<DG_  _QM?\ P_'OW7NO?4<W'/\
MB/S?CW[KW7AS_3@GZCD<W]^Z]UZ]N!_B;_@ '^@]^Z]UX<_[ "W]!<?CW[KW
M7CP+<?GZCC@\\#W[KW77Z?\ 7^IYY/']??NO==_X#D<W M_MC;Z>_=>Z[XL#
M?@'ZW^O];^_=>ZZ)_-S;G^R/Z?U/OW7NN@?JU_J1_B;_ -/>V-37KW79_!'X
MO_O/Y]ZZ]UXB_P#@/KP.;_U]^Z]U[^G^N 3^20;#W[KW71X*\?UX'YO];#W[
MKW7KCA0/\1_0_D<GW[KW7?\ KL>+'Z6^O^O[]U[KW/\ K?ZUN/\ 7O;W[KW7
M5KD6)X/-R3?\CGZ>_=>Z]_M^#:_)OI^FKW[KW7?/TN?ZWT_BWTM[]U[KPY/%
MS:PN2?\ 8\>_=>ZZ )_I^DBQX(_'OW7NN_H2 #SS_3_>??NO==#Z&Y6_YL>"
M;?T/OW7NN[+P#R/[//']+<>_=>ZZ)4_U-_Q_K?D>_=>Z[_'' ^H/U_%OI_K>
M_=>Z[]5_R1_L/Z_X_P"'OW7NN@1>_P"3?GFW'^O[]U[KH<$BUN ;BWT'%^??
MNO==\DB]Q:WX/^QY'OW7NO$6M]3_ +SI_P!8#W[KW75[VMP0?H/I_KWM[]U[
MKNQO_7ZV^O-_K<^_=>Z\+DW_ ,"#_6X//(]^Z]UXD 6_!!'!_I[]U[KJYY'/
M'-[WMQ?_ &/OW7NO6)^HO_07 /\ O'OW7NNSS_M[#FU_ZJ;^_=>Z[_!_P-_]
MYU>_=>Z\+'\?3@_ZWTM[]U[KC]2; _0_7^I^MA[]U[KNQXYL?IQ]/K8<'W[K
MW71O8_ZDV/Y//U_'X]^Z]UXW/ )_Q%K6_P!C[]U[KE]!<6''X'OW7NNN2/\
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M72;<\_U]^Z]U[BY')XYL?Z?3G^OOW7NO#_6^H!O_ (GZ_7W[KW76D6%K_0$
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M=V'%QS^/Z>_=>ZZXO<_4#GZ_[?W[KW75C:_U)^A%K?6_Y_Q]^Z]UW_6]A>Y
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M $YN+^[=GSZ]UX<FUS]/IQ^FUK\>Z]>ZY?[#D_[$"WTO[]U[KKFQ!'TXN/\
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M N0>/^-^_=>Z]_7FUK7!L5_P]^Z]UW];<<7O_2UOIQ[]U[KKZ"Y^@Y_'U/X
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M$?['@_3W[KW7A8BPO;Z?GZG_ (I[]U[KQYL?P#8D\$'Z7]^Z]U[ZBY'']/\
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M]X][%//KW7N 3_A;_;H.?>NO=>_!^A_&K_#_  /_ !OW[KW7?TM?_8 "W/\
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M[WYMQ8W/]1_A[]U[KJ_^/^M8 W_/^]<>_=>Z]_47N ?]B/\ #_'W[KW7K^D
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M_P 3]>#:WT-O?NO==\7O<7_K^#_K\_7W[KW7@#_M^>;<-_7W[KW7C<\&W];
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M_/TT=VVH<;J$?;*@_P +=3?]%?9Q_P":<;\-_P#LT-P>K\6%J?W7]X[?_O\
MC_WM?\_37[\V7_E,@_YRQ_\ 0777^BWLXG_F7._;_3T[/W"/S_4T_O?[PV__
M )2(_P#>U_S]>_?FR_\ *9!_SEC_ .@NI'^B+MG_ )]AV)]+?\>3N;Z_U_X"
M^]?O';_^4B+_ )R)_P!!=>_?NQ?\IUO_ ,YXO^@^NO\ 1'VQ_P ^O[$L>2/[
MD;D_I_C3>_?O';_^4B+_ )R)_P!!=>_?NQ?\IUO_ ,YXO^@^N7^B+M>__,L.
MQ/\ T"=S?DW/_*+[]^\=O_Y2(O\ G(G_ $%U[]^[%_RG6_\ SGB_Z#ZP'JSL
MY2RMUSOQ&5F5@=H[AU*R\,I!I[@C\CZ^_?O';_\ ?\?^]K_GZW^^]D_Y38/^
M<J?Y^O?Z+.S?I_HYWW;^G]T-P?\ U/[]^\=O_P!_Q_[VO^?K7[\V7_E,@_YR
MQ_\ 0745^N>PX2ZR;#WE#X[F3R;8S:Z .3J+0BUA];_[#W;ZZQ.!-&:\.]<_
MSZ<&\;0>%W#_ ,Y4/^!CU!EV;O"$ R[4W)$K7 \N"RD88GDV9HO=OJ[0\)4_
MWH=7&Y;<>%Q$?LD0_P"!NH,FWL]"Q67!YB,J+L),;61E3];LKQBQMS[L+BW/
M!U_:/\_3PN[-EU+-&?L=3_@/3?+2U,*:YJ>>-+VU20R1H2W.DEP!?_8^W0RL
M:*0?SZ>5D8T#+^T?Y^H_-^>>/K;@C\@D^]T/5Z>N/]7RZ[_(_ YO^+W'!/OU
M*];T-Y_ZOV==@$D6 Y%@./H#R;FW'OU/]1J/\-.O:#2O^K^77CP+ \CC\W_W
MKWZF:=:TDFG^4==&X ^O L2!<7MQS[]2G6]'S'7N3S8\?7BX'%C?WL"N0<=:
M*T-*BO71)M?@_3Z@?6_XL?>NO!:^8Z]^+<6YL+\\&Y_K_O7O>DGAGK?AOY#_
M %?GUWS?Z?['G@?T(]^H/7K5/0_ZOSZY?T%OQ^".+?6P^O'O7E7KVFO#/75C
M?2!?C\ DL?\ 8?U_WWY]^ZUBE2>NN?I<_P"!XY_)^@_V/O9!''JQ1AY?R/79
M(_-Q]#;G_?6]^ +"HZ\$8BH_U?Y.NCQ_:'/^O_7ZCGWH9X9Z]H;_ %?[/7OK
M>PN2?R ./Z&_X][TMZ=5I\Q_A_P=>'/]>?IQ_0\+Q?W[2>/6])X?['^&G7OK
M_6]^"/J>;\>]=;T'_57_ #=>^@)L;$W'U^O^L.??J=: !\Q7TX=>_K];CZBY
M_I[]U7KO\_BY')_/^V_U_?NO=<1<\D<VX_IS_P 1_3W[KW7K7OQS8_UO?\>K
MW[KW7?\ C^"01>W%_P CW[KW7A] !<6^O^'%_P CW[KW71L;&VH\"P/'^O<>
M_=>Z[XM;D_X<GZ&WU ]^Z]U[Z?6P_P!@/I;D6'OW7NO<<'CG\_F_^ /OW7NN
MN 2/I^GZ_3CW[KW7@#QR1<FU^#8_7^OOW7NN_I];G\C\VYMP??NO=>_H/\;'
M^AO]3<>_=>ZZXX^O-^;&_P"1^/\ 7]^Z]UV"> ?J;V_UQ[]U[KH<#ZW'!'/U
ML;D >_=>Z[/Y(%B!]?\ >?\ 6]^Z]UTI_P #S;_8\<\G^GOW7NN5_P#'_'Z?
M4?T'OW7NNKZ?PW^N?I_MQ[]U[KKGB_X(/Y/U/T_WKW[KW7=S].;\_P"\#Z_[
M?W[KW7C;Z@C\W'%B2/S[]U[KP##^MO\ 8?3^GOW7NO _[T+?[V>>1[]U[KOF
M]K_B]O\ C=O]A[]U[KW^]G_;<<@GW[KW7&QYY'TMS:X'^)'OW7NNS_A_2W!_
MPO;W[KW7?('UO_@?]YY]^Z]UUSQ_K,/]<@_[#W[KW7N+ZN?I_KVM]?I[]U[K
MQM]+#Z>DV!^@_%_?NO=>_ X%P"1?\6X_/OW7NO6M8+QS<W_WKW[KW75_H.18
M<V']/\"/I[V!4TZ]UWQ<_P"-KVL#<G_#^GO77NNO]>X_H38?[WS_ +S[]U[K
MO^M^0.0?]]Q[]U[KQ%[@<?X?\C_WOW[KW77/Y'/!/] +6^G_ !3W[KW7(_0_
MG^O^/%O?NO==7^O(_P /\/K;C_;>_=>Z]_O'-SR./]<^_=>Z[^O^M_4VYL??
MNO==?[T>+&XY)Y]^Z]UZW]0";"_Y/]+V]^Z]UX\6X'YOQ_9'X]^Z]UU;^FH\
MD?7Z6_I^/?NO==@ $VM?GB_^/OW7NO"XM^1QS]./H![]U[KQ^G-_^0>/\;V]
M^Z]UZQ(M_4<_UY/)M_C[]U[KP( '_%3P+7_I[]U[KKG4?I>W/XXM_7Z^_=>Z
MYW'/^'_%+^_=>ZX@ 6M>YO\ 6_UM?GW[KW71/'%B/J;#D ?0'W[KW78N>>?Z
M6N/Z7O;^OOW7NNR;7-Q_A_MKV]^Z]UUI/]>?]<_T_K_L!^/?NO==7'UYN>?]
MC:VF_OW7NO'\7'//^M:W-O?NO==FX_!_!M<<!?K;W[KW75_S^1R>/J/]<^_=
M>ZY#D$\\_@_C\6]^Z]UU];$?[:X('-[^_=>Z[L3^3^;_ $_''''OW7NNC_B+
M_P!DDFW^Q]^Z]UT!;_8@\&W)'Z1S;W[KW7?TYMS;Z\ _X\?U]^Z]UX"W!N;<
MC_C7OW7NO'Z\\_3\$<_X6]^Z]UT1S9>#?ZW/]+CW[KW7=C_4_P!H_P"Q)L./
M?NO=>'_$'_7)!YN/]O[]U[KH?0@<DC_ _BP]^Z]UWSS_ +'Z  7_ *WO[]U[
MKJ]KG_&PM]+_ -3_ (^_=>Z[%P+7_'''Y/T]^Z]U[23^H_T^EO\ B1[]U[KQ
M'^/Y_-OZW"^_=>ZZ-A^!:]OH/S_3CW[KW7K<@6XYMS]/Z@_Z_OW7NN_IP+?X
MBW/^QOS[]U[K=M_X39?]D,=J_P#BU^^O_?0[%]PC[EXWV(?\(7_JY+U@C]Z+
M_IX%I_TKXO\ M)N^O__3VF/YX1M_*[^3Q_QZ5_\ @A]I>Q;R-_RM-K_S=_ZL
MR=3#[!?]/:VK_J*_[0KCKY\?^Q)/]+CG_8>\A.NCW7+_ 'W_ "+W[KW7$<^J
M_P!?Q^#86M[]U[KKZ_D#]/\ C:_'^^/OW7NNR>/KR>0>?H.??NO=>^AN"3S:
MQ)M?_#W[KW71%OJ2>?H>;_[#W[KW7(?B_/XO_4?7CW[KW7$\7N >;WXX_ !]
M^Z]UX&WT'].>#^+?7_C?OW7NN[6O:W'U)')_)Y]^Z]U[_8<@V_(!+?6WOW7N
MO ?2WTM^/]?\W][KVTZ]UXDF]OQ];'G^GY]ZZ]UZWXL+_P"/)/\ L??NO=>L
M/R3];>HV]^Z]UV>;#\W-O]<>_=>Z]_M_]Y%K_P"(]^Z]UQ-B"1<?I_P_P'OW
M7NN^>;7L?]A^+?7Z^_=>ZX_X_P!/J?ZW^G^/^\^_=>ZY\?X?6U^+_3Z^_=>Z
MX\$<<W(_Q_'%_?NO==\G^MA>XO:Q'XX'OW7NO7N!S:S7Y_P_'^V]^Z]U[Z#Z
MDW_((-N/ZGW[KW7A?GD6'^-@+?3@?\5]^Z]UV+_G^GX^M[7]^Z]UQ_I_4 L>
M!_L/]C[]U[KE_L!>X_I^6^GOW7NO7/\ K_X< ?\ (_?NO=<;W%OI>RC\_FQ]
M^Z]UR_IR1?\ K;_;?3W[KW7$_0\7-VL/]<7X]^Z]UV.;V/(O>W^)O;D>_=>Z
MZ!M8?Z]^+@WY!X]^Z]U[T_[?Z6X(XY]^Z]UWR+  _P")N+_Z_OW7NNK?[$BU
MCS_7G@>_=>Z[_(XX/%QS^/I[]U[KJW/'(/-K<6_''OW7NO7_ -JO_L0 >>;C
MW[KW7?/(OS]1Q_L/S[]U[KH"P'%[_7Z_[#CW[KW7+^G^(M_OC[]U[KB+ M_3
M\V 'XMQ[]U[KL?0\_D_3BW-S]??NO=>_K_OM5A[]U[KS6 X^@XO:X%N/S[]U
M[KQ^E[?7]7^M_K^_=>ZZO]?K_06!O:_'/OW7NN^=7T/UO]?\+>_=>Z\.;<?7
MU?7\^_=>Z]<_7\W/U-N+$K]?]?W[KW7OIS8 DVY)_/\ K>_=>Z]?DV%_Z_TL
M.0?Z^_=>Z\;'ZC_$<GFWOW7NO7^G!Y7]7U/^MQ[]U[KJUCQ];6'T)_X,??NO
M==\?2PM>_P!;<VO]#[]U[KWY)YYM;_&P]^Z]UUS8?T'U/(^GUN#]??NO==C@
M?[&_'Y/] /Z>_=>Z]<_X#\\@WM>U^??NO=>_H";W_I].!;W[KW7C_C?Z7_Q%
MC<^_=>Z]J!YO:W];&_X^GU]^Z]UX<&W^'^-O]M[]U[KUR1?Z#Z_DV_/^'OW7
MNO #D<D^F][<V^GOW7NNBO'Y^M[7!Y_K<^_=>Z]Q8#\G_6-A?D<#W[KW7@+@
M"XX^I)'TU6/!_I[V01^?#Y]6*D?\4?\ -UR-A].>?HOUX_V(]ZIUL*3PZXW_
M !8?I_UKF]K"_P"/?J'SZT5(I7SZY6O];"_^/].18_G_ &'OU/\ 5G_-UZGJ
M:=<;BW%C:UO]A]?^->]D4ZWH(R?]7[.NR 3:]^38BY^H_ _I[U3K6GTH?Y?X
M:=='\?FWT(!_!_I?WZE*UXCRZ]I-:?[/79%C_46/]>+FU[V_/T][H>O:3\OV
MCI3X?9>\=PZ1@-I;FS@>V@X; Y7(J]SZ=)HHI/K[3275K#7Q9%6GJP'^$](K
MC<-OM?\ <FXBC_TTBK_QXCH5<#\4_E'NDJNV/C=W[N-I"/&,%T[V'ES)?C2B
MT&.DO_OOS[2MO.SQFDEW"M/65!_S]T47'./)]I_N5N]E'_IKJ%?\+CH8,1_+
M7^?F;5#1_#WY P:QZ?XQUIN/ :;_ $U_Q^&FT_ZS6]HGYIY=C-&O(_R.K_CH
M/1'/[J>W%M_:[W:'_2S+)_U;U="AAOY/'\RG/.GV/Q3WC#Y+:?XSN3KG;@'^
M+MN',TH7_D(CVF/.G*X_XEJ?L60_X$Z*9_>[VLM_[3>(S_I8KA_^.PGH5\7_
M "(OYE^0T-5=*[:P>L L,KV_U5*4N.-9PN7K!_R23[12<_\ +2$A9'>GI&__
M #\!T3S_ 'A?:Z(T2]DE_P!+;S#_ (^B="5A_P#A/1_,(R5A6IT?MZ]N<MV5
M63*E_P#5_P !Q5=_O%_:9_<;E]>"S'_:+_E<=%4WWE?;F+X%NY/]+ H_X_*O
M0KXG_A-?\Q9T1LUW+\:L:[D%DH,[VAEG0GU6;S;7I!<#Z@$C_'VED]S-I&(K
M>8CYZ!_S\W17<?>EY,#5@L+U_P#3+ G^"=^A!Q?_  F;[TD*#,?)KJ>A6PU-
MC-I[QRK*;W.E*IJ(,/\ 7(]IV]S[7\-HY^V0#_GT]%DWWJ]D_P!!VB=O]-+&
M/^?6Z$O$?\)BLE)I;/?,S'TI6VJ'$="U%>'YN0*FMW?3$?ZYC;_6]L/[H"E(
M[']LO_7//19/]ZY*:;?8R?FUY3^0MS_AZ$/'?\)D>N8B#EOEIO6M^A88[JK!
MXO\ /J"_<9FKM_A]?:1_<^_/P6L8^UF/^0=%4OWJ]Y8?H[/"O^FGD?\ Y\7I
M>8S_ (31?&N+2,Q\A^\:X>G6,;CM@XHM;]6DU6/K+7_%[V]IV]R]V/"WA'VZ
MS_S\.B^7[TW-I_L-NM%^TS-_@D7H0L=_PF[^#U,%-?V7\G<K+8:_)O7K*DIR
M?H=$-+L\.!;\&9N?;$GN3S XTJD*CY*]?YR'HOD^]![@,-,5M8QCY13D_P [
M@C^72YH?^$\?\OJDT^=^],G8\_?=E8^/5_K_ ,-Q%/[2M[@\R-P>,?[0?Y:]
M%LGWDO<N3@]LOV05_P"/.>EGC_Y!?\MVC %3UQO[+6(-Z_MG>T=["W(Q512C
MG\V ]M?U]YG/^CK_ ,XT_P H/2*3[Q/NF_P7L:?9;P'_ (\C=+K'?R.OY8E!
M8O\ &Z7(R@W\N1[?[QF)-PW,4.Y(XCR+_P";_P /IQ[:?GCFA\?54^R.(']N
MCI!)[^>[$G#=BH^5O:#^?@5_GTKZ/^3=_+3H540_%;:LI7Z?>[O[.R%^+>K[
M[-R7X_J/:5N;>9#_ ,2W_+2/\ Z0/[U^Z4F&WF8?8L2_\=C'2KHOY4'\NJ@*
MM!\2NJF*_P#*W1YC(CDEB&&0JY W)_(_XCW1N:>8FXWDO^]'I$_NW[E2"C;S
M<_DP'^ #I5T?\M3X T)4P?#[X_N5(L*SK;;N04VN/4,A#+?ZD\WYY^O/MIN8
M^8&XWLW_ #D;_/TE?W/]Q)/BWN]_*XD'^!ATKJ/X%?!Z@_X"?#CXM1N/I*W0
M/5<LWX^L\V*9[< VO:_/U]M-OV^/\=[.?EXTE/V:ND<GN#S[**/O=^?^HNXI
M^SQ*=**E^'7Q)HA:D^+GQTI0+:?MND>LJ<\$GZPXM?R3]/\ B3[3MN>Y-\=Q
M(WVNW^?I&_.'-LO]INEVWVW,Q_Y_Z4%-\9OCE1 "CZ Z2I@ 0!!U5L2  :=
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M>+WY_P"F<>U:>Z&*2V-?LEH/V&(_X>C2W^]>1_N3L=3ZK=_Y#;?\_=!ID_\
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M#21_LU>+3^?1:=V?\)E>U:-Y/[C?*SK[<,=F\7][>M]Q[09N;J)!B,CG0/\
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M$_0'\ 7]^Z]UX_7\\"_]/Q:_^O[]U[KPY_WF_P!0?KQS_O?OW7NO$_U XO\
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MV,BC6P/T%O97(\DIJ[$GYD_[/04N;R[O'UWDKRGU=BQ_:Q)Z4ICN2?R>./\
M>"2?Z?@'CVW0@U!_E_J_U>72;Y'KV@V^H/\ K@6_P^G^P][[O,_ZOV\>O==A
M+&_YX'^PM].?\>??J8IY>77NN?O?7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW
MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>
MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO
MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z
M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW
M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z]
M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7
MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][
M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KAHXMS_ ,E-R?SR
M/]Z]UH3D^G6^O!;"W'T XXY_UA]/]@?>Z&E!U[KK1^!:WU-P#<_X_P"^_P!Z
M]^IGY=:Z9\UMK;^Y:%L9N/!X?<&.>^O'YO&466HGOP==-D(Y$/''(]V1FC-4
M.D^H)K^WIZ"XGMG$ML[1MZJQ!_:*'HM.\_@=\*^P4D7=WQ2^/V6FEOKR ZGV
M5CLP=7ZK9O%4<%6MSR0LP%^?K[,H=[WFV_W'NI5^0D>G[*T_ET)[#G[G?:Z"
MPW>[C'\(N)2O^\%BO\NBH[T_DC?RU=Y1RD?'L;4K)=5J_9O8?9>#:(->XCQQ
MRTU!]?I>C-OQQQ[-H.=>9[?"W)8?TE5C^TBO0QL???W3L,+NC2KYB6*"2O\
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M[EN5H0;6XDB_TKL/\M/Y="+;N;^:]G(.U[E<VX'DD\BK]A4,%(^1%.B0;_\
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ML0_X0O\ U<EZP1^]%_T\"T_Z5\7_ &DW?7__T=IC^>&+_P KOY/#_P 0M_\
M!#[2]BWD;_E:;7_FY_U9DZF+V"_Z>SM7_45_VA7/7SY#]#_AR1]?Q;\^\A.N
MCO7'_#\WU ?[3^ ??NO=<K?7D\_3_#W[KW71_'XO_7\WY(-_?NO=>X(TWO\
MZ_\ @?\ #W[KW7N2?J+$@_X_X>_=>ZZ^MOQ>_P#O'_$?X>_=>Z['/T_WK\?7
M_>!]/?NO=>-A;_4GCCCF_P!>/?NO=>(_/T^EP0#?GCZ>_=>Z]_B0+?X\?[?Z
MW]^Z]UZ_'T ']3]/I8>_=>Z\/R.#^?\ 7O\ 6_X]^Z]UZ_UM?TWO].3[]U[K
MOCG\?U%Q;^G/OW7NNA<V-S;B_P#C8?CW[KW7OK<?T^MOS_A[]U[KL"WU-_\
M>OI:UO?NO=<>+@<6M;FP(/\ 47]^Z]UW<?U'']./H>![]U[KUR+?4_ZUN>+\
M>_=>Z[_Q/']?Z'C_ !]^Z]UU<_BQ XL/]XN3[]U[KUC;Z'BUAQ].#_Q'OW7N
MNK6!_-_]M8?0\>_=>Z\?I]%'+?[8?GW[KW7('_#G^EQ?GD^_=>ZZ']1P3^2#
M;ZVM]??NO=>N>#^+$W_J!]+GW[KW7N+7/%]/)^I(_P /^*>_8ZOH/K_A_P W
M7=N?K:X)X%KA>1]?]]_L/?N.1_Q76BI&3P\_*G[?\G7$ @D$<D?D WYO]/\
MBGOWE7R_U?GUX*2*C/[>I-)25>0J8:*@IJFLJYV6*GI:2&2HJ9Y3^F*&"$,[
M,?\ 4J"?\/=69476Y 'S('\^'\^J2LD$9EF8(J\22  /4DX ^9Z-OUK_ "__
M )M=NI3U'7_Q;[LS&/JY%6ES5;L/-;;V[/K%[P[CW1'14# 7]3"HLMP6(!%R
M:ZYEV"SQ/>15]%;6?V)J/0*W7W)Y!V6HW'=[56'%5E65Q]J1:V'[.K".M/\
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M%_Z_[Q_7U7M]+\^W*8KY=.D4X_X#_FZ[MS8$<@ +<?G@?G_$?[?WK[>MZ?\
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M^F ZM(ZB_P"$WWRFW0**K[A[=ZGZDH:EU:HH,*N<[+W111_VA/04B8K&,_\
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M3^+_ -/K]/?NO==_T(Y%B.#S_@1[]U[KH7/TXX)Y_#'W[KW79) _P_U0L?\
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MGJJ3N+_A-#ONA^ZK>A/DIM7<::7--@>V=JY7:E3$5'H@;=.T6RZ3%QQJ_A4
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MXMS]2/Z_3ZW_ *?GWNGGUK220!Y_D?V&AZYA&8JH1F=[(H0%F+,;!0HY))X
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M !.J ];^SKCH;^B\@<7-@1];<6Y_K8?U]Z (-?\ 5^WKU>@X[&Z;ZH[?Q?\
M!.U^L]@=EX=8I(DQN_=H8#=E)$)O\X8(,Y3SK$2;'5& ;V-P0#[4075U:N);
M65HV]58J?V@C]G1CMV\;KL\WU&TW,MK)Y-%(\9_:I!_GU5AW/_(<_E\]KBJJ
MMN[%W9TIFJA)&_B'5.\LA2435)YBEEVYO!,QCD13:\5'2T]Q>S*QU 4V//7,
MEG1991<**8E%33_3+I8_*IQ\QCJ6]A^\%[E;*52:Z2^C7&FXC#&GH)(S')^;
M,W52'='_  FH[7Q'W5;T%\AME[TIT5YJ?;_:&W\KL/)H "5HXL[MTYJEJ9&
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E7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>May 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IZEA WORLDWIDE, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">37-1530765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1317 Edgewater Dr.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text"># 1880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Orlando<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">32804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">674-6911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IZEA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,926,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001495231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 50,612,348<span></span>
</td>
<td class="nump">$ 44,644,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Accounts receivable, net</a></td>
<td class="nump">4,269,114<span></span>
</td>
<td class="nump">7,781,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">697,635<span></span>
</td>
<td class="nump">1,079,045<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term investments</a></td>
<td class="nump">1,572,233<span></span>
</td>
<td class="nump">6,427,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">10,511<span></span>
</td>
<td class="nump">97,215<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">57,161,841<span></span>
</td>
<td class="nump">60,030,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">80,619<span></span>
</td>
<td class="nump">103,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Total</a></td>
<td class="nump">2,098,571<span></span>
</td>
<td class="nump">2,086,660<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets, Total</a></td>
<td class="nump">59,341,031<span></span>
</td>
<td class="nump">62,220,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="nump">892,636<span></span>
</td>
<td class="nump">1,511,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,081,263<span></span>
</td>
<td class="nump">3,734,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Contract with Customer, Liability, Current</a></td>
<td class="nump">7,095,245<span></span>
</td>
<td class="nump">8,188,651<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,069,144<span></span>
</td>
<td class="nump">13,434,521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance obligation, less current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,034<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">11,069,144<span></span>
</td>
<td class="nump">13,438,555<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 9)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock; $0.0001 par value; $10,000,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock; $0.0001 par value; $50,000,000 shares authorized; shares issued: $17,661,220 and $17,518,018, respectively, shares outstanding: $16,893,885 and $16,931,169, respectively.</a></td>
<td class="nump">1,766<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock at cost: 767,335 and 586,849 shares at March&#160;31, 2025 and December&#160;31, 2024, respectively</a></td>
<td class="num">(2,065,873)<span></span>
</td>
<td class="num">(1,622,065)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">154,793,924<span></span>
</td>
<td class="nump">154,593,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(104,439,855)<span></span>
</td>
<td class="num">(104,297,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss)</a></td>
<td class="num">(18,075)<span></span>
</td>
<td class="nump">105,287<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">48,271,887<span></span>
</td>
<td class="nump">48,781,719<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 59,341,031<span></span>
</td>
<td class="nump">$ 62,220,274<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - Parenthetical - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued (shares)</a></td>
<td class="nump">17,661,220<span></span>
</td>
<td class="nump">17,518,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (shares)</a></td>
<td class="nump">16,893,885<span></span>
</td>
<td class="nump">16,931,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (shares)</a></td>
<td class="nump">767,335<span></span>
</td>
<td class="nump">586,849<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 7,968,363<span></span>
</td>
<td class="nump">$ 6,952,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">4,401,574<span></span>
</td>
<td class="nump">3,967,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">1,121,782<span></span>
</td>
<td class="nump">3,056,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">2,940,507<span></span>
</td>
<td class="nump">3,783,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">160,352<span></span>
</td>
<td class="nump">204,186<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">8,624,215<span></span>
</td>
<td class="nump">11,011,538<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(655,852)<span></span>
</td>
<td class="num">(4,058,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_ChangeInTheFairValueOfDigitalAssets', window );">Change in the fair value of digital assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">106,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(1,654)<span></span>
</td>
<td class="num">(2,001)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">514,706<span></span>
</td>
<td class="nump">669,865<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">513,052<span></span>
</td>
<td class="nump">774,023<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossAttributableToParent', window );">Net loss before income taxes</a></td>
<td class="num">(142,800)<span></span>
</td>
<td class="num">(3,284,632)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,782<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (142,800)<span></span>
</td>
<td class="num">$ (3,265,850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">16,927,166<span></span>
</td>
<td class="nump">16,333,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">16,927,166<span></span>
</td>
<td class="nump">16,333,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per common share (in dollars per share)</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per common share (in dollars per share)</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_ChangeInTheFairValueOfDigitalAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the fair value of digital assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_ChangeInTheFairValueOfDigitalAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (142,800)<span></span>
</td>
<td class="num">$ (3,265,850)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on securities held</a></td>
<td class="nump">13,903<span></span>
</td>
<td class="num">(58,177)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax', window );">Unrealized gain (loss) on currency translation</a></td>
<td class="num">(109,459)<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="num">(123,362)<span></span>
</td>
<td class="nump">62,347<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive income (loss)</a></td>
<td class="num">$ (266,162)<span></span>
</td>
<td class="num">$ (3,203,503)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 38<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477346/946-830-45-38<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482739/220-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,666,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2024</a></td>
<td class="nump">$ 62,501,847<span></span>
</td>
<td class="nump">$ 1,667<span></span>
</td>
<td class="nump">$ 152,419,065<span></span>
</td>
<td class="num">$ (1,019,997)<span></span>
</td>
<td class="num">$ (88,710,644)<span></span>
</td>
<td class="num">$ (188,244)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for payment of services, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued for payment of services, net</a></td>
<td class="nump">75,006<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">75,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">354,189<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">354,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share withheld to cover statutory taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld to cover statutory taxes</a></td>
<td class="num">(37,233)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(37,232)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">4,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on securities held</a></td>
<td class="nump">58,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,265,850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,265,850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,602,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 65,313,388<span></span>
</td>
<td class="nump">$ 1,660<span></span>
</td>
<td class="nump">152,027,110<span></span>
</td>
<td class="num">(1,019,997)<span></span>
</td>
<td class="num">(85,444,794)<span></span>
</td>
<td class="num">(250,591)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (shares) at Dec. 31, 2024</a></td>
<td class="nump">16,931,169<span></span>
</td>
<td class="nump">17,518,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 48,781,719<span></span>
</td>
<td class="nump">$ 1,752<span></span>
</td>
<td class="nump">154,593,800<span></span>
</td>
<td class="num">(1,622,065)<span></span>
</td>
<td class="num">(104,297,055)<span></span>
</td>
<td class="nump">105,287<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,602,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2023</a></td>
<td class="nump">$ 65,313,388<span></span>
</td>
<td class="nump">$ 1,660<span></span>
</td>
<td class="nump">152,027,110<span></span>
</td>
<td class="num">(1,019,997)<span></span>
</td>
<td class="num">(85,444,794)<span></span>
</td>
<td class="num">(250,591)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (shares) at Mar. 31, 2025</a></td>
<td class="nump">16,893,885<span></span>
</td>
<td class="nump">17,661,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2025</a></td>
<td class="nump">$ 48,271,887<span></span>
</td>
<td class="nump">$ 1,766<span></span>
</td>
<td class="nump">154,793,924<span></span>
</td>
<td class="num">(2,065,873)<span></span>
</td>
<td class="num">(104,439,855)<span></span>
</td>
<td class="num">(18,075)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Stock issued for payment of services, net (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock issued for payment of services, net</a></td>
<td class="nump">90,002<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">89,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock-based compensation (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">285,132<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">285,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share withheld to cover statutory taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(56,130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld to cover statutory taxes</a></td>
<td class="num">(174,996)<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">(174,990)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury stock</a></td>
<td class="num">(443,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(443,808)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(109,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(109,459)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gain (loss) on securities held</a></td>
<td class="num">(13,903)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,903)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (142,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance (shares) at Dec. 31, 2024</a></td>
<td class="nump">16,931,169<span></span>
</td>
<td class="nump">17,518,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2024</a></td>
<td class="nump">$ 48,781,719<span></span>
</td>
<td class="nump">$ 1,752<span></span>
</td>
<td class="nump">$ 154,593,800<span></span>
</td>
<td class="num">$ (1,622,065)<span></span>
</td>
<td class="num">$ (104,297,055)<span></span>
</td>
<td class="nump">$ 105,287<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (142,800)<span></span>
</td>
<td class="num">$ (3,265,850)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets', window );">Adjustment to fair market value of digital assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(106,159)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">22,955<span></span>
</td>
<td class="nump">26,557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">137,397<span></span>
</td>
<td class="nump">177,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems', window );">Deferred tax benefit, divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">285,132<span></span>
</td>
<td class="nump">354,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Value of stock issued or to be issued for payment of services</a></td>
<td class="nump">90,002<span></span>
</td>
<td class="nump">75,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">3,512,710<span></span>
</td>
<td class="nump">213,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">468,112<span></span>
</td>
<td class="num">(243,987)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(619,111)<span></span>
</td>
<td class="num">(347,852)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(652,859)<span></span>
</td>
<td class="num">(148,183)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="num">(1,093,406)<span></span>
</td>
<td class="num">(58,121)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">2,008,132<span></span>
</td>
<td class="num">(3,341,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from investment maturities</a></td>
<td class="nump">4,869,158<span></span>
</td>
<td class="nump">5,059,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(4,034)<span></span>
</td>
<td class="num">(14,846)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Capitalization of software development costs</a></td>
<td class="num">(149,307)<span></span>
</td>
<td class="num">(73,678)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">4,715,817<span></span>
</td>
<td class="nump">4,971,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfEquity', window );">Purchase of treasury stock</a></td>
<td class="num">(443,808)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments on shares withheld for statutory taxes</a></td>
<td class="num">(174,996)<span></span>
</td>
<td class="num">(37,233)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(618,804)<span></span>
</td>
<td class="num">(37,233)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(137,265)<span></span>
</td>
<td class="num">(3,414)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">5,967,880<span></span>
</td>
<td class="nump">1,592,018<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">44,644,468<span></span>
</td>
<td class="nump">37,446,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">50,612,348<span></span>
</td>
<td class="nump">39,035,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">1,654<span></span>
</td>
<td class="nump">2,001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental non-cash activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Fair Value of common stock issued for services</a></td>
<td class="nump">$ 90,002<span></span>
</td>
<td class="nump">$ 75,006<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Fair Market Value of Indefinite Lived Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482630/740-20-55-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Company and Summary of Significant Accounting Policies</a></td>
<td class="text">COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Corporate Information and Nature of Business</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IZEA Worldwide, Inc. (together with its wholly-owned subsidiaries, &#8220;IZEA&#8221; or the &#8220;Company&#8221;) is a Nevada corporation founded in February 2006 under the name PayPerPost, Inc. and became a public company in May 2011. In March 2016, the Company formed IZEA Canada, Inc., a wholly-owned subsidiary incorporated in Ontario, Canada. In December 2023, IZEA purchased all of Hoozu Holdings' outstanding shares of capital stock, which it subsequently divested in December 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company helps power the creator economy by enabling individuals to monetize their content, creativity, and influence through global brands and marketers. IZEA compensates these creators for producing unique content, such as long and short-form text, videos, photos, status updates, and illustrations for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#8220;Managed Services&#8221;). While the majority of the marketers engage the Company to perform the Managed Services on their behalf, marketers may also access IZEA&#8217;s marketplaces to engage creators for influencer marketing campaigns or to produce custom content on a self-service basis by licensing the Company&#8217;s technology.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated balance sheet as of March&#160;31, 2025, the consolidated statements of operations for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of comprehensive loss for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of stockholders' equity for the three months ended March&#160;31, 2025 and 2024, and the consolidated statements of cash flows for the three months ended March&#160;31, 2025 and 2024 are unaudited but include all adjustments that are, in the opinion of management, necessary for a fair presentation of its financial position at such dates and its results of operations and cash flows for the periods then ended in conformity with generally accepted accounting principles in the United States ("GAAP"). The consolidated balance sheet as of December&#160;31, 2024 has been derived from the audited consolidated financial statements at that date but, in accordance with the rules and regulations of the SEC, does not include all of the information and notes required by GAAP for complete financial statements. Operating results for the three months ended March&#160;31, 2025 are not necessarily indicative of results that may be expected for the entire fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December&#160;31, 2024, included in the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2025.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Principles of Consolidation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of IZEA Worldwide, Inc. and its wholly-owned subsidiaries subsequent to the subsidiaries&#8217; acquisition, merger, or formation dates, as applicable. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments purchased with an original maturity of three months or less from the date of purchase to be cash equivalents. Deposits made to Company bank accounts are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to a maximum amount of $250,000. The Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) insures deposits made to the Company&#8217;s bank accounts in Canada up to CAD 100,000. Deposit balances exceeding the various limits were approximately $50.0 million and $44.2 million as of March&#160;31, 2025 and December&#160;31, 2024, respectively. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Accounts Receivable and Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable balance consists of trade receivables, contract assets, and a reserve for doubtful accounts. Trade receivables are customer obligations due under normal trade terms. Contract assets represent amounts owed for work performed but not yet billed. The Company had net trade receivables of $4.3 million, including $4.2 million of accounts </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivable and contract assets of $61,480 on March&#160;31, 2025. The Company had net trade receivables of $7.8 million, including $7.6 million of accounts receivable and contract assets of $0.2 million on December&#160;31, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer&#8217;s financial condition, credit history, and current economic conditions. We will continue to monitor these factors and adjust our credit and collection policies as necessary to address evolving market conditions and potential risks to financial performance. An account is deemed delinquent when the customer has not paid an amount due by its associated due date. If a portion of the account balance is deemed uncollectible, the Company will either write off the amount owed or provide a reserve based on its best estimate of the uncollectible portion of the account. We assess collectability risk both generally and by specific aged invoices. Our loss history informs a general reserve percentage, which we apply to all invoices less than 90 days from the invoice due date, currently 1% of the outstanding balance. The general reserve, which we update periodically, recognizes that some invoices will likely become a collection risk. When an invoice ages 90 past its due date, we consider each invoice to determine a reserve for collectability based on our prior history and recent communications with the customer, to determine a reserve amount. Generally, our reserve for such aged invoices will approach 100% of the invoice amount. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had a reserve for doubtful accounts of $0.2 million as of March&#160;31, 2025, and $0.2 million as of December&#160;31, 2024. Management believes this estimate is reasonable, but there can be no assurance that the estimate will not change due to economic or business conditions within the industry, the individual customers, or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. The Company did not recognize any bad debt expense in the three months ended March&#160;31, 2025 and March&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company&#8217;s customer base, thus spreading the trade credit risk. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. The Company had three customers that each accounted for more than 10% of total accounts receivable on March&#160;31, 2025 and two customers that accounted for more than 10% of total accounts receivable on December&#160;31, 2024. The Company had three customers that each accounted for more than 10% of its revenue during the three months ended March&#160;31, 2025, and one customer that accounted for more than 10% of its revenue during the three months ended March&#160;31, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Property and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost, or if acquired in a business combination, at the acquisition date fair value. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and Fixtures</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 10 years</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the year of disposal, with resulting gains or losses included in general and administrative expense in the consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-08, Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60), which requires certain crypto assets to be measured at fair value each reporting period, with changes recognized in net income. It also introduces new disclosure requirements, including asset name, fair value, units held, cost basis, and annual reconciliations. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance early and sold all digital assets in September 2024. As of March 31, 2025, no digital assets were held, and no impairments were recognized for the three months ended March 31, 2025 or 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets, including capitalized software and intangible assets, for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable. Impairments are recognized when the asset&#8217;s fair value is less than its carrying amount. In connection with the Company&#8217;s 2024 reorganization and divestitures, all acquired intangible assets were written off. See &#8220;Note 5 &#8211; Intangible Assets&#8221; for additional details.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Software Development Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 350-40,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Use Software,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i)&#160;the research and planning </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stage, (ii)&#160;the application and development stage, and (iii)&#160;the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. The Company also capitalizes costs related to cloud computing arrangements (&#8220;CCAs&#8221;). These software developments and CCA costs are amortized on a straight-line basis over the estimated useful life of five years upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess carrying value over the fair value in its consolidated statements of operations. In December 2024, the Company reviewed its software assets, wrote off fully amortized balances no longer active, and accelerated the amortization of certain software assets no longer in use, with further details provided in "Note 6 - Software Development Costs.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, established a right-of-use model that requires a lessee to record a right-of-use asset and a right-of-use liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company does not record leases on the balance sheet with a lease term of 12 months or less at the commencement date.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue primarily from Managed Services when a marketer (typically a brand, agency, or partner) pays us to provide custom content, influencer marketing, amplification, or other campaign management services (&#8220;Managed Services&#8221;); additionally, we generate revenue from subscription fees charged to access our software platforms, license and transaction fees from self-service customers, and fees from such as inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#8220;SaaS Services Revenue&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 606&#8221;). Under ASC 606, revenue is recognized based on a five-step model as follows: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) performance obligations are satisfied. The core principle of ASC 606 is that revenue is recognized when the transfer of promised goods or services to customers is made in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are distinct performance obligations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also determines whether it acts as an agent or a principal for each identified performance obligation. The determination of whether the Company acts as principal or agent is highly subjective and requires the Company to evaluate a number of indicators individually and as a whole in order to make its determination. For transactions in which the Company acts as a principal, revenue is reported on a gross basis as the amount paid by the marketer for the purchase of content or sponsorship, promotion, and other related services, and the Company records the amounts it pays to third-party creators as cost of revenue. For transactions in which the Company acts as an agent, revenue is reported on a net basis as the amount the Company charged to the self-service marketer using the Company&#8217;s platforms, less the amounts paid to the third-party creators providing the service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains separate arrangements with each marketer and content creator either in the form of a master agreement or terms of service, which specify the terms of the relationship and access to its platforms, or by a statement of work, which specifies the price and the services to be performed, along with other terms. The transaction price is determined based on the fixed fee stated in the statement of work and does not contain variable consideration. Marketers who contract with the Company to manage their advertising campaigns or custom content requests may prepay for services or request credit terms. Payment terms are typically 30 days from the invoice date. The agreement typically provides for either a non-refundable deposit or a cancellation fee if the agreement is canceled by the customer prior to the completion of services. Billings in advance of completed services are recorded as a contract liability until earned. The Company assesses collectability based on several factors, including the creditworthiness of the customer and payment and transaction history.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not typically engage in contracts that are longer than one year. Therefore, the Company does not capitalize costs to obtain its customer contracts as these amounts generally would be recognized over a period of less than one year and are not material. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Services Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Managed Services Revenue, the Company enters into an agreement to provide services that may include multiple distinct performance obligations in the form of (i) an integrated marketing campaign to provide influencer marketing services, which may include the provision of blogs, tweets, photos, or videos shared through social network offerings and content promotion, such as click-through advertisements appearing in websites and social media channels, and (ii) custom content items, such as a research or news articles, informational material or videos. Marketers typically purchase influencer marketing services to provide public awareness or advertising buzz regarding the marketer&#8217;s brand and purchase custom content for internal and external use.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company views its obligation to deliver influencer marketing services, including management services, as a single performance obligation that is satisfied over time as the customer receives the benefits from the services. The majority of revenue is recognized using an input method of costs incurred compared to total expected costs to measure the progress toward satisfying the overall performance obligation of the marketing campaign. The Company&#8217;s performance obligation in certain contracts with customers may be a stand-ready promise to provide influencer marketing services for an unknown or unspecified quantity of deliverables for a specified term. Under a stand-ready obligation, the Company&#8217;s performance obligation is satisfied over time throughout the contract term, and therefore, revenue is recognized straight-line over the life of the contract. The Company may provide one type or a combination of all types of these influencer marketing services on a statement of work for a lump sum fee. When multiple performance obligations exist in a contract, the Company allocates revenue to each distinct performance obligation at contract inception based on its relative standalone selling price. These performance obligations are to be provided over a period that generally ranges from one day to one year. The delivery of custom content represents a distinct performance obligation that is satisfied at a point in time when each piece of content is delivered to the customer. Based on the Company&#8217;s evaluations, revenue from Managed Services is reported on a gross basis because the Company has the primary obligation to fulfill the performance obligations, and it creates, reviews, and controls the services. The Company takes on the risk of payment to any third-party creators and establishes the contract price directly with its customers based on the services requested in the statement of work.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SaaS Services Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SaaS services revenue includes subscription fees charged to access our software platforms, license and transaction fees from self-service customers, inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#8220;SaaS Services Revenue&#8221;). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscription and license revenue is generated by granting customers limited, non-exclusive, non-transferable access to the Company&#8217;s technology platforms for an agreed-upon subscription period. Customers access the platforms to manage their influencer marketing campaigns. Fees for subscription or licensing services are recognized straight-line over the term of the service. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-service customers instruct creators found through the Company&#8217;s platforms to provide and/or distribute custom content for an agreed-upon transaction price. The Company&#8217;s platforms control the contracting, description of services, acceptance of, and payment for the requested content. This service is used primarily by news agencies or marketers to control the outsourcing of their content and advertising needs. The Company charges the self-service customer the transaction price plus a fee based on the contract (&#8220;Marketplace Spend Fees&#8221;). Revenue is recognized when the transaction is completed by the creator and accepted by the marketer or verified as posted by the system. Based on the Company&#8217;s evaluations, this revenue is reported on a net basis since the Company is acting as an agent through its platform for the third-party creator to provide the services or content directly to the self-service customer or to post approved content through one or more social media platforms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Fees Revenue is generated when fees are charged to the Company&#8217;s platform users primarily related to monthly plan fees, which are recognized within the month they relate to.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advertising Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are charged to expense as they are incurred, including payments to content creators to promote the Company. Advertising costs charged to operations for the three months ended March&#160;31, 2025, and 2024 were approximately $5 thousand and $617.5 thousand, respectively. Advertising costs are included in sales and marketing expenses in the accompanying consolidated statements of operations. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes are accounted for using the balance sheet approach, which requires recognizing deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the assets and liabilities tax basis. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized. The Company incurs state franchise tax in ten states, which is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits, and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company&#8217;s tax years subject to examination based on the statute of limitations by the IRS is generally three years; however, the IRS may examine records and other evidence from the year the net operating loss was generated when the Company utilizes net operating loss carryforwards in future periods. The Company&#8217;s tax years subject to examination by the Canadian Revenue Agency is generally four years.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on quoted market prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on quoted market prices for similar assets and liabilities in active markets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management&#8217;s best estimate of what market participants would use as fair value.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. As of March&#160;31, 2025, the Company holds Level 1 and Level 2 financial assets; this is discussed further in Note 3 - Financial Instruments of Notes to the Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation for options granted under the 2011 Equity Incentive Plan and the 2023 Inducement Plan is measured at grant-date fair value and expensed on a straight-line basis over the requisite service period. Fair value is estimated using the Black-Scholes model. The Company applies the simplified method to estimate the expected term, assuming even exercise between vesting and expiration, and uses the grant-date closing stock price as the fair value of common stock. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates forfeitures when recognizing compensation expense, and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and a revised amount of unamortized compensation expense to be recognized in future periods.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may issue restricted stock or restricted stock units (&#8220;RSUs&#8221;) that vest over time, including up to 1,800,000 performance- or time-based RSUs granted under the IZEA Inducement Plan adopted on November 30, 2023. The plan was established to provide equity awards to new employees hired through acquisitions transactions. These awards are recorded at fair value on the grant date and expensed on a straight-line basis over the vesting period. See &#8220;Note 10 Stockholder&#8217;s Equity&#8221; for more details.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Business Combinations and Asset Acquisitions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations in accordance with Accounting Standards Codification (ASC) Topic 805, &#8220;Business Combinations.&#8221; The acquisition method of accounting is applied to all business combinations, whereby the identifiable assets acquired, liabilities assumed, and any non-controlling interests in the acquiree are recognized and measured at their fair values as of the acquisition date. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets acquired and liabilities assumed in a business combination. Goodwill is allocated to reporting units, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which are expected to benefit from the synergies of the combination and is subject to annual impairment testing. Acquisition-related costs, including advisory, legal, and due diligence fees, are expensed as incurred and are included in general and administrative expenses in the period in which the acquisition occurs. The financial statements include the results of operations and the financial position of businesses acquired from their respective acquisition dates. Any adjustments to the preliminary fair values of assets acquired and liabilities assumed, known as measurement period adjustments, are recorded during the period of the adjustment.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Segment Reporting: Improvements to Reportable Segment Disclosures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improving Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This update is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The ASU also requires all annual disclosures currently required by Topic 280 to be included in the interim periods. The update is effective for fiscal years beginning after December 15, 2023, and interim periods within the fiscal years beginning after December 15, 2024, with early adoption permitted and requiring retrospective application to all prior periods presented in the financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes: Improvements to Income Tax Disclosures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company adopted this ASU for the annual period beginning on January 1, 2025 and does not expect a material impact on the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Disaggregation of Income Expenses:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2024, the FASB issued ASU No. 2024-03 (Subtopic 220-40) Disaggregation of Income Expenses, which requires entities to provide enhanced disclosures related to certain disclosures related to certain expense categories included in the income statement. The update is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company is currently assessing the timing and impact of adopting the updated provisions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Acquisitions</a></td>
<td class="text">BUSINESS ACQUISITIONS AND DIVESTITURES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Divestiture of Hoozu Holdings PTY Ltd.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 18, 2024, the Company completed the divestiture of Hoozu Holdings PTY Ltd. (&#8220;Hoozu&#8221;) through its sale to a private Australian company, as part of a strategy to optimize its market focus and enhance the profitability of its North American operations. The acquisition of Hoozu was completed on December 1, 2023, for $2.5&#160;million in cash, common stock, and contingent consideration.</span></div>The sale of Hoozu resulted in cash proceeds of $73,529, net of approximately $28,000 in transaction costs, and resulted in a net loss of $1.9 million, net of a $0.3&#160;million deferred tax benefit, which, together with the year-to-date results of operations through the sale date, is reflected in the Company&#8217;s financial statements for the period ended December&#160;31, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">FINANCIAL INSTRUMENTS<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Marketable Securities (Available for Sale)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has appointed a leading national bank for custody services with respect to investment securities. Investments comply with the Company&#8217;s revised investment strategy policy, designed to preserve capital, minimize investment risks, and maximize returns.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s cash, cash equivalents, and marketable securities by significant investment category as of March&#160;31, 2025:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:31.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.767%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Marketable Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,010,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,999,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,997,569&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset back securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,186,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,184,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,612,348&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,572,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current Marketable Securities have a holding period under <span style="-sec-ix-hidden:f-398">one</span> year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">      (2)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 1 fair value estimates are based on quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;padding-left:7.44pt;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the fair value of cash equivalents and marketable securities on the balance sheet. The adjusted cost, which includes unrealized gains and losses, reflects settlement amounts if all investments are held to maturity. The Company recognized a gain of $23,799 for the three months ended March&#160;31, 2025, and recognized a gain of $810 for the three months ended March&#160;31, 2024, respectively. Realized gains and losses are a component of other income (expense), net. Unrealized gains and losses are a component of other comprehensive income (loss) (&#8220;OCI&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of investments in marketable debt securities by stated contractual maturity dates:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March&#160;31, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31, 2024</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,427,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572,233&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,427,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents fair values and net unrealized gains (losses) recorded to OCI, aggregated by investment category:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,612,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,644,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,184,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,071,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025, the Company did not recognize any credit losses and had no ending allowance balance for credit losses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">PROPERTY AND EQUIPMENT<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following: </span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense on property and equipment recorded in depreciation and amortization expense in the consolidated statements of operations and comprehensive loss was $22,955 and $26,557 for the three months ended March&#160;31, 2025 and 2024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets</a></td>
<td class="text">INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no definite-lived intangible assets on its balance sheet as of December 31, 2024.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense recorded in depreciation and amortization in the accompanying consolidated statements of operations and comprehensive loss was $0 and $49,287 for the three months ended March&#160;31, 2025 and 2024, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Digital Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines the fair value of its digital assets on a recurring basis in accordance with ASU 2023-8, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for and Disclosure of Crypto Assets</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, based on quoted prices on the active exchange(s) that have been determined to be the principal market for such assets (Level 1 inputs). The Company performs an analysis monthly to identify whether the fair market value of the digital assets has changed. If the then-current carrying value of a digital asset is different from the fair value so determined, an adjustment in the amount equal to the difference between their carrying value and the price determined is recognized.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gains and losses on digital assets are recognized within other income in the consolidated statements of operations and comprehensive loss in the period in which the change to fair market value is identified. In determining the gain to be recognized upon sale, the Company calculates the difference between the sales price and the carrying value of the digital assets sold immediately prior to the sale.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no digital assets on its balance sheet as of December 31, 2024. the Company recorded a gain of $0.1&#160;million for the three months ended March 31, 2024.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Goodwill</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no goodwill balance as of March&#160;31, 2025 and December&#160;31, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Software Development Costs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Software Development Costs</a></td>
<td class="text">SOFTWARE DEVELOPMENT COSTS<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs consist of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(946,835)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809,439)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086,660&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized software development costs of $0.1 million and $0.1 million during the three months ended March&#160;31, 2025 and 2024, respectively. As of March&#160;31, 2025, the Company has capitalized $3.0 million in direct materials, consulting, payroll, and benefit costs to its internal-use software development costs in the consolidated balance sheet.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company amortizes its software development costs, commencing upon the initial release of the software or additional features, on a straight-line basis over the estimated useful life of five years, which is consistent with the amount of </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time its legacy platforms were in service or its actual useful life, if shorter. The Company recorded amortization expenses associated with its capitalized software development cost of $0.1 million and $0.1 million during the three months ended March&#160;31, 2025 and 2024, respectively.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, future estimated amortization expense related to software development costs is set forth in the following schedule:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Software Development Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">ACCRUED EXPENSES<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">During the quarter ended September 30, 2024, the Company announced the departure of two executives. In accordance with their Separation Agreements and the payments they are entitled to receive, a severance amount of $0.9&#160;million was accrued and will be paid over a twelve-month period. In December 2024, in conjunction with a targeted workforce reduction, the Company accrued $0.3&#160;million in severance costs to be paid in January 2025. As of March 31, 2025, the remaining balance for severance accrued is $0.4&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text">NOTES PAYABLE<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Finance Obligation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company pays for its laptop computer equipment through long-term payment plans, using an imputed interest rate of 12.9%, based on its incremental borrowing rate, to determine the present value of its financial obligation and to record interest expense over the term of the plan. The Company refreshed a portion of its computer inventory during the fourth quarter of 2022, entering a new three-year payment plan with the same vendor. The total balance owed was $48,573 and $63,420 as of March&#160;31, 2025 and December&#160;31, 2024, respectively, with the short-term portion of $48,573 and $59,386 recorded under accrued expenses in the consolidated balance sheets as of March&#160;31, 2025, and December 31, 2024, respectively. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense on financing arrangements recorded in the Company&#8217;s consolidated statements of operations was $1,654 and $2,001 during the three months ended March&#160;31, 2025 and 2024, respectively. As of March&#160;31, 2025, the future contractual maturities of the Company&#8217;s long-term payment obligations by year are set forth in the following schedule:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Notes)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lease Commitments </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have any operating or finance leases greater than 12 months in duration as of March&#160;31, 2025.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Retirement Plans</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a 401(k) plan to its eligible employees. The Company matches participant contributions in an amount equal to 50% of each participant&#8217;s contribution up to 8% of the participant&#8217;s salary. The participants become vested in 20% annual increments after two years of service or fully vest upon the age of 60. Total expense for employer matching contributions during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#8217;s consolidated statements of operations as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Negative expense in Sales and Marketing due to our targeted workforce reduction that was announced in December, 2024 and executed in January 2025.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div>From time to time, the Company may become involved in lawsuits and various other legal proceedings that arise in the ordinary course of its business. Litigation is, however, subject to inherent uncertainties and an adverse result in any such litigation that may arise from time to time that may harm the Company&#8217;s business. The Company is currently not party to any legal proceedings or claims that it believes would or could have, individually or in the aggregate, a material adverse effect on the Company.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has 50,000,000 authorized shares of common stock and 10,000,000 authorized shares of preferred stock, each with a par value of $0.0001 per share. 500,000 shares of preferred stock are designated as Series A Junior Participating Preferred Stock.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 28, 2024, the Company announced that its Board of Directors had authorized a $5.0&#160;million share repurchase program of the Company&#8217;s common stock. In conjunction with the Cooperation Agreement signed on September 6, 2024, the repurchase maximum was raised to $10.0 million. On September 30, 2024, the Company entered into an agreement adopted under the safe harbor provided by Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The agreement assists the Company in implementing its stock repurchase programs, providing for the purchase of up to $9.0&#160;million, the remaining amount under its $10.0 million share repurchase program. Purchases under the Rule 10b5-1 plan commenced on November 1, 2024, and terminate on the earliest of May 15, 2025, until the aggregate number of shares are repurchased or upon certain other events. Purchases will be made from time to time, depending on market conditions, in open market or privately negotiated transactions, at prices deemed appropriate by management. As of March&#160;31, 2025, 401,480 shares had been repurchased under the active program with an average price per share of $2.61, for a total of $1.0 million. 767,335 shares have been purchased under expired and active programs with an average price per share of $2.65, for a total of $2.0&#160;million.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders approved an amendment and restatement of the 2011 Equity Incentive Plan at the Company&#8217;s 2024 Annual Meeting of Stockholders held on December 12, 2024, to increase the number of plan shares by 700,000 shares, from 3,675,000 to 4,375,000 shares. As of March&#160;31, 2025, the Company had 1,269,384 remaining shares of common stock available for issuance pursuant to future grants under the 2011 Equity Incentive Plan. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2011 Equity Incentive Plan, the Board determines the terms and conditions of each restricted stock issuance, including any future vesting restrictions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, the Company issued a total of 125,863 shares of restricted common stock with a grant date fair value of $0.3 million for their annual service as independent directors of the Company. The stock was granted in installments on the last day of each quarter and vested immediately.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the three months ended March&#160;31, 2025, the Company issued its six independent directors a total of 42,858 shares of restricted common stock, respectively, with an aggregate grant date valuation of $90,002 for their service as directors of the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about restricted stock issued during the years ended December&#160;31, 2024 and March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.177%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,863)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although restricted stock is issued upon the grant of an award, the Company excludes restricted stock from the computations within the financial statements of total shares outstanding and basic earnings per share until such time as the restricted stock vests. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses recognized on restricted stock issued to independent directors for services were $90,002 and $75,006 during the three months ended March&#160;31, 2025 and 2024, respectively. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;31, 2025, the fair value of the Company&#8217;s common stock was approximately $2.10 per share, and the intrinsic value of the non-vested restricted stock was $0.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board determines the terms and conditions of each restricted stock unit award issued under the 2011 Equity Incentive Plan. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2024, the Company issued a total of 474,195 time-based restricted stock units, initially valued at $980,632, as additional compensation: 346,918 restricted stock units initially valued at $0.7 million to non-executive employees and 127,277 restricted stock units initially valued at $0.3 million to executives. These restricted stock units have vesting periods ranging from 36 to 48 months from issuance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025, the Company issued a total of 47,280 time-based and performance-based restricted stock units, initially valued at $0.1 million, as additional compensation: 23,600 time-based restricted stock units, initially valued at $59,000, to non-executive employees and 23,680 time-based restricted stock units, initially valued at $59,200, to executives. These time-based restricted stock units have vesting periods ranging from 36 to 48 months from issuance. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The performance based restricted stock units include a market condition tied to the Company&#8217;s stock performance. These awards vest only if certain stock price targets are achieved over a specified performance period. Because the vesting is based on market conditions rather than service or financial performance metrics, the grant-date fair value was estimated using a Monte Carlo simulation model, which factors in stock volatility and other market-based assumptions. The expense is recognized over the requisite service period, regardless of whether the market condition is ultimately met.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about restricted stock units during the years ended December&#160;31, 2024, and the three months ended March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(956,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,958)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses recognized on restricted stock units issued to employees were $0.2 million and $0.3 million during the three months ended March&#160;31, 2025 and 2024, respectively. On March&#160;31, 2025, the fair value of the Company&#8217;s common stock was approximately $2.10 per share, and the intrinsic value of the non-vested restricted units was $2.6 million. Future compensation related to the non-vested restricted stock units as of March&#160;31, 2025, is $2.5 million, and it is estimated to be recognized over the weighted-average vesting period of approximately 1.25 years. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2011 Equity Incentive Plan, the Board determines the exercise price to be paid for the stock option shares, the period within which each stock option may be exercised, and the terms and conditions of each stock option. The exercise price of incentive and non-qualified stock options may not be less than 100% of the fair market value per share of the Company&#8217;s common stock on the grant date. If an individual owns stock representing more than 10% of the outstanding shares, the exercise price of each share of an incentive stock option must be equal to or exceed 110% of fair market value. Unless otherwise determined by the Board at the time of grant, the exercise price is set at the fair market value of the Company&#8217;s common stock on the grant date (or the last trading day prior to the grant date, if it is awarded on a non-trading day). Additionally, the term is set at ten years, and the option typically vest on a straight-line basis over the requisite service period as follows: 25% one year from the date of grant with the remaining vesting monthly in equal increments over the following three years. The Company issues new shares for any stock awards or options exercised under its 2011 Equity Incentive Plan. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2011 Equity Incentive Plan during the year ended December&#160;31, 2024, and the three months ended March&#160;31, 2025, is presented below: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,736&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2025 and the three months ended March 31, 2024, no options were exercised. The fair value of the Company's common stock on March&#160;31, 2025, was approximately $2.10 per share, and the intrinsic value on outstanding options as of March&#160;31, 2025, was $36. The intrinsic value of the exercisable options as of March&#160;31, 2025, was $36. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the nonvested stock option activity under the 2011 Equity Incentive Plan during the years ended December&#160;31, 2024, and March&#160;31, 2025, is presented below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Nonvested Options</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were outstanding options to purchase 31,147 shares</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a weighted average exercise price of $18.01 per share, of which options to purchase 30,736 shares were exercisable with a weighted average exercise price of $18.10 per share as of March&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenses recognized on stock options issued to employees during the three months ended March&#160;31, 2025 and 2024 were $7,501 and $51,965, respectively. Future compensation related to non-vested awards as of March&#160;31, 2025, is $1,862, and it is estimated to be recognized over the weighted-average vesting period of approximately 3.7 years.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inducement Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 30, 2023, the Board of Directors adopted the IZEA Worldwide, Inc. 2023 Inducement Plan (the &#8220;Inducement Plan&#8221;) to accommodate equity grants to new employees hired by IZEA in connection with acquisition transactions, including the Hoozu acquisition. Under the Inducement Plan, IZEA may grant restricted stock units (&#8220;RSUs&#8221;), including performance-based and time-based RSUs, with respect to up to a total of 1,800,000 shares of IZEA common stock to new employees of IZEA or its subsidiaries. Pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules, the Inducement Plan was adopted without stockholder approval. In accordance with Rule 5635(c)(4) of the NASDAQ Listing Rules, awards under the Inducement Plan can only be made to individuals not previously employees or non-employee directors of IZEA (or following such individuals&#8217; bona fide period of non-employment with IZEA), as an inducement material to the individuals&#8217; entry into employment with IZEA or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the NASDAQ Listing Rules. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about inducement grant-related RSUs during the year ended December 31, 2024, and the three months ended March&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inducement Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Time-Based</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Based</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,354</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,354</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,355</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,355</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,355)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328,354)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(507,709)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at March 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inducement shares forfeited in 2024 were related to the divestiture of Hoozu in December, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amended and restated IZEA Worldwide, Inc. 2014 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) provides for the issuance of up to 125,000 shares of the Company&#8217;s common stock to employees regularly employed by the Company for 90 days or more on a full-time or part-time basis (20 hours or more per week on a regular schedule). The ESPP operates in successive six-month periods commencing at the beginning of each fiscal year half. Each eligible employee who elects to participate may purchase up to 10% of their annual compensation in common stock, not to exceed $21,250 annually or 2,000 shares per offering period. The purchase price will be the lower of (i) 85% of the fair market value of a share of common stock </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the first day of the offering period or (ii) 85% of the fair market value of a share of common stock on the last day of the offering period. The ESPP will continue until January&#160;1, 2028, unless otherwise terminated by the Board. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock compensation expense on ESPP options was $10,789 and $1,010 for the three months ended March&#160;31, 2025, and 2024, respectively. As of March&#160;31, 2025, there were 77,931 remaining shares of common stock available for future issuance under the ESPP. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Rights Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 28, 2024, the Board of Directors declared a dividend of one preferred share purchase right (a &#8220;Right&#8221;) for each share of the Company&#8217;s common stock as of June 7, 2024 (the &#8220;Record Date&#8221;), pursuant to a Rights Agreement between the Company and Broadridge Corporate Issuer Solutions, LLC, as Rights Agent.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Right initially entitles the holder to purchase one one-thousandth of a share of Series A Junior Participating Preferred Stock at a price of $8.25, subject to adjustment. The Rights are not exercisable until the earlier of (i) the tenth business day after a person or group acquires 15% or more of the Company&#8217;s common stock, or (ii) the tenth business day after a tender or exchange offer is announced that would result in such ownership (the &#8220;Distribution Date&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Distribution Date, the Rights trade with the common stock and are not evidenced by separate certificates. Following the Distribution Date, the Rights will separate and be evidenced by Right Certificates mailed to the stockholders of record.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rights will expire on May 28, 2025, unless earlier redeemed, exchanged, or terminated under the terms of the Rights Agreement.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary is qualified in its entirety by reference to the full Rights Agreement, filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, filed with the SEC on May 28, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock-based compensation cost related to all awards granted to employees is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the employee&#8217;s requisite service period utilizing the weighted-average forfeiture rates as disclosed in &#8220;Note 1 Company and Summary of Significant Accounting Policies.&#8221; Total stock-based compensation expense recognized on restricted stock, restricted stock units, stock options, and employee stock purchase plan issuances during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#8217;s consolidated statements of operations as follows: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,270)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,189&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense for the Sales and Marketing department due to the targeted workforce reduction that occurred in January 2025. This is due to the reversal of previously recognized expense for unvested awards that are forfeited upon termination. Because we recognize stock compensation on a straight-line basis over the vesting period&#8212;rather than when the shares actually vest&#8212;expenses related to unvested awards are recorded in advance of full service being rendered. When employees depart before completing their vesting schedules, any unrecognized expense is reversed.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize activity in other comprehensive income (loss) for unrealized gains and losses on securities and foreign currency translation adjustments.&#160;The activity in&#160;accumulated other comprehensive income&#160;(loss) for the three months ended 2025, and 2024, respectively, was as follows:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation  Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassification of foreign currency translation adjustment to income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,218)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,218)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,075)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192,414)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,244)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per Common Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss per Common Share</a></td>
<td class="text">LOSS PER COMMON SHARE<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings (loss) per common share is computed by dividing the net income or loss by the basic weighted average number of shares of common stock outstanding during each period presented. Although restricted stock is issued upon the grant of an award, the Company excludes restricted stock from the computations of the weighted average number of shares of common stock outstanding until the stock vests. Diluted loss per share is computed by dividing the net income or loss by the sum of the total of the basic weighted-average number of shares of common stock outstanding plus the additional dilutive securities that could be exercised or converted into common shares during each period presented less the amount of shares that could be repurchased using the proceeds from the exercises.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:58.219%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265,850)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic and diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,927,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,333,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted loss per common share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following weighted average items from the above computation of diluted loss per common share, as their effect would be anti-dilutive: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.518%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total excluded shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,280,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717,527&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">REVENUE<div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the Company&#8217;s revenue by product service type:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,907,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS Services Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed Services revenue is comprised of two types of revenue, Sponsored Social and Content. Sponsored Social revenue, which totaled $6.8 million for the three months ended March&#160;31, 2025 and $5.9 million for the three months ended March&#160;31, 2024, is recognized over time. Content revenue, which totaled $1.1&#160;million during the three months ended March&#160;31, 2025, and $0.8 million for the three months ended March&#160;31, 2024, is recognized at a point in time.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SaaS Revenue is comprised of three types of revenue, License Fees, Marketplace Spend Fees, and Other Fees. License Fees revenue, which totaled $28.7&#160;thousand for the three months ended March&#160;31, 2025 and $217.0 thousand for the three months ended March&#160;31, 2024, is recognized over time. Marketplace Spend Fees revenue totaled $1.3 thousand for the three months ended March&#160;31, 2025 and $13.1 thousand for the three months ended March&#160;31, 2024, recognized over time. Other </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fees revenue totaled $31.0 thousand during the three months ended March&#160;31, 2025 and $26.2 thousand for the three months ended March&#160;31, 2024, recognized at a point in time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the Company&#8217;s revenues as determined by customer geographic region:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from North America</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,628,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,490,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from APAC</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Assets and Liabilities</span></div><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about receivables, contract assets, and contract liabilities from contracts with customers reported in the Company&#8217;s consolidated balance sheet:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Billed Contract Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,835,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled Contract Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,095,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,188,651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not typically engage in contracts longer than one year. Therefore, the Company will recognize substantially all of the contract liabilities recorded at the end of the year in the following year. The contract liability balance as of December&#160;31, 2024, was $8.2 million. Of that balance, $5.1 million was recognized as revenue during the three months ended March&#160;31, 2025. The contract liability balance as of March&#160;31, 2025, was $7.1 million. The Company expects to recognize the associated revenue during the next twelve months. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract receivables are recognized when the receipt of consideration is unconditional. Contract liabilities relate to the consideration received from customers in advance of the Company satisfying performance obligations under the terms of the contracts, which will be earned in future periods. Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized upon the Company meeting the performance obligations. As a practical expedient, the Company expenses the costs of sales commissions that are paid to its sales force associated with obtaining contracts that are less than one year in length in the period incurred.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to most of the Company&#8217;s contracts being one year or less in length. As such, the remaining performance obligations at March&#160;31, 2025 and December&#160;31, 2024, are equal to the contract liabilities disclosed above. The Company expects to recognize the full balance of the unearned revenue from March&#160;31, 2025 within the subsequent twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure</a></td>
<td class="text">SEGMENT DISCLOSURES<div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#8220;Managed Services&#8221;). Our Chief Operating Decision Maker (&#8220;CODM&#8221;) is our Chief Executive Officer (&#8220;CEO&#8221;). We evaluate our financial performance based on the results of one reportable operating segment, as defined by ASC 280.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM monitors revenue growth and profitability trends to assess market demand, pricing strategies, new customer growth, current customer retention and expansion, and growth by market vertical. Personnel cost trends are studied to assess efficiency, efficacy of incentive programs, and to determine the need for headcount adjustments. Cash operating cost trends inform how non-payroll costs are impacting cash resources. Taken together, net income is the ultimate measure of performance, or investment in growth. Resource allocation decisions include funding new technologies, additional headcount to drive and manage growth, informing cost management strategies and evaluating financing needs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table depicts reportable segment results reviewed by the CODM:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue-direct</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,337,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,753,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human capital costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,943,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other cash operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,757,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(490,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred federal tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Loss</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,800)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265,850)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following descriptions provide additional details regarding certain components represented in the accompanying table, including cost of revenue, human capital costs, and cash operating costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue includes the direct costs associated with providing our services to customers. These costs primarily consist of influencer fees and other costs directly tied to the fulfillment of customer contracts. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Human capital costs represent expenses related to our employees, including salaries, wages, bonuses, commissions, payroll taxes, and employee benefits.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other cash operating expenses refer to the recurring operating costs of running the business, excluding non-cash items such as depreciation, amortization, and stock-based compensation. These expenses include professional services, software subscriptions, travel, and other general business costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income includes interest expense, net realized gains (losses) on the sale of securities and cryptocurrency, as well as realized gains (losses) on foreign exchange transactions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAX<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for interim periods is determined using an estimated annual effective tax rate in accordance with ASC 740-270, Income Taxes, Interim Reporting. The effective tax rate may be subject to fluctuations during the year as new information is obtained, which may affect the assumptions used to estimate the annual effective tax rate, including factors such as valuation allowances against deferred tax assets, the recognition or de-recognition of tax benefits related to uncertain tax position, if any, and changes in or the interpretation of tax laws in jurisdictions where the Company conducts business.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax expense and effective tax rate were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">SUBSEQUENT EVENTS<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company has completed an evaluation of all subsequent events through May&#160;13, 2025, to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements and events that occurred but were not recognized in the consolidated financial statements. The Company has concluded that no subsequent event has occurred that requires disclosure.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_NatureOfBusinessPolicyTextBlock', window );">Nature of Business</a></td>
<td class="text">Nature of Business<div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IZEA Worldwide, Inc. (together with its wholly-owned subsidiaries, &#8220;IZEA&#8221; or the &#8220;Company&#8221;) is a Nevada corporation founded in February 2006 under the name PayPerPost, Inc. and became a public company in May 2011. In March 2016, the Company formed IZEA Canada, Inc., a wholly-owned subsidiary incorporated in Ontario, Canada. In December 2023, IZEA purchased all of Hoozu Holdings' outstanding shares of capital stock, which it subsequently divested in December 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company helps power the creator economy by enabling individuals to monetize their content, creativity, and influence through global brands and marketers. IZEA compensates these creators for producing unique content, such as long and short-form text, videos, photos, status updates, and illustrations for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#8220;Managed Services&#8221;). While the majority of the marketers engage the Company to perform the Managed Services on their behalf, marketers may also access IZEA&#8217;s marketplaces to engage creators for influencer marketing campaigns or to produce custom content on a self-service basis by licensing the Company&#8217;s technology.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">Basis of Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated balance sheet as of March&#160;31, 2025, the consolidated statements of operations for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of comprehensive loss for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of stockholders' equity for the three months ended March&#160;31, 2025 and 2024, and the consolidated statements of cash flows for the three months ended March&#160;31, 2025 and 2024 are unaudited but include all adjustments that are, in the opinion of management, necessary for a fair presentation of its financial position at such dates and its results of operations and cash flows for the periods then ended in conformity with generally accepted accounting principles in the United States ("GAAP"). The consolidated balance sheet as of December&#160;31, 2024 has been derived from the audited consolidated financial statements at that date but, in accordance with the rules and regulations of the SEC, does not include all of the information and notes required by GAAP for complete financial statements. Operating results for the three months ended March&#160;31, 2025 are not necessarily indicative of results that may be expected for the entire fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December&#160;31, 2024, included in the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2025.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Principles of Consolidation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of IZEA Worldwide, Inc. and its wholly-owned subsidiaries subsequent to the subsidiaries&#8217; acquisition, merger, or formation dates, as applicable. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cash and Cash Equivalents</span></div>The Company considers all highly liquid investments purchased with an original maturity of three months or less from the date of purchase to be cash equivalents. Deposits made to Company bank accounts are insured by the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) up to a maximum amount of $250,000. The Canada Deposit Insurance Corporation (&#8220;CDIC&#8221;) insures deposits made to the Company&#8217;s bank accounts in Canada up to CAD 100,000. Deposit balances exceeding the various limits were approximately $50.0 million and $44.2 million as of March&#160;31, 2025 and December&#160;31, 2024, respectively.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Accounts Receivable and Concentration of Credit Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s accounts receivable balance consists of trade receivables, contract assets, and a reserve for doubtful accounts. Trade receivables are customer obligations due under normal trade terms. Contract assets represent amounts owed for work performed but not yet billed. The Company had net trade receivables of $4.3 million, including $4.2 million of accounts </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivable and contract assets of $61,480 on March&#160;31, 2025. The Company had net trade receivables of $7.8 million, including $7.6 million of accounts receivable and contract assets of $0.2 million on December&#160;31, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer&#8217;s financial condition, credit history, and current economic conditions. We will continue to monitor these factors and adjust our credit and collection policies as necessary to address evolving market conditions and potential risks to financial performance. An account is deemed delinquent when the customer has not paid an amount due by its associated due date. If a portion of the account balance is deemed uncollectible, the Company will either write off the amount owed or provide a reserve based on its best estimate of the uncollectible portion of the account. We assess collectability risk both generally and by specific aged invoices. Our loss history informs a general reserve percentage, which we apply to all invoices less than 90 days from the invoice due date, currently 1% of the outstanding balance. The general reserve, which we update periodically, recognizes that some invoices will likely become a collection risk. When an invoice ages 90 past its due date, we consider each invoice to determine a reserve for collectability based on our prior history and recent communications with the customer, to determine a reserve amount. Generally, our reserve for such aged invoices will approach 100% of the invoice amount. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had a reserve for doubtful accounts of $0.2 million as of March&#160;31, 2025, and $0.2 million as of December&#160;31, 2024. Management believes this estimate is reasonable, but there can be no assurance that the estimate will not change due to economic or business conditions within the industry, the individual customers, or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. The Company did not recognize any bad debt expense in the three months ended March&#160;31, 2025 and March&#160;31, 2024.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company&#8217;s customer base, thus spreading the trade credit risk. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. The Company had three customers that each accounted for more than 10% of total accounts receivable on March&#160;31, 2025 and two customers that accounted for more than 10% of total accounts receivable on December&#160;31, 2024. The Company had three customers that each accounted for more than 10% of its revenue during the three months ended March&#160;31, 2025, and one customer that accounted for more than 10% of its revenue during the three months ended March&#160;31, 2024.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Property and Equipment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are recorded at cost, or if acquired in a business combination, at the acquisition date fair value. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and Fixtures</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 10 years</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the year of disposal, with resulting gains or losses included in general and administrative expense in the consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsFiniteLivedPolicy', window );">Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Intangible Assets</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-08, Intangibles&#8212;Goodwill and Other&#8212;Crypto Assets (Subtopic 350-60), which requires certain crypto assets to be measured at fair value each reporting period, with changes recognized in net income. It also introduces new disclosure requirements, including asset name, fair value, units held, cost basis, and annual reconciliations. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance early and sold all digital assets in September 2024. As of March 31, 2025, no digital assets were held, and no impairments were recognized for the three months ended March 31, 2025 or 2024.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets, including capitalized software and intangible assets, for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable. Impairments are recognized when the asset&#8217;s fair value is less than its carrying amount. In connection with the Company&#8217;s 2024 reorganization and divestitures, all acquired intangible assets were written off. See &#8220;Note 5 &#8211; Intangible Assets&#8221; for additional details.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">Software Development Costs</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Software Development Costs</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Codification (&#8220;ASC&#8221;) 350-40,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Use Software,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i)&#160;the research and planning </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stage, (ii)&#160;the application and development stage, and (iii)&#160;the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. The Company also capitalizes costs related to cloud computing arrangements (&#8220;CCAs&#8221;). These software developments and CCA costs are amortized on a straight-line basis over the estimated useful life of five years upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess carrying value over the fair value in its consolidated statements of operations. In December 2024, the Company reviewed its software assets, wrote off fully amortized balances no longer active, and accelerated the amortization of certain software assets no longer in use, with further details provided in "Note 6 - Software Development Costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-02,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, established a right-of-use model that requires a lessee to record a right-of-use asset and a right-of-use liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company does not record leases on the balance sheet with a lease term of 12 months or less at the commencement date.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Revenue Recognition</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue primarily from Managed Services when a marketer (typically a brand, agency, or partner) pays us to provide custom content, influencer marketing, amplification, or other campaign management services (&#8220;Managed Services&#8221;); additionally, we generate revenue from subscription fees charged to access our software platforms, license and transaction fees from self-service customers, and fees from such as inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#8220;SaaS Services Revenue&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 606&#8221;). Under ASC 606, revenue is recognized based on a five-step model as follows: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) performance obligations are satisfied. The core principle of ASC 606 is that revenue is recognized when the transfer of promised goods or services to customers is made in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are distinct performance obligations. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also determines whether it acts as an agent or a principal for each identified performance obligation. The determination of whether the Company acts as principal or agent is highly subjective and requires the Company to evaluate a number of indicators individually and as a whole in order to make its determination. For transactions in which the Company acts as a principal, revenue is reported on a gross basis as the amount paid by the marketer for the purchase of content or sponsorship, promotion, and other related services, and the Company records the amounts it pays to third-party creators as cost of revenue. For transactions in which the Company acts as an agent, revenue is reported on a net basis as the amount the Company charged to the self-service marketer using the Company&#8217;s platforms, less the amounts paid to the third-party creators providing the service.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains separate arrangements with each marketer and content creator either in the form of a master agreement or terms of service, which specify the terms of the relationship and access to its platforms, or by a statement of work, which specifies the price and the services to be performed, along with other terms. The transaction price is determined based on the fixed fee stated in the statement of work and does not contain variable consideration. Marketers who contract with the Company to manage their advertising campaigns or custom content requests may prepay for services or request credit terms. Payment terms are typically 30 days from the invoice date. The agreement typically provides for either a non-refundable deposit or a cancellation fee if the agreement is canceled by the customer prior to the completion of services. Billings in advance of completed services are recorded as a contract liability until earned. The Company assesses collectability based on several factors, including the creditworthiness of the customer and payment and transaction history.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not typically engage in contracts that are longer than one year. Therefore, the Company does not capitalize costs to obtain its customer contracts as these amounts generally would be recognized over a period of less than one year and are not material. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Services Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Managed Services Revenue, the Company enters into an agreement to provide services that may include multiple distinct performance obligations in the form of (i) an integrated marketing campaign to provide influencer marketing services, which may include the provision of blogs, tweets, photos, or videos shared through social network offerings and content promotion, such as click-through advertisements appearing in websites and social media channels, and (ii) custom content items, such as a research or news articles, informational material or videos. Marketers typically purchase influencer marketing services to provide public awareness or advertising buzz regarding the marketer&#8217;s brand and purchase custom content for internal and external use.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company views its obligation to deliver influencer marketing services, including management services, as a single performance obligation that is satisfied over time as the customer receives the benefits from the services. The majority of revenue is recognized using an input method of costs incurred compared to total expected costs to measure the progress toward satisfying the overall performance obligation of the marketing campaign. The Company&#8217;s performance obligation in certain contracts with customers may be a stand-ready promise to provide influencer marketing services for an unknown or unspecified quantity of deliverables for a specified term. Under a stand-ready obligation, the Company&#8217;s performance obligation is satisfied over time throughout the contract term, and therefore, revenue is recognized straight-line over the life of the contract. The Company may provide one type or a combination of all types of these influencer marketing services on a statement of work for a lump sum fee. When multiple performance obligations exist in a contract, the Company allocates revenue to each distinct performance obligation at contract inception based on its relative standalone selling price. These performance obligations are to be provided over a period that generally ranges from one day to one year. The delivery of custom content represents a distinct performance obligation that is satisfied at a point in time when each piece of content is delivered to the customer. Based on the Company&#8217;s evaluations, revenue from Managed Services is reported on a gross basis because the Company has the primary obligation to fulfill the performance obligations, and it creates, reviews, and controls the services. The Company takes on the risk of payment to any third-party creators and establishes the contract price directly with its customers based on the services requested in the statement of work.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SaaS Services Revenue</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SaaS services revenue includes subscription fees charged to access our software platforms, license and transaction fees from self-service customers, inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#8220;SaaS Services Revenue&#8221;). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscription and license revenue is generated by granting customers limited, non-exclusive, non-transferable access to the Company&#8217;s technology platforms for an agreed-upon subscription period. Customers access the platforms to manage their influencer marketing campaigns. Fees for subscription or licensing services are recognized straight-line over the term of the service. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Self-service customers instruct creators found through the Company&#8217;s platforms to provide and/or distribute custom content for an agreed-upon transaction price. The Company&#8217;s platforms control the contracting, description of services, acceptance of, and payment for the requested content. This service is used primarily by news agencies or marketers to control the outsourcing of their content and advertising needs. The Company charges the self-service customer the transaction price plus a fee based on the contract (&#8220;Marketplace Spend Fees&#8221;). Revenue is recognized when the transaction is completed by the creator and accepted by the marketer or verified as posted by the system. Based on the Company&#8217;s evaluations, this revenue is reported on a net basis since the Company is acting as an agent through its platform for the third-party creator to provide the services or content directly to the self-service customer or to post approved content through one or more social media platforms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Fees Revenue is generated when fees are charged to the Company&#8217;s platform users primarily related to monthly plan fees, which are recognized within the month they relate to.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Advertising Costs</span></div>Advertising costs are charged to expense as they are incurred, including payments to content creators to promote the Company. Advertising costs charged to operations for the three months ended March&#160;31, 2025, and 2024 were approximately $5 thousand and $617.5 thousand, respectively. Advertising costs are included in sales and marketing expenses in the accompanying consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Income Taxes</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes are accounted for using the balance sheet approach, which requires recognizing deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the assets and liabilities tax basis. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized. The Company incurs state franchise tax in ten states, which is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits, and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company&#8217;s tax years subject to examination based on the statute of limitations by the IRS is generally three years; however, the IRS may examine records and other evidence from the year the net operating loss was generated when the Company utilizes net operating loss carryforwards in future periods. The Company&#8217;s tax years subject to examination by the Canadian Revenue Agency is generally four years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on quoted market prices in active markets for identical assets and liabilities.</span></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on quoted market prices for similar assets and liabilities in active markets.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management&#8217;s best estimate of what market participants would use as fair value.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. As of March&#160;31, 2025, the Company holds Level 1 and Level 2 financial assets; this is discussed further in Note 3 - Financial Instruments of Notes to the Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Stock-Based Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation for options granted under the 2011 Equity Incentive Plan and the 2023 Inducement Plan is measured at grant-date fair value and expensed on a straight-line basis over the requisite service period. Fair value is estimated using the Black-Scholes model. The Company applies the simplified method to estimate the expected term, assuming even exercise between vesting and expiration, and uses the grant-date closing stock price as the fair value of common stock. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates forfeitures when recognizing compensation expense, and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and a revised amount of unamortized compensation expense to be recognized in future periods.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may issue restricted stock or restricted stock units (&#8220;RSUs&#8221;) that vest over time, including up to 1,800,000 performance- or time-based RSUs granted under the IZEA Inducement Plan adopted on November 30, 2023. The plan was established to provide equity awards to new employees hired through acquisitions transactions. These awards are recorded at fair value on the grant date and expensed on a straight-line basis over the vesting period. See &#8220;Note 10 Stockholder&#8217;s Equity&#8221; for more details.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations Policy</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Business Combinations and Asset Acquisitions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for business combinations in accordance with Accounting Standards Codification (ASC) Topic 805, &#8220;Business Combinations.&#8221; The acquisition method of accounting is applied to all business combinations, whereby the identifiable assets acquired, liabilities assumed, and any non-controlling interests in the acquiree are recognized and measured at their fair values as of the acquisition date. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets acquired and liabilities assumed in a business combination. Goodwill is allocated to reporting units, </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which are expected to benefit from the synergies of the combination and is subject to annual impairment testing. Acquisition-related costs, including advisory, legal, and due diligence fees, are expensed as incurred and are included in general and administrative expenses in the period in which the acquisition occurs. The financial statements include the results of operations and the financial position of businesses acquired from their respective acquisition dates. Any adjustments to the preliminary fair values of assets acquired and liabilities assumed, known as measurement period adjustments, are recorded during the period of the adjustment.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Recently Issued Accounting Pronouncements</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Segment Reporting: Improvements to Reportable Segment Disclosures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2023, the FASB issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improving Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This update is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The ASU also requires all annual disclosures currently required by Topic 280 to be included in the interim periods. The update is effective for fiscal years beginning after December 15, 2023, and interim periods within the fiscal years beginning after December 15, 2024, with early adoption permitted and requiring retrospective application to all prior periods presented in the financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Income Taxes: Improvements to Income Tax Disclosures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company adopted this ASU for the annual period beginning on January 1, 2025 and does not expect a material impact on the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Disaggregation of Income Expenses:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2024, the FASB issued ASU No. 2024-03 (Subtopic 220-40) Disaggregation of Income Expenses, which requires entities to provide enhanced disclosures related to certain disclosures related to certain expense categories included in the income statement. The update is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company is currently assessing the timing and impact of adopting the updated provisions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_NatureOfBusinessPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature of Business [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_NatureOfBusinessPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479515/805-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsFiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 920<br> -SubTopic 350<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478609/920-350-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsFiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-40/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/730/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and Fixtures</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 10 years</span></div></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following: </span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s cash, cash equivalents, and marketable securities by significant investment category as of March&#160;31, 2025:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:31.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.767%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted Cost</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Gains</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and Cash Equivalents</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current Marketable Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,623,346&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">US Treasury securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,010,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,999,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,997,569&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,989,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset back securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,186,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,184,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,612,348&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,572,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current Marketable Securities have a holding period under <span style="-sec-ix-hidden:f-398">one</span> year.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">      (2)     </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 1 fair value estimates are based on quoted prices in active markets for identical assets and liabilities.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;padding-left:7.44pt;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock', window );">Fair Value of Investments in Marketable Debt Securities</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the estimated fair value of investments in marketable debt securities by stated contractual maturity dates:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March&#160;31, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December&#160;31, 2024</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,427,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572,233&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,427,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents fair values and net unrealized gains (losses) recorded to OCI, aggregated by investment category:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:32.429%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Unrealized Gain (Loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,612,348&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,644,468&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,685)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">563,666&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,430,539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,184,581&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,071,956&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value of Investments in Marketable Debt Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer Equipment</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office Equipment</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 10 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and Fixtures</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 - 10 years</span></div></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consist of the following: </span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(235,653)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(212,698)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,574&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Software Development Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Software development costs consist of the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896,099&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(946,835)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(809,439)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086,660&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Future Amortization Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2025, future estimated amortization expense related to software development costs is set forth in the following schedule:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Software Development Amortization Expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374,767&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2030</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,098,571&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consist of the following: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,338,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189,531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,573&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,081,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734,123&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt">During the quarter ended September 30, 2024, the Company announced the departure of two executives. In accordance with their Separation Agreements and the payments they are entitled to receive, a severance amount of $0.9&#160;million was accrued and will be paid over a twelve-month period. In December 2024, in conjunction with a targeted workforce reduction, the Company accrued $0.3&#160;million in severance costs to be paid in January 2025. As of March 31, 2025, the remaining balance for severance accrued is $0.4&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text">As of March&#160;31, 2025, the future contractual maturities of the Company&#8217;s long-term payment obligations by year are set forth in the following schedule:<div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,836&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,573&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock', window );">Defined Contribution Plan Disclosures</a></td>
<td class="text">Total expense for employer matching contributions during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#8217;s consolidated statements of operations as follows: <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,524)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total contribution expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,332&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,101&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Negative expense in Sales and Marketing due to our targeted workforce reduction that was announced in December, 2024 and executed in January 2025.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Nonvested Restricted Stock Shares Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about restricted stock issued during the years ended December&#160;31, 2024 and March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:50.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.177%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125,863)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,858)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Nonvested Restricted Stock Units Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about restricted stock units during the years ended December&#160;31, 2024, and the three months ended March&#160;31, 2025:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.838%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962,849&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858,023&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(956,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(305,821)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,958)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249,178&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.32&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of option activity under the 2011 Equity Incentive Plan during the year ended December&#160;31, 2024, and the three months ended March&#160;31, 2025, is presented below: </span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,601&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,154)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244,588)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,736&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.10&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock', window );">Schedule of Nonvested Share Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the nonvested stock option activity under the 2011 Equity Incentive Plan during the years ended December&#160;31, 2024, and March&#160;31, 2025, is presented below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Nonvested Options</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant Date<br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Years<br/>to Vest</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,728)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at December 31, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.60&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested at March 31, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.01&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock', window );">Share-Based Payment Arrangement, Performance Shares, Outstanding Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table contains summarized information about inducement grant-related RSUs during the year ended December 31, 2024, and the three months ended March&#160;31, 2025.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inducement Shares</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Time-Based</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Performance Based</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328,354</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,354</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,355</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,355</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,355)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328,354)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(507,709)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grant Outstanding at March 31, 2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award</a></td>
<td class="text">Total stock-based compensation expense recognized on restricted stock, restricted stock units, stock options, and employee stock purchase plan issuances during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#8217;s consolidated statements of operations as follows: <div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,571&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,270)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,132&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,189&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense for the Sales and Marketing department due to the targeted workforce reduction that occurred in January 2025. This is due to the reversal of previously recognized expense for unvested awards that are forfeited upon termination. Because we recognize stock compensation on a straight-line basis over the vesting period&#8212;rather than when the shares actually vest&#8212;expenses related to unvested awards are recorded in advance of full service being rendered. When employees depart before completing their vesting schedules, any unrecognized expense is reversed.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">The activity in&#160;accumulated other comprehensive income&#160;(loss) for the three months ended 2025, and 2024, respectively, was as follows:<div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation  Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassification of foreign currency translation adjustment to income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Gain (Loss) on Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Currency Translation Adjustment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Accumulated Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,209&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,218)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250,591)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,903)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123,362)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,694)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,218)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,075)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192,414)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,244)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:58.219%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.574%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265,850)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic and diluted</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,927,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,333,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted loss per common share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.20)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following weighted average items from the above computation of diluted loss per common share, as their effect would be anti-dilutive: </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.518%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343,244&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total excluded shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,280,325&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717,527&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table illustrates the Company&#8217;s revenue by product service type:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Services Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,907,410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SaaS Services Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the Company&#8217;s revenues as determined by customer geographic region:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.110%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from North America</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,628,344&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,490,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from APAC</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,027,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from Other</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434,609&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Schedule of Contract with Customer</a></td>
<td class="text"><div style="margin-top:5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about receivables, contract assets, and contract liabilities from contracts with customers reported in the Company&#8217;s consolidated balance sheet:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Billed Contract Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,400,418&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,835,041&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unbilled Contract Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(192,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract Liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,095,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,188,651)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table depicts reportable segment results reviewed by the CODM:</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.375%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,968,363&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,952,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue-direct</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,337,826&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,753,852&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human capital costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,943,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other cash operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,757,159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(490,908)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(671,517)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred federal tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,782)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,145)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,158)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Net Loss</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142,800)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,265,850)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s income tax expense and effective tax rate were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit (expense)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash, uninsured amount</a></td>
<td class="nump">$ 50,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash, FDIC insured amount</a></td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CashCDICInsuredAmount', window );">Cash, CDIC Insured Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CashCDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash, CDIC Insured Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CashCDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies - Accounts Receivable and Concentration of Credit Risk (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease', window );">Bad debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, after Allowance for Credit Loss, Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_AccountsReceivableExcludingContractAsset', window );">Accounts Receivable excluding Contract Asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable', window );">Contract with Customer, Asset, Reclassified to Receivable</a></td>
<td class="nump">61,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Accounts receivable, net</a></td>
<td class="nump">4,269,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,781,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts receivable</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue', window );">Accounts Receivable, Noncurrent, Threshold Period Past Due</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivablePercentPastDue1', window );">Financing Receivable, Percent Past Due</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer Concentration Risk | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer Concentration Risk | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_AccountsReceivableExcludingContractAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable excluding Contract Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_AccountsReceivableExcludingContractAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period for when accounts receivable, classified as noncurrent, is considered past due, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes threshold period past due to write off as uncollectible.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetReclassifiedToReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetReclassifiedToReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablePercentPastDue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of financing receivable balance that is past due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablePercentPastDue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=izea_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=izea_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=izea_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=izea_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies - Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_SignificantAccountPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_SignificantAccountPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_SignificantAccountPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_SignificantAccountPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_SignificantAccountPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_SignificantAccountPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Account Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_SignificantAccountPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies - Software Development Costs (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_AmortizationPeriodOfSoftwareDevelopmentCosts', window );">Amortization period of software development costs (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_AmortizationPeriodOfSoftwareDevelopmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Period Of Software Development Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_AmortizationPeriodOfSoftwareDevelopmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies - Revenue Recognition (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_InvoicePaymentTerms', window );">Invoice payment terms</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers', window );">Contract assets and contract liabilities length of agreement with customers</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract Assets And Contract Liabilities Length Of Agreement With Customers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_InvoicePaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Invoice Payment Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_InvoicePaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies - Advertising Costs (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_SignificantAccountPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 617,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_SignificantAccountPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Account Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_SignificantAccountPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Company and Summary of Significant Accounting Policies - Stock-Based Compensation (Details)<br></strong></div></th>
<th class="th">
<div>Nov. 30, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_SignificantAccountPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)</a></td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_SignificantAccountPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Account Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_SignificantAccountPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Acquisitions - Additional Information (Details) - Hoozu Holding PTY Ltd. - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 01, 2023</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to Acquire Businesses, Gross</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=izea_HoozuHoldingPTYLtd.Member', window );">Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Payment for divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,529<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashDivestedFromDeconsolidation', window );">Cash Divested from Deconsolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts', window );">Loss of divesiture of business net of transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred Income Taxes and Tax Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_LossOfDivesitureOfBusinessNetOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss of divesiture of business net of transaction costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_LossOfDivesitureOfBusinessNetOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashDivestedFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashDivestedFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=izea_HoozuHoldingPTYLtd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=izea_HoozuHoldingPTYLtd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=us-gaap_SegmentDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Marketable Securities by Significant Investment Category (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 52,186,275<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,694)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52,184,581<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,612,348<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 44,644,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Current Marketable Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,572,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6,427,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,623,346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,623,346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,623,346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">44,999,254<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(1,685)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">44,997,569<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">43,989,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Current Marketable Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">1,008,567<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commercial paper</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">43,989,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">43,989,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">43,989,002<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | US Treasury securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,010,252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(1,685)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1,008,567<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Current Marketable Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">1,008,567<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">563,675<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">563,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Current Marketable Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">563,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Asset back securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Current Marketable Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">563,675<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(9)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">563,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Current Marketable Securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">$ 563,666<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Current Marketable Securities have a holding period under <span style="-sec-ix-hidden:f-398">one</span> year</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 1 fair value estimates are based on quoted prices in active markets for identical assets and liabilities.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;padding-left:7.44pt;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_HoldingPeriodOfMarketableSecurities', window );">Holding period of marketable securities</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainOnSaleOfInvestments', window );">Gain on Sale of Investments</a></td>
<td class="nump">$ 23,799<span></span>
</td>
<td class="nump">$ 810<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_HoldingPeriodOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Holding period of marketable securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_HoldingPeriodOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Fair Value of Marketable Debt Securities (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Due in 1 year or less</a></td>
<td class="nump">$ 1,572,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 6,427,488<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">$ 1,572,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 6,427,488<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Current Marketable Securities have a holding period under <span style="-sec-ix-hidden:f-398">one</span> year</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Fair Value and Net Unrealized Gains (Losses) By Investment in OCI (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FinancialAssetsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">$ 52,184,581<span></span>
</td>
<td class="nump">$ 51,071,956<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Net Unrealized Gain (Loss)</a></td>
<td class="num">(1,694)<span></span>
</td>
<td class="nump">12,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FinancialAssetsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">50,612,348<span></span>
</td>
<td class="nump">44,644,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Net Unrealized Gain (Loss)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US Treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FinancialAssetsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">1,008,567<span></span>
</td>
<td class="nump">998,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Net Unrealized Gain (Loss)</a></td>
<td class="num">(1,685)<span></span>
</td>
<td class="num">(5,103)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FinancialAssetsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">563,666<span></span>
</td>
<td class="nump">4,430,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Net Unrealized Gain (Loss)</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(5,180)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset back securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FinancialAssetsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">998,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax', window );">Net Unrealized Gain (Loss)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_FinancialAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Assets, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_FinancialAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 316,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 316,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(235,653)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(212,698)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">80,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,574<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">22,955<span></span>
</td>
<td class="nump">$ 26,557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">29,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">8,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 277,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 277,918<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=izea_DigitalAssetsMember', window );">Digital Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net of accumulated depreciation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Gain (Loss) on Disposition of Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=izea_DepreciationandAmortizationExpenseMember', window );">Depreciation and Amortization Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 49,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=izea_DigitalAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=izea_DigitalAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=izea_DepreciationandAmortizationExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=izea_DepreciationandAmortizationExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Software Development Costs - Schedule of Software Development Cost (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Software development costs</a></td>
<td class="nump">$ 3,045,406<span></span>
</td>
<td class="nump">$ 2,896,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(946,835)<span></span>
</td>
<td class="num">(809,439)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Total</a></td>
<td class="nump">$ 2,098,571<span></span>
</td>
<td class="nump">$ 2,086,660<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Software Development Costs - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAdditions', window );">Capitalized computer software, additions</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized computer software, gross</a></td>
<td class="nump">3,045,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,896,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Capitalized computer software, amortization</a></td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="num">$ (100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additions made to capitalized computer software costs during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Software Development Costs - Schedule of Future Estimated Amortization Expense (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear', window );">2025</a></td>
<td class="nump">$ 374,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne', window );">2026</a></td>
<td class="nump">598,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo', window );">2027</a></td>
<td class="nump">567,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree', window );">2028</a></td>
<td class="nump">301,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour', window );">2029</a></td>
<td class="nump">157,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive', window );">2030</a></td>
<td class="nump">99,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareNet', window );">Total</a></td>
<td class="nump">$ 2,098,571<span></span>
</td>
<td class="nump">$ 2,086,660<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Computer Software, Expected Amortization, Remainder of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Computer Software, Expected Amortization, Year Five</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Computer Software, Expected Amortization, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Computer Software, Expected Amortization, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Computer Software, Expected Amortization, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Computer Software, Expected Amortization, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrentAndNoncurrent', window );">Accrued payroll liabilities</a></td>
<td class="nump">$ 2,338,452<span></span>
</td>
<td class="nump">$ 2,189,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxes', window );">Accrued taxes</a></td>
<td class="nump">11,202<span></span>
</td>
<td class="nump">47,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CurrentPortionOfFinanceObligation', window );">Current portion of finance obligation</a></td>
<td class="nump">48,573<span></span>
</td>
<td class="nump">59,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent', window );">Accrued other (1)</a></td>
<td class="nump">683,036<span></span>
</td>
<td class="nump">1,438,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">3,081,263<span></span>
</td>
<td class="nump">3,734,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits', window );">Supplemental Unemployment Benefits, Severance Benefits</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember', window );">Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CurrentPortionOfFinanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current portion of finance obligation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CurrentPortionOfFinanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4.b.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Imputed interest rate</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTerm', window );">Payment plan</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 48,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current maturities</a></td>
<td class="nump">48,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">$ 1,654<span></span>
</td>
<td class="nump">$ 2,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Schedule of Future Maturities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">2025</a></td>
<td class="nump">$ 41,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2026</a></td>
<td class="nump">6,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 48,573<span></span>
</td>
<td class="nump">$ 63,420<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Retirement Plans (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Company contribution percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Percent of employees' gross pay</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage', window );">Employers annual vesting percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService', window );">Employers matching contribution, service period (in years)</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total contribution expense</a></td>
<td class="num">$ (19,332)<span></span>
</td>
<td class="num">$ (110,101)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total contribution expense</a></td>
<td class="num">(19,235)<span></span>
</td>
<td class="num">(22,478)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing (1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total contribution expense</a></td>
<td class="num">(16,524)<span></span>
</td>
<td class="num">(43,039)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total contribution expense</a></td>
<td class="num">$ (16,621)<span></span>
</td>
<td class="num">$ (44,584)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Employers Matching Contribution, Years of Service</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Authorized Shares (Detail) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A Junior Participating Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Share Repurchase (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 06, 2024</div></th>
<th class="th"><div>Jun. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized for repurchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased', window );">Share repurchase program, remaining authorized, number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=izea_ActiveRepurchaseProgramMember', window );">Active Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized for repurchase</a></td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased during the period</a></td>
<td class="nump">401,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Shares repurchased during the period (in dollars per share)</a></td>
<td class="nump">$ 2.61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=izea_ExpiredAndActiveRepurchaseProgramsMember', window );">Expired and Active Repurchase Programs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased', window );">Number of shares authorized for repurchase</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased during the period</a></td>
<td class="nump">767,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Shares repurchased during the period (in dollars per share)</a></td>
<td class="nump">$ 2.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares remaining authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=izea_ActiveRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=izea_ActiveRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=izea_ExpiredAndActiveRepurchaseProgramsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=izea_ExpiredAndActiveRepurchaseProgramsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Equity Incentive Plan (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 12, 2024</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 11, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease', window );">Increase in number of plan shares (in shares)</a></td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance (shares)</a></td>
<td class="nump">4,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,675,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=izea_TheAmendedandRestatedMay2011PlanMember', window );">The Amended and Restated May 2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,269,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved For Future Issuance, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_TheAmendedandRestatedMay2011PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_TheAmendedandRestatedMay2011PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>director </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Numberofindependentdirectors', window );">Number of independent directors | director</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 90,002<span></span>
</td>
<td class="nump">$ 75,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,858<span></span>
</td>
<td class="nump">125,863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CommonStockFairValue', window );">Common stock, fair value | $ / shares</a></td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, nonvested</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Director | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="nump">42,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 90,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted stock or unit expense</a></td>
<td class="nump">$ 90,002<span></span>
</td>
<td class="nump">$ 75,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=izea_IndependentDirectorsMember', window );">Independent Directors | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CommonStockFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CommonStockFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_Numberofindependentdirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of independent directors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_Numberofindependentdirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=izea_IndependentDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=izea_IndependentDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Non-Vested Restricted Stock (Details) - Restricted Stock [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units, nonvested beginning of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units, nonvested grants in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,858<span></span>
</td>
<td class="nump">125,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock units, nonvested vested in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,858)<span></span>
</td>
<td class="num">(125,863)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units, nonvested ending of period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested weighted average grant date fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested grants in period, weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10<span></span>
</td>
<td class="nump">$ 2.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units , nonvested vested in period, weighted average grant date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.10<span></span>
</td>
<td class="nump">2.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested weighted average grant date fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock Units (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 90,002<span></span>
</td>
<td class="nump">$ 75,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">47,280<span></span>
</td>
<td class="nump">474,195<span></span>
</td>
<td class="nump">1,858,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 980,632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CommonStockFairValue', window );">Common stock, fair value</a></td>
<td class="nump">$ 2.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, nonvested</a></td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Fairvalueofcommonstockissuedforfutureservices', window );">Fair value of common stock issued for future services</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Restricted stock units, nonvested weighted average remaining contractual terms</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=izea_EmployeesMember', window );">Employees | Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockExpense', window );">Restricted stock or unit expense</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officer | Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">23,680<span></span>
</td>
<td class="nump">127,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 59,200<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officer | Restricted stock units | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period (in years)</a></td>
<td class="text">36 months<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember', window );">Executive Officer | Restricted stock units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period (in years)</a></td>
<td class="text">48 months<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=izea_NonExecutiveEmployeesMember', window );">Non Executive Employees [Member] | Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">23,600<span></span>
</td>
<td class="nump">346,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Stock Issued During Period, Value, Issued for Services</a></td>
<td class="nump">$ 59,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CommonStockFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CommonStockFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_Fairvalueofcommonstockissuedforfutureservices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of common stock issued for future services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_Fairvalueofcommonstockissuedforfutureservices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=izea_EmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=izea_EmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=izea_NonExecutiveEmployeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=izea_NonExecutiveEmployeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Restricted Stock Units Schedule (Details) - Restricted stock units - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units, nonvested beginning of period</a></td>
<td class="nump">1,558,372<span></span>
</td>
<td class="nump">962,849<span></span>
</td>
<td class="nump">962,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock units, nonvested grants in period</a></td>
<td class="nump">47,280<span></span>
</td>
<td class="nump">474,195<span></span>
</td>
<td class="nump">1,858,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Restricted stock units, nonvested vested in period</a></td>
<td class="num">(167,516)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(956,679)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(188,958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(305,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Restricted stock units, nonvested ending of period</a></td>
<td class="nump">1,249,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,558,372<span></span>
</td>
<td class="nump">962,849<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested weighted average grant date fair value</a></td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested grants in period, weighted average grant date fair value</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units , nonvested vested in period, weighted average grant date fair value</a></td>
<td class="nump">2.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested forfeited in period, weighted average grant date fair value</a></td>
<td class="nump">2.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Restricted stock units, nonvested weighted average grant date fair value</a></td>
<td class="nump">$ 2.32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.33<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Restricted stock units, nonvested weighted average remaining contractual terms</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Options (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Percentageofindividualownershipofcommonstock', window );">Percentage of individual ownership of common stock (percentage)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value</a></td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Stock option plan expense</a></td>
<td class="nump">$ 7,501<span></span>
</td>
<td class="nump">$ 51,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=izea_May2011AndAugust2011EquityIncentivePlansMember', window );">May 2011 and August 2011 Equity Incentive Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FairMarketValueOfIncentiveStockOptions', window );">Fair market value of incentive stock options</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=izea_EquityIncentive2011PlanMember', window );">Equity Incentive 2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Grants outstanding</a></td>
<td class="nump">31,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,339<span></span>
</td>
<td class="nump">343,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price</a></td>
<td class="nump">$ 18.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.60<span></span>
</td>
<td class="nump">$ 9.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Common shares expected to vest</a></td>
<td class="nump">30,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Common shares expected to vest weighted average</a></td>
<td class="nump">$ 18.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Employee service share-based compensation, nonvested awards, compensation cost not yet recognized</a></td>
<td class="nump">$ 1,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm', window );">Weighted average remaining years to vest (in years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(65,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_StockOwnershipPlanAxis=izea_IndividualStockOwnershipInExcessOf10PercentMember', window );">Individual Stock Ownership in Excess of 10 Percent | May 2011 and August 2011 Equity Incentive Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_FairMarketValueOfIncentiveStockOptions', window );">Fair market value of incentive stock options</a></td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_VestingFrequencyAxis=izea_TotalvestingperiodMember', window );">Total vesting period | Stock options | May 2011 and August 2011 Equity Incentive Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_VestingFrequencyAxis=izea_TwelveMonthsAfterGrantDateMember', window );">Twelve Months After Grant Date | May 2011 and August 2011 Equity Incentive Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Percentageofindividualownershipofcommonstock', window );">Percentage of individual ownership of common stock (percentage)</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_StockOptionVestingPeriodFromGrantDate', window );">Stock option vesting period from grant date (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_VestingFrequencyAxis=izea_MonthlyInEqualInstallmentsMember', window );">Monthly in equal installments | Stock options | May 2011 and August 2011 Equity Incentive Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_FairMarketValueOfIncentiveStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Market Value of Incentive Stock Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_FairMarketValueOfIncentiveStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_Percentageofindividualownershipofcommonstock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of individual ownership of common stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_Percentageofindividualownershipofcommonstock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Nonvested, Weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_StockOptionVestingPeriodFromGrantDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Option Vesting Period From Grant Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_StockOptionVestingPeriodFromGrantDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_May2011AndAugust2011EquityIncentivePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_May2011AndAugust2011EquityIncentivePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_EquityIncentive2011PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_EquityIncentive2011PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_StockOwnershipPlanAxis=izea_IndividualStockOwnershipInExcessOf10PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_StockOwnershipPlanAxis=izea_IndividualStockOwnershipInExcessOf10PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_VestingFrequencyAxis=izea_TotalvestingperiodMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_VestingFrequencyAxis=izea_TotalvestingperiodMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_VestingFrequencyAxis=izea_TwelveMonthsAfterGrantDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_VestingFrequencyAxis=izea_TwelveMonthsAfterGrantDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_VestingFrequencyAxis=izea_MonthlyInEqualInstallmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_VestingFrequencyAxis=izea_MonthlyInEqualInstallmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Options Outstanding (Details) - Equity Incentive 2011 Plan - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning of period</a></td>
<td class="nump">33,339<span></span>
</td>
<td class="nump">343,601<span></span>
</td>
<td class="nump">343,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options, exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(65,154)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Options, expired</a></td>
<td class="num">(2,187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(244,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Options, forfeited</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, end of period</a></td>
<td class="nump">31,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,339<span></span>
</td>
<td class="nump">343,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, beginning of period</a></td>
<td class="nump">$ 18.60<span></span>
</td>
<td class="nump">$ 9.53<span></span>
</td>
<td class="nump">$ 9.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, expired</a></td>
<td class="nump">27.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, forfeited</a></td>
<td class="nump">15.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, end of period</a></td>
<td class="nump">$ 18.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.60<span></span>
</td>
<td class="nump">$ 9.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining life (years), outstanding</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Common shares expected to vest</a></td>
<td class="nump">30,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Common shares expected to vest weighted average</a></td>
<td class="nump">$ 18.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining useful life exercisable</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_EquityIncentive2011PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_EquityIncentive2011PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Nonvested Stock Option (Details) - Equity Incentive 2011 Plan - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Common shares, nonvested beginning of period</a></td>
<td class="nump">1,125<span></span>
</td>
<td class="nump">26,373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Common shares, vested</a></td>
<td class="num">(709)<span></span>
</td>
<td class="num">(24,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Common shares, forfeited</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Common shares, nonvested end of period</a></td>
<td class="nump">411<span></span>
</td>
<td class="nump">1,125<span></span>
</td>
<td class="nump">26,373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, nonvested beginning of period</a></td>
<td class="nump">$ 18.60<span></span>
</td>
<td class="nump">$ 8.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, vested</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, forfeited</a></td>
<td class="nump">9.24<span></span>
</td>
<td class="nump">9.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, nonvested end of period</a></td>
<td class="nump">$ 18.01<span></span>
</td>
<td class="nump">$ 18.60<span></span>
</td>
<td class="nump">$ 8.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm', window );">Weighted average remaining years to vest (in years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">1 year 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Nonvested, Weighted Average Remaining Contractual Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_EquityIncentive2011PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_EquityIncentive2011PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Inducement Plan (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">47,280<span></span>
</td>
<td class="nump">474,195<span></span>
</td>
<td class="nump">1,858,023<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="num">(188,958)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(305,821)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Hoozu</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=izea_InducementGrantRelatedRSUsMember', window );">Inducement grant-related RSUs | Time-Based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Grants outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179,355)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=izea_InducementGrantRelatedRSUsMember', window );">Inducement grant-related RSUs | Performance Based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Grants outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">328,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(328,354)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=izea_InducementGrantRelatedRSUsMember', window );">Inducement grant-related RSUs | Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Grants outstanding</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">338,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(507,709)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Inducement shares forfeited in 2024 were related to the divestiture of Hoozu in December, 2024</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=izea_HoozuHoldingsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=izea_HoozuHoldingsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=izea_InducementGrantRelatedRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=izea_InducementGrantRelatedRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_TimeBasedRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_TimeBasedRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_PerformanceBasedRSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_PerformanceBasedRSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_PerformanceBasedAndTimeBasedRSUAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_PerformanceBasedAndTimeBasedRSUAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Employee Stock Purchase Plan (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>h </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 12, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 11, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,375,000<span></span>
</td>
<td class="nump">3,675,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense | $</a></td>
<td class="nump">$ 285,132<span></span>
</td>
<td class="nump">$ 354,189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP', window );">Employee Stock Ownership Plan (ESOP), Shares in ESOP</a></td>
<td class="nump">77,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=izea_A2014EmployeeStockPurchasePlanMember', window );">2014 Employee Stock Purchase Plan | Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance (shares)</a></td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based compensation arrangement by share-based payment award, award vesting period (in days)</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_MinimumhourrequirementforemployeesparticipationintheESSP', window );">Minimum hour requirement for employees participation in the ESSP (hours) | h</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan', window );">Annual compensation limit percentage, employee stock purchase plan (percentage)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Annualcompensationlimitemployeestockpurchaseplan', window );">Annual compensation limit, employee stock purchase plan | $</a></td>
<td class="nump">$ 21,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan', window );">Shares issuance limit per offering period, employee stock purchase plan (in shares)</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_Fairmarketvalueofsharesavailableforissuance', window );">Fair market value of shares available for issuance (percentage)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense | $</a></td>
<td class="nump">$ 10,789<span></span>
</td>
<td class="nump">$ 1,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_Annualcompensationlimitemployeestockpurchaseplan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual compensation limit, employee stock purchase plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_Annualcompensationlimitemployeestockpurchaseplan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_Annualcompensationlimitpercentageemployeestockpurchaseplan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual compensation limit percentage, employee stock purchase plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_Annualcompensationlimitpercentageemployeestockpurchaseplan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_Fairmarketvalueofsharesavailableforissuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair market value of shares available for issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_Fairmarketvalueofsharesavailableforissuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_MinimumhourrequirementforemployeesparticipationintheESSP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum hour requirement for employees participation in the ESSP</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_MinimumhourrequirementforemployeesparticipationintheESSP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Limit on stock issued during period, employee stock purchase plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the allocated, committed-to-be-released and suspense shares of the entity held by the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480489/718-40-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=izea_A2014EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=izea_A2014EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Shareholder Rights Plan (Details)<br></strong></div></th>
<th class="th">
<div>May 28, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockDividendRatePerDollarAmount', window );">Preferred Stock, Dividend Rate, Per-Dollar-Amount</a></td>
<td class="nump">$ 8.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_ExercisableShareholderRightsPercentageHeld.', window );">Exercisable shareholder rights percentage held.</a></td>
<td class="nump">0.15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_ExercisableShareholderRightsPercentageHeld.">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercisable shareholder rights percentage held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_ExercisableShareholderRightsPercentageHeld.</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockDividendRatePerDollarAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount per share used to calculated dividend payments on preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockDividendRatePerDollarAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Stock-Based Compensation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 285,132<span></span>
</td>
<td class="nump">$ 354,189<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,449<span></span>
</td>
<td class="nump">51,571<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing (1)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(10,270)<span></span>
</td>
<td class="nump">56,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 232,953<span></span>
</td>
<td class="nump">$ 246,130<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Stock-based compensation expense for the Sales and Marketing department due to the targeted workforce reduction that occurred in January 2025. This is due to the reversal of previously recognized expense for unvested awards that are forfeited upon termination. Because we recognize stock compensation on a straight-line basis over the vesting period&#8212;rather than when the shares actually vest&#8212;expenses related to unvested awards are recorded in advance of full service being rendered. When employees depart before completing their vesting schedules, any unrecognized expense is reversed</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">$ 48,271,887<span></span>
</td>
<td class="nump">$ 62,501,847<span></span>
</td>
<td class="nump">$ 48,781,719<span></span>
</td>
<td class="nump">$ 65,313,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent', window );">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">(18,075)<span></span>
</td>
<td class="num">(188,244)<span></span>
</td>
<td class="nump">105,287<span></span>
</td>
<td class="num">(250,591)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other Comprehensive Income (Loss) before Reclassifications, Tax</a></td>
<td class="num">(123,362)<span></span>
</td>
<td class="nump">62,347<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_UnrealizedGainOnSecuritiesHeld', window );">Unrealized gain on securities held</a></td>
<td class="num">(13,903)<span></span>
</td>
<td class="nump">58,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease', window );">Foreign currency translation adjustment</a></td>
<td class="num">(109,459)<span></span>
</td>
<td class="nump">4,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=izea_UnrealizedGainLossOnSecuritiesMember', window );">Unrealized Gain (Loss) on Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">(1,694)<span></span>
</td>
<td class="num">(192,414)<span></span>
</td>
<td class="nump">12,209<span></span>
</td>
<td class="num">(250,591)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="num">(34,218)<span></span>
</td>
<td class="nump">$ 4,170<span></span>
</td>
<td class="num">(34,218)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=izea_CurrencyTranslationAdjustmentMember', window );">Currency Translation Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' Equity Attributable to Parent</a></td>
<td class="nump">$ 17,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_UnrealizedGainOnSecuritiesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrealized gain on securities held</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_UnrealizedGainOnSecuritiesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=izea_UnrealizedGainLossOnSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=izea_UnrealizedGainLossOnSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=izea_CurrencyTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=izea_CurrencyTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per Common Share - Schedule of Dilutive Shares (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (142,800)<span></span>
</td>
<td class="num">$ (3,265,850)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">16,927,166<span></span>
</td>
<td class="nump">16,333,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">16,927,166<span></span>
</td>
<td class="nump">16,333,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per common share (in dollars per share)</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per common share (in dollars per share)</a></td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="num">$ (0.20)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss per Common Share - Schedule of Anti-Dilutive Shares (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,280,325<span></span>
</td>
<td class="nump">1,717,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">31,147<span></span>
</td>
<td class="nump">343,244<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,249,178<span></span>
</td>
<td class="nump">1,374,283<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Disaggregation of Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 7,968,363<span></span>
</td>
<td class="nump">$ 6,952,883<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember', window );">Revenue from North America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">7,628,344<span></span>
</td>
<td class="nump">5,490,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Revenue from APAC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">237,827<span></span>
</td>
<td class="nump">1,027,859<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=izea_OtherMember', window );">Revenue from Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">102,192<span></span>
</td>
<td class="nump">434,609<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=izea_SaaSServicesSegmentRevenueMember', window );">SaaS Services Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">60,953<span></span>
</td>
<td class="nump">256,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=izea_ManagedServicesRevenueMember', window );">Managed Services Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 7,907,410<span></span>
</td>
<td class="nump">$ 6,696,542<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_NorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_NorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=izea_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=izea_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=izea_SaaSServicesSegmentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=izea_SaaSServicesSegmentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=izea_ManagedServicesRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=izea_ManagedServicesRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Contract Balances (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Contract with Customer, Asset, before Allowance for Credit Loss</a></td>
<td class="nump">$ 4,400,418<span></span>
</td>
<td class="nump">$ 7,835,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled Contracts Receivable</a></td>
<td class="num">(61,481)<span></span>
</td>
<td class="num">(151,783)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss', window );">Contract with Customer, Asset, Allowance for Credit Loss</a></td>
<td class="num">(192,785)<span></span>
</td>
<td class="num">(205,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="num">$ (7,095,245)<span></span>
</td>
<td class="num">$ (8,188,651)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 7,968,363<span></span>
</td>
<td class="nump">$ 6,952,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_LengthOfContractWithCustomers', window );">Length of contract with customers</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 7,095,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,188,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract liabilities, revenue recognized</a></td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_ContractLengthForSalesCommissionsPayment', window );">Contract length for sales commissions payment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_PerformanceObligationContractTerm', window );">Performance obligation contract term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=izea_SponsoredSocialRevenueMember', window );">Sponsored Social Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="nump">5,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=izea_ContentRevenueMember', window );">Content Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=izea_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">28,700<span></span>
</td>
<td class="nump">217,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=izea_MarketplaceSpendFeesnetMember', window );">Marketplace Spend Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">1,300<span></span>
</td>
<td class="nump">13,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=izea_OtherFeesMember', window );">Other Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 31,000.0<span></span>
</td>
<td class="nump">$ 26,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_ContractLengthForSalesCommissionsPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract Length For Sales Commissions Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_ContractLengthForSalesCommissionsPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_LengthOfContractWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Length of Contract With Customers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_LengthOfContractWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_PerformanceObligationContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Performance Obligation Contract Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_PerformanceObligationContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=izea_SponsoredSocialRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=izea_SponsoredSocialRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=izea_ContentRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=izea_ContentRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=izea_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=izea_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=izea_MarketplaceSpendFeesnetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=izea_MarketplaceSpendFeesnetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=izea_OtherFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=izea_OtherFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($) </div>
<div>Reportable_Operating_Segment</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 7,968,363<span></span>
</td>
<td class="nump">$ 6,952,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">160,352<span></span>
</td>
<td class="nump">204,186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">$ 285,132<span></span>
</td>
<td class="nump">354,189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Reportable_Operating_Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember', window );">Reportable Segment, Aggregation before Other Operating Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 7,968,363<span></span>
</td>
<td class="nump">6,952,883<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CostOfRevenueDirect', window );">Cost of revenue-direct</a></td>
<td class="nump">3,337,826<span></span>
</td>
<td class="nump">2,753,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_HumanCapitalCosts', window );">Human capital costs</a></td>
<td class="nump">3,440,502<span></span>
</td>
<td class="nump">4,943,804<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_izea_CashOperatingCosts', window );">Other cash operating costs</a></td>
<td class="nump">1,400,404<span></span>
</td>
<td class="nump">2,757,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">160,352<span></span>
</td>
<td class="nump">204,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">285,132<span></span>
</td>
<td class="nump">354,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperatingAndNonoperating', window );">Interest income</a></td>
<td class="num">(490,908)<span></span>
</td>
<td class="num">(671,517)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Deferred federal tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18,782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other income</a></td>
<td class="num">(22,145)<span></span>
</td>
<td class="num">(104,158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Segment Net Loss</a></td>
<td class="num">$ (142,800)<span></span>
</td>
<td class="num">$ (3,265,850)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CashOperatingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash operating costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CashOperatingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_CostOfRevenueDirect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of revenue-direct</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_CostOfRevenueDirect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_izea_HumanCapitalCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Human capital costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">izea_HumanCapitalCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>izea_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeBenefitsAndShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for employee benefit and equity-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeBenefitsAndShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperatingAndNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income classified as operating and nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperatingAndNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Effective Rate Reconciliation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income taxes at effective rates</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Tax benefit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (18,782)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( &6 K5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( &6 K5H;>#:9\@   "L"   1
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MNIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X8-DOV]:[MR_>X%<R)!%!,!FGK_#
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M"CS<_N\-L,+$CN'MB[\!4$L#!!0    ( &6 K5HB7%#QY 4  +$?   8
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MO3NQ:M.\XKU5%@1[<[@6'!)P!O#[2H'*V9^XM\;M?PGF_P%02P,$%     @
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MUZQ!HH/$++3NIH<'AGZL\GK#T+?_K3E72)J+W#@F"#DF".GC>2/QWM"25KD
MY&O:,/X"T1;]1)M7R,4O$7&(9TH$*V0WN[[F6YJSFYEH.&?- YO=?OT5#ISO
M3.FQ!_-[L&YF?;C%@?CG8_=Z_G":"9!1$TBP%!(L P*3LL$]9H-[439<D@1[
MI."$MX#X#HZ\4.9MH1L*@A6CI<'()QZ.G<"7+1/=\@H[.(YC!3(U&$91B)W
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MVP;-.S>E66 [6]FQ_]>P2H0HAO67<8"'%+I%@(><%B("CA(HL:D_A%BQKA'
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MK=2R2P+Z\&TV5=,P &MP1[BXLZ<^.,1'-^Q0YZ5MQ>V$M=KWT^ &?V^$N ,
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MU)N, S#M\Z45G*[]DV&E'3U _+*@%Q\:/D#?<ZW=3F #W1MR_C=02P,$%
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M0*%0TV$CD#0\86^1'JE;8+&\%Y5<UJTBSP >O])9;@:!Z<)3.4Q?H$J B6Y
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M4K3DC]V+EY(QYFT1((CY*$U$"E'_M9/HV20-HG1\CI$B0F1!QT5G\7@<I#-
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MO.R+_,[%;:^+WXOLU3LK;FW63![>>IH;R>\Q87#!H\!?<7[O6(!V$)Y:U*:
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M[SSSZO/&0;SZ2 1$*PDBE5A"->Q/1CU65!]>JAMG<O^Q8V$<"LA?K@5'G9,
MGB^-<<T-;=!^_;K[%U!+ P04    " !F@*U:ZK 7#@H'   ;#P  &0   'AL
M+W=O<FMS:&5E=',O<VAE970R,"YX;6R-5^]OXS82_5<(MR@20&O+LITXV23
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MV%PJ+76N9"UP=*B".J=0"0J!TQD_:( B@+-*S/ CYTZN:Q@8X+J86 3"<=5
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M!$JL1*?<K>E_PVT\)YZO,(K"%_IH.QXG4'3D3+,%LX)&ZO@7C]L\' !FV0N
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MZ=QSPK3@)H_6&_#YTAC:+GR [K<Q^0U02P,$%     @ 9H"M6HO#F 3J)0
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MD+ON'( LQM>QNWWN[_;YT>OXV#++?=]VQ18'F+K0/[+" *@7'J@71Y>\@BX
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MZOTV&6 V4"BKOEPA7G<D!*M#?M1O-0(A]-,LM&:B9V!?UGL7*OT4DEG<4X!
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M'M+R7>434P5',+M4L)K<FH%M,:-"PQ6 W\W!@]6)DE2=5C*8NV"XVC1C6_K
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M^:AX@+Y?67)?]1_8P/]F]^O_ 5!+ P04    " !F@*U:5H?=>",#  #J!@
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M0"C1%#(#^8C*:5$;3L_&>6#>"!#T_K2E;[5,:S2:%LBEH-&@IW#51E [UY'
M,S*EX5N>\Q3W%.\A"COM3:,J;AJ%KA W_,G*&H:[-GN-CCU.*FF^:+-EU7*A
M_*9 ?9<6?>/!-:98KHA<=S+X)VJ^C7H"\;D_&4Q>A([\2]")/PQ'W;=/^D4=
MC\?^>33IU^_2,$%Q1WX\COOU"VHJ7YHV92-<E;/="WL7)T-_-$Q.28IB?W0^
M.7VE!#Y4-/M/8!+ZH^B<A"A,_.%X (=Z-MB9-"6JM9NGMC>:RK1#IS_M1_9%
M.ZE>S-MY3_5=\TJ#P)Q<P[/QT /5SM!V8V3MYM9*&IJ"3BSHMX/*&I ^E])L
M-S9 _R-;_ 502P,$%     @ 9H"M6KQ#QY0K P  C <  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&ULC55M;^,V#/XKA#<,+>#5[TZ<)0'2WAUVP!4H
MVMOV8=@'Q:9CX6PID^2FVZ\?)2=>@J7&OB2B3#YZR(>BE@>IOND&T<!;UPJ]
M\AIC]HL@T&6#'=-W<H^"OM12=<R0J7:!WBMDE0OJVB .PSSH&!?>>NGVGM1Z
M*7O3<H%/"G3?=4S]=8^M/*R\R#MM//-=8^Q&L%[NV0Y?T/RR?U)D!2-*Q3L4
MFDL!"NN5MXD6]YGU=PZ_<CSHLS783+92?K/&YVKEA980ME@:B\#H[Q4?L&TM
M$-'X\XCIC4?:P//U"?V3RYURV3*-#[+]C5>F67ES#RJL6=^:9WGX&8_Y.(*E
M;+7[A</@FR8>E+TVLCL&$X..B^&?O1WK<!8P#]\)B(\!L>,]'.18?F"&K9=*
M'D!9;T*S"Y>JBR9R7%A17HRBKYSBS/I%UN; %,('?"6%]E1O P]2&PTW7]FV
M17V[# P=9-V#\@AZ/X#&[X F\"B%:31\%!56E_$!$1Q9QB>6]_$DX"-3=Y!$
M/L1AG$W@)6/6B<-+WL%[1HU,E0TP45UD_OMFJXVB5OGC6M8#:'H=U%Z?A=ZS
M$E<>W0^-ZA6]]0_?17GXTP3E=*2<3J&O7^@Z5GV+(&OXQ 4W^.,7ZN<*/@O#
MQ(Z35+#1&HV^QGP2^SKSL3.JL_J4KC-*29=2&TO%- BU;.EN<[%;P*.KZDDI
M*FV)W1;5:2>%"=3O(?'#-//3,*=U[,^+W ^+ KZ@UG1[R[[K6V8H8]9)9?C?
MS%WKFR+-_7F2W<+-/"S\-"EN)P[Q0="@L^AA,?>S632LY[F?YR%,R)2-,F7_
M7Z;>]$1B<T[WXQN-4XW7-)H$OJ[11MMS+HON0SV<B]KP[K\%PX$!3=2AFD:"
M?E\4KH%ZBB16I@$N+O4&?<QV 5?GR+7,A\9(9JD_RV?6R"$C*?(HLL8,LGSF
M)TELC3DD841".:. *)OY69:0D80D6U'X<93#5VE8>Z'H-16#LPG9H=JY=\ V
M<B_,,"S'W?&IV0P3]E_WX9VB:N^XT-!B3:'AW8QT4\/L'PPC]V[>;J6AZ>V6
M#3V7J*P#?:^E-"?#'C ^P.M_ %!+ P04    " !F@*U:9P(YZZP#  #0!P
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M0EF: 'Y9T\A%[0SH^TXI>]RX -,0W_P/4$L#!!0    ( &: K5H<)QIHC@(
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M^Z5/C.T\_*3#V;0XP2LX(=SJDG(+'\L4T__C?>;4$PM>B&V"LX"WPEQ".!I
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M<'9OYU/3DY(:[RVXONN$?;U!9;:S)$_V!U_DNB5_D,ZG&['&!Z0_-_>6=^F
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M ;:\*'*HJM%X4D&LZV'EAB*'Z&59^$6>C?(L#Z$^XSH"[>VX2M]IW0VT&DZ
M#)C> @F[1E\LKX7<NQHYQ::/"DBMH%!VH;7I=1WK?HLU=DNTHU@9#XTO6/<4
M7W\2NF>U#K4[/S:UZ8'X=,CAO<3ZUO6:H@X-IX.*7T?Q^FX>/P&<TEIR0Q6N
MV#4[OQPG8*.LQ@V939"RI2$6QK!L^4N$UAOP^Y4QM-_X ,.W;?XO4$L#!!0
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MGA*?4<(]'H[(\WM_?2O/?\[?E=#RS27$,2-7X@'P59,+K45U*^WU?R\6IM:
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M[VZ&52*'D3MLM.CLF,N$QBS9985?*4P: [S?"Z'/&_. \;MG_3=02P,$%
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M/QXT'D#[E=;N,/$''']EZV]02P,$%     @ 9H"M6O9W4<A_ @  ?P4  !D
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M\D;00W&JLJ%"QH'B<H]@C%C^@OQ^2ZDXW^0-U"=YJW\!4$L#!!0    ( &:
MK5K+$CZ3ZP(  *4-   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;+U7
M:VO;,!3]*Q</1@==;3F//I8$^EA9866A8=N'L0^J<YV(RI(KR4T"^_&3[,3)
M(%6Z4/=++-D^YYY[=>(K]692/>@IHH%YQH7N!U-C\K,PU,D4,ZJ/9(["/DFE
MRJBQ4S4)=:Z0CDM0QL,XBKIA1ID(!KWRWE ->K(PG D<*M!%EE&UN$ N9_V
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MER$2-W="F'8\-BV/^!4>,_:@%9:6?5499/_GAZ2I%Q9?A&WB4< ';B9L-OW
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MPSU9#D]$MBUO.K+(A,B2\N&&43F8BP/D^^M,?J+5DZ*!XYUQ9O\#4$L#!!0
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MICL[;^"9"K2G'>@+K;T%.P,*_@'?5,FM+VC'B8)PL%>/'8%Q'#F#(U6)FY$
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MX09(#$QMD,]7E(K=1#EHFXGS_P%02P,$%     @ 9H"M6C.6>8HO P    T
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MW&I(U,\BJ'Z54*LT"RHRVX':S*$V2Q?C%D=J.9X3CF>/F.(&'2Z394PUTHX
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M95IOIPTM%K8"G0B-]:R]G.,G"D@S .]/A=";A@F0?_0,_@)02P,$%     @
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M-\WY1++,M)$3)E53:H8+]9T!7!NH^S/&Y&:B-RB_7,*_4$L#!!0    ( &:
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M=BZ?0U9L,Q<G@J[R?=0'*@1-\L,EP2%A:H"\/Z=4;$]4@FJS?_(O4$L#!!0
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M:M&"E6B7@97QBHHSTO)/2. %G:8%V>$A1#6\W0 /?QW>LGC3JD.@9?A:NT)
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MEM[EB^)S4XQ.N,+2UC03H%A]:@,<GW*N5B]Z@OH/D.%_4$L#!!0    ( &:
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MSDFJ'I<819A* ?%]3@C?O4@#U;\N^O\ 4$L#!!0    ( &: K5J]83:W.P<
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M.@/58W@^_><WDFW,/+Q@4DW7YG(-1 W VD"]7S(F7V_T N4WF,E_4$L#!!0
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MA9"P" C6B/!@$^'!"V]L!I 9 0D+(&$A)"P"@C4R KOUUV'W?US^[8,[-V%
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M(XQ"S)2 _+ZB5.Q>5 ?U[=GT/U!+ P04    " !F@*U:RF^^)U<"  #J!
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M9E*RK+A= 8V!:P/U?,&8W _T G6#*OP?4$L#!!0    ( &: K5KGL1]]JP(
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M"^#:0%U?,B9W)WJ":N=W^C]02P,$%     @ 9H"M6M@H\X=<!   PQ   !D
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MIYH#JZ E%VL?[D%@IH32D;%E8=-U(5+_\G#7]Z!B&IV22Z5=;I_!_YTVPP^
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MV%.2)%D61@ +.T@2#(&G$4<P!^ !0Y+$O0</WD?QYCT5;W_C&O\&4$L#!!0
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &6 K5HB7%#QY 4  +$?   8
M          " @24(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !E@*U:Y'G()3\&   Q&   &               @($_#@  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 98"M6E?TKPD> P  S H
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M965T-RYX;6Q02P$"% ,4    " !F@*U:J<"2/GHF  #9>   &
M    @(&X,   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M9H"M6@6S![(= P  J 8  !@              ("!:%<  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( &: K5JF0FB$X 8  ,81   9
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M970Q-"YX;6Q02P$"% ,4    " !F@*U:\6?TC! $   ?"0  &0
M    @(%N<@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M &: K5JS7N+** 0  .P(   9              " @;5V  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ 9H"M6EH!)&H+%@  E$8  !D
M             ("!%'L  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " !F@*U:82-"]1,$  #B"0  &0              @(%6D0  >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( &: K5KF/N"@U08
M  D3   9              " @:"5  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ 9H"M6NJP%PX*!P  &P\  !D              ("!
MK)P  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !F@*U:
MZU&(+Y(#  #/!P  &0              @('MHP  >&PO=V]R:W-H965T<R]S
M:&5E=#(Q+GAM;%!+ 0(4 Q0    ( &: K5JZT3HKK (  $(&   9
M      " @;:G  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%
M  @ 9H"M6HO#F 3J)0  OWL  !D              ("!F:H  'AL+W=O<FMS
M:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !F@*U:5H?=>",#  #J!@
M&0              @(&ZT   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+
M 0(4 Q0    ( &: K5IA_SUWJ 4  !@/   9              " @134  !X
M;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 9H"M6E'S)V8
M P  U 8  !D              ("!\]D  'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6Q02P$"% ,4    " !F@*U:O$/'E"L#  ",!P  &0
M@($JW0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( &:
MK5IG CGKK ,  - '   9              " @8S@  !X;"]W;W)K<VAE971S
M+W-H965T,C@N>&UL4$L! A0#%     @ 9H"M6APG&FB. @  ?P4  !D
M         ("!;^0  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
M    " !F@*U:TW1?93H#  #G!@  &0              @($TYP  >&PO=V]R
M:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( &: K5J;ML! 9P@  " :
M   9              " @:7J  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
M4$L! A0#%     @ 9H"M6BS<\!%$ P  H <  !D              ("!0_,
M 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !F@*U:E#X
M)=L#   #"0  &0              @(&^]@  >&PO=V]R:W-H965T<R]S:&5E
M=#,S+GAM;%!+ 0(4 Q0    ( &: K5I\1!+Y90,  -8&   9
M  " @=#Z  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @
M9H"M6O9W4<A_ @  ?P4  !D              ("!;/X  'AL+W=O<FMS:&5E
M=',O<VAE970S-2YX;6Q02P$"% ,4    " !F@*U:?7_:PY4"  "+"   &0
M            @($B 0$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4
M Q0    ( &: K5JMXI%,XP0  -4;   9              " @>X# 0!X;"]W
M;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 9H"M6LL2/I/K @
MI0T  !D              ("!" D! 'AL+W=O<FMS:&5E=',O<VAE970S."YX
M;6Q02P$"% ,4    " !F@*U:RU^DT$8"   ,!0  &0              @($J
M# $ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( &: K5H&
MHK/7:0(  *0%   9              " @:<. 0!X;"]W;W)K<VAE971S+W-H
M965T-# N>&UL4$L! A0#%     @ 9H"M6E$'6EZ& @  S 8  !D
M     ("!1Q$! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &: K5IZV,X/Q0(  #4'   9              "
M@3\F 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 9H"M
M6I3GSJ_U P  W1(  !D              ("!.RD! 'AL+W=O<FMS:&5E=',O
M<VAE970T-RYX;6Q02P$"% ,4    " !F@*U:DE/^/\L#  !8%   &0
M        @(%G+0$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0
M   ( &: K5HSEGF*+P,    -   9              " @6DQ 0!X;"]W;W)K
M<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 9H"M6NXD(:." @  > 8
M !D              ("!SS0! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q0
M2P$"% ,4    " !F@*U:M6M8FC4#  #%#   &0              @(&(-P$
M>&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( &: K5K4Y_%Q
MT0(  (@)   9              " @?0Z 0!X;"]W;W)K<VAE971S+W-H965T
M-3(N>&UL4$L! A0#%     @ 9H"M6K .T'2N P  "Q   !D
M ("!_#T! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " !F
M@*U:QV;DI!P#  #,"@  &0              @('A00$ >&PO=V]R:W-H965T
M<R]S:&5E=#4T+GAM;%!+ 0(4 Q0    ( &: K5K%4$!,60(  &P&   9
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M970U.2YX;6Q02P$"% ,4    " !F@*U:&C\KQ1(%  #X'P  &0
M    @('J5@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (
M &: K5HT]&4!^P,   P1   9              " @3-< 0!X;"]W;W)K<VAE
M971S+W-H965T-C$N>&UL4$L! A0#%     @ 9H"M6B#%8_"'!@  %C   !D
M             ("!96 ! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"
M% ,4    " !F@*U:>(R#9O8$  #&&   &0              @($C9P$ >&PO
M=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( &: K5J]83:W.P<
M  \V   9              " @5!L 0!X;"]W;W)K<VAE971S+W-H965T-C0N
M>&UL4$L! A0#%     @ 9H"M6E@,N"@N!0  +QP  !D              ("!
MPG,! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " !F@*U:
MU[A^TSL$  "/$0  &0              @($G>0$ >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;%!+ 0(4 Q0    ( &: K5K)<Y=O(08  ,@O   9
M      " @9E] 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%
M  @ 9H"M6J#=@*LD!0  21L  !D              ("!\8,! 'AL+W=O<FMS
M:&5E=',O<VAE970V."YX;6Q02P$"% ,4    " !F@*U:RF^^)U<"  #J!
M&0              @(%,B0$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+
M 0(4 Q0    ( &: K5KIHQ*9N00  +X1   9              " @=J+ 0!X
M;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 9H"M6O4NKHTQ
M!0  \1\  !D              ("!RI ! 'AL+W=O<FMS:&5E=',O<VAE970W
M,2YX;6Q02P$"% ,4    " !F@*U:ZL(W3?L"  #8"   &0
M@($RE@$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( &:
MK5J$W1@K*0,  $ ,   9              " @629 0!X;"]W;W)K<VAE971S
M+W-H965T-S,N>&UL4$L! A0#%     @ 9H"M6I990_VW P  K!(  !D
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M=#<X+GAM;%!+ 0(4 Q0    ( &: K5K@ S>%+P,  / 2   -
M  "  =RO 0!X;"]S='EL97,N>&UL4$L! A0#%     @ 9H"M6I>*NQS
M$P(   L              ( !-K,! %]R96QS+RYR96QS4$L! A0#%     @
M9H"M6D@^:/.S!0  8#,   \              ( !'[0! 'AL+W=O<FMB;V]K
M+GAM;%!+ 0(4 Q0    ( &: K5IZ! -=7 (  "$N   :              "
M ?^Y 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( &:
MK5HN* K8%0(  /PL   3              "  9.\ 0!;0V]N=&5N=%]4>7!E
<<UTN>&UL4$L%!@    !6 %8 D1<  -F^ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>184</ContextCount>
  <ElementCount>316</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>73</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Balance Sheets - Parenthetical</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets - Parenthetical</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Company and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Company and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Business Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/BusinessAcquisitions</Role>
      <ShortName>Business Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/IntangibleAssets</Role>
      <ShortName>Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Software Development Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SoftwareDevelopmentCosts</Role>
      <ShortName>Software Development Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.izea.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Commitments and Contingencies (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.izea.com/role/CommitmentsandContingenciesNotes</Role>
      <ShortName>Commitments and Contingencies (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Loss per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/LossperCommonShare</Role>
      <ShortName>Loss per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Company and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Company and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Company and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Company and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/FinancialInstruments</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/PropertyandEquipment</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Software Development Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SoftwareDevelopmentCostsTables</Role>
      <ShortName>Software Development Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/SoftwareDevelopmentCosts</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/AccruedExpenses</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.izea.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/NotesPayable</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/StockholdersEquity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Loss per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/LossperCommonShareTables</Role>
      <ShortName>Loss per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/LossperCommonShare</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/Revenue</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/SegmentReporting</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.izea.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Company and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails</Role>
      <ShortName>Company and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Company and Summary of Significant Accounting Policies - Accounts Receivable and Concentration of Credit Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails</Role>
      <ShortName>Company and Summary of Significant Accounting Policies - Accounts Receivable and Concentration of Credit Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Company and Summary of Significant Accounting Policies - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails</Role>
      <ShortName>Company and Summary of Significant Accounting Policies - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Company and Summary of Significant Accounting Policies - Software Development Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails</Role>
      <ShortName>Company and Summary of Significant Accounting Policies - Software Development Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Company and Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Company and Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Company and Summary of Significant Accounting Policies - Advertising Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails</Role>
      <ShortName>Company and Summary of Significant Accounting Policies - Advertising Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Company and Summary of Significant Accounting Policies - Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails</Role>
      <ShortName>Company and Summary of Significant Accounting Policies - Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Business Acquisitions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails</Role>
      <ShortName>Business Acquisitions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Financial Instruments - Marketable Securities by Significant Investment Category (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails</Role>
      <ShortName>Financial Instruments - Marketable Securities by Significant Investment Category (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Financial Instruments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Financial Instruments - Fair Value of Marketable Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails</Role>
      <ShortName>Financial Instruments - Fair Value of Marketable Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Financial Instruments - Fair Value and Net Unrealized Gains (Losses) By Investment in OCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails</Role>
      <ShortName>Financial Instruments - Fair Value and Net Unrealized Gains (Losses) By Investment in OCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/PropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.izea.com/role/PropertyandEquipmentTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/IntangibleAssetsNarrativeDetails</Role>
      <ShortName>Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Software Development Costs - Schedule of Software Development Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails</Role>
      <ShortName>Software Development Costs - Schedule of Software Development Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Software Development Costs - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails</Role>
      <ShortName>Software Development Costs - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Software Development Costs - Schedule of Future Estimated Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails</Role>
      <ShortName>Software Development Costs - Schedule of Future Estimated Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/AccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.izea.com/role/AccruedExpensesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Notes Payable - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.izea.com/role/NotesPayableAdditionalInformationDetails</Role>
      <ShortName>Notes Payable - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Notes Payable - Schedule of Future Maturities (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails</Role>
      <ShortName>Notes Payable - Schedule of Future Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Commitments and Contingencies - Retirement Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails</Role>
      <ShortName>Commitments and Contingencies - Retirement Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Stockholders' Equity - Authorized Shares (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail</Role>
      <ShortName>Stockholders' Equity - Authorized Shares (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Stockholders' Equity - Share Repurchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails</Role>
      <ShortName>Stockholders' Equity - Share Repurchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Stockholders' Equity - Equity Incentive Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails</Role>
      <ShortName>Stockholders' Equity - Equity Incentive Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Stockholders' Equity - Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityRestrictedStockDetails</Role>
      <ShortName>Stockholders' Equity - Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Stockholders' Equity - Schedule of Non-Vested Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Non-Vested Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails</Role>
      <ShortName>Stockholders' Equity - Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Stockholders' Equity - Restricted Stock Units Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails</Role>
      <ShortName>Stockholders' Equity - Restricted Stock Units Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Stockholders' Equity - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityStockOptionsDetails</Role>
      <ShortName>Stockholders' Equity - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Stockholders' Equity - Schedule of Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Stockholders' Equity - Schedule of Nonvested Stock Option (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Nonvested Stock Option (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Stockholders' Equity - Inducement Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityInducementPlanDetails</Role>
      <ShortName>Stockholders' Equity - Inducement Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Stockholders' Equity - Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails</Role>
      <ShortName>Stockholders' Equity - Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Stockholders' Equity - Shareholder Rights Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityShareholderRightsPlanDetails</Role>
      <ShortName>Stockholders' Equity - Shareholder Rights Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Stockholders' Equity - Summary of Stock-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Stock-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Loss per Common Share - Schedule of Dilutive Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails</Role>
      <ShortName>Loss per Common Share - Schedule of Dilutive Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Loss per Common Share - Schedule of Anti-Dilutive Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails</Role>
      <ShortName>Loss per Common Share - Schedule of Anti-Dilutive Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Revenue - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/RevenueDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - Revenue - Contract Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/RevenueContractBalancesDetails</Role>
      <ShortName>Revenue - Contract Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.izea.com/role/SegmentReportingTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="izea-20250331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - Income Taxes - Effective Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.izea.com/role/IncomeTaxesEffectiveRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Effective Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="izea-20250331.htm">izea-20250331.htm</File>
    <File>izea-20250331.xsd</File>
    <File>izea-20250331_cal.xml</File>
    <File>izea-20250331_def.xml</File>
    <File>izea-20250331_lab.xml</File>
    <File>izea-20250331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>izea-20250331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="6">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="713">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="33">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "izea-20250331.htm": {
   "nsprefix": "izea",
   "nsuri": "http://www.izea.com/20250331",
   "dts": {
    "inline": {
     "local": [
      "izea-20250331.htm"
     ]
    },
    "schema": {
     "local": [
      "izea-20250331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "izea-20250331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "izea-20250331_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "izea-20250331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "izea-20250331_pre.xml"
     ]
    }
   },
   "keyStandard": 275,
   "keyCustom": 41,
   "axisStandard": 22,
   "axisCustom": 2,
   "memberStandard": 38,
   "memberCustom": 33,
   "hidden": {
    "total": 33,
    "http://fasb.org/us-gaap/2024": 25,
    "http://xbrl.sec.gov/dei/2024": 7,
    "http://www.izea.com/20250331": 1
   },
   "contextCount": 184,
   "entityCount": 1,
   "segmentCount": 73,
   "elementCount": 501,
   "unitCount": 8,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 713,
    "http://xbrl.sec.gov/dei/2024": 33,
    "http://fasb.org/srt/2024": 6
   },
   "report": {
    "R1": {
     "role": "http://www.izea.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.izea.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets - Parenthetical",
     "shortName": "Consolidated Balance Sheets - Parenthetical",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:PreferredStockSharesIssued",
       "us-gaap:PreferredStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.izea.com/role/ConsolidatedStatementsofOperations",
     "longName": "9952153 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "longName": "9952154 - Statement - Consolidated Statements of Comprehensive Loss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity",
     "longName": "9952155 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.izea.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "izea:AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies",
     "longName": "9952157 - Disclosure - Company and Summary of Significant Accounting Policies",
     "shortName": "Company and Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.izea.com/role/BusinessAcquisitions",
     "longName": "9952158 - Disclosure - Business Acquisitions",
     "shortName": "Business Acquisitions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.izea.com/role/FinancialInstruments",
     "longName": "9952159 - Disclosure - Financial Instruments",
     "shortName": "Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.izea.com/role/PropertyandEquipment",
     "longName": "9952160 - Disclosure - Property and Equipment",
     "shortName": "Property and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.izea.com/role/IntangibleAssets",
     "longName": "9952161 - Disclosure - Intangible Assets",
     "shortName": "Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.izea.com/role/SoftwareDevelopmentCosts",
     "longName": "9952162 - Disclosure - Software Development Costs",
     "shortName": "Software Development Costs",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.izea.com/role/AccruedExpenses",
     "longName": "9952163 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.izea.com/role/NotesPayable",
     "longName": "9952164 - Disclosure - Notes Payable",
     "shortName": "Notes Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.izea.com/role/CommitmentsandContingenciesNotes",
     "longName": "9952165 - Disclosure - Commitments and Contingencies (Notes)",
     "shortName": "Commitments and Contingencies (Notes)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.izea.com/role/StockholdersEquity",
     "longName": "9952166 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.izea.com/role/LossperCommonShare",
     "longName": "9952167 - Disclosure - Loss per Common Share",
     "shortName": "Loss per Common Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.izea.com/role/Revenue",
     "longName": "9952168 - Disclosure - Revenue",
     "shortName": "Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.izea.com/role/SegmentReporting",
     "longName": "9952169 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.izea.com/role/IncomeTaxes",
     "longName": "9952170 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.izea.com/role/SubsequentEvents",
     "longName": "9952171 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Company and Summary of Significant Accounting Policies (Policies)",
     "shortName": "Company and Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "izea:NatureOfBusinessPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "izea:NatureOfBusinessPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Company and Summary of Significant Accounting Policies (Tables)",
     "shortName": "Company and Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R25": {
     "role": "http://www.izea.com/role/FinancialInstrumentsTables",
     "longName": "9955513 - Disclosure - Financial Instruments (Tables)",
     "shortName": "Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.izea.com/role/PropertyandEquipmentTables",
     "longName": "9955514 - Disclosure - Property and Equipment (Tables)",
     "shortName": "Property and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R27": {
     "role": "http://www.izea.com/role/SoftwareDevelopmentCostsTables",
     "longName": "9955515 - Disclosure - Software Development Costs (Tables)",
     "shortName": "Software Development Costs (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.izea.com/role/AccruedExpensesTables",
     "longName": "9955516 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.izea.com/role/NotesPayableTables",
     "longName": "9955517 - Disclosure - Notes Payable (Tables)",
     "shortName": "Notes Payable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.izea.com/role/CommitmentandContingenciesTables",
     "longName": "9955518 - Disclosure - Commitment and Contingencies (Tables)",
     "shortName": "Commitment and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.izea.com/role/StockholdersEquityTables",
     "longName": "9955519 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.izea.com/role/LossperCommonShareTables",
     "longName": "9955520 - Disclosure - Loss per Common Share (Tables)",
     "shortName": "Loss per Common Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.izea.com/role/RevenueTables",
     "longName": "9955521 - Disclosure - Revenue (Tables)",
     "shortName": "Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.izea.com/role/SegmentReportingTables",
     "longName": "9955522 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.izea.com/role/IncomeTaxesTables",
     "longName": "9955523 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails",
     "longName": "9955524 - Disclosure - Company and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "shortName": "Company and Summary of Significant Accounting Policies - Cash and Cash Equivalents (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashUninsuredAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashUninsuredAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails",
     "longName": "9955525 - Disclosure - Company and Summary of Significant Accounting Policies - Accounts Receivable and Concentration of Credit Risk (Details)",
     "shortName": "Company and Summary of Significant Accounting Policies - Accounts Receivable and Concentration of Credit Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
     "longName": "9955526 - Disclosure - Company and Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "shortName": "Company and Summary of Significant Accounting Policies - Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-42",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-42",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails",
     "longName": "9955527 - Disclosure - Company and Summary of Significant Accounting Policies - Software Development Costs (Details)",
     "shortName": "Company and Summary of Significant Accounting Policies - Software Development Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "izea:AmortizationPeriodOfSoftwareDevelopmentCosts",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "izea:AmortizationPeriodOfSoftwareDevelopmentCosts",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails",
     "longName": "9955528 - Disclosure - Company and Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "shortName": "Company and Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "izea:InvoicePaymentTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "izea:InvoicePaymentTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:RevenueRecognitionPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
     "longName": "9955529 - Disclosure - Company and Summary of Significant Accounting Policies - Advertising Costs (Details)",
     "shortName": "Company and Summary of Significant Accounting Policies - Advertising Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-47",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-47",
      "name": "us-gaap:AdvertisingExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails",
     "longName": "9955530 - Disclosure - Company and Summary of Significant Accounting Policies - Stock-Based Compensation (Details)",
     "shortName": "Company and Summary of Significant Accounting Policies - Stock-Based Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-49",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R43": {
     "role": "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails",
     "longName": "9955531 - Disclosure - Business Acquisitions - Additional Information (Details)",
     "shortName": "Business Acquisitions - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-50",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails",
     "longName": "9955532 - Disclosure - Financial Instruments - Marketable Securities by Significant Investment Category (Details)",
     "shortName": "Financial Instruments - Marketable Securities by Significant Investment Category (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.izea.com/role/FinancialInstrumentsNarrativeDetails",
     "longName": "9955533 - Disclosure - Financial Instruments - Narrative (Details)",
     "shortName": "Financial Instruments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainOnSaleOfInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GainOnSaleOfInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails",
     "longName": "9955534 - Disclosure - Financial Instruments - Fair Value of Marketable Debt Securities (Details)",
     "shortName": "Financial Instruments - Fair Value of Marketable Debt Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "izea:FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:MarketableSecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "izea:FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
     "longName": "9955535 - Disclosure - Financial Instruments - Fair Value and Net Unrealized Gains (Losses) By Investment in OCI (Details)",
     "shortName": "Financial Instruments - Fair Value and Net Unrealized Gains (Losses) By Investment in OCI (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "izea:FinancialAssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "izea:FinancialAssetsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.izea.com/role/PropertyandEquipmentDetails",
     "longName": "9955536 - Disclosure - Property and Equipment (Details)",
     "shortName": "Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
     "longName": "9955537 - Disclosure - Intangible Assets - Narrative (Details)",
     "shortName": "Intangible Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-74",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-74",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails",
     "longName": "9955538 - Disclosure - Software Development Costs - Schedule of Software Development Cost (Details)",
     "shortName": "Software Development Costs - Schedule of Software Development Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CapitalizedComputerSoftwareGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails",
     "longName": "9955539 - Disclosure - Software Development Costs - Additional Information (Details)",
     "shortName": "Software Development Costs - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CapitalizedComputerSoftwareAdditions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CapitalizedComputerSoftwareAdditions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails",
     "longName": "9955540 - Disclosure - Software Development Costs - Schedule of Future Estimated Amortization Expense (Details)",
     "shortName": "Software Development Costs - Schedule of Future Estimated Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "izea:CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "izea:CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.izea.com/role/AccruedExpensesDetails",
     "longName": "9955541 - Disclosure - Accrued Expenses (Details)",
     "shortName": "Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedSalariesCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedSalariesCurrentAndNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.izea.com/role/NotesPayableAdditionalInformationDetails",
     "longName": "9955542 - Disclosure - Notes Payable - Additional Information (Details)",
     "shortName": "Notes Payable - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails",
     "longName": "9955543 - Disclosure - Notes Payable - Schedule of Future Maturities (Details)",
     "shortName": "Notes Payable - Schedule of Future Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails",
     "longName": "9955544 - Disclosure - Commitments and Contingencies - Retirement Plans (Details)",
     "shortName": "Commitments and Contingencies - Retirement Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail",
     "longName": "9955545 - Disclosure - Stockholders' Equity - Authorized Shares (Detail)",
     "shortName": "Stockholders' Equity - Authorized Shares (Detail)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:PreferredStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails",
     "longName": "9955546 - Disclosure - Stockholders' Equity - Share Repurchase (Details)",
     "shortName": "Stockholders' Equity - Share Repurchase (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-85",
      "name": "srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-85",
      "name": "srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails",
     "longName": "9955547 - Disclosure - Stockholders' Equity - Equity Incentive Plan (Details)",
     "shortName": "Stockholders' Equity - Equity Incentive Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-90",
      "name": "izea:CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "izea:CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
     "longName": "9955548 - Disclosure - Stockholders' Equity - Restricted Stock (Details)",
     "shortName": "Stockholders' Equity - Restricted Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "izea:Numberofindependentdirectors",
      "unitRef": "director",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "izea:Numberofindependentdirectors",
      "unitRef": "director",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails",
     "longName": "9955549 - Disclosure - Stockholders' Equity - Schedule of Non-Vested Restricted Stock (Details)",
     "shortName": "Stockholders' Equity - Schedule of Non-Vested Restricted Stock (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-98",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-99",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
     "longName": "9955550 - Disclosure - Stockholders' Equity - Restricted Stock Units (Details)",
     "shortName": "Stockholders' Equity - Restricted Stock Units (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockIssuedDuringPeriodValueIssuedForServices",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:StockIssuedDuringPeriodValueIssuedForServices",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
     "longName": "9955551 - Disclosure - Stockholders' Equity - Restricted Stock Units Schedule (Details)",
     "shortName": "Stockholders' Equity - Restricted Stock Units Schedule (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-115",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.izea.com/role/StockholdersEquityStockOptionsDetails",
     "longName": "9955552 - Disclosure - Stockholders' Equity - Stock Options (Details)",
     "shortName": "Stockholders' Equity - Stock Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "izea:Percentageofindividualownershipofcommonstock",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "izea:Percentageofindividualownershipofcommonstock",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
     "longName": "9955553 - Disclosure - Stockholders' Equity - Schedule of Options Outstanding (Details)",
     "shortName": "Stockholders' Equity - Schedule of Options Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails",
     "longName": "9955554 - Disclosure - Stockholders' Equity - Schedule of Nonvested Stock Option (Details)",
     "shortName": "Stockholders' Equity - Schedule of Nonvested Stock Option (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
     "longName": "9955555 - Disclosure - Stockholders' Equity - Inducement Plan (Details)",
     "shortName": "Stockholders' Equity - Inducement Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-107",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
     "longName": "9955556 - Disclosure - Stockholders' Equity - Employee Stock Purchase Plan (Details)",
     "shortName": "Stockholders' Equity - Employee Stock Purchase Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-92",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.izea.com/role/StockholdersEquityShareholderRightsPlanDetails",
     "longName": "9955557 - Disclosure - Stockholders' Equity - Shareholder Rights Plan (Details)",
     "shortName": "Stockholders' Equity - Shareholder Rights Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-150",
      "name": "us-gaap:PreferredStockDividendRatePerDollarAmount",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-150",
      "name": "us-gaap:PreferredStockDividendRatePerDollarAmount",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails",
     "longName": "9955558 - Disclosure - Stockholders' Equity - Summary of Stock-Based Compensation (Details)",
     "shortName": "Stockholders' Equity - Summary of Stock-Based Compensation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails",
     "longName": "9955559 - Disclosure - Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details)",
     "shortName": "Stockholders' Equity - Accumulated Other Comprehensive Income (Loss) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails",
     "longName": "9955560 - Disclosure - Loss per Common Share - Schedule of Dilutive Shares (Details)",
     "shortName": "Loss per Common Share - Schedule of Dilutive Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R73": {
     "role": "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails",
     "longName": "9955561 - Disclosure - Loss per Common Share - Schedule of Anti-Dilutive Shares (Details)",
     "shortName": "Loss per Common Share - Schedule of Anti-Dilutive Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails",
     "longName": "9955562 - Disclosure - Revenue - Disaggregation of Revenue (Details)",
     "shortName": "Revenue - Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-179",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.izea.com/role/RevenueContractBalancesDetails",
     "longName": "9955563 - Disclosure - Revenue - Contract Balances (Details)",
     "shortName": "Revenue - Contract Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractWithCustomerAssetGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractWithCustomerAssetGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.izea.com/role/RevenueNarrativeDetails",
     "longName": "9955564 - Disclosure - Revenue - Narrative (Details)",
     "shortName": "Revenue - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "izea:LengthOfContractWithCustomers",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.izea.com/role/SegmentReportingDetails",
     "longName": "9955565 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "reportable_operating_segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.izea.com/role/IncomeTaxesEffectiveRateReconciliationDetails",
     "longName": "9955566 - Disclosure - Income Taxes - Effective Rate Reconciliation (Details)",
     "shortName": "Income Taxes - Effective Rate Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "izea-20250331.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "izea_A2014EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "A2014EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2014 Employee Stock Purchase Plan",
        "label": "2014 Employee Stock Purchase Plan [Member]",
        "documentation": "2014 Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/AccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r62",
      "r66",
      "r1002"
     ]
    },
    "us-gaap_AccountsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r1028"
     ]
    },
    "izea_AccountsReceivableExcludingContractAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "AccountsReceivableExcludingContractAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable excluding Contract Asset",
        "label": "Accounts Receivable excluding Contract Asset",
        "documentation": "Accounts Receivable excluding Contract Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r940"
     ]
    },
    "us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDue": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNoncurrentThresholdPeriodPastDue",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Noncurrent, Threshold Period Past Due",
        "label": "Accounts Receivable, Noncurrent, Threshold Period Past Due",
        "documentation": "Threshold period for when accounts receivable, classified as noncurrent, is considered past due, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes threshold period past due to write off as uncollectible."
       }
      }
     },
     "auth_ref": [
      "r321"
     ]
    },
    "us-gaap_AccruedIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued taxes",
        "label": "Accrued Income Taxes",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r66",
      "r115",
      "r637"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.izea.com/role/AccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails",
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_AccruedSalariesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedSalariesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll liabilities",
        "label": "Accrued Salaries",
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/PropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r179",
      "r645"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive income (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r78",
      "r185",
      "r641",
      "r681",
      "r682"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r12",
      "r20",
      "r516",
      "r519",
      "r557",
      "r677",
      "r678",
      "r915",
      "r916",
      "r917",
      "r927",
      "r928",
      "r929",
      "r930"
     ]
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedTranslationAdjustmentMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r12",
      "r20",
      "r76",
      "r77",
      "r200",
      "r201",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r915"
     ]
    },
    "izea_ActiveRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ActiveRepurchaseProgramMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Active Repurchase Program",
        "label": "Active Repurchase Program [Member]",
        "documentation": "Active Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r858",
      "r1064"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r927",
      "r928",
      "r929",
      "r930",
      "r1007",
      "r1067"
     ]
    },
    "us-gaap_AdjustmentForAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentForAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization",
        "label": "Amortization",
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "izea_AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Adjustment to fair market value of digital assets",
        "label": "Adjustment to Fair Market Value of Indefinite Lived Intangible Assets",
        "documentation": "Adjustment to Fair Market Value of Indefinite Lived Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares withheld to cover statutory taxes",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used for operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising Costs",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising costs",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r844"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r470",
      "r476"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts receivable",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r282",
      "r316",
      "r319",
      "r320",
      "r1030"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bad debt",
        "label": "Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r955"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r341",
      "r348",
      "r822"
     ]
    },
    "izea_AmortizationPeriodOfSoftwareDevelopmentCosts": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "AmortizationPeriodOfSoftwareDevelopmentCosts",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesSoftwareDevelopmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period of software development costs (in years)",
        "label": "Amortization Period Of Software Development Costs",
        "documentation": "Amortization Period Of Software Development Costs"
       }
      }
     },
     "auth_ref": []
    },
    "izea_Annualcompensationlimitemployeestockpurchaseplan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "Annualcompensationlimitemployeestockpurchaseplan",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual compensation limit, employee stock purchase plan",
        "label": "Annual compensation limit, employee stock purchase plan",
        "documentation": "Annual compensation limit, employee stock purchase plan"
       }
      }
     },
     "auth_ref": []
    },
    "izea_Annualcompensationlimitpercentageemployeestockpurchaseplan": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "Annualcompensationlimitpercentageemployeestockpurchaseplan",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual compensation limit percentage, employee stock purchase plan (percentage)",
        "label": "Annual compensation limit percentage, employee stock purchase plan",
        "documentation": "Annual compensation limit percentage, employee stock purchase plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r239"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "srt_AsiaPacificMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "AsiaPacificMember",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from APAC",
        "label": "Asia Pacific [Member]",
        "documentation": "Region of Asia Pacific."
       }
      }
     },
     "auth_ref": [
      "r905",
      "r906",
      "r907",
      "r908",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ]
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetBackedSecuritiesMember",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset back securities",
        "label": "Asset-Backed Securities [Member]",
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans."
       }
      }
     },
     "auth_ref": [
      "r836",
      "r859",
      "r947",
      "r948",
      "r949"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Assets, Total",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r126",
      "r180",
      "r213",
      "r243",
      "r251",
      "r269",
      "r273",
      "r313",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r511",
      "r513",
      "r538",
      "r636",
      "r731",
      "r814",
      "r815",
      "r858",
      "r888",
      "r966",
      "r967",
      "r1018"
     ]
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r189",
      "r213",
      "r313",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r511",
      "r513",
      "r538",
      "r858",
      "r966",
      "r967",
      "r1018"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r287"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r288"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjusted Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r284",
      "r324",
      "r635"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r285",
      "r324",
      "r526",
      "r630",
      "r847",
      "r850",
      "r944",
      "r1009",
      "r1010",
      "r1011"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails",
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r506",
      "r839",
      "r840"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r506",
      "r839",
      "r840"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r506"
     ]
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisitions",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r507"
     ]
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationsPolicy",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combinations Policy",
        "label": "Business Combinations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r111"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedComputerSoftwareAccumulatedAmortization",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less accumulated amortization",
        "label": "Capitalized Computer Software, Accumulated Amortization",
        "documentation": "For each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r797"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedComputerSoftwareAdditions",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized computer software, additions",
        "label": "Capitalized Computer Software, Additions",
        "documentation": "Additions made to capitalized computer software costs during the period."
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Capitalized computer software, amortization",
        "label": "Capitalized Computer Software, Amortization",
        "documentation": "Amount of expense for amortization of capitalized computer software costs."
       }
      }
     },
     "auth_ref": [
      "r796",
      "r797"
     ]
    },
    "izea_CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Capitalized Computer Software, Expected Amortization, Remainder of Fiscal Year",
        "documentation": "Capitalized Computer Software, Expected Amortization, Remainder of Fiscal Year"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CapitalizedComputerSoftwareExpectedAmortizationYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CapitalizedComputerSoftwareExpectedAmortizationYearFive",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2030",
        "label": "Capitalized Computer Software, Expected Amortization, Year Five",
        "documentation": "Capitalized Computer Software, Expected Amortization, Year Five"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CapitalizedComputerSoftwareExpectedAmortizationYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CapitalizedComputerSoftwareExpectedAmortizationYearFour",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Capitalized Computer Software, Expected Amortization, Year Four",
        "documentation": "Capitalized Computer Software, Expected Amortization, Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CapitalizedComputerSoftwareExpectedAmortizationYearOne": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CapitalizedComputerSoftwareExpectedAmortizationYearOne",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Capitalized Computer Software, Expected Amortization, Year One",
        "documentation": "Capitalized Computer Software, Expected Amortization, Year One"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CapitalizedComputerSoftwareExpectedAmortizationYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CapitalizedComputerSoftwareExpectedAmortizationYearThree",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Capitalized Computer Software, Expected Amortization, Year Three",
        "documentation": "Capitalized Computer Software, Expected Amortization, Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CapitalizedComputerSoftwareExpectedAmortizationYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CapitalizedComputerSoftwareExpectedAmortizationYearTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Capitalized Computer Software, Expected Amortization, Year Two",
        "documentation": "Capitalized Computer Software, Expected Amortization, Year Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedComputerSoftwareGross",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails",
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Software development costs",
        "terseLabel": "Capitalized computer software, gross",
        "label": "Capitalized Computer Software, Gross",
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software."
       }
      }
     },
     "auth_ref": [
      "r347",
      "r797"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedComputerSoftwareNet",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets",
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofFutureEstimatedAmortizationExpenseDetails",
      "http://www.izea.com/role/SoftwareDevelopmentCostsScheduleofSoftwareDevelopmentCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Capitalized Computer Software, Net",
        "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r177",
      "r801"
     ]
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsMember",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents [Member]",
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "izea_CashCDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CashCDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, CDIC Insured Amount",
        "label": "Cash, CDIC Insured Amount",
        "documentation": "Cash, CDIC Insured Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r89",
      "r210"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r89"
     ]
    },
    "us-gaap_CashDivestedFromDeconsolidation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashDivestedFromDeconsolidation",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Divested from Deconsolidation",
        "label": "Cash Divested from Deconsolidation",
        "documentation": "Reduction in cash due to no longer including the former subsidiary's cash in the consolidated entity's cash."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, FDIC insured amount",
        "label": "Cash, FDIC Insured Amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental non-cash activities:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CashOperatingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CashOperatingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other cash operating costs",
        "label": "Cash operating costs",
        "documentation": "Cash operating costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashUninsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashUninsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesCashandCashEquivalentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, uninsured amount",
        "label": "Cash, Uninsured Amount",
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "izea_ChangeInTheFairValueOfDigitalAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ChangeInTheFairValueOfDigitalAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in the fair value of digital assets",
        "label": "Change in the fair value of digital assets",
        "documentation": "Change in the fair value of digital assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r182",
      "r183",
      "r184",
      "r213",
      "r233",
      "r234",
      "r236",
      "r238",
      "r245",
      "r246",
      "r313",
      "r378",
      "r380",
      "r381",
      "r382",
      "r385",
      "r386",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r538",
      "r687",
      "r688",
      "r689",
      "r690",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r719",
      "r740",
      "r759",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r895",
      "r923",
      "r931"
     ]
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r377",
      "r882",
      "r883",
      "r884",
      "r885"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies (Note 9)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r118",
      "r638",
      "r718"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesNotes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r370",
      "r371",
      "r782",
      "r961",
      "r963"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, capital shares reserved for future issuance (shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "izea_CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase in number of plan shares (in shares)",
        "label": "Common Stock, Capital Shares Reserved For Future Issuance, Period Increase (Decrease)",
        "documentation": "Common Stock, Capital Shares Reserved For Future Issuance, Period Increase (Decrease)"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CommonStockFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CommonStockFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, fair value",
        "label": "Common Stock, Fair Value",
        "documentation": "Common Stock, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r878",
      "r879",
      "r880",
      "r882",
      "r883",
      "r884",
      "r885",
      "r927",
      "r928",
      "r930",
      "r1007",
      "r1062",
      "r1067"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r719"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares, issued (shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (shares)",
        "periodEndLabel": "Balance (shares)",
        "periodStartLabel": "Balance (shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r70",
      "r719",
      "r737",
      "r1067",
      "r1068"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock; $0.0001 par value; $50,000,000 shares authorized; shares issued: $17,661,220 and $17,518,018, respectively, shares outstanding: $16,893,885 and $16,931,169, respectively.",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r640",
      "r858"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total comprehensive income (loss)",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r195",
      "r197",
      "r203",
      "r632",
      "r650",
      "r651"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r54",
      "r55",
      "r280",
      "r781"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r54",
      "r55",
      "r280",
      "r684",
      "r781"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r54",
      "r55",
      "r280",
      "r781",
      "r897"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r135"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r781"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Concentration risk, percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r54",
      "r55",
      "r280"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r32",
      "r33",
      "r34",
      "r54",
      "r113",
      "r781"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r54",
      "r55",
      "r280",
      "r781"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r803"
     ]
    },
    "izea_ContentRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ContentRevenueMember",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Content Revenue",
        "label": "Content Revenue [Member]",
        "documentation": "Content Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "izea_ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract assets and contract liabilities length of agreement with customers",
        "label": "Contract Assets And Contract Liabilities Length Of Agreement With Customers",
        "documentation": "Contract Assets And Contract Liabilities Length Of Agreement With Customers"
       }
      }
     },
     "auth_ref": []
    },
    "izea_ContractLengthForSalesCommissionsPayment": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ContractLengthForSalesCommissionsPayment",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract length for sales commissions payment",
        "label": "Contract Length For Sales Commissions Payment",
        "documentation": "Contract Length For Sales Commissions Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/RevenueContractBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Contract with Customer, Asset, Allowance for Credit Loss",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r316",
      "r319",
      "r320",
      "r415"
     ]
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Contract with Customer",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability."
       }
      }
     },
     "auth_ref": [
      "r973"
     ]
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetGross",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/RevenueContractBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r321",
      "r971",
      "r972"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails",
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r415",
      "r426"
     ]
    },
    "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetReclassifiedToReceivable",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Asset, Reclassified to Receivable",
        "label": "Contract with Customer, Asset, Reclassified to Receivable",
        "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional."
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/RevenueContractBalancesDetails",
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Contract with customer, liability",
        "terseLabel": "Contract with customer, liability",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r414",
      "r426"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Liability, Current",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r414",
      "r426"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities, revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate debt securities",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r836",
      "r838",
      "r847",
      "r859",
      "r876",
      "r1059"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r213",
      "r313",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r538",
      "r814",
      "r966"
     ]
    },
    "izea_CostOfRevenueDirect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CostOfRevenueDirect",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue-direct",
        "label": "Cost of revenue-direct",
        "documentation": "Cost of revenue-direct"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and expenses:",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "izea_CurrencyTranslationAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CurrencyTranslationAdjustmentMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Currency Translation Adjustment",
        "label": "Currency Translation Adjustment [Member]",
        "documentation": "Currency Translation Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "izea_CurrentPortionOfFinanceObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CurrentPortionOfFinanceObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of finance obligation",
        "label": "Current portion of finance obligation",
        "documentation": "Current portion of finance obligation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r280"
     ]
    },
    "izea_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer One",
        "label": "Customer One [Member]",
        "documentation": "Customer One"
       }
      }
     },
     "auth_ref": []
    },
    "izea_CustomerTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "CustomerTwoMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Two",
        "label": "Customer two [Member]",
        "documentation": "Customer two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/NotesPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Payable",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r212",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r376",
      "r377",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r396",
      "r399",
      "r400",
      "r402",
      "r550"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.izea.com/role/NotesPayableAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Imputed interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r404",
      "r550",
      "r551",
      "r857"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Unrealized Gain (Loss)",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r945",
      "r946"
     ]
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred federal tax",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r925",
      "r1005",
      "r1006"
     ]
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Income Taxes and Tax Credits",
        "label": "Deferred Income Taxes and Tax Credits",
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Total contribution expense",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r436"
     ]
    },
    "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanDisclosuresTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/CommitmentandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan Disclosures",
        "label": "Defined Contribution Plan Disclosures [Table Text Block]",
        "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percent of employees' gross pay",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company contribution percentage",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employers annual vesting percentage",
        "label": "Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage",
        "documentation": "Percentage of employer's matching contributions to a defined contribution plan that vests in a given year."
       }
      }
     },
     "auth_ref": []
    },
    "izea_DefinedContributionPlanEmployersMatchingContributionYearsOfService": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "DefinedContributionPlanEmployersMatchingContributionYearsOfService",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employers matching contribution, service period (in years)",
        "label": "Defined Contribution Plan, Employers Matching Contribution, Years of Service",
        "documentation": "Defined Contribution Plan, Employers Matching Contribution, Years of Service"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r43"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r243",
      "r256",
      "r273",
      "r814",
      "r815"
     ]
    },
    "izea_DepreciationandAmortizationExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "DepreciationandAmortizationExpenseMember",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and Amortization Expense",
        "label": "Depreciation and Amortization Expense [Member]",
        "documentation": "Depreciation and Amortization Expense [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_DigitalAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "DigitalAssetsMember",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Digital Assets",
        "label": "Digital Assets [Member]",
        "documentation": "Digital Assets"
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "DirectorMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director",
        "label": "Director [Member]",
        "documentation": "Person serving on board of directors."
       }
      }
     },
     "auth_ref": [
      "r909",
      "r939",
      "r1063"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r425",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/RevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r48"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r893"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share [Abstract]",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic loss per common share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r231",
      "r233",
      "r236",
      "r237",
      "r238",
      "r242",
      "r504",
      "r510",
      "r523",
      "r524",
      "r633",
      "r652",
      "r807"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted loss per common share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r233",
      "r236",
      "r237",
      "r238",
      "r242",
      "r504",
      "r510",
      "r523",
      "r524",
      "r633",
      "r652",
      "r807"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss per Common Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r239",
      "r240",
      "r241"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://www.izea.com/role/IncomeTaxesEffectiveRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes at effective rates",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r845"
     ]
    },
    "us-gaap_EmployeeBenefitsAndShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeBenefitsAndShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Employee Benefits and Share-Based Compensation",
        "documentation": "Amount of expense for employee benefit and equity-based compensation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee service share-based compensation, nonvested awards, compensation cost not yet recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r471"
     ]
    },
    "us-gaap_EmployeeSeveranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeSeveranceMember",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Severance",
        "label": "Employee Severance [Member]",
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPSharesInESOP": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOwnershipPlanESOPSharesInESOP",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Shares in ESOP",
        "label": "Employee Stock Ownership Plan (ESOP), Shares in ESOP",
        "documentation": "Sum of the allocated, committed-to-be-released and suspense shares of the entity held by the plan."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "izea_EmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "EmployeesMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employees",
        "label": "Employees [Member]",
        "documentation": "Employees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r894"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r172",
      "r199",
      "r200",
      "r201",
      "r216",
      "r217",
      "r218",
      "r220",
      "r225",
      "r227",
      "r229",
      "r244",
      "r314",
      "r315",
      "r354",
      "r412",
      "r494",
      "r495",
      "r501",
      "r502",
      "r503",
      "r505",
      "r509",
      "r510",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r552",
      "r553",
      "r557",
      "r648",
      "r677",
      "r678",
      "r679",
      "r694",
      "r759"
     ]
    },
    "izea_EquityIncentive2011PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "EquityIncentive2011PlanMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Incentive 2011 Plan",
        "label": "Equity Incentive 2011 Plan [Member]",
        "documentation": "Equity Incentive 2011 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ExecutiveOfficerMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Officer",
        "label": "Executive Officer [Member]",
        "documentation": "Person with designation of executive officer."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "izea_ExercisableShareholderRightsPercentageHeld.": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ExercisableShareholderRightsPercentageHeld.",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable shareholder rights percentage held.",
        "label": "Exercisable shareholder rights percentage held.",
        "documentation": "Exercisable shareholder rights percentage held."
       }
      }
     },
     "auth_ref": []
    },
    "izea_ExpiredAndActiveRepurchaseProgramsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ExpiredAndActiveRepurchaseProgramsMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expired and Active Repurchase Programs",
        "label": "Expired and Active Repurchase Programs [Member]",
        "documentation": "Expired and Active Repurchase Programs"
       }
      }
     },
     "auth_ref": []
    },
    "izea_FairMarketValueOfIncentiveStockOptions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "FairMarketValueOfIncentiveStockOptions",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair market value of incentive stock options",
        "label": "Fair Market Value of Incentive Stock Options",
        "documentation": "Fair Market Value of Incentive Stock Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r534",
      "r536",
      "r563",
      "r564",
      "r565",
      "r823",
      "r824",
      "r836",
      "r837",
      "r838",
      "r847",
      "r850"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r430",
      "r435",
      "r527",
      "r534",
      "r563",
      "r836",
      "r837",
      "r838",
      "r847"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r430",
      "r435",
      "r527",
      "r528",
      "r534",
      "r564",
      "r823",
      "r824",
      "r836",
      "r837",
      "r838",
      "r847"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r534",
      "r536",
      "r563",
      "r564",
      "r565",
      "r823",
      "r824",
      "r836",
      "r837",
      "r838",
      "r847",
      "r850"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "izea_FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Investments in Marketable Debt Securities",
        "label": "Fair Value of Investments in Marketable Debt Securities [Table Text Block]",
        "documentation": "Fair Value of Investments in Marketable Debt Securities"
       }
      }
     },
     "auth_ref": []
    },
    "izea_Fairmarketvalueofsharesavailableforissuance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "Fairmarketvalueofsharesavailableforissuance",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair market value of shares available for issuance (percentage)",
        "label": "Fair market value of shares available for issuance",
        "documentation": "Fair market value of shares available for issuance"
       }
      }
     },
     "auth_ref": []
    },
    "izea_Fairvalueofcommonstockissuedforfutureservices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "Fairvalueofcommonstockissuedforfutureservices",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common stock issued for future services",
        "label": "Fair value of common stock issued for future services",
        "documentation": "Fair value of common stock issued for future services"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance obligation, less current portion",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "izea_FinancialAssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "FinancialAssetsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "label": "Financial Assets, Fair Value Disclosure",
        "documentation": "Financial Assets, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r317",
      "r318",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r401",
      "r410",
      "r521",
      "r537",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r649",
      "r820",
      "r847",
      "r848",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r859",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r950",
      "r951",
      "r952",
      "r953",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013"
     ]
    },
    "us-gaap_FinancialInstrumentsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentsDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/FinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments",
        "label": "Financial Instruments Disclosure [Text Block]",
        "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivablePercentPastDue1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancingReceivablePercentPastDue1",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Percent Past Due",
        "label": "Financing Receivable, Percent Past Due",
        "documentation": "Percentage of financing receivable balance that is past due."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r349",
      "r350",
      "r598",
      "r599",
      "r797"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r347",
      "r349",
      "r350",
      "r352",
      "r598",
      "r797",
      "r822"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r342",
      "r343",
      "r344",
      "r346",
      "r347",
      "r349",
      "r350",
      "r797"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net of accumulated depreciation",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r598",
      "r958"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealizedAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCurrencyTransactionGainLossUnrealizedAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on currency translation",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, after Tax",
        "documentation": "Amount, after tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r693",
      "r779",
      "r887",
      "r1065",
      "r1066"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (Loss) on Disposition of Intangible Assets",
        "label": "Gain (Loss) on Disposition of Intangible Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r922"
     ]
    },
    "us-gaap_GainOnSaleOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainOnSaleOfInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on Sale of Investments",
        "label": "Gain on Sale of Investments",
        "documentation": "The difference between the carrying value and the sale price of an investment. A gain would be recognized when the sale price of the investment is greater than the carrying value of the investment. This element refers to the Gain included in earnings and not to the cash proceeds of the sale."
       }
      }
     },
     "auth_ref": [
      "r918",
      "r919",
      "r922",
      "r1026"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r743"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_HoldingPeriodOfMarketableSecurities": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "HoldingPeriodOfMarketableSecurities",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Holding period of marketable securities",
        "label": "Holding period of marketable securities",
        "documentation": "Holding period of marketable securities"
       }
      }
     },
     "auth_ref": []
    },
    "izea_HoozuHoldingPTYLtd.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "HoozuHoldingPTYLtd.Member",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hoozu Holding PTY Ltd.",
        "label": "Hoozu Holding PTY Ltd. [Member]",
        "documentation": "Hoozu Holding PTY Ltd."
       }
      }
     },
     "auth_ref": []
    },
    "izea_HoozuHoldingsInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "HoozuHoldingsInc.Member",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hoozu",
        "label": "Hoozu Holdings, Inc. [Member]",
        "documentation": "Hoozu Holdings, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "izea_HumanCapitalCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "HumanCapitalCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Human capital costs",
        "label": "Human capital costs",
        "documentation": "Human capital costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss before income taxes",
        "label": "Income (Loss) Attributable to Parent, before Tax",
        "documentation": "Amount, before tax, of income (loss) attributable to parent. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r201"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails",
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r362",
      "r365",
      "r531",
      "r532",
      "r535",
      "r674",
      "r676",
      "r744",
      "r797",
      "r849",
      "r1032"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails",
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r365",
      "r531",
      "r532",
      "r535",
      "r674",
      "r676",
      "r744",
      "r797",
      "r849",
      "r1032"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r480",
      "r484",
      "r486",
      "r487",
      "r488",
      "r489",
      "r492",
      "r496",
      "r498",
      "r499",
      "r500",
      "r692",
      "r845"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/IncomeTaxesEffectiveRateReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax benefit",
        "terseLabel": "Tax benefit",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r141",
      "r228",
      "r229",
      "r243",
      "r259",
      "r273",
      "r483",
      "r484",
      "r497",
      "r654",
      "r845"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax benefit, divestiture",
        "label": "Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations",
        "documentation": "Amount of current tax expense (benefit) and deferred tax expense (benefit) pertaining to income (loss) from continuing operations and income (loss) from discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r481",
      "r482",
      "r489",
      "r490",
      "r491",
      "r493",
      "r686"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r592",
      "r921"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "izea_IndependentDirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "IndependentDirectorsMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Independent Directors",
        "label": "Independent Directors [Member]",
        "documentation": "Independent Directors"
       }
      }
     },
     "auth_ref": []
    },
    "izea_IndividualStockOwnershipInExcessOf10PercentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "IndividualStockOwnershipInExcessOf10PercentMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual Stock Ownership in Excess of 10 Percent",
        "label": "Individual Stock Ownership in Excess of 10 Percent [Member]",
        "documentation": "Individual Stock Ownership in Excess of 10 Percent [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_InducementGrantRelatedRSUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "InducementGrantRelatedRSUsMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement grant-related RSUs",
        "label": "Inducement grant-related RSUs [Member]",
        "documentation": "Inducement grant-related RSUs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r339",
      "r351",
      "r353",
      "r794",
      "r797"
     ]
    },
    "us-gaap_IntangibleAssetsFiniteLivedPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsFiniteLivedPolicy",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets",
        "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets."
       }
      }
     },
     "auth_ref": [
      "r594",
      "r595",
      "r596",
      "r598",
      "r804",
      "r956"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/NotesPayableAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r398",
      "r405",
      "r825",
      "r826"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r920"
     ]
    },
    "us-gaap_InterestIncomeOperatingAndNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeOperatingAndNonoperating",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Operating and Nonoperating",
        "documentation": "Amount of interest income classified as operating and nonoperating."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r814"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r208",
      "r209"
     ]
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_InvoicePaymentTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "InvoicePaymentTerms",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Invoice payment terms",
        "label": "Invoice Payment Terms",
        "documentation": "Invoice Payment Terms"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of stock issued or to be issued for payment of services",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "izea_LengthOfContractWithCustomers": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "LengthOfContractWithCustomers",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Length of contract with customers",
        "label": "Length of Contract With Customers",
        "documentation": "Length of Contract With Customers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r61",
      "r62",
      "r63",
      "r65",
      "r66",
      "r67",
      "r68",
      "r213",
      "r313",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r512",
      "r513",
      "r514",
      "r538",
      "r717",
      "r808",
      "r888",
      "r966",
      "r1018",
      "r1019"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r119",
      "r643",
      "r858",
      "r924",
      "r954",
      "r1014"
     ]
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r176",
      "r213",
      "r313",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r512",
      "r513",
      "r514",
      "r538",
      "r858",
      "r966",
      "r1018",
      "r1019"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_LicenseFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "LicenseFeesMember",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License Fees",
        "label": "License Fees [Member]",
        "documentation": "License Fees [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/NotesPayableAdditionalInformationDetails",
      "http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt",
        "totalLabel": "Total",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r117",
      "r394",
      "r403",
      "r823",
      "r824",
      "r857",
      "r1029"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/NotesPayableAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, current maturities",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r215",
      "r397"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/NotesPayableScheduleofFutureMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r926"
     ]
    },
    "us-gaap_LongTermDebtTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtTerm",
     "presentation": [
      "http://www.izea.com/role/NotesPayableAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment plan",
        "label": "Long-Term Debt, Term",
        "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1010",
      "r1011"
     ]
    },
    "izea_LossOfDivesitureOfBusinessNetOfTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "LossOfDivesitureOfBusinessNetOfTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss of divesiture of business net of transaction costs",
        "label": "Loss of divesiture of business net of transaction costs",
        "documentation": "Loss of divesiture of business net of transaction costs"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r831",
      "r869",
      "r874",
      "r974",
      "r1031",
      "r1033",
      "r1034",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "izea_ManagedServicesRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ManagedServicesRevenueMember",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Managed Services Revenue",
        "label": "Managed Services Revenue [Member]",
        "documentation": "Managed Services Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Marketable Securities",
        "documentation": "Amount of investment in marketable security."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r911"
     ]
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails": {
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueofMarketableDebtSecuritiesDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Marketable Securities",
        "verboseLabel": "Due in 1 year or less",
        "label": "Marketable Securities, Current",
        "documentation": "Amount of investment in marketable security, classified as current."
       }
      }
     },
     "auth_ref": [
      "r911"
     ]
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesLineItems",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities [Line Items]",
        "label": "Marketable Securities [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesTable",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities [Table]",
        "label": "Marketable Securities [Table]",
        "documentation": "Disclosure of information about investment in marketable security."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesTextBlock",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities [Table Text Block]",
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets."
       }
      }
     },
     "auth_ref": []
    },
    "izea_MarketplaceSpendFeesnetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "MarketplaceSpendFeesnetMember",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketplace Spend Fees",
        "label": "Marketplace Spend Fees, net [Member]",
        "documentation": "Marketplace Spend Fees, net [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r146",
      "r148",
      "r149",
      "r151",
      "r170",
      "r171",
      "r372",
      "r373",
      "r374",
      "r375",
      "r437",
      "r477",
      "r530",
      "r591",
      "r673",
      "r675",
      "r683",
      "r709",
      "r710",
      "r762",
      "r764",
      "r766",
      "r767",
      "r769",
      "r792",
      "r793",
      "r819",
      "r827",
      "r841",
      "r850",
      "r851",
      "r855",
      "r856",
      "r870",
      "r968",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ]
    },
    "izea_May2011AndAugust2011EquityIncentivePlansMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "May2011AndAugust2011EquityIncentivePlansMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "May 2011 and August 2011 Equity Incentive Plans",
        "label": "May 2011 and August 2011 Equity Incentive Plans [Member]",
        "documentation": "May 2011 and August 2011 Equity Incentive Plans [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r146",
      "r148",
      "r149",
      "r151",
      "r170",
      "r171",
      "r372",
      "r373",
      "r374",
      "r375",
      "r437",
      "r477",
      "r530",
      "r591",
      "r673",
      "r675",
      "r683",
      "r709",
      "r710",
      "r762",
      "r764",
      "r766",
      "r767",
      "r769",
      "r792",
      "r793",
      "r819",
      "r827",
      "r841",
      "r850",
      "r851",
      "r855",
      "r870",
      "r968",
      "r1020",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ]
    },
    "izea_MinimumhourrequirementforemployeesparticipationintheESSP": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "MinimumhourrequirementforemployeesparticipationintheESSP",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum hour requirement for employees participation in the ESSP (hours)",
        "label": "Minimum hour requirement for employees participation in the ESSP",
        "documentation": "Minimum hour requirement for employees participation in the ESSP"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MoneyMarketFundsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MoneyMarketFundsMember",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Money Market Funds [Member]",
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities."
       }
      }
     },
     "auth_ref": [
      "r975"
     ]
    },
    "izea_MonthlyInEqualInstallmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "MonthlyInEqualInstallmentsMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monthly in equal installments",
        "label": "Monthly in equal installments [Member]",
        "documentation": "Monthly in equal installments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r831",
      "r869",
      "r874",
      "r974",
      "r1031",
      "r1033",
      "r1034",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "izea_NatureOfBusinessPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "NatureOfBusinessPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nature of Business",
        "label": "Nature Of Business [Policy Text Block]",
        "documentation": "Nature of Business [Policy Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r207"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r90",
      "r91"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r122",
      "r174",
      "r193",
      "r196",
      "r201",
      "r213",
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r228",
      "r229",
      "r235",
      "r313",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r504",
      "r510",
      "r524",
      "r538",
      "r647",
      "r739",
      "r757",
      "r758",
      "r886",
      "r966"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "izea_NonExecutiveEmployeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "NonExecutiveEmployeesMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non Executive Employees [Member]",
        "label": "Non Executive Employees [Member]",
        "documentation": "Non Executive Employees"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonvested Restricted Stock Shares Activity",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "srt_NorthAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NorthAmericaMember",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from North America",
        "label": "North America [Member]",
        "documentation": "Continent of North America."
       }
      }
     },
     "auth_ref": [
      "r905",
      "r906",
      "r907",
      "r908",
      "r1069",
      "r1070",
      "r1071",
      "r1072"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r810",
      "r818",
      "r934"
     ]
    },
    "izea_Numberofindependentdirectors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "Numberofindependentdirectors",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of independent directors",
        "label": "Number of independent directors",
        "documentation": "Number of independent directors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OfficeEquipmentMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Office equipment",
        "label": "Office Equipment [Member]",
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossAttributableToParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r809",
      "r933",
      "r935",
      "r936",
      "r937",
      "r938"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/AccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued other (1)",
        "label": "Other Accrued Liabilities",
        "documentation": "Amount of expenses incurred but not yet paid classified as other."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r858"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r78",
      "r539",
      "r540",
      "r542"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent",
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r12",
      "r112"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized gain (loss) on securities held",
        "terseLabel": "Unrealized gain (loss) on securities held",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r190",
      "r191",
      "r192",
      "r648"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r199",
      "r648"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive income (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r17",
      "r194",
      "r197",
      "r202",
      "r225",
      "r543",
      "r544",
      "r549",
      "r631",
      "r648",
      "r915",
      "r916"
     ]
    },
    "izea_OtherFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "OtherFeesMember",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Fees",
        "label": "Other Fees [Member]",
        "documentation": "Other Fees contract revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income",
        "label": "Other Income",
        "documentation": "Amount of revenue and income classified as other."
       }
      }
     },
     "auth_ref": [
      "r653",
      "r741",
      "r770",
      "r771",
      "r772"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense):",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "OtherMember",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Other",
        "label": "Other [Member]",
        "documentation": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of treasury stock",
        "label": "Payments for Repurchase of Equity",
        "documentation": "The cash outflow to reacquire common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r690"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments on shares withheld for statutory taxes",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r205"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to Acquire Businesses, Gross",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r508"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToDevelopSoftware",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Capitalization of software development costs",
        "label": "Payments to Develop Software",
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "izea_Percentageofindividualownershipofcommonstock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "Percentageofindividualownershipofcommonstock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of individual ownership of common stock (percentage)",
        "label": "Percentage of individual ownership of common stock",
        "documentation": "Percentage of individual ownership of common stock"
       }
      }
     },
     "auth_ref": []
    },
    "izea_PerformanceBasedAndTimeBasedRSUAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "PerformanceBasedAndTimeBasedRSUAwardsMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total",
        "label": "Performance-based and time-based RSU awards [Member]",
        "documentation": "Performance-based and time-based RSU awards"
       }
      }
     },
     "auth_ref": []
    },
    "izea_PerformanceBasedRSUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "PerformanceBasedRSUsMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Based",
        "label": "Performance Based RSUs [Member]",
        "documentation": "Performance Based RSUs"
       }
      }
     },
     "auth_ref": []
    },
    "izea_PerformanceObligationContractTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "PerformanceObligationContractTerm",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance obligation contract term",
        "label": "Performance Obligation Contract Term",
        "documentation": "Performance Obligation Contract Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r977",
      "r978",
      "r979",
      "r980",
      "r981",
      "r982",
      "r983",
      "r984",
      "r985",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991",
      "r992",
      "r993",
      "r994",
      "r995",
      "r996",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001"
     ]
    },
    "us-gaap_PreferredStockDividendRatePerDollarAmount": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockDividendRatePerDollarAmount",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareholderRightsPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred Stock, Dividend Rate, Per-Dollar-Amount",
        "label": "Preferred Stock, Dividend Rate, Per-Dollar-Amount",
        "documentation": "The amount per share used to calculated dividend payments on preferred stock."
       }
      }
     },
     "auth_ref": [
      "r407"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, par value (per share)",
        "terseLabel": "Preferred stock, par value (per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r406"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r719"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares issued",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r406"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares outstanding",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r719",
      "r737",
      "r1067",
      "r1068"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock; $0.0001 par value; $10,000,000 shares authorized; no shares issued and outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r639",
      "r858"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r328",
      "r329",
      "r802"
     ]
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment for divestiture",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from investment maturities",
        "label": "Proceeds from Sale of Short-Term Investments",
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r169",
      "r276",
      "r597",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r799",
      "r829",
      "r868",
      "r870",
      "r871",
      "r875",
      "r877",
      "r910",
      "r964",
      "r965",
      "r974",
      "r1031",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r169",
      "r276",
      "r597",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r799",
      "r829",
      "r868",
      "r870",
      "r871",
      "r875",
      "r877",
      "r910",
      "r964",
      "r965",
      "r974",
      "r1031",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r556"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/PropertyandEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r136",
      "r139",
      "r140"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/PropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r178",
      "r646"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.izea.com/role/PropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net of accumulated depreciation",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r556",
      "r634",
      "r646",
      "r858"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r136",
      "r139",
      "r644"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesTables",
      "http://www.izea.com/role/PropertyandEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r556"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment, useful life (in years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r146",
      "r148",
      "r149",
      "r151",
      "r170",
      "r171",
      "r372",
      "r373",
      "r374",
      "r375",
      "r429",
      "r437",
      "r466",
      "r467",
      "r468",
      "r477",
      "r530",
      "r566",
      "r575",
      "r591",
      "r673",
      "r675",
      "r683",
      "r709",
      "r710",
      "r762",
      "r764",
      "r766",
      "r767",
      "r769",
      "r792",
      "r793",
      "r819",
      "r827",
      "r841",
      "r850",
      "r851",
      "r855",
      "r856",
      "r870",
      "r880",
      "r962",
      "r968",
      "r1010",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r144",
      "r146",
      "r148",
      "r149",
      "r151",
      "r170",
      "r171",
      "r372",
      "r373",
      "r374",
      "r375",
      "r429",
      "r437",
      "r466",
      "r467",
      "r468",
      "r477",
      "r530",
      "r566",
      "r575",
      "r591",
      "r673",
      "r675",
      "r683",
      "r709",
      "r710",
      "r762",
      "r764",
      "r766",
      "r767",
      "r769",
      "r792",
      "r793",
      "r819",
      "r827",
      "r841",
      "r850",
      "r851",
      "r855",
      "r856",
      "r870",
      "r880",
      "r962",
      "r968",
      "r1010",
      "r1021",
      "r1022",
      "r1023",
      "r1024",
      "r1025"
     ]
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r42"
     ]
    },
    "us-gaap_ReportableSegmentAggregationBeforeOtherOperatingSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReportableSegmentAggregationBeforeOtherOperatingSegmentMember",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment, Aggregation before Other Operating Segment",
        "label": "Reportable Segment, Aggregation before Other Operating Segment [Member]",
        "documentation": "Aggregation of reportable segments before other operating segment. Excludes intersegment elimination and reconciling item."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r815"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development [Abstract]",
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCosts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software Development Costs",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r479",
      "r794"
     ]
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software Development Costs",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination."
       }
      }
     },
     "auth_ref": [
      "r960",
      "r1003",
      "r1073"
     ]
    },
    "us-gaap_RestrictedStockExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock or unit expense",
        "label": "Restricted Stock or Unit Expense",
        "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted stock",
        "terseLabel": "Restricted Stock [Member]",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails",
      "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring and Related Cost, Expected Cost",
        "label": "Restructuring and Related Cost, Expected Cost",
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r366",
      "r367",
      "r369"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r367",
      "r368"
     ]
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveLineItems",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost and Reserve [Line Items]",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r101",
      "r642",
      "r680",
      "r682",
      "r691",
      "r720",
      "r858"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r172",
      "r216",
      "r217",
      "r218",
      "r220",
      "r225",
      "r227",
      "r229",
      "r314",
      "r315",
      "r354",
      "r494",
      "r495",
      "r501",
      "r502",
      "r503",
      "r505",
      "r509",
      "r510",
      "r515",
      "r517",
      "r518",
      "r520",
      "r522",
      "r552",
      "r553",
      "r677",
      "r679",
      "r694",
      "r1067"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails",
      "http://www.izea.com/role/RevenueNarrativeDetails",
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenue",
        "terseLabel": "Net revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r124",
      "r243",
      "r252",
      "r253",
      "r267",
      "r273",
      "r276",
      "r278",
      "r280",
      "r424",
      "r425",
      "r597"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.izea.com/role/Revenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r428"
     ]
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueRecognitionPolicyTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources."
       }
      }
     },
     "auth_ref": [
      "r742",
      "r798",
      "r805"
     ]
    },
    "izea_SaaSServicesSegmentRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "SaaSServicesSegmentRevenueMember",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SaaS Services Revenue",
        "label": "SaaS Services Segment Revenue [Member]",
        "documentation": "SaaS Services Segment Revenue [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r896"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r1015",
      "r1016"
     ]
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost."
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareScheduleofAntiDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r52",
      "r506"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/LossperCommonShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r932"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r845",
      "r1004"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.izea.com/role/IntangibleAssetsNarrativeDetails",
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r347",
      "r349",
      "r350",
      "r352",
      "r598",
      "r797",
      "r822"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r822",
      "r957"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/NotesPayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Long-term Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Nonvested Restricted Stock Units Activity",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_ScheduleOfNonvestedShareActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfNonvestedShareActivityTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Nonvested Share Activity",
        "label": "Schedule of Nonvested Share Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested shares."
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.izea.com/role/PropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r556"
     ]
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Cost [Table]",
        "label": "Restructuring Cost [Table]",
        "documentation": "Disclosure of information about restructuring cost. Includes, but is not limited to, expected cost, cost incurred, statement of income caption that includes restructuring cost recognized, and amount of restructuring reserve."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail",
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Option, Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r104"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r822",
      "r959"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "us-gaap_SegmentDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDiscontinuedOperationsMember",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Discontinued Operations",
        "label": "Discontinued Operations [Member]",
        "documentation": "Component or group of components representing strategic shift that has or will have major effect on operation and financial result, classified as held-for-sale or disposed of by sale or by means other than sale, and business and nonprofit activity on acquisition and upon joint venture formation, classified as held-for-sale."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r57",
      "r58",
      "r59"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r126",
      "r243",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r280",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r352",
      "r366",
      "r369",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r811",
      "r814",
      "r815",
      "r821",
      "r873",
      "r1031",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r147",
      "r150",
      "r152",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r278",
      "r279",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r706",
      "r707",
      "r708",
      "r763",
      "r765",
      "r768",
      "r773",
      "r780",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r800",
      "r830",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r872",
      "r880",
      "r974",
      "r1031",
      "r1033",
      "r1034",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentOperatingActivitiesDomain",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Activities [Domain]",
        "label": "Operating Activities [Domain]",
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.izea.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Disclosure",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r243",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r263",
      "r265",
      "r266",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r280",
      "r810",
      "r812",
      "r813",
      "r814",
      "r816",
      "r817",
      "r818"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Net Loss",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r265",
      "r266",
      "r273",
      "r814"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://www.izea.com/role/CommitmentsandContingenciesRetirementPlansDetails",
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing (1)",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesAPreferredStockMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series A Junior Participating Preferred Stock",
        "label": "Series A Preferred Stock [Member]",
        "documentation": "Series A preferred stock."
       }
      }
     },
     "auth_ref": [
      "r912",
      "r913",
      "r969"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, award vesting period (in years)",
        "verboseLabel": "Share-based compensation arrangement by share-based payment award, award vesting period (in days)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units, nonvested forfeited in period, weighted average grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r458"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted",
        "verboseLabel": "Restricted stock units, nonvested grants in period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units, nonvested grants in period, weighted average grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r456"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Restricted stock units, nonvested beginning of period",
        "periodEndLabel": "Restricted stock units, nonvested ending of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Restricted stock units, nonvested weighted average grant date fair value",
        "periodEndLabel": "Restricted stock units, nonvested weighted average grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r453",
      "r454"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Restricted stock units, nonvested weighted average remaining contractual terms",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Restricted stock units, nonvested vested in period",
        "negatedTerseLabel": "Restricted stock units, nonvested vested in period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units , nonvested vested in period, weighted average grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r457"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails",
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail",
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails",
      "http://www.izea.com/role/StockholdersEquitySummaryofStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, number of shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Options, expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, expired",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r982"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Options, forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueRollForwardRollForward",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] [Roll Forward]",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grants outstanding",
        "periodStartLabel": "Options outstanding, beginning of period",
        "periodEndLabel": "Options outstanding, end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r446"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price",
        "periodStartLabel": "Weighted average exercise price, beginning of period",
        "periodEndLabel": "Weighted average exercise price, end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r446"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares expected to vest",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares expected to vest weighted average",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "izea_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining years to vest (in years)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Nonvested, Weighted Average Remaining Contractual Term",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Nonvested, Weighted Average Remaining Contractual Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails",
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails",
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsScheduleDetails",
      "http://www.izea.com/role/StockholdersEquityScheduleofNonVestedRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r441",
      "r442",
      "r443",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, exercised",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average exercise price, forfeited",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r438",
      "r444",
      "r463",
      "r464",
      "r465",
      "r466",
      "r469",
      "r472",
      "r473",
      "r474",
      "r475"
     ]
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement, Performance Shares, Outstanding Activity",
        "label": "Share-Based Payment Arrangement, Performance Shares, Outstanding Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for outstanding performance shares."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "srt_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "srt_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, nonvested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation arrangement by share-based payment award, options, exercisable, intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Common shares, nonvested beginning of period",
        "periodEndLabel": "Common shares, nonvested end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfSharesRollForward",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common shares, forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "documentation": "Number of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value, forfeited",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average grant-date fair value of non-vested options forfeited."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted average grant date fair value, nonvested beginning of period",
        "periodEndLabel": "Weighted average grant date fair value, nonvested end of period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price",
        "documentation": "Weighted average grant-date fair value of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining life (years), outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining useful life exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common shares, vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares",
        "documentation": "Number of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofNonvestedStockOptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value, vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' Equity",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r103"
     ]
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Share withheld to cover statutory taxes (shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "izea_Sharesissuancelimitperofferingperiodemployeestockpurchaseplan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "Sharesissuancelimitperofferingperiodemployeestockpurchaseplan",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issuance limit per offering period, employee stock purchase plan (in shares)",
        "label": "Shares issuance limit per offering period, employee stock purchase plan",
        "documentation": "Limit on stock issued during period, employee stock purchase plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short term investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r121",
      "r914"
     ]
    },
    "izea_SignificantAccountPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "SignificantAccountPoliciesLineItems",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Line Items]",
        "label": "Significant Account Policies [Line Items]",
        "documentation": "Significant Account Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_SignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "SignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAdvertisingCostsDetails",
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPropertyandEquipmentDetails",
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesStockBasedCompensationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "documentation": "Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company and Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r211"
     ]
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://www.izea.com/role/SoftwareDevelopmentCostsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software Development",
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "izea_SponsoredSocialRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "SponsoredSocialRevenueMember",
     "presentation": [
      "http://www.izea.com/role/RevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsored Social Revenue",
        "label": "Sponsored Social Revenue [Member]",
        "documentation": "Sponsored Social Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.izea.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r126",
      "r173",
      "r243",
      "r248",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r280",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r352",
      "r356",
      "r366",
      "r369",
      "r655",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r811",
      "r814",
      "r815",
      "r821",
      "r873",
      "r1031",
      "r1033",
      "r1034",
      "r1035",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAuthorizedSharesDetail"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r182",
      "r183",
      "r184",
      "r213",
      "r233",
      "r234",
      "r236",
      "r238",
      "r245",
      "r246",
      "r313",
      "r378",
      "r380",
      "r381",
      "r382",
      "r385",
      "r386",
      "r406",
      "r407",
      "r408",
      "r409",
      "r411",
      "r538",
      "r687",
      "r688",
      "r689",
      "r690",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r719",
      "r740",
      "r759",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r895",
      "r923",
      "r931"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r70",
      "r73",
      "r74",
      "r172",
      "r199",
      "r200",
      "r201",
      "r216",
      "r217",
      "r218",
      "r220",
      "r225",
      "r227",
      "r229",
      "r244",
      "r314",
      "r315",
      "r354",
      "r412",
      "r494",
      "r495",
      "r501",
      "r502",
      "r503",
      "r505",
      "r509",
      "r510",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r552",
      "r553",
      "r557",
      "r648",
      "r677",
      "r678",
      "r679",
      "r694",
      "r759"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.izea.com/role/RevenueDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r147",
      "r150",
      "r152",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r278",
      "r279",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r706",
      "r707",
      "r708",
      "r763",
      "r765",
      "r768",
      "r773",
      "r780",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r800",
      "r830",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r872",
      "r880",
      "r974",
      "r1031",
      "r1033",
      "r1034",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041",
      "r1042",
      "r1043",
      "r1044",
      "r1045",
      "r1046",
      "r1047",
      "r1048",
      "r1049",
      "r1050",
      "r1051",
      "r1052",
      "r1053",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1060",
      "r1061"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r244",
      "r553",
      "r597",
      "r685",
      "r705",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r719",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r738",
      "r742",
      "r743",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r759",
      "r881"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "presentation": [
      "http://www.izea.com/role/BusinessAcquisitionsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Activities [Axis]",
        "label": "Operating Activities [Axis]",
        "documentation": "Information by continuing and discontinuing operations."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r244",
      "r281",
      "r553",
      "r597",
      "r685",
      "r705",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r719",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r738",
      "r742",
      "r743",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r759",
      "r881"
     ]
    },
    "us-gaap_StockIssued1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssued1",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of common stock issued for services",
        "label": "Stock Issued",
        "documentation": "The fair value of stock issued in noncash financing activities."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued for payment of services, net (shares)",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation (shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r69",
      "r70",
      "r101"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityScheduleofOptionsOutstandingDetails",
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Options, exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r69",
      "r70",
      "r101",
      "r450"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued for payment of services, net",
        "verboseLabel": "Stock Issued During Period, Value, Issued for Services",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r69",
      "r70",
      "r101"
     ]
    },
    "us-gaap_StockOptionPlanExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockOptionPlanExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option plan expense",
        "label": "Stock or Unit Option Plan Expense",
        "documentation": "Amount of noncash expense for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "izea_StockOptionVestingPeriodFromGrantDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "StockOptionVestingPeriodFromGrantDate",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock option vesting period from grant date (in years)",
        "label": "Stock Option Vesting Period From Grant Date",
        "documentation": "Stock Option Vesting Period From Grant Date"
       }
      }
     },
     "auth_ref": []
    },
    "izea_StockOwnershipPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "StockOwnershipPlanAxis",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Ownership Plan [Axis]",
        "label": "Stock Ownership Plan [Axis]",
        "documentation": "Stock Ownership Plan [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_StockOwnershipPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "StockOwnershipPlanDomain",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Ownership Plan [Domain]",
        "label": "Stock Ownership Plan [Domain]",
        "documentation": "Stock Ownership Plan [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized for repurchase",
        "label": "Share Repurchase Program, Authorized, Number of Shares",
        "documentation": "Number of shares authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r970"
     ]
    },
    "us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share repurchase program, remaining authorized, number of shares",
        "label": "Share Repurchase Program, Remaining Authorized, Number of Shares",
        "documentation": "Number of shares remaining authorized to be purchased under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchasedDuringPeriodShares",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares repurchased during the period",
        "label": "Stock Repurchased During Period, Shares",
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r69",
      "r70",
      "r101",
      "r690",
      "r759",
      "r777"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets",
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "periodEndLabel": "Balance",
        "periodStartLabel": "Balance",
        "terseLabel": "Stockholders' Equity Attributable to Parent",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r73",
      "r74",
      "r94",
      "r721",
      "r737",
      "r760",
      "r761",
      "r858",
      "r888",
      "r924",
      "r954",
      "r1014",
      "r1067"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events [Abstract]",
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://www.izea.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r558",
      "r559"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalUnemploymentBenefitsSeveranceBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalUnemploymentBenefitsSeveranceBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Unemployment Benefits, Severance Benefits",
        "label": "Supplemental Unemployment Benefits, Severance Benefits",
        "documentation": "Liability for amount due employees, in addition to wages and any other money that employers owe employees, when their employment ends through a layoff or other termination. For example, a company may provide involuntarily terminated employees with a lump sum payment equal to one week's salary for every year of employment."
       }
      }
     },
     "auth_ref": []
    },
    "izea_TheAmendedandRestatedMay2011PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "TheAmendedandRestatedMay2011PlanMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityEquityIncentivePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Amended and Restated May 2011 Plan",
        "label": "The Amended and Restated May 2011 Plan [Member]",
        "documentation": "The Amended and Restated May 2011 Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_TimeBasedRSUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "TimeBasedRSUsMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityInducementPlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Time-Based",
        "label": "Time Based RSUs [Member]",
        "documentation": "Time Based RSUs"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title and Position [Axis]",
        "documentation": "Information by title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": [
      "r939",
      "r1017"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityRestrictedStockDetails",
      "http://www.izea.com/role/StockholdersEquityRestrictedStockUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title and Position [Domain]",
        "documentation": "Title and position of individual or group within organization."
       }
      }
     },
     "auth_ref": []
    },
    "izea_TotalvestingperiodMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "TotalvestingperiodMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total vesting period",
        "label": "Total vesting period [Member]",
        "documentation": "Total vesting period [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r941",
      "r942",
      "r943"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.izea.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r401",
      "r410",
      "r521",
      "r537",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r649",
      "r847",
      "r848",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855",
      "r856",
      "r859",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r950",
      "r951",
      "r952",
      "r953",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013"
     ]
    },
    "us-gaap_TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Translation Adjustment Functional to Reporting Currency, Net of Tax, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in cumulative translation adjustment, after tax, from translating foreign currency financial statements into the reporting currency."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r1015"
     ]
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityShareRepurchaseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares repurchased during the period (in dollars per share)",
        "label": "Shares Acquired, Average Cost Per Share",
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://www.izea.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.izea.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock at cost: 767,335 and 586,849 shares at March\u00a031, 2025 and December\u00a031, 2024, respectively",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r70",
      "r73"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r45",
      "r101"
     ]
    },
    "izea_TwelveMonthsAfterGrantDateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "TwelveMonthsAfterGrantDateMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Twelve Months After Grant Date",
        "label": "Twelve Months After Grant Date [Member]",
        "documentation": "Twelve Months After Grant Date [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.izea.com/role/AccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r367",
      "r368"
     ]
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USTreasurySecuritiesMember",
     "presentation": [
      "http://www.izea.com/role/FinancialInstrumentsFairValueandNetUnrealizedGainsLossesByInvestmentinOCIDetails",
      "http://www.izea.com/role/FinancialInstrumentsMarketableSecuritiesbySignificantInvestmentCategoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "US Treasury securities",
        "label": "US Treasury Securities [Member]",
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years)."
       }
      }
     },
     "auth_ref": [
      "r806",
      "r836",
      "r838",
      "r847",
      "r1027"
     ]
    },
    "us-gaap_UnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnbilledContractsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/RevenueContractBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unbilled Contracts Receivable",
        "label": "Unbilled Contracts Receivable",
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r593"
     ]
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnbilledReceivablesCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesAccountsReceivableandConcentrationofCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled receivables",
        "label": "Unbilled Receivables, Current",
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "izea_UnrealizedGainLossOnSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "UnrealizedGainLossOnSecuritiesMember",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized Gain (Loss) on Securities",
        "label": "Unrealized Gain (Loss) on Securities [Member]",
        "documentation": "Unrealized Gain (Loss) on Securities"
       }
      }
     },
     "auth_ref": []
    },
    "izea_UnrealizedGainOnSecuritiesHeld": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "UnrealizedGainOnSecuritiesHeld",
     "crdr": "credit",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityAccumulatedOtherComprehensiveIncomeLossDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain on securities held",
        "label": "Unrealized gain on securities held",
        "documentation": "Unrealized gain on securities held"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.izea.com/role/CompanyandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r133",
      "r134",
      "r137",
      "r138"
     ]
    },
    "izea_VestingFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "VestingFrequencyAxis",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Frequency [Axis]",
        "label": "Vesting Frequency [Axis]",
        "documentation": "Vesting Frequency [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "izea_VestingFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.izea.com/20250331",
     "localname": "VestingFrequencyDomain",
     "presentation": [
      "http://www.izea.com/role/StockholdersEquityStockOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Frequency [Domain]",
        "label": "Vesting Frequency [Domain]",
        "documentation": "Vesting Frequency [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r238"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.izea.com/role/ConsolidatedStatementsofOperations",
      "http://www.izea.com/role/LossperCommonShareScheduleofDilutiveSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r238"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-12"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1D",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1D"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "715",
   "SubTopic": "70",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480489/718-40-50-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1A"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1B"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-1C"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-7A"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-3"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-12"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "920",
   "SubTopic": "350",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477346/946-830-45-38"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482630/740-20-55-7"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Subparagraph": "(ii)",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "1",
   "Publisher": "SEC"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "6",
   "Subsection": "04",
   "Paragraph": "12",
   "Subparagraph": "(b)(1)",
   "Publisher": "SEC"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-40/tableOfContent"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/730/tableOfContent"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-6"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0001495231-25-000102-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001495231-25-000102-xbrl.zip
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M >/X!FP&&[=;5X+-]J.[*B(35.TJ;!:YXT)L\QFOYQ[RM>#? 5!+ P04
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M<6T5>*JU=_86/$Z?SKE 9'/QD]<VUY4TXGMM)3[BD[1*O,ES5]M(B^#' @W
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M;0+(MB0_$C\2P'4<U,,:I[&#=OLRT"(5<Z5$C:*2>'_]CI1DIW&>V+HD6(-
MD'4/_N[NQ^.CO]"1..@O&*$'/_1_K%;A4 99Q&(-@6)$,PI9RN-S^$19^@6J
MU4)K*).EXN<+#;[KM^"35%_X!<GEFFO!#DH__7K^NU^W@_3GDBX/^I1? *?[
M%3YW._-&QVV[?C!OM@,R=UW\M+L7^&WJ[NUV?O<J:(KJN4VJEX+M5R(>5Q?,
MC-]M^K7=5J)[EYSJ1==SW9\J5O6@'\I8XW@*[?/7W,V&,\VN=)4(?AYW;4B5
MW+04!U)(U=UR[5_/2*HAB;A8=M_.>,12.&:7<"HC$K]U4A*GU90I'N:**?^+
M(2:$9W]>YI!WT8_@,2M#\'P#>O3Y_?C=> 8-O^9_C?AAK+>$>;O1'UFJ>;C\
MYB$V;PWQS9;7=GN/P1D@<YAZIDH,1Z>S\=%X.)B-)\=P<G8Z/1L<SV V>?'(
MO3TXJTUKPQI,1T.+WFNT7.?%XQY,87 X.9F-#E]5NLLD8_^"R1',WH]@.CA]
M-S@>3:N3S[^,?H7!<&8DONL^:DZ_ENE9X.S93SRF6(1NHYU\^]9Y._!Q#(&,
M8Q9H+F.XY'H!>L'@8T84DD,LX90E4FF0(8Q_&PW,<B4H+AC,@7$<U!P@B.2"
M4()N%&H2ZV?;^'BSM>?[;F\HHX3$2_O+Z^TX@/(CJ2+PW.I'"*6R R8(7U)@
MF! *'X@*%GE*&YYCUTD<*(60"Y2N0$Y9D"FN.6:#Q!1&5\&"Q.<,5]@HXFEJ
M@."_T:2X',."*89A7,>6![>&-G;@A&'<\',-WG'4=V"XX"R$(QZ3..!$P"0,
M>8 :Z,DX*J)S +^9NCJ09"K-"%922[C65(H,VZ9B8B%4)F:/<%V]5#*3HO _
M)6I.8I96)U>"+6$0V%*82>&@G"#VUMY3>/>RYL?S@-GV=G(\_^0YP^(4<R/,
M!$Z4 )D@#!=7_%3LSXPK9K9RJ:G:F@/;9 >0^%YKF^ZL*KUF\XK)1;F]3J.)
MA>[T#,^_%_MIQ?;_I6+S&'M5E/<W;)F:X% 4O]KBE4P@W/3,1+'4%-TQ8B($
MH!FBQ^Z!@@19D#K6*EQU%71(N75M.AEJ92+GC,3&:,=,;W2<VG<>/ G,H3F1
MV6YYO; ?R#)_\1KY.O/*LWK[:>8Y@6X^[TQQ1-0YGDZU3+HMNR'29"Y8*9U+
M19FJ(GI!DI1URY<>Y6DBR+++8XO!&O4*7W.IM8R,N]Z%6: #(HHBVGKFXN(
MW/+P^%@,C$G4M!RY.!_77"NK:[HI;'CMFGN/_%[C^X6=%:J'C>L6N"HURG(T
M\Z HMAF18O/8KS0JI4Y"*.7Q>==/KL##-%WCN6#A9MID\M_SWLWIU-SMI?9Y
M8Y.V(E21G]<=Y5=3Y.ZB-AKW%+68*V8F^0G&( 6G4()_8B[R.?),Z;A1:&QN
M=^S'C6C[1''\F.#7M=RLIX,@D%FLS65<H;[S?^!,W;;"1ZX1-^A5W@TF,K7[
MDJYB O<A%VSCMG#-.=MJW;4)F2/Q,KUI\L %8_',KSOK]IKU;U!+ P04
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M']B'OWQ@0_="]ZWSB^L]2W'RYI-?:ZX7CWS[[2(( P( >*\7^"")V*^>ZY*
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MJ44M2MC/032),9Y(O1<1^T?=[@.L%[;_ KX"!B6BUPSGO68J8"*]6+(EWX[
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MB2P%)%GJ8&F;X:)0"51;4F:LB;H@*? LCO*[EPPNTQB61"(:KWTCR:8"8H&
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MC;+A ]K4HK%TR=DLAL92!Z,PIAN2%Q'Q;:R]^OCBN<D@E[^I%S.V5":OV#T
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M'V9=AWO_'*X?NPSCK),Y>1V1 !3(.CV,>>":S3I85T<:3KRS=V4.>*%DX&Y
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M0>XB,B!!#!(A?9FNOCK^NHIY?"[9-@_FT(Z>@ EQ$V^N!GL,-77O)M).-_T
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MCC(XM5V"!1"9WMW9YJK?)P[MP4U>(0 +GH@4@>V7V._4I4?3(4[S[<\>,!)
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M=+0^T<4#P>_ :N 6,#YP&M(XDSR9R9> 4K913\<#0A+4HK!^:NB9=ZRK,II
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M_]E[]^:VD21?]*L@='?NM2,@-@'P =IG%2&_>K7';7DMN>?._><$1((BIDF
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M:XRZQ5L"GX]X5^QH^4O#U^!;Z?66)Y#V07/Z)\^X8AYJ;D%&!T*,$E8+C\@
M(28 ]_TAB%H(1<(3J @:!)O?D#R@Y.N@-0>!'D57T,-^3O%&-/"C4"XD5Q39
MNL3MPEMGT*WRZ*(+D'E^#2\*2$9(:1RO/U"1@_YKHC< [^[!C\M;HTO0]1;6
M6B:V<'@H(E#DA+-;,$_8 2^JL[BSZ%1(")#2S6!9W-DEZN(O8;=+@_G2(UU
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M(P%;9OM;<60&/\X+Y9@E:02U=_%X(G#QAD"=6'R!\S _]IL?=Z&?9DD""XU
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M9 9/8:9QS*1>0(G/$:.&E6J%$H:PI80N&UDUBPW^[C@S2K6*%-OS:&D$=3
M=6%:?U8W+GB2>M87[$#*1<LW@2$B9&UO9'YX'AP=8<9ZY8BL-;IHY:[G:S7V
M5/I=?G27'[UW?O2HH-BG.J[AB7@AK)"+6F\\32T"A?1BF[  ,P1CC0#,$,I&
M+(G*L&VT%2.-#GVFJO6B-_VER)2CXI:H&6#,P"9SW!=$X7Y$^'1R(&P0- /V
MC&64F:*]:5:+U0 !<,>T5VXLQA#+HS>(,\4$7*96AY[G2'YL%-0-+I?-,C-G
M-IZ-'"1G(O8;OQ+,R!TB3L-R(X5"J8L-DY-1[PBLXH!MX);#A#\;<Z.CER3>
M_N6N*UEBH$R&%\NUX;L5>:4<U_MG&S?HB!:8X;2GP4_J+;L$[@A5J.^N8SL;
MT2"7Z=]YQ0B#?DG%^T1<7+WKV)3Y#V_0?)]%%<OXMIP!<DRPUFMN"N^UV).;
M&)7"N84Q%/.1V/2'T!O?23<K*DT/Q /[BC17\?0GRT.W-_KCWITT1GP3<6B@
M,X-%!+]<WWU@/BDXY[N?O$VGJEWVQTWKD97:?]&Q4]7[;\59X,?%IW#*0^ (
M&QO6)I7*27Q6$(Q-%1@Q<;N$IN_QZ<^"Z8O"'WX]A!7\PJ'$FYC/(K^!>^<!
M88ABO<YCF?!X\M31)FPJNEP*]2,Z4!A(X4]2!D%P#-RE&]46R*A%%=%:Q=/(
MPTTP6:_/)]8^:6ZAYX]GE#^8($<H\D+&0]B 61G*G(I9!_O8"Z+8!)6&&\BB
M\P:FS9(KD&/XK"S?YQ=ZF ?AFF!LAQI$I.\\-_A91P$Q*VX>A_N2I?*T)#!3
MFU2-EOFE!6KX;:,$:;0/^%9!.I&EZ"*%U!H/0JFU;<&IJK](S_<H>U+RLJ@O
MI*"+8W.'#&;^$)\Q79IUU03U;PJZ:<3^B%8G8FA2EAY<YR_31C@?4<C!"9W2
M3UA1TS]!,?5F5L1S'3KNN!)!\37<F"!KG4D7$3,+.!-F\M\&? 7:-<]=B<<]
MF8%%36XXGK$H^\HHM<ODL'/2T;;IHYA_(_T#7</L'$IF,"IJ.H7Q/.0-<)7Q
M^(A@U,)&Y"S',2=.+URB6MJ@4+@,+ON:].9N\^"S"UCM7X)0D;8N,25.T./*
M2G,C8:PL12)2E"<2U[9\+8*]Z'9]=%R65YM4#[+Z=N?I!UQNA-Y;<;UNN]Q'
M,56A^N_'B>+AJ#;$FO4(X]RW5B(M)BQ)9=H$?X(M;A8"U6^+EV5[G]':MB8C
M737-J6HH4VTPG4X?Y@^SB:*I<W,V5<;3^?]1L"?3-G6B=B^J4LXA>7O_65)[
M>:7">\<)PTLTPTFAI&.& R4=,_SP\^[FV^>[.^GZX__\O+F[N;^Y_0;_^/9)
M^G3SY^>[^YO[GS\^WZ6/+"%I\UVD.>Y/-I>,&:H7D0%/?QE]LBB"3(D;0.C_
MY3C_WL"?RQEU3?A^_P_IJS\[@U2.VXCBI^AR1#X'F(4!""!^.BNU+T&"!WT?
MR? (H?<0GXA,"C0HGE J7F_0Y[K$:EH.2T2H_IAHS3H DDO6?&1PV6L42/]F
MO3B#VL'IAI?<,SG/79O.W/(CQ>X6:1 NAE*)J@T["G"4BH,&JWPVHHB(3G3C
MA-V&LKP2?M2P7YB?PE-.O'OGFKE?/P2^W]\1(KM<NLDHE [ 96H&SA033"ML
M \<!_0UO(<<2]4)@;#AI@A2+-0ZL#@+55*UL)P@W)L"0=(BN YIA_GVF%E :
M(U#C%'%!\9%JE*(44PH?]XOKK"*RZW8>4LPWT[^=?X1)L.^K)RL-M(NKL28/
MU4F*@&16>3_?!^%MRPJC,Z=5FJ%5!$-77LP 6$'/3KNRXG"V/ ;%_"3A>3+P
M4<(8V/LPT8WUGQ>7L9Y>7V'DVSDM.7&6=)+WX0P)+S&+W8<75THO?5H2Y_3P
MU/:9/J)!Q8]*  ,%^$XFMB2#_WZD_HW5Q=;HXJK?T[:(K1A<3H#/058!W&C.
M(VLP'70R1>\92!R6Q9T=AXL")Q-?X[,RRR&E8NQ0W\\OTX]$_H(.S<P_P+RD
MXA:)U;8,M@/M5=&5M8N4SG82I5BK22G. KPHU(K'&3KG.*T5?[GY=OWMX\WU
M5^GFV]W]CY]_?/YVOT4)SKL0QIEZ[ECHN<T.&UY<?20% /^DG$A6-,"%( .9
MYK$(L!>9F?WF.BA#0#J_@U^\;;]^G"QP@/L->Z<P,"%$=T"@;]&-[,&P62,<
M@GR>O818T21U>&2>XB(V7F2\A978PIYT$WS,5<V75.?E0,*(Y/3H4$)!7E,(
MFZ#484]%*J^)TS%%&T99PC0'ID.'0V )"C_FE?&+?>V:</VDK/E*#!N23$@Q
M&6RJ9[",7CKAM?F4-'<0#XX<)BP6MG">O<S3Y0HX\I^9Y+]5R'\A\: C.QH,
MBYPI=U.]\)3'C$K*=UV:8+4T0:5+$^S2!/=*$Q2Z0-ZW>G&:('S')8!@)L1%
MNL1^.L;:,]^)O[R?6=YZ:;R\LVS:$OK1^[@)CB1'<-*@=_.ET2K9UYP:)^.>
M-M*1('T7_C<3+^:TVH,M_BW]N:;T!KJ:^56_IV1^GC?4I*>/LK_I1HI]WN^-
ME.R?[##4>#3>-A20&A(](9KS9P31P25BXE._$<VX>8]S9(QW?0ELB?Q1Q6/J
M^A<^^#[%BDDJ9@1\?'E#@OM:%%>B=1[(!7]V'JO[:0OX6>EWPXI4YISA M$1
M8Y[?"D,(Q;-;&MFMJ"HG#=C]5HK(/;GK;);*P[:!Q7)S#/:#Y 2,$-9HZ]0R
MK 34:RZU7H8N@O6N+,_AC9+P*!0<8\4KZ,&8_O7H8KNT2[X'TZEISN?ON6*%
MTP-JD$AKE'"#WN]**$<V6.(,D;0HDPQ1SW;TI9-NRJ34GOS'@=8>7;.+[VO2
MHBNY^=7"@$S@[_OBN.CM^V0^^*%XN18X":C^?,#B[,H1FLG%U4@>J9JL#48Y
MOO_#'"%^5>DH?^MXYQ7P#CGGU/<=Y764UU%>1WFO@O(.J"^$ND)<<ZBJ)PS[
MG9[0\4R#%ETCSZ#==FW/\#\1+\:U_Q&;FL!ND/NF,L,H'<-T#-.@13=7O3F$
M8VE._[>S^^B02?*%IW30MA1IOV'6)';U&ZKE_89;SVM+D*K[_7Z_K\MOF\7\
MXZ9[:9W5"N&(L8346)MNB6C%UO6S[:ZFD\#POSSKG6TM><;5WIX_H7E@QD-2
MX4@O3ZUVO)D7>^,NN:HGL+OG=<JA<,T9%8F$D4R,U'Z@Q@?WQJ^XUCBW?IFS
MRW^;KI.E,&K!'5V3NECGU=Q1RV&H!</>.U'+H*.6\Z&6<EZ:8H(8=@317H+8
MP0513 VCCAK:9%^WRHINA9K_!ZSY)2A:AC7EIR45D6/&#K2#'"L)I\%)<Q"&
MXXNK@29/](G<[ZO[RJL"FCV$O.H(Y 2FDE[;[=912VNH96=3:=)1R_E02UT!
M[5&_NW1:31@'B=J.E(XJVF(Z'6!WNP@)5>7<A;T-P]KGG<RGUEKSE035\*3F
MTTC%]F9]I2^KP[U%5N?M:1I]U&X]C;I T[&IY4T#R*7 ?"HA8P8H8T9Z&M7N
M;4<L[1$MM1E/0[IR^KH\'(T[(=(ZNJ@[W#3JPDTMIH8LW"A>U5Q9,(R;+1B.
M$QM3M(9;>(3\[AO+?4)B>^2#MYN91J>U]O2+J\% GDPF8.X-:O)0'2>]NR.J
M Q%5_29B[2&3CL).;E8>AL3V,BO'_?W-RH[ 6BG"ZC)%QPJ_#\>@<J91N#MI
M=8[$=)#8WU@]0.ROHZ1F4U*-MN]8J]'V/2KY'#SLV9:Z2[6-=9?:/G67I>M[
M*U<D=B.W:^37G"Q^[7FF+^&2]DUX:&T.3J4[=7Q %UBA8V)<7]E;EYS5-,*H
MW8TUKJ\FKJ.6UE#+KGGBX_J"F!VUG)Q::BBI'8\[@F@O0=2=XS#NBHY:3 VE
M_3S%--#H4J(N>YWA^[AK!UNT 3D\^%T">QG>T4^:TJ#W+ZZ&(TT>C?.:)G?9
M8ZVECMJ-.EWI<@T;G6=P&'))6'5ILE OKM+AWRX[O462HZZ4 %WC]\FH+N#=
MCBJ.1Q5UVVUZAY368FJH,3ZO#YLL%KK,]"XS?5]6FIS6C!O59L9UR5/G0%'U
MFWZU.^0["CNYN7@8$MMJ+NK[F8L=_;120M5F8DYJTR4[2FH%)=5MED[ZW5WV
MNBBH1E-VHK13_!PG0JE,&F[DWF=9N"43?-G$WX$=+\V<#78;IU/JNG/MN3-G
M(X7VZE.QMQ-@HH)D4F5%'\EJ;>'<.@YX1]'5<67'E2?GRMH=*9/:(> Z%CT]
M/78LNI\KZN@=GDI<IPQW;Y(&>JF<V=!QZ.G)L>/0(UZB=?GZ)D.NT@[DH:YT
M]V7'C1TW;N?&@T!T3##$W)='BBIK [UCQ8X5.U;<SHIU.IX)WW,X5F55T]K/
M?V4=T[_1[@F #?A#/+TRW$?+IMF-XASVSXWG6_,7]I%ESV"SWRDZ=8FNE9B&
M/7TKN(A:!"ZB%*.+*&\E_+^#X*)L9015,,+<<7S;\4U&A_:E@H3+/OKAX%P6
MOK]^]]MOS\_/O5\/[K+GN(^_J?V^]IL+7_\FGKVXXG0OA3PAA4PA+8PG4S*D
MA;-$RI+6,%]G!IP'%"C%E@Y+F5Y:ORX7U@Q.]AURAGYQ!23#]TEZ,0V7^$.\
M^JH71VFI0D0MHQDB&.F-&J><C%-4=SW%4Y A0PA2I+EAN=(3:B^2":<#PA->
M8;BFA!LPDT!2_VL#DYQ):]>:PE>6+:%X!,)BS2@]%+FP T"%N'N2@=@C,((]
MDY:6\6 MB11#:HG2T%;:X3+Q$N_W=ZI*R$%;A-*E0@!#]=.8N@>)J3V]).91
M!EEIS2"KTEP6/;-Q;S# <]R1\TXHI@6"UG;^<![@#4\D>RU[O0'B=_P%2%A_
M8=3#/')BE/AOX!^>!>LWW)R?XULM._Y>&7_&ILGG#+/U:5V1Y< S4UC#@PF:
MA>LZ#U2'.I,>7J(/\9ZT,\,W:&;>YL'S#9B<L5R^P+"F--\LEY)ONBO)F=,'
M.\@(_ R51,O>&*2<[:ZV:*/ZQ</V2#D1U3TL_J.S@C>_2*X)FSKSV Z%1 9;
M- 4C4S)#*Y,V:A7>\&$-,)(?_O[!6!KV%+Y9F*;?D_ UQ@S7;J)2Z/FR]+RP
MI@LXZ^ER,X/?;0)_KO1H6#8_"P?.!4C#->=+<PKOA5/RE^8*%0QC!:HN?&3-
M)3A7&.@)N&'%9@=$LS"7,\EW8)8^3NV%S2&ZU$>;WF;0^W"5_U'%(E *+0*,
M&]W:Z"2[G=^$,ZML#4PNKE1-'D_2F91$V;C3_L(U@>9A<@M/,H&@9JA[31?,
M5M 465+[ZE"F_=Q_V<6-#G*7G5P9$./%E:[T]US6 $G#6YLD299PQC_R:(AH
MPH#%K-:@1 +YP,*%M($/3>F-^6MMVI[Y5I9LI-B?^?28/Q9^Y)H+& <EFQ@9
M?_56>H/Q0+7__O;C#?U->?\VH;&RK?BV60$K3]/DQK8:9F2\^P+<2?Z=V#;?
MV*'2'??(WN-']S#:AZ4S_2L\!!C5A*-9P[B^NS$OVBO#YLYRZ3RC3<$ETF8%
M\X=!F#@3%^4L(=BB4@.X(2+2$M@&>,7 )<+$E^TCN6[@JA/2!2\;TWM7T@*!
M?>*SY)8[,\%AOY;&VC/?B;^\%[:R9=.JZ4?O^5C<G,]05^A8V-?OGZV9OT"'
M1Z_/G!X\!8R_F7_=@Z]^2W\^@E\I2N97_5[VYWE#*7I/&PSJ&VI8.-269+>2
M@(U[8*R*(2(_F0*1F>[!662<Z>O*N!%*8YJ>T39\,J?FZL%TXY=(QD[LFBU9
MVIG6Z/3)3QN\O, 41R<+ZMQ+TTNAN]2S%2=VGI?<D%V]YPWUCY=<=1,=Y(.^
M>C '^4E#4!V?O H^*6ZY7B>?:!=7(WF@CN6!7G,@]P!\LN6^3<:,ZGRJINK_
M1O-EM7J(>,5*FV/CM8NM.K?F?(1:]<N_LC0;U'CKUWB(=>L$'>MUK'=@?:(R
MZPUK5"1.S'H9N2:_Q;RN)9VP8G_OI@MSMD%O]S6+1OP('.PW]BVZA#]&/<(W
MY!#&?/4\A^RHJD.VF=Y76+)'/M70V\H<Z+;IIR,];YA;_2T/0)D4M[G]>"-+
MQN.C:SZ*$%_HK)6F\-FCX[XTUN,ZF?0&RK"JPU53>P-U4H^7=-@;*N,S'TK-
M_JH.-_"HC/^3.3-/='D4>'JEE),WZ=YMZ_*$!U=*.6]+N&WW]_LW<$<P%BA1
M,##WL-NZM&]P6T3BL!A=EM[@]9FJS6K]4KM3?-TA%RSC( TIF6K3A5TZ=W)!
M.HZ::?^Q)!'+-NRI92RI^9X7Y(Q\LKPI:-P;MVIUT* _/EQU4!=\Z;CE1-PB
MK/E$P7FBVK48)&+'GFB#?GU-CSI^ZOCIN/PTZA_U]IE<7 T&\@C^-QAUMT_'
M+0U8=0W<<LK;1ZD/(_/4*0)G$:?_W8'9V.3A?G#LV=ETR#X$-V478!SH[E$4
MC#_W^[H\'(T;V)GP/.FA$KA4BB \F/]_7EP>2<Z6H"'*7!SI:=#&RJCH'>G4
M*DJ.ZD11M(NKR427^^-T]5,G2)H@2)+DT#A!,KBX&LI*/YT(=71!4A.J=*.5
MLK/O=WL(D9J=$G@HD=KHQF/G20W51&J2' XO4M-$,NKZES9/3F3G+QY*3HPO
MK@;R0.O+0RU-"IVD:(*D2!)$XY0OG90O/:V\'UV4O :/&/&^A$LQ9_NJ7NVU
M7RIQ4#9$QTXBM=AY/*F[P5)GR!Z!$$X9;U!K[\G5D4RM)#,ZICJF*LP3IH_W
M5L8Z:C@>-9Q<!5/5BRM5E0<3M2%D4VMOM:8W$'^MO=4.G ?1%306U1(?Z@;2
MNLX3'1N^%C;<JU=3T_PP:M>XJ6/8,V?8_8$ #G5O8L!-D?MC19X,ZXJY=6S8
M )+KV/"0>!RGNRU'<%NJLMJO*^S58 2/- @$GZ6"#1.:":+Q"4@"T3,JX'G[
M$3CS&6RO[?@AOK>$GTY=<V;Y 6BU/9,6!CZ'H^+;# 3M()1V@=:.X-NQ7R40
MJLM@WE??[*O_]>#BT18C>;1F7'ZP [4W'F9VF@@PF?\6QW?A,^F'/S$>@'4V
M?OY/C@^LFTV_BIH@E,B?.%T40]9DI*NF.54-9:H-IM/IP_QA-E$T=6[.ILIX
M.O\_B@9BBO]JX8;5[H_FY0.(PK\NC3DL\9VQ?#9>/)0&T=.$<TOL?'+3\D\O
MF&CF[DTT=3@>[;1[RK8*>=J];[?WGZ5!3V(LGOZS&BC1=]=9@_A\^0X\[5_;
M,^P.N,::@E#?2R,/J6-VDP%GF[-KGW]VF0*(__[C]OOG'_?_D*Z_?9(^_\_/
MF^]_?/YVGY+!25S[J- (7PG#YWVK*9-+M0WP1V*W2;Z:8JMQ+SW+\T5_D0 @
MZ9VT31[1I:FT!R1^..FI>C$.SP%!XO,_'VHU3FIT6KCY8Z)Z))L1[04S=-Z;
ML!<8T9D#FGS9N& F;;!3"@C&.9@I\/<.S:2KD"T*.(\+K>=<Q8:LY<HFL7YQ
MI4YDO1U )O4*D*@0[EBP8\$("^K'9,%):UCP->3:WL[GUM0,C9@NR3:?329'
M9!,->^7)P_[>@98#9,E58(%,S;\CI7$Q+$C-I*0TBY1>1_WH:KT!RW5/P=K>
M J!*\;-BB+::N0$32<=C>:+4I8 <6=/?6;2^#F(:%S?IK9F8M*814TTZ*Z,+
MM:<.&RYH,S.3JV@:>YBZ[6:4X@8^-?/)X.)*4T:R.JXK??_TCI?2$]E5!WZU
ME%F<3U,S90[;0YFO07'^:GJ>9(1)44 ):Q=.C^+$KTR'WBMW.\XTD32S3Y$-
MA;\O3?P+\-'URH&E_YL^S^6QRNPU @5)&\JCX3[ 19VBW42**Q;3)Z.X,5"<
MHLJC25HE;RM:0VNT\>S$&!E;@'6=2+MVB(TR9+Z9U66+?G&E8R^,NFK73UC^
ML(.-L_,T2X6>.[[O^/X89N(N?#^YN%+ZFCP<IRL/V\7X.:44V_+[8_FW;,Q_
M;CS?FK\T)24WJF-*YJ^U:7NF!']=9Z?J!EU'+3MF8=)C1D0O#<:"!S&I%W-\
M\3C(-O5\^,^*FIXZ<PE?1+]A=1?3:!=8*JV0G@U/^H\J)![S9=]\^Y*N+0JG
M7I6H!WU"U)@,T]C4-/]*$]T&.[3'-!68YD@>#M,0[%2Z4KY\AE:%&9LR'+^W
M-J=8F+%\*5/N4EP#4K;087)QM:TB99+'0,>I1QC658]P8_N&_6B!F&'UIT5E
M"!C^2Y8A#-1T&<+-M_OK;[_??/CZ6;J^N_M\?[=3!0*-G%_W4:.@RM[G3^;<
M D8RI:] ?3,IW"B)[52*O$K5'S5$"M]'ZM-XW=F,K_=R2>NUPO4:M%X4TA;\
M1Y2C>0O3].$[E*BI7.O>MD**D(TRZ[H:>75=9UTWY2\H?C$9TRG;>*SR.^XM
M-2Z.WT?7=SM/2H8LD:]=7*6A-JM?2N,M/M$M\ZIX3PTNK@836=6/=$]54=*.
MWP26B3KKT?*-99Y@JTW'S-6R3R'V9J9ONBMXQ&-%8-CC]PF1%Y#Y4-#-^*Z$
MXL] ;M^X5 W\8'B6ASR-_.S.2"0^6_X"KKR?2!3:I2X'Y63'W@1ZU3N<O34M
M(]A@"1N\@1^) Y"L0ST M^.C^[+VG01]-.ID93P08%,XI7]M')2F:] T3#HV
M)G61.4%J3Q<@/<PWWEOXV/#A\H-/'TS3#NEA)L%2'TSZ&0QB3ZTU4 $0_U]P
MW^'^>)OI0E#%FZ\F\+RD "6L-[[WMB=%:0Q$. HGE.#P_\;R!6F&Q,KR!=]B
M(:< XTC/"Q->YX:4R%\7$"1^D2#(!8A_MII93[J9<\%EVI=(HE3F:+@NW3+!
M*$9\#,E"*I_/37I\[CJK)"MX3F1?9%K&#)F=;#-QH:V0>-!F@W%A46RJ;%0L
M7S?]9]Q?^!B&3<P)28WO\]2,'@',+*B7G^TA41LODA ]@MWP' H "#9QT(9K
M1C:#I QLO4,$ ^3IK.HQ>OD8\)SED#KSO+" T&E<(C,\W#1QHA1D9&P1(8:<
M)$ 3'K&I...IR#(V:UBI!Y=S'"T!KNLI1:.\ D*BWWF<:@0-I<D]@VE@>V!M
MJY4Y S4-+FL< R]])QCVG(DMJ?974M**W7A?R'@@6RFIH:4<>84PQ(/AQ97M
MI'6S]'5<WAJ)45B@L1N,,N$7U;358A^*@(.YM>$.%6 1NZJMHW!;1J!K]_)@
M$(%6ECCO;0IL>0.M<4KJ[XXS>X9E[@L9TDC3,L,>?^3K#4B<$7>>'2*(/O95
M\IBS7<@EW6(#M?%NL5%=;K$?IF?B1G]"[<XA5_2U/1/% G?.W'^&6[G069:!
MV3'(P.RXN_UR__?K'Y^E3Y___/SUEA [I(^W=[MZS>@5&2]6@YA-R2VXFR[,
MV69IWLX+1/L]!B@R%J\GE]E 'Y@X11#FP2'#IGAPJU0 "&D/$,A +0;*. D0
MB*97&ZD# BE[:;X&))"2N]!!@>0'\O.E8 <'TF$1[)K,]=%8D_<1#/VDTK13
M]O]@<G&ER?W!4![L7Q[;08)T;'@N;%CLE*F;#8>8BB+KDY'<G]0,5MN$,IP6
MPH*DRG"B(>=7AA%28QE. >-$ZB6B@>G*K(3]M08C6=?2:5U'[Q3>@88<L>#F
M"+2E8OK[1!YD--)M:Q?ZUI36Y!M4U<IKNNX&1]F:9HN=H]QH.R3:#Q%/ Y1
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M<<)J'V^Y#)I)RU'1-42ZM;=V&Z+R'M;(P"$S*Z (8^:L_0!/F^'1STVTFQY
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M!5GEK;9^H=6V'8*U'=BJS'N5S-(]E]7]G?X!A\?#2N2&(*5 ^@3W+OWS"]H
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M"+H\8O4!8#_/DZY:)>[CE+63N!_4(^X; BN[JXK_"ER(@WUL@M?N0MQ:?--
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M&#7#-Z"-^.+3X3:E*1\]/V@-1E2]!2E?&U9%RF^D)A(#S^?MRWCWLE@7FKT
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MYQDGY&W YHJ,3,E)X_?2@V,;TARD0>2."P>FB=*R<4A@"=PY&\<1J\"+T+6
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MB$H#HAJ,9$5+ZSFG(:K7@#Q8'/'O+J?J^NVVW]2!07-N#K<ZM^9\Q/!)I/
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MF]XPV[CX'].8+CA8/S87\!"":]:3KI?^PMD\+A"!VX>#Q=>P,:@]@;<)V@C
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MM@Y?[U1Y5!U_'#YY_C3\,4+^&"MC>:BVO5M!B72?0@"\K-R.O/R?*H!W6@L
M[]2: .]^F$^FO3$9M=H^$M+?+7_Q$9;HP  9"4SC-/[=8)S&O_OQ^<_/WWYN
M0;S+0:ZC\2KF;'VR/./QT34?.;OQA>6@6PTR4/P&&2A^E? 6FY2K%:9EL6PG
M:[F$2;J&;WI1M#GJT3I^CV!SM%V(U;9VG=EF"IQNND_6U)3\E[7Y+C?!*K(K
M0UKQ<;.K0*[W^OU=<, 496MF3B/TXA8]53J]JK9,II$VJBV]JEJB5M&D!L5#
MG7<*3I=>=;YGV]2GSC7%J$NO*LE7327,[JF#.IA//\'NJ2;%%<XCF?(/PS8>
M0<.X8P:8)W%;M@LZ'"_HT*6D': Q3[$_=8LKBCE687^N/<^$_Y_MT,%],+FX
M&LN3_E@>*#5W[VE,_* CV3I)-MGU^^@D.^Q?7(WDT60D#P=JXTFVT]=>Y5.O
M(5/VSC#N.I7L%"I9EZY8[JX:G_RN4N"NZLN385/2$CL*JY?"DCVICT]AZL65
M.AS)VB -N-1EOG9/-5?CR<Y\)7(;-T;SR0E^409LI_$T(O.UI&W7(:2]2H2T
M?7IH'/\RU\@;-])E;;2WQOAZ<WT[B=!)A'HDPLG]\\,!.CLG0U76]R]M:WYV
M<QN32U/!29$YRIL"NZR?[ESRGQU*':7&O?PA6;I;.[;GN#B ,[5 K424;R0G
M6%8O_6WPN^>%-5VPOL'P[7]4,ULG]=,U)]U12+I#(-U>NA)8@C-8XA2!$UCO
M8THE6[%4,C-,)6/4K2FRA(D_M"_5ECGN'V.9HXNK86]2TS(',I*-:TZ=_[^]
M-VUN&\D21?\*PJ]J1KX!T01WVMU^(<MRM:9MRVVIIF;NEXXDD"11!@$V%LGL
M7W_/D@F )$B1%,5-F(BIED$LF6<_)\\R\($&@6Z G8P8Z+6BB6([)-#>D[&3
M US[U7NKLBAJH:&GYDRO3B?F)H2RO"_(E@BE@^UIM\4/<X0B8D,8X\#U<=HX
M4\PJ*>J'+5OIB.'[(GE*<)J7J)]!"ON1-#Y)&9D(NA\R!J?3EB!- 9SJ.E+)
M#8 [I']7II[:$HO5]\-B]8SDNJ_>USJ51651\3!((H3#\TOBY5T#GL)@V6Y;
M5=BMU:[,YS$8F^UTF3 N)JM4]V](,<]@;\Z#R4*Y.V],;@BDC<CA&9((YO=9
M@WW6"Q3,YM103 HL1387MGN2K=N@UZD#MK5KZ59%9!W;O"UEZ[6MA$V(]AG.
M>N;W"OY>K569SVO9"M$^:B,L*C_L4/GA(T2]?W.AJ,YO' ;WKK.\R"_"MNJ.
MC&4X@G<Z6/-G*[P9 QD,0C$&.P#N'@!0RLJ_ S\].(B[%L%QYGI9^7?*U6%E
MY=_IXO90[SK5ZK>R\J]LK,[]6=ECH2DZ7X,P'AH7='H@RD2,W25B/,N![(L^
M<GTYAZI6^QF.G]8[5FTU,=&B5>N8]2-HNUWR9LF;N^+-SC.<F:[)FWB@:C:Z
MU<*AXX?&FR^AT&?*Y+KX=G%96EH[L+3*$HS5!-;>LS9;;7#2ZFVS\_3^DV65
MST&2V#.DAZQ)8AUL<EJM 9$UYU.-#K+.YR1:G4]I/CKG+57??JL]5I)+!91V
MDG)I3PE&.;G4!;E4K9E6=UN=&';L*Y<D]@B)/4/BUGHDUJZ^>M^H-\Q6]<F*
M;TLDMB67CZFE5JDU#UP)4K5CJ?=VY_+MI!9J2]\ZQ>#?-D%S0KI@[YK VF)U
MY!9QO ,/O90(I40X/(FP]^K(=FV+U9%[E@@+JB,7SGJ92S;=<6X*)=QJQ!J(
MQ#BBK.K/KNBY'HW^F4LN]E>>7E)$,O21"]_17Y@LF&6"A3<K32U)+>^#3%V.
M=.ZRX?K,%\B0HA<D6 -H2_>>[C()E(0%05C@VJ;THI?A@^-8^I?(> #@IIG.
MF T]#D(<?(S)X079TC;6H@+!"[RG)SSAV]*(AE+&)Y<3W:W4.EM+@JTWUDOR
MW4EF;KWQ:+KPUOR?[62"'E?:7IH3:[SDY,6/(*=&/1EJ0#2>+8[PLK,B/[@>
MEF_-Z.-G2G<Y,>/^I>;Z+#\]6&B _18&4;2VI=YX];YAPIK-AO7DX?!EPEW)
MA*?"A,O/5[;,A)3UVJDWS>K3NX7NB0G+=MR+J.YWO[>2$5!F]JRH 35 -3RC
M[ZG3O3;GM5Z];UEFHW,H37K+#+'="?%MTA'V3&I:9GMKX<ZCEM)'F%%V@2$^
M"IQA'X>/0=*+^XEG7-@V#C_?3%@?;R[*V0[\%0!M,DH\#%JFP/\4A)>A=-SX
M\R9F%"9C=FO A//E":_+?*>CIK$-S?'MTQAV[JJ"H5Z=;WMS(#166N*+*"XU
MP(N.PEZ&%?[,@CT] 5R7KSI5=(&KW:99:SQ%>I=F^"$2TOK2>W-"LEZ][YA6
MIV.VFO-.W8$0TA-$]"9]FKL'W4OT+CO1-IP WNL',78/17AZ$T/Z S' H_;<
M^;@7^ -L\S>$U:Z6O@#K$6\_P[OBX4V_B."F+0'8B_W62<*'('0BZ6?457OU
M'K!A3*0(9X%?,6 GH82W2#-_3&\\@)>9=7LSHJ07Q<*/7=H>_(=[ILKBS !\
M+G2X1QS>A!TMU?VX")T2D*4HX%5:ROS[)FER@*#.K/H0<+8SW0/\O%8/OBG^
MQO2CM1A\KB-OIPX\7-1K3W7DK1@W" & B-J/N6;+P,W%D4J>^I[V[BM:?@,[
M3Q?TM]0-A1&^^>Y_6;O'M?LEKHCIPG[,:Z.YOF4T8]A["9QX;YJ+Y,^Q1-Z/
M@QPO(:!$%&$+=LQ]*0"C#\LWX@?IW6M@5I[0$O109&9JR>;RC0P1RCQ9/0PE
MRP:Z!W07T %F"KF.#%47R0C0#9? %X)_"J^2A:BG11 Z4 AX):5RK^#OP]<X
M@RE-60*Q))Q[HD EK30>(W@PZD\0/V,9DLRENWH 9WHG+LJ1JI>F#$?1K'R,
M=/MG$JP]D(DB]#D[JI_$"4 !7NP&3K1@/ZYOAU)$Q!L"=A E7LR-JG$ON# ?
ML*27/Q:3$6 [FMTAM3>5V9MRTP5R2$C&P53.EC&2,M:TN6#_%>,"%S8F?@"F
M(=)W7%C$M%[!RWZD.FC:0103I"*!M& 'HY$;101.DI1('&/A.HA&%^[DV^#S
M]A0'4>99T(N%Z^,J,Y6;O@0>BZ8T[[SH "L-M,IJ4I<4LT83*VAPT&]Q=9?9
M'KXQ$N9U-'PJU='SMF"+M/6\@-&:TZ/O:1W*5(/DD82A=%9JTUYL6NTIZ_.[
M'"F\?<M1UDU&6<<O^#Y23V20Y%$\(UCRV9"*9GL28;&&@9@#6P8U39QW((M6
M,Q+;BXU$(PB9@U+J(VZ/$GMH*F&M<;A(.@(?+FJ<O,B@0[Z5_TI E&1"?%XN
M@K]A>P$V\1>]X%ZNJ'[["0IA96THE"2^$LEAODZ[:-4H;Q3[H5T,B\1)&M/Z
M>IIJER9?*UIIU"IM3$,=!Q&IMK>DPD!/9=FGOTXG'ZO<U6KVB.A%@9?$BQ^9
M2_#;$TO4JC, ROT7EXM4Z79;G9J4=DU8=KUAVW:OWW.Z5KW6EXYMM>W^/W&
MO'YJ&&9)C0-YW@,=]^-<]&&+;X7W("81>J-YZ0&B8P;RZP+M_5]Z(;JX"^33
M.H\](MR*L=2MUYKMUD98LE:2S5]O[JX,JUY941QIF_I6#E#Q?:<,<) *'YE'
MP<B93Z_O=%CE F=(YR)6U_"=TTGWMU>_?;GZ>F=\O+Z]_'QS^_OWJ]NY0,(J
MW<<[*W4?/T@UDI=L:2/R>^$EY'<%R6!HC'!\%-E 9/(QHD V@;3_T0=?VS30
M]HM!GD>24HI1 ,<  ++O3*/G4N0(D_Z%-P%#3N7_*WL2/VN#(L OG*'X0_U5
MJ[Z;G5I%EZUWK\'G34+C<NC*OG$S)O,;G@2![Z*!!++U!YC,9^HEES<?O^@'
MT2 -TD>O?DH[04D(+G0?WI][YNHF^]8?H"\0'&CWX\-]UP?YCG.N\EJI)VCB
MB_8RT(XF$W2A8<B%#.BM_#/0>_AGQ"2^U%R\_OIIEC.^DI%YT_^>OE/Q2D$D
M)V\E:N+M+K -LS4:Z1H-M4:3^]'W=3/ZB]M+H]:IGL! 'V((H!K4N2X0=>;/
M#,+@(6;J!I+MN[&.,,2A]!TR" 15B@''X.@5@ ^LQC'A;M<FV(&E$<N!BQ4Q
MZ%AE'?SIS<!':&X#1Z0_A!(YC8IJX*M@><#&X%_,/VH] 'WU/1U[K:#5&P6^
M+SWRAO0"T?B)X@0<*">W6(GD#SZ5/3'Y;V%/D';!^L=OW]. @D$H1HIMX<ET
M$($*+$B>^3"4PJ$D 7 9$:M$@^!ZBFB8HZ#\BKALR!@&#P:0WCE(A##P/.7"
MX7)=D$PV/X9O =8")K1Q&M(=\#GP6P!29BA#!"B.C !OCQQ/LKV\&)@&^'8$
MGBDZP["I'-.::(&Z_KWDA:(=RA"M&-_59S F&=@LZATE8,AK]A('[3W?T3YR
M+.VA#Q3*R,50.0<2<C!!N(4(3@0BR529(I[AD$*'?Z55933#),"R".]4DH@6
M()VY8,Y:RA6C>/ NL(%QV3?]5*Y^(T+'\V&LDM1RY2ZXS!5:S>O?;G7%\K;#
M%P6SPSH<.7;1^L\)1R424[D/\L*5#RP78R5-5BH_6SA\YR@JTEI6I=ZJ;Z?X
MJUVIMYM;JDBK=]:;.K%T4<M?]90JLG+8P@D6E[WDPKIR*L 4.+[*="YJ6?16
MUMLL/EM\ALF#ZR6.=+?9Q::LA"LY\U0XL[UWSMQF-YEC:3S/S%,_<.[Y##A]
MNX*IMUGFY#Z>WU*M"Z'OX#M(7JIC5&6AG3MN*.WXA=6Z/-U*43D,48S1:(+D
M1P+DVH(.!^J:=6I9WSJ0IJIE'<OSZ]*MT0\.*3;;S;K9:1Y*W^=MJL.#EZ=_
M2^ 5ABW&;BQ4//^%U9=L29@2("\9CL@8:]=I=9LH2AN-JMFL/ID5RJ*2 Z2>
M):+TZ=33PJXXW08(TNJ3Q] =UEB/XQ"D--*##S^GCU!?6B'VMHQ3@&1ZNKD9
M2V"' VX4]726*&W3 R2?9;;IT\FGPZ9IV[2>/BBI-$W7IX2/<@PNA2O2M!HQ
MPHS"?].%TDC=\%PB#U7XVY/XQX7O7.2 NS:KX.R>5M6L/]V'*PW7 Z2HY?'T
M9Z"H3K6*Y](-T^H\.:I4&K/K$\=M'-@_5+*L'8RP:&MSJ?LR;)'E4O=J-/:"
MB90?I"_[;AP!>]P.12@_((@O<Q!>FU$L8)1.T[3JAQ(^*TW<W8G>YR.KVJOW
M]2;*W]+TW0.%7&.2F(QTHO0+,W;7:M0R*W<C6/Y?7YW/<HJ&Z#4!-/4,@6&^
M!GX:L%F;3>JOWN-X^6YUOA/U@31N*6W>#0EK5O+NEK :K]ZWVI;9M.8'@>^<
ML%Z4Z?M1]B76TAM]B2TC/",6/TNS=^-@ P/S$\.2>>1._+SB/A#*;)EFCK[[
M4SKG_Y9A4,07S5?OJ6R^]NY [)+2W-V'U-V$L%:0NJU7[ZV.V>[,^U([[Y3Y
MHNQ=/CPKC=TM&;L$3N:)M5F@_>I]K69:94O+DR.>%47K4X@'VUECU+9Y .[0
M:;6 +R[=4G6^!M8L8>WOACGEJNAT)JV\K)EX(F1.2':LJ'AF>[^P+(GEZ&*$
MI?5KRQ,\5VS4S,XV6I=O :.[*WO:=)4;U$25S%\R_U8,ARTSOU7%?-A:JVEV
MFL?+_AMWP+9J1]1RPY&1';IC[O:G1TWGFJLX,A:NAQTW!B*D7BPV $Q0A^S1
M./"I6VF(>001UL>G8Z.%;7/+J[2OAZFZNJ0M6+):(-,8SB>SJPG6!6F9)] "
M::882C>\X:XZ7!FE6_3,]$ME'"$LL%=6I#IW8>N;M%TL-5.,=)O6<0AL&L(6
MN)LN?]?U^UXB?>S)U9>J\4W >;#T$"\!GHE5)R/5?;'O>A[9K=C?5[=02IM@
MGD*WXX*RBHR^LS:XW*>80(-XD.HX-\I3>20\ #Q>>Q #_)]>X"<1#VM/N\V:
MAF[)%(N?4E&]?IW14\?#)T#RA6G6.7CVL0USH)M()R%UU9[A?&*9Q/=U4^->
M$L%W(H":U+6_U.6*ON*" N-NI]Q)+<MU,J<2$AGD$2;.G,\GSFAF2E>J>U-A
M@S)). 0ZT7QH@@;JQP_4!BSI9:+5-(!#[J5GYCAM +C%8PJ]B9,1;OF88";9
M7'TRKB#)_<1""5O YM4#T"F1<>8%6+O]6C?ZP\[1U&@:*8([QY)6""=CP!?U
M<L.F:H#?!PDL1*VQ%[X0IR4 N)!6AL(?2,0)8-GF1MAEY]?EG5^M+75^K9U:
MZ]=]]GAM5/CL;/Z_ZW6G2X]AEO1\[5C67,]7N#;?\_7ZZ^7-EROC[N)_EK=Z
M36%7!-[B/K#\O44X.S YB)8VF6O4-;4?I#*1-+VZ $3FCO00 >RKF'9^=(R$
M.K;"PD%L4I]%!_[A8VMM\(O /L-6A_ N _L7TA0$&^>W4+M4LA6Q96B[43VO
MM:NFP2@V[MC*N%8?3GT^[L!=\-Z1F.#< U!G?Z)5"BH:3$<[3E2'\-SX"^IT
M#R(8NS5RN\5T] -W^9>.GJ: +Q7T+3U6(QDI)R2)V*S2>^8;%FT[;V_U091C
M-U&M\E4C1ZQ!T//X0'V07L#.H2I; -\D:$BR;HI.'<?I.<"0(\^GKO3I 6V7
MY>W Q->N$=ZA)3PLL _+GRAWAA0/=60/>.H$40"8)K'(O]\3#W33GP#=R'%9
M1>&4C5!.C67 @1H)M9]71D1ECHO6Z/]L#Z63>/*F?Z7AG,J%[[#+Z1:6=^C4
M%0B)VLDTIIQM]I]QK[9AV%B?YYD'Q).(E)\=S;>F/):&D_"4M5XWR(6]'3N5
M>J.QO5<]VKNR(';[+-,JEQY>MHZTL^#*+2>?'X1'W)QQG<:41[.IQ@;X?][1
MWZ?1O?(ZTR[*NC#.E)K9-&3^HL^ CON89WLC!I^>NFG5MYVZ^:R'MB5SE,R1
M,4=SU6* K>2A6HV%>:@'R"G[T]S%F6('S6I7<V[>"\MW?<H(QOI<_6-AA.&2
M(WZ8@C!64S^C1Q75>2UCO^T5&6PCEW$_>/JUI,ME=-G<&ET6T%_KU?MJY2 :
M'QP:[>U@(/W2,[O"J2_+CH16/-!J-U\=R%E0<^%9T"8G0K?IA,RK>QI(-!_I
M;1<<![4+1@#^_N'VZA^_XQ3 J_^&_SXR ' 69RH6W&A7L!AF"=(6G1BUC^+$
MR&K.C H<"IJLC%U9Z-PG'4S%IP3"\_)33"4A*1TH^$5,&.E674]@QR,5GX9T
MT7CE6*4(94.F<H/WHA@N\"1JG>X@QN,P&(>8B:2'MZJ!7^K3('>&^6G4*A'L
M\2_PT"VU?%A98/-,9*.7Q!Q)]X-XDS=/#Y5E>/)N'/Z2'\R!D&Y+5T!WA?"[
M&V8S:V';ZR0+K$?$ZTB>SJL"GID^'.CN;0;I]=W5%Z.F1))A**O,,+Y<?+WX
M[0IG@JISE5N:#?K[[>WUS5?CXNM'^/^+S_][>WUKW'PR/EU_O?AZ>7WQV;B\
M^?KQ^D[?LTC&?;^Z_?WS'3UZ\^WJ^P4^<+LQA#O6$@@O'2>VX]@LYQ2*A)(V
MPXGQ-0 N_9ZF;'X*P@?X\_QS$/S ?U]GA[/'GVUT-W0CXQ^)"&,9>A-UH(WI
M/I]P[J%5/?\'SCR%>]3LT=E;T]FER,&4,Z1N["NH>0IJF6!1C]#9+9V-@&S%
MB=< %3K5Y\REO@1A$H(#SQ.I]?3K"9YL@QGC1L-L@-VWT+U'R7J;Y3E]AO_A
M,=RP4)KA>&%3WJ75[38KQH4W)40YI0SDE3]UM6_ SN,@1/N0SL?U+K48=?6<
MO?Q!>CP,6#=D=WY)YR6FQZ&8*I)0 AR)\ L</1NY]-%/J30&RYESB>F>[]G<
MULR0YI&70Q+SG,F*&96/2G=,G$3#-_$$(I/73 (;V,"CB>&41P%D.)BD.0$*
MMR,Q,346U:4'U_/FK@6)Y\Q>M(4_=ZGP/F4;S5YW),:@9J]&PZ)WJ$GHLY>%
M.YJ_!E^SW3& 9^XGG4HQ]T-/>BZHO;GK."?]Q]Q5)O>YRY[[0WISX 1KX<^B
MI8-1[\]?3,)H'E!J,.?<J_M)##IX[FH )H*(YK\X",0<8H?!.+=KQ;*^'%#Z
MGIHL#^1$@WSQ9V:O])^ EI!S/XF6(Q?DF@AQ"BJFIIHT5W6Q^*@8MTB->1,H
MS TX5B-J@:;%O8#W3DT'-G.\0 DEF*H:N[3L7,X-9YNH-%2=M^/ZF#^"8S3=
M"+";):S$KDX\SN6GV&YH)R-8)*7-$&/A^QP7!]@"%^,; 0J8G*+GK=)06T[P
MP5N#)(ZPG  N*HZ.P\"K&)\(?]KFHX18^%E@3I&7COC$R]E6[52,8.80K@'0
M@20-!JD'D"()RR(@E'T/-IS:B=%R5-PA3)!V3&,2) :SH;(XX<4DN"8912Q[
MU?6(!I8"@'4F$D&-A(-ABX3D$[Z$UR\)L,J^-LG:%<K8]8"@.*N(<Y+2>HV5
MAYRJV,$YAE%).S^FP<^MSMY4./%A*XV/['X)T^"R&A4RTH5S+T-,_0;J"T;@
M,@>AG@.=TJ/",5(E*/L14;+.Q7J7KP5(QF-O<@[\Y6)"'$@[X#C@;<PP PT=
MNKV$^3;+!F=70S$F%FP(;=Z1\,'?WCV1'$K<+\2]T8>7:\FE*VLHPS+Q>3@T
MH$[0<9*+$[V!ZRF3DKUS?&H0!H!&L/G@BP,6:.IQM+EL"18?E45I\P<SU>%9
M&IH-<C6Q00" 8@22P;(#E'"FDA^I0LH6-A3WE"N:"D4CI5Y.L\1UP:*R@@HE
M:$L2>C82 KTAPS#P99!$/ E=8& ![?S4(L/K?R8.#_WF;%*RP)41C+X FNXY
MNAN#56R[)>\_'^+(&E&^&B B%&ZDLI"SNLAL,KU4#B!>F1+_FM<P%.FK CHT
M?$K$[0AQ6, 5]2<JJYN">,QF*+K3R#486Q$Q5FJFCD:!S_5@N@SIJX@<\2]#
MC7G!5$@P DH\[@B/(W11T&[*,JTI:]YGQP"="B.XQU+6U%\(=5G#3(9V+G*M
MGF3%#-XJJ-O2I-HA5@'D,1DF"9?!>.BUH0>(YPS@ETYRI9)\]"!C-'[IT!-L
MZQ)/.^8^1 ?8M \S/DZ)AV?"0Y@%2]&49.,!M%4:%N;X3\2'='Q@17T9?%]R
M)@05@>&S%/W,GBQEW'/A+ W'948?  N\M'"R&.@OLIRXMKB<^$3J@DN>V@Y/
MW8LP/3I#&WTN@E&JH'V8 M(?4J4Q60,A7"FURK-%DBAL9/,Q!/SQ0U=<<X8C
M7D[@<VEXL>2(9PWJJ68D$P,UDSV4N1-"\"_#1!6RHRT0!B,WTLV:\EY,OCZ>
MN.DGZG"X,:$3\#19H&2JYY1MCKR77C"FCE9\RA*' 1;4JS ^=C(8\Q6.$^@^
M/R6'/2M>P/)U6;FHDVQ*A'33SA8F6@'^>03WPA7=<JGDE>?""24T)380?M1/
M/ K7#,(L%=6FV"IC2?B43!!+>TBI-VEJ ??8P&?Y; ,#=/W <P/*H-!=LTHF
MVPE"^1A;QT=9=Z7G%GFIZ&+?$_)"2W0\'SIT*[@!AK%] GPH!PF?^)=P?S:X
M.W*,"9RL:8P?<H*-F"(,H'DEU)]5F^2\2A%3]U#3&+JA2H? =DC@9J;(,!Z&
M 794BE \X>.D7NAD//KA>NH0!Y,EP;Y&;/H2=14:VNBV2LEMII1BF3X,G,WQ
M*!'_K(@?!S% !\_HLH1H+,L N4?J2+6ZBL4/Z6-V-'57_:F.:.FH3F /2=UO
MM<36L[JZW#V3DE<H9\UXX(9PP&08:9#4[TU0LC95T=B2#4);COE,/32&@4>9
M$HX[H,-SM@-+6_VYT.:"#6ZS7".9Y\;)5!+*%]=Q/&E<(1OIU+,1\B%*2T!D
MW\.,WIZ,'R1PX'?,\!=TX^\_0BP'R!+6!E[0XXS=<4"M<;E][ZC$[;,="6+B
M]EQ+<"= _DK-=Y4;P8E*WN0=XJM,&]ZMEF./2J$+V&4JU5XUW>]EI8S?X4;C
MDVY?*=/X$]7G7'#O2ZY66MP>>O4*K4<.NZ8K" ]\F@&602W.R4]KG)S 3CC*
M5U!I87"5C5"=NJG,1?V-N*,BF7ZDNK%.!6[3^@QL_XF,J:4NEBVE")RM.'N'
M6I1:GF*VOQ'T/'VBCZ\9T[-TXK]P7]3O'%0L-[Q6T1<PECSQH"HN/RV#R7W@
MW4OCAQ\\^(HZ^>_%=2%,SU-E#6@&I$4-L]4;L)$%11JY5 9ULXEV/@$5ODO9
MS\(>8ED2+U?5VB#&P K!,"#OE7(:EI1C;%[UV3BJJD]5WGQSC\Z-?#C^@L[K
M_WMU8?P1A)[SX&)AS+5O5XPS5;B%/ZJR+5,7<RD0S!7OR=D;D[1R$TA)70/_
M(JT ==&6]:1PF-']X%[$E+?-]>:AI']R.<C$-*(Q#A3PW'_S[;G1'%BI+]-B
M_!'63M(, _(QN?,"B)V'(/S1]X(',WUU)*G))AE8@"[)%5\]E[0,<J+P)K%K
M*Z8<BPG)-$I>C**TB?-LWUHU:@*W1X>X/^;V8E#6"#E>_;3(A2:)_(%B#/DX
MNX.+XJF!/G&T?I<88#/^Z9$DZJ=\-)A<?O6)L2=LJ:ND*&TIRC[.QHUZ!2SE
M TK$"*4)GWYRB:K*=<(A&Y@<!60$(K0(7_PZI)_(.#?(@O+.^VX8Q1HA)GS;
MD2A;]$?-K.X-2]Z2D.18*#UY+]21T2@ 42I4?&$L44SUU<U N_90C,9N,$5
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M2F-*/(HQP/ZG.P*2]B:&9?TZC?&%*@<7IM^,&!Z'\(X0 & X(6@&'S\VA(T
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MM<Q:L[9SU&S5;#IPJ70G?AH]Z<N^&Y^41#I>C5R>]1TT>L[^XOY$:OP4<JL
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M((]#RL\^!2;_E X\OPQ\QB%M_B:)O2#X<?P,7Y1J_T%X2&G&[5"BIQO!FD+
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M=QHUYN-,9ZQ(T^8^C-Q]Q?M5!!L#TIP"X&E5R$E,6:3YNPY9'+]*O)D1U]2
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M+_407N=+0?O@@,)K=2KZXF)0PB)) 2T#T*I2UCKAF>T&);$FP",_J!XMF'_
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MT!6+&>6]8B+X_A"_1T%'W:->][BGD.HIC[M'X.<E)1V1DN4U/#N,ONQ81(B
M#4-!;P'C:SHBH0LDH?<])"X;,>I  +D40V2I0>YK08(Q%5_(E/(9L:G&@1]_
MLBS$E$UG?B L3R$;$3Z4:O) (-EIQXKPO_=M(F188TN>6*2T/Z2NX/A7%_\Z
M>.5.Y]!<:LB[8T)FM23G:2+I\9,Z&E0%49$:A23X5S>AZ^*C;N\80F)M';(N
M4D^'A&Y#'0K[11DH.DKY-]]4C;23U58CIJRE1G&G-<0B(4 0SNH(Y-0^&/OS
M0X<RDXZPVAP_%(0^\3Q?2'I\$C^;S9@W\J,'\ CCYB()GB<Z2H8R922/Q_W>
M^?GYH?P61CU)3 ([\%U:W?AP%O@S&@A&>7X6D PF 1U==G#DZB:CUK]G 3T
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M'S>Q#[^0 *L$<[IA-"A\M!@;[FCJ6BGK/6BQ4VX)"_Y!W)#ZHZP#7-.AR/K
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M6B)>2\8CRU[;[6H"C^AVL8O^NM\N;B_/0]\NKC?05?_HKQ-T)Y=][ZNC5V1
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M;(HERP!D*-1I39)#Y&0N<,DSY\D8D^50]J=7PRL"*5XF;C(#*W0$E;4#%W4
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MS,.&=ME-&BCDM&;/Z"*X])I#SL;7/N4:0DH)T*/@M' XIEY\CX-P^^3@?B3
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M/',PJ993,)O +V<Z".M9<JB<V.Z(O?O[G[#YW$#@_6-@W1UB"Z(ZF=";GG0
M([J%'N[7ZPY";+V7;R2N:)YBI$TMT"8&RG@)CD>B5>;@2BI>9S] S=YG3.]-
ML5UDUUJA7^<=?TL>'3*?$\YFKPMGO].^2)O6Y2%C?8C%!@YT5"DR)4RU(EP!
M3D:%+%P*,B2WTG3G1^_Y^&ZCK\G>A-U#B?R-,9V<$]=90%@:+HQ8#D)$\%PX
M3=ZD%GFK$8)/MT_88P[[W75QB-R<1PT+WH*GYSYAW09"=X')7@9"/T+'1],G
M3$;'C+" J8;7K%X.K'-0D,5HA=&\_=W6T>"VVT#HH<&VBVI[@.O/%Q_/)U\0
MK]V37[G\642E/* COU]9>A4]24KXJ- A)\NT=8?QC<0,,$6E=UU/^E!4#Y;<
MFL>5"X->*ZP)^CSG6G)#RRLX,F"%90PQYLBVFD;: 337G_^T[;A':Z*'],R;
M33RWH*8G VP(IM/C-;-!Q3N(M8=#Y.8VE^VR\ ZLK47VVFKPD2EP3B4MI=!&
MM.ZD-  [HR\==Y%F\PN6\$4PSNDD>[%XOYC-ZR_K),@:2QA]PDKM^I8@,^&#
M- &<KU,A7#6SO#80BB\R&V\4;G>IUNVY^[<.=E'19#_R;7VC>H.L2FDE[9*R
M9.L!1:9,,+Y4"2 X&330.A \$_^J;)?)=.]CCE?1[:37>HE?1@7#>YR0.-=1
MQ,DZ@/C-9*:S)(U&B;502S)0J#AXH<B>Y5CK+WGQ?+L(;9>G#M#X[R=-LE]]
MM-X0:C7(KV'Z#YPO:T)>ERMT7\^Y/M,&;64:E*%UHTJQX'1,$#)/-0TD.+/=
M->UVSWM:8.E!!T-JA'#7L-XHT!OK::],F7QHXQBXH#0PD0(3,3B6!U.M<S*3
MFG?)^3Z4\OM)05BNJ&^H^H4D?I44=5;H\(Z(%I*QM"/;H"#47X,I7"243*/:
M:KO;ZG%/!DT]::#A_=7F:=/96LL4MQ"-(^O.U9O6&$R=>1J81$UG]X/54R<V
MS?NQ"-A9OD,J1+Y=,_CMU-PSJ9:UU XXR@Q*U2&+F!E$2[++&E$Z,92C[B%F
MG@Q.AP6+AC.4OV$L/LQ8W,#8SY_)PQG-:K3[6\;X&28T0LL )BS=Z^PA\IA!
M"R=39EE[U\LU9R_</$W$'QX80QK]?'LMK_O0LJ2]U1$R)UY(SA&\2_6NQV<7
M8V')#J;6=Q,33Q/@!X/!QC'*@\#UC78'EVL9?Y^.$IY9;TS20H WG):O1TUN
M&YU=6:%/(BFRT@8S6J,;:\]K8 "0N;TRW*%7QJHAVHMQ_OGS1ZQ#W=Y-ZEO7
MCKC+'<"BCL*0+HSP'!1S"*YH!$ZJ""@B3Z5UPL2^>'M>&T, S>W%X8>_..[=
M&K0OT@N5 :VK%8<A@LL2(0=GM58R)1Q,0^HF'#\OI.$"[([KDMW'!WZ-<]9+
MXLK$>(9GCN=@3$:($0,H@0F"=QPD%UQ+8:.4K8LD[J;DZ>%Q=X7<@9-VN;LX
M_42XO5M(5UW]EO*8+:OUK__]Q\EL_MMD_I\X?X-I\GX\^A_,9RFB,Z@DI&P*
MJ$@_@E1U3(HL3) !EDWKSJ2],?/DT#H,6-P!^!WOW_HY%#9UO=S4L.\L1R6"
M2@EXO552+&6@\T)!3#'4_"R7V98W?,-@Z,FLCR$)O1.*[EA*NY?9U2/MY6RV
MP/S38GIUE;KD?78]>61M&N4SHX0MC,2=BW2T^JV#P+(#:R6Y'3'8=+.G41O[
MHQ.53P;->U+D'=A3_;<<O2RGF)3;4:.V+4BW>%#[EJ1=N1M.BU)F'(^9@(J%
M$5!5W;"T$X J<\X)I\$/9O;$J^&U*#7HT'$=@,>DZPP3#4Z6 LD([JV4M/B:
MMPM_@BU*NZ"TOQ:E791]Z!:E=]:P*#J6R#I1D-*R,;5FX/+2O97<>2N*:WYK
M<UJU?)T0<%\M7Q=-]%_>M0TU3Z66KY-F[J_S>HQ8^U>V$W4P;K$0Z05AN+;X
MM$J"%N3^.\Z";]YY8&BU? UUW$6:K0M][B]!(G^C^*0X1,D2D&/*("@;0)<4
MM<P!6>(G4,#520';%W!UD5X/)?@-+^6O#RFR)60DQB"AX'5*5X"06 &>M!*9
M1V7WWW7D49P<95!@)ROV\( 8-LPO+]*3+-K'7/.O'&WM0EL(G"MPS!21-0M)
M\N$B_.C2+!JBJ_?4O"[0Z*-FKGM8+Z!-06@/ JN[H7@ .M$2,!Y1!ALCYN9Y
M$:<<G^T1K?TJ=TCC;Z\8^3B:+O_/U<C?,Y%\"DE9D%'5.@;TX /94%B2<U%R
MH_5@@HF;V7@&] #@,:09L;=G:5ZQI+@WMA8O,%<,J!(%.&W(^U 8K8U!H1K,
MP-?-;#PC?@#P&'8AXZ4-)=$S83SY+-'JVN^.@4-B32(95RE;%NR \_[O,J\'
M6V-1<5TN<1VXTDH%"ZA5[0K"R'-TNF8R"MI&+3>LY.&*?4LNCV@7&IQ/WP>0
MAM0WI&.M"5<8#/>T\4=A0041(#+2BJ -*I,7Z(P8<)SK1#+']X32 Y4S=8'8
MH)I2WW!$KXR5>[EEF4BH,Z&D(!M&H0[@HUJUO0U%1ROYWL-J33E\7E>[KJO#
M 6Z T9%KSL JL_2F,WPO\X@I!\DS".4=*&DR!&42&)Z0>UUSM8=F[NW$\//B
MZ_E0VQ\<!S4_9+-G?C^_64MCBX/B"MGT,GH(3F3PB-P6:TO O7?I:<SC\XKK
M^[CK$W3##A7=RV;.'%W)"D3A 13S IRP'K@7.DF=BR_-2QX/X9D]4@/Q83)C
M9S(WE:R(,^E0VUB6K<P-.3%*U9%A'DHP.B<?!>I>#(W]LGE$FUW#P-* H31
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M %IR?:1D9*3O0G[5X2[%CV?3TMVE_$4#WP(-A/([+\WO=80$_*HC)/SW.E)
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M&J5W.]Y@\:0Y[$NCV&0$P7J^ 7OH5('?%)/4.S\[6'!@0*=^5ME&50\)J'R
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MX;ADW!"JV$$"UFFSP=8]"EWL8W]S7]-81<FW4?B4)]YDH0I[=;<+(3%'X[G
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MAIZ$'1T/;MWI^OE]PLK50DQ':2.MJMWD[A%34-#'A;BTY&@-+FG<LCA]_&N
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M]KC0U!11CLT6=3ZN\DJ'5VYRPXARV%G)C2[BT1O0#LF\<LS*<%]\/()KJ+Z
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M6ND_T\>W_('N".0_&MD/"_O&XX]R10<Z^2&TW$#%_S,S_L.Q3R')?R:^OU/
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M>D_IGEY>"EXQ7C/>4-Y,WM>\RWS\?/I\/GRW^)[R3?'OY-?D/\U_G?\Q_[@
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MWM'9U=W3.SSR=71L?&)I>65U;7V#G2PR^40&-145%0T-M3<H,CO5WAW4TC2
M$(>6*:V,$Z<OG7:$<#R768;S3EGZ$I&&]SI^<]R?S\GM2S#?!3\R?Z]TOSR/
MA8*NBRB#__E$/3197DL$QDKQPL4M@1</[KY^OYQ\-"/IV]F, _K6KDH_CV?\
M.AUB8.,>=/GF@^H7W6-KRH:V'L%1MW)K7O:,KXNI'+4['1*=DE?[JG=BXX^'
M. :'!FM73Z[.U'?5;Q9C9L,G!T*W@6U@&_@[ ##2N^W^NPUL W]3 $9ZO]U_
MMX%MX&\*P$@?MOOO-K -_$T!&*EMN_]N ]O WQ2 D=JW^^\VL W\30$8J6.[
M_VX#V\#?%("1.K?[[S:P#?Q- 1BI:[O_;@/;P-\4V/;_;@/;P-\7V/;_;@/;
MP-\7V/;_;@/;P-\7V/;_;@/;P-\7V/;_;@/;P-\7^ ?_;[,)"?"27*O'-0]@
M&-J*,=/.33W5"D+]). Q";#_. %]V56[<E?C/K9* #8^V[&.F:GM5/JT0(\3
MB%LFK.TF ?D$_>*P^@ ;%F71#?OTR5DWOI#(HI.$KMI5'&:F?G8@M#AT]>3D
MQVU@&]@&_MO %U[V4($'O-T"RU-ADV;O4CX%DSLL"W.U&@DH)&X2JG"G^4*+
M[,[BXU:&-F"$R?3PPT#NY("OQ+U5//8RV.$'(V@CP:)T=U8[A2N;0;F_DH#/
MLTT1=NO8_'5,+:;UXT;7SZ'C-U=T^]&\"97=IU-Z>V\>&!O[E))=6I3GGCON
MX>'Q[J6ZD=&1^T)ZT8QU9<#='095]93FQE!C:$]'$D^W$$."._"R.$NI*T]V
MW1._&2ZR1!U@[+XL+F$\7(EO-I0_/-C_.DF#NV!,+ /.>7W9\:HYU]$.MH:C
M+R]E%%Z\V/# :K?!D/NP^*@_H_@;<6>Y#)]CZ278,9EZX]NIJT&C)Q 6CP9>
M30=,:S.].AE ^UJ3(6D]ZJ1"-KI-W730'=L8J1$P*U:CUY Q(7'WV2%<3_.Y
MGN+:Q8-[]A0/NJR^T0V3^\"BZ>[[3AQ7,N7O.?WX&0/K X]]3HL,N(0(4^)2
M2-I*>IV^H*V@ZO5DQ>*U"@-A'6(2W!*SR70E/ PHP:K%?0WC,KY#-&@SWED(
M0T"/+ZE\2,*QWXCT$NDD >P'H$-3+1N1KYK,QU]HW+/UW&3\@$O6UENA[76-
MT^SC,9YGS"_%.MV.&WE_?\)XS33G=5BFFAPAOT0EIMH7,G3ZEO SE]I9C.'N
MBJRC9SHI;.=+)@22&UYHX=GH]G&?[)W>P3JO?/]"G+ ^K*=W<+[HW)[6@;B$
M8K;*%HR_R^A9Y[+GT-Z'^M#%:QB4^AX2P""P9M]]*?9\Y4/'^'?!MX8-\O(6
M=\%F9UK.OK@K&>/CU;!?]U(17U9#TUV;1,]KK(]79L,KJ*?1_1+A.S\\3\O[
MQ-IM;/*<!*R>'ATHX D(B/35&K[ZV7#]_C.+L'-Z4(DB[ARB$3YT':)]B^7Z
M#+)ZJKN7TE1\_X>!:J]LUTN"7LV'SL::.NH]/??2TG@/H"6<?FKS#3C_H,*X
MKSURVSBJ/R5*NZ"N7==ZV)];XN5GU W9WI1W0?&UN23@:).'TZ)9R!Y\#!'Z
MN5FD=Z4*U.TG_?)3[6WW#B]WQQN(IK+.C1*JNB:;A0?S$PYV/51:!JWX?\R$
MO UL _\? YIM*DA UX;_TD:L^II;Y :N8W%R$*GRQ<5TF782]:2$!,")O"3@
M.6&B_.7D4S45ICK5NEK_K!)1U;Z!K"X"XO*\H1RF;S+P5, C^8,"$W9[;Z;M
MO/-RJ<#G4H"G6*X(ZVGQ0F0QK[X;QROCA%S4'.M:0>?UL;;3/8I7%[!9/86(
MVL0UYZOWH3=-W#7<^"R,@T@ =#""8+]:OH=QW^/-2?7CV;LRN_<XGY'HW;Q[
MV*P,@_*_"N/##;1S)GF^^+ GE;$@F/8F<NE6DG=7W(0"]J.UJ<#TY0E$M\9,
MVI>9SRZ/8\4?RZ:\$2J+GQ".L2U><FCN@ 9*X@]R#'>.I^7%W:\]GU^;RGHH
MO;*H_P-B4Q;S=-=.ZZ-57B?$;6M<#:7-;>[LO5JDIZ#1ZSUO6CP:;.-6>?G0
M:)/TY@']0I64 &@M"3AL]R#\%*ZZ#FMP3C/=J3AZ=)HE9^2]4A$Q./WU3&GN
M:,XZNTYTC%6&3MSXX[@;M[1&#1)%J\3V5PW=,B0!>Q:GII59;W"YGW+5R#8\
M1 )X$ (M&>TGGX2:[AX/J[BO4>B/9L6[DD%8$3BW:Z6_YG:W-F^M\[MCVL=Y
MP,+2%$FLS6@P%/,1D>I8'NXVY[P .W9S0&OX^=,X]Z+ZVI'UZP1H%&,PVS+E
M-!,SUGWSS(9(/W'Z<?_'Y[K)[3VX^%C'4V'W4&SI#]F,'TR,/#Y, AHC'RNN
MW#FIZ(F/ZJEIC;-/*,S(<NPRMMJ<+=B?ZYEO"$O(S#DO>L56P(#?X<R<7M:5
MCNC<@G.K*.2JO:Z,=T'50;QPI7$29\H.=<C^FIQDDT@%0F]PL=O5F76D2_]G
MA[&VSR=H[W#%B*1/NU@A&?E\.Y^DHM#3A2,1SY"%F>E/D5?+[F3$B%[H5PT5
MU;W5.#*_&//4_LHK>)J!:!2N3.2$!0F G>)A_QP0C3C0TL2NS7I3>*13Q:'/
MH<=!/FO8F_,!NE0E">$4+?.0B?G,9=J<6<QX[-::Z_N7/ :$5=R*F\W4])MN
M51+@"P](>]73'3)%_-H?'/5,0Y$CJEG;+3__0>(-!<JC>M&MPDD&'7?>V[[8
MF_+5Y=P XZ,+U(!+XE,"[*OZX;Z5S8'.%?$ZY-7LM "ZR_<*WCZ/T']-?")C
MP.>>CG\+3:UR/_.AGZ>H8E(,W^6 /]7<\<8PMG>I[+&J3\ 9]*( _Y<IC_&4
MKSQ>I1\^=;QFHRB$]EN(O4@L%EOP+GJS>^!DQ+XN#KMXOC,W<)>Q7!J-U"%C
MW.7$5],.<52AC^?R,;4/J>KE]]4('Z*]D=&0E7W/IU97*UOK60%JO6KGABT2
M^W2CCQ"N'GM:R7RQ6. 6+[1CI'V"1WL\BW8#Y[1YL$NOP7!T$KNBB(=]K$45
MPS92L0])0-0P>64Z>,)X670\G&YTG+@*:JZHP?35!/'VR:?C2R +:\YFJ^A@
M7/&F/ FP'NU89JTBV&H$3P0HBL8_[3(;+N%AZ+<Z<0Z3F_D"/I%W('_<5:_6
MZ)CET1=C+6]O:#.3 +7-_/M^>V,M67(X!=F-;X[7#%V:4+CTF3*3@4N0"^HN
M&+<<O SGVXL'=[0WN8\P'%6O7V#UGU6C%M/:,5W4%YU8-E]X[ 36.>'PI0G#
M!72)(,3R0"G;V4K3)SN9!A=0$K".E/XC@\_XS.-X*7/4POG5=>M(0.G'/G]Z
M#]$^LUXK?$#3$ZR\SF<%M5X9SW2[?M:CV,9D?S9"(>N+XJOE/-3[J?,&^&1K
M]C<?VW&@3?5IR6J=Y>$"W1Y4M1#WE_Y^2E18249'93\A1HCX=J08[__ /GRS
M($-<\C#R/I8IT#1N5,Z":))61'F?!-P179B;&2R_GS.S$5[\MJ-6'T]9,\\5
MAMVG:J"=TX\\G:D ^&/V^C-I\9ZE$]D;]O+14V=&^9IX77^>KJ?#JI%?Z[7[
M9DN((U[RP0HKM5?"55TY*%>$B,735S"NJ2C,]-6AR*Q^57W?4ZM6-#7'3%U7
M/MH+W&FR?+!1H6#,+?+00'FCX$(HD\HCX\\OLFS (2CV7DN,?:IARL<9A6C=
M+T59-F%Y3]C78]//1(=?^C*\@^ZA\%PP"7":A4DN8_.GQM7U'8-IEU 9BD*#
MQL6TZ:MQ(<79V([-D I66_79PO\Q<]<VL W\G0 '^>*-P8AP">_0T.R2D33H
M'6@',:-SS']ALEBLG]+7CU:H/_WN*O8F"1#=>!SFR:?S$E$2Y!5VTE[ZVKUG
MSF."(7E3-XX6I5TZ%YLB'2R:5Y"'B)4S?1EXBG9Y=23_V@-&CK,TQM:QROM]
M><5L;[X#Z$4V *6T_.(Z;&K<PN98A/VQ&HTCWHZ#:?>HL76.)DEAZ8DI&4C^
MJ_F5T19#![/LV<8=KYTWW&US::@[^FF2(N$)S:6>).,OX<\(A4>)EA/'NNMO
MKPK<1->G=1TVK3QC.$YAWK5\M(PUY9!U2U[XS.R:V<?^^_(W9V.QO#(]?GP)
MD9A5_N&LQK8'1CH.J<*N*<U)-AMGE<>B(UZ=\\ID%/!"BD"J]EQ[G+_[AO"T
M:YOQ:F)[VT-"I^1]1E%99)0 7N*C@A_VZW"M' EXJS!QMZYNO9T$2+V=LLLS
M5,W=2*>T^"#P*4ST<G:W'O4U+O:VF0=73WQFR/P >9T^N3S:W?@TO@;9=&F.
MJ<E'1OHTMF*W.5%VX7/[^X>;[-/934<N-4\ZA!_*GO=<R=HIN9'3<6I&O*U&
M,=PY'UJGR()"N^6G.B)1OHA2GM?U#A?ZZT\8[Q,I>X%:DA@FHORG+#G9^G(B
MD=$QMP\ X0U:1-BM'+..K*RT063E#781:4FJJUR<V H3VA%-UH7Q6!*@J41+
MP&9=?8+;&!V?GEC'YN/5#SXH- !;V=&FIWJ8GW4-JS7K:%ZTOC&A4%_H1/ F
M+UA@B41HJD!SYQ#Q('D6MA8)DV".@L8J\\<3--)G(^O;P6(&[' 3BQ,OL<FM
MB[*S A&A;Z/5]FO7A2Z%6^]/G$U+;7'91V2UYGR]HTRU+"?5INDKE[+=Y>M/
ME2V/5F=;ZET1?WVF$(YKM(G@:XSMH=T1)K"6O!XG<0_G5Y\[0@)\IE(,-:OZ
M30081C2+E$0R:0PF1^;WG8Z\[+VI <5'3+0FWC$NW\S,J>*T3W1!;DA6WT\]
MVI#8U-7XD3=[L%]I^GC[+0:>\UK6)YIZ+MWW$'(?#J(AOIKTJ@L]U'10R%=
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M\'V+#7AL%'G T)GWG1"8_#AX+'433'H(%5[ \OIZAD.;P0'$$6N*G:,A >?
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M7?R$0^QJBPW"2$_!,#,>=1\VEY=VN@<5.,V(X$E V16!E!<#%L5H;&.$1G"
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ME?LOW )WZCD\MBK2;DKO3W,3W.'%.OK1K$^+J[#6_LB!^ >F*P?N@BUY:[)
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M)$42G4%P.=!5*OQC-XUR-7W<'CU.^M&QS_5KB"J7G*H?[]FX7D-,\TA.31$
M!)EB<S,?(M/')>,UQ6ZX1[/6P-9 37XV=PK+YN/,CZIR;6[N2JP(H/6]O(8V
M/LMHQ#3DL<F:TDI05+V GL?S<Q.G5]&PO@9$6A8DD@RB#@,@2(;(\%%SJ1V\
MW_D^)[2]RIL(!_5#K42N,0ED-A!2P\-X]D'4#0%-YRK\(*/XB?FVW_7.HJ.@
M.7>+R_5X/EK$/)DZF X:;Q$,G@94O*'S ?K>!'*1'RB//"##CJCKC6K X3M
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M$>:INM46O;0O1/H,,"UQC\B\1P3)19CBJG 8<5=FT,?#!**KD^+,43,4A9X
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MCVBG4@9'2N03Q5Q-.^TAU'7:OC"5@PN:TEHW*!Q:;WR858-KQLF@ #JDDUI
M<YMO3IJ>X#D:&2-\?_2J5-Z-MH/LS<+\:2E)%ER$:)A7-YD"ZR$;4$'LU+@Y
MH5@[8N(+Y:FT-W$O1_*VQPW[V3 EHTN(TQ:8GR,&K7H2MY(*B=&.,$)(J;1[
MCLQ96IFKL@&RK7!T.\4!P3BF\<VF$J@2\/B<S.20BW04=8F!YP^B4'XAO2 R
M8HET#+2VIJ@YN$N<B\#$?*M8<H<+UD *; C@1!_4'T;AE[&X *SIRC%WK$EK
MC&0IT1636P0I0NYP"3+$!(E#^6V1(],? :KJT' (EH,&IX"H-M";6%I&Y,]C
M.:B>XJMB<=8H(+'.#(>SIVVU JYLC!.*3X@5<Q )*)JJW1"^S#Q!4P:HZ77B
M<UM5I.(I"-/:G@ONZG$4%$AO3]85I!-BCB8/9#70#@5U[I0_"*1V[O6OK53H
M2- =>('V:C/C$1FR%J2:J%9'E'8DK1P4=8^[&A/%65(+$/%FVE7/3R2G.J'M
M B",TY]2U9&#G%?@#]G0.RTS#CURO)Q2L)'<R%1W1".U@0+HLV!RJ5?$\*(0
MF='.$E#P?'3356EO**"!Y"3T$?_5:S%9>JS*+,UXI$QQ&]J2A.+5@-1" Y$^
M5.ZN9R4CD546KPF?9=H!)ST*\XJ07/%T0B4L(7@:Y:8UTH&C$]K ?,(Q5\J7
MFA8'N.#70PZ/8?64-\@G/;1BNEY_RCN?%0CZ*W&*>SE&[RSX//V(GZT\T F!
M!MZKV:V2,:V1/1F)+YS0U+] )RZ/V#I NZ;*S!V.[Y<_=D*G^OFC*]"^+N4V
M27LV53!)1@R'.:'=@2+46?^_X[3[FLL]T4VH2@/(#65]$P\>J:8NX&RCZ!W.
M'_0MD3=9.T':\N0:>D%Y1O0R2%/IJ,;')!H,[K&RELJD3V7'*%AXU 3E6A#^
M)=K$,Z<'SA68RI "\5D0OM)0A2OGL$\H)!8+XB*S9X9@((M0%.>2(C"5DE&@
M%C] ^:"KA)FUX#3)M].!,_^*.RQA;\6D(6$$Y4(P[=#R))'WJ) 4U("MU<!-
M1#M]+5-0<'S&<'DC(ZD LB]$Q(Q%Z5@]^R4EDYU0)\<Q >D$^5)H1&MT$2/-
M((8W%B#!49&CVUE1222_O8W[C_R*HH$YO/>:=.3QR=KU(,LWV#;'5FKSS;,
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MQJ&=&^J9OB(3)<V.L98K].WTAR]:2EW(9G496N1QL-J11"X%V5E$8O7&M49
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M,@NT#A]Q0AKRRZX6%9D%:AF,)O'ZD#.LL) X)#,'9:>KT8&1V\0VUZ0X&H6
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M[N-UMD6YJCLD56-W-ND9=0\%I%U-&U=Q.N.2^0VYE!6YA(% [@50(HDCQ'^
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M.KPB]BX&\#U6)375B2^,@H-8>=8UTPSKMJO V=89$L-=^\) $Z<H?G$XWO.
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M> : ^4?4#;/,P>0D"5N8HK>U8$4GJ-@!$W#."7V^5"?M!6>Y$EM%)JA@,!Q
M[D%?0R<T\WXF$$SH%R=R@]%B"N@]GI#@'<U[_80Y:\;AB?]VJEDJUX"U+?=L
MRXQ+D9$2T*50B;@::O3#8B#MHAT(Z%01"2D @_BCM5D&-R>T_1%()MM*R]P4
M$VD7S^S*"P4UYVLGM).5_*"!LFA&]=@4Q]G?<&\G-.7_98C"_YCR_/]%4%-
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MBM.@AZ4[\XD?U?8D(XT^(7D=DV/@[^#H[^^/I]GPX;SQ<+>_M62 HW^.ZXI
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M*,IG&_/%NSU86U5!UP<%/S!]ND!$Y'S>*U"6KLHR%4__<" 1L& ;Q;:02&H
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M'C%J#LO0N9<BR&RIY0:3,:Z!$?<>XCG16D7"IS@7C%2HL0C+>D;K"C;37NB
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M.G(!V!SONG><+BTPSYW"4:?GRZQ.5B2!0H@V%51%K&OC>%?:/CP0I:?=P7)
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M[1PIBI%.'G. N)0N?Z:?K]L#O#*3\>;+@^@GZ2D/Z.'RAU:%JYVLYG/@@WS
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M/%RJ-E*_Z@]A*0)[U&^:" R\PO>C;94>\QS? GL.V:)#V/DC</G<QCE&HC]
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M%D$ ":.I.W.,N(RT/P<[\+8-"Y\XSN_'7A+4Y;/4Q.2* .JO)Q1AGARO&AZ
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M#Y?9<X>PA<WU]>2&:*+;: (96CX<;O$S6:4HC+-H%8U,T3W<4<X(>AV+)G&
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MQDMTAR!_M[@A C>8"2MA,(T9VK$:X(R##,)!5%MZ%F(<-096694J>R2-K1<
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M4RYMFW%0H(]7RZ5=0C)]7.;:0DD90Y1K!"#7PT_-3GD2(X+.^GHVX9P3V-H
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M$LHH+"C6J#'^=!J73JR#E -A&N>DAC#6:]JC*UPKNX1NR*!XHTP9[&6ND5:
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M:ROE,\#[Z&:6R"<3^A"D:+X';E&C$&T$:835L7I!0Z3D.UH\:T,C;#;=4 &
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M_C@(+WG1L")*UBOKA_#&/I1Y.I=V8^A JJ[ +X\P+-8P=>:YWA#3H-MQ4:C
M4LCQ,!9L-)T0[.1TW\.6Q[I/N>N$GH"[$#.GY-"ME>5K:?CV>6</T)70\H;R
M="BM1:.&^Y0HCG3[67-.W)3N06JRT2YK'K3LAB&?2U1>ID\L9^6P6&Y%/Q'@
MS$;LPZRN75;98R=78&SUCC<X3 0KA6\5G:\A2A(X"H++G/O:$6N7@&120253
MO)-/H;%FN!Q?(--8<"V-03CE75RENSCS)B5VDVF=ZC<$2U$(9SB%)%!F' !%
MBE.:.4%OE5G_]L_?[7.>%N*:OX%__(HIT.7U#IK6?!S<J-TDH3#.9E5D#N(!
M8LP=,;8GKL8S2U561<4YM D/P1EE:'\NK85)W?.%JAK*R632X/]R82U]Q\&>
MQ?ZXU4G)M"^ULIJBI[&./JTI+>4L%DQ+VQ YB(.Z3VE..'.65L7<@1Q_6(T)
M&LDGF7IN$P;U/&6,IH@"&:)X^/=>-ZW;#_>DA&@E1OCD S. %/+=_!NN>KR8
MD'$J]5K<GV)Q@!HE!ON]  'YII;]:]U^&+$$FT<LTKS)IMQ$> N&,?J%-UPZ
M@#G#8:O4;[3!QNV\+I></K=?CIW]/A+'%.P5COH @&N^\* IRO<>_[OPAQ;(
MUBR_7BN'LOC\$/D^<I+'0M@:\XO6<)D #@<5\3[!<V\'V4Y\B;<H;$$2ZPW5
MX#)SRB%((L4!WM1C@48YY>RAH.0:F2^T,&WE*M-K69*@OGZ8#.[ TO2/N>\(
M#1+,B:?=WK.5A18""\3ZJKE[%J[A'>"[#%W-1-A6?COWE4LG(6]#W?+]R;D:
M:IVO D!_Z^79")7)+>7W8CZKHW]G18T,BR;V_EZ3[CKWE:#.!=7CKP6K].0V
M<@HO8*959<FI&R*LB1XECZGM4>ZA,0J:JQ6Z>UWL#_UA+ U@(0Z*+#,K,IBX
MWR<.(M-H2R0C!%7S8@N7-I=U/@TS8[C'P6%:@]VW)":_H<-.*!H ZU*0/E',
MZ1K8NCAR;?D\\5(5FL'F<>33F<?AL[6@.OQK;X@O[!W=?!4#N 55OV\YDK=4
M7HI/HE18K56]]F:ZZ(^JN2<G7<"?JM9G6LV$1]<;@@YOCR)<-I',(9A2OG*Y
MA?F=DGV%F4NZ@EAE?GM+U R;P*X"Z19O8(!:!S@3.GATADE@ ;[:=Y8]AQX'
M.!B/WMT0&<ACJ<U8U*E3>3? _R,9A"=O7W>_9J'EZ=ES(NXS-6PU7KD:^E5V
M "MX;ROX#_^WX0@#97'3@=-H0HMNQ,4(S7PCH@C'S;L</5>HI'$Y]FZ/2C=$
MQ4D1W#WU'61)MPZ6:\%PF>$6WSUB=7T31S:7&<+\8P.IOX=9D9ZZ&8<?NU/(
M/F50XV@<GG9JDOV8:\28#@6?A0YSCZ"WOD(Y+#T<-9_% 2O'I#U *Z])TB?#
MD%QV&X-K?KV:PQ(RY&'N224)3</]&7=]S-]0!MNU3EN$&%72Z I^>Z>J),Y@
M68ATP%[/:2'U"OWD,BN'WO%QDX3OWJ$T.1^S?M?29TAT.Z +H!MJ693!G -L
M"+.3DR5$/46L:@UC2]6QM B;!:JXG0,4_]Z$;ATF9SMKKQZB1E$7'7>25[)E
MU\COFE0C@+O,Y"_=/<SK<8^SV[;87O?"IW299PIHOK,'CL)'V_*JQ-FD7H<9
MXQ'!X&:8,P-ZTGF[F9/R40W_4TX*]8P^.NW$YE=Z;8+'S4ABN,W*I:^0AZ-Q
M.8O#^DGCB6C2'+9XYQ/=H91N6AE?K&;OOE8H*&_06&GO)>HT!;A_ $J!H/<_
M_/WB#1'<WU>9%:+N:285$Y[K:"Y+==.GAC%<W#X;R\8ZP3[[WY:-_9\84?S;
MV*5/]K#EMB0],F>O7OWEAWP6+IMPTZ@1*OF3EHQ +3K,@2CS1_)L/\/'8,QP
M[=^$NOB>$NL7?$ZU:M@$+X,!AS^:87:R$AGJAC%#S&_L6",<V \Z^3+?I$R@
M]^/^.8GNMU71'-H%E!SOV:@LS"U'I# #-73,)Q6[M'BBU'4H9=.$5CY:CZW"
M:J?<"S:I'R3_IA5Z29A/Q^'X&_DZ_YZ,#PAQ ,MOR..Q32<]R>'(GDDXCQ^A
MM$M\L#KQS DSV.Z^#A3NHW)@,_)A_O5LF4N756J#UQZ2Y&W/]@?PTIU_X:0Q
M&/'2B0 W7NRP3?MIUS)V_5ZD4[5B&9O+ !:F<'!>9PS+L6_ @Z*)-_D3S0+I
M+;K(?B\G+1R1%6-EFCUMDJ1+KVF:-B?;F']W<AEHWZ-,I8J]BB;Q>,WNX:2&
M&"9PG8@PZ/+#3V$)VFT>5P:J$$!FYW?:(HPR:!O'*/ ;=*+<,PFSLJ=,BV#D
M4@Q3[2%!>F?DX75R$<_W"?E-(>YB)G%$ICQN3D=*6"P\MXK0CS9$WM?45YOC
M<815E:$^Z-3VL+K&V<R8.9O C"S-8#WW<Z^A RLK;HBN2M9K)UNU8FQ^]<P;
MI#O%L258BRO:*LBDV7SJ?7B0T<M6&5N!_[NY)R<?LV8^*.(9TC#Y[F:\PF24
M :[+'SP+,QG+7L:E-  6_L/M(X8M[O&X.+&59L5.PS!Y4/CX01URI+L; I %
M^0_4/,3WG8=PY_:AJK1V4A^2>(/03?Q-&]_O-!T@7H+3C5G*5YX,N0?BQT1Q
M<NJ;A90(KTZ'9<FI&KLWP +(-'K%D!GQ!B)FO*HGWBN0=J6K!SL@*R;X"/MX
MY4FW'+@M4J_Q#O<9>\"+S714)J*$?(KU''ZG#FR(+M)5N5W0] 9D:FY)"R=
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M7A^)B8-X+$(134?SFB1^C-E (Y>MW.=807PQM,W/Z#X5P_W<43A ZT@I60*
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M"CRRXVI !,SNLB<9HGE\+("]VT*^L3WV(@Z#6.:Z91R:W(D9Y++E,RI=I@H
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MIM+D;BC4?JZY*4='5-Y0C4+='YV=*@XO@5,^!J\$((;Y %THQLPA$[-N".@
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M:3&PUZ=F3D!9>6_T!(#Y+_$OT_@Z&LT#NRL=FKB-"HE:#Z18.@/E9MQ9OT<
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M.NC;'_17V7A*-]TX@Q- H9[*[MP+S#4@")]*G&4GCBO[ >VG25)BTPT%]?)
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M1D !,W*/A3>1DL'0[]FC_O4TIU!EED.ILP0SVM$1@",&1%@2Q%*R ^EC=QW
M9##6*5G,W!8.Z%ORS+C,C/O"W0DL2Z=GMTA +6+CGILW5EO&!7P7X=G0\]J,
M8!VD78HCU=D8<R!!.#O>F-6J;\D T\\YN$V<4$MJ(*<PDTGS_.L#H/8L+5$A
M:J,I!$H7ZD@>DI>4#M=O>7KZVORPLMX4H)/6FQ2$QKDR6 B,;0>I<(E/L@H!
MQ?(C.[%3K=T\E@@(MV-1_9DT2P\ [&+%GL2(?GH>DS$ E&VO=,[9/")$@&A
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M^P3:)5J% 89E7P/E1.,C$J\IF+*45 :B-8/(DR%O6QC)WD!9K6.8][5*E\^
M75P-G"T5S?@,)E1_4"OB@3T&4HRI>__6"[O;2T=,W>N;YD@ =GPB**RY60Z:
MHP=1-3I25\D\4%!'R0/Q$.P3 @KZ#<?RE+:>7LH?L W'64?5M#7B8P#XICT]
M2R9,I<N@9=9.2RN37U*X0-W^-JX^BUYBNYE@',(4.^[YV51BZ'GPS:HI(<_(
M[D2K_TO_("9?PH#.,00*?J4FKMK<3..@PHXYBW;F,(\.4,C46DI !$ 7#WZ.
MDVL(5E*KD(#ATJAFBYT* ^++I<-8!_/JZ%@(H(".IJ./:_]+QN&AW(9EECM:
MMA^3+B*LD'DC0'W1RAV:Z[K<BJI!>Z!EFM.3@4I+P"RF4EK81'8CXPH[*%B?
M]K^*\:V2RY!"?1R[-F#QT!C@-I>[*/0\(8X, $H/WC8"D:GAZ'<!=HTM("XY
M"$IWE>.8C!UJLQ\9*<SPRHF ]ML*6QD2QW7U<!@$R]6$5#8%M?[-)?'2(9XI
M$ 2,TVMNA(5X1L#PE*O+M,D)!L& G@?/8/;BZ?>F"HT .WW G+5)50#1V0GN
MDLS<-C^,A(OW[*86JS;]$KNI]5]JT_]Y4PO8U*22_]FFYK]M:@GBW;OR&D<$
MLNK/#5?8VC>KH[:32@L$/:,&,>9U+IC4D)@VCCV9>\ULDJEC, >(SP6AU3%&
M<SL4'=CA,2E^-96&IC0M2E.@CNB&W9P;JX-<EY$L@_3=,##:?)9/299WR($$
M6G*9G%#3U<E[@51Z7T<\EG4/NPEB)L9)"<W*SC4!<=HG)I1?4DE$\P 9[!Z3
M)78'>XA!ACDDD\JXQL0(2)(U5Q$BKH>[U.IHV0PG)&*N( T?9(#CD5Y1&G!]
MJ48Y>BK$L2-6R1\?L+@-U ^"G_@+\UWI"_U8^=\GT_^2CFV],>\8X#/E"2+_
M(7//WTD'IF7#T4Q=F?]PFC,4 85*Z0KZ1U*T&HC:5+EGFO!^*AC.,!"STM1/
M8Z"%<>9,K4>TNRC2U] ,XRTV@^T>D0 RM2O[NZC-.%RFL<E;,UM*$C$U2,=9
M-FIU<*!7*F#@GZ:O&.Q,?$C3P25A*I@),AOZW9, "[CFN&&/\AZ?PJP@@_I,
MQDL+94J"!(V,$R-[5!S-4#J1Y%"<BZ56HS//KL:* #YOUR.O"[#+D I_[^O6
M9XD#RJ1#;RZY^<IYR<H'K[F[;_<X]=;&3?Q;*_;M]\[=V+_X R9++E+]&I._
MN*OHZZ0=*W@#3[=:/KCXS.1BV>SZRLW/7?%9]&+HYV\V8"^IV^3K16N?3PP*
MI.4^PL8?UH;RF<3N'_NUP5]A+E6P#XI]0* ?REZZO__#4PUA;G)R,;(!91U/
M")XY2[$-E8\T:R<,=XN>T+))<PE*_FO;XP#-HT?AZR?7?[SGNC[0^GY'KT6U
M_[UW6Y<UW[HU%KSSFQ!7@;]V8'_UZM?W[_STR0LQPT//;J#71&_WD23*'WCA
MKZU2$:GO%9U]?\4V"_<9V1]/):_]"'DDDZX^$'BS/U[MEW#DN=[K])\'EWSO
M_T/3%PU?'KYVJ;CBX&-436GS&DOBA=_=:OE34:<U*)G#%0=(_V_$C(LS)M),
M4!3X:&=2FCR$3[AC=]G@WQO1+[%PI27#<*] YI4?DST;ZEMLV\U54P(C7!)B
MO>'J#;7<?,!C>1R?=)=,V3R"@:9>EDT<U$H%$U#\]ACJE2DP0_J)EG[8OW.:
MTP8#EB(>^YB6%:&O!\/UI"$!Q57G"0'UXA%^W3>?J4>@9!03K1ZWV&9*6T#I
M<D8UE8(Q,!@8GBHG--J]@I;,<G"*->KQCBI48H :JOW.F$Q-<@. ]HZ:X.D%
ME^53\[%KH-CZ(9)K:!Q&9VCX=@2PDH((OCY>A%[ZFWM^O:IJ)6!^L.H9>%]'
M.90W9:*!WDPWPWUQ\2HTT*$:6HKNZ'=AWE1$JT,%*H 4B1E@"0RG92FAGU/A
MJK9)X+BX*^9<Z/?.2C,"=@N^EN@*$D._QZ#4^S1GFXF@T.5WV#RCK55D\PTM
M-5(0JSL7-([%:R:A]&-'E3=E1<?PGK7#6ZN8)#'2J+*-^V.6'C/+Z!2TX$7J
M7$BI)3S1SMS=J^<U@DF?D])<SI)\""?(W,>C.BS,K?(&U+8C.F*A&!]*!-3-
M,:D%N=_-*H8 PT<*O8:[DF#=4&C<RRZL?,X !D#HXIG+"='J- 2PO-TG$A)#
MJ_DP09D"*RCO#%XO@ '"/#ID//P&% DH#=;JF_$ =!C2/)E\LH4*IX^!2J='
MFY__- ;0)[U.RVXEN@.BCVS1'BK()UH#24-Q/)-;!:X$]?&MF7&U?'VS#NX*
M$#FKL.5W-=F@;.E.25"Z:8^#]!:&_%FZ6<)4>W _5?S]>.B%_FX1D,\<HS(X
M8A3)[Z)P12M+C+,0QL_P*9<8(TN,*\7'9'9@F62N"QF/F/H !5_0$QNROE'"
M!$>@2982)F_'&*AR!)3L\T.KG80B=+D%WACG^#QE6]Y>6)+<UN6:Z*QL$0C*
MBF0505(8V(T03FS0C<^R*7 P<"Z?H<FT:S-"LZ I-6*8CR):&HR&S)+6_ 5[
M,.4 :-;73\5J\ET<#,A2"?I8==_" )N90//''.,9:1-!H3S-)N>FD.Q4H<M9
MD%L6B].9,$F) =SR9_-?B$MVIY.24!8 ]P,[3AYPF0!"P2OI8$*4X)@N>&++
M[]SI=J+!.G\:\X?CP@;(9*">&%=>WJ?VRD8,-!2M-@A:9'N;Y2:N8YT5/1;I
M1@#X7U7E1DQP*B130D@Z=:9?2"<[ 4O1@!1F:B=FT=(\T,ZD@A@89JT%/U+W
M]=W13OB!W1]9='9!I)JMN$&9:V,R+9^Z!7X2&YM-85U HUP<,< <\;CZJ3A0
M"SL5$3OO6B"@/)3(Z>>(CP^%5Z3"[<).YKS'Y&&L7A ;>#39#%2YJY3 QHW!
M3&0V]3HE-U?"=3PF/AG,2!OL+3559.BHK"FPNL1$0)X7[6\&*Z;6UO&(#B5S
MBZO!&UNX>MX(W1![7 4@(5(H$\[@$?V30/]PFN-<2W#2H4'NI"F$FBLW*:#O
MBP3A%PWU=6/AVI[::[(=3VW:MU1(3)KER%;N?8M5]E:Z^><O@\R]V'5</1CZ
M?:>S0%@4=T\C+9+NRMA(7^CE#[J3_K2&DNLDAX(,#U^8R\WJHA-O!3#G[A>*
M.96A%ZS[WSO+X\E+]IE>G>9$39!$]$AH]? \:HM%Z/Z!8*E^1^P;*VX6/&@9
M?>&8+A/)YLUL*29<A)O7/KIX,_'C#=.<UA?YX[E_';(8*D:.W?[ZCP :*UX6
M(8D;F"$-7>J1<)HLQ;Z)VKOQ[=N'^Z*2MI3L?O/8+GUF=LF^WS81/N>*RW]L
M7+;"\]*?M3'2HI_?M_]RP>_TPEV7O6W[F>A3^VA&(._PVE\?_NY2,M"MUSY^
M24K?6/4U>>NU1]@T9^Z@G;H=YWTK_\=;/W_[:W7](<OB!S\UU?5????0R.P/
M? ^1LR]&4;('SRBKW&=&G_@H-_/NURYVZXNOD+=FC*+I6.)PA<OSMVZ'AB^;
M4S3R<K,[KSDRXK",23<O?[O"=4U.J_VC]1O4D:&^,N+F_O%:\177Q]W?'A'&
M#+[Z@8IM"WQXP5/WTN**7U7%N/T9+BF\Y*JU%B]>^>N!!R%+]DUS= T2^N>#
MG]U$2-_(WM('.=Q'75G54\M*#G[WU1^" \M[&MZN'SK[5X+'YJ5O?XI=B7H-
MJYCRKK0N^N;Y5S+"Y]!?1-&A,9<\M=9OK/-'3O^\*6;=DQ\6CDQ]=)@[\6[H
M+O?-./D==KZTZV30M9K5(S\-G(EZ;^KX8<O'3[[[9,L'$]_3B87I(5^';Z<S
M7'@?+9S,^O=;C6>ZOK#/>P'5OH *$&G8[](CU%^W12FC$RN80'[U)0;!5ZH+
M->2KGTR,_J6=YGR$7'NE<QZ_;C]9+3ZJ268RFO8GNG6:\WY5%KWM>2;*K?6:
MYNR2I>"#YD/3G."7IE:\DULUUJ\G;P8NWMJXR\C_=.OI[5_5< ]^%M"99L;V
MS^Y*_V+KY^)7<D<&JVY_N^>?YT=:T.Q-42-M/^(7C^Q*&(NZY?JEY]J^'=XG
M*[[8PM28"VZM4)Q@ON!NV]+;_[R>(#T[FE-:DC20-Z6H^?3P_-5SHPEQ7];1
MO3]O7W@7;7O^@,!$U26^XZ>H'_C7L\^]G<K3+\^S+UX9V7GDV00\G9]\H]M=
M\V.UI]@G_%DZJ7HW<G&._=#.7<S'F7MC=)7/]D,4=\)EK^4?+Q6WS-<,'Y@=
M63JY^EKWEJT#23]_LN*%Y[U-S6NV%-K61(0VW/34Q6QX7=/U<U3VFX=XG0\W
M%!$?#VWK%)NZ0AJW?7.S.:'E7W'<1?X/MS1\%-6_9'W[OXZ>M#TW8>B[W;[Y
M$?6,XK,?9Q>D.O5\=3 W473BM45I1X5=!]9^_.K.<+//RVU7\>//[@YS'ZEN
M_"6QS75;\4NDCUY@/7\9_3I"=5U]7G2WOU3PU.WYCQ?_+#4M7QY\(HC^*C.V
M]8]K*P>/_.N[2%MR\\RD"#-.:(S\HM _:1;&1IT_XM[*X*WB"<.E)5K]]9J?
MTCVRV;Z MT1XF65<X9_$W=\75^U?CZVK)?(:SU"&G\P:FRBR+;>N8@PT+CN9
M4GJ\ E>[ZGKTW[%EOYX0"6KE@$=RA$%F,;E)0<[G0*<K*9TMR*S9L 1'[V$G
M2FP$'U0A5/I,9\PRSPS%0'A&BO7 H*'-JN6RR6V/#:I3X0$X=Y"KRX8H4*9'
MLV..H6H@W>J)%GEH\A<)^9 >N<A$=)9-<Q*@8U:TYQQ<=VRGM1>:'<S'>K"[
M8/)^,&WF-.<TJAX"OQ8C;6)J$PKZO/V%&I H"^Z& !&CKTM2Z><K>P&_Y8N)
M>2,JDS83&"(H5%,NDT6#?O$[00UWF!2)T*NI, '%=AZWE57VL[@/T*V5IE!9
MRRCJ&'6?J=(.H;XD7 &\Q!2)#OW<!=.<A7/7X#(;H(V*-C+__D;X"7L J#.9
M4M]73\M-#@&P,UEF(C:3$.. <3IVF8.=GDEQO*6PB/)*P1 I ]BMH&7Y<[Z3
MS:M30TE LF52U[ND4Y(8!Q-KO+:52N= THS&VV@GY@<I3D!1$-Q[(A0_!F@K
M^PBLFIWA@G9X%;)^CZF*0(SEL WKDM^5DZ:%Q@RK-B'F&CP;;!X*"\17J)30
MC$F0J=Y@WH# /,)ZO8.U?$%2,-EI-$,Y$G8J?8$ZJV0">Y]Z3$:97G/K]AZ-
M"^S,(O^)#?4K=DMZLNF"6474RKYISJ_Y-?ATQ_^O4F1HAGM/M_^,VJFF=VZM
M5?L/'7B/$NPQR4&#*2UF,CY[4:/D/M@BB>WLUNB%QX)@FVC2CK0E4SPPYA">
M9)X^%ED(75C;,RN4U+P]MC) 8R=$LTJ9NO84.,EW>J/G^T]S9L\$:$+9NVA/
MLD!I Q;6FM8AGBYOK\  =A%.>V 2HC[;(67ZP"=I<\W-@*HRN!?,'0K-,IA=
M42D0GJJ>D8]EF5UG K;";<+=W3DQ.,"AC!WHU94O0M55_4",FLXR* .XXV@O
M(.NU"HI^U,0)0%^M.B$^1UQ=$ JDDT:U9*(?=BED$BKH+U(BAIW=7<1.L,:8
MPU/GTQM)L$PL2D?N-XBXMN-P<:154(O?6Y0*>?-\E<^DP SZ$U%H*SM& Z2M
M<,E]C=1<B0Z!21R6M9QEG<BK0L&:+NTTT*?V)MF51#Z\$3%GL6N]3G"]O9<N
MQ90$E@7:%"ER=(S_#BA).3SR>"KE!]10<EOC-4/I_0Z:T!TKOKS/,J,>ZC![
MQ-WI[R[P:V9@J1+2;Z2%%PJ"@-7>K@5".IBYF$; @S]1>@(Q7CP2+;5/+?T,
MDY%W%V-,>CHLL#\?.\UI68%JLWY(_ 2=\.C&=048\2LEVD#UZ6*__;]K_O_S
M/PQ^A;WTAY]K?&_$'V^]_?G&5]>BRM#./][\\E6]K*LK0+8V^YO]I'+[YG]D
M2'\S[AW67'@_#_N%.?I7&EZ:3$)K/TW37E;=?/F5T+X#'X<L$ATH&O#<OG[J
MO;-'[#<*(CQFI!/G(M62]%?56VY90SP3;&2R>0!$H&5H3PG-G'_0!8[X1YKB
M5,#?:@4]FG=7!?=RUL'95#DQ'FGV2J85@%R>&$Q0F"\AACOX?*.)2$EH; 1+
M+J.U].IP_(Y%"]@,H@V*,2JL-UH#I/J?$#G8':9H+V#M;0B6U!^D/8:UT[)?
MHXKW^9[$?K=@Q:1B"9Z#SJ'?._KK3^<]C^DO/J@I_ZH"W7?VD?B%D-E-=[<[
ME>@-UM(GYR7/_K*,:'FY_94G!W8$5%:%ZO 1=P;<?[;H\_U1[VQ"FF9$//PT
M]."@>XL']9O'-U>(1I''P@7;3VU_LJ?_C2TGCR#+O?RO+XW^7#HNY0]XO50<
M6_G.#^>NG[QR\AW5E>=\UOAK]WU8N//ER/N&'1&VJ7F\Y*J#-Z7M4T=18@G^
M^[4_1/VBFR\/EK2CV;5+,"V!:]>Z/1HA\Z<YWWHVKF;@W'.!\U.^77?PQH.8
M*[L%R2_P1@KG=_[6OKUDFN/BMZ:<+OBC5Q>W\_L9JU^7OAFUC>R0_GEQ[BK1
MN.46]>;%]@]\?XO^,4>Z[],[XKMK%[<8C+Y/T)A?SE#&VXK/CG[JLN1B7;N[
M]KG7!_'W_]FT_=T;"WVG8E->GN9(?DD++"GHW^%R+7\X-WYJY1:[Z>5R7=SF
M[EI*<WOGVY$<^0+7:4YZ^Q;+T[RP6>%^FWTF[K>WMFS<[F+[L>C:Z=Z"%4[3
MG,!5B<XKG<P[.%,O[XAZ][=UW#\^%/<LG;OE_'L+WUA__,ZW2MD?1Y71023O
MTJU),_*8$HW]I@AZ+W-;SNTEDEXJP83?F^9DF5F.SCU,0.#M3]0[Y$]*YXU@
M):I6^E5:H[D6N?-^&G:-S1M[/@@]J8GS%P@O:Y^HC^75HQ]C=6K^ECHFV.M_
M))/0 .O0D4^H.$7:BE>++NRB5[&BC>/6TF)U+-+RC:0H 'I637/*UB0(BJ:
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MN.V83L[]Q PL&(W&B$"5L"$ ?PICZ.-9 #=$MV,79MG/HQL :HV;UI^2SJQ
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M42"1FH*2ZL4&2+V%HX6+@/ZME"UKB\9TIM/7"SEIQ 1[G7:L(+Y6$*5G@C#
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MX@#7R$#9\9YV&D(47@9VJTAX&[9 4 WJL'%X?EAJS0&NG]D(KTU-D8,[GVS
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M#=)Y%%ZDB,U[O*4Z1:3S]C7M8@]IJT!( "( 9>UDL1JI >U-9Q.Z]8\R_/
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M7UW7YFZV.V!&^+1G?^6C*6]<.M4W--"QY1;(B15/[ HI^$X^KM :>H+13H^
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MA!("+.AI,P>GX6;.ZT:JO%W76]E<CK'A-ABDYE C>88AAQ0/<DO7-5 ]SJ2
MQ%^7]"!B@<,@P 3)U&Z,'OHE)K =/LWI(TXDY42 &A$O^CU)F8DYF!E?O&25
MR6@-M%4/_S'?5A\A*Z H.6@\ZIHBTS+4]@,ZL#TP2$^-DI=<9 *GEM9 &V*9
M.'>"&#; <A#L@/D1,%C^KJB1V-\]4C>_<P#%?3%FFFH*N.(,F.\PUQILA&^<
M!HJXFJ<"Z#C#H 6#3=0_)D)QQ%QB>[X9P,$7'A4@,]9 %"F![8%?CP8REI_(
M@5MUO5(A$FR)LVVV'<X&^.).O0C+UEH=A&M?_#+'SN#'=)1,7B=*43OF_QC
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M[$5 ?: T5(1&(VMQ !U+S-5T-LKLUD+,L#8-M-U4JJNTI ;)V/Q8^)ZN%7D
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M$UE0F-.)1D?C6EN;S\G*8$EZD+IHA/0EV2#_P(DC0M-S"YKL;\V?FIR7NS3
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MWD1K#I.O[EIE'D$V89N94ES4>@-[#^PK4*.*\-7B=\PDAL) (L_10.'X8/C
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M<\O%AO7/>#[*UO1FB??!1/6L!;\@/X4GOWI[MOJWGSZ->R4]LU,=:3ER:K4
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MP_/9RF;=+)_T*2.66 SX4O-;J9472E,!A\3O)G))"?^HLH:IYQKR^-%#&WE
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MJP'KXHI[ /5)W@]"+52OU<<=.9[:VG67!GKF@-'O^M.9("GC9]-C D<A3TO
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ME\A5CV_W. !N1H=PR,1!P !A/H<4C^?%ZAS\--!3DPZ^29[.025P(Z.>;VS
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MT0H/'YVO 2;10-6HR -W\T: /L$A5_(F630AD=H_(P1-58%^\ &JG8\?(_V
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M*%"#YO=LR33W=4IRP2ZJYC1?4EVF)L%8G+\AJ.IL4 #.,4TLVF;3F8>92\T
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M7,O$=>$?JZUCJ((PP#TOKR9])?27@!?Z$Q6!MC^/ CFBI]6^.!6N(UA+^]0
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M#98BML&RR<2&D_GW9>L6=*DWYO^&]LHEDFNOQ/VKO?)3E-KS@AAKBO?RS%8
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M^Z:9OYXW]7^)?V7Y88GMQP<!P^UMP@,G3%[>S!>0,SNT>]\K^'8J?O14UI7
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MV@WT^:H%8^[OB^!#20V'OIE\L?F^:\:.S\.K.^?/7S& O_-AKNNUN)KO[)K
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MF(&QQTZ=)($"T\AAJ*:D-4JXAAW E[ECL#%V+YAMIJI#S%%H";BXRQ 9='%
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MV_ZLH*1=T51[.UA<":0(:])E^P'ZI,XR@Z"F3QKP/*%]D+[6*+/5OZ2<P;^
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M:>Y *,I@"D0^TX2G,KR$H+=^OC' ^X14,QZM3\B!%%^!.[B6(TKQ5#FF1):
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MLEDD<26Y2<K7.KMOGSA4]/;2Z![AQV^%MQ^8-B+VWY+$7?!H9/#TWL>_%:[
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MC/41\X6W,OW,8*)<M;'LD)9([U4P"B*)<$%S(IN63:43K0.]%G5&%E)8!C2
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MSP^&F-R2/-?[)(Z489V,54LJV2F2S:WA@@52[V8K1)*6AXSJ+)6-JSY8GNJ
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M5>7<T6B 2:OZ5TR:>+"1RN9>T^H,<['^\*A=FU4B:R!L0!C7.3/^J!B^C<K
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M@N13M8YWMD>A,0+CT6AM1OYJ*\8ECH+'H%I_J8[='\1XA"3Q"EVM4JN *MI
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MQQV!73)(L%.*B' U^4&WDJG"[!.6<A3C]I#FH?E(D:$>I"3FHSYLBV^&RLB
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M%2S8CU[RKIC+;AZ[OX_66*OJC0.5\GMC.E(YQ =OFY6.)_.;52UQ #-TXMP
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M):\+$)Z2[NGPT67LA]/)D0\Y;2@)E#*@<PFWZ,T(7+0KK;-$47IQ/4 XV/C
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MWJO/\PL]S(YY^@'A0^]-\<83%J*SDU<0"!0]*!F9Q"FB,$#>PBY.UBY6(0]
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M2FA7MG.0U61P-0ZFGG9I[2N_5MPH:(7M3SGIY% XN=8V1?"5"WJA'>O;_R_
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M9;B0I1IMRUV9;>]@1U2N<YIN;C!9 ]4:,Y J#G:XTU AV1'*PD_57(.ZF<A
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MZ<G7?Y;\FQ#'<W]\,C[)^9T.AT")V>[V*L=E.+"^ZX@U=<^SSF0Z?^#04+G
MR<6K3N]MQ(K$%OPHO<S8=MLU2D&T"Z<=AE>!(PA5YG+LGJB29:15*F9W[D]&
M33UL#B(@PLOL$<+ '9- 6+76]\:1 BUY$*P0P4;-;$D"P5&!(TEW.L(%%0>3
MHK,LJ#WO@KJU<>/#Y(>Q%C=R:F\Z2 5GQ_O0MXUBS1A^J*U21)[F/0 5D.UH
M[$2.W%D+1J%U:9'9HXC[L>TIS)_J7-#U"8$TX 6?-ZNA8<B &.ESB,_.6Q.C
M?$M?+P/TUD\BY%00?-P%O;$P^\KW-"*ONOMT?.&@Z-=ISQP3.P^4ZL4!QU3K
MKUW^6/S*NK&,3;S/KRS9$>[6E7S_G3NE#6D7CH6--'L\WDJ>7!IW47^_*YFZ
M,!K8IY_57_YEAI>CT/2W24LXISYYENM0F(W]?27]#]XXZ+XB9\)3498<N'^[
M"#/Q,KH6SY/I"0,EMU=5B./77J%L;7^@3\S\15LT]>3.T;\/)5PV!A^NW/V\
M[I>QSU=%WAY\<?;Q]X\''OXQ:>.)CW6O)*YYLB:O8?Y7R[9OMV,7E7_/'[K:
MK$OXN?+=-Y]_=NVOQ>V)YN<7%R-/$-]+']7<YO&4]].%3>O??&%D<P#I@EX<
MGDOZS\M&^K&@'TT4MGISHIIIBY(-SVU5;<K)\>21?%:MZ1K2L\S#0'D '\!B
M.IOIR$L2\8&.XS7BJ5*LF0C2LG,GR[M)KH88=T&X38<\4@<8OM=TY&"<T:+0
M@=I:I=*N/\ WL5G]S9%D.]X)!&L]^?)>&D\"A;4$ZE279N+,(#ZKNH?VI"#>
M2-Q& E"$.SLE(K00W@\0Z^Y0:(1KAPUV(.H&QXC[E];W<APP<T<-\\9ZZ9\D
M9UU^VG.G>F$6XEX7:.!IK+K^Q;B)TC)CSW'FE*4W9H^ZL:*!M=5$*C5Y+  8
M*+16ZPLR/8A@P1X05@;YI(<=5NO)07#UPBFS?3H.6.%!5D"]Y1-OK'$Z IIR
M&HM[EBC9RD@#&9FEN.*T.%5Y-;4[[M/D!UM$Y_ZV!1=L<9(_2<BYJ(J[/)3G
M>.$^VWLOTK2N[7K96E?UQ[72G-V_\)W^R%=+7)!;S76T:T]-P&#-OPL$%CE_
M)Q 85S#I$=+K%_F9DU4[/]5>@,S6&ME3TPX?N.A&J4 ?*$,X)2(N2T8F@<QG
M)RDZDZH*]6*'2.]IHVK(%+0+H&SQ;+'!@8RP!&I8WG3SP);PB'10BD)CCB%%
MU"D@4%'>84Y"KT0>QQ!@*C=('P\I2'M6+:O?1Z16ERB\"<"TN%8"#Z =/!,%
ML@]O(K5!W1WO@K:!T6PRHS0B9P/$(K"]I@%W0[4O2.MKW"W(<!6#$ R81J$S
ML,S7!+UY2_*.^9$8:'J5*R;7Y(JPX0A0YL'1N+QTOMH.C&S*E4"*HV?^8K@9
M)Y$.5FC%3HC"0Q2:6  "'NESESYRHV02%(C6=G[L(;7MSW1!":S"%+W2;GB5
M [,IN4#(\8=M5<&/[HD2Y3O;=3D^TT7737;=_3WT6LOID%K+8,"W <VV+X'.
MN4+LD)'\!FQ05Q\OR!'^^@\WIDG_IVY,_P_^PGR(2CH!_Q+W$$/,ZRZKJ>\-
M'O\M1\>]0G'T5EU%.3 E*IE" Z ]H0HGN^"^%6'->2K6<*>&B)0:_5!?<,RD
M<4.:;R@T($VLM0>0FZL5=$H*%%=*7="L6O$<UOKI@ IIG&$!-<)-;A1R00-S
M"\%#'C8Y]";^^:I3H'::17E3IP9T(V"6*2-D(ES/:'J!JF;/S>F!E"IG%)1I
MR0P,TI+KQ,#9>;<%[\S-G,2FZIY'H^$H#U:KH=-$3=:NRL2E!G8X.MZ3#GI>
MF)[P9EYI<O@*^70"X =F&-%+"U=B%R- OBJ/,U'F1,97"O2OM<-1<60VJQ<4
M"TDVCOF[H"4D*$,\LF&]Y!2<AJ! #2("C8,OZ<S @>QZY/$Y6N,,D@^<9MRW
M)%L#)%J#  +2(H1P<3D<1Q\."<QO&YPI.M['&"O)G8 R4W<4T7+8&=(Z70ZU
M',\#64PLSE#,,T .O6]:D<77;$&,[BI6Z35@%"FR$ZP?O +FRINZ?7B Y;Y
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M$WP!^G(=T? V53&?D4/=(D9=K]5 P-1/IZC +?RC ,/<;24VC?@S-T\&<Y/
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MIBB;EB9>3O\%G9NF?Q5Q,Q=['FLV<W ;Z6*OC.6(R.I0 56K0&@)</-GGG'
MG"1LJT[E.7F@]G.-:%7TQ- J0"6HZY'WDE2HL(_C[ =BMTJ)88YKB!--WE@1
M$Y6!CXP5(EJYB4SGQM.ZL'0*0^Z14HYA>)O$RA)!U>:FJT@QXC+D!PL&-7;1
MR5LK1+0P>7GP%#U%>1FM*BVWNY8CBT.TIBVU>DJE;Z]01AHS?=)I85>D9HBG
M;X<11<%<V?Y>&0:Z\E-I7NN1Q<65"*??5&.B ]NK*!L':U&YI-;[DW#[NI8Q
M=SB><U9E"N9 Q;G#FE$!N*)@$VU%A,Q/ GKFV-+"4F*ZS)=VMY5M?**]-LQ<
M4N8"=8C8$2"::D$?HCE!H&_WF8+IR\?+%"NX*3&-KO;;#-L+:XN&8#X#DP-L
M&<Q)"7LD=U.K_7$K.QLZ0)\?*?0ALKFU_65,>3_NV4"FO+_,/O%W:)\^F2(=
MYGHLLRLZ2%7B";"X0*9$P36D$ #YU^ACGDC^X7P0)6<NQSH'NP8^Q5F!&\T.
M0MX;&X,I0:NG)YV]NT0;5@"L,K<]SSMYMW;TBFM?+M**@IE3CTE?/(2S=?O1
MIT+R#5"^^:N3]R2L#?M'0\-O?[VAH>"OV)BAX;_A[O_DY+WSF#G9Z0W:5C&1
M)$%(6POVP&+L/K"-$,YB*JA626W!M6^T?\2"J>3B>FTFQ,KP/6([T::H&=/A
M2V8>U/T:.XP"&CH2[?ZE>$!@,Z8&I+"3%SU9;J<60!L_M9)(M!;7@2)]O5VG
M.,74204:N%KAJ1-F"!$ ,3 %Q^6-?4N56^@JB*$.PD/!\4[B&VF-XC2.-&F@
MJ>L/UC/]3 45 JKTX1_G+"[5RW-AX3('.1782JWVGY ^K'+RMM"F0<WX7"H<
MK7_PXW>-^08F2OM4%]W#!-DE5YIUQ4RM\>H?EI>]<V?&=Y=B5:TWHH6B-87W
M)FW*FKUBWA=O"5Z,#AR?TR&*"UA7(L96_.[RKJIE^I5)]V7MS\F6R,.IT>K$
MW8/T[G??N>XB+KYX<%WJR1ZSHGC9LO(/?K^74.LV9YR:\LOSJ&\#YAEN1%.E
MBD>MQZ[-_:"MQ1Y8T%7_Y%+&=]&?3N<OF2WT/7)A3H+7ODEG,VOXJ=54^]N?
MGPT]<^<MGF#M2KY9T[U0UMXBN?[M@.]?RGXH?']-]5\/KE]C]DY9Z#A.ECA<
MLATKAT-*),; !U-KF[/OO))U<_7Z99\>=RU^S=+I_ZE+!',K9U8'AZS8:3GV
M=2$Q6JO.BHG(C=HO7O6:6O.[;<<" YN_F_%VI?'2WF_NK$Z0OQXZ3/Z."*U(
M)!.F7PKQG#39ZP^\))>/UGW_1(9-D,XO#4RG%_W5\JKQ)G95;]0T.7DP_-EC
M(/TDHG3L*J09&LT-H+\(X^;NDK;P> G3PY%CM+%PYM&I).+F(VNP(<B"!35,
MW_Q>K- ^!=.Q(_^(:6]3O@G \S#*<_7&S;'+BV&3Z=<G]%)8*WR. ,\&NRG*
M09O(>( $*F5!N4:LNKK$'V)J@%LILF2+^#00^LN3_4EJDD^O!1WV SX0[KG/
M3\.4 Y @BVN97":H'YM_F,8W$;+)!SLBNZ$VMW6T-U$;T$8CFV^24K?RT4Q)
M:Z\#E7/;@:>3Z2_,3,1,4S>RL RL3Z>H=*'D+#J%>MM4E[_-;H!.:=!B,&(:
MEV6<-_$5K+*KO0V[RJWHHP)86U8FV '3Z/N0422W2V#"81Y]/=Y.?,Z$?"%L
MLP?/X1=9 :H1/?T.\ZKG@JI=1ID7T^SH0-T1TZXTX\ BVVB:WQC0YRD^_&&9
MD_?=6DPC%*T7)>5K9_V*Z:FO[BTGK_\(O1[K+-E]G!Y]7E$\NI'\QA?OOHR9
M3 WR+.Q)7 MN^*&55H9H?UHG'U(%N+D5!B)@8V@]7-NID1MI]HO9_'$RW2C=
MP%[CPRDX43&<A(!^E<Y J2^'-#AY4:"Q0=^D0BST<6CPDX8Q=V)X 1&?" 2<
M:TP;<>Z@OXJH8,/#[JU)$ZMZ600?1ZR*$.0B35VR$'^ 03XD$L:I)N0(&T$E
M5QIC):EQ'7(3#%OB=E!!N>0"Y#[P]%((W; 0K&G5VZ+BZ6(NU#/-5#'MQF(1
MXR9!EEE>2M""0,YV[-K,U/B=3"%%BZ';T#%-RGLA]U@3'!CB"D;OA&4L\ )I
MRW"1B76R0"#?BJWEK*.Q#C@?%>CC\V2<KP,P:TB_T#)[Q,D+Y4)N6$^,I1"!
MN9<)35E )%)\2"-/=<(A-:X%2/2'3EY1:;>-OLH',"J3ZW2=T;XT>'"6>,ID
M)[ 4G*VLPA9A-_Z$=D?MS>_4F>37F.C'5';)O] )2/^?[@2>X&PC(,6ZMVMU
M3(9;>$UXCNK:[<,TJ,6?TT></$UVP8E1YMRNJOJ4.? ^=!"U\8&=/K')AG?:
M0%#G^Q!RJ4/-M N<T;#'5$W3G7I.7Y NQ>VI"6@^8,BQPPXB/)$>XFKL4_J<
M).:Y7<[I+3[ >:YQ6+Z\DS-S9@H%9' "+<8J.#.UB+AG4@T*I4$NA$:3-T6
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M"N_K,CFL.+780,Q @2)VN%8UBIRKI$''9.,$J9^=$%&@8V>[K]",>C0SZ1
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M!N>; 4P\.E<H:C51\L$HIB2-"<=3\(F5N6#]?#0BH(E557( <3[E,A%/TJ-
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MUCZ!-42<K%_4UAR&)IF5\1C33G3#RP5&&0>/5VS".BJ::'-0&GJ&3VL_>U0
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M^0-;^]4%SKO#B#(Z1,[1<N*6"T*46=QUPSY.Q,K0:ROM/(9NC2@+%SEKS)_
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M2S\I"$ Z62^/0OR[%5^L$.X*PCC0JDA+VF"IN0-Q0H6/J $B5XG)T C\*08
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M8JKD?FNJ[3"[<AC^J?S;,V\8<=+99V\8F\?=PG_\A+TK>M^%XZ7+DWY[^&Z
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MTW80\-:%=I8]2-89:S+]!^F;0EE)Q,24GP)%0KT]3XE(I!CXL"/(DX94V/F
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MC^[ 25%RX<B5.TB(5 +JGBX>R1?;@;EMM*')$V(ERJ\@X3_P.9J.S I&4GC
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M>T 9D:3=!!BS2A,CGR@=&A]!/K\TRN0U7]?O2MD$633($Y&'+'Q@N(%X])1
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M_$0+3U'C68B\^WZ:M9?7\@#+7]_>OYZUE2U,;2D6'NCUWLEBWF!NB?O\VHJ
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M0*<.IWQ3H3A:A=EZDU AH&2F0BF!Q@BD#$09MZ:.<9RU\@0@3"P,]5=K9K<
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M<(%(SQ? &Y8"=NO\Z/(^Y&E</&UAC3-,C!WC<+BAC5KZKL__YQ2< 5AYJ?<
MTNG_XWAJXOR4M=1 11.C*N]GY,;?HZHKXY&TD<%Z*!Y,56RW4* J0VXA7:Q;
MSN_&8? <@F>9&!N0U ;,IQO@7EDMRI-VD_L\ M!JN7_*4%\3XYM(4+J[ <-U
MJ!_&'65B@%1?;G3CK"1_F1;H\K4&+"YD#,P#*ACO"'.,3>1@0($@KIG,=9*
M<JFNWD]G8C!6BQIII&O#3ZE@0#?=0L6@^O73D[AQ#,I$G)8U\FHXD29&(-,(
MN$F'W6S,Q-W46'I0=O#V-/K[8,,#+\+9RI!(>!/1!/A.?3)FSS*''MIZNMC-
MNTVH%0)37S]LPE)S-!09 $73L/'GJ3F/3'T68#7D6L^*XT;8TBK'XCHQ*F,.
MR8"%0?]-\E88&LHMG 5.OR<4EX@SG5'<$Y3J_?GI9#HMD0),/[N,W TC%&H\
M E2T&@H*\P1(>B[X@ZC+([G',1*5@8&)_;JG##(@@AMF7/PZ-]D LXX>Z%+>
MBRC)S<L'5:-IE+Y@(I$S&C"QBTI,C-9K&/L1J,(5$TB#"_2-QU7@MF+;PHU$
M>2DF1J-EE"#\J,Y/V(%[&LVB!B)UV2724OZ=%C+P$@__C>YR7]$F.2A3#XHX
M+!-C-5T-/3\TX[^NAH*9*L'87Y=Q1MN:26!^)195L:'(7>IYD7C*L9#&CZ56
MSY[\DD,D$G8J!Q,AS:-VQ/E<!.51@6%6:'6O/Q>HVK)"HR9*I+P4(!=P(4\O
M&=<M@<-QG0T79DJ'[8Q*;R?RNQRY?S:#LB7N]&@$B1&L@ *A1"]RX_*[RSI
M16H&]S8';K4 0DYQ-Y$+92820.ZBC87>50C-E2'TTMS4U@616_N381KJ.W:J
MOE4'Z)!#3WVVS^I!@=8RQ)S?+>XF@\W1X7F*L1K4<NA91^L3NOKEP]\(]8K
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MVG@0%;NLIM8M= MUJ%#9W8JTW987FS)::]'UT=2ZK=0@\67;;I>7 *D*ILF
MU*)-)2+;NMM8HJT6K4*@%@,*#!8QL"X;"D@H($$2"2$@A"20##.39^8>>LYY
MSMG?>?;\/L]_HIB7F>_<]W7=+]=U?9D;&_KE0]&TOO=^;\Q1V[W>F[^V/8*U
MHX-EB>W9A;\2(8[TB@[4]5EE-+D_8-VKXOT9:53?BS57O)=.SMQ^Y[E?KFBC
M+S9,)=;CS'4^/OO&$_5U$<\_^PWU<3#I_Y52]G3@;T4;7T==%R[1/WO_9O?P
MS"!6/[DQF*3E]:_GN"XF^:W]]?3C^V_NO&56-<96U1*4_,%7OZ#J)6_Y>&^@
M;<85_"!S%Q9)651ZC^R'LT-K)O_@"A^S5U$; ]3JOEE4> >;^6KB;NH;"Y_!
MHIW[VX,H@8]WHZ&T-)Z8O?K5_3O5VK\K]C/H(EF!;TO=:0D1W]F=0V JXT#^
MK:SN:D<K8B!?RB9ZAT;Y%[(R$L[\"1FO)VK*G$YZO[WWR*^>=3*?8HT;7ZYF
MR-:JM3,5:G93$2DS%DNT'J@B^[L9M+ 7&P&Y.\+_MA]FHV\B, W9J.LP5M:@
MW?H[H/*1E66P?AHPHC@-D*73X,8[QMOP;]B\DJ.<PL()1 MTXT08%<^31_EX
MC[)Y<9EKR!AD.:'0@&J"21V8,D-,"<UT+/N:R=0ZGHB,8R )R4W+33*\Q^D"
M]CJ2Q"ZBI2:EL#EM=!I9G[J4YE+A0:PQTLDJ#\("G*9YW,V0Y7K ,+5FC=9H
MHW&P73"]GAB+=NW\OANO[WR4R:"(T!#&O^AO:ZYG $I/I+*4WY[$-WBXT>VU
MG9+S!H_*P2WEG4 CD-:@>1S3RGFF=N4,6@3<HSZ;;QSA5>UQ0_OWOL1&ARKB
M!# C(59.+;B!;F71=TU^\U'DY42C$PKMMT]LN2QQ68NY#4XYPWF<& RC+JH^
M1F3FH-US6V?Q!%U"864P4:-U(06-]&>LA"]8R[D8-+O0XN3FUG<I^>-+9<NR
M8;\"59U7^2M!E7G-49V58'DL_%*R.I!:X!&P^ILJVX3BK='&]MW%TUBSVQ@;
MZB\[O*4545U@*P=N#&WA.]WIR;_91%ZD_8T5B@_]#(.JLD&9XZS96.W7J#!-
MKQGAGZ^-*.*O:"J5>"R:0_HO,,F;W1JT%S,85R?D)QSNIS%C%:O2J#?5J-S8
M!=?=+4NV8C>\1FT2XHWI)OG,UQBMWY]:DMIKP9HE'!5VA<Y;E:&X&L[-&.23
M(D>F,$()% SOBB.44OTL3%?8Y:AVY4U: C^8][2&4HJZ+%B5%=L4"QH*\QMU
ML9R,R 4!A?9@QR<X9QM3$)J70U\=ZI_5IMAO^GAK;YE>XX<ZX-VB=F[\S?.Z
MKH=O'FK0+4C;H.H<L ]+-??I;_:-CUHN[9XTG!)M\/&84VPU;JB<OM5O0]3^
M+Q7?''SOO6=DXH9,UWY90?3"Y7]]\V=KEK?=V/ZGRY=G__C=EV\[["_\KZ-+
MW_WZ,^%3FU\A;X\[V\+%:;O?.+YSQ<M6E:W[<.$/1\N*5^3M19D$=_ M2<9]
M4^W\%=^=J_LL[<;"*R?3^W]8^-6MR/9O% &!KX2L2..?9G*O;#VRI;C']*LU
MOXU]XO6OGEIV(*6K^=T5SRD^+._[ZS>?IQUY4>-^]!<73/<>Q-3^."-:OUG]
MWO;A;1>]C[]&O^+^).34"F?I#[]69O=6?!G^]QM/;I]><_%-Y(6(#XCGXG;I
M\_K_?!C/&';$CSZ2]G1F[>.KRI^,_+1ZBW_+:3I^.O_3$S_<"&C_&/FQ_9T_
M1NK2EWT5SE^Y0#CVO,W\&D'SVQUM=*DM^??O?GUM[%O5160SA2'= ^3&T"SC
M1>/./YN*&P-&$PIM$S?R&6K@V),9'TFB_D3)1.[Y0S.[<H-56G1]JI2*)QE>
M6[_#ZWZ07^3C>0/NH(]=TTIGD.R,0[O*OYVN#[_]_+??O?X'YUN1QS1/7+TZ
M$/]%BNZIG:/[SIW[Y.[Q'S]^]>1&9<QL2/D_QM,NGZA3-6;J_QK9FOC7N)&)
M4[D'#PZ7#SQ1\H</V[+BS\S[;MOP@_<V;/CE.W'(<VO1.-5?L,C8=__.+]Y5
M8NJ[MFS]MOKG1I])6HI^_L2E*U7/K'[Z3^D7GN(]+2__^;:H5_YVR7KZ]F]_
M]1Z_KOC'F L'TJ^^N&CJM3=4COCSF[R'WCSW\QT5IZ=B?_/65.+3O5/W_WIG
M\.,65]FQ\"]>QWO:CBR\]MIOC$\$I>3X>+FA22K#E90C\OT9J)$HWD-S(O?X
M0G)Y+G,: D%]0!C<2>-D, GK/[C;W)%374/RM3 =59\O4%.+:P?E('\K"%0D
MG-MID7[#L1T#HI[,70S:D;EAU%HKA;EQD)'H1NW.C WC4C<GP6Y7\-TQ@U(?
M;RE8B%9X=>T:]W@+$V<@-@G;_3/X1A@,J6! 1R?%[0]5)'983ZS*$+J).3=[
MS"Z91I40W>8D<:.+<#?2;YHE9R+KY%:#=V=& O.JHUURJ7K"GX$"[[X_&X6-
M/[*D'.]9?^'=?T%WX[30N0N=?E;\69.3_O22E\2:*TY0<]6E*W]$O_QGU25+
MEDP>+=%V-*GV)IS+J/<.RG,%R]/0L[!)A$6<4. .<%=*T1$S,4QT%Y>WP$H2
MNKE_9_^A'*L-0@,V7N@6( Y"XX'ASCWNP>+&:H^N'?22KFLF$;&6W,XEL+"0
MI?IVI4,O@+VW%H9DIBP*9E $U''BKSE=81HNHW37XC_4$I@V [:S?+SJ?;*=
M1HLT@ZMN#3(9D(>>A7*62<G+6<'\13U[1U(B^I-"%&D,^07OKAT^WA,[%C9.
MQG'EX)P%1*^Y=$LYW4>_P'Z:5]@RR_RD L,L*[I;49%HM5.)L\N@A/8@GLY[
M#_V&3:9VYUXFM 69*9!;,LM\O'78"!:I\;!B/K6'^;,37-D+L>N[LJ,R ES0
M(_;Q>+DU1'$JO9%+M"3?XVRK9<GH2!9#HRHC\G+I,YS%L3'_'*;CMIZPND/"
M]C[5)%SF&,%=)O)WJF!_1A<^*32K]!T0[BO6^7@R'-WN!HV/4*G'_S!J!&W.
M>E<0?;Q9-<M]I#_3N2@#9;10?=VE.4\7$$MEG !D?E4LJ6%(2+D6-$O?%BSA
MHUOCP,1OSBWBW6H,=7XZ:__7ANS:_VV+2IIQ:(>&K)&?'WNKQ33U7:^/UV8@
MKD1NYU>*7=-7M<3'/MYW3Q<U?)",;?ZT@^]19+QDB=ZUW'XSGV*PDA,[KW)!
M72^;H?FT@(J?4R?(K21&D3'LPAQL*6\>]T;"*;IGZ$I6+G43"*@JC\X,%E#"
M63\/.VO.W-1$M3S=&\HYBYQ-S=PP[C8[7)RL\0!)I>]S!3@ O.G=0:$A/2(-
M6$L?I ,<;EHC!%&QFUF[-^%!R&8>.._LZE'D?%M,1T#E2$:FM]36@Z@0 WCB
M!HL2$3 ^O*202-J:+PL[K/2O84?K]+R'?+QE &*PLU8G_743-W]'R<23+PEH
M4$[8>>M[H\Y#+X8J9@>&FEWH9F[0=$3EB(DEG* TLB**'< CHV0GH<3E8#>T
M%XS#U&G%.,W._VCU,-"66U5/GXJ0QPGZ.#<''R]Y61M>-@SU+RWM\,:@VS,X
M:5O$K3<Z)).U4$G*">'%QPHP%6@8'#)U6QUZ'HS>P_,5>G+#N-=LEW"5W=<2
M-&4G,3.(^PDHY@Y1[),&I6-$WS$=(<\($,#EK96O2G?'!/%2.(3X?MQ"DM[@
M$02JX=#?K5FNAH'E]U>Y(DG#UD]Q\]4UPY9^Q$/^JM;<^X0Q9!?SI8]P^@>U
M&OJ-MMO_IG^@8O4/_@7%\&,^GC,@V!/^TP;5P)K.I\;Z=O]C]@_H/6Z4+OT_
MC=(1\@#!E.(P72&WF'9MLE_::0P3%6=)W%R_HKF\!=W>K'<1:AC<_;UFFI2O
MBN>4M<TV;PRY))<;U%QH)&F)A(M5UT4D0VVP4?;8ZJGZ&E&6&^%<#6=W6$E%
M 06/GS&VMBHF2&>F<&0B869G)FNLDQ$0NM/"0 ;09_O44VE5RG-WKZXS.=KT
M]=[7-.C].[=_]M%C"8HO'L.*T*>9$#64XMSE;G^IN+3GKV]]\.SPLUW?KA==
M/;@E])'<1PKWIW]R^/9Z,3\B[$)^Z8KF>SD#;6-7WO]Q>GP8\<_\)&Y*\,NL
MWUW\)5FSX^C4R+-M LUM@6V?2Z#_XY4+%1^UG'SN W/QQC_\8\N2SP;_]NJ2
MOYE"T7N;U*]_>[(P<.KZ.6E<\H4W/KZB>/^[+F_:"[__\ID%&[8VWWWAF3>V
MG;_QW&//N8_O^\-1OWV/92A^[#_[W/BR -=;ORGW/K-@D_=$_5[];REC]-"!
M&LNL^_.$%4]__I5JY-B^URL4/68DH5SV-A:ONJ]K^-69B^>\T7E]=QXY\UOS
MP8H>TXNO?OOQYA_/7#CUPB<??WJ4_.[11R)=TK%?9[62K1F].W_HK?O9>YG8
MP*;1L/Z73LZLS\@^F?[<QKB/CGWUYZ6CS\>'CX4AIS;_+YUS-[WKL:3%&]Z]
MO;7\\Q=V;<AZ(_[R6'=ES"]ZUJPY]I E<'[]@ZC,M7MRQ7]);G_K;PEWPA2=
MZSH6R;^:^<V!#O4++6C':P73M=M(8O5LD]>-1;55113OO;[^T$3WQX-?:.Z(
M!GYUM^O0R5_/?+KZR<=-6]9]I[FP-W[Z[> 5TN=/[WZ(_OP5'R]\^8?=V$'\
M_8S&]U9]E8?,W+^)#B9*R4L_) \@D^<8VO%8V[:QC),3;3^N6/C=7WL.+/G'
MEZ<2R>R3IZ(_.UV.1V\M(U_ZO'G\:U=3LO.5@O%]/EZ"CW?J;/JIN](O5GZ5
M8GJK2?S4;S<VC2]_))I,_;*I#KVWY:_'/BP>BSZ:,QI,)(JO7R^ZM#)$(RQ9
M>J2OZU!: GZ_')O478F35S9G1$M'JB;)VSZ>H?YG:0VCQ8,/7C3TAE<CK:7,
MVX2.5#_ /:\C?Q_[=M/".Z,FE>AWD7>^_CJ]'M<%O1ZM'?E<F[E^HP+O_9*!
M4W]=/_YU>X';^BG]_3>H^1S]_9I'WY(;O2L>?V%\W/+WEQ[_Q7;O(B5VZUJ4
M3.,=PYXK__[*4\'2\;N:7_SMQE>]=[=W[RP6CU;]_L&JE)??)B9OA^WQ[)9_
MOKY%<.6A2S>GMG]T\3'^WZ/\1K:_._/!]-7NTJ@_ES!Y9_,Q_$;(+?1.TY?F
M6O2O3 A8=#<]_.V$E(/IL9_=_ZC_;G5(3+,JX:G>IU]>1CZ_TZ1Z9]N4)JKI
MS]^]C)T+Q/3'1H3IX]%7#[P_>57T3IGC8LFTYQ,W<Y-E7UG>;=DR-K6Y_L6^
MVMCW2QYYIT0Z?6#:\-TG5J,E[?S[YX\AKPL3_OYE[X$+V)6KQQ0M/V"-:Y;U
M3NF>?FNI2Y1^^?E[7PX\Y>/-4]UO?TG@[/J;>]GMIUZ9^D(H^$?'[7#UZ+NY
M#T5H1C>AYO',-P+/\ +._,+?$I!8=73HM://YUM^%3#&PW[#/Y6D=?$JPT2S
MKZBI'-0AGJ;'Q6[LFX)I=_8@@ST"/-E/SZZ9H+"+'8FSRWFOYYH'JE2G"!PU
M:!>^45$L%"9<H\^I^]4EKL&>9(5\8IN/MT/39ZQ>C9U*+F]SY>])C;I!*!XB
M9.ZU]XP%0\<U6Y_(FJ\YS^U(=3#)X)"MX?I0=VRE>227GG,+1L_?4BN+4Z4<
M&!Y2?(BI(J'Y)5)3":>Q<GJ6FC&SADP.EXX!??N:(=.%9;G--HKS;\TYX4>?
M"F,8N  ZQ&/R^(735GH=S"Z+'1)'-6Y9"F/'_8IT+T.%P/K4+G591*.;F-2W
ME@VE]ZL([)8^ELW)9F]M</VX[&241U=OWB(@9G;U8U<K@^?WT-!+.R1$S1Z2
M0N] RLYR\>225+5<DLT)W=ZF*@-L$H"TUTBQFG^&]:?$H0Q!_*D6#^7#5UL2
MO](8X>.IT'5S*IU+)%Y";#\'FQ#?G(RF))C!P@>IH*.ADVDYE3[>66C>)CLR
M ]Q$B)I;UL#U)&86V[F][&M*N>)RE >!)L^7?T?]*2ME9_+D6U'T#%O<R!S$
M='@4E5#(]27X'B:KEF["X=?/*A2GT-<3W<$Z(]> ,A/9.3KD".S-YV#;/(1<
M43!:9J>;!ASB4PS._K9G4MBE*3/F8X>8%VM*"LF.IAT>KGW.7-*J.VWE;6Q2
MNM54[-W>2/9Q@Y5_,RF78A=Q@7PQ@">#1S.2J_O)S1?=EEG'+BUPZ\5TL2*
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MG/ ^-G,=$V%:&#J*"4.F^^6)+G]04;I;D7#8Q[,/F$!LNMU,YO#HM$2(2XX
M:L)%2:CTB??;ULRD#,VX4YB\K[I8KZIG3M-@?Y]K<A'Z$^SU=^/&D\*8V!J<
M5)KPKM_2WS!AOV+C5(3"X,96UXR2^;L#DTKCT,GMK,/L'TKTZ*AWNW8A0^G8
M!G&SFX&"'OF&RXJS:Y%Q:N*-A6@;62C:\8NSVONJZ4,3VZJ0EQ=%*-6'HR0S
MIHD4MSC:+2_]4+%+]IK38$$S4DNO!2$OIZWJOBZ5M%'V[_[ =V.7[G<KYSU?
M7%1S(C&B=Z8F@,IC'H*M]?0Y[.5UG"#'M^NJAF;,))-PX8EH'^AGV)J!VX>^
MWJ.>5.C(0"B5GB42+93B*KNLP.F@N2PA6"4)"4+*0H1'4&$ ](NQ.FQ=JFH3
MR#UI0XAUY(#9AD&,'N&WQI)]>2]@0MAKO5-+^N_+Y(7Q.9?@"45&8D?CY&)5
M&&0'3[C#0V1>K8;2[D)DO3LF9M@$<FE7LA/#3N2:J4L  PYG2%PUD=0$_-"O
MF0P?P2+!>NRZ;KB?4I010%%'EJ.HO2>IGP*OGH.&SE'3X;35Z!F8>I11N?YV
M#U(\U[VM98CBL3"IIP8B!L,FKR<OI1*-*I!C.)BY"6]79*!]G%YMB(C<X$%@
M+7LP+H )3KI:<DXU]^8CFX+1J==\O!PST,)=5+SNDDK+O+@(+N]-?F-HB*8L
M@$" =GZP/#?2MA>+@"WUZ_SS*FMI' XM]%&SS15)!(H=T ]H..V_SQT^RCFW
MX&5FNTQ-8UINFUUSAO"CT#4P@CAAD^[F$VHY-H^>?N\^ZW%X&.T[_JJI>VC
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M,BE0S#QX[1#V&4#HS(QJ.P:V+B-2B=:?C.,:Q=>K"X=(C=8C@LI;CKJG3UE
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MK20=AXHPF+%[IW^@&R[1I?Z>DXOHC[AAE:$ CYSO(N6@G!2:+-^B-;334.[
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MFS6QG\/#:G20KYD H#R\B!QHS,I,J(,"VU(?;UG;N+=>!3BQD=KB1==E*@J
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M:NND*L-_F+Y-9B*-TUT INNI!>[B\T00TY*,H<&].6S;Y'BW)P3ME]05@UE
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M/]<Y1:"&8YGY2+Z%_-83D4-,2EZE:Q+$J3 P9]?TFRPZ21%# D8VD'],028
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M1!Y5\ZF&&V,0=^Z20=K%!#0.CIOPPTZI#.C19<&'N$T#6@V8JU9!-S%V@RH
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M?($1;Y+H)!/>^-@T"6/^'2\N#*ISLG3[P<C5#L<B;IFJ9K:!&7MU):3!7!G
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M*/6K253-$$,VF^!P6&-!8EC#X'K'0C&C((ZZ(T!7R,@)5J*MM',F,&#=;[9
M!A)T><),BW=8+G_  QCWI$8;+0HOK]))F;%9EGX)]=-+ $+ '3(D4<_*%[PS
M/Z0(%R!Z._"/P3*1^]$$*!Z_F=<K0F0Z Z,MB;:V8J2'#3:B8%B.W-5F9R8E
MVL%$]$JR6-I(E5)KV0S_'!.M*A]6M5K1X$F28;94;NFE]?5!5Q@\KT^'I1 (
M$WXG;F/N8O&WX/RMX\L74$^B>!2(G5C[6F&)@2^7444T/='TU>IIQ%$9X/Y)
M;RHLV*$$6 6>=#UL\!E_IE0!M@[[U18='HKY_3/N6F%(WB<2?RM(898) PF*
MLK[6N>!:MDE4+B>C"06C3-K#FF^Z5XZZ$)(F,""H#'O! SWC#SR*EVN6NY"_
M+OZ4A!^B5/(;Y4422\\^3BF/<;(:WH!U6?CC%X S1OY_<,:(,>1M^]\&@:'6
M1[W_%@1V_#!93::AF(;9VSQ_H0-CL1C0T+$%N&<@E9Q ?I UGV1KTB.!<MV0
M29A!4L<S#2 KI!82E=Q&L@!=;AO5F4202K0=[0%X3\2JY=8QM.YN>'/3"?@,
M!)PU;I":8 Q9RQ<B->";Y*IZ4\0T;A.LQ4O@>9I_DM8HD=5/]&,=C$+"%*'$
M$,\S@R7W=2]7@J644)<<P RJ9B(R!S2(M(-9_?&:8K/.8 FF;>1!F2$M"NM,
M435ADW:])-LR%[+4.EF KC!D)%8I^JQ>.)!4BL:0XPV52G"]@BSTBAUL##4.
M [0N@-&R3\?8Q<K-3M8L&SCLE5!SLIBN=T$/N4DW"&^DC^Q6[2BCH-5Y:%K-
M.>IGA2NJ:(I>B*[ELD'2H=G?K1T,O]3I0JJTEW_>]]MS7^R4;]$25[C^.)]?
M%$ZHJ*9T,Z9<_.C%GEV:H[UT&;..D)^%&Q$)NJ%X(.$@-N3N"?>>X N-M)>I
M$CORH\6PE5L8WKGO[TJ\(!IWHYH[GE 6VT26P-V&.QUC&XOM7@%4AGEXH.WC
ML;F6/GK)(\?N1)M&FPV?RJ>RL9J]^H[9"E-5Q3M/DD\?K,[W_RC(Y[,3)T+#
M%OW\X5=5M+#U^C7/A9YN@9O>YHWE-LWJC-Y:<N7T^G>(!1N=K!DN9S?,,,I[
M-_6]'JR-V+_IR:Z%_B'AOVD_VV'%OM[Z[.P9$\>MB9?#EQ0=7OK%.C+VV(*^
MKHW4Z]G#6;+*R6J*68X^$33>S"*W:</^."J)&#/U'KAPR%@3)5,\>"%X_:*K
M/A^L7+L0<3T!=Q'G\T]7'7C34)WME^.#OS3P,Y*BO%'QOFB$JBDO5AZG4M[W
MCV?8>$]?Q55_M*^$[HS4R33QSS6L?=AQ-(@L5GA^]$,0_FWDM>(',;]+7VK7
M-5+W>VKA=PNLY]MMX4M[_,D?OT1LO8F-?WQ'?@3]U3'??W=.9MWV]6L6PM]-
M.%EKO;;Q+H2E5ELVL(VO),%SA9$!X>-_'GSO/2(7Q?'SYXZ18WZM*\:2V$%8
M5+S$CKTVL+H.N25RLGXZ%;GJ2JUE 7OS8&C2@W,_O>9D>;[]0WD6N=JM?;/5
M)W_3->.:I?Y.UA+/[[YTU L37Q[BK$<NIB/J!\IG4R6V-=J&ZRVKWU6>->9Y
M'M%6</9_V1O_HF=2/??:MP'X^W\A/2)97F?QC]/\#WUE/Y%)_NZ7W>=XN.?-
MOJZ'&+<BY"5D>*[T:>/A'"?KV\:#.3]<OG_P._V;T"7YD[9?K7D/D<7BOASJ
M:T.BB_R4A*R;N_N'OX1ZE[ZTQGKYJ=8<^-O3FD?^D-E[^:( <M8<9< [WUO_
M\I ?7Q^9;XO\UY<I*[U-/2\52/Q>=K)*-G<$CGR/'+GW<_+5,V+MPZ5>4=:K
MO[\T]@V'7S&\&?<:;<R-H$Y*=KNQPR;[ZR"QDX,\(>9([@Y2C4-GTF\WD#+T
MVDFA=*_V4?OKCB\"2-&<E^Y;KZ+P2/C]5T2*A=KNPP>VZIRL)^]M"_"3]D@#
M;JPM=8\GH3^""SF;L2NB.RV;T&8:I"F2A?>-2 ^UOSJ1#W?[7WA!-!B:4YX9
M7\$K?\H?S\G_26U;L_G.Z\N=K-DCVI.A4P.OV)*BK[XS-]MT?F2BY9M"6#/1
M),ROEAYY!GXGP#Y_SMR\T2CUBQ>\@M\B3R_RP;W='_9DD[,D8\&GM(+JFH^_
M.,I1)CE9;>\,8@22-;PJD*Q4-!%"&5]0]2T^[S7'3/3/_G-ZL4FLJQ^[^+/H
MQ#U$UZ3X^#K7QN6.6R\I3DFO__[**O]1X:(7E35GJ%1W]^;GR"WMAN',$?:[
M:8O9$YE$82[<!7=6?/!9H&8H@XNG*CYNAWIGXXK+@=8Y G3/*<4'C\N49Q?<
MZOQEVQH.AD=W()J1KZD*O,CA'T&N/5EO/6I=RSTR/M\1>!8V]B:=:H;OZ>S;
M_WZ=;:Q)R#P>6<_K7#IPMZ\?;PE^^AU<3ZH<ZO V<6I?/C2R,?Q>#V217'A7
MZ!BY<YK0RX8JKD&6=+-,1OX+OA^<CVOJKKJ(^-8E#L65<.HZ_UA\B[K-'53-
M\>4\Z:;;0\_ _5VYJT?W7]]S,+I:^D,R>^S#Q:)+Y"?2^]_\]%C\>H*W_\#.
M/_D'T.'=81N??D'USM4",UK!_2!E]HN<D^)((B</KA;WKQ(J3CM9@2[X,XN1
MB^2G3M;]WW.ZH&-S/FJ/_L3Q_<K$G7^7/ZJ9N!1E(A!?T=)F$_P.QZ<>6>!_
M871$4[7^8'2+YNFK4+?LXU>0IV=Q5)][$LXBIJYPCSU?4OI2,>FV[8NU2%<:
M[KC<MW;[Q6E#VM%$<D63QTA^Y8/=^^]K_^R)(*?/"5^!5X>[W2R2WY9\/[)E
M5WC2*0.6X^:RNNC,'KA-F&#R)%.[J-HJE$<>TL-8K^/PTQJ>Y/<1 >FF'PRB
M0KF;OJ';)C!NG;?,5::J.;]IKFB1CIU":A]'B[4OKY,'P D/D<9M[W9UFPRX
ML*\;&7Q71U;LU;-OH5E[>U\.#SBX*UUO)-4K]^W=M"QDG>Y.3HB?5.;8/GSJ
M\?Y-NGT<O!?!GG&RI!>&'W3VMB6VFPD%5>PVBD("[D#'C/J_C5FZ6ZY>&]?^
M:-BWD?5X;\;Q4H5->+E3X7^WAV>EWAO\K\*DOC^H9[P$=;Q>0&8.[G2\22L2
MC_HL=G>R/AR-12PW'HMK' 01X.A I+]1Z<TN(W,V\R;6!1%NK:O(M_ =V9NI
M%F1%7='QV$7G#.:6I)7FN"Q+.&&Q:D?U<%<'3NRJDITNZ.E,DG0(Z'_$F]@L
M?A_I6F+FV9"[_@82MDA'M3P12>81PZBZ!;[:>=_)BO21V]5!Q+3F#*-,=RX[
M*&+O&1:+-:C\_OWT0'VY!PV&O*RL"?L*L5ZB?HN-Y.\IWKBL$WF0A@R$GW>R
M?K]AE))&+95^S>NH H/*842'8135CB-*A1U36 I.(P.Z?=1[>^IDG;E^.Z .
M^3[OI?<.[AG8];XV:]"S)CY&_(%.@FDE8LPQ:C5+J:,AOEK=]->])1R?BXY%
M5!3W]RR3?@=YM3TO#MX[P_7Y"/V#&V6N6PYY+M&3TTG"<5M W<-Z<D)K]MY$
MEILB"=\2=.@<'V,7K3\(VTZ__1;=I.4\7%3\\>][95OO7;_6L<[C>QK=1G0F
M"4_BG!<D=JI/Z!_4%=C+Q',>#HGRWV-3S<"E1^(7\/>EFSL/KK;5K[MLD<++
M+9_F\RV1FP+RR(#'^?L?:PXWWR:34#N6EJ;[=8-C:8]%?/^RRC9??^Y\-WSS
M>MENR1'M2_6:WJ\D5$3]]/9;I9CWS[X?ESE9SW-A*9]*HZ)U$4(8?YJ'OW)]
M?6&/,./E82UG"M53Y4.6WW]]=PU>53.M>?>[!Y?8NBY*ZU,79WZYX3,Y(9WV
M2AN23M7!'5@=BOR9H#7]Z&2IFVYWHLDJCQ&'Z?I/3M;AZ]P69"'[J?$S4MCC
M'1DXBI0_NK8WX%2+JNVG82?K19U^1-L:^[EO$/5TA7%DK)2[;ZGJ^Y;]5] '
M.^$G 1>&(\=/D]M>^C M?('E6T0S?$[]L#"(O_&#/0A/3W7*.^'BL#MPSQ=9
MP[N=K*R+;XR,5NVZG5:)MT%C.3_MAO,4XYK+:%Y/84-T0=[TOJ$#ZQ.H.O?U
MJA_P6:1**K]!'9&T'Y)OI$R<0&ZQ/][0)=GK_^?H+''\3"?KN9V7GI7W7L3+
M#"XSQ(MT_L^E.6(;1[!%K/*,\YU_MSM9OU)E'U^MR/LUM! ^,HQ^\#WUR[(_
MCK.J'V^I\7B$AB1*;-N7^K_E9.5ZCS^X@G:8Q=UUG9W/>G8/RV8(>5QC6!W7
M'$!C0G\("D\)<;*.L8@RZG@LV_NY-!7>EZ_K7$=VQ//&ER^.;*%:6@3.7[D2
M]]EPS:C!1-)=?07<)KW5J"9AWB!RZX$GTK>U^4\9F2BSL_0Q2*IZ[ZR>JL,U
M':E.5OW:DQ;>V*]:ZLQON%(7K?W4F_KW<4]>Z8R6U-QL(,>Y"N_.15] LSX2
M-[OAC]^4C+XVLOS@1RTU;6S<,5?_Z@FJBGB,^U[Q_-H1T#NQ:/E2/X_AUHUO
M9XI7J*+_>$Q588?^A+M&SL%[TC+$[Q^N:4'&5[F-ZP_RTIRLY#CX,G^'DY6P
M06(;OB5Y^M"-*GEF7+#54Z_@6_S0Z'=!%OC.&]>IOH._D> E?G_>C2CMEXY-
MV*Q!WTR5<ME/KR*')1^M(_3VRF>YBL_0M@70DQ^OK]0@M[Z\?FF9SF?\2NGE
M&00DTD3OG^M=T&9[]U/:*C*)^LEL?E#5C9P/HB/M7E"_?H=H<+_6G'CI<4W]
M%[QQOQ-5L.U?*V>]]0O<\&P1][5Y]6;7EY9)BW\^L.VI!WKQ3B3!W^UO7?Y)
M_&LG8/V7;Y$O)GU_UJ%Y@'8,?8P\C'U7TI;8@2]U2Z.^AVSG2L$1^_:R=UDO
MS+))MXP\%]%$7:[3NSMFV3''^J7J='Q30G@]50,]NS<.ZKJ2R!^N^,R;"+RE
ML.V(/3$;LJT)^O-E.>[?Z[:\M6WLW7>^\0KZA&HSN,>N*ASN#I&HH:-^M/R$
MZ'L9_GBVREKT]!OJ.%3Q2N]HGWPQ\/Y?U)$0D/MT]RN6B [N5I_U7A=1XYAZ
MZGQ&XG.G15?6?J<MF$%E"&@W52=F_/[WO]#A%R5/ SXJ$_43Z _B\G+S3LVM
M0U)C05[CSEQR&?S75^FSHJXM1H.])LC9[:DO9V:/?=*W/H]<Z]]^V#HK?XO+
M9]-$&_ [YNW>77#'ZO W%FT83I?:#)R("I[=S\EZ+V%Y6!F^3W:_-CUO@4\%
M%GNYH_"YO4U)+_\&D1%'I;O/]3_8DO?]4[@I,L#^HIG/'^TOW_!$\=YLLU H
M';NZ$)9&A//L7"?KG>\7E6TT!EQ[^L[8V@4%;H542OHZ84[B*GI+WR(/V7,_
M^0;W+^JF//N=6.1S>S2@PAMZ-/HVVWSK0R=+<E<Y?3;ZE#"=3SI?_Z---+[I
M]9-]'_^\-G_(MWCALI3?/OYEF^O?18JG/[%W/^E;>NA@9)K'P8Q]KL2/%P\$
M*ZP!'0;ID.)&T(3FG5>)G#^1_&4C.ZE(*1P>G3?BF3=</3/*$*.*'@W;\%&D
M:TC)N1SMD.C*-DW\@:^KCFH.S^>:S/O8[XTWJ!V2RO9Z\E3/ BK*5PU\<&_'
MNY7'/IP=$[O"^QVS[<K ;U\_==/O^/'9"TB97XMJX9[CZ][>/OB,O]WO>/?/
M[A<#$^?=<QLKA;OUU=GLWS+4;@,A)-K4<6TI3-6)19")5F<8XI/3,:X9&MU)
MH,JTIM\:O[<\/MK3R9Z82ZYQLGK%!&[ R0<*63])_?V6+-P[4[!C38V49]/0
M;23R*N^1!I'*H=]PI/05N=UZ_8#4@ES1R+^&I;+8&P(;E7Q85-1_0>18;=B:
MBM<TD:P#EF+2]V3:W,*@FS#O@"P_UGVKOF'QP"EH&ZP93\7WA%B?%,XV;)]=
MB>27?'3'G5U$TH+ULMCI^)Y (I  <^2!QVFTOX-%P6B=F,//"Y&U,$<' )S*
M>R3Z",LPHP\9AW?6E'H<<,N\FAK2G:RX2=O$2A3#]WPP:2>3$4O#3XYQ ""4
M2*V""Y)34;!O+4L./T(]ID 2B.%;;='2B5MWQ@'H[A@'B]5,U[A)C,R(+'IL
M6?<)L?0A(-Z?4%A\B35UY"F _;SALZ7-R0):>8UXBLV7_8!!%K3D%89+=22*
M;Z _X*NKPV:I@^$\,.1]G*4QD7?&Q(RC\"K4E=UPM%M:#$"Q,069EDUN.4@8
M,]C:ZF2UU@JVI]QCN#<E'\:DD)5S"08L-P]_(8D%5DU@5!CF4JNC6I324F#=
M+7*!<[.(&^XZ.1%IY9!.UM+Z42C-1&XJD/P.8^503)^CEJK('ST.O\]S?)AY
M)7GB^<'9_UZ-Q- _"]<@PSW:0+6%SJ-$R\,4FF=-;KRR@G!QLOR2KJ<,J8@E
M'@7DUU*;P\+;C&587(RUJ(X>N9>@7:&]3A9O A"<=1)C+]@O'[^:$&F36D@9
MX)K<(9#+U"M;SICEUK#=<*0+B)RKB(PPK9Y8ZC^)A#*+0A18YZ36*+)!=4FC
M9*PXSB&RY@*?Z!/PF4D=>E3N34H+"CUNZF@;D;ECTX;C9U+YDX$<VGS((&$N
M?Y 1&S/ZBI8I&/&"<^$5<W?3F]%@>N0T)!DKPUR(R:EI;5>G=H [Z2G=KX\7
MK\( 3<>.MXE2%;YB!' E6] ['4WQ2!:CP+2_OA+3XL]2'QCLY0LC,*2>*@P2
MP3,8K>]3$4(R#PR5##');M1A@>]JF8&CS:3NEMB]Z8_;?S($;3H9&=8%^!]:
M U*&*3A UT5H4CFT,$\&IO('HZFJMOXV,_ZE+?5\QV$OC+%/^X:Z)Q842%QN
M$X64E5?!T48 SZD.P=[PINZ1&8"@(@UF_'E$;@''Z9NTTO)1"\2U2867=E%'
MHI=(FXL<OEGF9]%<-V*0K,>JP &ETH#M0:C&"!#;_.M0N+4[3P7D5(L[X"?!
M!_'9PSQ\*V&RH_C#?\N,^%],X_X!,_W1\+_PJW_]'_QJ[^;L6<0R/'G14L")
M4$DO5@7#PU2<$H'USA=[J'#E'IV-R&G$T=[.%%H"F*L&.+3L9"[URMIBF+>.
M1A-PF#@) 0O!TJ30N4@Q8^]E\:+5L)IRB1D /V.Y!QW&MO8SN\?1NKI*924I
MU8$IL&6JDV708BE@)'E#66Q'&TG&GV?46-6MGTLR%D7I>"&MYP*6+W(7_IAW
M4QS!!YZI/J3X%Y^M$T[65"!M3&8-ABZ$[Q@!+4:[#JF=WS86 64#D.XXTB)*
MF.$].=',2>374]<PI.6?3>K)\(HP\:JY*0!Y2ENXS;(H/(#*RH +.>YQ>)2\
M"U:US8%F*)JU,@L03&_,-_'UZIZ[&@:UW19@LM 4?=J!"Q##5Y&U 40I+ 7@
M*"B"/V%U)=(F;7%="#>H610TJ9N\%9W::_S'N2LUUHH&=V])1UJ!IJ[Q<_BB
M7 P#Q.XMJO@EPPJ 4$@AVQ]/4]H #R>VI:ZN@_0G@'VI/(6\B\^,JP,1=O0>
MJP-K<^<Q$K:R9C$,12%'Z3.H:Y C@PF!C(?G<M7RF>0O6+34?F7.'K9CCO;#
MI6<?"\H[F<'Z\;\Y[TGL'B,\DQHFMHIK+M084TK^]>^WCWL_@7_B$"<D?Z'X
MQA'J%6IWGIS@4VWI>"S5*14>109[S!],=)"%?BHJ\DY(+:+%]K,N_"*%-Z8E
MNAV 5;W,?6NGJ>$PP&[WBL+3B4 UK%,S;VE*O ]TEN/%<*)>-ED@H-9BI*?'
MW4@QL7#R)(61H?BDH'?L76US'GD' "?_[NZ$] )AGAI0&X<*"GC$8?0LLQQT
M/Q$Z-R-ENPH# *A7S;X"$OXD<M)7WB_2"X_6"P$9>A9B*0FM)*L9:..,N5U]
MG<@R9B/J*QGV2R2#,7"^W(DI:-.AI9O"B8\%@^W<4^('ROO)@?04.2)%U42,
MDIS19D/=*AT9>WU=RO9Z!7V)MFJ;M)?7TE".?D,IWQ),BZ\W4W=?*,/^T%13
MO^7&->(_]_6\O$7D4<D26/ \LJO+TGKHY RSH:Q! JT@*Q6MO6)8U340OU9Y
M8<RL&Q_<YOF>?_[EC\-B%RM>VQST1I3D0F%%293 D;SA+5K]B)U8G7OG^M//
MSS>?<%NS9F&POF?M8#;^KZ_A70-[VZ6SQ.M'[QX+YM[MLC\^M^TU*&D?]2'_
MBCS77GT\'/8;\.H<G,\*1:^],+HD[ -CTI.M!^ZA_0-+TA[\(E5H#/OC0R[W
M:M[.=+AK['MW!/>/7R1W%%PXIPN?/U'WSLGVM;VJN. #QR./)][XK6@YDG,E
MVL3_\O<4)##2N.VLPX5C>]$\^[HUN\/G8]N-OSRXW9J H;&_K]CW;@^VCON2
M7]C/SKYG\6ML7Q[U'I)Z@U^R\^W+WBUO#A\\LDIB20^_?]'J<DJ7^(9_/?FC
MI[AAZP&/;:*>I26*^2OW+VPFW=,BB6U;L+<+XLA9::8- :]$52WAZ HUD?[X
M+TE)-Q]\,<OQ8=BGT8(W;/BNW\+O]UG?V[EAU:NGCYK.O4Y5R7Y'@\3F&(FW
M(^O+M'?L%UY'K_W5X&3-'CC0@8R=7G3GM[U+;C^]].>MLWWK*C!9:!7=WR$O
M-NQ8A-SI(/A?S[<NGPM__%>>Z01[[-6!)2G6XK*/":^&MQ!9U:=.ENN[>\.Z
MX2?O/H[Z5]R2\T\C=_0M[[CW]IRTBHHF&/_CX'%Q--?Q?-?]7NL2 7]H^#SO
M&G6KIDO']_I6.II'&\B>Q&"CDW7IY$=4\7Q5Q!8*R5G98SN]<G]IM=MG5PVR
MIO.JNSJ\?5:IG:S@,[>'?WIM(W1\XW.(ZM'!+EV*J_31U3<F7H6-?4O=2DA3
M87?G*Q'3?G#!WOF8.YSV$[+HB%*)'T9.W7WI7$+^1OZ:QSU82<]PR<V,KZ@C
M71U<_,U[Q.]ZO\9Z]2]_SWTU::HH5R5IEYU[2U+-N9[R[$J1+ZP/I(IPJ4Y\
M! \8SR2C"Q 5#O?DW):JS"0G7^MS2D<F>:A^_(UJ0%_EM<\._>/T?)M\/GX4
MZIXJS?_0V\\D/+N/*#%1O4O465AW5.E1(.P.NN5Q];>W>3/%G/6+R9]/'XB3
M__Y!MWN;;PX7>K]_,'5<N'*!7=E %'<VC+^KA+_<A5]_];K571JT<M'^ HW?
MD<%$>/356G*;>V7LMP-$!;U>66-9ZZJ2W4E6IEU[YZO ,,GLL^=S6L,;RQLZ
M\/55CL_0PA2[.3+<KGR,5&W.JR=__LP'7WC@Q3,7#YUZ1G]Y^Y&?G\G_\).(
M%Y-OOT!ZA>@^84&-4X:_F[4^A5>!*HXY69L.+%RX93!N@Z$U<4%K3R>=QXZZ
M$%G*3PI#<!M1:8A\FJ.\A+\S;67EP]"YQA1:J.5Z',$SBH1NDIAB H$U4BLJ
M/F-X'/>P5;=F%+FL:*7MWCD<>$ADDRR#6^S[T/ J?<]MB:4$IBHM>%"]]8RA
M':E%2N<C"H62=1"W86278JO1D']C7\F_!ZC^_^4/*G^$LWEXI,-EY )D0>K\
ME)JKB4EL*CQ*K1*;1'C&_X;)H-VY[25,[YXBU ZL0><*C6[C3M;F_%A#+NWX
M:B$&OUTO?6+XW'+GLK\A3FA4];3V:XMVK2TWS=FC<!4%V;P4-D>96AH[.&?;
MM#D'V5&\J*AM47.O_=!R8N4Z[ESR9,2;/\83M*:D?O>E&G$-HKCRUN]S5JT*
M/Y/;N/%GFZE1^/V]CLSS6.;B)J0PM*3\4=6*0++FH^)S>Y V;?L/U3=R?GY-
MP(WDF\SQ;F_S6[4C'YBIJWKQ%#TK=^G(M!\\^/)CUB_J.]#QAW]V'WNS:''*
MCNUO^3E9ZULJM[Z\( "/TF)0_#FMHFW9EM$%K&1B,WSOY[UI_!$.W+[#8]#,
M7I'R'KOM0>3XP"L-2,#HTW*IQJI]<2)L>E3GDQ2A*3%7/;'V\?WU+SE9)Q))
MKXGB4,5I_[G%';KF3'(F*<XI)IY:PS6.P#YDXA95T$C.[W4;@7K]\0K3FE?O
M6L36]E<?G=Z0-/& *-J2$;80Z;K^U_DMGDO_)9*O/=BW[^+.38XX[OCK Q&)
MUL/6C]C#_+@"8FFU"UE\;J_[3B?K20@R?4_NO62'J?=(^Z\9QF?7#)>.?_JU
MRKAPMDC^?HF;;:T,%Y5D=8H_S]9MX1'G@_!]JL@*-$V=_#DLG_:#-OC(,F3W
M7^?M>UUWHD_>)2+7?[$D[BDG[DF&VYVJX8P*Q8+L@L</%M^8=85(Y\4W=0[7
M(KOB9SIF:R8V;X2ER]T1Y5K\&E9\Z;&3]7#U/$3U[:\L1QXYZ[6V]R^B54Y6
MX#=?[8JX[G&_979QZ5TG:YW_#M-G K+*13JP]"=9U5CNZH54!(^:*QMZ??$+
M'2+#4,QZQY>Y\,-M;SE91U[&INP/PA>8^DX%A[[6\>M%HSKEC&OQPHZ"TN33
MLZ]>OZ::MJGCE!1?NN^MX83POJ'A8T]^W'6GZ".7X1&W"4_)$&G^O]A[U[ F
MSG9M>!0U6JJIFT);D*A8:56@.T$M,FYJD5I,K6U%0.)^AQ !42 F(U)++86(
MM%JE$O>@"!$5 T@8%#&XP:AL@NR"! D0=B'[R<SDG=SCL]9ZWO5\W^HZON\X
MGO4>[_-+"9M,9N[[OL[KNL[K//W2/K1!KH5E*<3LI2JC^8KRT3EK,7Q4KO.X
M:UGE>\5GWX"V16S:?ZMT6/00<J>."VF<69Y?,"^T=Y$XM<4M).-0F7 J\HN/
MK#EG[=(YG#+XEO.H<5$7#Z$R+O6'\S:M2KVO(K^#'X?N^BSO-_/O347L=R-.
M2Y;_W+8BTJ M?YIGUQ$=/U.I1;;M?.)ZP^M;+:/)%3D<L#04B9<6EN8<+JN8
M@R>JB/(9[\/^J>7]YM/#)S8^F,'EIK5J;Y:M]6I.S349W::=[^U(Q!/=/7S?
M?"?9,*;M\;FV?0F'-Y4>+G\P";U>1$C'Y2^09PY6^(06_5E$NOP12"1I\-*1
MU]]I.3[K8O?U/["6R$TN#U9RV(O>_GK#L-_1[ZZ4:HF &Z/V9L1]>2<E=YKP
MU=.?WMV8_?%<KX*<I&_'$N>DRV:TA.I)KRAFAXI(N5V;L_?/ ^8#-JA>I[F1
M)^IK#-/&!'0V:P?#YAMZU_XD".?OA58;G'V+2J12*\'IU6D27:A_;!!C?6B/
MX9I[$F(8O-1F6I7'OF%,OSVF4QO!T5!)T!G>M6WSSKYLT O=PTL+(8)KD?[L
M%\O=VRO=OV&\99;B&JVM-!S?[E E4V<"8<T-<Q=+G'W16L#P<>&S1\4"$R?#
M0&2U7T8,T@:*%6MQI!!^23,K1/GE?X8FD_KS=L@88L0R8KR) #_"GX:72NLW
M%. Z@CX%6EQ*3F^"I!,1\P Y"N+RA+FH=0(PVNYLV0,5_4RB]'S0<,*82CQ^
M&JC*M.Q"8;:8UFW?Y3RSA3_"+IEB3VIW1_($@O.]GF;[%6)C$'>F=9^SC(L)
M![@$R<ML\]>I\7Q?UA;$L,N_I,:49(-R;I3RCZ/&(XP?7O9-K_L+'G&*)QZ6
M AO47"4(13CZ/(X-*GW(3IA*)6+#5YN8W:+_/.UE81UG:(B@\N3>R+Z NC3%
M@0FCT<NC7A>2GE$)>M75(%1,*\2%0QWM6:$ZP(@_=5<9/IYZ)S D]]* *U-C
M HDP,-Q4T&^9EAYI8='R'H-#(Y6JC73>2G"Y1M9K=:("QBS5$$-!:-IJYJ1+
M%0?L<@JM2+/=GE!9=Q!I9HDQ, ^U-PC-40PQ];1S9,' ?+L@T&::>_]4G8%<
M9@D?@">;69-?463!&J-C8"!J]$A$G?<C]BRPCTP !9+&:,*;K!@"J4,*?"S(
M,HII!(,]@UKN&4Q+,H <'>MB-:Q!#MN@,V AU12@&H% Q ;Z;A2B"&^96'&M
MD*1M90;@7%9H,UB)Q<3ROBA/>;MN(Q=P#K_0;5A<E$]6#@%9$6X>GUV+PPVF
MP1OV<3)#APQGPH-T,F5R34U?X$Y['U9H'SCY8,,)M"?QF2A/F3K-SQ$!VB2M
MY<>+78GQ:8-Z,.</LZFG.@$^^UJ 6>$[4MFA3$+.T*F:-X_T%'@:4*#_L=N;
M5]@NNHP!/^B2MU9(J 7*>NT)P3(KG4D1H-CM3<#L52:[SE%#/SJ4]3$W>=$5
M> C,>TW]K^:]ZO]6(EEE@_Z?!KYLT+]/?"TZ8/$_KS.X)U=WM0U/+A#&U3^0
M"KM,3M1%XD):L86I6FL= <:R]D7J9^#-!.UX52"0M&=E<L\4D:C6+O[!TT1O
M6N"NJP%I93B<&J[.LFN+@M+1#ZC[4"!+0P:\'@$KN#.>*\=H%ESKS\4X2Z9'
MP:S>F0NQB$;F@P+%@Z3J0NKGPVD7S;9X.U=?ABG!<.,/=KN3GB>BB_E UJF'
ME."A&E(FI-7([R$K$\O1K-?BS[[MP7Q$/#,$D!W[&D=P<_S"8J,)6G3&UPEM
M4'+$'G]3)#-)S==& LN8?'BQ)PGGI-/V;"FNR+7R3#-8IWW-R5%<[F779'HF
MI5JE(>\YTM/L E0[IDN62B)T;4=3W=G8PLG: P3V-0?CL<P:,$Z>=CBIR(QS
M:&7R,J](B_MP/)1LIEWBIGH,C6!Q E4$F-W2M#1.IE;82(C62;V-XBN<\0P]
M&(<N*,C1D*S!6;01KA)3M&=NK,#"'( "=KN;IUPA G*\)E_4RLRU<SA7AOQM
M9O%E1;&]\FJ@C3HU!\?+:I/(0KIH:8,H+!1^+R/'7GUQG#HF -O;LZ:*@A&R
M,.&0*OZ98-&95K3S1 SR\EM$QOP"I]*JV6TJ&^2GHV)1CJ8W<- YL5/V7X_$
M+G>P)$</_;N&Q,V_:4BL0VKB_V')1*?'7*C H")B%G4JUG^E:>$CLBR264N/
MI!8DJ#,W&EQ9H(X[<X2\2ZV1 1[R?D3<[MB+UN*[@5P6NRZ)FV-U 64-!Z[9
M6X41\'W 6<R,@DJ<84X.J#3YD8RGA. \Y@:4$!4]T=&Q53(S.$D>)=>4GTE%
M#O<# GT8=4D^HW[O4FDOL'AG9YR'>TGDQ ^7YI!B75P'PWEDP\P)7)D9N<<S
M?+I*ROXTJ6'%AE/GMAP:F[VS,WK*1\M= F<>6W#]?L:9N<'9(Y-XUKRW4B^G
M,>17T)X"2<6[3S[6_+E&_;3_.CD'/]VW+\V'(0L?:KL4L3,SPO"#I::VQSTE
M\6K<FQGG!"MOCW8XMMBXWE][,Y2I*#TL^/([<5_]&LM>UW*UUS?-(XB7I4U+
M S);OL@Q.HE?R<ZONX'\QM1-5W[R1;'H%ZOJG6/#SP?GEC]N#)Q$Q%7[7EJ5
M-,!8N/0X/MI#N/437<[<N^-\%]<^^+Y&L#25E,G/\-72;$7PH2VMJAB_\X$7
MR>C[E1;]SELIN$>>Y5!4X(QW&[$U8E7,*'&I==;YZ2_UP^_N\_KTT\OHF3$*
M/*GO$C?:(OCHP,=S19OLM86%>J?;UD?6V%VG(JM:.I%1;\"]?1GZ73XI^*S-
MQ1%;4JW$<&:^3^?N);F?+]LX<+I;FXS=&W<RKV*,^U P%:#JKG-B^V5&IU^5
M/1<<2'Y4DDF4*#T[QWI[^RDVVVD+V]R[\IFH"1TZ69YQ/C[=:/F\J?GP&-'L
M_DC1S5NQ\\K+9SU\\*<CZ3R>JS5^[UN2E8ELC)Q$7&S&1R>.:R5Z%Z1I]"[K
M;WY/^A[G-"^;BISX<G\$<C<1/E&N_-CUYM07Y7[[&GP#MM8^.])O&#[]^Z^5
MV<C"-VS08>GOCP:</UFQ*B5]H0UZ<S-K, 0]G3BNC=_)?U0J/OQ^D111[G%@
M6QX^1_Q_?=) KA(]VK[CJKN+=ON.M3=GGRGO;CF=7/;K8_2'D[ZKP@M\2CH+
MTN"#9Z+[K@@BN]8UWFCS1WZ<74MT,G4XYAANK1TX;)D5V;'5!IV*F (;=GW6
M_3"2^Z-R@O';+VZOZ4!E!R;?&W/JU(13FD;-R93I%ZMO^3U1$Y<[/7#^\9K;
M49*1F2T/J;AP(0;>N&@T=X'R3\D;Q+[^A _\@V(_9AT[<08_R/+Z=0QS=R11
M^-4'^QH<QQT\.XI5>'=3=_040<9%3[8P;7*27M\B&%]L3#K94G_$HRO0!GDO
MZ2F(\@I=_SC-/;%P+K+3(R?#*7OTP7+QF5?E:='<:DP4=U8GQ]!Z=:UKO*':
M8Y3+Q!JT ?Z&W[=9'%>=ZXX)EN??(<N)8>J(OV"#DL@3U$85ES[-GH7>$"<H
M"@3]_[.R]?^1+[P\0WC+K"Z$YSY8%/?&@1I!..<5=?RR:Y/TA=(F&]3?3S#\
M\27#.7W4JX$DVO_ G>AH,)4BN8:RN'LR@[I7P0I?P! :VPQ+Y^^A0'0S*2A:
M4^NU/R*RYMF*';X^#N.*=P1Z]'\:_]"OZ(/ZRI!LZ<S5T7>NJ8FH1:WOJN;]
M_#L\ Y'7#H6U-/L>B73_LNU*%;M_2G?Y /JC:(+D7LRE/K-8JYJO<T@L??*G
M1I?Q)3>O*O.7I%WN7&/NJS6D_^/I;;X\KLFM]WOKU,O6.:M^_"%,^X07;8,F
MMHIGN*7&?K3&6%#*>O%L:ROGP0W+[JC./];BX<WS7VQ]\XMF3IS1Y^E')9C?
M-_U_5LT-<]M[_6WR2H#;X[-=Y+;D]K)8\@\JFY7]1H6OO;-OF&ZTNDQZ,[1,
MS#9U5'D3Z]-0N:[[1I30S&8-XRUNR$O/-A?W!\B[S8LREP1/\^@YNS_;W9,G
MF'>#-R^EQ6O3K\G3TQ?[_?(-RW1,^L95<ECP*B1#-:]()CXR[FWK 8]4_+33
M(H4-&G>RI_1^IC5C6'C#9SC+_&5?8U9HPB?(99V/6][(F3;(931JYGV6VM)Z
M[ZWMM](NX^^?P!>6.JVC3J&D#ZV5NR3'18,E[PN-N[0[<6Q.U@URLF_;%/8'
MC:)96$[T_0MFEWU]A/)Z]F*F6_"07#1V!=:SS1C)*C&F$=+SPNN+E2^_[UZW
MTW3YQ4P'C?&(2LR:$-Q)G#KN]<O](1OTHQGY2'IKV,ME:BW_8.Z324$77T0L
MO9&ZBS.)V^0Z?13I "'B&_.E]U_U^$^?G=B[1&@ZSGT5?O@XD@!'#NQ4N>11
M,1R=QB#S SV6KXFW01_"70L*M_S^*6NRU67ZRYG.+ZY'%MQ->X9\['-/_&#7
MS)B1.M)9]>)FF.K1FC5!3;_8H+?BB-+?)APVANNL&_ELQ_C#<TA\$@5PUTY,
MG/VY7,6M3B\]MN.VPUFK:'/9PE\?W2ZM3.Q_]DYXX+;'W]S]K#FKK4'=([^Q
M8__Z@H[L\8^#.(%OV:"#V3_]$%;_L/DH@]O2[U%?65E,)0^JJXECUKGYQK>^
MNW[J\>5[WOY=G!/(L,M3<UX<?/OM8<,PO#W@T9=O+^/<*/#(T(^YJ_H^1=$3
M87?IN32G09]=.M/%P6*#DIG&F2R9W6XSD8F5V85L.'+,^)RAQYK;RO(:[FVA
M;JFW)2#LH*]KJ)9$L4[=X&*%FW1MH/Q1O^:LW)<\TZ@=Y*\5L\2=S3U[J.,R
M!* . Y+B()*K@'H0JC#$\HY!1>5@\&EH"94'/B@!4$?96V(GVB>1H ^6HAY6
MJB((,!_5JWRNTO!<='HPF8#"BN0K76!B"QMC@]SA@.%*<Z^+QM3Z:*->:I5'
M-VO(YK9%.A53$U3%G\$R!'YH353[MHU,:4U[*ES)L7YQ,"[*[>[ZOZ:YCIX:
M),K6OI*0[X>ED)H/%W7N]T >2G:21ZE=EE7PI_5C&[2J<AL5HCQ(?V+M'6RB
M@/TTFA>*\28:W.,TC@C'8"D"H+J$_+%1&^,%Y]0"Q3HQ?QRLZ&;0VM*;B?GD
MG\T:N\\QC;*','Y\L1.%:8%-FI"U&C$Z$$<PVOD1K1E VB6N=-::Y'Z,6U-^
MP@,'(_V;>U>PTAFUW:\EYVQ0$<M808Q'P;"&KVL3'J[2Y-%.'D?(@TCH,93S
MVDUXF%O!P+U))]!';D&$YLN@U9V:K,=T%5(+4-+;%TF6L/IKB@D.$'$P&0KM
MBDL<"P.T-">2,BPKO$$*1),7$P$=+<3RJPO PSS@MCSI.9*+D6!$15Q3_F>;
M\D(V#(R0Y(JLYEY$89]7 3JX!S)D>B<I2O?XT;LMHF_\"#! 50:5J#3ZC@YE
M'Y"H* KMC4(NIM"Z\JTV*,<7%KX6N2CQA4@V_))D@":?O$[+LX]$V7_N!75+
MZZ*Y9E\P=852RWDS.=(&U=)J[!,WFO&69@SHKLWU4B;;)V6 'X-*9M;IG9Q>
M#^J.0SM41V&X5F16T@\OJ%SB%T-_FLU(79!%)92!G/MVIEYBW92 QP)N /K2
MYT_\O?XU5-3GE".FI[LY>U)*.,/K4\D=?^_4E#T6[9\U*+8U_'>%3@[Z95A<
M0S$R2 B$3GA8^N[Y'9VO%3/N*]OASI=<.1B=G66#-BV0RJR;:7V<EV:\^1"C
M 51/SHQEX&R'H=>:^512.CDOF7L99*QK>PB&CWMW5"20Z&VMJK$/P"&:B-=2
M1ZTRZZ !R%';OZK8@S2FPTZP1D#+E43S@F-[.Z.)L?9W='$A YY.]8LU@+S[
M=JA]NCKR]<B5DMVC=PKW<L'M-87;:K8O:G[+DP0SQ$(KJSO!#:CC\CWU3I@C
MZ4EK>F%L=3;#&:5UC:DT.I9KGD=M4"VM7QDQB5LCMRH!!X 4=0A2M#4/[-<T
MY",M/UYL-R&AV25$2A?^8==]XVOU:/,U3&1TPE\+[U'_*-+]RT(Q^FNQ"\'E
M:E7=?/-[[QD&2GW]1EA8H027]]J00NX::[9!&V ED*N,+GH O^0:JM FD#43
M@K+TA.+;R&I2 N[_AD/S0C%1#AP.2GZ-P4PM2V4!]8(6&U269(,F1=(^3\$A
M#24=-NB0M\54R@RWJ]"UIW/WK#V&*.S275^$-;4<8UHA3Z"N?7O"^&IJH6*(
MW>EM[]R][[!Z:B\&'9;MCE/44@<#Z_#;:=*S5,[[>ZP-^HR"HNEN1TK^M$'5
MW!AJ!2;8H-Y:@V&F*?5TS%]0FCV'X'=L4-^/_A16[Q";<DCKUR=N"#@VZ)CA
M;P9.G/_-P.EML\27\,4Y;4%Q=06WNY0KLY2], /(_-7;H$9BW Q0HXO7/7+D
MSQWG0!\!)=$U27A6<"KMY1@D;$^'[Z6#JMMV?(1JV),$14)WX44RF5A;QX?!
M0Y:TVT?N)\?2,AW(:F(! P.EDN-\GH*GO+7__@N-H+AYP7I5^?[T'[+&W;K5
MX/1G_9:8D^]=ZOC@V,O5$Y<%?O;\NFS*KN&O>M[[=(Q7P;3K$E[>I7&NFRYD
MNXEN%>>(3DQ\[ED;<^V%CV7_^H;O#[6-]G0O//,-?')F^XAO98[?!H1&X_X4
M%NDSN#55=$C8C_DUQ_O2^M>.7Q3'#=Y]H'5?4Z,+_]7BX8[KS5DN'8^V;E\Y
M^ECBPE,?)$=\,7G6R9"I;?S[Z"F.X_8E4^(JKXV6/_GQ[=7#YUFBX.U/E FG
MC<;>E:L"TR(][TP+FGTUTW_/P[3@#H;YJY(SC&]/Y4K2,O%"Y 1U_)5]2^VO
M(XL\_(XF=63&1;X11#WUW:-_/.)/D#.Q.YT+-E4,CR=^W-851.[Y867)#O[4
M$\/GGJ[)#;&V>D?[OK7\B6Z?0_2X3[^ MX2,]@];.*]YV952N?BHUQU-?LKU
MQ4)9SH[^J=);/QTJ7<<<"MG!G[EG^4&)ZL77F6%!1-X-Q9&Y;#/2:$T<&Q[%
M.]Z^DA.V<H$AXX4-^C0W^X1@SHA-(R0-"F>?F<W";J39NN.--YAV'N;4Z0ML
MT#<:*4O#$M<AA0Y$BJHM-]YB81D2J#UY(KSC@\2^RY+VB623J@?AY?0-#VOJ
M\%+U(/^?GI_\W_E"P7OQ7?>5[ I,$#D8$A J#A^G;]_#=DB2.ZDHQ/'%QRHU
M*3:\$5=0W#T]<L\*U^@+G$->"\AL$WLZ*1Y"\N3YJC.#\7KEM_N<CPZVY6O2
MAI[G!KK$[TXK*OGUY]$WJV._JSTVMD.F[>\>\-KX^)-/)E:NG,A6/SM\:?!V
M,#37Z](A*HO8PC9K)OP2921_0!\U7W/;^:ER4FE,AKIN*U\D8:[_>"[_ZQSQ
MUJH>[I.B0M07O;$CX<0?&W)2>%Y^)XN8C?7=&S<.H,76/8Z19:VKXR../L(O
M-BS\@*<@)QOPV_N_R_1G1NX3A\Z5/'-[V.^:OVN-LGOZU,,3XAN1FOO<[1_I
MJ.6\7/OP&'(I+0#?SUX6RBS;7G)KKS;G4)=HL#F^"E$S#^.7GRUN0X9.II^Y
M.H]10*XVKGKQ0]W.$PE]087E(9]&S)9[O9$7E<+JF,@V\Q:DM/3?>RLJ<G,B
M,FXK\:,F1]>]<[/ILO+\M('0[\OJ;!!_Y4S.C>!LD?Q<<ID->OF9\OWHNQ=+
M;5 G,S J5U57UU.JM:JWL+\Y?_3-^(>NF'M&Q9B5G-Z*V+XFYEZ?X<4EMS*F
M:&<_U!.E"UV"^3TEVT*\7MT*J^S=O..2#1+>7#0Y38=3B<5)I\?IEQ(GG&FF
MT,0?GS_ZOM#Z^:8G@V]AC]AI+?7%I0^0]HQ:9XF1?SI49_)\LK<L;2)YS!>W
MY.[]M)D<$C1RWKK>^F 7VXJ-^]!R<]-RULYI![!9GP^V;Z\)OQ&8TZ9\^[9F
M_+*O@[_;NN:J9-M:QCAB<>#INVN^>Y8<M?C3X07.;D_Z+:F;2LF[ ^[&XC76
M]U+./FD=\)TV<,$S7;?C<?R'IR?*K0&SE8_.E?QV[]5'<<<VZX(?_S2KW-&R
M(V9OW#M8=4+MS@^OU$]-0'M7]S4M</]]V;T[OUD.V?N.CNVG''/O-3RY/KW]
MX9TDZQN9G$>72.0LQO^JUX]"HC:(A_'VO#&T:-%7T>[&]++X3H=<$JX(Z9)I
MR,JVXC=$YH*R*=E3X#\T#1$$<V2GTS6)2F06HPFUXIWS#?[?P5J.O""?6V5I
M5VJX.?@:96'(6O'.')$9J5'L@[,(?U$JP>TQ#>0I-G4VOB60J+]QQF+@-NE
M2FT>%2%]U3WD5<2K_&?1 _6&[0MK+5%X>+,U/3WQS8*5D5%I&F/]"NV*/Y[(
M^ESOVZ#FZS<_@;Y;F5;]_*L1194.!K_-R/SU[RL_61\X>NP/CN'S/LA[-Z?I
M.]$KQ:=$3TM[JU3>6I#_\Y9UDV8+.PY]\#+QVZ+WGAT^4-%;0Z0DIOZ%_6ZY
M9X/FR:WQDD<\H3ABK;)'3[X=2/#_WQ,CN1HC=B/PRB'^SUA&:3<?PH>\+=@Q
MX$R(:BE4KB$"],#00^P8XY^318Y#:?]HM#*+)6,E"3QIS\\%HW1$I-S92443
M07F(I)W*B)UIR6B<V2GZ7FX%/=%BPIG8-AJ1 4D\"M(P<ZEDO E(+T@-6)*
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M4NJPM4%I((R'.A()TJML*_A<I"F:-\PU.(/;@;MYRNILT,I@VE !$>:HM16
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ML218SPA["&+UR)U @:8+SX;=M7H@O1#&U3.ZQ]8*F*Q04 U4$H>OLG,TM-1
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MNFPM\4$?S^\2R5+B;DKT1<WS,]]/FDG*9J[O;UQW:-+'T]O8?SU(*"G^=4^
M28G; EOXV4%?W+*^I(__2Q[F.\NWLP.OF!PQ<S_66/@^SXI_LXHLKRKEXRN,
M69(O$<V4P2=,SI,9\])DGEF_K?/Z((S)LJMK/&XF+EW1H'W-DKWF#BH/45ZO
MB<:;>E8HEYQBW#"NO"KJSRK*<>:>O0![3W>S5AU8'C5/H(,FG^C]Q$'ZCW_
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M;J:P@ L.>:P.BL-,RHC(!(/J!?H8A7=L R#.2S2,RQ2%1??!M***,JAA0$[
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MU=$^2\M*!](B"CMQERNEL9T/6I,P 1_XW: ^E=L0$N#,CL/9^AKKF65R:ZW
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M!G4:;)1;<C4).FB10;WU'#)HAZ/LQR!H2K43Q>RWUAH:V%)XGCZ(V^DMV[C
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M*?VO=K$'F6L3!7UG-NQK&KS@,.$O2N><W<K=WRI_UD']Z8<_;:]_4QI;NC6
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M<2'???XRW'B5PWB3@0'J,1-Y:TKYVHU6B]*NZE,*L89KC// W%*PZ4X,A@>
MB* E(L28-\'1^A6#ZU"+)LDUD(TM)5<'.+\&LMA=L^%ZW%@%RO[*^VX:8P:Y
M?EBU (@5L;OYJNF1GB!*YXI97#-)MQ]0("2RZ?6'Z4%TCD)?G/=."7]%YEM0
MU&9 *UMK4XJY.R$[ =.SC?T4C^DB 1R#[M5!=K"4Q:F<#B)G7 )3SWMA@59
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MX6I%D$&L+]"-0N-3JH ]848NG."G@W8@9N -Y_>,+R$.3K9A@K>]OBU$T8$
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M<)]^SQ=/"\-OVEOWD QN):)NI@UN!"KLY%3M3+F6\K@(W$W&&-B30:70TOL
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M9%XN,_B88!\I)9N5=9/\@9,BI;0JS2\9WU%? ..EQSTFOX4H7X>$6>JJ=L,
M?_VAU7Z\@,+5Q%DR"2+P_O7$<K-]W#H@/$ '<7].6 "\S0!S:K/'YYQ-!B*X
MBZWP94D]"M@P7RTO+)31!"H_LB;:(QH;8Y&5R_BFE8TV#H]!\O!/5<GTD>28
MZD+H/4_QGW1"4(,M;D5,QSY7NZT(OPAC[ROX[@*B%OM5 9I\=WB4L40CIJ,X
MLG?QD7QWS4_#1,<&953]EM>8[/6$4><VD*'E4IPZ0;WTEZ(T+SZ)7<C9=+=#
M/3)'A^01>C-[EAT_1%R;.]9*3-81%\)N.<^M9+"YQ(#HO>>3!1'83=T<_I K
M_/,OJP\0U=Y._*'3G+V<WC\\>3@3>RE=0)2-'5_W?3<@$GM=)TZGIGTXR]RD
MZGR"ODA>I&JC^I0E5?E6)BT1'["@ 3367U7<[AS'@4]/7C)<8?':/N H\;@_
M5EG@BP%YV+LF+"NLL #0N<?N/92@(,Z TEGA85-UT]$Z$QRE<:5,E1$0#20"
M#':O]B\9:":A"SO?5U;,+8TL*BR-@.;IM1'K'E^4IA^&G4\"(I?[L+@W$N7F
M;QQL,I^;'ZN"GC''\4&)J_8\_\%@>,(U!D21LZ4<>%56;A(G)6WD7Y*+ N9>
MR?I-MX==Q$64!X]N(L)#RSH_A.Q\4.,J5,:5RUE($@HOE:),D-61\,U?F6_9
M:&'Q(31O,&*ZBYBYBH7J8(%6)1!7$\-'>6P 58XN$<SU;^?,\7=*.-1Q&JJ%
M_PB[JJ&,?GUK2ZC.DU+NAZQU^F2+(:[:Q^<JR!G9_-\+B%Z!&O(^_V<FGP%:
MW4<WIV2Y>(">?1+&&%'\]6V/>@J_IQ9^\#]CQL6+KX,^[.5SJ1]87Y*9: ;E
M@Y[^(\2@8)B(F@VX[08F;<=S5  XVF[8N!7-3:0>-BR_ZZ>/K'@.2'H'+;H)
MF;LE3NM%PLF7]Z\I%1B!O<B>T!<1+>]*;$9B>KV/UEV,9B/I05@#?2M6HO<E
M\E'-D5#[WPTGC^NY>!4?=:S;03/@5'T8$/W?10/]_UTT\(^2EOC?2MH?ON<G
MDZ+4%J)[/=A,CA:N;OO8HIF0S9,P=]'W:8D&P3U:&-,?&&.RE7SR#X/7TA+>
MP-1(_#6@G=\W64CH^?(\\ZKPA==UVUU=I%UC$L[IM]QR1XVD/UN)C\ @I!#'
MI!2)07">T;*E0@B7^Q$=Y:CJ(Z?F:G3--@.<<$+#OUB7!?%)#Q(Y^.5V>F0>
M"6,'SWTB+&%%&)664#VF7N*W(HB/3+F/C-)&!HGUUI,2OS+$ 'X71$.<&?B\
M6:X\A<2X* P+;N.8UIOG1_FY-<VE6MVFDU)!326;C.<0]T2P_]DI_ #F4K[
MWV&TQ#IB P^QMADI&L3XQ^Q^;.\1ZZZ Z 9RV^2B,+[P/85TG;<35(4%G,&!
MU!=;;5[C7#T^ @;O:U*OQ_,H'Z@U/Y3.I+"E#,RY)L?F# ^L?6RK!CS/#WJ*
M5.^K=L82UR'A;0YWK!IF)."GJIC@/_!>-M-. >75>\>F5H<%J_LTE\DYGOII
M&2#A'.YDMN6$K/ [B^B&9.IQ3Z8+N6%,=TX1=ZW78#C7FJ?0LL3@D> W=>TS
MGT_',R]A0&I]U.PXM07?:Q2#!X1H*Q\PLGA0"G*=DC*%G")[E3A(,CK&=[3B
MGNB Z S@:8Y_%EE_L"%>Q7N>.Z/V\512C4RR\%TY _PMUU# 1<:$LS2Y["3W
MT?R-G_^<_X*52MQ522RQ"3NYZ^)[SIZ>R<T%T_5Z8V]-:9*()48@-Y^NP%[-
MI)I%-3B\/Z\)?X5<E$ KK1G;\[KJL_6EG YF/)X(IC(YVFOR!;7(%=@>RL&5
MXA!I1PMJO7FLZE.^I =DXLE?GX[9-O]#*6PG[FP8G6MPP"CU;>D$YP7NBKY8
MYC$\,*.FU'Q2:QMI]A2N)N$U[&O8<-],8SQJT(/%&=E-5Q;PI<XJY'%R%!\H
M))8/.+)/0N_R^<*,MMM9;OZJ*)96_E"@\W:F+:XA.NA(86AR8B!6XO\7[B2"
M(W@O#Y7*&):(@Z_9;GAP#TP2UL+<F'E^*_=^6/@<()/CV'2+(T>8'\+@D9[%
MDY9:B#T$LN+74W8=I>T#O"62]*LD?JL7,H9+E;;$R)08%B%DF9P:RB]0V:!I
M:)YKH8?+^0L] U//)W/+F2SWYC$S(YS$$_>.W,!TW<%ZZ@VK>GTA+@J(ZI&C
M/;Y-P(NKT+<P+1J=$PH"-"UMG[<K-^%\Y:+<,IVQ^@2/-;%NFS+#M-&:.4\*
M0Z/*S7S9U',64H!>$1#M3C:(=0^$FW5KN4,E+&V0]IS60$]IY#[_V)5IO4!)
M,E+%7'CT+-$.[/I]%'&Z8K$;G(M=@_NKN69#"K$7DC.[F2+.=MX)1?)?ET\
M?$8;?"4G6W&MRA=.0[R^289SNIGP*"G\[@U#9^N,^%X*1N<'N>=W"*/:=?!S
MK76<Z 0Q@J,;-#,=F<67! P4@:2QIL2V1J4#,O9=,WX^]4*<>U-PJ0(??*65
M!8HB&'MZ'">7F:+6R#@P7)FYU&3J/9=:SL*0DUSJE>W#P1;YW04^+.TZJ=+M
M0NPCE<XNF]=-QE-06-6G57%&OD!) 5N#4)><BM,J$X3%3@+!FDBGB9,I05^5
M6WPM;'#H+E<@,[93XEX=\@W2\O_X]H5&&C2)YE#:RBIR+-G0)B]F\:]D^A@F
M'4E0JOTY@I )6HO7BBGNLQSK7CY6%8"![GLGVC[F+YE6!6$PA#_S'^M, V,0
M6V,QOGHYM$U<)H=C/.'C'D[[#>"-5Z+%QO'!XKQBR)C<I][\(2<+F5::=<#:
M?S[U1B* (.-X?)XRR:XFLF ZP!Y6?60_A=\+ 8IX,1L2-3C,5L!%T-3V::[B
MCVN1(5VXH<\W8LGRY(%AR[2IKUQV*;B+0Z5ZWR.;K]D"1:#ND^'9$'P/\@D.
MB)J*?0W@?GBRV;!TQ$FOA[]1+*<< E%E#L)O+)>JZP\^W5;5)A59*5E<E0TE
MIAG;>AB_-#J/1"#Z[&*CCTUSL1)\!C#<_8%HK<:="&AO\NX\F=14KS(TZ1'7
M7^\?:3]'##0 \.'?6E88@;L(J<*8X_HDHV(@(#J/APM#YXJ(E/,%K&2LHP:B
M6IBX5SMD[0=RY D^]NK[W&F+($'Y,(K(&LRJE($BT/K /E[@,]2R1X"1GRW1
M1[M321#K#>LZ>_2R6I#9M:MU;MJZB*L!5/* ^D! 9&;BX?5ICXCQC(U6%\1Z
M34JDMS"MCUX+1 .Y/\+I%OM("AGM\"7VH)+ JXS@=<,'LB6/ZPDD5/C+CK:/
M&J*XE? M6Q.Q*FXH()J"?$K@KZZFUO88H7?L6:KF"EXGKC!P#2-U$^P+.E,$
MUS9?R1^Y-3(C-L 04B&,:*U:01 YB+DA8/=ZA")UE)'X8?=)55?3V8#HLI'_
M/4(^;WD'?Q 0E1<>MGK 0IQBE*]9-5<C<*2"F*;8Q$1!S[L%S:IMQ+#&% 7?
M-]KZ(#FJ7-;.%*.W%5/--;7=!D;PTO,%W ,"VPY/XHK7R(<UF0N>F'<!WR.K
M!8)K#O]K52L<PT*2AXAQ?*-Q<>L@%R("=F:[ >O34?M@.H1E]I#A20P'[@V8
MJX>[$=ZJ[X:BCKR\8.C57.HO@ "GC.=+CT)Q/UI/8E/B1K:"#YO;H2_QNIVU
M:RY&#8-.\4EIZXS?MDI:!EF[[2.#67LN :'O \0]BW+3X9 ^J&&N:;-H5@*2
MH9N)XDF5KH8(;R:A"R*PD"@#_BKR+:'&YIW,"FP:.EN)M%MLGDQH#V]&=-:3
MM[WYPSHHJX_BH>.%.VT S/["EP>9?G,O"*DTG7Y#%%\8@?EJ1WE[ Y^F5094
M+NB+51)?(E/, D=)UL.1N\7.">A?7,\T[TM1X69H$BAJDL/I]2K2A4A/ZTS+
MC64*:3G\8$LB:7?EC]AA7%-LPK<3KDX2'C8Y%\.>-HT)#1T@I:BUA'0A"6HA
M K?[Q&QA1@6D]UN:#/V"P2:'M..J$<=J9[=BPN\]NLS/Y^8EJG*V5<@$5N?$
M@H//WWJ8JHRVK]*R>%V9$\(XQ4A<!6F:.2CP1CN\JAT?8@,#09;9RR</)Q#Z
M 0M;"AW/XQDF2I1CKR;<R*,*SQIJ]_I;X%#0H12CH\@ZD.3I9?[*!-36NR5C
M-G[-=;W5E.9;D+81(R?*7]<=T;246%_'W*<#HFOGJ5/XB02Z)%SGTZNY!X5T
MX.$_!F;!XF)X%ZT(GTUBZA))[[O<]>[^CJD(=DO=->X3<OH[=KWN^[&"_:YF
M@AL>>>G8-_PU_8&&[CB'W&?;-F-FS94@\2<I*1';=229 ??Y"[AT'V7 I"8H
M3X]Q[=J1^28_<IQ_6$?OW&CT=I-H%II)=U8X0/U^+-?'K$]>&JD!ZWEBYK4-
MUJWQZ'0SFJN&I=+9S6* MK=2+&NY!DQ:![VUA-#SDKZ)'CV\I_MW'9:3J@_X
MPA%Z4X_:3K(1U<0EH0@!"@P3Z?5%K:,08#Q8DVH *]MT>,@D9O>1_&43/HM<
ME'UR)]E7YD/Z3?+*BVT7FO%=!%!5_,(67)80/(*@77Q/FZ5]=/HZ'RZ$=WYE
M-6[GW!*X:YK%OT<T/*?P0'#X]T:;G+,B5]H98XI<\8$3(74?;N]N\C=">:Z8
M7=U-]FF03\HD,US-[NBL@_Q$_0<VK^M&?>:W)B_*>SA=GP?.7(QV)""J3+V(
M71+^N=M"\SMFWS]V&&55KC9AZ@-&!O -KJE;Z)/-UT/6]XL*<KNBSN/ R%<'
M1 =3!N6YW.#BHY_M;C6716F)QN8DH7(\*" ]UQ+KGH66&,BO![5A/T]:[$2M
M_^/<!V9#7Y41E(LD#[.FS1X*":(_.[&S =GOC(KCO/Q91\8PCRG<S,H)*GC/
M]F>Q1U /\NR'#F5I:]N-C?,0KOG4@6?.@W]:9A\]2PS8-=-(B.XN>7HG+3?!
MP/[>D%&CQUU5$/?>#9WPOYC&?PCH9ZQ_P9UZ494&?/KZ&/X;[HJ4_F$C((L+
M#E7&=?X*\#&I%N&D7(Y: #'[T<,JW53RDGLJ;7 )@F"YMZ:$M)\&L'HHK9<3
M+5TGZP$ ]"Y_\]78_"UH0\_@,Q$^^"8C];+"Y-9FR',=$]P/5.4:"GX^6QG?
M1:9X>M :4\'(N3:)18TUZV+O!C,CSUU '@UZ=PRW^A]#4'NU:L<,'U51-\)M
M9JPL(M'/G"OMZ^EVC+2K(&%(RXD)F1[+ M/A&1?73)=QY"0N6.L!1KY"6W63
M$GA4I%UZ;J5A )[A@#!%T/BMM Y.ZH+0#^.1:PJ@0[XDE5[!!VS@<&SW[>&B
MUQ,C*Z#1%9?!7P$^Q78 <%QU1'5AJ8K'MGPE (T>W#C!+IM"ZICPAD:L=[W*
M0*,I@X<S+'>LY1"?@TV+JDS&]N;!$SK;'! =CN_IU.<!9Z,K:I7DHM,%5\"-
MYZ3^D3\6>< O:\TO*EQMZ@<;@]8>_>OQ?G%E,F0ULH-)_=UFP?8(FOM,M8)]
M@4.:;3O;JO<E0L"51Y_;W!AN<, E:E6PD@'+.QL&F##A!P?IP;5W'%DLM  +
M=UR7R?G3 4#3I2A69&>OE8$\^DE"SX+/JEZ')!$5$216;<*G*Q"Y3W!2B"?F
M %!6^)JNQQ. "TJ.X%=I#]</\N^I(4NEV*\$&<SH[:=V=+5>YZNK7(#%+>1&
M,[VJ&/PK!AR$9LPAYSK@A"IT%Y</Q##;0F%&-,^1TO$283TQ_*8HH@DSA@(/
MY9I4 ]M":"V1"8-W1X(/>\P><&A1K9OGL\F-O<,3P"4E,8V^5J>'#K^B,K[G
MC+CO"T'I ITQ<K%3[T/]3#YH.B<EW[8)W<4<I]:;KTJF@\[BOVYQK-FR+\(
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MHF"QK!+?M3\@*DL1$I[P+$0A17@L(86VA70H)=07IV614LKHG,@?GN ZN&>
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M?!&4B\A0<=KB]F;'_DBX?I2@?/Q[EH<SLG!<OV:)N6AM66?0.F('N=2B\=B
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M>G57G6[$F1=T:WP1H ?7NH.$AK8HE[6C'W7J?MUVPZ$B$,W6W%]EI/!18=%
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M]*2Y6K:-KJ^5KJKITA$DHKTS4XT08[JJ0#JY(&U1=HY$9+L\9U)#M$H;'85
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M&=E<OK/0TL0^B_Q?HR++R'_:<5?8OO:UJ#CZ0>DY@V7>Y,-NQ'<WYV9[KE0
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M"D2F73ZSJ7FAO+T9ZE$#O4\(HCKM-%A)/)";A5=0[!@'\)75(!J[.S/FRKL
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M^JQB.V!<T-54='#CP54HPJV4R;.E4G=2AA6G9WOT9PYZW-B4*E2I9@MX+:/
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M9+U.-[A7#^2O45?6#H]_\3WPR?)O>;*_K/"A#NL_VL*1*UV_0F&7[)N3>J\
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M$^!TB>+H\*R<=\=%AFU0Y\"Z E/HW-'$F[+OA9F,1K4YN2IK%4@KZ"6CVFM
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M_SC)9$W%VUXWMS%5M/C,Q_U[J%(=8KQ7L,:[/*@)*HU8$SWLXVE2=60PHT'
M\G!<\^7N+VDE'OBJ U05X0&DQ_VN9J:-?([E;11*V<!")JC+G9 %*.M8,)H-
M.A"O-Y;3J#8L!6UQES1 #0CT6[TQR6_%^88U$;7.<M29'>*@9_(ZQ@K85_.=
M&*S_(16U6.50_-PG1/>LA'QH0A<;#]S+&D#W%[O)Z0:J.EF(_BVB%V;:EK $
M3^+$9?PA4:(,.Z^RR4O[9D*KY%O0JCG9Y OY:SH_[).R>NC1.FE4#7C@Q1N>
MLWE?<E>!ZK% W1.9S%MTT;@=;T<H2JBM8?8;4,5[(*G*]PC4+0$ B(7U3#91
M[4_!(^]_U@JAN(K0Y8ID_J^6R4<@./%GAIQUU:OKJ(?0-NB$X)!PC7V-Q-4G
M,=QLR"T"?Z#YQ[ZZ3>A;8BZFJ);&!ADV?D[;-QL>ZO-]H+M1Z1?L-=%.[%C\
MU#[JUPTJ9CEPD4,=^/%("LU(67@S6X0\<U7^6G'<R[.E!R5531173A^RHHV$
MT =^("-LD4?46Q>VPVMZC7:QVJ$D'I9.EWO;R(EULB9?/0[>Q#SJ7['-&=7&
M%1CUN1ZX+DNJ72NMK-Y0141$?N^OKM<9K@>+&1H*7;JWY%PYQV?ASN1 YW8S
M54"U*O'\J">ITFW$RB&%SQ[W!<_E?8Z);B]6'^B8V9C$".=^1!E:367/4=E0
M,&T[T&%+P9_)[IP1J)WG,DM@JK,H]/-Y])M99['($84RDY^Z!2R'YR4%O-:1
MT7!:B^'=K5U#G5)V"5A/]AU3C:654VZ8)C](WI:0VE7KQ0C>7Q2Y8A*]/0RK
MUU=WEX<;#]!.VZC[(RUZ!F;K"F4/".V -UPE V[+2F,NUGVAWZ&"VZ"1R!>_
MA7G2@AIV/,H9=HQ:1LN@>JQN[W[H-M8(XWBHU;JS)IIT(0<OV-T>OBP7%9I8
M5OX#DAA;HB;5\*5WQ23O,.VK[7;B>5Q-\Z1.Q[31X6R <90KY'S^F#YN6FN?
MYIZ)4(U6S(2W$G<4W!9=KTW4-P$D0M?BP.46,CT(KU\B4S:6"O2/((0'A>N%
M5 $ZAF+#)XH!6_7EH@965:XHGAH0U?\O;3=L9&L<4!LMZ/A]MK7-%1E8D9RV
MCA6YBS+M>+87J-O4J03NR4/R!BN4*ZM[@"O8QF^R:NR0N3?G?2+E=J^W8[?.
M$^X+>]8WWUX6=?'A6<U^97_"%3F]0!P)&%1//-4#]/5M0 /[EE8>=]H4HWQ.
M'N.ZS_3IJ=N^)1DD2.HRJH.#S%G8E+3\]$K.-/H)7G#1MQ6L\6H>;8;QKU]C
M'],-P[M\25D3(RRQ(L5B[ZAT/DOV:XMA1RR"E]3S>[?K2>DS_V\9$::FOH[R
M3ZJ\2-26"LQIPNP_9$!5BZY56Y=#D;X,#,*+5:WD]"OQO/&"7,X2%_FE, %8
MD 48X?.0 )N25]=W?Y)MVS&E9C"<;%\G-Z6N^5YA,8$F%\YD0E^3@&J/)M^3
M_/A(W327OR8;7LBCX=CM/E2PF10%!&#-_:#M!V>H%!^ZHF)9'/#SF4)?8/4'
MW30\A^[<[46/IPPY$"#SZ,"RRA?LP8)UD@1'^@4,I+DLV%J%WR2B]P&%MM,2
M;.^VO"ENZD&/\)JH$%O0B"6KMQ932SLM*Z21@(!#!1.G7LO%4RD?/]\S$2%&
M\>@A)BE3*2?L-= ^_2HF^06E&L)8(:>7G9JB!FELJ[U/5"'V&.-Z.2_+*KQ+
MF0YLN. .E23F"E]F ]"%;AZ@[?-Q@MJL/5A2P%+W@-4SZRHP'N<L3=#/3U'6
M8> #W$=]=H(&K^WMT>2:DG.96-N:N/*Y9;@3(#+6%+D>?6OK&L[5M,NHC=I\
M(=SDL88RRF[&8/;G3 JJR<,9#3"8+_)R64RW!8: Y>975<0BW:[!DX8$*IAD
M/B9;@8/]DPV=Q&TB"FWG[V@RH,^K9>$?EY1I2Z_L<'MYT+"I3F4M#KF 507;
MPF*!RGN#<26';7HUH.L#?@?JBC]I%RR'L02"]9?9A+B5((MRH)DAG'V!Z(R1
MKX#28+K/=,@3UV&NK(YVV0'NVM&@6]T1DSQ!Q_<P-GP-,!PQ?S!%^!PNBNGW
M=WG*A<ES8; /J)3=@11)IQ*J7E;FQRNIPXU9)9/FX&+/7XV"Q@8*6T7DL^:X
MA)W:+X2TPQV8RQ*L;&_)>RCL@<"7'K KMPPXHO"W7Z;Z^;V*3CQQ-S&VM2.F
M5!HN]KB:,]!O8R_XS\JRAN^5%MO7  _V(3HFE E87F=WS"0Q25=E:]_"D^IL
M0Y42C7?#2]O5_B@;'+@'V3\PG^4GWBP5Y/!7W>082HD.%.O^$<H0+G^D$)T
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MX74"$1%G,B8_-E9L4O@NOPM1ODDN:UHK ?0."H2_=3=H6AH F3I?03SGJ1^
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MK:3%P<0%R^M7Z1&48[H,(@CE'#T?DYQ\A5 W@0J (=>CSR5-6#A:6*K@MI;
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M\#''G0 8_6I9YC'J\\&,+'B23$57O<T;A(XHP*#*:(D(4%@YLS:<*MX#YI\
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M J^NN 7VNR9IRY V]_J_MF48_1]56Q);I-NG*LK69478L@#]Q$(HZD^6!JO
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M/5G7YR7_B8H8C(!]$;["6' 55L.TZ4QG"IAJV:I.5[N&R2>)D"4>\75>8<O
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MF8A#8:T3&=XF!$PE.TYIQ9H4^F'%'K9D4>%%1*B2<0O3R3YW6N*P\7)RV2V
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M^Y=(L#:LW*!]XOV693Y!_'C*32'!3M90\20[W2)&T\GHKW\N+4>,J7R]%(?
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MUBJ7J+,VU*QK;V(AL98L]T!D%K1#;5$*C07Z+<O3M(F&AG AQ+_&&[L05&E
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MR6]^>BJ+CU\X_'6]H1:'>$[N6I?-:ZPP54N3[37>Z^[IBL]U&0.N&BTFNG8
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M_'(A=0UAF(?Y ^_5<<D:H1 V&842Z@7AXL7>;^BV/,J5Y$@OF(L,.<3"&VG
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MKSKM^%$7='DSY$WO!&N:@/S[U462T<[*[(@M\*OY)SY^!6G*<=NBW0NQ'6;
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MS79+EEM@>_W](C6F3L,C-+TZS1O)'0R*R!%85FOWT9%;>1KZR5]Q5 9C6\^
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MK1V7Y<V#QG;^"FX#>A?4N8W96+G6YI*?1%5E#-9 U1S0I. (.F.S?S:I#!C
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M-V/&-E(7DHAHE#Q>C:C;'Y*@IN93R^64V0.GVY<T[&/Y7!!<=LUO,">Q:3X
M/TRJT\JXO1;["CA;+TZ69NNL=7N[P$R\MU9\,[$!70#A5^4V:/73LF5YA1V+
M7S3DB?7Q)0HN#&9=@[X9].0T6!S)-L2]8%@/X]>! )Q)9X7OB_(</X%;>R*'
MV]#U2;YZ)^S7,K,X31/TS%=3?.&VU_9/3[ AHG&!P]7-ZP!&\%0I.!NZJ ,
MG"G7+M,Q#(>9-/2R<<[/TQ"BGPQJL[3Z&);2XM'.(/T]RG8&@)/J?>2;J)&^
M.0/C,S.1XQTVST(XJ2&?>NU.;P9@/A^N4+<(Z=F=40Z0/45]I&R9? 3:Z[?+
MJ*: K*K00BP*[^5^.(OZ'JNG"'+@D<GQWOF#:\PX5N?DK[0R#76Y0M[,IZWQ
M8YK,F*\P%/IUU:7=IC4P;7Q@YZHZ.EH[8)WX[@N&:10$XV3P-+0C-M>)E$ 2
MUO(U>1WS%>PE\:<S$!#OLIH*(:=)0\[88UL'*Z-<F,B\IW2_H#B+SG$O-&[J
MW P4@LZS@"\L+^,RDQ=VQ<.2V&0D9A0!$0&V?$\MZZ(4;H,9(T2CE6M,7686
M;,:L3O00%BIFL66N+; E-R/<]NP"9(VEV@A-&&-S<:#*_#X[.:%;U#J!%7,O
M:L&*NA,ASDR-C5B%:+4U0*];'%,"_C4HFL[NW(+=)):<O#&2W[\1,EW"U]Q<
M.=' G80#7?=UL9L8XG-#$^H6<RUQHXMVA;K.9EZ0$BD U,[;'3')U8,#&2QF
M7?C7-9OU UVZ3V&J:GGL8&R2&1MX=O1>[AN\DXH>4B$$:I'.R>QKPQH%]YF7
M1%D>#FO*##%Q']!SYK/%F#SZ^;(X:3W+S:7 W_IKB2^#I9K7H$=QFR,6Q%:W
MH@G2VM(3:H!81!DPU&]$HO+RLJ;"$"II>UX>G8ZK54=AP=>5?::^Y@"Y6 '+
M_QA!4J 3/6_L3ZL:GWQ14^WDL4?@H@(UIXR':@9 9>I!5-!5<W(QT)?++VZ@
M([?V8#-P1[TE?LHO!"<PR,C3W:2]L:+0HOYWEG75EF)JX5/H 9:I;AOG$/0N
M.G=2Q"$Q@Q^1=J0APDO*%C1WA8_UW%QW4O.1.OMNO'""?ZDHY#\9XR6D#)^5
MC*QPZN&1T5!')LM1'C?#/JAE'RJ0[%H?[K'<L1$NJFG=!7B0= >G<!4..*:Z
MA6+&*O Y&'54/"<1&M .DQ$L<63@V'54?#6+Z"9'L.TGW4]*G(I!,S36<83>
M41W@]FB_ FLV.4MWBM<!JMXMT]T4%A9G ,%;?HF,H6<IF=XIA"I?S>T%LIG7
MN6!VI5@E:U')V7X'&U9QNB:?D? *F_'[G.Q9,^7&M/^,':.D5.OL9N%W^>*E
M7'L?#5L[YSZ#EZ>Q!"11D,+M:R.Q.,G>Y@%1= 3_ !O:*>6DM6V6%V,S<6\,
M4YJ+BG>\TUACW %3E1V#?LD,.E:T@AX>"#X_#TOG/P2$1Z\V4*O>T$4#9*20
MZM-3?C _/>7-VN9M]Z(LA3F;S.T5^EG-XZ]H7Y7:%EW3.@"D.G?%*ZD;0-QP
M>03=G#P!W2H<T0SBL7_6TVT8@3BDN:9!17P7C&]16CUQL,87B6N')1<G)I]Q
MT(_^4J-;4/#QR^5@!JTOHVX:B0/<05JHFWWF$=M*DP?E7^&M75,,)+/[$M%C
M?BO4FA?^J",]"T5:[%6L/D"]AD)SHFX9UFRMTEJ;KI^EX*,96_^:;AINI/"Z
M0*;39T0J>Z+<6&3NUQ$!CK3C<DL=->H7.'< J/,/H>@@%=:[]<*C^Y!TZ^'O
MQT>@CBA5OAO51C -RI,V;F(FP/,E7W@LW>Y2<D*3@MVO\S@R<DSPR,2TPZ H
M9XT\)-\%.(+/J0@VC!6<P.$+*E&*)/<H8%-K5RD'6 %0P?!D[U=(UJ6(6DX.
M/H^DM*S,$BF,A.!REE*CZ6WQV_".]SW]DT%ZC$O!TL!5QI@8UET$&[AIX75M
M.VY^&?A"^KZ.1$U+13RV. F@JI=8$<=C:.=C5IV9H,>;X<-SM@NYG&D@I*%A
M%5WNHY,\% !)$BF]EUZ/5D-)^U*V@;\2Q8B; 1#:031XFNH5?B!'O)_DY-O8
M">Q0,S8MU5G2&=P%7 @8!(C+29!\LQ"R80N)?3'T&BHVJYI:;@4RMIN5:7U]
MS[@7H-VV-N03:[&8E+", F@A-3A88P6;J\[]D0U;Y&&$E ^##X\2T'1982'&
M;OZNFQE_F+#!2(,BT"]/IAYJ3!6UPE1CJ;XD5:Y0"BIST!'$S$UJ2$(&E>$\
MRAD4N7)Z6 M?NM*NE5CK)!AR]@#%K' YE9%.0\^Q_+(UZ6!7M4<!HC$S!P/I
MY-$=DQ[(4,]3<Y/K3E)-PV#NHQ?[NJ[&!47O8S#*:/WQ(M06KV #KF.3F@JA
M4P%^]W1M:7$?#:?ZNGG[F(9$H;X ^A:3@)#2*+S;N9T4R#!]R>OL16+L$#2B
M6[:[CPG_=2;'[J+<A@#\HF>[N=QU91_J=H2G5>RE[1YONMW%J1=?RA3F6O4J
M]2YB6G.US"< L%^)LVE]:_3Z$GSSW-IMZ %M0?U5:#K03<RCBE:,_<;79D91
M$L?0O?+&\J1U4G(+2ZUK14J5FKR!GBU,Q_KXCZB6S,0"&\9I/#=[%,N&> Q5
M5Y/AJW1\!.Y3(L>BQ[B#(>"HRL7IFB\,A&BJ)T:9"&^Z*(++Q:B9L8:&2:UE
M!,-ST%.QK&_KIAVP$G=P3:XU1K:"^WA]-[VN>BGJF\6HA_KRYZHS_GQM%N'D
M*M*%KWLX49W"I5#->AC!_+37Y6T7>J!+$!,)B1OEOPM]O YKB*TOK5Y;$+8@
M\+B3.=7XG']SJ+Z6&J@')_NZ_F+U)DJP>ALI87_P_=C)I.<%&6,U[+?_1T<Z
M[A54\OZ^H8O^'QPD_C=7%L^+>?29VND?6< _XA27:1Q),:_NP\_KW:M;BODQ
M+&-MG)1>?J#KS]*"]$F'TI?U8E32O#P%>'EFIR7"74*.4?U 1ESF:<DMIFP0
M)%3U7L).N4W/,0IG"?4$B?HHIP9:"HJH137<6Q!:T!^R,\HR;C]V_ C;3VJ=
M/*!83)R8N)@V^ P=U5]!-58;QIW<?#Y$ *JDUR-4];X,&N#K;M08GN/O\G=#
M!AW/%;Y6-K\ <I_M0&58K(C?-#.)D8H!.R??<"<'+B2J8J6"R,_Q$_"BTML<
MSC[SD!J^ZS:%"]B2QGJ><(UQ%(DWST;63;EY&A#TW+FNJV+]^HL0@W["OV=[
M6IJ&T;.%C+K<:'J^.42RTS>-% @5,U0'70HOG4ZX0=AJIJ*].ZEQ/U[?N^,%
M>K*C-L(7 2N;9^D&J],R%*&XL80+[<W>#@>+X454)_?W^64\+ -JAAEU2DDY
M"_OE+^GDA=3->KQ_R&XZNR%$FZC3+P=%)S75;"Y6FO4Q5([7X8'A6.<GPI9O
MIJ8!X L)J?N2W9KL*ZA&@88Z2T-%N!3+F!UFGM;V#S/G+*'N/6>P8_LOR-'5
M=LQ\>"XOIS]#QW*WXGAHE_1<$E&]1H#6J;FJC(]@U)OARZSQ'ZG)YF[[/"0[
M0A\CR%X6D#:8XBB-LTJ?0T"!PQ;['*JUT;>(P 'OZ1IO2$;9_"' 2.RJ?.6:
MHU80V!3^(KM CDB92@D(22[F1VC$VSW=R2 "8_8RR]E70^O8.#49RVPMH?2K
M<)I^4"IYW,O1T)[.OU2!NB4Y-47K(=JKM#=G5NDA36I:".OQ?L0"ZBEE&(1D
M]QJ&G5ZF]"06PZ1NHD#J,UA=/ 0E#3EV2<(, I*>4S5NMB1I;V&.]N7;3J?!
MQT[AM1&O&+2@T%@'_4C34#5O&*G"XB9-W(4.\JFB";^T4K&]H;Z'QH2>:_(P
MIGEPB8>1T1<=\=0=>:KF0_A?UP>ULX0Y@ZC&6J8R7QS59H0W+5Y@\PJZP[P\
MK%5?41^T#'.8.L0GGJTX3EEB0I LRLY'OA//D6",_6]A[3W@5!_ZS0MT>GQ^
M?LC[<[',:PA<("7+H<OWC$M1Z&.QI,'1(P\;][.H!%2883QAY#0?56FBB"69
M<('*:,')90HCKDWHR:&(?1Z&656#-8&M:_0P%,GR ]+EG:055#;RF_EQVZ<V
M^,@^/>\N[!'<FO0XY 1%^74[4T/NELS$L&5$W ?GXG2?ODPNL3*P ?DX!Z5G
M*UD;/0&W;,E_6^KRA0R'$G92O?/4#3V(SM!#_*[XA*BAD-H096;E)[^)#C<V
MFW%[=SAJ4:%G "#84$1C&(-:K3=0/GQL%)AD5NV\Q$NZ" $,S#:6QVNOI1M@
M"IL7'3>IID+@KZ-C94)FW%P3P)!DS69Z%%T@+< NM>12EL?BQ8YF&X,B5%V1
M$0R,GZ7UBIMVEGIDAB=$N6GFDD:W\CJ\N<4TLUTWZ,6=P]QD7?:5N<F+6-!F
MR#!RMOC8)J$W OJ*-WR.G91B(;B\A-U)S%;<5H7;I'$356OM=W)!Y\&$^I1#
MV9^E8%7A'FU H-&[**R.V<\5<PIY5"1FYS*KK>%6\DTQ./789/U/J]!-!Y[I
MC*-N;P?*2; 5?(CN](G#+MZP'>LAY%HOEL<XL*[0L;/[6$ X!T4)V9U$#UN"
M"5KO.EP\V9"?D"K\HNF3U&UB-2A:A+?Q+.=KI!XO=1?\,7?UJZBZDK_Z_%_T
M0LM)+%+=_$Z!!FXE9>XVU 7$ 92O,_NCN)7]B>IB6(6U*\N4_:P:6QN/3TZQ
M&LU'I6*3]9Y)U7(G9<W@%>:&5A3+S5Z#U^[LA;5LN4Z2S+6A7A=6"5\V>R-T
MPC90^.ZWS[Z _C-UHQ_P#:<I/7EH7QM#5=&F^CV'4$6O=3.<)""(C[1LMU5N
M'NSZV KG8\G9CS[P+?+U7"P31]GR2_"'TGS7P$Q2NU/%>&5?K"K)!%[72V)6
M0BS0D&G]X:/\$.I@61A5G:96"9>[:#GD:56&*M/=F78PDV5TJ]LU]5ZB%K=J
MY=3#%R6Q(9OW6:F'"R-T-[-@UW(_NFY7%K?7#/.NAQ'>-F:+& Y).WUS9C1F
M5HRUH/_L8,+1P:JF)#=I@.7<9_/= N,A2XKY]36)8]%;4@(T"O189TA14B%2
M%JE389V);L%^$EWE@5SAD[J+JOA>S$E80M'#LOX<^I#--7:FENK$7#%&U]^:
M53OA5(4<B4=-Z'?)6-(,#?!]ALMU:%=78<Y!O;9W8,[.XN'[AX$QF]O[E<U%
M>9MQ=DNQPD)@$1WKRMU(W>ID&"1"38T ?S< 3MK V([*WI2,XE7?F^)UXG$:
M'YN,A4O)0Q*&G:B=!!NL:0W]>%6D#'1DP0UDQ:Y'M_,:HP(APD^:+ZF!R[56
M^:#*N3\S-[WE9":#O\,I3K[[B2]J(1.ZWT+S<%UN! \,I_L-X2D6!K-9HX3E
M<8V/? L>:P?_H:#U]J+F(QCP]'';Q<Z!#(C379I/)KA*P0B9A[[Q_5CB=?'P
MR@:LFLK4KNPC:]54-SX!9ZQMJ 6KP5S,XWUF5(@)4=5HLHQL"3&'GUS0^Y+G
M]S;[:*SZ8?.9SCW?S6SMJR%<H6WJBYO7LB@)-B/W^)AWYFQ+!" $?F>>5II#
MJ[2M_5EJ23QJ:4N$M_J'1_Y8ATMP=("S%Q2U*U4O1EGQ;Q@J*QHS,+"HB$,]
M@M<8*<;.$9:7F?.",I(+.RRX%3WM>KX7&B0E)_'R]X!>DE4KU;K30^99]V9+
M-O,?*;L)>*%T(%^KGZW&BAB%O$WK#"1#("R(9;FHQ$O9(8#KNQ7A5F8E^T-@
M8+=TQ$OKH@)2S"P_NJUH91*U8C4,H+3NL]5KX0]%$IC^=E4(,EF*[M QRYG6
M''Q.79V;@Q;Z[8AY3>>6OY?I\*>GGJ$4MDI':0493<@*O)C84Z36Z')X+)_>
M1DCT\>)5$A@CY24[K61C+IY_$=7></OE'DRY"T07/(R3,GA*%!0=JR!US<_@
M1QB*@J)??T%]\1>K>C[E/91G*Q8V_T;](/O?T8T[D[9VE?:5%K3F+NU%9R%\
MF/_ _1^,)/[W"=EW*M!!I ^HHQ[/3*W$MFA/N?1#LN5=3$,<+/(6Y:2H=(/1
M@9]S:RNJ-3I$NN8[4#N6)Z+T>?P$V8N%0R_S8PD5,2G0KW:2;Y#V3ZC66#Q!
M"]@:MEF<\/V-Z0X7M;IJ6%^"TV-OS/EFC=5=!F2OQ>C:\1E_^U*@'?3*IJ.&
M+U*HEQR'NLT\@MX,H<=,[-MAW1UL/?<5'(JI/"QXBT,=U&$8904M7Z#O=K#1
MPMK,C17(WMU$V@4WM%RXZ$>YJ(R,K$D.Y+C+NAV<L@CCL&JWH@9B68(])&T_
MG+6YBFP<%O-:S6#BB)X0T$I-VO+KL#]EL[?5D,1131DP:CP=&[&0:T7Y78)O
M")>:.^0I+<<F/Q$,81;$0>1IS[_49:,HN\-*2IJ(3T?I!!>Z)GSO9?YAM!I4
MM3O:(M69 ED9SJ!V*"[_<K<)0V#0+\@@AP#HP<D/W3;,36*PX'*DQT<';/-"
M!;* ZI*"W!W6+ JOCSPE%4Q] "@J<QVH<MJ?A 4>2.U@']W+@%"/FWRJ*3?X
M&.QU=;16L]<R.Y8O]8#IQMRC62UZ']U\,5;/7&.4/"';/PNM_QKMD#"S1!-
M:,K'SA3SK0X.P"V=Y4'1T6:>@=+GS)R932M;,V)3O:-&T[E^1EU!^_SW3@AY
M.\?>F#) DS*!L']_]O) ^V(FKRO QH.I5-/()-7L#%V=B>K^V3&HE\NH:\GN
MM3>PLE)CBBKZ;*8=L*7W^$^MCEHMC&AL&8;U$OG>9OXV1HP?RTVL*N12L%I4
MK,'+U'.0M?/?]O/5U68?/*<OS4E,R6:]'-!N8?S4@X?::_'B=T?1]TTG%[1/
M:A;X:I?B%*J,8TDK=][NZL&,G4'ZT;1VF;PH@30N<UM&\E%2S0 >Y+G%[+OV
MBU'$4QYSQ-(X:N(,!25(BYB41G#D6 &P-LHLUEI*NXXM/,KYW-F&":8V#V!6
M>5,S;#3UFL2*27J=*'292&E(2.4=0G*#'E.+(R!##C:;']O>\!F&.3 *N5VR
M*WUNKK<!$":,>(!= <.'>W:V8H>=%4,V*7<7>51:M\.)F>"<IK$QI*],W4E;
M8]42R*')[H$VF1]: ?N^\-D$TBY4<W[?W&A[3YL,RT=+E7U+J+MH@AYA/E53
MK3./\"*HW=U!49ZT5DGI856MXI[/1O!&(Y8TR#!VQ&1I3F;BNAU=2R6HWQY]
MD=HWK50L&R (O_V*EVVLB _I>Z+ZJE[J5NBQQ8RJ*BC:$&[F5/"T"FR[R8DJ
MR[025E[OHK;(/*S#B^_#C#JUW)A!/,70R<X&_1Q?#X9J,\6J,K-W6A#B@0G!
MMPN/]QA&IW5^8#1R^X*B:)VS""J;YR3I$@]:0@6#R4R^?E [$C& =]-T^&I\
M'CIOCR?Q8+*=;K*?W<](,=[A[T0O5O#5(8_!-P5-NHNX?C?/"$ %8*+XO8X%
MJKD'KWV)!F%CB<("Z0;4 F5%E\SA+,+N-)WJW/!'?K ^\_O(0XHRWL@2JN9R
MW_/.G'2V@7H=E>=PM1PK8:AHU<?"L/K%?>2_DF_UV)D)/("6\MF=<7$- #)>
MTD>XBLI\[<^PDO4M=#^I6RR Q70^>JH2M-*^X'6U8J<Y"Z\4K)7[DCP!NUM.
M0N<PG>MDW);UL$(,Y7G,QFT16[D+L&96O;1_VNWE:_"5C"C*;]C*FS'-\=SY
M5E.73G<K-(TV-Q#=Z=N7<Q@(HDQMO1E%\O<!7NW0]1 %Y QEU_@+Q@4O2[<\
MN]$GX*Y=8Y1V!!MK+/4U*YK( ]BO?>_[Q&=!T6W89(X9C28CS18UP!,LD1 "
M(V!DK!&#'[>D:5(S8TBPDG[XDCB "G)7.*S2*PW#+L%[+2X:DUX8L=ON-(]B
M<C/QEJ7IXBX4?Y^:36VW] +INK9*I<GCTKS"PF.^3E[L,\R^0\(^X,/IRSU$
M(]DT"BH,J)H1Z[<OIYD=>,P=UI9<S44)PIKP L:(&^U*R@<7/3J_NL@M%\:F
MVRQXHJ5;.A\4$>!<HN+.&4TUF+):7M;#:%>CZF'(1,?$;_498D@[=B1M61.&
MJ$2U:MR.@<Q\>Q_W@W$_ 49J9V9+J=%PVS.(7!U)U<=5)30.QX1?M[@L'L:Y
MOW8J*+HH#ES$3&VSQS)48'L*0/TO%_>>JS+$Y_$D7FBB>]HZ*W8;LS%SH;MA
MRE8-NHKHGFN*+62##;))P! X,LI0-3!"H#+8,#,Y[*3@[IVQ/>WF__0Q1E>W
M[%G83S/=EW;AVD_)ZZ;3O+1](07SG-MXP_"\>-0&X^'1R#-&8D1#PH1O/#>B
M:F#&]@90SO.IF;@G<A*D4?.-6?DO;:)G5O%]&ZSQ\1\R.HC!2L:FTR?I_%K5
MUSV"KI@D(.7N;1'ZU*4>AG@D#.PB0BLKZH",JPR?1 D8+M'-MMB7)PM0CV>&
M'4<Z:;U4P8J@C_)[TR,;J+89++=M(!=%#"7#L_73Q_9J?0:B5@WIYQUR>/Y@
M4)2DQ42/=PU#5,V(NVP0ML9S#E= <,F=A*=GG*T^L>%9 .MQMQ2K*"F_>0"S
M09^AZN5;B1/,%.3WR0F6NL8",0'5&9TR%S\%BFN+'NYDA2"7)8(VH7V-42N.
M\UEY\!E7,@4OCS<(EPY\@X_8=+<Z&!2C(15]9*M2\@82Z%WZK8$,9O(BB>7;
M:SUFJ_,S:R+T$#8OJIS[BF&::?+%3S*",@,H(["4H95)V-L/!X1_[SBU+. @
MA0@O"E/ZR#W>^)#,GPTEH]OU )3S.RX7J5\PD*,8CK!,3:4IFH9!ELK43UJK
M+&"B6/ ]FJB6:V@73)5Z/5[C-%43 Z+MY7EE :9$#J5@7$+N=NI]H0F#D'I(
M,G(Q<\[LA&7'MD$SN5BLP/#;?I826HX;D'Z,LV7\CKE1I@PLR.+SM_'M_2_;
M9(]AS% S:VLHW>]@P";RW50Y=<.\GH"5_FOLZX ,P2_<&V.,XJBK6*]+2[Q>
M85HS/%YE(!C]8;;A%T&1O#Q4YR:@?N7$!DM4 R>&.N(^53-DT_83!X23*I\(
M>4?\U;.W.,WA)9V_3C=6+:PE3L]K_U=KB<?_<_/PGZXEUE*4_40U;_8L??M[
M\_ZC>>/F)WQ4;4A=:8C2QLXFI,*DX>&$TS+T#483!5CO#AF3/\E)B*4]4!OM
MBV)3^$>3,M!G*>C@KPB^A-1AF+QQNR*E*YN@#J>'E<)S*;D; 6'Q'B.K^E.]
M0A]#@_ <[5)<I1.Y%'X8"O.4OK5V2_+EH.CKL &8L;O76+'3 @*E*B>_4JP<
MH&.$0&QW,N-VI\4.T*D.Y9I]@20_ 6/SI6L&1M]OA^OT&QMSV9MN=_/K,/)+
M>_Q@-,/T/DT"SZU#>8)\8*MMW 5E5*3X:J$7*Q8;^6(S,^DD,4,RS?^O;R?R
MY;'8EU ?B-(Y?4R(1H2NI"BSE49)5OBW'8MIQ\U#+TK6 =SU8?PV597/0,+\
MOB4Q;/#"<\T5+%XZGY#)Y@GKXB\BL&XEBF 'JLN\)@C6O_+\L33,$,MXX,?8
M7A=[,V+8*IC0+ P>2_%F$)*K.)FB1'IG]ZP^!N8F1R?K.9!IT&!JKZ:X[X+%
MAV.AGB==>1&49=V*"XQ8=%C/?^57K7>*U/OL(<7*>[.7%UKCW1R@OGU\IYH\
MG.7VXI,QVML8%H&.28AX<L7 RH7"4_B4Y^G'LT?&]4'15GAFW^;1UY:3$Y@]
M/"0J1@&$QSHW9_PLEZ*:E"Y+<(4DN$&Z(QH2**N_\_"_6^\MQ_K$3<PDE^(3
M7K-_?:LOV7-L$S,.[)9*9K)60TU@8O.J?IE\UB6HWA2T&>:"HM&@:"G*B77X
MN5>*9"PU&A(D/=.!,J9O>MRV!V@;?4M*RA4@71[XK)7DL[6YR0SXYPN6C;;1
M;NB9RNNY?3$S-AV&]P9%YRX\0WW^>6QI>%F3HEBF/_-CM0ZW970UAK<"1!*E
MG+H<U%ZW[0AQX51<%<U8-Z)G!C,JFG3'LK:O;)/TONVVA5RR %#4!1M',W:P
M5 Z,?F=3^"1G(*O*VR&4[/FYWK;DNI0B;$3S12Q3%1"@!Q(S&,$>/;/?X>(?
M8B/IGSKF]TV[%<T 2HQ7.MF7BGD26X>@SS_FYLWUF$N0W:D16Y>QYM_Y9*Z#
MF9@O!QUY?\;.<@.AN_$<NG>.2D^D[@)F_WGYM&>-%A G,+M,JKUXW8G>WQ9@
MK/P*%1*'4LSH:]="$7-)LEUL)I[ZH*\^=V%Q@W98V]P%W_H:_U W$$F9".#F
M_ '%T*9A)[\#$QX47GI(TQ -5]G>$Z4U)W+EZ'K]\M7_]D\&\7*"2;/+WE =
M2#H\HK(F$ N<J?P[N_)11>BPWI%K/GDQ[9@\C4==QKV$WV^0[G/=]_30@6A=
M3X: PAAQC22WG+>?LR_O1$7'.PF^46_5W/>67(H;W2CWUWO3%1I/D_1O#J=H
M?;^ZYR8NACU121?*^1K7TB];?D@ICOPH!86E,RY.Y5[+B!>4.I1>9MWW2OTH
M_7?KN4<G-:_*7"JKKN#&QC,S&\8G:W776.H..:4.G,WTF5+^P>VZ&)M]D<SB
M<QAU]MUI[M6 O2Y[RO1)4/292>4<#)P0&0WI++&:P"K-**U,ZPL>4T]X<W[Y
MQE54&.XG'[-UKP9^EM2\]="KY5M+%7W&:;=@$?.;]:G+HW_X+RNN-O,P5RI
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M,IVR86Q&M"N%Z(#@^5A^9;BTF#!:.,L,H\F,O4>T>B,BVPQK#5 521K<R;0
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MT,L4T<EGHX("$ *?C+TNI/4F*CR]OV,2Z[*,ZZ?6.V5T=V(\L<+K8J6JFVM
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MZS[@LCI_;+GW]1"^AP?SV_N[WYR;<6C,2+:7)C%Q#0IE6/F I17,V[2AP"Q
M>BN+9LM%2Q[R,.)8S/C;B(V$*MZT-_B%B?WZU6T+NK\^&;U]+_DDN1@%4>G9
M4?8^S_N;VH>7 $UU*/9:9IUSJLQX^='JI%!085OBL^3LL;-@BWK;]P:%V>5
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M!O?E9 $[\'X(:_SX?MXXR7^%W"E\<V:#6]2=E.MQ\=D>DX,RKNC/D)]LW[B
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M8*:#=%$4T-YZJ.$29D :[I\A]D\R-:4-812HKEJZDD"JO5F P4H/8\B;1^,
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M3:93R/[8QO(D24WA #97%V'^5C7);FV%L)@.'G>2S%9AT1+!EN!9<R=6X[1
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M^W,/?J-1-L7%L@FMA%VL8\%W)ZT-+>'0B8'5GL;C?7+&P4K#$XY.O\L,MZ]
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M&[1#GZ>K]CI4*A=DSE:14N:R, +Y0U*/P==N'I:X.4)M<LKRU6'CV(G9/13
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M ?*<!]*U@E4#(3A,2=<Y3'I'D86U5944W2 -G%CO<K/ GX25^(^".2IZKCU
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M2R@,&3HK,F\;PM436C]M#943"6,.\$*)'%E(EJBS#\J,]$@\M>Z+Z&'VRF9
MQ,=-V8-#\\MU1U@26D^3W<,6W5S*(&/-)!U,H2\[O?1B\E@#_BR"J.T/,6["
M8D-?+@^1_H@_40*FB.9.)SDVBM@E/'W9SVH*3J9ZTOF J.[ZAX=9"U_RYXF$
M(,G#"C"M JY#DFB$;S8/[R'X*@QAL$TA3TP0V+WH4%$D.\81["J\:RUWFVC^
MW8.RL*4F*XT/B(R39SR1O9!7NIC"(5'L<*M<<-\F,1.B&'A.9G2 !QN$+7L[
MMCMBZZ+6443:@A0ZNR<MC;<<7\?.P-FCG84BR4^*5L'PJL:Z65#4ESP U^0#
MCBC86U'<'+&/C=;'32[R,,MA>;LV'W!@WQ+Y3LYT>UXQX0-?Y_V]X$.4.\HV
M/W@(G'5K^#S9&F9!@E$?#K&[0=KZO9%Y$F=.+["@<ZWI8</8;!DY!0SL K)$
M9:TNNS\Q1-@D7X1'P7H<YCQGV^O"NIRL7NT0A!7LW.:4@C";,J3UNUV7"JAQ
M#5.W<KKJI#2_=O6\"6I4?E7\435DH_U=(UTM&K>G^V#>Y\_?B7:ZOA9Q!*NL
M::77GB1T5VE$;F UH70--N:8[Q"Y/ I.P,.2HA85IA*Q<4LMY9IULN^+DWE1
MZ=WRZ ,MTS^?-;;%O\-?A1V44BK@1DS='4L7! PVU..XLS;>H]*1BXJ!"C/.
M2TB7TM70 +L7/K:N3\W1WRP/@V1YA?QJ 1/O"R_[13*UZDHO:NE#F1Z_]R2D
MF]=3O=B>#=]M?\LQ<*VD7LU=W:0U+*7?4DWE:5>A\[9[XMGI&V&?2:R U;T@
M+1RW1J*DJ[<7MWOP1#PORH$P?7JL96Z2LG21>=Y5^6U2,7@Q"#UW=F.'927D
MYK17E;$#M:5./\SD^W<"(??2&SH-=\U&870&@GA7&JMW7/H6NE$>7IG2_^;9
MVW;-V/S^_AJ_!F42>'1@*U8+P0=V8T=J"ZO\KNG$^#".7],)#TR/[.*TEGZ5
MK31^W"-EF[I!@[?GC0L/('S<E!$RZA"1Z2@&;3%$C)W!X,P80[-\H.+DG?V$
M2:^\.I<'>WB/O\_ ]H[/3$'O02$5%2=2KG"OCJ<3='7?F2=]"(H]A[PL#4?5
M(8S5_!/HZ\X_*!Q&*I7U:WD0F7M';3A.V3"5-BY4A[:ZMWPL7>LN)M2+[+^F
MSCXT #POMY^;\N;D6GD]Y4-MK09KU737)QB8BAW^LOGPN0K7N/VO-[Y_?\(*
M6#55_."J7:SQXB*/2&61L:>O7MA&4I[7#Z3K5[LUPU[J4C(P.M74J(@_'!B,
MCNXO-EZ8K/4$NRG-$4W#&#RI.N+BUFHR#+DLY^0L7/BB<CIZ!5@!_C? M?6K
M[82N0\*736@XFP],<G*@16UM D92A)>C-\=]VD1A)[&&P(-+PLQK+<HXJQOC
MW<,0G+>';ZVUK]OQU_=35VI3C*TW;R$)#5R14MGZZ<C73")Z=[C=])YL^9CY
MIDRM)QUGBSLXD;F,&P8'\XB6\2/O7G.R*: 7_)#W/$&![##CD/QJ7>>@$;&U
M$K+0Q@K8W5-.3&7X;267._9$#"?5YS*D-F_')FP?C_?F \/WN00F]<?N@(L]
MLDI_NW(M\(09SJ<*:7%N_^YW-;G2I9I*W#L]$[2AWR,$G<7C!:WJ@?@W[V&+
M!W-9--V>:B83[KT*$QI"A6UNJ=N#[CPPB/G&5D)%\8$-64LCSQ+=PXC#$)\I
M@_VJ\5Y3EYJG['7<U_,.O=.4K];&LE63-_.!3H,I-J6W^C?@\&QW4F?J$USZ
MK<_$%'/IW\QWHS]\UDT0>APM'AFH*O-*W"VASR[K._T%?A:\3#O#GW_9F%/1
M5A.&0!D KFOUQS/[G5")'V)-/N_1D]\;]EP9=C^QQ()=KX=S0*83BEH'NX43
MD<F8N?%CU#,]:%HO7F_==&EO#Z9Q;]QU\5'C^SF, ^/1C'T+EN U5-#']@OS
MC*S09GB>(<;96RVATM[\ 3-F+3S>,:=L6/*4^- DJ6C2*V2D,N[HLZ8W;R"C
MJQ!CS9S;S*%N7I.X+SN(EKHS"3S^Z@T?B*49<&0$Q$/A5>)-CL4;CD?^+IR%
ML3ICLOIW:0YM4_?9]S]:#65?L:/@*G#%A"F0$MBC/D$C2-0[W+$Q]Y@XY>&<
MJ5:4&NH6MH:I/^09X' G.J2/V&]@"4T N!7K/)$4KJ=(#!J*'^M>/-W",A>P
MHA3\:N,2DH#[KPH4\$5P$8,FX9U;3^60G MK7L)I<O.\#4+-[U_I2.,_H[I%
M?$"*_)#MN%5UP]Y.L:VF1(E+^A@"8S-]6HT<+(>I0D/83.9,+AG/$AS\&&?C
M(9&*L,.$2_WPID51^\HDYRQH2.Q<-NM#)_"!O8+(!25*HMZ&:0HI+!TV)3*9
M!C]XDYHQIE21N;T7NDK6%R2(C,-1RCR(9H&6G#U7U,X2X=&S*.2^I@R*J$=D
M3AG$= DM>41>>[F(Q7KPGK_W*U'^,ZV;.0Q9BO-:'J'P4?.MEX&:BL0Y9N,!
MP3:*+2M9-O"#7H*)Q6%@(INW3[AY364'*DQFV=L6_)+D)[Z$%<U_(=I%Y1/!
MBU\TK](CH/AAH6,BBAP,PH; 1:3([V<FA \ 1F!FG*AM99(MK!(HZ,%^"R]1
M0UC-E'-<;N@+;)Q&HDY EW5U#PU-H-%$'$/4SQ*_=N:$M!(/2Q8%+S59"8UY
MWGG$KTE\0&*YVZ]K#K:)QA.YN@@;TN;9OCX"0M4ITA?VK24(*&#>A)8H9!F:
MKYMN$D-C>D1\N*T-F<3&TKB@J*^/UKN)#YA[DMHF799$PTZ4_VW8B3,>I%$&
M[ZWR+H0LG>$#'0UAM=!J&9[N)E.V4#;670N%6;;M%2JT$).^"-@\X7]G\V/+
M;%[CO[-Y QKL3P,444?47Y#,CZ.3N#"M=G&.J4CAQX] 3FIJ6];TYJ(U>!BM
MX4A1N>/NL7[!.Y,/1"R7#I")Z-=?(T&82*^HII0K(/ZST/EEJR>2T#* 1.8-
MB(*F(1=O^KZX$Z/_V-D-PF"F;VL!2H:^B.4NQ:N!NAC"LEX($7I*G"[X6!@0
M5,&4(@6+6JC%#(HB-9XGQF26-BR\B37:7(R9K_>$:$9*1E-+<U 07(ENH.#I
M0MLFO9>5FPK4Z,*<-WLY+%90%Y<N*2\02L")"DF^/#BT#?MJ0#3#LYMB 9:4
M+_OH$>=U,8CQ_TKG^R\5KHF!,&.2EA?<>$A)%/021-3T55$2P:7P2J*:1<V#
MT*P6N!K8)0H.ZJ%S8VQ'1(;(I C:[F,Z'.F=ET=?+J# 8B0Q5/%640PT2-9%
MF.X3ZI5!EK*(KKGC^L0_?$#+J0>7E[]AP/Y/*!3!I$SI<>+@7!M[E7.F$)@*
MFK(0^'7U!C$_^/ :M#=-M.V2PXD=+/I 9O1CL#^SU=QJ6,7E]<MW.1]RTY^J
MA-D;7<O.R;!@7WVPWN#D8<%R>XF;8UI?-^P<7K6HB-&'-KT_WR!VP^[9;OPV
M(P!B?@E@9<02[?F !A](<ZIX0I?'S'M7'MW!+I=R][>JA!PO94RQZV:W#O5)
MM%P^)$,_E/VQ5UI1PL\C_WJ7ZKS>L!7-NA-S]9;>:@+"+U3\>G9O,-+*I<[:
M*IG4G>#APM$IB"L6G!$LS"&U*5I39;8.+ON O+4=L:8O<NNMFO4]3^-4G$O>
M_3JW@#ZF=_86IH.SM9<3\Z/YJH3RMQKCTXR[=49<DMFW2682@_I)JI"=UGIB
MQV!S)O=GD^PJQ@%J;049E%1[;#20,Z.1;-5A?MC ZO[DI8J[]Y4VL>_KC_=I
M;TP<CCNN*7\[5+'_$RQP)O#+U5\=\,9>P@)@L>#U)IT\:Q/0X91TTPI\LBB-
M[TYXC>GX]4$\GQB_;V&V:UJL,M(]R/1VDWBVPI>I#]7'MIT79S6XZU#UB+*K
M0P]_? ([D^D[==*_J:I![ZR?LF"EK=Z,NE\"'4/@S&K&F-%,+9^U5\H>M)AR
M1L6R.9O[#W!KQ=],DZ&KT=+T_?<K^,#@&'R ^D?%]:<).2U8N\SR)0U#3/(Y
M;>5LR"K,*6&Q.8KE_828V@MI.8AAIQQP\;).','41WLH++M/RZ/<$I34C8#U
M2]V%-(0=+RX^UG[(\(*AV/8GS><2:DU--ON<WNR;_W H>L>9]^_O )?5O/22
M4Y,L.!X9=U5_3CDU&@]>,N;RT"BW_9ALP6J<\,[B8,)>-7%MV,2.N*HM.K,F
M)1)7OJ($!UJ*8)?7NC/8@]4>>OY,K_]Q7K<"_%\'=/X-!62A69S:L00>G-P7
M0-8/Q+.+XJK)U]5#2VJB%GW@@LWUC3>3X8H/M2#G:TB77+NR4\XNN=QZ<X7\
M#H=X^- BN*;_R9&$S#D.)MDX:X3+9AH6%:)WA)^?+J/:?-37I#V=R<[=\^[[
M=1VR.Q]0V$K)-]*2.JYB\Y5$M5>YOV\!]:S'JR?O.1_87I9X>#S_$_1[<=;W
M] VE-0&CTT^P?2?3.\J@]_?&:XQ6%.-^!IQ!*K&V\@%U$["U,7I2OJ^#GG3+
M784]5L@\NZ8><S%^*/A)^?L=GDNV[E*8]YR_'/PI1QWN;!X\!8O=GL2(ER(^
MIQIT@W,*8YXO#_;O:<4>>/48-'PC4<ZY8#/6 DSAERY^^Y0KY4]C?M>CW+FN
M,^Z;GEQ04%E]#6!?>?_+,ZQJ'Y9[_:(''ZC59OQ=PM29-V+_L+P"BWB.2?*@
M&G>#=(?B:ULFW1]<#GFV)^0AZWZ\":*@@!.&S_@A>!'/A$]U*]@%G4.\Y=Q*
M:F]O]N1-.I4>O60SGM3B72$7*'>1<N?Y3G&Z4M>#GM[TN,OZ;_=$3:]*840B
MEIK,]3N8SX9EOV_Y=C!-<[%C6WWDU,WT%Z!O7&[/1^+3K*9+F9P&K:RZ2X-Q
M<5$V_=<8->2T@H+V^JIC;6XZO(]/8J#<OD7!S8=>E?5R'YFL,@B&<ES?@+"L
M'.@MID5/WO#]PG[!";Y*Z=D.7LR)Q^21\]R*O7:W-1%KG,P>-UU=.'$[5KO-
M+.Z'F95K;DZ7K'M&7*&Y(6S YG>O>9W.Y/U([.5;L)OCP=YZU;UGD';2EEZ;
MH\QQ!=&1G+#;?QLNL671K_R\O=;RRD$\W2+K\[:;.G02&4N_4]T>@V5^H62'
M*%2_*D3HE_MM>0@]%3(P%RK-G*5CLNDO,Z/C*H9[TH1VBFDBJPD;/#K^MAJ=
MRX.]%<D"?CC!7@CA]F)R!H1DI5/71[^4RX.([-;QLO'H!Y1$;7&VJ-GF6Z]#
M)$J1,HX120" I<0E8/T_D\)1NTESG@*.]U8D]#A#^4,;_2R:&7E7I%9''$Q9
MGAW'0B=M4:KZQ&Z13%G6FL10L6X^(.0J^8_*I6&FC'6D20_A_TK82YK#0(?
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M\$_\E0/N/];4[GFDO. ]==(W.#3H@M/YUJ342NFF,<= 62^'T<4JXJ-*I\:
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M:2:YI0\^]SY_<?8"4C4Y]+V]O_%J1*1RV^[(6J7?U_OG2[IL)M65'L<I%G2
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M<?KW%D'.XE27F_RF@-2V? %;F.1I*TL(!2F_4K#(5SLFNTT%;!%4J/90V-+
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MG25$Y\==8(,S)^*GS;4/JD^IOF<=VWA'MWDL;N?H/ BF5+F5519>ZQF.\C+
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M\.\%5NJ_*\ *\.\%5NJ_*\ *\.\%5NJ_*\ *\.\%$/S?_PM02P,$%     @
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M\ENIG_G+T^^U%.\6'Q]EI6W]XNZ6K\IOY:J4]2VK5Q7EJUE6%##.8@)PG$J
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M;)0J-'],)G?5GJ<VS1\@?]<M4,7:5],7:UT]-27[;?5^%[9 #+.$(:)?!^8
M46V6J& 09)P(&B>%?IQ31/<LI9&M3T^W;13A9F;.HV-G38+([&8T]L6]B;HN
M&>%C.Q=E"Z3\Y^E,JN,7Q3U4Y<LW^&GL[U\V3]Z$=[N/,DN0Q$5!M2>1,X $
M9X!PD8&<IGG"$TZQ<*HL/4]J9)W]_4NT^8[K#6DWW1W R4YYPTCOIKV[@F^I
MCJ"]EX4+I+X#A";5W\L"'RJPQ1W7)I_=<KV)7,]-<]:^@?5C)>_EHBZ_Z6T*
M7SY(TP7C<)8K(1+'3*NY8AB@0DA BC@!B90%*CA)<.QTV'(E/Q.FJ>WP%VTZ
MKV\YC%H6N]XOOMEJ?B_%SJ9,"+6;X?%&>:(6DE?!%3PESH^;9\J3NPJZ\\ES
MUSTVY$S83[)JAMAK7-JF8TV*\4[GL3/]7J5VAZ#VD@"A2IB<%0BHRE-0I+ @
M**&FY<_U0V$]N1O;JIXJ5MCF;=]$.VR?ZJWGVZ WZ NTM+G/]5H<+7"H-S*N
M11X#S%$GA?KR]@)&A5X)J]VLT&N)7-?XY/9'6<\HH;#(N 0QCPE 69H!AF ,
M1)[Q0I*\4-2I"?#NPT>VHSM]00PUSY8G#0IVULQ7-C=C9"V6=[.37?X#MSII
M'OTLC4YVA3K7YF3O&D_EJ>0C+<6;'T:)9=\'*V6*(#-])&.FB0F$"2 L1R"G
M<0[C&*642"<M.D5E;'5J:4:R)>H8\CF-BZ5>72NMHX)U@G;T1FC_-2A0*(T[
M26-:U1L2\T@'!R_VW).L]!;(>&AM3:-96I<+4]+8&'7$<%ID:0)R@I3I;\\!
MHXJ!0A'!4ZRU-'=2RD%J(RMG5\6\I>FUY@WC9>G2AT+!36F= 7!WKVT$"^4N
M#]*:UOVU$?O(G;6ZZ8JYG6U"2+^,Y*P@'&48D%0B@)0@@,:%7F,)S+26"XF+
MV'E@YQZ)D=6W#>7QEI93.M8 *G;Z>IVL;DK:BMD2&V%9/2]*R F<^P2F'[UY
M4L"3,S=/7^FI=4J57!IU;KIL=:=U"4X%HS$&6)E$!-.'FQ6YWB<2_4M&")6%
M4U/,DU3&UKV&9M,XIB'JJ'<G<;%4O6NE==2^5M -O1&.+@<E"J6$)VE,JX=#
M8AZIXN#%(8/MQ\T]?CEL[M&U\/A;TZCC=M&XVV;.U->E^=6;'[+B96V"27^7
MY=V]N>:;K.B=[/Y%?JJT+#.,N4JDZ;:A"@Q0+ I0)"P#J=[B%@1E4J1.:O^\
MXHQL7_K94^W0*=EQ&*V6D6F7$GWO.(MHRUJ(H/UD'\(U4?Z7^'K]CP4\NT]M
M^DNU,C;]2]_L?"+FUS?1CJ0W42]KU G;_ZN,&G''/D^8^K6->@ QF3 OX,1B
MZA=G=\0Q.5?>O:M7U9JOUE6YN#.=F34?IOEL]:T]("B0WH%"@4'!$S,]@J2@
M$ D!6:8WHI(6L1).Y]47Z(V\9.U1C[[JR[W"29= LUL] D+A9M[=4?#I&6TC
M6[CNT(/4INX#;2/ZB8[/5K=Y]E+Y1LNY,25OE]47.M_ITO!:LM7VIUFA-[=I
M4N2 2F'*M NM[S)-@"I01E)*,<[<>JI8$AY9\4WE5=O6TK%_BBUN=BH_!AIN
MNF_H[/51V; $U+("AJF S50<Q0W55,66[+3-51S!.&JRXGJ_;W$.%5+;GC;0
M=C2YOFWQ-"LP3W$<*P 1-6ELB .60 [T7](B(R+%=D763E1'MA$]V6A+U[5R
MQP8Z.TL1'! W,W$"BW&'3#C)&ZS*QX;FQ!4_#C <5_^XW.S1?N'=XMM2;SFZ
M/<Q763W4LQQ3RBED(,XS!)# VG50A0+:$*0H0ZGD=I/ESA$86>D[BIMNZRM#
MTZ%AP"E(AC4\A*!NRMS+V(=HO@:0T:$)PI6R^C4]<)/9K;_!@$"#_0Q.W3==
M_X(!KO?Z%0Q=YSM89G#>.\&)(*1 0#L-!* T98!B[5ID-),$QP7)$BL+8D=N
M['R5=L+*J3GQ5F/B?0 <MC?A87&S/M<BXC%ZQD;0*^;/##Y^XB$T-J(>3Z*Q
MNLLW3W3)I12UF7K[NC0G0>5^DUA9?Y"KC\JT'&C_78J93'BF$@Q!RA4&*&<Y
M*"!2@,%$,8C3/,\<TTC=F1C9,/0+D=YE1V++DFNRJ0>X=AN.L2%S,QH]-VWS
MEAU^=GL[-VU@Y<K\JFE9TK,5,I_5'Y1@Z:X>+$R<#>L/TG&R[!7/\NQM4.O'
MO]&$'NA*UC-$"R@*@H% *@6(*@E8S!@0&549$46!W#HC[3]^9".CB1EMV)!S
M[%ZPCX2=W?"7S\TB'(HVS>S+T]*%:E.P__!I6Q.<%.RH'<'IJWP'U=>KNCOF
M-'46,Q%#5<@X-MU^%$ 026!Z"0"69)S%F:)292XM80\)."F;>^/7K^:6B!NB
M37J#7_W($2IV:G>-K&Z*]VHCX)M+ GJ,BS\M1;#1\ >/GW@,_&GACD>^G[G.
M3\WZE?*6_^>ZK,LF%\'\M9)]SW^D<))!E(&,2!.HDQ 0I!* 64Z3/":24:<S
M_8L41U[U-K,^=ABXB7H6/"<G7(;13E&#@N.FN=?BXJS.UK(&TN_+]"95>&OQ
M#RV _8W/DU6[$QW8'XTW(VELBLH@4,),E&*DB=T5 &L[4N0Y@:QP:PLT%J<C
MFZ   UXW(UR76QEN#J>X3IM$>_Z]V]F^%_$VW6QFR-37C[LO\F"ZZLO)9KT(
M\@M)5#W/YS]5#NI%N$.GEUXFZ!GHI4_F5-EXKK><5VLZW_8])GG!XSA1($V$
M7A8PE8 2F0*.:2$EI)EP6Q8&:(T?MFTH-QN@GK9-QV-GS"S#M&&0<(S&^H+@
M'G"]+%ZHN.H I6G#IY=%/HJ26MSB&:.A]?W;^?+[!\V[_NN[9O*QZ<>S$&_+
M!5WPO7[0K\N:SY?UNI*;KQAR O,T52"1) ,(*@*8R!) 4IYSTS%2QMA%\Z]E
M:&R_;_WX.&^L,)U'B^4"-). O%O,7PV_9?!H0E =@TT&/L-:,WV^ 7/#76-]
M-OSM-J#?<CB*40H%5ZBHUK7L3!L%"P3>4=0LU'-]<UJ^/-#YO-^YSUB>I'F*
M,C-!P\34, $$0@HX0B2+DT)FJ6,2R][SI\E::4@Z#E0^!\BP)0H@IIMA<9/0
M(^?DI!Q7))GL/V_BK)*3PARGD9R^S".QU#1M-3-QM X?G/<VI[U?]5ZG-HOJ
M<M$$RV<4HY01++5O8=HS2,@!PX2!.$V*&#)$$FKE9?@0'UD5#3?M9*:>'_,3
MZT.YBS;?8;5EJCV!<DCG= 5[6)/'AM!-S5\>>@Z)LB.BZ)=$&QI-MS1;3S@&
M4W!=GSE=>JZGM'NIN[[/\*PI["H,NMUHOQF5XGU)63D_\+NV'92S#!8H80Q(
M3+6KE#$%:(H5R'"2%Y@KBJ%P*C'TXV-D.][Q</G0/"BV=ON_"1!S,]N;<J..
MHVV@22.XP]3>3F^4A)\KH0E5P>C)Q;0%C==!=53?>.7CW(Q87:VVS?Q^E<N[
MBC[>EYS.FP+^1 D>9U0"5604($&@V<U)4+ B%;E".6+<QD0-4AG9 .V2<^IR
M, S-L(4))K";_7"1U=HD6,DRI/#Z 3O*KG_:*OKPLR=18ROQ>B6UN]ACY_=:
M/E:2EXU?JHW^[<.R6I7_U?S8K9Q=Y[E8PCPG"0,,QMIK2#D#!8HY(#(6DDB8
M2665E^M$=605W66C7?)V&.D]!X>]B368%ENZ,2!R4VHK="[W^KL")H>]VQAP
M^6W: L'FME=S%7]PDV;]L.EV9Z[R[6W+G&^>.,OKO=XBOM.FO9Y)R054H@"4
MQ E 4":@H%S_F+(XSWB<<V[E]X1C:<*\K<OI/NPXW2?ZP[ :-;RZ-B6__GW9
M;?>F?0MN1O[J?"N[%S!=5M419L^=/K5EZ)\C3^H(P& )4<=/]C2T<CYO3QI_
MH]4_I#EUW/<;BIP6(L$4<(810)3'H."H  6D"N80\@Q1)S-Z@>#81I+VN3\/
M/?GH)^@ZZ_(2:):V+" 4CI:JI=S@L*$]@C_E*FDH^W*)W+36PU+X(]M@>Y]W
MR/L@(M7/)% H3;,BDUK1TQ2@&,> %@D"4C]'JWY.)73KFW>.TD1A:[]BMO/X
MQ"GBC H".$DS@'BF ($J!<WX<(:%8#AVJ?4+@X][T=]8^%@'[J^7VCDT?QB%
M'V'"Q47!P@76S]"9.G0^+.Z)X/B%&SP-VF)5BG*^7I7?=AH*OOG!YVLAA:G"
M-S[6N@U!?%1O:+70)K7^)*O&Q=);V;7^>%&>,\6@!!@)[>]D" .F( 0P53%2
M628+G#@9OQ!<C6TH=WB,Z@V3VC"T7+:=*_B63W-4+CM.HT=9M;5 T4]EWT+?
MT:$*\^HL[<[4+\311NV^BRU_T9N]=_%J_UWT3)H9M^WV\B9J&0UHUD+B%LH$
M!N%I6G,9$L8CTQKTX1Y'(*8W<5/<MU2\Z<M4F[Y,95UK@Z^6E5J;5 [3"+KD
MLIZ1A*@4000R0DRW-,Q D3,$L& BY@AI0VQ56N-.>F2#VK1H;I@QVLF[X2*&
MGZAEJ&F=U+(4]3PY1/W=8+8X(1D-/#?C][)P<S@R&0T_OW.3L#BZ'9]X03%X
MAN+VQ.D.4KPDW3M-\7N"=S/L13UOXXOB/];URGQ6;]>+)H>.SK\N/\M'<YBS
MN&O=<?[4)MK1'WIY*)?BW8)7DM;RM6S_G.&4)Q+E"L0"FMRWY@ [(T"F-!4"
M(<7=6F^$9G!L&[^L9'FWZ 9"\J<V=W3>G55N!'!NNQWV)=GYQ,\)O=L*L<-I
MM&4UVO)J!C)MN(UZ=C?-]33+-U'+=-1S'?W4\WU^V^+3!'P42,/U"P_+WM2M
MQ4<!]T07\G'H^%>TFO^;.85ZV9!-2_1Z595FTI+YAW;.RLXO=JZ<%5PE>9HE
M(%=2F.F?%- L20!$DI."89KI%>FQX?O+BE8K.ZM]%4\N=N*0,VN3T=1AFI..
MI@13;JG?1$S>E0NS!3*FH27@7N3J_T8X(IBI%((B3ID92!4#ED@&5$J5(HC$
M%)/NC;Q9B!?Y/GJ^0KP-J7_[+._!;I&<#%FW%=$0NFF;QK[917/+2M1>8D _
M^.7N'6%KC*\&*F"!L3\ODU<77PW;J=+BZQ]Z11(7NYS<P :'"1X,#/Q5W[UZ
M35?2[)W:!DY) BE7*08Q3W)M1CD'E.8%R*'>F="$$*IRYTRO\?D>>7_R]X.9
MM=&=X2 2FH5(;>(#-]&%/M//^F8M\RA>WOMR3,<(/J/VQ 3:1J#(2!193)#S
M2S*;[B6$S$2;@.OIT]6F>Q4G<]HF).^W.+UY>)POGZ3\TD;73B?B?5@N6O/8
M\%<W79)W_]V4GGY8KOZ/7'V6?'FW*/]+BEE*,I%@!0''VK5'2BC3-H@"E.84
M<R(X9T[I,Z-Q.O("U//=!YCW&D;N-I:\,=V&OG6SM1OV;_8;3YI*;'W-*GJ2
MJZC:\.^V9HWWPNU6J1?Q&OW7I<UZL]7CIJ]1]]ZZ9<CPIW_;OJDMB^%/HT='
M,] ",QZ?DRXIH\-]N(B,3]#C=+O93+U^]^K=PI3MBDW&$&*8B10DO&  ,96#
M0NG_H)3GF.$\I:E]-=])$B,;ZBZ"H*E&'=E+ZFH+C<7)\]4">T5+1I#5X;3X
M:IG]3H7=97<[^1T4:_"$]_2=TYWD#G*^=V([?*5GXF)=RU6?!+EI?X@EQ#3%
M!1"%B@&2I  ,2PXHRR!EVN:(S*GO[$DJ8UN6EEI$&]J.#21/PV+G;%TMK)M5
M:<EM<HE'Z=PX*%*H?+J3-*;-CQL2\RC?;?!B_T.VWQ?EGFU/N"(%I 5 "3&#
MM+  !5$%R I"2(80S=UJ24_0F&2-7_<T(^JPZ TA8W]T<H6\/DO\AESPK<>
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M@"D7 &7"I **'.2TB!%+)4XE>1E%0*?8']N8[HP'N5S-P:ZHYM@(I_^Z-AM
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M29&P7 F/C<@ R6EV)#T#D6PY<+,30XC9V89K ?"R!QNA.ZHWT2[=< ; 0KA
M2C]$:5)%MQ#Y4+EM;@G<:_K46L:*E$I)]8Z#20R0UFE04**= 9CGC/.,,N64
MZN1"?/1-QTX?ZLM]X*_'TG9S,0Y"KON+@>;4XSL)/B",W;OZV=T%'U"L^UJ'
M=QR.!C5^U<]YO7R@Y6)&$YS10L1 929% 2KM.*2Y AC%,B&8,.76T'Z UMC)
M64?S02-#._JCI>[89' (,SOS$0@)-VOA#<+U8U*/Q1MK2NH.I><=DGHL\L49
MJ2=N\78>N)2B?JO9-#7J']67^V6UTC[VP[MF&'.S"YG1G#$%E03:1>  Y:D
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MF<]6K'!#]RY2G'J>GBT$)T;E6=]ZG=)K*R++;X;(![GJZ,P(5+& A5;T# J
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M\'ZYN#/G\V8DR8PIE<1(,< DU'9<D100" N $Y4D4/^/9T[=SW<?/K()-J3
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MP67?GKC2;+B>F+J :7LZ.A)$KB>A;+73O_TFVG1Q;N= ;)B)/ET^;O8X\O0
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M)R6*">=)P>.<:N?Q%.=)C*Q0>Z)12]5]8L4%2+JU*HR@P)N8YS(&GF;1+<^
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MRC)3<LHA<*Z,CVS/VQ9Z:\OJNNZP45?";I:1+7Z==I*5\[MTM.6O\ T!C7W
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MX?+A"BXQ=%Q^MJ9CY+HB;VI2+C_S>WBY/#^8DKVS/6K-B2ER+BE@O"@!EIP
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M;NE#01B[\.!4[/.H/K@ AG<)PJ7/Q_F2=W,NYHN:(N/EX[IN%E$B!2%!%;!
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MMQ#RJU:/"WUO7MMI[)K4:AL(K+[I!_['1[[5'[6S:;Z8US(?'(7//KG(E(K
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M_]C6D6,#=<X )X8X:D %N-("&,)R^W\&8^$56_0-/K*W:=/JG;RL$1A:/7"
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MC#Q'=VGP>[E9(S@\X_\,G^%IFLKJL"D:87!4YO\EBVY*_C\;=/+\_TMF]94
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MKI=Q0S_K:ID#VV^ME3D<ZI)+/WS)[^Q/__XOW6_L?QS+Q+__R_\!4$L#!!0
M   ( &: K5K )<^L*9L  '9%!P 5    :7IE82TR,#(U,#,S,5]P<F4N>&UL
MY+U9=UM)DB;XWK\B)N=U+,/WI4Y5]5%(H2J=C@QI0HJJ[GG!\<5<0B<(J !0
M(>6O'W-P)P$2BU]>5_3)# JBR'O-S3XW-S.WY9__^]>SV0]?<+F:+N;_\A?^
M5_:7'W">%GDZ__@O?_G]PVMP?_GO__K?_ML__U\ __.GWW[YX=4BG9_A?/W#
MRR6&->8?_IBN/_VP_H0__.=B^??IE_##NUE8E\7R#.!?-[_V<O'YVW+Z\=/Z
M!\&$OOJQJW]=_E,,V?&4%7BI,B@I&7@,$J11C"=O0T3S_WS\)^VLB[PD*"XE
M4$Y&<&@D6.N595$:YM7FH;/I_.__5+_$L,(?:'GSU>:O__*73^OUYW_Z\<<_
M_OCCKU_C<O;7Q?+CCX(Q^>/53__E\L>_/OCY/^3FI[GW_L?-OU[_Z&JZ[0?I
ML?S'__FW7]ZG3W@68#I?K<,\U1>LIO^TVGSSET4*ZPW7GZ3KAYT_4?\&5S\&
M]5O !4C^UZ^K_)=__6\__'#!CN5BAK]A^:'^^?MO;^Z\<OH/#']-B[,?ZS_^
M^')!8" R-[^V_O89_^4OJ^G9YQE>?>_3$LN__*7^$E1Y,GGQLO_[XA=_O'GG
MYR6N""B;-?Y"W[C\_?J6P]Z/7]<XSWBQGJNGSQ;IS@_-*C<7U[\Y(]3,-M^=
M9)Q.-D]]$5?K94CKB=+*!\XU%%8**)TCA$S88^A5M#P5^M>[RZWDKHC>#?-7
MF/[Z<?'E1WHP"4&H^J'R0FWX\.!U%SPYCNZKW?:!?G:2?(I6,PTY(>V C IB
MS @E"H$8,EJG3R+[]MON4GU;EB^6Z8?%,N.2U,75Z\(R/9#K7:!>_L2/G\.2
M'@3ITW26KWZ[+!=G+62U7C3@W(58B-R__$"K+KA<8O[E0BH[%[=9V9J4*&Y^
M\A2)OSQ?5@:]GJY2F/TO#,N?Y_D5*=I)DD8Z*QRMH3!0B4OPQ01@)7-3K',Y
MYM- N^/->R%!](N$)AP=&177:%Z&^6I:>?\;?EXLUY/HHW2H"-2%(2CDA.S@
M EB-1J 6GCC31B?<>_->J)#]HJ()1T=&Q<_S]73][?5TAK^>GT5<3EBV/FIA
MH7!/B&:$;:<=F4R>ER"U*B&==D+<?^->*%#]HN D#G8A_=_PX[0R8;[^-9SA
MA$D1!4<-GHQE4,HAA*@-6)&4L%D8)D[3!]O>NA<*=.\H.(&372#A#;EM2U)A
M&\:_)_[CR\7Y?+W\]G*1:3FT#&=BA%QT=9\*\4:D ,4FG7(,/K(6JN%1(O;"
MB>D=)^WXW 5L/H2O;S*Q;UJF%_[HE2:T/(:B!'C%JG6D"@3,'!!-I$-0HA>B
M 6!VO'XOJ-C>H=*"MUV Y$7.)(+5Y1_DS2.?Y*B<5]E")GI!!3HJ/7<9C):>
M&V;I?ZH!0+:\>B]PN-[!<2I/.P6&F 2IDK6(('7(U:]"PKD.X)1QVF@54XF#
M $/L!0S__0'C,)[V!(R7]/'M\L/BC_G$*24+6H02@@'%303GD$%@B:!=N%92
MMH/%S8OWBV2Q[P051S*T)TQL;*:WRW?+Q9?I/.&$.YY$U!%D%)*P'0.$4 )P
M69QP"E&6T X8]]Z^'SHZ#G0V8VU/$'FW6*W#[/^;?M[8U#Y+Y4G/ <^9E)\S
M'GQP#E16P>5(AE1H:&G<>?=^\.@X^MF(K6-'Q>L:EA@V=&>6DI+>0W&%C"1F
M$CBA.!BRGNB,U,;ST^R+VV_;#P =!SJ/9MW((J_7H[-WGQ;SJ]"<,2&P6,.Q
M0M%QAS9#M)H^L>1*$L:D?)K]</^-^XF^X^CF22P<6?SO,9TO";I<Q _3]0PG
MR+/)(D00!2.0V5O <<\A1^^%1FY%3">)__X;]Q-_QV'-DU@XLO@_+$--07G_
M[2PN9A.=+ \Y&<B,U?,I9O)^H@(ZHE@1G'NEV$FRO_.Z_03?<9SR>.9ULNE_
M_IH^A?E'W 3BHS&%B:P@"&F)?J_(Z\T!8O+)"\E=\J==:6Q[ZWX8Z#@ >3(K
MNW 'ZLW<\B7Y-!\7RV\3HV-!(70]M(A\B0:\"QF0699TP>RT/0D)6UZZ'Q"Z
M#S8>S\@N</#^+,QF/YVOIG/R8B:>(!R9E9#(7JWD._!11F"%\2!M=K:4!CBX
M\]+]<-!];/%X1G:!@Y_/</F1CK9_6R[^6']ZN3C['.;?)C;S$J.IM[1)DUTC
M$W@4"$;Q)+.++)C34J,>>?E^V5'=1Q=/9VP7^"#"S^JE["+]_?TG8N#J[?FZ
M9MY6<VC"6,I<R RYAL^580Q\T 5J$$RFB"A/S*![FH;]T-)]M+$9F_L #7%N
M&69OYAF__@_\-E'"9^F9!U>4!!4% R?(:=9,\\A=R1Q;'"_W7KL?-+J/-)["
MS$Z2+&\R15_3=U83B^0Y11] ,EF#9@G!VV@!K8Y:&>,(V4UR+.^]>#]$=!QZ
M;,'0KC#Q#I?31;Y8A,)0O"16,"3S6=7$X5#OZZ5!U,24G)AIB(I;K]X/%QW'
M)=LP=61DO* 5Y,TJ9N'CQ!6>4N3D0B7Z0H>> E_![4V**60LI>!):+CSNOT0
MT'%H\GCF]6$Q7)047&2,UT@;,9_06R1ZC$1]D9ST6@QTUBE50#J9M;&>"=,B
MQW+[V_?#1,=1RV:L[>3(N-!K5\4FV?IL)6<0G7*DV;B$*&LZ,>.&6V^E%;[)
M<7'GM?N!HN,PYNG,[$)AO)G3TX@/TR]("PB7()]P+6P)Q@!Z$4#YG,"Y[  #
M64A6TWDG6V3K;W_[?MCH/K+9@+6=*(S_]SPLZ8FS;Y>52+R8A-EQ*+Y6(*3J
M1$G!P=HL98P\27W:C>>.%^\'C(Y#G2T8VH7:>/\)9[.;8)Q4RMH )GH!BKL$
MOM888"XRTW^.S.464>];[]ROR*_[X.;1;&P&@G_^\0$'?Z%O'%>@/U\M9M-<
MFR_\%&:UJP"M#]>KNT3O6[2_ZV$-"OGWHO/$XO[S%7P,X?-DD_A8]_S;\GHZ
MIY=-R;%<7!1V7J,H^^A)O J,C!(4"R1ZH\C9Y!*M9F1@FL?N#TM8Q8V<+U]Z
ML8UPMEY=?>=F/QU"U[%ZXNH=+U8K8NOEP7>]6)<+ZN0*'8#.T@&HL ;>.'@9
M/$LA<8&/U>\<L]BMA(S32& P7%QIEW;,'_&DN5K$R[#Z]&*>ZQ\__]?Y]$N8
MT6)6+]8OPW+YC9RP_PBS<YPH-$4)*8&99&A17M)ZD(&6R1EO<S*/5H0=@ZB]
M"!L780T L!A:&CU ;#'?<.8_I^M/+\]7Z\49'>^5=;_B>L)\T([L<DAIDY<2
MR;N7](EIEU/V6F%Y++_K*&0]0L\X'2\&!%0KWG> HW=+_!RF^>>OGW&^PBMO
M+W-M7>W2@%A3V:50$ Q]H4]>>N=X+JXQ@+82,DY7C.&0<SJW.X#,^T_D_'W
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M_PW7GQ9YXAF9WTX5<A"=!&6*I*TJ'*04K,A!Z?9#7?:A:_3:]V?#97,I]0/
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M1@Z.E/^^\#I<&!U Z];MYFU539]GN!'879V]<_&3H$OQD25@SKK:\XB!3\F
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MF?QIDQ5(C]HGKXMIWFWQS'&FA54#83^(8+3A?+\@VM:N<9-XCLF!RTC$.&/
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M!YL2DJJQ(M^?BOF$W3#HLSOAV)X9CD>63B_/0#?]A%;GH)-#*$QJLNF%J9E
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MD^UR&@*W;V[_PX7024L6R3/T/H*JD_"#$P(*,\J*;%T._F0NXS>\9[3/NW@
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M0"X2EN1<E-QHW8V'\#09)]I:W^\;<"A4SN?2W%D7?<L)Q;VQM1N+N6) E2C
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MM+!=GSS =(]/(\$N6G-Y8JC\L5A>?7A%?A\=?ZL:A2JXGI0N:F>7TD*#<SI
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MN'*M07:(RS=:"F\L1+7@^_AOX/8?ZB\QK/#__*__#U!+ 0(4 Q0    ( &:
MK5JC1^LNK0<  !TL   6              "  0    !E>&AI8FET,S$Q,C R
M-3 S,S$N:'1M4$L! A0#%     @ 9H"M6I+]W5VP!P  FRP  !8
M     ( !X0<  &5X:&EB:70S,3(R,#(U,#,S,2YH=&U02P$"% ,4    " !F
M@*U:>?X\LX0$  #!%   %@              @ '%#P  97AH:6)I=#,R,3(P
M,C4P,S,Q+FAT;5!+ 0(4 Q0    ( &: K5H3@I5SEP0  &T5   6
M      "  7T4  !E>&AI8FET,S(R,C R-3 S,S$N:'1M4$L! A0#%     @
M9H"M6@S"'G6)-@$ G9L/ !$              ( !2!D  &EZ96$M,C R-3 S
M,S$N:'1M4$L! A0#%     @ 9H"M6NI Z;9U$P  5-\  !$
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M2P$"% ,4    " !F@*U:F;!>&='@  "\\@@ %0              @ ':>PD
M:7IE82TR,#(U,#,S,5]L86(N>&UL4$L! A0#%     @ 9H"M6L ESZPIFP
M=D4' !4              ( !WEP* &EZ96$M,C R-3 S,S%?<')E+GAM;%!+
4!08     "P + -P"   Z^ H    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>izea-20250331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:izea="http://www.izea.com/20250331"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="izea-20250331.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2025-05-08</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">izea:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">izea:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">izea:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">izea:HoozuHoldingPTYLtd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2023-12-01</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">izea:HoozuHoldingPTYLtd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">us-gaap:SegmentDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">izea:DepreciationandAmortizationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">izea:DepreciationandAmortizationExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">izea:DigitalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">izea:DigitalAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2024-06-28</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2024-09-06</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ActiveRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ActiveRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ExpiredAndActiveRepurchaseProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">izea:ExpiredAndActiveRepurchaseProgramsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <startDate>2024-12-12</startDate>
            <endDate>2024-12-12</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2024-12-11</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <instant>2024-12-12</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TheAmendedandRestatedMay2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:IndependentDirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:NonExecutiveEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:NonExecutiveEmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">izea:EmployeesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="izea:StockOwnershipPlanAxis">izea:IndividualStockOwnershipInExcessOf10PercentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="izea:VestingFrequencyAxis">izea:TotalvestingperiodMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="izea:VestingFrequencyAxis">izea:TwelveMonthsAfterGrantDateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:May2011AndAugust2011EquityIncentivePlansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="izea:VestingFrequencyAxis">izea:MonthlyInEqualInstallmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:EquityIncentive2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">izea:HoozuHoldingsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-30</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:TimeBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedRSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">izea:InducementGrantRelatedRSUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:PerformanceBasedAndTimeBasedRSUAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:A2014EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:A2014EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">izea:A2014EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
        </entity>
        <period>
            <startDate>2024-05-28</startDate>
            <endDate>2024-05-28</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:CurrencyTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:CurrencyTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">izea:UnrealizedGainLossOnSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ManagedServicesRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ManagedServicesRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SaaSServicesSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SaaSServicesSegmentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SponsoredSocialRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:SponsoredSocialRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ContentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:ContentRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:MarketplaceSpendFeesnetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:MarketplaceSpendFeesnetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:OtherFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">izea:OtherFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:NorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">izea:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001495231</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">izea:OtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="director">
        <measure>izea:director</measure>
    </unit>
    <unit id="h">
        <measure>utr:H</measure>
    </unit>
    <unit id="reportable_operating_segment">
        <measure>izea:Reportable_Operating_Segment</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-27">0001495231</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-28">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="c-1" id="f-29">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-30">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-31">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-32">false</dei:AmendmentFlag>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="0" id="f-33" unitRef="shares">16926102</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-100"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-101"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="4"
      id="f-102"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-103" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-104" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="0" id="f-105" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-106" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-107" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-108" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-109" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="0" id="f-110" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="0" id="f-111" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="0" id="f-112" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-113"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-114"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="4"
      id="f-115"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-116" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-117" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="0" id="f-118" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-119" unitRef="shares">17661220</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-120" unitRef="shares">17518018</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-121" unitRef="shares">16893885</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-122" unitRef="shares">16931169</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="INF" id="f-123" unitRef="shares">767335</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-124" unitRef="shares">586849</us-gaap:TreasuryStockCommonShares>
    <izea:HoldingPeriodOfMarketableSecurities contextRef="c-1" id="f-398">P1Y</izea:HoldingPeriodOfMarketableSecurities>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-37703</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">IZEA WORLDWIDE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">37-1530765</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">1317 Edgewater Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10"># 1880</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Orlando</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">32804</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">(407)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">674-6911</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">IZEA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-20">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-21">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-22">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-23">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-24">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-25">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="0" id="f-26" unitRef="shares">16926102</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="0" id="f-34" unitRef="usd">50612348</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="0" id="f-35" unitRef="usd">44644468</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-3" decimals="1" id="f-36" unitRef="usd">4269114</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-4" decimals="0" id="f-37" unitRef="usd">7781824</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-3" decimals="0" id="f-38" unitRef="usd">697635</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-4" decimals="0" id="f-39" unitRef="usd">1079045</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:ShortTermInvestments contextRef="c-3" decimals="0" id="f-40" unitRef="usd">1572233</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-4" decimals="0" id="f-41" unitRef="usd">6427488</us-gaap:ShortTermInvestments>
    <us-gaap:OtherAssetsCurrent contextRef="c-3" decimals="0" id="f-42" unitRef="usd">10511</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-4" decimals="0" id="f-43" unitRef="usd">97215</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="0" id="f-44" unitRef="usd">57161841</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="0" id="f-45" unitRef="usd">60030040</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="0" id="f-46" unitRef="usd">80619</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="0" id="f-47" unitRef="usd">103574</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="c-3" decimals="0" id="f-48" unitRef="usd">2098571</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="c-4" decimals="0" id="f-49" unitRef="usd">2086660</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:Assets contextRef="c-3" decimals="0" id="f-50" unitRef="usd">59341031</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="0" id="f-51" unitRef="usd">62220274</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="c-3" decimals="0" id="f-52" unitRef="usd">892636</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="c-4" decimals="0" id="f-53" unitRef="usd">1511747</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="0" id="f-54" unitRef="usd">3081263</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="0" id="f-55" unitRef="usd">3734123</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="0" id="f-56" unitRef="usd">7095245</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="0" id="f-57" unitRef="usd">8188651</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="0" id="f-58" unitRef="usd">11069144</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="0" id="f-59" unitRef="usd">13434521</us-gaap:LiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-3" decimals="0" id="f-60" unitRef="usd">0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="0" id="f-61" unitRef="usd">4034</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="0" id="f-62" unitRef="usd">11069144</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="0" id="f-63" unitRef="usd">13438555</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-64" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-65" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-66"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-67"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-68" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-69" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-70" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-71" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-72" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-73" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="0" id="f-74" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="0" id="f-75" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-76"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-77"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-78" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-79" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-80" unitRef="shares">17661220</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-81" unitRef="shares">17518018</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-82" unitRef="shares">16893885</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-83" unitRef="shares">16931169</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="0" id="f-84" unitRef="usd">1766</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="0" id="f-85" unitRef="usd">1752</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="INF" id="f-86" unitRef="shares">767335</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-87" unitRef="shares">586849</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="c-3" decimals="0" id="f-88" unitRef="usd">2065873</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="c-4" decimals="0" id="f-89" unitRef="usd">1622065</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="0" id="f-90" unitRef="usd">154793924</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="0" id="f-91" unitRef="usd">154593800</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="0" id="f-92" unitRef="usd">-104439855</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="0" id="f-93" unitRef="usd">-104297055</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="0" id="f-94" unitRef="usd">-18075</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="0" id="f-95" unitRef="usd">105287</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="0" id="f-96" unitRef="usd">48271887</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="0" id="f-97" unitRef="usd">48781719</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="0" id="f-98" unitRef="usd">59341031</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="0" id="f-99" unitRef="usd">62220274</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="0" id="f-125" unitRef="usd">7968363</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="0" id="f-126" unitRef="usd">6952883</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="0" id="f-127" unitRef="usd">4401574</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-5" decimals="0" id="f-128" unitRef="usd">3967975</us-gaap:CostOfRevenue>
    <us-gaap:SellingAndMarketingExpense contextRef="c-1" decimals="0" id="f-129" unitRef="usd">1121782</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-5" decimals="0" id="f-130" unitRef="usd">3056291</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="0" id="f-131" unitRef="usd">2940507</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="0" id="f-132" unitRef="usd">3783086</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="0" id="f-133" unitRef="usd">160352</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-6" decimals="0" id="f-134" unitRef="usd">160352</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-5" decimals="0" id="f-135" unitRef="usd">204186</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="0" id="f-136" unitRef="usd">204186</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="0" id="f-137" unitRef="usd">8624215</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="0" id="f-138" unitRef="usd">11011538</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="0" id="f-139" unitRef="usd">-655852</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="0" id="f-140" unitRef="usd">-4058655</us-gaap:OperatingIncomeLoss>
    <izea:ChangeInTheFairValueOfDigitalAssets contextRef="c-1" decimals="0" id="f-141" unitRef="usd">0</izea:ChangeInTheFairValueOfDigitalAssets>
    <izea:ChangeInTheFairValueOfDigitalAssets contextRef="c-5" decimals="0" id="f-142" unitRef="usd">106159</izea:ChangeInTheFairValueOfDigitalAssets>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="0" id="f-143" unitRef="usd">1654</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="0" id="f-144" unitRef="usd">2001</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="0" id="f-145" unitRef="usd">514706</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="0" id="f-146" unitRef="usd">669865</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="0" id="f-147" unitRef="usd">513052</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="0" id="f-148" unitRef="usd">774023</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossAttributableToParent contextRef="c-1" decimals="0" id="f-149" unitRef="usd">-142800</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeLossAttributableToParent contextRef="c-5" decimals="0" id="f-150" unitRef="usd">-3284632</us-gaap:IncomeLossAttributableToParent>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-151" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="0" id="f-152" unitRef="usd">-18782</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="0" id="f-153" unitRef="usd">-142800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="0" id="f-154" unitRef="usd">-3265850</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-155" unitRef="shares">16927166</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-156" unitRef="shares">16927166</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-157" unitRef="shares">16333415</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-158" unitRef="shares">16333415</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-159"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-160"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-161"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-162"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="0" id="f-163" unitRef="usd">-142800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="0" id="f-164" unitRef="usd">-3265850</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-1" decimals="0" id="f-165" unitRef="usd">-13903</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-5" decimals="0" id="f-166" unitRef="usd">58177</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax contextRef="c-1" decimals="0" id="f-167" unitRef="usd">-109459</us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax contextRef="c-5" decimals="0" id="f-168" unitRef="usd">4170</us-gaap:ForeignCurrencyTransactionGainLossUnrealizedAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="0" id="f-169" unitRef="usd">-123362</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="0" id="f-170" unitRef="usd">62347</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="0" id="f-171" unitRef="usd">-266162</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="0" id="f-172" unitRef="usd">-3203503</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="0" id="f-173" unitRef="shares">16602155</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="0" id="f-174" unitRef="usd">1660</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="0" id="f-175" unitRef="usd">152027110</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="0" id="f-176" unitRef="usd">-1019997</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="0" id="f-177" unitRef="usd">-85444794</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="0" id="f-178" unitRef="usd">-250591</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="0" id="f-179" unitRef="usd">65313388</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="c-14" decimals="0" id="f-180" unitRef="shares">32470</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-14" decimals="0" id="f-181" unitRef="usd">3</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-15" decimals="0" id="f-182" unitRef="usd">75003</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-5" decimals="0" id="f-183" unitRef="usd">75006</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-14" decimals="0" id="f-184" unitRef="shares">50021</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-14" decimals="0" id="f-185" unitRef="usd">5</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-15" decimals="0" id="f-186" unitRef="usd">354184</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-5" decimals="0" id="f-187" unitRef="usd">354189</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-14" decimals="0" id="f-188" unitRef="shares">18133</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-14" decimals="0" id="f-189" unitRef="usd">1</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-15" decimals="0" id="f-190" unitRef="usd">37232</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-5" decimals="0" id="f-191" unitRef="usd">37233</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="c-16" decimals="0" id="f-192" unitRef="usd">4170</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="c-5" decimals="0" id="f-193" unitRef="usd">4170</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-16" decimals="0" id="f-194" unitRef="usd">58177</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-5" decimals="0" id="f-195" unitRef="usd">58177</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-17" decimals="0" id="f-196" unitRef="usd">-3265850</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="0" id="f-197" unitRef="usd">-3265850</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-18" decimals="0" id="f-198" unitRef="shares">16666513</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="0" id="f-199" unitRef="usd">1667</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="0" id="f-200" unitRef="usd">152419065</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="0" id="f-201" unitRef="usd">-1019997</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="0" id="f-202" unitRef="usd">-88710644</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="0" id="f-203" unitRef="usd">-188244</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="0" id="f-204" unitRef="usd">62501847</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-24" decimals="0" id="f-205" unitRef="shares">17518018</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="0" id="f-206" unitRef="usd">1752</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="0" id="f-207" unitRef="usd">154593800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="0" id="f-208" unitRef="usd">-1622065</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="0" id="f-209" unitRef="usd">-104297055</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="0" id="f-210" unitRef="usd">105287</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="0" id="f-211" unitRef="usd">48781719</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="c-29" decimals="0" id="f-212" unitRef="shares">42858</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-29" decimals="0" id="f-213" unitRef="usd">4</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-30" decimals="0" id="f-214" unitRef="usd">89998</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-1" decimals="0" id="f-215" unitRef="usd">90002</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation contextRef="c-29" decimals="0" id="f-216" unitRef="shares">156474</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-29" decimals="0" id="f-217" unitRef="usd">16</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-30" decimals="0" id="f-218" unitRef="usd">285116</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation contextRef="c-1" decimals="0" id="f-219" unitRef="usd">285132</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-29" decimals="0" id="f-220" unitRef="shares">56130</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-29" decimals="0" id="f-221" unitRef="usd">6</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-30" decimals="0" id="f-222" unitRef="usd">174990</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="0" id="f-223" unitRef="usd">174996</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-31" decimals="0" id="f-224" unitRef="usd">443808</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="0" id="f-225" unitRef="usd">443808</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="c-32" decimals="0" id="f-226" unitRef="usd">-109459</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax contextRef="c-1" decimals="0" id="f-227" unitRef="usd">-109459</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-32" decimals="0" id="f-228" unitRef="usd">-13903</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-1" decimals="0" id="f-229" unitRef="usd">-13903</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="0" id="f-230" unitRef="usd">-142800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="0" id="f-231" unitRef="usd">-142800</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-34" decimals="0" id="f-232" unitRef="shares">17661220</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="0" id="f-233" unitRef="usd">1766</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="0" id="f-234" unitRef="usd">154793924</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="0" id="f-235" unitRef="usd">-2065873</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="0" id="f-236" unitRef="usd">-104439855</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="0" id="f-237" unitRef="usd">-18075</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="0" id="f-238" unitRef="usd">48271887</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="0" id="f-239" unitRef="usd">-142800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="0" id="f-240" unitRef="usd">-3265850</us-gaap:NetIncomeLoss>
    <izea:AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets contextRef="c-1" decimals="0" id="f-241" unitRef="usd">0</izea:AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets>
    <izea:AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets contextRef="c-5" decimals="0" id="f-242" unitRef="usd">106159</izea:AdjustmentToFairMarketValueOfIndefiniteLivedIntangibleAssets>
    <us-gaap:Depreciation contextRef="c-1" decimals="0" id="f-243" unitRef="usd">22955</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="0" id="f-244" unitRef="usd">26557</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization contextRef="c-1" decimals="0" id="f-245" unitRef="usd">137397</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="c-5" decimals="0" id="f-246" unitRef="usd">177629</us-gaap:AdjustmentForAmortization>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems contextRef="c-1" decimals="0" id="f-247" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems contextRef="c-5" decimals="0" id="f-248" unitRef="usd">-18782</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsDiscontinuedOperationsExtraordinaryItems>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-1" decimals="0" id="f-249" unitRef="usd">285132</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-5" decimals="0" id="f-250" unitRef="usd">354189</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-7" decimals="0" id="f-251" unitRef="usd">354189</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-1" decimals="0" id="f-252" unitRef="usd">90002</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-5" decimals="0" id="f-253" unitRef="usd">75006</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="0" id="f-254" unitRef="usd">-3512710</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-5" decimals="0" id="f-255" unitRef="usd">-213681</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="0" id="f-256" unitRef="usd">-468112</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-5" decimals="0" id="f-257" unitRef="usd">243987</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="0" id="f-258" unitRef="usd">-619111</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-5" decimals="0" id="f-259" unitRef="usd">-347852</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-1" decimals="0" id="f-260" unitRef="usd">-652859</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities contextRef="c-5" decimals="0" id="f-261" unitRef="usd">-148183</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="0" id="f-262" unitRef="usd">-1093406</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-5" decimals="0" id="f-263" unitRef="usd">-58121</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="0" id="f-264" unitRef="usd">2008132</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-5" decimals="0" id="f-265" unitRef="usd">-3341872</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments contextRef="c-1" decimals="0" id="f-266" unitRef="usd">4869158</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments contextRef="c-5" decimals="0" id="f-267" unitRef="usd">5059647</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="0" id="f-268" unitRef="usd">4034</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-5" decimals="0" id="f-269" unitRef="usd">14846</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToDevelopSoftware contextRef="c-1" decimals="0" id="f-270" unitRef="usd">149307</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware contextRef="c-5" decimals="0" id="f-271" unitRef="usd">73678</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="0" id="f-272" unitRef="usd">4715817</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-5" decimals="0" id="f-273" unitRef="usd">4971123</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForRepurchaseOfEquity contextRef="c-1" decimals="0" id="f-274" unitRef="usd">443808</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsForRepurchaseOfEquity contextRef="c-5" decimals="0" id="f-275" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfEquity>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="0" id="f-276" unitRef="usd">174996</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-5" decimals="0" id="f-277" unitRef="usd">37233</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="0" id="f-278" unitRef="usd">-618804</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-5" decimals="0" id="f-279" unitRef="usd">-37233</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="0" id="f-280" unitRef="usd">-137265</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="0" id="f-281" unitRef="usd">-3414</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="0" id="f-282" unitRef="usd">5967880</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-5" decimals="0" id="f-283" unitRef="usd">1592018</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="0" id="f-284" unitRef="usd">44644468</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-13" decimals="0" id="f-285" unitRef="usd">37446728</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="0" id="f-286" unitRef="usd">50612348</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-23" decimals="0" id="f-287" unitRef="usd">39035332</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="0" id="f-288" unitRef="usd">1654</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-5" decimals="0" id="f-289" unitRef="usd">2001</us-gaap:InterestPaidNet>
    <us-gaap:StockIssued1 contextRef="c-1" decimals="0" id="f-290" unitRef="usd">90002</us-gaap:StockIssued1>
    <us-gaap:StockIssued1 contextRef="c-5" decimals="0" id="f-291" unitRef="usd">75006</us-gaap:StockIssued1>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-292">COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Corporate Information and Nature of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IZEA Worldwide, Inc. (together with its wholly-owned subsidiaries, &#x201c;IZEA&#x201d; or the &#x201c;Company&#x201d;) is a Nevada corporation founded in February 2006 under the name PayPerPost, Inc. and became a public company in May 2011. In March 2016, the Company formed IZEA Canada, Inc., a wholly-owned subsidiary incorporated in Ontario, Canada. In December 2023, IZEA purchased all of Hoozu Holdings' outstanding shares of capital stock, which it subsequently divested in December 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company helps power the creator economy by enabling individuals to monetize their content, creativity, and influence through global brands and marketers. IZEA compensates these creators for producing unique content, such as long and short-form text, videos, photos, status updates, and illustrations for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#x201c;Managed Services&#x201d;). While the majority of the marketers engage the Company to perform the Managed Services on their behalf, marketers may also access IZEA&#x2019;s marketplaces to engage creators for influencer marketing campaigns or to produce custom content on a self-service basis by licensing the Company&#x2019;s technology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated balance sheet as of March&#160;31, 2025, the consolidated statements of operations for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of comprehensive loss for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of stockholders' equity for the three months ended March&#160;31, 2025 and 2024, and the consolidated statements of cash flows for the three months ended March&#160;31, 2025 and 2024 are unaudited but include all adjustments that are, in the opinion of management, necessary for a fair presentation of its financial position at such dates and its results of operations and cash flows for the periods then ended in conformity with generally accepted accounting principles in the United States ("GAAP"). The consolidated balance sheet as of December&#160;31, 2024 has been derived from the audited consolidated financial statements at that date but, in accordance with the rules and regulations of the SEC, does not include all of the information and notes required by GAAP for complete financial statements. Operating results for the three months ended March&#160;31, 2025 are not necessarily indicative of results that may be expected for the entire fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December&#160;31, 2024, included in the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of IZEA Worldwide, Inc. and its wholly-owned subsidiaries subsequent to the subsidiaries&#x2019; acquisition, merger, or formation dates, as applicable. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less from the date of purchase to be cash equivalents. Deposits made to Company bank accounts are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to a maximum amount of $250,000. The Canada Deposit Insurance Corporation (&#x201c;CDIC&#x201d;) insures deposits made to the Company&#x2019;s bank accounts in Canada up to CAD 100,000. Deposit balances exceeding the various limits were approximately $50.0 million and $44.2 million as of March&#160;31, 2025 and December&#160;31, 2024, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Accounts Receivable and Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts receivable balance consists of trade receivables, contract assets, and a reserve for doubtful accounts. Trade receivables are customer obligations due under normal trade terms. Contract assets represent amounts owed for work performed but not yet billed. The Company had net trade receivables of $4.3 million, including $4.2 million of accounts &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;receivable and contract assets of $61,480 on March&#160;31, 2025. The Company had net trade receivables of $7.8 million, including $7.6 million of accounts receivable and contract assets of $0.2 million on December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer&#x2019;s financial condition, credit history, and current economic conditions. We will continue to monitor these factors and adjust our credit and collection policies as necessary to address evolving market conditions and potential risks to financial performance. An account is deemed delinquent when the customer has not paid an amount due by its associated due date. If a portion of the account balance is deemed uncollectible, the Company will either write off the amount owed or provide a reserve based on its best estimate of the uncollectible portion of the account. We assess collectability risk both generally and by specific aged invoices. Our loss history informs a general reserve percentage, which we apply to all invoices less than 90 days from the invoice due date, currently 1% of the outstanding balance. The general reserve, which we update periodically, recognizes that some invoices will likely become a collection risk. When an invoice ages 90 past its due date, we consider each invoice to determine a reserve for collectability based on our prior history and recent communications with the customer, to determine a reserve amount. Generally, our reserve for such aged invoices will approach 100% of the invoice amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had a reserve for doubtful accounts of $0.2 million as of March&#160;31, 2025, and $0.2 million as of December&#160;31, 2024. Management believes this estimate is reasonable, but there can be no assurance that the estimate will not change due to economic or business conditions within the industry, the individual customers, or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. The Company did not recognize any bad debt expense in the three months ended March&#160;31, 2025 and March&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company&#x2019;s customer base, thus spreading the trade credit risk. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. The Company had three customers that each accounted for more than 10% of total accounts receivable on March&#160;31, 2025 and two customers that accounted for more than 10% of total accounts receivable on December&#160;31, 2024. The Company had three customers that each accounted for more than 10% of its revenue during the three months ended March&#160;31, 2025, and one customer that accounted for more than 10% of its revenue during the three months ended March&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost, or if acquired in a business combination, at the acquisition date fair value. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and Fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the year of disposal, with resulting gains or losses included in general and administrative expense in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-08, Intangibles&#x2014;Goodwill and Other&#x2014;Crypto Assets (Subtopic 350-60), which requires certain crypto assets to be measured at fair value each reporting period, with changes recognized in net income. It also introduces new disclosure requirements, including asset name, fair value, units held, cost basis, and annual reconciliations. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance early and sold all digital assets in September 2024. As of March 31, 2025, no digital assets were held, and no impairments were recognized for the three months ended March 31, 2025 or 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets, including capitalized software and intangible assets, for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable. Impairments are recognized when the asset&#x2019;s fair value is less than its carrying amount. In connection with the Company&#x2019;s 2024 reorganization and divestitures, all acquired intangible assets were written off. See &#x201c;Note 5 &#x2013; Intangible Assets&#x201d; for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 350-40,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Internal Use Software,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i)&#160;the research and planning &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;stage, (ii)&#160;the application and development stage, and (iii)&#160;the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. The Company also capitalizes costs related to cloud computing arrangements (&#x201c;CCAs&#x201d;). These software developments and CCA costs are amortized on a straight-line basis over the estimated useful life of five years upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess carrying value over the fair value in its consolidated statements of operations. In December 2024, the Company reviewed its software assets, wrote off fully amortized balances no longer active, and accelerated the amortization of certain software assets no longer in use, with further details provided in "Note 6 - Software Development Costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-02,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, established a right-of-use model that requires a lessee to record a right-of-use asset and a right-of-use liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company does not record leases on the balance sheet with a lease term of 12 months or less at the commencement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates revenue primarily from Managed Services when a marketer (typically a brand, agency, or partner) pays us to provide custom content, influencer marketing, amplification, or other campaign management services (&#x201c;Managed Services&#x201d;); additionally, we generate revenue from subscription fees charged to access our software platforms, license and transaction fees from self-service customers, and fees from such as inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#x201c;SaaS Services Revenue&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 606&#x201d;). Under ASC 606, revenue is recognized based on a five-step model as follows: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) performance obligations are satisfied. The core principle of ASC 606 is that revenue is recognized when the transfer of promised goods or services to customers is made in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are distinct performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also determines whether it acts as an agent or a principal for each identified performance obligation. The determination of whether the Company acts as principal or agent is highly subjective and requires the Company to evaluate a number of indicators individually and as a whole in order to make its determination. For transactions in which the Company acts as a principal, revenue is reported on a gross basis as the amount paid by the marketer for the purchase of content or sponsorship, promotion, and other related services, and the Company records the amounts it pays to third-party creators as cost of revenue. For transactions in which the Company acts as an agent, revenue is reported on a net basis as the amount the Company charged to the self-service marketer using the Company&#x2019;s platforms, less the amounts paid to the third-party creators providing the service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains separate arrangements with each marketer and content creator either in the form of a master agreement or terms of service, which specify the terms of the relationship and access to its platforms, or by a statement of work, which specifies the price and the services to be performed, along with other terms. The transaction price is determined based on the fixed fee stated in the statement of work and does not contain variable consideration. Marketers who contract with the Company to manage their advertising campaigns or custom content requests may prepay for services or request credit terms. Payment terms are typically 30 days from the invoice date. The agreement typically provides for either a non-refundable deposit or a cancellation fee if the agreement is canceled by the customer prior to the completion of services. Billings in advance of completed services are recorded as a contract liability until earned. The Company assesses collectability based on several factors, including the creditworthiness of the customer and payment and transaction history.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not typically engage in contracts that are longer than one year. Therefore, the Company does not capitalize costs to obtain its customer contracts as these amounts generally would be recognized over a period of less than one year and are not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Managed Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For Managed Services Revenue, the Company enters into an agreement to provide services that may include multiple distinct performance obligations in the form of (i) an integrated marketing campaign to provide influencer marketing services, which may include the provision of blogs, tweets, photos, or videos shared through social network offerings and content promotion, such as click-through advertisements appearing in websites and social media channels, and (ii) custom content items, such as a research or news articles, informational material or videos. Marketers typically purchase influencer marketing services to provide public awareness or advertising buzz regarding the marketer&#x2019;s brand and purchase custom content for internal and external use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company views its obligation to deliver influencer marketing services, including management services, as a single performance obligation that is satisfied over time as the customer receives the benefits from the services. The majority of revenue is recognized using an input method of costs incurred compared to total expected costs to measure the progress toward satisfying the overall performance obligation of the marketing campaign. The Company&#x2019;s performance obligation in certain contracts with customers may be a stand-ready promise to provide influencer marketing services for an unknown or unspecified quantity of deliverables for a specified term. Under a stand-ready obligation, the Company&#x2019;s performance obligation is satisfied over time throughout the contract term, and therefore, revenue is recognized straight-line over the life of the contract. The Company may provide one type or a combination of all types of these influencer marketing services on a statement of work for a lump sum fee. When multiple performance obligations exist in a contract, the Company allocates revenue to each distinct performance obligation at contract inception based on its relative standalone selling price. These performance obligations are to be provided over a period that generally ranges from one day to one year. The delivery of custom content represents a distinct performance obligation that is satisfied at a point in time when each piece of content is delivered to the customer. Based on the Company&#x2019;s evaluations, revenue from Managed Services is reported on a gross basis because the Company has the primary obligation to fulfill the performance obligations, and it creates, reviews, and controls the services. The Company takes on the risk of payment to any third-party creators and establishes the contract price directly with its customers based on the services requested in the statement of work.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SaaS Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SaaS services revenue includes subscription fees charged to access our software platforms, license and transaction fees from self-service customers, inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#x201c;SaaS Services Revenue&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subscription and license revenue is generated by granting customers limited, non-exclusive, non-transferable access to the Company&#x2019;s technology platforms for an agreed-upon subscription period. Customers access the platforms to manage their influencer marketing campaigns. Fees for subscription or licensing services are recognized straight-line over the term of the service. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Self-service customers instruct creators found through the Company&#x2019;s platforms to provide and/or distribute custom content for an agreed-upon transaction price. The Company&#x2019;s platforms control the contracting, description of services, acceptance of, and payment for the requested content. This service is used primarily by news agencies or marketers to control the outsourcing of their content and advertising needs. The Company charges the self-service customer the transaction price plus a fee based on the contract (&#x201c;Marketplace Spend Fees&#x201d;). Revenue is recognized when the transaction is completed by the creator and accepted by the marketer or verified as posted by the system. Based on the Company&#x2019;s evaluations, this revenue is reported on a net basis since the Company is acting as an agent through its platform for the third-party creator to provide the services or content directly to the self-service customer or to post approved content through one or more social media platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Fees Revenue is generated when fees are charged to the Company&#x2019;s platform users primarily related to monthly plan fees, which are recognized within the month they relate to.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are charged to expense as they are incurred, including payments to content creators to promote the Company. Advertising costs charged to operations for the three months ended March&#160;31, 2025, and 2024 were approximately $5 thousand and $617.5 thousand, respectively. Advertising costs are included in sales and marketing expenses in the accompanying consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes are accounted for using the balance sheet approach, which requires recognizing deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the assets and liabilities tax basis. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized. The Company incurs state franchise tax in ten states, which is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits, and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company&#x2019;s tax years subject to examination based on the statute of limitations by the IRS is generally three years; however, the IRS may examine records and other evidence from the year the net operating loss was generated when the Company utilizes net operating loss carryforwards in future periods. The Company&#x2019;s tax years subject to examination by the Canadian Revenue Agency is generally four years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valuation based on quoted market prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valuation based on quoted market prices for similar assets and liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management&#x2019;s best estimate of what market participants would use as fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. As of March&#160;31, 2025, the Company holds Level 1 and Level 2 financial assets; this is discussed further in Note 3 - Financial Instruments of Notes to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation for options granted under the 2011 Equity Incentive Plan and the 2023 Inducement Plan is measured at grant-date fair value and expensed on a straight-line basis over the requisite service period. Fair value is estimated using the Black-Scholes model. The Company applies the simplified method to estimate the expected term, assuming even exercise between vesting and expiration, and uses the grant-date closing stock price as the fair value of common stock. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates forfeitures when recognizing compensation expense, and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and a revised amount of unamortized compensation expense to be recognized in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may issue restricted stock or restricted stock units (&#x201c;RSUs&#x201d;) that vest over time, including up to 1,800,000 performance- or time-based RSUs granted under the IZEA Inducement Plan adopted on November 30, 2023. The plan was established to provide equity awards to new employees hired through acquisitions transactions. These awards are recorded at fair value on the grant date and expensed on a straight-line basis over the vesting period. See &#x201c;Note 10 Stockholder&#x2019;s Equity&#x201d; for more details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Business Combinations and Asset Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for business combinations in accordance with Accounting Standards Codification (ASC) Topic 805, &#x201c;Business Combinations.&#x201d; The acquisition method of accounting is applied to all business combinations, whereby the identifiable assets acquired, liabilities assumed, and any non-controlling interests in the acquiree are recognized and measured at their fair values as of the acquisition date. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets acquired and liabilities assumed in a business combination. Goodwill is allocated to reporting units, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which are expected to benefit from the synergies of the combination and is subject to annual impairment testing. Acquisition-related costs, including advisory, legal, and due diligence fees, are expensed as incurred and are included in general and administrative expenses in the period in which the acquisition occurs. The financial statements include the results of operations and the financial position of businesses acquired from their respective acquisition dates. Any adjustments to the preliminary fair values of assets acquired and liabilities assumed, known as measurement period adjustments, are recorded during the period of the adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Segment Reporting: Improvements to Reportable Segment Disclosures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In November 2023, the FASB issued ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improving Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This update is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The ASU also requires all annual disclosures currently required by Topic 280 to be included in the interim periods. The update is effective for fiscal years beginning after December 15, 2023, and interim periods within the fiscal years beginning after December 15, 2024, with early adoption permitted and requiring retrospective application to all prior periods presented in the financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes: Improvements to Income Tax Disclosures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company adopted this ASU for the annual period beginning on January 1, 2025 and does not expect a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregation of Income Expenses:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In November 2024, the FASB issued ASU No. 2024-03 (Subtopic 220-40) Disaggregation of Income Expenses, which requires entities to provide enhanced disclosures related to certain disclosures related to certain expense categories included in the income statement. The update is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company is currently assessing the timing and impact of adopting the updated provisions.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <izea:NatureOfBusinessPolicyTextBlock contextRef="c-1" id="f-293">Nature of Business&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IZEA Worldwide, Inc. (together with its wholly-owned subsidiaries, &#x201c;IZEA&#x201d; or the &#x201c;Company&#x201d;) is a Nevada corporation founded in February 2006 under the name PayPerPost, Inc. and became a public company in May 2011. In March 2016, the Company formed IZEA Canada, Inc., a wholly-owned subsidiary incorporated in Ontario, Canada. In December 2023, IZEA purchased all of Hoozu Holdings' outstanding shares of capital stock, which it subsequently divested in December 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company helps power the creator economy by enabling individuals to monetize their content, creativity, and influence through global brands and marketers. IZEA compensates these creators for producing unique content, such as long and short-form text, videos, photos, status updates, and illustrations for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#x201c;Managed Services&#x201d;). While the majority of the marketers engage the Company to perform the Managed Services on their behalf, marketers may also access IZEA&#x2019;s marketplaces to engage creators for influencer marketing campaigns or to produce custom content on a self-service basis by licensing the Company&#x2019;s technology.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated balance sheet as of March&#160;31, 2025, the consolidated statements of operations for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of comprehensive loss for the three months ended March&#160;31, 2025 and 2024, the consolidated statements of stockholders' equity for the three months ended March&#160;31, 2025 and 2024, and the consolidated statements of cash flows for the three months ended March&#160;31, 2025 and 2024 are unaudited but include all adjustments that are, in the opinion of management, necessary for a fair presentation of its financial position at such dates and its results of operations and cash flows for the periods then ended in conformity with generally accepted accounting principles in the United States ("GAAP"). The consolidated balance sheet as of December&#160;31, 2024 has been derived from the audited consolidated financial statements at that date but, in accordance with the rules and regulations of the SEC, does not include all of the information and notes required by GAAP for complete financial statements. Operating results for the three months ended March&#160;31, 2025 are not necessarily indicative of results that may be expected for the entire fiscal year. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the fiscal year ended December&#160;31, 2024, included in the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2025.&lt;/span&gt;&lt;/div&gt;</izea:NatureOfBusinessPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-294">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of IZEA Worldwide, Inc. and its wholly-owned subsidiaries subsequent to the subsidiaries&#x2019; acquisition, merger, or formation dates, as applicable. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-295">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-296">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;The Company considers all highly liquid investments purchased with an original maturity of three months or less from the date of purchase to be cash equivalents. Deposits made to Company bank accounts are insured by the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) up to a maximum amount of $250,000. The Canada Deposit Insurance Corporation (&#x201c;CDIC&#x201d;) insures deposits made to the Company&#x2019;s bank accounts in Canada up to CAD 100,000. Deposit balances exceeding the various limits were approximately $50.0 million and $44.2 million as of March&#160;31, 2025 and December&#160;31, 2024, respectively.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashFDICInsuredAmount contextRef="c-3" decimals="0" id="f-297" unitRef="usd">250000</us-gaap:CashFDICInsuredAmount>
    <izea:CashCDICInsuredAmount contextRef="c-3" decimals="0" id="f-298" unitRef="cad">100000</izea:CashCDICInsuredAmount>
    <us-gaap:CashUninsuredAmount contextRef="c-3" decimals="-5" id="f-299" unitRef="usd">50000000.0</us-gaap:CashUninsuredAmount>
    <us-gaap:CashUninsuredAmount contextRef="c-4" decimals="-5" id="f-300" unitRef="usd">44200000</us-gaap:CashUninsuredAmount>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-301">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Accounts Receivable and Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s accounts receivable balance consists of trade receivables, contract assets, and a reserve for doubtful accounts. Trade receivables are customer obligations due under normal trade terms. Contract assets represent amounts owed for work performed but not yet billed. The Company had net trade receivables of $4.3 million, including $4.2 million of accounts &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;receivable and contract assets of $61,480 on March&#160;31, 2025. The Company had net trade receivables of $7.8 million, including $7.6 million of accounts receivable and contract assets of $0.2 million on December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management determines the collectability of accounts by regularly evaluating individual customer receivables and considering a customer&#x2019;s financial condition, credit history, and current economic conditions. We will continue to monitor these factors and adjust our credit and collection policies as necessary to address evolving market conditions and potential risks to financial performance. An account is deemed delinquent when the customer has not paid an amount due by its associated due date. If a portion of the account balance is deemed uncollectible, the Company will either write off the amount owed or provide a reserve based on its best estimate of the uncollectible portion of the account. We assess collectability risk both generally and by specific aged invoices. Our loss history informs a general reserve percentage, which we apply to all invoices less than 90 days from the invoice due date, currently 1% of the outstanding balance. The general reserve, which we update periodically, recognizes that some invoices will likely become a collection risk. When an invoice ages 90 past its due date, we consider each invoice to determine a reserve for collectability based on our prior history and recent communications with the customer, to determine a reserve amount. Generally, our reserve for such aged invoices will approach 100% of the invoice amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had a reserve for doubtful accounts of $0.2 million as of March&#160;31, 2025, and $0.2 million as of December&#160;31, 2024. Management believes this estimate is reasonable, but there can be no assurance that the estimate will not change due to economic or business conditions within the industry, the individual customers, or the Company. Any adjustments to this account are reflected in the consolidated statements of operations as a general and administrative expense. The Company did not recognize any bad debt expense in the three months ended March&#160;31, 2025 and March&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-3" decimals="-5" id="f-302" unitRef="usd">4300000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetReclassifiedToReceivable contextRef="c-1" decimals="0" id="f-303" unitRef="usd">61480</us-gaap:ContractWithCustomerAssetReclassifiedToReceivable>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-5" id="f-304" unitRef="usd">7800000</us-gaap:AccountsReceivableNetCurrent>
    <izea:AccountsReceivableExcludingContractAsset contextRef="c-4" decimals="0" id="f-305" unitRef="usd">7600000</izea:AccountsReceivableExcludingContractAsset>
    <us-gaap:UnbilledReceivablesCurrent contextRef="c-4" decimals="0" id="f-306" unitRef="usd">200000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:FinancingReceivablePercentPastDue1 contextRef="c-3" decimals="3" id="f-307" unitRef="number">0.01</us-gaap:FinancingReceivablePercentPastDue1>
    <us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue contextRef="c-3" id="f-308">P90D</us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-3" decimals="0" id="f-309" unitRef="usd">200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-4" decimals="0" id="f-310" unitRef="usd">200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease contextRef="c-1" decimals="0" id="f-311" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease contextRef="c-5" decimals="0" id="f-312" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-313">Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company&#x2019;s customer base, thus spreading the trade credit risk. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers but generally does not require collateral to support accounts receivable. The Company had three customers that each accounted for more than 10% of total accounts receivable on March&#160;31, 2025 and two customers that accounted for more than 10% of total accounts receivable on December&#160;31, 2024. The Company had three customers that each accounted for more than 10% of its revenue during the three months ended March&#160;31, 2025, and one customer that accounted for more than 10% of its revenue during the three months ended March&#160;31, 2024.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-39" decimals="2" id="f-314" unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-39" decimals="1" id="f-315" unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-40" decimals="2" id="f-316" unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-41" decimals="2" id="f-317" unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-318">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are recorded at cost, or if acquired in a business combination, at the acquisition date fair value. Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and Fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of assets sold or retired and the related accumulated depreciation are eliminated in the year of disposal, with resulting gains or losses included in general and administrative expense in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-319">Depreciation is computed using the straight-line method over the estimated useful lives of the assets as follows:&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and Fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 - 10 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-42" id="f-320">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-43" id="f-321">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-44" id="f-322">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-45" id="f-323">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-46" id="f-324">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:IntangibleAssetsFiniteLivedPolicy contextRef="c-1" id="f-325">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-08, Intangibles&#x2014;Goodwill and Other&#x2014;Crypto Assets (Subtopic 350-60), which requires certain crypto assets to be measured at fair value each reporting period, with changes recognized in net income. It also introduces new disclosure requirements, including asset name, fair value, units held, cost basis, and annual reconciliations. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted the guidance early and sold all digital assets in September 2024. As of March 31, 2025, no digital assets were held, and no impairments were recognized for the three months ended March 31, 2025 or 2024.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets, including capitalized software and intangible assets, for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable. Impairments are recognized when the asset&#x2019;s fair value is less than its carrying amount. In connection with the Company&#x2019;s 2024 reorganization and divestitures, all acquired intangible assets were written off. See &#x201c;Note 5 &#x2013; Intangible Assets&#x201d; for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsFiniteLivedPolicy>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock contextRef="c-1" id="f-326">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) 350-40,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Internal Use Software,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i)&#160;the research and planning &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;stage, (ii)&#160;the application and development stage, and (iii)&#160;the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. The Company also capitalizes costs related to cloud computing arrangements (&#x201c;CCAs&#x201d;). These software developments and CCA costs are amortized on a straight-line basis over the estimated useful life of five years upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess carrying value over the fair value in its consolidated statements of operations. In December 2024, the Company reviewed its software assets, wrote off fully amortized balances no longer active, and accelerated the amortization of certain software assets no longer in use, with further details provided in "Note 6 - Software Development Costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <izea:AmortizationPeriodOfSoftwareDevelopmentCosts contextRef="c-1" id="f-327">P5Y</izea:AmortizationPeriodOfSoftwareDevelopmentCosts>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-328">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-02,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, established a right-of-use model that requires a lessee to record a right-of-use asset and a right-of-use liability on the balance sheet for all leases with terms longer than 12 months. Leases are classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The Company does not record leases on the balance sheet with a lease term of 12 months or less at the commencement date.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="c-1" id="f-329">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generates revenue primarily from Managed Services when a marketer (typically a brand, agency, or partner) pays us to provide custom content, influencer marketing, amplification, or other campaign management services (&#x201c;Managed Services&#x201d;); additionally, we generate revenue from subscription fees charged to access our software platforms, license and transaction fees from self-service customers, and fees from such as inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#x201c;SaaS Services Revenue&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 606&#x201d;). Under ASC 606, revenue is recognized based on a five-step model as follows: (i) identify the contract with the customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) performance obligations are satisfied. The core principle of ASC 606 is that revenue is recognized when the transfer of promised goods or services to customers is made in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company applies the five-step model to contracts when it is probable that it will collect the consideration it is entitled to in exchange for the goods or services it transfers to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and determines those that are distinct performance obligations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also determines whether it acts as an agent or a principal for each identified performance obligation. The determination of whether the Company acts as principal or agent is highly subjective and requires the Company to evaluate a number of indicators individually and as a whole in order to make its determination. For transactions in which the Company acts as a principal, revenue is reported on a gross basis as the amount paid by the marketer for the purchase of content or sponsorship, promotion, and other related services, and the Company records the amounts it pays to third-party creators as cost of revenue. For transactions in which the Company acts as an agent, revenue is reported on a net basis as the amount the Company charged to the self-service marketer using the Company&#x2019;s platforms, less the amounts paid to the third-party creators providing the service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains separate arrangements with each marketer and content creator either in the form of a master agreement or terms of service, which specify the terms of the relationship and access to its platforms, or by a statement of work, which specifies the price and the services to be performed, along with other terms. The transaction price is determined based on the fixed fee stated in the statement of work and does not contain variable consideration. Marketers who contract with the Company to manage their advertising campaigns or custom content requests may prepay for services or request credit terms. Payment terms are typically 30 days from the invoice date. The agreement typically provides for either a non-refundable deposit or a cancellation fee if the agreement is canceled by the customer prior to the completion of services. Billings in advance of completed services are recorded as a contract liability until earned. The Company assesses collectability based on several factors, including the creditworthiness of the customer and payment and transaction history.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not typically engage in contracts that are longer than one year. Therefore, the Company does not capitalize costs to obtain its customer contracts as these amounts generally would be recognized over a period of less than one year and are not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Managed Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For Managed Services Revenue, the Company enters into an agreement to provide services that may include multiple distinct performance obligations in the form of (i) an integrated marketing campaign to provide influencer marketing services, which may include the provision of blogs, tweets, photos, or videos shared through social network offerings and content promotion, such as click-through advertisements appearing in websites and social media channels, and (ii) custom content items, such as a research or news articles, informational material or videos. Marketers typically purchase influencer marketing services to provide public awareness or advertising buzz regarding the marketer&#x2019;s brand and purchase custom content for internal and external use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company views its obligation to deliver influencer marketing services, including management services, as a single performance obligation that is satisfied over time as the customer receives the benefits from the services. The majority of revenue is recognized using an input method of costs incurred compared to total expected costs to measure the progress toward satisfying the overall performance obligation of the marketing campaign. The Company&#x2019;s performance obligation in certain contracts with customers may be a stand-ready promise to provide influencer marketing services for an unknown or unspecified quantity of deliverables for a specified term. Under a stand-ready obligation, the Company&#x2019;s performance obligation is satisfied over time throughout the contract term, and therefore, revenue is recognized straight-line over the life of the contract. The Company may provide one type or a combination of all types of these influencer marketing services on a statement of work for a lump sum fee. When multiple performance obligations exist in a contract, the Company allocates revenue to each distinct performance obligation at contract inception based on its relative standalone selling price. These performance obligations are to be provided over a period that generally ranges from one day to one year. The delivery of custom content represents a distinct performance obligation that is satisfied at a point in time when each piece of content is delivered to the customer. Based on the Company&#x2019;s evaluations, revenue from Managed Services is reported on a gross basis because the Company has the primary obligation to fulfill the performance obligations, and it creates, reviews, and controls the services. The Company takes on the risk of payment to any third-party creators and establishes the contract price directly with its customers based on the services requested in the statement of work.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;SaaS Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SaaS services revenue includes subscription fees charged to access our software platforms, license and transaction fees from self-service customers, inactivity fees, early cash-out fees, and other miscellaneous fees charged to users of our platforms (collectively, &#x201c;SaaS Services Revenue&#x201d;). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subscription and license revenue is generated by granting customers limited, non-exclusive, non-transferable access to the Company&#x2019;s technology platforms for an agreed-upon subscription period. Customers access the platforms to manage their influencer marketing campaigns. Fees for subscription or licensing services are recognized straight-line over the term of the service. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Self-service customers instruct creators found through the Company&#x2019;s platforms to provide and/or distribute custom content for an agreed-upon transaction price. The Company&#x2019;s platforms control the contracting, description of services, acceptance of, and payment for the requested content. This service is used primarily by news agencies or marketers to control the outsourcing of their content and advertising needs. The Company charges the self-service customer the transaction price plus a fee based on the contract (&#x201c;Marketplace Spend Fees&#x201d;). Revenue is recognized when the transaction is completed by the creator and accepted by the marketer or verified as posted by the system. Based on the Company&#x2019;s evaluations, this revenue is reported on a net basis since the Company is acting as an agent through its platform for the third-party creator to provide the services or content directly to the self-service customer or to post approved content through one or more social media platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other Fees Revenue is generated when fees are charged to the Company&#x2019;s platform users primarily related to monthly plan fees, which are recognized within the month they relate to.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <izea:InvoicePaymentTerms contextRef="c-1" id="f-330">P30D</izea:InvoicePaymentTerms>
    <izea:ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers contextRef="c-1" id="f-331">P1Y</izea:ContractAssetsAndContractLiabilitiesLengthOfAgreementWithCustomers>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c-1" id="f-332">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Advertising Costs&lt;/span&gt;&lt;/div&gt;Advertising costs are charged to expense as they are incurred, including payments to content creators to promote the Company. Advertising costs charged to operations for the three months ended March&#160;31, 2025, and 2024 were approximately $5 thousand and $617.5 thousand, respectively. Advertising costs are included in sales and marketing expenses in the accompanying consolidated statements of operations.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-47" decimals="-3" id="f-333" unitRef="usd">5000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-48" decimals="-2" id="f-334" unitRef="usd">617500</us-gaap:AdvertisingExpense>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-335">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes are accounted for using the balance sheet approach, which requires recognizing deferred tax assets and liabilities for the expected future consequences of temporary differences between the financial reporting basis and the assets and liabilities tax basis. A valuation allowance is provided when it is more likely than not that a deferred tax asset will not be realized. The Company incurs state franchise tax in ten states, which is included in general and administrative expenses in the consolidated statements of operations and comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;The Company identifies and evaluates uncertain tax positions, if any, and recognizes the impact of uncertain tax positions for which there is a less than more likely-than-not probability of the position being upheld when reviewed by the relevant taxing authority. Such positions are deemed to be unrecognized tax benefits, and a corresponding liability is established on the balance sheet. The Company has not recognized a liability for uncertain tax positions. If there were an unrecognized tax benefit, the Company would recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. The Company&#x2019;s tax years subject to examination based on the statute of limitations by the IRS is generally three years; however, the IRS may examine records and other evidence from the year the net operating loss was generated when the Company utilizes net operating loss carryforwards in future periods. The Company&#x2019;s tax years subject to examination by the Canadian Revenue Agency is generally four years.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-336">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments are recorded at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valuation based on quoted market prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valuation based on quoted market prices for similar assets and liabilities in active markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management&#x2019;s best estimate of what market participants would use as fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. As of March&#160;31, 2025, the Company holds Level 1 and Level 2 financial assets; this is discussed further in Note 3 - Financial Instruments of Notes to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-337">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation for options granted under the 2011 Equity Incentive Plan and the 2023 Inducement Plan is measured at grant-date fair value and expensed on a straight-line basis over the requisite service period. Fair value is estimated using the Black-Scholes model. The Company applies the simplified method to estimate the expected term, assuming even exercise between vesting and expiration, and uses the grant-date closing stock price as the fair value of common stock. The Company uses the risk-free interest rate on the implied yield currently available on U.S. Treasury issues with an equivalent remaining term approximately equal to the expected life of the award. The Company has never paid any cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates forfeitures when recognizing compensation expense, and this estimate of forfeitures is adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from such estimates. Changes in estimated forfeitures are recognized through a cumulative catch-up adjustment, which is recognized in the period of change, and a revised amount of unamortized compensation expense to be recognized in future periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may issue restricted stock or restricted stock units (&#x201c;RSUs&#x201d;) that vest over time, including up to 1,800,000 performance- or time-based RSUs granted under the IZEA Inducement Plan adopted on November 30, 2023. The plan was established to provide equity awards to new employees hired through acquisitions transactions. These awards are recorded at fair value on the grant date and expensed on a straight-line basis over the vesting period. See &#x201c;Note 10 Stockholder&#x2019;s Equity&#x201d; for more details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="c-49" decimals="0" id="f-338" unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:BusinessCombinationsPolicy contextRef="c-1" id="f-339">&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Business Combinations and Asset Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for business combinations in accordance with Accounting Standards Codification (ASC) Topic 805, &#x201c;Business Combinations.&#x201d; The acquisition method of accounting is applied to all business combinations, whereby the identifiable assets acquired, liabilities assumed, and any non-controlling interests in the acquiree are recognized and measured at their fair values as of the acquisition date. Goodwill represents the excess of the purchase price over the fair value of net identifiable assets acquired and liabilities assumed in a business combination. Goodwill is allocated to reporting units, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which are expected to benefit from the synergies of the combination and is subject to annual impairment testing. Acquisition-related costs, including advisory, legal, and due diligence fees, are expensed as incurred and are included in general and administrative expenses in the period in which the acquisition occurs. The financial statements include the results of operations and the financial position of businesses acquired from their respective acquisition dates. Any adjustments to the preliminary fair values of assets acquired and liabilities assumed, known as measurement period adjustments, are recorded during the period of the adjustment.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-340">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Segment Reporting: Improvements to Reportable Segment Disclosures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In November 2023, the FASB issued ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improving Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This update is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant expenses. The ASU also requires all annual disclosures currently required by Topic 280 to be included in the interim periods. The update is effective for fiscal years beginning after December 15, 2023, and interim periods within the fiscal years beginning after December 15, 2024, with early adoption permitted and requiring retrospective application to all prior periods presented in the financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Income Taxes: Improvements to Income Tax Disclosures:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company adopted this ASU for the annual period beginning on January 1, 2025 and does not expect a material impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Disaggregation of Income Expenses:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In November 2024, the FASB issued ASU No. 2024-03 (Subtopic 220-40) Disaggregation of Income Expenses, which requires entities to provide enhanced disclosures related to certain disclosures related to certain expense categories included in the income statement. The update is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The Company is currently assessing the timing and impact of adopting the updated provisions.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-341">BUSINESS ACQUISITIONS AND DIVESTITURES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Divestiture of Hoozu Holdings PTY Ltd.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 18, 2024, the Company completed the divestiture of Hoozu Holdings PTY Ltd. (&#x201c;Hoozu&#x201d;) through its sale to a private Australian company, as part of a strategy to optimize its market focus and enhance the profitability of its North American operations. The acquisition of Hoozu was completed on December 1, 2023, for $2.5&#160;million in cash, common stock, and contingent consideration.&lt;/span&gt;&lt;/div&gt;The sale of Hoozu resulted in cash proceeds of $73,529, net of approximately $28,000 in transaction costs, and resulted in a net loss of $1.9 million, net of a $0.3&#160;million deferred tax benefit, which, together with the year-to-date results of operations through the sale date, is reflected in the Company&#x2019;s financial statements for the period ended December&#160;31, 2024.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-50" decimals="0" id="f-342" unitRef="usd">2500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested contextRef="c-51" decimals="0" id="f-343" unitRef="usd">73529</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:CashDivestedFromDeconsolidation contextRef="c-51" decimals="0" id="f-344" unitRef="usd">28000</us-gaap:CashDivestedFromDeconsolidation>
    <izea:LossOfDivesitureOfBusinessNetOfTransactionCosts contextRef="c-51" decimals="0" id="f-345" unitRef="usd">-1900000</izea:LossOfDivesitureOfBusinessNetOfTransactionCosts>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits contextRef="c-51" decimals="-5" id="f-346" unitRef="usd">300000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:FinancialInstrumentsDisclosureTextBlock contextRef="c-1" id="f-347">FINANCIAL INSTRUMENTS&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Marketable Securities (Available for Sale)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has appointed a leading national bank for custody services with respect to investment securities. Investments comply with the Company&#x2019;s revised investment strategy policy, designed to preserve capital, minimize investment risks, and maximize returns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s cash, cash equivalents, and marketable securities by significant investment category as of March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.611%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current Marketable Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,623,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,623,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,623,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,010,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,999,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,997,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset back securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,186,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,184,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,612,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,572,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current Marketable Securities have a holding period under &lt;span style="-sec-ix-hidden:f-398"&gt;one&lt;/span&gt; year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;      (2)     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Level 1 fair value estimates are based on quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;padding-left:7.44pt;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records the fair value of cash equivalents and marketable securities on the balance sheet. The adjusted cost, which includes unrealized gains and losses, reflects settlement amounts if all investments are held to maturity. The Company recognized a gain of $23,799 for the three months ended March&#160;31, 2025, and recognized a gain of $810 for the three months ended March&#160;31, 2024, respectively. Realized gains and losses are a component of other income (expense), net. Unrealized gains and losses are a component of other comprehensive income (loss) (&#x201c;OCI&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of investments in marketable debt securities by stated contractual maturity dates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,427,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,427,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents fair values and net unrealized gains (losses) recorded to OCI, aggregated by investment category:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.517%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.517%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.517%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,612,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,644,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,430,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,184,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,071,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2025, the Company did not recognize any credit losses and had no ending allowance balance for credit losses.&lt;/span&gt;&lt;/div&gt;</us-gaap:FinancialInstrumentsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock contextRef="c-1" id="f-348">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s cash, cash equivalents, and marketable securities by significant investment category as of March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.482%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.860%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.611%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjusted Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Current Marketable Securities &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,623,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,623,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,623,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;US Treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,010,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,999,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44,997,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;43,989,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset back securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,186,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52,184,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50,612,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,572,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current Marketable Securities have a holding period under &lt;span style="-sec-ix-hidden:f-398"&gt;one&lt;/span&gt; year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;      (2)     &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Level 1 fair value estimates are based on quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;padding-left:7.44pt;position:relative;top:-3.15pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-52" decimals="0" id="f-349" unitRef="usd">6623346</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-52" decimals="0" id="f-350" unitRef="usd">6623346</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-52" decimals="0" id="f-351" unitRef="usd">6623346</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-53" id="f-352" unitRef="usd" xsi:nil="true"/>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-53" decimals="0" id="f-353" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-53" decimals="0" id="f-354" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-53" decimals="0" id="f-355" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-53" decimals="0" id="f-356" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-54" decimals="0" id="f-357" unitRef="usd">43989002</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-54" decimals="0" id="f-358" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-54" decimals="0" id="f-359" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-54" decimals="0" id="f-360" unitRef="usd">43989002</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-54" decimals="0" id="f-361" unitRef="usd">43989002</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-55" decimals="0" id="f-362" unitRef="usd">1010252</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-55" decimals="0" id="f-363" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-55" decimals="0" id="f-364" unitRef="usd">1685</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-55" decimals="0" id="f-365" unitRef="usd">1008567</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-55" decimals="0" id="f-366" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-55" decimals="0" id="f-367" unitRef="usd">1008567</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-56" decimals="0" id="f-368" unitRef="usd">44999254</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-56" decimals="0" id="f-369" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-56" decimals="0" id="f-370" unitRef="usd">1685</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-56" decimals="0" id="f-371" unitRef="usd">44997569</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-56" decimals="0" id="f-372" unitRef="usd">43989002</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-56" decimals="0" id="f-373" unitRef="usd">1008567</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-57" decimals="0" id="f-374" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-57" decimals="0" id="f-375" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-57" decimals="0" id="f-376" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-57" decimals="0" id="f-377" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-57" decimals="0" id="f-378" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-57" decimals="0" id="f-379" unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-58" decimals="0" id="f-380" unitRef="usd">563675</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-58" decimals="0" id="f-381" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-58" decimals="0" id="f-382" unitRef="usd">9</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-58" decimals="0" id="f-383" unitRef="usd">563666</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-58" decimals="0" id="f-384" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-58" decimals="0" id="f-385" unitRef="usd">563666</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-59" decimals="0" id="f-386" unitRef="usd">563675</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-59" decimals="0" id="f-387" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-59" decimals="0" id="f-388" unitRef="usd">9</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-59" decimals="0" id="f-389" unitRef="usd">563666</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-59" decimals="0" id="f-390" unitRef="usd">0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-59" decimals="0" id="f-391" unitRef="usd">563666</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-3" decimals="0" id="f-392" unitRef="usd">52186275</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-3" decimals="0" id="f-393" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-3" decimals="0" id="f-394" unitRef="usd">1694</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-3" decimals="0" id="f-395" unitRef="usd">52184581</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="0" id="f-396" unitRef="usd">50612348</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-3" decimals="0" id="f-397" unitRef="usd">1572233</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:GainOnSaleOfInvestments contextRef="c-1" decimals="0" id="f-399" unitRef="usd">23799</us-gaap:GainOnSaleOfInvestments>
    <us-gaap:GainOnSaleOfInvestments contextRef="c-5" decimals="0" id="f-400" unitRef="usd">810</us-gaap:GainOnSaleOfInvestments>
    <izea:FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock contextRef="c-1" id="f-401">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the estimated fair value of investments in marketable debt securities by stated contractual maturity dates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March&#160;31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,427,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,427,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</izea:FairValueOfInvestmentsInMarketableDebtSecuritiesTableTextBlock>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-3" decimals="0" id="f-402" unitRef="usd">1572233</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent contextRef="c-4" decimals="0" id="f-403" unitRef="usd">6427488</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecurities contextRef="c-3" decimals="0" id="f-404" unitRef="usd">1572233</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecurities contextRef="c-4" decimals="0" id="f-405" unitRef="usd">6427488</us-gaap:MarketableSecurities>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-406">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents fair values and net unrealized gains (losses) recorded to OCI, aggregated by investment category:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:32.429%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.517%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.517%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.517%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.520%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net Unrealized Gain (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,612,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,644,468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;563,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,430,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,184,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,071,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-52" decimals="0" id="f-407" unitRef="usd">50612348</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-52" decimals="0" id="f-408" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-60" decimals="0" id="f-409" unitRef="usd">44644468</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-60" decimals="0" id="f-410" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-61" decimals="0" id="f-411" unitRef="usd">1008567</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-61" decimals="0" id="f-412" unitRef="usd">-1685</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-62" decimals="0" id="f-413" unitRef="usd">998070</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-62" decimals="0" id="f-414" unitRef="usd">-5103</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-63" decimals="0" id="f-415" unitRef="usd">563666</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-63" decimals="0" id="f-416" unitRef="usd">-9</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-64" decimals="0" id="f-417" unitRef="usd">4430539</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-64" decimals="0" id="f-418" unitRef="usd">-5180</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-65" decimals="0" id="f-419" unitRef="usd">0</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-65" decimals="0" id="f-420" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-66" decimals="0" id="f-421" unitRef="usd">998879</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-66" decimals="0" id="f-422" unitRef="usd">22492</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-3" decimals="0" id="f-423" unitRef="usd">52184581</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-3" decimals="0" id="f-424" unitRef="usd">-1694</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <izea:FinancialAssetsFairValueDisclosure contextRef="c-4" decimals="0" id="f-425" unitRef="usd">51071956</izea:FinancialAssetsFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax contextRef="c-4" decimals="0" id="f-426" unitRef="usd">12209</us-gaap:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-427">PROPERTY AND EQUIPMENT&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(235,653)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(212,698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense on property and equipment recorded in depreciation and amortization expense in the consolidated statements of operations and comprehensive loss was $22,955 and $26,557 for the three months ended March&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-67" decimals="0" id="f-428" unitRef="usd">29848</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-68" decimals="0" id="f-429" unitRef="usd">29848</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-69" decimals="0" id="f-430" unitRef="usd">8506</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-70" decimals="0" id="f-431" unitRef="usd">8506</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-42" decimals="0" id="f-432" unitRef="usd">277918</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-71" decimals="0" id="f-433" unitRef="usd">277918</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="0" id="f-434" unitRef="usd">316272</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="0" id="f-435" unitRef="usd">316272</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="0" id="f-436" unitRef="usd">235653</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="0" id="f-437" unitRef="usd">212698</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="0" id="f-438" unitRef="usd">80619</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="0" id="f-439" unitRef="usd">103574</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="INF" id="f-440" unitRef="usd">22955</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-5" decimals="0" id="f-441" unitRef="usd">26557</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-442">INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Definite Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no definite-lived intangible assets on its balance sheet as of December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense recorded in depreciation and amortization in the accompanying consolidated statements of operations and comprehensive loss was $0 and $49,287 for the three months ended March&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Digital Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines the fair value of its digital assets on a recurring basis in accordance with ASU 2023-8, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for and Disclosure of Crypto Assets&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, based on quoted prices on the active exchange(s) that have been determined to be the principal market for such assets (Level 1 inputs). The Company performs an analysis monthly to identify whether the fair market value of the digital assets has changed. If the then-current carrying value of a digital asset is different from the fair value so determined, an adjustment in the amount equal to the difference between their carrying value and the price determined is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gains and losses on digital assets are recognized within other income in the consolidated statements of operations and comprehensive loss in the period in which the change to fair market value is identified. In determining the gain to be recognized upon sale, the Company calculates the difference between the sales price and the carrying value of the digital assets sold immediately prior to the sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no digital assets on its balance sheet as of December 31, 2024. the Company recorded a gain of $0.1&#160;million for the three months ended March 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no goodwill balance as of March&#160;31, 2025 and December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-72" decimals="0" id="f-443" unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-73" decimals="0" id="f-444" unitRef="usd">49287</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-74" decimals="0" id="f-445" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-75" decimals="0" id="f-446" unitRef="usd">100000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="c-1" id="f-447">SOFTWARE DEVELOPMENT COSTS&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software development costs consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(946,835)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(809,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,086,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized software development costs of $0.1 million and $0.1 million during the three months ended March&#160;31, 2025 and 2024, respectively. As of March&#160;31, 2025, the Company has capitalized $3.0 million in direct materials, consulting, payroll, and benefit costs to its internal-use software development costs in the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company amortizes its software development costs, commencing upon the initial release of the software or additional features, on a straight-line basis over the estimated useful life of five years, which is consistent with the amount of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;time its legacy platforms were in service or its actual useful life, if shorter. The Company recorded amortization expenses associated with its capitalized software development cost of $0.1 million and $0.1 million during the three months ended March&#160;31, 2025 and 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025, future estimated amortization expense related to software development costs is set forth in the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Software Development Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-448">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Software development costs consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(946,835)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(809,439)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Software development costs, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,086,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-3" decimals="0" id="f-449" unitRef="usd">3045406</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-4" decimals="0" id="f-450" unitRef="usd">2896099</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization contextRef="c-3" decimals="0" id="f-451" unitRef="usd">946835</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization contextRef="c-4" decimals="0" id="f-452" unitRef="usd">809439</us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="c-3" decimals="0" id="f-453" unitRef="usd">2098571</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="c-4" decimals="0" id="f-454" unitRef="usd">2086660</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:CapitalizedComputerSoftwareAdditions contextRef="c-1" decimals="0" id="f-455" unitRef="usd">100000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:CapitalizedComputerSoftwareAdditions contextRef="c-5" decimals="0" id="f-456" unitRef="usd">100000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-3" decimals="-5" id="f-457" unitRef="usd">3000000.0</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-76" id="f-458">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:CapitalizedComputerSoftwareAmortization1 contextRef="c-1" decimals="0" id="f-459" unitRef="usd">100000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1 contextRef="c-5" decimals="0" id="f-460" unitRef="usd">100000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-461">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2025, future estimated amortization expense related to software development costs is set forth in the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Software Development Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2030&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,098,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <izea:CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear contextRef="c-3" decimals="0" id="f-462" unitRef="usd">374767</izea:CapitalizedComputerSoftwareExpectedAmortizationRemainderOfFiscalYear>
    <izea:CapitalizedComputerSoftwareExpectedAmortizationYearOne contextRef="c-3" decimals="0" id="f-463" unitRef="usd">598611</izea:CapitalizedComputerSoftwareExpectedAmortizationYearOne>
    <izea:CapitalizedComputerSoftwareExpectedAmortizationYearTwo contextRef="c-3" decimals="0" id="f-464" unitRef="usd">567332</izea:CapitalizedComputerSoftwareExpectedAmortizationYearTwo>
    <izea:CapitalizedComputerSoftwareExpectedAmortizationYearThree contextRef="c-3" decimals="0" id="f-465" unitRef="usd">301092</izea:CapitalizedComputerSoftwareExpectedAmortizationYearThree>
    <izea:CapitalizedComputerSoftwareExpectedAmortizationYearFour contextRef="c-3" decimals="0" id="f-466" unitRef="usd">157553</izea:CapitalizedComputerSoftwareExpectedAmortizationYearFour>
    <izea:CapitalizedComputerSoftwareExpectedAmortizationYearFive contextRef="c-3" decimals="0" id="f-467" unitRef="usd">99216</izea:CapitalizedComputerSoftwareExpectedAmortizationYearFive>
    <us-gaap:CapitalizedComputerSoftwareNet contextRef="c-3" decimals="0" id="f-468" unitRef="usd">2098571</us-gaap:CapitalizedComputerSoftwareNet>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-469">ACCRUED EXPENSES&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of finance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;During the quarter ended September 30, 2024, the Company announced the departure of two executives. In accordance with their Separation Agreements and the payments they are entitled to receive, a severance amount of $0.9&#160;million was accrued and will be paid over a twelve-month period. In December 2024, in conjunction with a targeted workforce reduction, the Company accrued $0.3&#160;million in severance costs to be paid in January 2025. As of March 31, 2025, the remaining balance for severance accrued is $0.4&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-470">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consist of the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,338,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of finance obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,081,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.2pt"&gt;During the quarter ended September 30, 2024, the Company announced the departure of two executives. In accordance with their Separation Agreements and the payments they are entitled to receive, a severance amount of $0.9&#160;million was accrued and will be paid over a twelve-month period. In December 2024, in conjunction with a targeted workforce reduction, the Company accrued $0.3&#160;million in severance costs to be paid in January 2025. As of March 31, 2025, the remaining balance for severance accrued is $0.4&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrentAndNoncurrent contextRef="c-3" decimals="0" id="f-471" unitRef="usd">2338452</us-gaap:AccruedSalariesCurrentAndNoncurrent>
    <us-gaap:AccruedSalariesCurrentAndNoncurrent contextRef="c-4" decimals="0" id="f-472" unitRef="usd">2189531</us-gaap:AccruedSalariesCurrentAndNoncurrent>
    <us-gaap:AccruedIncomeTaxes contextRef="c-3" decimals="0" id="f-473" unitRef="usd">11202</us-gaap:AccruedIncomeTaxes>
    <us-gaap:AccruedIncomeTaxes contextRef="c-4" decimals="0" id="f-474" unitRef="usd">47046</us-gaap:AccruedIncomeTaxes>
    <izea:CurrentPortionOfFinanceObligation contextRef="c-3" decimals="0" id="f-475" unitRef="usd">48573</izea:CurrentPortionOfFinanceObligation>
    <izea:CurrentPortionOfFinanceObligation contextRef="c-4" decimals="0" id="f-476" unitRef="usd">59386</izea:CurrentPortionOfFinanceObligation>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-3" decimals="0" id="f-477" unitRef="usd">683036</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-4" decimals="0" id="f-478" unitRef="usd">1438160</us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="0" id="f-479" unitRef="usd">3081263</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="0" id="f-480" unitRef="usd">3734123</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-77" decimals="0" id="f-481" unitRef="usd">900000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits contextRef="c-4" decimals="0" id="f-482" unitRef="usd">300000</us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits>
    <us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits contextRef="c-3" decimals="0" id="f-483" unitRef="usd">400000</us-gaap:SupplementalUnemploymentBenefitsSeveranceBenefits>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-484">NOTES PAYABLE&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Finance Obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company pays for its laptop computer equipment through long-term payment plans, using an imputed interest rate of 12.9%, based on its incremental borrowing rate, to determine the present value of its financial obligation and to record interest expense over the term of the plan. The Company refreshed a portion of its computer inventory during the fourth quarter of 2022, entering a new three-year payment plan with the same vendor. The total balance owed was $48,573 and $63,420 as of March&#160;31, 2025 and December&#160;31, 2024, respectively, with the short-term portion of $48,573 and $59,386 recorded under accrued expenses in the consolidated balance sheets as of March&#160;31, 2025, and December 31, 2024, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense on financing arrangements recorded in the Company&#x2019;s consolidated statements of operations was $1,654 and $2,001 during the three months ended March&#160;31, 2025 and 2024, respectively. As of March&#160;31, 2025, the future contractual maturities of the Company&#x2019;s long-term payment obligations by year are set forth in the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-3" decimals="3" id="f-485" unitRef="number">0.129</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebtTerm contextRef="c-3" id="f-486">P3Y</us-gaap:LongTermDebtTerm>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="0" id="f-487" unitRef="usd">48573</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="0" id="f-488" unitRef="usd">63420</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent contextRef="c-3" decimals="0" id="f-489" unitRef="usd">48573</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="0" id="f-490" unitRef="usd">59386</us-gaap:LongTermDebtCurrent>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="0" id="f-491" unitRef="usd">1654</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-5" decimals="0" id="f-492" unitRef="usd">2001</us-gaap:InterestExpenseDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-493">As of March&#160;31, 2025, the future contractual maturities of the Company&#x2019;s long-term payment obligations by year are set forth in the following schedule:&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:79.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="c-3" decimals="0" id="f-494" unitRef="usd">41836</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-3" decimals="0" id="f-495" unitRef="usd">6737</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="0" id="f-496" unitRef="usd">48573</us-gaap:LongTermDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-497">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Lease Commitments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have any operating or finance leases greater than 12 months in duration as of March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Retirement Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers a 401(k) plan to its eligible employees. The Company matches participant contributions in an amount equal to 50% of each participant&#x2019;s contribution up to 8% of the participant&#x2019;s salary. The participants become vested in 20% annual increments after two years of service or fully vest upon the age of 60. Total expense for employer matching contributions during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#x2019;s consolidated statements of operations as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.347%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Negative expense in Sales and Marketing due to our targeted workforce reduction that was announced in December, 2024 and executed in January 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;From time to time, the Company may become involved in lawsuits and various other legal proceedings that arise in the ordinary course of its business. Litigation is, however, subject to inherent uncertainties and an adverse result in any such litigation that may arise from time to time that may harm the Company&#x2019;s business. The Company is currently not party to any legal proceedings or claims that it believes would or could have, individually or in the aggregate, a material adverse effect on the Company.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch contextRef="c-1" decimals="2" id="f-498" unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch contextRef="c-1" decimals="3" id="f-499" unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent contextRef="c-1" decimals="3" id="f-500" unitRef="number">0.08</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage contextRef="c-1" decimals="2" id="f-501" unitRef="number">0.20</us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage>
    <izea:DefinedContributionPlanEmployersMatchingContributionYearsOfService contextRef="c-1" id="f-502">P2Y</izea:DefinedContributionPlanEmployersMatchingContributionYearsOfService>
    <izea:DefinedContributionPlanEmployersMatchingContributionYearsOfService contextRef="c-1" id="f-503">P2Y</izea:DefinedContributionPlanEmployersMatchingContributionYearsOfService>
    <us-gaap:DefinedContributionPlanDisclosuresTableTextBlock contextRef="c-1" id="f-504">Total expense for employer matching contributions during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#x2019;s consolidated statements of operations as follows: &lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.347%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,524)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total contribution expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Negative expense in Sales and Marketing due to our targeted workforce reduction that was announced in December, 2024 and executed in January 2025.&lt;/span&gt;&lt;/div&gt;</us-gaap:DefinedContributionPlanDisclosuresTableTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-78" decimals="0" id="f-505" unitRef="usd">19235</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-79" decimals="0" id="f-506" unitRef="usd">22478</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-47" decimals="0" id="f-507" unitRef="usd">16524</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-48" decimals="0" id="f-508" unitRef="usd">43039</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-80" decimals="0" id="f-509" unitRef="usd">16621</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-81" decimals="0" id="f-510" unitRef="usd">44584</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-1" decimals="0" id="f-511" unitRef="usd">19332</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-5" decimals="0" id="f-512" unitRef="usd">110101</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="c-1" id="f-513">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Authorized Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has 50,000,000 authorized shares of common stock and 10,000,000 authorized shares of preferred stock, each with a par value of $0.0001 per share. 500,000 shares of preferred stock are designated as Series A Junior Participating Preferred Stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share Repurchase&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 28, 2024, the Company announced that its Board of Directors had authorized a $5.0&#160;million share repurchase program of the Company&#x2019;s common stock. In conjunction with the Cooperation Agreement signed on September 6, 2024, the repurchase maximum was raised to $10.0 million. On September 30, 2024, the Company entered into an agreement adopted under the safe harbor provided by Rule 10b5-1 and Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The agreement assists the Company in implementing its stock repurchase programs, providing for the purchase of up to $9.0&#160;million, the remaining amount under its $10.0 million share repurchase program. Purchases under the Rule 10b5-1 plan commenced on November 1, 2024, and terminate on the earliest of May 15, 2025, until the aggregate number of shares are repurchased or upon certain other events. Purchases will be made from time to time, depending on market conditions, in open market or privately negotiated transactions, at prices deemed appropriate by management. As of March&#160;31, 2025, 401,480 shares had been repurchased under the active program with an average price per share of $2.61, for a total of $1.0 million. 767,335 shares have been purchased under expired and active programs with an average price per share of $2.65, for a total of $2.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s stockholders approved an amendment and restatement of the 2011 Equity Incentive Plan at the Company&#x2019;s 2024 Annual Meeting of Stockholders held on December 12, 2024, to increase the number of plan shares by 700,000 shares, from 3,675,000 to 4,375,000 shares. As of March&#160;31, 2025, the Company had 1,269,384 remaining shares of common stock available for issuance pursuant to future grants under the 2011 Equity Incentive Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2011 Equity Incentive Plan, the Board determines the terms and conditions of each restricted stock issuance, including any future vesting restrictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2024, the Company issued a total of 125,863 shares of restricted common stock with a grant date fair value of $0.3 million for their annual service as independent directors of the Company. The stock was granted in installments on the last day of each quarter and vested immediately.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the three months ended March&#160;31, 2025, the Company issued its six independent directors a total of 42,858 shares of restricted common stock, respectively, with an aggregate grant date valuation of $90,002 for their service as directors of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table contains summarized information about restricted stock issued during the years ended December&#160;31, 2024 and March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.073%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Years&lt;br/&gt;to Vest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125,863)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although restricted stock is issued upon the grant of an award, the Company excludes restricted stock from the computations within the financial statements of total shares outstanding and basic earnings per share until such time as the restricted stock vests. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenses recognized on restricted stock issued to independent directors for services were $90,002 and $75,006 during the three months ended March&#160;31, 2025 and 2024, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;31, 2025, the fair value of the Company&#x2019;s common stock was approximately $2.10 per share, and the intrinsic value of the non-vested restricted stock was $0.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Board determines the terms and conditions of each restricted stock unit award issued under the 2011 Equity Incentive Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2024, the Company issued a total of 474,195 time-based restricted stock units, initially valued at $980,632, as additional compensation: 346,918 restricted stock units initially valued at $0.7 million to non-executive employees and 127,277 restricted stock units initially valued at $0.3 million to executives. These restricted stock units have vesting periods ranging from 36 to 48 months from issuance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2025, the Company issued a total of 47,280 time-based and performance-based restricted stock units, initially valued at $0.1 million, as additional compensation: 23,600 time-based restricted stock units, initially valued at $59,000, to non-executive employees and 23,680 time-based restricted stock units, initially valued at $59,200, to executives. These time-based restricted stock units have vesting periods ranging from 36 to 48 months from issuance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The performance based restricted stock units include a market condition tied to the Company&#x2019;s stock performance. These awards vest only if certain stock price targets are achieved over a specified performance period. Because the vesting is based on market conditions rather than service or financial performance metrics, the grant-date fair value was estimated using a Monte Carlo simulation model, which factors in stock volatility and other market-based assumptions. The expense is recognized over the requisite service period, regardless of whether the market condition is ultimately met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table contains summarized information about restricted stock units during the years ended December&#160;31, 2024, and the three months ended March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Years&lt;br/&gt;to Vest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(956,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenses recognized on restricted stock units issued to employees were $0.2 million and $0.3 million during the three months ended March&#160;31, 2025 and 2024, respectively. On March&#160;31, 2025, the fair value of the Company&#x2019;s common stock was approximately $2.10 per share, and the intrinsic value of the non-vested restricted units was $2.6 million. Future compensation related to the non-vested restricted stock units as of March&#160;31, 2025, is $2.5 million, and it is estimated to be recognized over the weighted-average vesting period of approximately 1.25 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2011 Equity Incentive Plan, the Board determines the exercise price to be paid for the stock option shares, the period within which each stock option may be exercised, and the terms and conditions of each stock option. The exercise price of incentive and non-qualified stock options may not be less than 100% of the fair market value per share of the Company&#x2019;s common stock on the grant date. If an individual owns stock representing more than 10% of the outstanding shares, the exercise price of each share of an incentive stock option must be equal to or exceed 110% of fair market value. Unless otherwise determined by the Board at the time of grant, the exercise price is set at the fair market value of the Company&#x2019;s common stock on the grant date (or the last trading day prior to the grant date, if it is awarded on a non-trading day). Additionally, the term is set at ten years, and the option typically vest on a straight-line basis over the requisite service period as follows: 25% one year from the date of grant with the remaining vesting monthly in equal increments over the following three years. The Company issues new shares for any stock awards or options exercised under its 2011 Equity Incentive Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2011 Equity Incentive Plan during the year ended December&#160;31, 2024, and the three months ended March&#160;31, 2025, is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2025 and the three months ended March 31, 2024, no options were exercised. The fair value of the Company's common stock on March&#160;31, 2025, was approximately $2.10 per share, and the intrinsic value on outstanding options as of March&#160;31, 2025, was $36. The intrinsic value of the exercisable options as of March&#160;31, 2025, was $36. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the nonvested stock option activity under the 2011 Equity Incentive Plan during the years ended December&#160;31, 2024, and March&#160;31, 2025, is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Nonvested Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Years&lt;br/&gt;to Vest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were outstanding options to purchase 31,147 shares&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;with a weighted average exercise price of $18.01 per share, of which options to purchase 30,736 shares were exercisable with a weighted average exercise price of $18.10 per share as of March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenses recognized on stock options issued to employees during the three months ended March&#160;31, 2025 and 2024 were $7,501 and $51,965, respectively. Future compensation related to non-vested awards as of March&#160;31, 2025, is $1,862, and it is estimated to be recognized over the weighted-average vesting period of approximately 3.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inducement Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 30, 2023, the Board of Directors adopted the IZEA Worldwide, Inc. 2023 Inducement Plan (the &#x201c;Inducement Plan&#x201d;) to accommodate equity grants to new employees hired by IZEA in connection with acquisition transactions, including the Hoozu acquisition. Under the Inducement Plan, IZEA may grant restricted stock units (&#x201c;RSUs&#x201d;), including performance-based and time-based RSUs, with respect to up to a total of 1,800,000 shares of IZEA common stock to new employees of IZEA or its subsidiaries. Pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules, the Inducement Plan was adopted without stockholder approval. In accordance with Rule 5635(c)(4) of the NASDAQ Listing Rules, awards under the Inducement Plan can only be made to individuals not previously employees or non-employee directors of IZEA (or following such individuals&#x2019; bona fide period of non-employment with IZEA), as an inducement material to the individuals&#x2019; entry into employment with IZEA or in connection with a merger or acquisition, to the extent permitted by Rule 5635(c)(3) of the NASDAQ Listing Rules. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table contains summarized information about inducement grant-related RSUs during the year ended December 31, 2024, and the three months ended March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.040%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Inducement Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Time-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328,354&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,354&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179,355)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(328,354)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(507,709)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant Outstanding at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inducement shares forfeited in 2024 were related to the divestiture of Hoozu in December, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amended and restated IZEA Worldwide, Inc. 2014 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) provides for the issuance of up to 125,000 shares of the Company&#x2019;s common stock to employees regularly employed by the Company for 90 days or more on a full-time or part-time basis (20 hours or more per week on a regular schedule). The ESPP operates in successive six-month periods commencing at the beginning of each fiscal year half. Each eligible employee who elects to participate may purchase up to 10% of their annual compensation in common stock, not to exceed $21,250 annually or 2,000 shares per offering period. The purchase price will be the lower of (i) 85% of the fair market value of a share of common stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the first day of the offering period or (ii) 85% of the fair market value of a share of common stock on the last day of the offering period. The ESPP will continue until January&#160;1, 2028, unless otherwise terminated by the Board. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The stock compensation expense on ESPP options was $10,789 and $1,010 for the three months ended March&#160;31, 2025, and 2024, respectively. As of March&#160;31, 2025, there were 77,931 remaining shares of common stock available for future issuance under the ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholder Rights Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 28, 2024, the Board of Directors declared a dividend of one preferred share purchase right (a &#x201c;Right&#x201d;) for each share of the Company&#x2019;s common stock as of June 7, 2024 (the &#x201c;Record Date&#x201d;), pursuant to a Rights Agreement between the Company and Broadridge Corporate Issuer Solutions, LLC, as Rights Agent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each Right initially entitles the holder to purchase one one-thousandth of a share of Series A Junior Participating Preferred Stock at a price of $8.25, subject to adjustment. The Rights are not exercisable until the earlier of (i) the tenth business day after a person or group acquires 15% or more of the Company&#x2019;s common stock, or (ii) the tenth business day after a tender or exchange offer is announced that would result in such ownership (the &#x201c;Distribution Date&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Distribution Date, the Rights trade with the common stock and are not evidenced by separate certificates. Following the Distribution Date, the Rights will separate and be evidenced by Right Certificates mailed to the stockholders of record.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Rights will expire on May 28, 2025, unless earlier redeemed, exchanged, or terminated under the terms of the Rights Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This summary is qualified in its entirety by reference to the full Rights Agreement, filed as Exhibit 4.1 to the Company&#x2019;s Current Report on Form 8-K, filed with the SEC on May 28, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary of Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The stock-based compensation cost related to all awards granted to employees is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the employee&#x2019;s requisite service period utilizing the weighted-average forfeiture rates as disclosed in &#x201c;Note 1 Company and Summary of Significant Accounting Policies.&#x201d; Total stock-based compensation expense recognized on restricted stock, restricted stock units, stock options, and employee stock purchase plan issuances during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#x2019;s consolidated statements of operations as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.347%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for the Sales and Marketing department due to the targeted workforce reduction that occurred in January 2025. This is due to the reversal of previously recognized expense for unvested awards that are forfeited upon termination. Because we recognize stock compensation on a straight-line basis over the vesting period&#x2014;rather than when the shares actually vest&#x2014;expenses related to unvested awards are recorded in advance of full service being rendered. When employees depart before completing their vesting schedules, any unrecognized expense is reversed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize activity in other comprehensive income (loss) for unrealized gains and losses on securities and foreign currency translation adjustments.&#160;The activity in&#160;accumulated other comprehensive income&#160;(loss) for the three months ended 2025, and 2024, respectively, was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.806%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation  Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassification of foreign currency translation adjustment to income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-514" unitRef="shares">50000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="0" id="f-515" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-516"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued contextRef="c-82" decimals="0" id="f-517" unitRef="shares">500000</us-gaap:PreferredStockSharesIssued>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-83" decimals="0" id="f-518" unitRef="shares">5000000</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-84" decimals="0" id="f-519" unitRef="shares">10</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-84" decimals="0" id="f-520" unitRef="shares">10</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased contextRef="c-85" decimals="0" id="f-521" unitRef="shares">9000000</us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-85" decimals="0" id="f-522" unitRef="shares">10</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-86"
      decimals="INF"
      id="f-523"
      unitRef="shares">401480</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-86"
      decimals="2"
      id="f-524"
      unitRef="usdPerShare">2.61</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-87" decimals="0" id="f-525" unitRef="shares">1000000.0</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="c-88"
      decimals="INF"
      id="f-526"
      unitRef="shares">767335</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="c-88"
      decimals="2"
      id="f-527"
      unitRef="usdPerShare">2.65</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased contextRef="c-89" decimals="0" id="f-528" unitRef="shares">2000000</srt:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased>
    <izea:CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease
      contextRef="c-90"
      decimals="INF"
      id="f-529"
      unitRef="shares">700000</izea:CommonStockCapitalSharesReservedForFutureIssuancePeriodIncreaseDecrease>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-91"
      decimals="INF"
      id="f-530"
      unitRef="shares">3675000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-92"
      decimals="INF"
      id="f-531"
      unitRef="shares">4375000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-93"
      decimals="INF"
      id="f-532"
      unitRef="shares">1269384</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-94"
      decimals="INF"
      id="f-533"
      unitRef="shares">125863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-94" decimals="-5" id="f-534" unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <izea:Numberofindependentdirectors
      contextRef="c-1"
      decimals="INF"
      id="f-535"
      unitRef="director">6</izea:Numberofindependentdirectors>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-95"
      decimals="INF"
      id="f-536"
      unitRef="shares">42858</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-95" decimals="0" id="f-537" unitRef="usd">90002</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-538">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table contains summarized information about restricted stock issued during the years ended December&#160;31, 2024 and March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.073%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.175%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.177%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Years&lt;br/&gt;to Vest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(125,863)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,858)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-96"
      decimals="INF"
      id="f-539"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-96"
      decimals="2"
      id="f-540"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-97"
      decimals="INF"
      id="f-541"
      unitRef="shares">125863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-97"
      decimals="2"
      id="f-542"
      unitRef="usdPerShare">2.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-97"
      decimals="INF"
      id="f-543"
      unitRef="shares">125863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-97"
      decimals="2"
      id="f-544"
      unitRef="usdPerShare">2.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-98"
      decimals="INF"
      id="f-545"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-98"
      decimals="2"
      id="f-546"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-99"
      decimals="INF"
      id="f-547"
      unitRef="shares">42858</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-99"
      decimals="2"
      id="f-548"
      unitRef="usdPerShare">2.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-99"
      decimals="INF"
      id="f-549"
      unitRef="shares">42858</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-99"
      decimals="2"
      id="f-550"
      unitRef="usdPerShare">2.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-100"
      decimals="INF"
      id="f-551"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-100"
      decimals="2"
      id="f-552"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:RestrictedStockExpense contextRef="c-95" decimals="0" id="f-553" unitRef="usd">90002</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense contextRef="c-101" decimals="0" id="f-554" unitRef="usd">75006</us-gaap:RestrictedStockExpense>
    <izea:CommonStockFairValue
      contextRef="c-100"
      decimals="2"
      id="f-555"
      unitRef="usdPerShare">2.10</izea:CommonStockFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="c-100" decimals="0" id="f-556" unitRef="usd">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-102"
      decimals="INF"
      id="f-557"
      unitRef="shares">474195</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-102" decimals="0" id="f-558" unitRef="usd">980632</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-103"
      decimals="INF"
      id="f-559"
      unitRef="shares">346918</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-103" decimals="0" id="f-560" unitRef="usd">700000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-104"
      decimals="INF"
      id="f-561"
      unitRef="shares">127277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-104" decimals="0" id="f-562" unitRef="usd">300000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-105" id="f-563">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-106" id="f-564">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-107"
      decimals="INF"
      id="f-565"
      unitRef="shares">47280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-107" decimals="0" id="f-566" unitRef="usd">100000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-108"
      decimals="INF"
      id="f-567"
      unitRef="shares">23600</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-108" decimals="0" id="f-568" unitRef="usd">59000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-109"
      decimals="INF"
      id="f-569"
      unitRef="shares">23680</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="c-109" decimals="0" id="f-570" unitRef="usd">59200</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-110" id="f-571">P36M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-111" id="f-572">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-573">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table contains summarized information about restricted stock units during the years ended December&#160;31, 2024, and the three months ended March&#160;31, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:51.092%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Years&lt;br/&gt;to Vest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(956,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(305,821)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-112"
      decimals="INF"
      id="f-574"
      unitRef="shares">962849</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-112"
      decimals="2"
      id="f-575"
      unitRef="usdPerShare">2.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-113" id="f-576">P2Y6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-114"
      decimals="INF"
      id="f-577"
      unitRef="shares">1858023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-114"
      decimals="2"
      id="f-578"
      unitRef="usdPerShare">2.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-114"
      decimals="INF"
      id="f-579"
      unitRef="shares">956679</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-114"
      decimals="2"
      id="f-580"
      unitRef="usdPerShare">2.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-114"
      decimals="INF"
      id="f-581"
      unitRef="shares">305821</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-114"
      decimals="2"
      id="f-582"
      unitRef="usdPerShare">2.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-115"
      decimals="INF"
      id="f-583"
      unitRef="shares">1558372</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-115"
      decimals="2"
      id="f-584"
      unitRef="usdPerShare">2.33</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-114" id="f-585">P2Y7M6D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-107"
      decimals="INF"
      id="f-586"
      unitRef="shares">47280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-107"
      decimals="2"
      id="f-587"
      unitRef="usdPerShare">2.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-107"
      decimals="INF"
      id="f-588"
      unitRef="shares">167516</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-107"
      decimals="2"
      id="f-589"
      unitRef="usdPerShare">2.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-107"
      decimals="INF"
      id="f-590"
      unitRef="shares">188958</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-107"
      decimals="2"
      id="f-591"
      unitRef="usdPerShare">2.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-116"
      decimals="INF"
      id="f-592"
      unitRef="shares">1249178</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-116"
      decimals="2"
      id="f-593"
      unitRef="usdPerShare">2.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms contextRef="c-107" id="f-594">P1Y3M18D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:RestrictedStockExpense contextRef="c-117" decimals="-5" id="f-595" unitRef="usd">200000</us-gaap:RestrictedStockExpense>
    <us-gaap:RestrictedStockExpense contextRef="c-118" decimals="0" id="f-596" unitRef="usd">300000</us-gaap:RestrictedStockExpense>
    <izea:CommonStockFairValue
      contextRef="c-116"
      decimals="2"
      id="f-597"
      unitRef="usdPerShare">2.10</izea:CommonStockFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="c-116" decimals="INF" id="f-598" unitRef="usd">2600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <izea:Fairvalueofcommonstockissuedforfutureservices contextRef="c-107" decimals="0" id="f-599" unitRef="usd">2500000</izea:Fairvalueofcommonstockissuedforfutureservices>
    <izea:FairMarketValueOfIncentiveStockOptions
      contextRef="c-119"
      decimals="INF"
      id="f-600"
      unitRef="number">1</izea:FairMarketValueOfIncentiveStockOptions>
    <izea:Percentageofindividualownershipofcommonstock contextRef="c-1" decimals="INF" id="f-601" unitRef="number">0.10</izea:Percentageofindividualownershipofcommonstock>
    <izea:FairMarketValueOfIncentiveStockOptions
      contextRef="c-120"
      decimals="INF"
      id="f-602"
      unitRef="number">1.10</izea:FairMarketValueOfIncentiveStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-121" id="f-603">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <izea:Percentageofindividualownershipofcommonstock
      contextRef="c-122"
      decimals="INF"
      id="f-604"
      unitRef="number">0.25</izea:Percentageofindividualownershipofcommonstock>
    <izea:StockOptionVestingPeriodFromGrantDate contextRef="c-122" id="f-605">P1Y</izea:StockOptionVestingPeriodFromGrantDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-123" id="f-606">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-607">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of option activity under the 2011 Equity Incentive Plan during the year ended December&#160;31, 2024, and the three months ended March&#160;31, 2025, is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-124" decimals="0" id="f-608" unitRef="shares">343601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-124"
      decimals="2"
      id="f-609"
      unitRef="usdPerShare">9.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-125" id="f-610">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-126" decimals="0" id="f-611" unitRef="shares">65154</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-126"
      decimals="2"
      id="f-612"
      unitRef="usdPerShare">1.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="c-126" decimals="0" id="f-613" unitRef="shares">244588</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-126"
      decimals="2"
      id="f-614"
      unitRef="usdPerShare">10.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-126" decimals="0" id="f-615" unitRef="shares">520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-126"
      decimals="2"
      id="f-616"
      unitRef="usdPerShare">9.24</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-127" decimals="0" id="f-617" unitRef="shares">33339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-127"
      decimals="2"
      id="f-618"
      unitRef="usdPerShare">18.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-126" id="f-619">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="c-128" decimals="0" id="f-620" unitRef="shares">2187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-128"
      decimals="2"
      id="f-621"
      unitRef="usdPerShare">27.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-128" decimals="0" id="f-622" unitRef="shares">5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-128"
      decimals="2"
      id="f-623"
      unitRef="usdPerShare">15.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-129" decimals="0" id="f-624" unitRef="shares">31147</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-129"
      decimals="2"
      id="f-625"
      unitRef="usdPerShare">18.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-128" id="f-626">P3Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c-129" decimals="0" id="f-627" unitRef="shares">30736</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-129"
      decimals="2"
      id="f-628"
      unitRef="usdPerShare">18.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-128" id="f-629">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-130" decimals="0" id="f-630" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-128" decimals="0" id="f-631" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <izea:CommonStockFairValue
      contextRef="c-116"
      decimals="2"
      id="f-632"
      unitRef="usdPerShare">2.10</izea:CommonStockFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-3" decimals="0" id="f-633" unitRef="usd">36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-3" decimals="0" id="f-634" unitRef="usd">36</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock contextRef="c-1" id="f-635">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the nonvested stock option activity under the 2011 Equity Incentive Plan during the years ended December&#160;31, 2024, and March&#160;31, 2025, is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.835%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.840%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Nonvested Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Years&lt;br/&gt;to Vest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,728)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedShareActivityTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c-124"
      decimals="INF"
      id="f-636"
      unitRef="shares">26373</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-124"
      decimals="2"
      id="f-637"
      unitRef="usdPerShare">8.83</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm contextRef="c-125" id="f-638">P1Y1M6D</izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="c-126"
      decimals="INF"
      id="f-639"
      unitRef="shares">24728</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-126"
      decimals="2"
      id="f-640"
      unitRef="usdPerShare">18.60</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="c-126"
      decimals="INF"
      id="f-641"
      unitRef="shares">520</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="c-126"
      decimals="2"
      id="f-642"
      unitRef="usdPerShare">9.24</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c-127"
      decimals="INF"
      id="f-643"
      unitRef="shares">1125</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-127"
      decimals="2"
      id="f-644"
      unitRef="usdPerShare">18.60</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm contextRef="c-126" id="f-645">P3Y8M12D</izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="c-128"
      decimals="INF"
      id="f-646"
      unitRef="shares">709</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-128"
      decimals="2"
      id="f-647"
      unitRef="usdPerShare">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="c-128"
      decimals="INF"
      id="f-648"
      unitRef="shares">5</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
      contextRef="c-128"
      decimals="2"
      id="f-649"
      unitRef="usdPerShare">9.24</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c-129"
      decimals="INF"
      id="f-650"
      unitRef="shares">411</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-129"
      decimals="2"
      id="f-651"
      unitRef="usdPerShare">18.01</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue>
    <izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm contextRef="c-128" id="f-652">P3Y9M18D</izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-129" decimals="0" id="f-653" unitRef="shares">31147</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-129"
      decimals="2"
      id="f-654"
      unitRef="usdPerShare">18.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber contextRef="c-129" decimals="0" id="f-655" unitRef="shares">30736</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-129"
      decimals="2"
      id="f-656"
      unitRef="usdPerShare">18.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:StockOptionPlanExpense contextRef="c-1" decimals="0" id="f-657" unitRef="usd">7501</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="c-5" decimals="0" id="f-658" unitRef="usd">51965</us-gaap:StockOptionPlanExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-129" decimals="0" id="f-659" unitRef="usd">1862</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm contextRef="c-126" id="f-660">P3Y8M12D</izea:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestNonvestedWeightedAverageRemainingContractualTerm>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized contextRef="c-131" decimals="0" id="f-661" unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock contextRef="c-1" id="f-662">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table contains summarized information about inducement grant-related RSUs during the year ended December 31, 2024, and the three months ended March&#160;31, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.040%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.522%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"&gt;Inducement Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Time-Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Performance Based&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant Outstanding at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328,354&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,354&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,355&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,355&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179,355)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(328,354)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(507,709)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Grant Outstanding at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardOutstandingActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-132" decimals="0" id="f-663" unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-133" decimals="0" id="f-664" unitRef="shares">328354</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-134" decimals="0" id="f-665" unitRef="shares">338354</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-135"
      decimals="INF"
      id="f-666"
      unitRef="shares">219355</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-136"
      decimals="INF"
      id="f-667"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-137"
      decimals="INF"
      id="f-668"
      unitRef="shares">219355</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-135"
      decimals="INF"
      id="f-669"
      unitRef="shares">179355</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-136"
      decimals="INF"
      id="f-670"
      unitRef="shares">328354</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-137"
      decimals="INF"
      id="f-671"
      unitRef="shares">507709</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-138" decimals="0" id="f-672" unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-139" decimals="0" id="f-673" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-140" decimals="0" id="f-674" unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-141" decimals="0" id="f-675" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-142" decimals="0" id="f-676" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-143" decimals="0" id="f-677" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-141" decimals="0" id="f-678" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-142" decimals="0" id="f-679" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-143" decimals="0" id="f-680" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-144" decimals="0" id="f-681" unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-145" decimals="0" id="f-682" unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-146" decimals="0" id="f-683" unitRef="shares">50000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-147" decimals="0" id="f-684" unitRef="shares">125000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-148" id="f-685">P90D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <izea:MinimumhourrequirementforemployeesparticipationintheESSP contextRef="c-148" decimals="INF" id="f-686" unitRef="h">20</izea:MinimumhourrequirementforemployeesparticipationintheESSP>
    <izea:Annualcompensationlimitpercentageemployeestockpurchaseplan contextRef="c-148" decimals="2" id="f-687" unitRef="number">0.10</izea:Annualcompensationlimitpercentageemployeestockpurchaseplan>
    <izea:Annualcompensationlimitemployeestockpurchaseplan contextRef="c-148" decimals="0" id="f-688" unitRef="usd">21250</izea:Annualcompensationlimitemployeestockpurchaseplan>
    <izea:Sharesissuancelimitperofferingperiodemployeestockpurchaseplan contextRef="c-148" decimals="0" id="f-689" unitRef="shares">2000</izea:Sharesissuancelimitperofferingperiodemployeestockpurchaseplan>
    <izea:Fairmarketvalueofsharesavailableforissuance contextRef="c-148" decimals="2" id="f-690" unitRef="number">0.85</izea:Fairmarketvalueofsharesavailableforissuance>
    <izea:Fairmarketvalueofsharesavailableforissuance contextRef="c-148" decimals="2" id="f-691" unitRef="number">0.85</izea:Fairmarketvalueofsharesavailableforissuance>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-148" decimals="0" id="f-692" unitRef="usd">10789</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-149" decimals="0" id="f-693" unitRef="usd">1010</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP contextRef="c-3" decimals="0" id="f-694" unitRef="shares">77931</us-gaap:EmployeeStockOwnershipPlanESOPSharesInESOP>
    <us-gaap:PreferredStockDividendRatePerDollarAmount
      contextRef="c-150"
      decimals="2"
      id="f-695"
      unitRef="usdPerShare">8.25</us-gaap:PreferredStockDividendRatePerDollarAmount>
    <izea:ExercisableShareholderRightsPercentageHeld.
      contextRef="c-150"
      decimals="INF"
      id="f-696"
      unitRef="number">0.15</izea:ExercisableShareholderRightsPercentageHeld.>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-697">Total stock-based compensation expense recognized on restricted stock, restricted stock units, stock options, and employee stock purchase plan issuances during the three months ended March&#160;31, 2025 and 2024 was recorded in the Company&#x2019;s consolidated statements of operations as follows: &lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.347%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:9pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense for the Sales and Marketing department due to the targeted workforce reduction that occurred in January 2025. This is due to the reversal of previously recognized expense for unvested awards that are forfeited upon termination. Because we recognize stock compensation on a straight-line basis over the vesting period&#x2014;rather than when the shares actually vest&#x2014;expenses related to unvested awards are recorded in advance of full service being rendered. When employees depart before completing their vesting schedules, any unrecognized expense is reversed.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-78" decimals="0" id="f-698" unitRef="usd">62449</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-79" decimals="0" id="f-699" unitRef="usd">51571</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-47" decimals="0" id="f-700" unitRef="usd">-10270</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-48" decimals="0" id="f-701" unitRef="usd">56488</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-80" decimals="0" id="f-702" unitRef="usd">232953</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-81" decimals="0" id="f-703" unitRef="usd">246130</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="0" id="f-704" unitRef="usd">285132</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="0" id="f-705" unitRef="usd">354189</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-706">The activity in&#160;accumulated other comprehensive income&#160;(loss) for the three months ended 2025, and 2024, respectively, was as follows:&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.806%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.987%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation  Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassification of foreign currency translation adjustment to income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Gain (Loss) on Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Currency Translation Adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Accumulated Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(250,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,903)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123,362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,694)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,075)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c-151" decimals="0" id="f-707" unitRef="usd">12209</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-152" decimals="0" id="f-708" unitRef="usd">127296</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-153" decimals="0" id="f-709" unitRef="usd">-34218</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-28" decimals="0" id="f-710" unitRef="usd">105287</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-154" decimals="0" id="f-711" unitRef="usd">-250591</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-155" decimals="0" id="f-712" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="0" id="f-713" unitRef="usd">-250591</us-gaap:StockholdersEquity>
    <izea:UnrealizedGainOnSecuritiesHeld contextRef="c-32" decimals="0" id="f-714" unitRef="usd">-13903</izea:UnrealizedGainOnSecuritiesHeld>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease contextRef="c-32" decimals="0" id="f-715" unitRef="usd">-109459</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent contextRef="c-1" decimals="0" id="f-716" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-32" decimals="0" id="f-717" unitRef="usd">-123362</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <izea:UnrealizedGainOnSecuritiesHeld contextRef="c-16" decimals="0" id="f-718" unitRef="usd">58177</izea:UnrealizedGainOnSecuritiesHeld>
    <us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease contextRef="c-16" decimals="0" id="f-719" unitRef="usd">4170</us-gaap:TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax contextRef="c-16" decimals="0" id="f-720" unitRef="usd">62347</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:StockholdersEquity contextRef="c-156" decimals="0" id="f-721" unitRef="usd">-1694</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-157" decimals="0" id="f-722" unitRef="usd">17837</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-158" decimals="0" id="f-723" unitRef="usd">-34218</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="0" id="f-724" unitRef="usd">-18075</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-159" decimals="0" id="f-725" unitRef="usd">-192414</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-160" decimals="0" id="f-726" unitRef="usd">4170</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="0" id="f-727" unitRef="usd">-188244</us-gaap:StockholdersEquity>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-728">LOSS PER COMMON SHARE&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings (loss) per common share is computed by dividing the net income or loss by the basic weighted average number of shares of common stock outstanding during each period presented. Although restricted stock is issued upon the grant of an award, the Company excludes restricted stock from the computations of the weighted average number of shares of common stock outstanding until the stock vests. Diluted loss per share is computed by dividing the net income or loss by the sum of the total of the basic weighted-average number of shares of common stock outstanding plus the additional dilutive securities that could be exercised or converted into common shares during each period presented less the amount of shares that could be repurchased using the proceeds from the exercises.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.219%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.574%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,927,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,333,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following weighted average items from the above computation of diluted loss per common share, as their effect would be anti-dilutive: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,374,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total excluded shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,280,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-729">&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.219%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.574%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.539%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,927,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,333,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="0" id="f-730" unitRef="usd">-142800</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="0" id="f-731" unitRef="usd">-3265850</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-732" unitRef="shares">16927166</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-733" unitRef="shares">16927166</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-734" unitRef="shares">16333415</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-735" unitRef="shares">16333415</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-736"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-737"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-738"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-739"
      unitRef="usdPerShare">-0.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-740">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following weighted average items from the above computation of diluted loss per common share, as their effect would be anti-dilutive: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.387%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,249,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,374,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total excluded shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,280,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-161" decimals="0" id="f-741" unitRef="shares">31147</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-162" decimals="0" id="f-742" unitRef="shares">343244</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-163" decimals="0" id="f-743" unitRef="shares">1249178</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-164" decimals="0" id="f-744" unitRef="shares">1374283</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-745" unitRef="shares">1280325</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-5" decimals="0" id="f-746" unitRef="shares">1717527</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-747">REVENUE&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the Company&#x2019;s revenue by product service type:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.636%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed Services Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,907,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,696,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS Services Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,968,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,952,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Managed Services revenue is comprised of two types of revenue, Sponsored Social and Content. Sponsored Social revenue, which totaled $6.8 million for the three months ended March&#160;31, 2025 and $5.9 million for the three months ended March&#160;31, 2024, is recognized over time. Content revenue, which totaled $1.1&#160;million during the three months ended March&#160;31, 2025, and $0.8 million for the three months ended March&#160;31, 2024, is recognized at a point in time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SaaS Revenue is comprised of three types of revenue, License Fees, Marketplace Spend Fees, and Other Fees. License Fees revenue, which totaled $28.7&#160;thousand for the three months ended March&#160;31, 2025 and $217.0 thousand for the three months ended March&#160;31, 2024, is recognized over time. Marketplace Spend Fees revenue totaled $1.3 thousand for the three months ended March&#160;31, 2025 and $13.1 thousand for the three months ended March&#160;31, 2024, recognized over time. Other &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fees revenue totaled $31.0 thousand during the three months ended March&#160;31, 2025 and $26.2 thousand for the three months ended March&#160;31, 2024, recognized at a point in time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the Company&#x2019;s revenues as determined by customer geographic region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.636%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,628,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,490,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,968,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,952,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information about receivables, contract assets, and contract liabilities from contracts with customers reported in the Company&#x2019;s consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Billed Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,835,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,095,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,188,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not typically engage in contracts longer than one year. Therefore, the Company will recognize substantially all of the contract liabilities recorded at the end of the year in the following year. The contract liability balance as of December&#160;31, 2024, was $8.2 million. Of that balance, $5.1 million was recognized as revenue during the three months ended March&#160;31, 2025. The contract liability balance as of March&#160;31, 2025, was $7.1 million. The Company expects to recognize the associated revenue during the next twelve months. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract receivables are recognized when the receipt of consideration is unconditional. Contract liabilities relate to the consideration received from customers in advance of the Company satisfying performance obligations under the terms of the contracts, which will be earned in future periods. Contract liabilities increase as a result of receiving new advance payments from customers and decrease as revenue is recognized upon the Company meeting the performance obligations. As a practical expedient, the Company expenses the costs of sales commissions that are paid to its sales force associated with obtaining contracts that are less than one year in length in the period incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to most of the Company&#x2019;s contracts being one year or less in length. As such, the remaining performance obligations at March&#160;31, 2025 and December&#160;31, 2024, are equal to the contract liabilities disclosed above. The Company expects to recognize the full balance of the unearned revenue from March&#160;31, 2025 within the subsequent twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-748">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table illustrates the Company&#x2019;s revenue by product service type:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.636%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed Services Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,907,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,696,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SaaS Services Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,968,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,952,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the Company&#x2019;s revenues as determined by customer geographic region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.636%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from North America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,628,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,490,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from APAC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,027,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,968,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,952,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-165" decimals="0" id="f-749" unitRef="usd">7907410</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-166" decimals="0" id="f-750" unitRef="usd">6696542</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-167" decimals="0" id="f-751" unitRef="usd">60953</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-168" decimals="0" id="f-752" unitRef="usd">256341</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="0" id="f-753" unitRef="usd">7968363</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="0" id="f-754" unitRef="usd">6952883</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-169" decimals="0" id="f-755" unitRef="usd">6800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-170" decimals="0" id="f-756" unitRef="usd">5900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-171" decimals="0" id="f-757" unitRef="usd">1100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-172" decimals="0" id="f-758" unitRef="usd">800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-173" decimals="0" id="f-759" unitRef="usd">28700</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-174" decimals="0" id="f-760" unitRef="usd">217000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-175" decimals="0" id="f-761" unitRef="usd">1300</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-176" decimals="0" id="f-762" unitRef="usd">13100</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-177" decimals="-1" id="f-763" unitRef="usd">31000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-178" decimals="0" id="f-764" unitRef="usd">26200</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-179" decimals="0" id="f-765" unitRef="usd">7628344</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-180" decimals="0" id="f-766" unitRef="usd">5490415</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-181" decimals="0" id="f-767" unitRef="usd">237827</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-182" decimals="0" id="f-768" unitRef="usd">1027859</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-183" decimals="0" id="f-769" unitRef="usd">102192</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-184" decimals="0" id="f-770" unitRef="usd">434609</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="0" id="f-771" unitRef="usd">7968363</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="0" id="f-772" unitRef="usd">6952883</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock contextRef="c-1" id="f-773">&lt;div style="margin-top:5pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information about receivables, contract assets, and contract liabilities from contracts with customers reported in the Company&#x2019;s consolidated balance sheet:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Billed Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,400,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,835,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unbilled Contract Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(192,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,095,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,188,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerAssetGross contextRef="c-3" decimals="0" id="f-774" unitRef="usd">4400418</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:ContractWithCustomerAssetGross contextRef="c-4" decimals="0" id="f-775" unitRef="usd">7835041</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:UnbilledContractsReceivable contextRef="c-3" decimals="0" id="f-776" unitRef="usd">61481</us-gaap:UnbilledContractsReceivable>
    <us-gaap:UnbilledContractsReceivable contextRef="c-4" decimals="0" id="f-777" unitRef="usd">151783</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss contextRef="c-3" decimals="0" id="f-778" unitRef="usd">192785</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss contextRef="c-4" decimals="0" id="f-779" unitRef="usd">205000</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerLiability contextRef="c-3" decimals="0" id="f-780" unitRef="usd">7095245</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="0" id="f-781" unitRef="usd">8188651</us-gaap:ContractWithCustomerLiability>
    <izea:LengthOfContractWithCustomers contextRef="c-1" id="f-782">P1Y</izea:LengthOfContractWithCustomers>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-5" id="f-783" unitRef="usd">8200000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-1" decimals="0" id="f-784" unitRef="usd">5100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiability contextRef="c-3" decimals="-5" id="f-785" unitRef="usd">7100000</us-gaap:ContractWithCustomerLiability>
    <izea:ContractLengthForSalesCommissionsPayment contextRef="c-1" decimals="0" id="f-786" unitRef="number">1</izea:ContractLengthForSalesCommissionsPayment>
    <izea:PerformanceObligationContractTerm contextRef="c-1" id="f-787">P1Y</izea:PerformanceObligationContractTerm>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-788">SEGMENT DISCLOSURES&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing (the &#x201c;Managed Services&#x201d;). Our Chief Operating Decision Maker (&#x201c;CODM&#x201d;) is our Chief Executive Officer (&#x201c;CEO&#x201d;). We evaluate our financial performance based on the results of one reportable operating segment, as defined by ASC 280.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CODM monitors revenue growth and profitability trends to assess market demand, pricing strategies, new customer growth, current customer retention and expansion, and growth by market vertical. Personnel cost trends are studied to assess efficiency, efficacy of incentive programs, and to determine the need for headcount adjustments. Cash operating cost trends inform how non-payroll costs are impacting cash resources. Taken together, net income is the ultimate measure of performance, or investment in growth. Resource allocation decisions include funding new technologies, additional headcount to drive and manage growth, informing cost management strategies and evaluating financing needs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table depicts reportable segment results reviewed by the CODM:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.363%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,968,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,952,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue-direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,337,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,753,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Human capital costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,943,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other cash operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,757,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(490,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(671,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred federal tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following descriptions provide additional details regarding certain components represented in the accompanying table, including cost of revenue, human capital costs, and cash operating costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue includes the direct costs associated with providing our services to customers. These costs primarily consist of influencer fees and other costs directly tied to the fulfillment of customer contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Human capital costs represent expenses related to our employees, including salaries, wages, bonuses, commissions, payroll taxes, and employee benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other cash operating expenses refer to the recurring operating costs of running the business, excluding non-cash items such as depreciation, amortization, and stock-based compensation. These expenses include professional services, software subscriptions, travel, and other general business costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income includes interest expense, net realized gains (losses) on the sale of securities and cryptocurrency, as well as realized gains (losses) on foreign exchange transactions.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-789"
      unitRef="reportable_operating_segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock contextRef="c-1" id="f-790">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table depicts reportable segment results reviewed by the CODM:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.363%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.375%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.376%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,968,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,952,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue-direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,337,826&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,753,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Human capital costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,943,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other cash operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,757,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(490,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(671,517)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred federal tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,782)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment Net Loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,265,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="0" id="f-791" unitRef="usd">7968363</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="0" id="f-792" unitRef="usd">6952883</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <izea:CostOfRevenueDirect contextRef="c-6" decimals="0" id="f-793" unitRef="usd">3337826</izea:CostOfRevenueDirect>
    <izea:CostOfRevenueDirect contextRef="c-7" decimals="0" id="f-794" unitRef="usd">2753852</izea:CostOfRevenueDirect>
    <izea:HumanCapitalCosts contextRef="c-6" decimals="0" id="f-795" unitRef="usd">3440502</izea:HumanCapitalCosts>
    <izea:HumanCapitalCosts contextRef="c-7" decimals="0" id="f-796" unitRef="usd">4943804</izea:HumanCapitalCosts>
    <izea:CashOperatingCosts contextRef="c-6" decimals="0" id="f-797" unitRef="usd">1400404</izea:CashOperatingCosts>
    <izea:CashOperatingCosts contextRef="c-7" decimals="0" id="f-798" unitRef="usd">2757159</izea:CashOperatingCosts>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-6" decimals="0" id="f-799" unitRef="usd">160352</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="0" id="f-800" unitRef="usd">204186</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-6" decimals="0" id="f-801" unitRef="usd">285132</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:EmployeeBenefitsAndShareBasedCompensation contextRef="c-7" decimals="0" id="f-802" unitRef="usd">354189</us-gaap:EmployeeBenefitsAndShareBasedCompensation>
    <us-gaap:InterestIncomeOperatingAndNonoperating contextRef="c-6" decimals="0" id="f-803" unitRef="usd">-490908</us-gaap:InterestIncomeOperatingAndNonoperating>
    <us-gaap:InterestIncomeOperatingAndNonoperating contextRef="c-7" decimals="0" id="f-804" unitRef="usd">-671517</us-gaap:InterestIncomeOperatingAndNonoperating>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-6" decimals="0" id="f-805" unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-7" decimals="0" id="f-806" unitRef="usd">-18782</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:OtherIncome contextRef="c-6" decimals="0" id="f-807" unitRef="usd">-22145</us-gaap:OtherIncome>
    <us-gaap:OtherIncome contextRef="c-7" decimals="0" id="f-808" unitRef="usd">-104158</us-gaap:OtherIncome>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-6" decimals="0" id="f-809" unitRef="usd">-142800</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-7" decimals="0" id="f-810" unitRef="usd">-3265850</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-811">INCOME TAX&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes for interim periods is determined using an estimated annual effective tax rate in accordance with ASC 740-270, Income Taxes, Interim Reporting. The effective tax rate may be subject to fluctuations during the year as new information is obtained, which may affect the assumptions used to estimate the annual effective tax rate, including factors such as valuation allowances against deferred tax assets, the recognition or de-recognition of tax benefits related to uncertain tax position, if any, and changes in or the interpretation of tax laws in jurisdictions where the Company conducts business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income tax expense and effective tax rate were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-812">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s income tax expense and effective tax rate were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.345%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit (expense)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="0" id="f-813" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="0" id="f-814" unitRef="usd">-18782</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-815" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-816" unitRef="number">0.006</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-817">SUBSEQUENT EVENTS&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company has completed an evaluation of all subsequent events through May&#160;13, 2025, to ensure that these consolidated financial statements include appropriate disclosure of events both recognized in the consolidated financial statements and events that occurred but were not recognized in the consolidated financial statements. The Company has concluded that no subsequent event has occurred that requires disclosure.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-7" decimals="0" id="f-818" unitRef="usd">-18782</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#f-385"
          xlink:label="f-385"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-373"
          xlink:label="f-373"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-397"
          xlink:label="f-397"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-379"
          xlink:label="f-379"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-391"
          xlink:label="f-391"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-367"
          xlink:label="f-367"
          xlink:type="locator"/>
        <link:footnote id="fn-1" xlink:label="fn-1" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Current Marketable Securities have a holding period under <xhtml:span style="-sec-ix-hidden:f-398">one</xhtml:span> year</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-385"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-373"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-397"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-379"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-391"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-367"
          xlink:to="fn-1"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-358"
          xlink:label="f-358"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-369"
          xlink:label="f-369"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-368"
          xlink:label="f-368"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-359"
          xlink:label="f-359"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-357"
          xlink:label="f-357"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-360"
          xlink:label="f-360"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-364"
          xlink:label="f-364"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-372"
          xlink:label="f-372"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-362"
          xlink:label="f-362"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-361"
          xlink:label="f-361"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-365"
          xlink:label="f-365"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-352"
          xlink:label="f-352"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-353"
          xlink:label="f-353"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-366"
          xlink:label="f-366"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-370"
          xlink:label="f-370"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-356"
          xlink:label="f-356"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-355"
          xlink:label="f-355"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-354"
          xlink:label="f-354"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-371"
          xlink:label="f-371"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-363"
          xlink:label="f-363"
          xlink:type="locator"/>
        <link:footnote id="fn-2" xlink:label="fn-2" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 1 fair value estimates are based on quoted prices in active markets for identical assets and liabilities.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-358"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-373"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-369"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-368"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-359"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-357"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-360"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-364"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-372"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-362"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-361"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-365"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-367"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-352"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-353"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-366"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-370"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-356"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-355"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-354"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-371"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-363"
          xlink:to="fn-2"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-389"
          xlink:label="f-389"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-390"
          xlink:label="f-390"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-384"
          xlink:label="f-384"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-383"
          xlink:label="f-383"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-378"
          xlink:label="f-378"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-380"
          xlink:label="f-380"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-375"
          xlink:label="f-375"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-376"
          xlink:label="f-376"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-387"
          xlink:label="f-387"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-382"
          xlink:label="f-382"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-377"
          xlink:label="f-377"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-388"
          xlink:label="f-388"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-374"
          xlink:label="f-374"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-386"
          xlink:label="f-386"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-381"
          xlink:label="f-381"
          xlink:type="locator"/>
        <link:footnote id="fn-3" xlink:label="fn-3" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;padding-left:7.44pt;position:relative;top:-3.15pt;vertical-align:baseline"> </xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets and liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets and liabilities.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-389"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-390"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-384"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-385"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-383"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-378"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-380"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-375"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-376"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-379"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-387"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-382"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-377"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-391"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-388"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-374"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-386"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-381"
          xlink:to="fn-3"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-671"
          xlink:label="f-671"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-669"
          xlink:label="f-669"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-670"
          xlink:label="f-670"
          xlink:type="locator"/>
        <link:footnote id="fn-4" xlink:label="fn-4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"> Inducement shares forfeited in 2024 were related to the divestiture of Hoozu in December, 2024</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-671"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-669"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-670"
          xlink:to="fn-4"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#f-701"
          xlink:label="f-701"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#f-700"
          xlink:label="f-700"
          xlink:type="locator"/>
        <link:footnote id="fn-5" xlink:label="fn-5" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense for the Sales and Marketing department due to the targeted workforce reduction that occurred in January 2025. This is due to the reversal of previously recognized expense for unvested awards that are forfeited upon termination. Because we recognize stock compensation on a straight-line basis over the vesting period&#x2014;rather than when the shares actually vest&#x2014;expenses related to unvested awards are recorded in advance of full service being rendered. When employees depart before completing their vesting schedules, any unrecognized expense is reversed</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-701"
          xlink:to="fn-5"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="f-700"
          xlink:to="fn-5"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
